S	341
T	165
MEK	0	3	NN	mek	B-GENE	_	_
inhibition	4	14	NN	inhibition	O	_	_
leads	15	20	VBZ	lead	O	_	_
to	21	23	TO	to	O	_	_
PI3K	24	28	NN	pi3k	B-GENE	_	_
/	28	29	:	/	B-GENE	_	_
AKT	29	32	NN	akt	I-GENE	_	_
activation	33	43	NN	activation	O	_	_
by	44	46	IN	by	O	_	_
relieving	47	56	VBG	relieve	O	_	_
a	57	58	DT	a	O	_	_
negative	59	67	JJ	negative	O	_	_
feedback	68	76	NN	feedback	O	_	_
on	77	79	IN	on	O	_	_
ERBB	80	84	NN	erbb	O	_	_
receptors	85	94	NNS	receptor	O	_	_
Alexa	95	100	NNP	Alexa	O	_	_
B.	101	103	NNP	B.	O	_	_
Turke	104	109	NNP	Turke	O	_	_
,1,2	109	113	CD	,1,2	O	_	_
Youngchul	114	123	NNP	Youngchul	O	_	_
Song	124	128	NN	song	O	_	_
,1	128	130	CD	,1	O	_	_
Carlotta	131	139	NNP	Carlotta	O	_	_
Costa	140	145	NNP	Costa	O	_	_
,1	145	147	CD	,1	O	_	_
Rebecca	148	155	NNP	Rebecca	O	_	_
Cook	156	160	NNP	Cook	O	_	_
,4	160	162	CD	,4	O	_	_
Carlos	163	169	NNP	Carlos	O	_	_
L.	170	172	NNP	L.	O	_	_
Arteaga	173	180	NNP	Arteaga	O	_	_
,4	180	182	CD	,4	O	_	_
John	183	187	NNP	John	O	_	_
M.	188	190	NNP	M.	O	_	_
Asara	191	196	NNP	Asara	O	_	_
,2,3	196	200	CD	,2,3	O	_	_
and	201	204	CC	and	O	_	_
Jeffrey	205	212	NNP	Jeffrey	O	_	_
A.	213	215	NNP	A.	O	_	_
Engelman1	216	225	NNP	Engelman1	O	_	_
,2	225	227	CD	,2	O	_	_
,	227	228	,	,	O	_	_
#	228	229	#	#	O	_	_
1Massachusetts	230	244	NNS	1massachusett	O	_	_
General	245	252	NNP	General	O	_	_
Hospital	253	261	NNP	Hospital	O	_	_
Cancer	262	268	NNP	Cancer	O	_	_
Center	269	275	NNP	Center	O	_	_
,	275	276	,	,	O	_	_
Boston	277	283	NNP	Boston	O	_	_
,	283	284	,	,	O	_	_
MA	285	287	NNP	MA	O	_	_
,	287	288	,	,	O	_	_
02129	289	294	CD	02129	O	_	_
,	294	295	,	,	O	_	_
USA	296	299	NNP	USA	O	_	_
2Department	300	311	NN	2department	O	_	_
of	312	314	IN	of	O	_	_
Medicine	315	323	NNP	Medicine	O	_	_
,	323	324	,	,	O	_	_
Harvard	325	332	NNP	Harvard	O	_	_
Medical	333	340	NNP	Medical	O	_	_
School	341	347	NNP	School	O	_	_
,	347	348	,	,	O	_	_
Boston	349	355	NNP	Boston	O	_	_
,	355	356	,	,	O	_	_
MA	357	359	NNP	MA	O	_	_
,	359	360	,	,	O	_	_
02115	361	366	CD	02115	O	_	_
,	366	367	,	,	O	_	_
USA	368	371	NNP	USA	O	_	_
3Beth	372	377	NNP	3Beth	O	_	_
Israel	378	384	NNP	Israel	O	_	_
Deaconess	385	394	NNP	Deaconess	O	_	_
Medical	395	402	NNP	Medical	O	_	_
Center	403	409	NNP	Center	O	_	_
,	409	410	,	,	O	_	_
Division	411	419	NNP	Division	O	_	_
of	420	422	IN	of	O	_	_
Signal	423	429	NNP	Signal	O	_	_
Transduction	430	442	NNP	Transduction	O	_	_
,	442	443	,	,	O	_	_
Boston	444	450	NNP	Boston	O	_	_
,	450	451	,	,	O	_	_
MA	452	454	NNP	MA	O	_	_
,	454	455	,	,	O	_	_
02115	456	461	CD	02115	O	_	_
,	461	462	,	,	O	_	_
USA	463	466	NNP	USA	O	_	_
4Vanderbilt-Ingram	467	485	NNP	4Vanderbilt-Ingram	O	_	_
Cancer	486	492	NNP	Cancer	O	_	_
Center	493	499	NNP	Center	O	_	_
,	499	500	,	,	O	_	_
Nashville	501	510	NNP	Nashville	O	_	_
,	510	511	,	,	O	_	_
TN	512	514	NN	tn	O	_	_
,	514	515	,	,	O	_	_
37232	516	521	CD	37232	O	_	_
,	521	522	,	,	O	_	_
USA	523	526	NNP	USA	O	_	_
#Address	527	535	NNP	#Address	O	_	_
Correspondence	536	550	NNP	Correspondence	O	_	_
to	551	553	TO	to	O	_	_
:	553	554	:	:	O	_	_
Jeffrey	555	562	NNP	Jeffrey	O	_	_
A.	563	565	NNP	A.	O	_	_
Engelman	566	574	NNP	Engelman	O	_	_
,	574	575	,	,	O	_	_
M.D.	576	580	NNP	M.D.	O	_	_
,	580	581	,	,	O	_	_
Ph.D.	582	587	NNP	Ph.D.	O	_	_
,	587	588	,	,	O	_	_
MGH	589	592	NNP	MGH	O	_	_
Cancer	593	599	NNP	Cancer	O	_	_
Center	600	606	NNP	Center	O	_	_
,	606	607	,	,	O	_	_
Building	608	616	NNP	Building	O	_	_
149	617	620	CD	149	O	_	_
,	620	621	,	,	O	_	_
13th	622	626	JJ	13th	O	_	_
St	627	629	NNP	St	O	_	_
,	629	630	,	,	O	_	_
Boston	631	637	NNP	Boston	O	_	_
,	637	638	,	,	O	_	_
MA	639	641	NNP	MA	O	_	_
02129	642	647	CD	02129	O	_	_
,	647	648	,	,	O	_	_
Phone	649	654	NNP	Phone	O	_	_
:	654	655	:	:	O	_	_
617-724-	656	664	CD	617-724-	O	_	_
7298	665	669	CD	7298	O	_	_
,	669	670	,	,	O	_	_
Fax	671	674	NNP	Fax	O	_	_
:	674	675	:	:	O	_	_
617-724-9648	676	688	CD	617-724-9648	O	_	_
,	688	689	,	,	O	_	_
Email	690	695	VB	email	O	_	_
:	695	696	:	:	O	_	_
jengelman@partners.org	697	719	NN	jengelman@partners.org	O	_	_
Copyright	720	729	NN	copyright	O	_	_
notice	730	736	NN	notice	O	_	_
and	737	740	CC	and	O	_	_
Disclaimer	741	751	NNP	Disclaimer	O	_	_
Abstract	752	760	NNP	Abstract	O	_	_
The	761	764	NNP	The	O	_	_
PI3K	765	769	NN	pi3k	B-GENE	_	_
/	769	770	:	/	B-GENE	_	_
AKT	770	773	NN	akt	I-GENE	_	_
and	774	777	CC	and	O	_	_
RAF	778	781	NN	raf	B-GENE	_	_
/	781	782	:	/	B-GENE	_	_
MEK/ERK	782	789	NN	mek/erk	B-GENE	_	_
signaling	790	799	NN	signaling	O	_	_
pathways	800	808	NNS	pathway	O	_	_
are	809	812	VBP	be	O	_	_
activated	813	822	VBN	activate	O	_	_
in	823	825	IN	in	O	_	_
a	826	827	DT	a	O	_	_
wide	828	832	JJ	wide	O	_	_
range	833	838	NN	range	O	_	_
of	839	841	IN	of	O	_	_
human	842	847	JJ	human	O	_	_
cancers	848	855	NNS	cancer	O	_	_
.	855	856	.	.	O	_	_
D	1

164	0	dep
164	1	dep
164	2	dep
164	3	dep
164	4	dep
164	5	dep
164	6	dep
164	7	dep
164	8	dep
164	9	dep
164	10	dep
164	11	dep
164	12	dep
164	13	dep
164	14	dep
164	15	dep
164	16	dep
164	17	dep
164	18	dep
164	19	dep
164	20	dep
164	21	dep
164	22	dep
164	23	dep
164	24	dep
164	25	dep
164	26	dep
164	27	dep
164	28	dep
164	29	dep
164	30	dep
164	31	dep
164	32	dep
164	33	dep
164	34	dep
164	35	dep
164	36	dep
164	37	dep
164	38	dep
164	39	dep
164	40	dep
164	41	dep
164	43	dep
164	44	dep
164	45	dep
164	46	dep
164	47	dep
164	48	dep
164	50	dep
164	52	dep
164	54	dep
164	56	dep
164	57	dep
164	58	dep
164	59	dep
164	61	dep
164	62	dep
164	63	dep
164	65	dep
164	67	dep
164	69	dep
164	71	dep
164	72	dep
164	73	dep
164	74	dep
164	75	dep
164	76	dep
164	78	dep
164	79	dep
164	80	dep
164	81	dep
164	83	dep
164	85	dep
164	87	dep
164	89	dep
164	90	dep
164	91	dep
164	92	dep
164	94	dep
164	96	dep
164	98	dep
164	100	dep
164	101	dep
164	102	dep
164	103	dep
164	105	dep
164	106	dep
164	107	dep
164	109	dep
164	111	dep
164	113	dep
164	114	dep
164	115	dep
164	117	dep
164	118	dep
164	120	dep
164	121	dep
164	123	dep
164	125	dep
164	126	dep
164	128	dep
164	130	dep
164	131	dep
164	133	dep
164	135	dep
164	137	dep
164	139	dep
164	140	dep
164	141	dep
164	142	dep
164	143	dep
164	144	dep
164	145	dep
164	146	dep
164	147	dep
164	148	dep
164	149	dep
164	150	dep
164	151	dep
164	152	dep
164	153	dep
164	154	dep
164	155	dep
164	156	dep
164	157	dep
164	158	dep
164	159	dep
164	160	dep
164	161	dep
164	162	dep
164	163	dep
EOX
Y	1
X	164	0	165	165	X	0	0	1	1	MEK	0	0	1	0	X	0	1	2	1	inhibition	1	1	2	0	X	0	2	3	1	leads	2	2	3	0	X	0	3	4	1	to	3	3	4	0	X	0	4	5	1	PI3K	4	4	5	0	X	0	5	6	1	/	5	5	6	0	X	0	6	7	1	AKT	6	6	7	0	X	0	7	8	1	activation	7	7	8	0	X	0	8	9	1	by	8	8	9	0	X	0	9	10	1	relieving	9	9	10	0	X	0	10	11	1	a	10	10	11	0	X	0	11	12	1	negative	11	11	12	0	X	0	12	13	1	feedback	12	12	13	0	X	0	13	14	1	on	13	13	14	0	X	0	14	15	1	ERBB	14	14	15	0	X	0	15	16	1	receptors	15	15	16	0	X	0	16	17	1	Alexa	16	16	17	0	X	0	17	18	1	B.	17	17	18	0	X	0	18	19	1	Turke	18	18	19	0	X	0	19	20	1	,1,2	19	19	20	0	X	0	20	21	1	Youngchul	20	20	21	0	X	0	21	22	1	Song	21	21	22	0	X	0	22	23	1	,1	22	22	23	0	X	0	23	24	1	Carlotta	23	23	24	0	X	0	24	25	1	Costa	24	24	25	0	X	0	25	26	1	,1	25	25	26	0	X	0	26	27	1	Rebecca	26	26	27	0	X	0	27	28	1	Cook	27	27	28	0	X	0	28	29	1	,4	28	28	29	0	X	0	29	30	1	Carlos	29	29	30	0	X	0	30	31	1	L.	30	30	31	0	X	0	31	32	1	Arteaga	31	31	32	0	X	0	32	33	1	,4	32	32	33	0	X	0	33	34	1	John	33	33	34	0	X	0	34	35	1	M.	34	34	35	0	X	0	35	36	1	Asara	35	35	36	0	X	0	36	37	1	,2,3	36	36	37	0	X	0	37	38	1	and	37	37	38	0	X	0	38	39	1	Jeffrey	38	38	39	0	X	0	39	40	1	A.	39	39	40	0	X	0	40	41	1	Engelman1	40	40	41	0	X	0	41	42	1	,2	41	41	42	0	X	0	42	43	1	,	42	42	43	0	X	0	43	44	1	#	43	43	44	0	X	0	44	45	1	1Massachusetts	44	44	45	0	X	0	45	46	1	General	45	45	46	0	X	0	46	47	1	Hospital	46	46	47	0	X	0	47	48	1	Cancer	47	47	48	0	X	0	48	49	1	Center	48	48	49	0	X	0	49	50	1	,	49	49	50	0	X	0	50	51	1	Boston	50	50	51	0	X	0	51	52	1	,	51	51	52	0	X	0	52	53	1	MA	52	52	53	0	X	0	53	54	1	,	53	53	54	0	X	0	54	55	1	02129	54	54	55	0	X	0	55	56	1	,	55	55	56	0	X	0	56	57	1	USA	56	56	57	0	X	0	57	58	1	2Department	57	57	58	0	X	0	58	59	1	of	58	58	59	0	X	0	59	60	1	Medicine	59	59	60	0	X	0	60	61	1	,	60	60	61	0	X	0	61	62	1	Harvard	61	61	62	0	X	0	62	63	1	Medical	62	62	63	0	X	0	63	64	1	School	63	63	64	0	X	0	64	65	1	,	64	64	65	0	X	0	65	66	1	Boston	65	65	66	0	X	0	66	67	1	,	66	66	67	0	X	0	67	68	1	MA	67	67	68	0	X	0	68	69	1	,	68	68	69	0	X	0	69	70	1	02115	69	69	70	0	X	0	70	71	1	,	70	70	71	0	X	0	71	72	1	USA	71	71	72	0	X	0	72	73	1	3Beth	72	72	73	0	X	0	73	74	1	Israel	73	73	74	0	X	0	74	75	1	Deaconess	74	74	75	0	X	0	75	76	1	Medical	75	75	76	0	X	0	76	77	1	Center	76	76	77	0	X	0	77	78	1	,	77	77	78	0	X	0	78	79	1	Division	78	78	79	0	X	0	79	80	1	of	79	79	80	0	X	0	80	81	1	Signal	80	80	81	0	X	0	81	82	1	Transduction	81	81	82	0	X	0	82	83	1	,	82	82	83	0	X	0	83	84	1	Boston	83	83	84	0	X	0	84	85	1	,	84	84	85	0	X	0	85	86	1	MA	85	85	86	0	X	0	86	87	1	,	86	86	87	0	X	0	87	88	1	02115	87	87	88	0	X	0	88	89	1	,	88	88	89	0	X	0	89	90	1	USA	89	89	90	0	X	0	90	91	1	4Vanderbilt-Ingram	90	90	91	0	X	0	91	92	1	Cancer	91	91	92	0	X	0	92	93	1	Center	92	92	93	0	X	0	93	94	1	,	93	93	94	0	X	0	94	95	1	Nashville	94	94	95	0	X	0	95	96	1	,	95	95	96	0	X	0	96	97	1	TN	96	96	97	0	X	0	97	98	1	,	97	97	98	0	X	0	98	99	1	37232	98	98	99	0	X	0	99	100	1	,	99	99	100	0	X	0	100	101	1	USA	100	100	101	0	X	0	101	102	1	#Address	101	101	102	0	X	0	102	103	1	Correspondence	102	102	103	0	X	0	103	104	1	to	103	103	104	0	X	0	104	105	1	:	104	104	105	0	X	0	105	106	1	Jeffrey	105	105	106	0	X	0	106	107	1	A.	106	106	107	0	X	0	107	108	1	Engelman	107	107	108	0	X	0	108	109	1	,	108	108	109	0	X	0	109	110	1	M.D.	109	109	110	0	X	0	110	111	1	,	110	110	111	0	X	0	111	112	1	Ph.D.	111	111	112	0	X	0	112	113	1	,	112	112	113	0	X	0	113	114	1	MGH	113	113	114	0	X	0	114	115	1	Cancer	114	114	115	0	X	0	115	116	1	Center	115	115	116	0	X	0	116	117	1	,	116	116	117	0	X	0	117	118	1	Building	117	117	118	0	X	0	118	119	1	149	118	118	119	0	X	0	119	120	1	,	119	119	120	0	X	0	120	121	1	13th	120	120	121	0	X	0	121	122	1	St	121	121	122	0	X	0	122	123	1	,	122	122	123	0	X	0	123	124	1	Boston	123	123	124	0	X	0	124	125	1	,	124	124	125	0	X	0	125	126	1	MA	125	125	126	0	X	0	126	127	1	02129	126	126	127	0	X	0	127	128	1	,	127	127	128	0	X	0	128	129	1	Phone	128	128	129	0	X	0	129	130	1	:	129	129	130	0	X	0	130	131	1	617-724-	130	130	131	0	X	0	131	132	1	7298	131	131	132	0	X	0	132	133	1	,	132	132	133	0	X	0	133	134	1	Fax	133	133	134	0	X	0	134	135	1	:	134	134	135	0	X	0	135	136	1	617-724-9648	135	135	136	0	X	0	136	137	1	,	136	136	137	0	X	0	137	138	1	Email	137	137	138	0	X	0	138	139	1	:	138	138	139	0	X	0	139	140	1	jengelman@partners.org	139	139	140	0	X	0	140	141	1	Copyright	140	140	141	0	X	0	141	142	1	notice	141	141	142	0	X	0	142	143	1	and	142	142	143	0	X	0	143	144	1	Disclaimer	143	143	144	0	X	0	144	145	1	Abstract	144	144	145	0	X	0	145	146	1	The	145	145	146	0	X	0	146	147	1	PI3K	146	146	147	0	X	0	147	148	1	/	147	147	148	0	X	0	148	149	1	AKT	148	148	149	0	X	0	149	150	1	and	149	149	150	0	X	0	150	151	1	RAF	150	150	151	0	X	0	151	152	1	/	151	151	152	0	X	0	152	153	1	MEK/ERK	152	152	153	0	X	0	153	154	1	signaling	153	153	154	0	X	0	154	155	1	pathways	154	154	155	0	X	0	155	156	1	are	155	155	156	0	X	0	156	157	1	activated	156	156	157	0	X	0	157	158	1	in	157	157	158	0	X	0	158	159	1	a	158	158	159	0	X	0	159	160	1	wide	159	159	160	0	X	0	160	161	1	range	160	160	161	0	X	0	161	162	1	of	161	161	162	0	X	0	162	163	1	human	162	162	163	0	X	0	163	164	1	cancers	163	163	164	0	X	0	164	165	1	.	164	164	165	0
EOS
T	22
In	857	859	IN	in	O	_	_
many	860	864	JJ	many	O	_	_
cases	865	870	NNS	case	O	_	_
,	870	871	,	,	O	_	_
concomitant	872	883	JJ	concomitant	O	_	_
inhibition	884	894	NN	inhibition	O	_	_
of	895	897	IN	of	O	_	_
both	898	902	DT	both	O	_	_
pathways	903	911	NNS	pathway	O	_	_
is	912	914	VBZ	be	O	_	_
necessary	915	924	JJ	necessary	O	_	_
to	925	927	TO	to	O	_	_
block	928	933	VB	block	O	_	_
proliferation	934	947	NN	proliferation	O	_	_
and	948	951	CC	and	O	_	_
induce	952	958	VB	induce	O	_	_
cell	959	963	NN	cell	O	_	_
death	964	969	NN	death	O	_	_
and	970	973	CC	and	O	_	_
tumor	974	979	NN	tumor	O	_	_
shrinkage	980	989	NN	shrinkage	O	_	_
.	989	990	.	.	O	_	_
D	1
10
2	1	amod
5	4	amod
5	8	prep_of
8	7	det
10	2	prep_in
10	5	nsubj
10	9	cop
10	12	xcomp
10	15	xcomp
12	11	aux
12	13	dobj
12	15	conj_and
15	17	dobj
15	20	dobj
17	16	nn
17	20	conj_and
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	3	0	22	5	PP	0	0	3	2	IN	0	0	1	1	In	0	0	1	0	NP	1	1	3	2	JJ	0	1	2	1	many	1	1	2	0	NNS	0	2	3	1	cases	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	0	4	9	2	NP	1	4	6	2	JJ	0	4	5	1	concomitant	4	4	5	0	NN	0	5	6	1	inhibition	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	of	6	6	7	0	NP	1	7	9	2	DT	0	7	8	1	both	7	7	8	0	NNS	0	8	9	1	pathways	8	8	9	0	VP	1	9	21	2	VBZ	0	9	10	1	is	9	9	10	0	ADJP	0	10	21	2	JJ	0	10	11	1	necessary	10	10	11	0	S	0	11	21	1	VP	1	11	21	2	TO	0	11	12	1	to	11	11	12	0	VP	0	12	21	3	VP	0	12	14	2	VB	0	12	13	1	block	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	proliferation	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	VP	0	15	21	2	VB	0	15	16	1	induce	15	15	16	0	NP	0	16	21	3	NP	1	16	18	2	NN	0	16	17	1	cell	16	16	17	0	NN	0	17	18	1	death	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	NP	1	19	21	2	NN	0	19	20	1	tumor	19	19	20	0	NN	0	20	21	1	shrinkage	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	31
Several	991	998	JJ	several	O	_	_
feedback	999	1007	NN	feedback	O	_	_
systems	1008	1015	NNS	system	O	_	_
have	1016	1020	VBP	have	O	_	_
been	1021	1025	VBN	be	O	_	_
described	1026	1035	VBN	describe	O	_	_
in	1036	1038	IN	in	O	_	_
which	1039	1044	WDT	which	O	_	_
inhibition	1045	1055	NN	inhibition	O	_	_
of	1056	1058	IN	of	O	_	_
one	1059	1062	CD	one	O	_	_
intracellular	1063	1076	JJ	intracellular	O	_	_
pathway	1077	1084	NN	pathway	O	_	_
leads	1085	1090	VBZ	lead	O	_	_
to	1091	1093	TO	to	O	_	_
activation	1094	1104	NN	activation	O	_	_
of	1105	1107	IN	of	O	_	_
a	1108	1109	DT	a	O	_	_
parallel	1110	1118	JJ	parallel	O	_	_
signaling	1119	1128	NN	signaling	O	_	_
pathway	1129	1136	NN	pathway	O	_	_
,	1136	1137	,	,	O	_	_
thereby	1138	1145	RB	thereby	O	_	_
decreasing	1146	1156	VBG	decrease	O	_	_
the	1157	1160	DT	the	O	_	_
effectiveness	1161	1174	NN	effectiveness	O	_	_
of	1175	1177	IN	of	O	_	_
single-agent	1178	1190	JJ	single-agent	O	_	_
targeted	1191	1199	VBN	target	O	_	_
therapies	1200	1209	NNS	therapy	O	_	_
.	1209	1210	.	.	O	_	_
D	1
5
2	0	amod
2	1	nn
5	2	nsubjpass
5	3	aux
5	4	auxpass
5	13	prepc_in
8	12	prep_of
12	10	num
12	11	amod
13	7	dobj
13	8	nsubj
13	15	prep_to
13	22	advmod
13	23	xcomp
15	20	prep_of
20	17	det
20	18	amod
20	19	nn
23	25	dobj
25	24	det
25	29	prep_of
28	27	dep
29	28	amod
EOX
Y	1
ROOT	0	0	31	1	S	1	0	31	3	NP	2	0	3	3	JJ	0	0	1	1	Several	0	0	1	0	NN	0	1	2	1	feedback	1	1	2	0	NNS	0	2	3	1	systems	2	2	3	0	VP	1	3	30	2	VBP	0	3	4	1	have	3	3	4	0	VP	1	4	30	2	VBN	0	4	5	1	been	4	4	5	0	VP	0	5	30	2	VBN	0	5	6	1	described	5	5	6	0	PP	0	6	30	2	IN	0	6	7	1	in	6	6	7	0	SBAR	1	7	30	2	WHNP	0	7	8	1	WDT	0	7	8	1	which	7	7	8	0	S	1	8	30	2	NP	0	8	13	2	NP	0	8	9	1	NN	0	8	9	1	inhibition	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	of	9	9	10	0	NP	2	10	13	3	CD	0	10	11	1	one	10	10	11	0	JJ	0	11	12	1	intracellular	11	11	12	0	NN	0	12	13	1	pathway	12	12	13	0	VP	0	13	30	5	VBZ	0	13	14	1	leads	13	13	14	0	PP	0	14	21	2	TO	0	14	15	1	to	14	14	15	0	NP	0	15	21	2	NP	0	15	16	1	NN	0	15	16	1	activation	15	15	16	0	PP	0	16	21	2	IN	0	16	17	1	of	16	16	17	0	NP	3	17	21	4	DT	0	17	18	1	a	17	17	18	0	JJ	0	18	19	1	parallel	18	18	19	0	NN	0	19	20	1	signaling	19	19	20	0	NN	0	20	21	1	pathway	20	20	21	0	,	0	21	22	1	,	21	21	22	0	ADVP	0	22	23	1	RB	0	22	23	1	thereby	22	22	23	0	S	0	23	30	1	VP	0	23	30	2	VBG	0	23	24	1	decreasing	23	23	24	0	NP	0	24	30	2	NP	1	24	26	2	DT	0	24	25	1	the	24	24	25	0	NN	0	25	26	1	effectiveness	25	25	26	0	PP	0	26	30	2	IN	0	26	27	1	of	26	26	27	0	NP	1	27	30	2	ADJP	1	27	29	2	JJ	0	27	28	1	single-agent	27	27	28	0	VBN	0	28	29	1	targeted	28	28	29	0	NNS	0	29	30	1	therapies	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	27
In	1211	1213	IN	in	O	_	_
this	1214	1218	DT	this	O	_	_
study	1219	1224	NN	study	O	_	_
we	1225	1227	PRP	we	O	_	_
describe	1228	1236	VBP	describe	O	_	_
a	1237	1238	DT	a	O	_	_
feedback	1239	1247	NN	feedback	O	_	_
mechanism	1248	1257	NN	mechanism	O	_	_
in	1258	1260	IN	in	O	_	_
which	1261	1266	WDT	which	O	_	_
MEK	1267	1270	NN	mek	B-GENE	_	_
inhibition	1271	1281	NN	inhibition	O	_	_
leads	1282	1287	VBZ	lead	O	_	_
to	1288	1290	TO	to	O	_	_
activation	1291	1301	NN	activation	O	_	_
of	1302	1304	IN	of	O	_	_
PI3K	1305	1309	NN	pi3k	B-GENE	_	_
/	1309	1310	:	/	B-GENE	_	_
AKT	1310	1313	NN	akt	I-GENE	_	_
signaling	1314	1323	NN	signaling	O	_	_
in	1324	1326	IN	in	O	_	_
EGFR	1327	1331	NN	egfr	B-GENE	_	_
and	1332	1335	CC	and	O	_	_
HER2	1336	1340	NN	her2	B-GENE	_	_
driven	1341	1347	VBN	drive	O	_	_
cancers	1348	1355	NNS	cancer	O	_	_
.	1355	1356	.	.	O	_	_
D	1
4
2	1	det
4	2	prep_in
4	3	nsubj
4	7	dobj
4	19	dep
7	5	det
7	6	nn
7	12	rcmod
11	10	nn
12	9	prep_in
12	11	nsubj
12	14	prep_to
14	16	prep_of
19	17	punct
19	18	nn
19	21	prep_in
19	23	prep_in
19	24	vmod
21	23	conj_and
24	25	dobj
EOX
Y	1
ROOT	0	0	27	1	S	2	0	27	4	PP	0	0	3	2	IN	0	0	1	1	In	0	0	1	0	NP	1	1	3	2	DT	0	1	2	1	this	1	1	2	0	NN	0	2	3	1	study	2	2	3	0	NP	0	3	4	1	PRP	0	3	4	1	we	3	3	4	0	VP	0	4	26	3	VBP	0	4	5	1	describe	4	4	5	0	NP	0	5	17	2	NP	2	5	8	3	DT	0	5	6	1	a	5	5	6	0	NN	0	6	7	1	feedback	6	6	7	0	NN	0	7	8	1	mechanism	7	7	8	0	SBAR	1	8	17	2	WHPP	0	8	10	2	IN	0	8	9	1	in	8	8	9	0	WHNP	0	9	10	1	WDT	0	9	10	1	which	9	9	10	0	S	1	10	17	2	NP	1	10	12	2	NN	0	10	11	1	MEK	10	10	11	0	NN	0	11	12	1	inhibition	11	11	12	0	VP	0	12	17	2	VBZ	0	12	13	1	leads	12	12	13	0	PP	0	13	17	2	TO	0	13	14	1	to	13	13	14	0	NP	0	14	17	2	NP	0	14	15	1	NN	0	14	15	1	activation	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	of	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	PI3K	16	16	17	0	PRN	1	17	26	2	:	0	17	18	1	/	17	17	18	0	NP	0	18	26	3	NP	1	18	20	2	NN	0	18	19	1	AKT	18	18	19	0	NN	0	19	20	1	signaling	19	19	20	0	PP	0	20	24	2	IN	0	20	21	1	in	20	20	21	0	NP	0	21	24	3	NN	0	21	22	1	EGFR	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	NN	0	23	24	1	HER2	23	23	24	0	VP	0	24	26	2	VBN	0	24	25	1	driven	24	24	25	0	NP	0	25	26	1	NNS	0	25	26	1	cancers	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	40
We	1357	1359	PRP	we	O	_	_
found	1360	1365	VBD	find	O	_	_
that	1366	1370	IN	that	O	_	_
MEK	1371	1374	NN	mek	B-GENE	_	_
inhibitor	1375	1384	NN	inhibitor	O	_	_
induced	1385	1392	VBD	induce	O	_	_
activation	1393	1403	NN	activation	O	_	_
of	1404	1406	IN	of	O	_	_
PI3K	1407	1411	NN	pi3k	B-GENE	_	_
/	1411	1412	:	/	B-GENE	_	_
AKT	1412	1415	NN	akt	I-GENE	_	_
resulted	1416	1424	VBD	result	O	_	_
from	1425	1429	IN	from	O	_	_
hyperactivation	1430	1445	NN	hyperactivation	O	_	_
of	1446	1448	IN	of	O	_	_
ERBB3	1449	1454	NN	erbb3	B-GENE	_	_
as	1455	1457	IN	as	O	_	_
a	1458	1459	DT	a	O	_	_
result	1460	1466	NN	result	O	_	_
of	1467	1469	IN	of	O	_	_
the	1470	1473	DT	the	O	_	_
loss	1474	1478	NN	loss	O	_	_
of	1479	1481	IN	of	O	_	_
an	1482	1484	DT	a	O	_	_
inhibitory	1485	1495	JJ	inhibitory	O	_	_
threonine	1496	1505	NN	threonine	O	_	_
phosphorylation	1506	1521	NN	phosphorylation	O	_	_
in	1522	1524	IN	in	O	_	_
the	1525	1528	DT	the	O	_	_
conserved	1529	1538	VBN	conserve	O	_	_
juxtamembrane	1539	1552	NN	juxtamembrane	O	_	_
(	1553	1554	CD	(	O	_	_
JM	1554	1556	NN	jm	O	_	_
)	1556	1557	NN	)	O	_	_
domains	1558	1565	NNS	domain	O	_	_
of	1566	1568	IN	of	O	_	_
EGFR	1569	1573	NN	egfr	B-GENE	_	_
and	1574	1577	CC	and	O	_	_
HER2	1578	1582	NN	her2	B-GENE	_	_
.	1582	1583	.	.	O	_	_
D	1
1
1	0	nsubj
1	5	ccomp
4	3	nn
5	2	mark
5	4	nsubj
5	6	dobj
6	8	prep_of
6	11	dep
6	34	dep
11	9	punct
11	10	nsubj
11	13	prep_from
11	18	prep_as
11	30	prep_in
13	15	prep_of
18	17	det
18	21	prep_of
21	20	det
21	26	prep_of
26	23	det
26	24	amod
26	25	nn
30	28	det
30	29	dep
34	31	num
34	32	nn
34	33	nn
34	36	prep_of
34	38	prep_of
36	38	conj_and
EOX
Y	1
ROOT	0	0	40	1	S	1	0	40	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	39	2	VBD	0	1	2	1	found	1	1	2	0	SBAR	1	2	39	2	IN	0	2	3	1	that	2	2	3	0	S	1	3	39	2	NP	1	3	5	2	NN	0	3	4	1	MEK	3	3	4	0	NN	0	4	5	1	inhibitor	4	4	5	0	VP	0	5	39	2	VBD	0	5	6	1	induced	5	5	6	0	NP	0	6	39	4	NP	0	6	7	1	NN	0	6	7	1	activation	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	PI3K	8	8	9	0	PRN	1	9	31	2	:	0	9	10	1	/	9	9	10	0	S	1	10	31	2	NP	0	10	11	1	NN	0	10	11	1	AKT	10	10	11	0	VP	0	11	31	4	VBD	0	11	12	1	resulted	11	11	12	0	PP	0	12	16	2	IN	0	12	13	1	from	12	12	13	0	NP	0	13	16	2	NP	0	13	14	1	NN	0	13	14	1	hyperactivation	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	of	14	14	15	0	NP	0	15	16	1	NN	0	15	16	1	ERBB3	15	15	16	0	PP	0	16	27	2	IN	0	16	17	1	as	16	16	17	0	NP	0	17	27	2	NP	1	17	19	2	DT	0	17	18	1	a	17	17	18	0	NN	0	18	19	1	result	18	18	19	0	PP	0	19	27	2	IN	0	19	20	1	of	19	19	20	0	NP	0	20	27	2	NP	1	20	22	2	DT	0	20	21	1	the	20	20	21	0	NN	0	21	22	1	loss	21	21	22	0	PP	0	22	27	2	IN	0	22	23	1	of	22	22	23	0	NP	3	23	27	4	DT	0	23	24	1	an	23	23	24	0	JJ	0	24	25	1	inhibitory	24	24	25	0	NN	0	25	26	1	threonine	25	25	26	0	NN	0	26	27	1	phosphorylation	26	26	27	0	PP	0	27	31	2	IN	0	27	28	1	in	27	27	28	0	NP	2	28	31	3	DT	0	28	29	1	the	28	28	29	0	S	0	29	30	1	VP	0	29	30	1	VBN	0	29	30	1	conserved	29	29	30	0	NN	0	30	31	1	juxtamembrane	30	30	31	0	NP	0	31	39	2	NP	3	31	35	4	CD	0	31	32	1	(	31	31	32	0	NN	0	32	33	1	JM	32	32	33	0	NN	0	33	34	1	)	33	33	34	0	NNS	0	34	35	1	domains	34	34	35	0	PP	0	35	39	2	IN	0	35	36	1	of	35	35	36	0	NP	0	36	39	3	NN	0	36	37	1	EGFR	36	36	37	0	CC	0	37	38	1	and	37	37	38	0	NN	0	38	39	1	HER2	38	38	39	0	.	0	39	40	1	.	39	39	40	0
EOS
T	30
Mutation	1584	1592	NN	mutation	O	_	_
of	1593	1595	IN	of	O	_	_
this	1596	1600	DT	this	O	_	_
amino	1601	1606	NN	amino	O	_	_
acid	1607	1611	NN	acid	O	_	_
led	1612	1615	VBD	lead	O	_	_
to	1616	1618	TO	to	O	_	_
increased	1619	1628	VBN	increase	O	_	_
ERBB	1629	1633	NN	erbb	B-GENE	_	_
receptor	1634	1642	NN	receptor	I-GENE	_	_
activation	1643	1653	NN	activation	O	_	_
and	1654	1657	CC	and	O	_	_
up-regulation	1658	1671	NN	up-regulation	O	_	_
of	1672	1674	IN	of	O	_	_
the	1675	1678	DT	the	O	_	_
ERBB3	1679	1684	NN	erbb3	B-GENE	_	_
/	1684	1685	:	/	B-GENE	_	_
PI3K/AKT	1685	1693	NN	pi3k/akt	B-GENE	_	_
signaling	1694	1703	NN	signaling	O	_	_
pathway	1704	1711	NN	pathway	O	_	_
,	1711	1712	,	,	O	_	_
which	1713	1718	WDT	which	O	_	_
was	1719	1722	VBD	be	O	_	_
no	1723	1725	RB	no	O	_	_
longer	1726	1732	RB	longer	O	_	_
responsive	1733	1743	JJ	responsive	O	_	_
to	1744	1746	TO	to	O	_	_
MEK	1747	1750	NN	mek	B-GENE	_	_
inhibition	1751	1761	NN	inhibition	O	_	_
.	1761	1762	.	.	O	_	_
D	1
19
4	2	det
4	3	nn
5	0	npadvmod
5	4	prep_of
5	10	prep_to
5	12	prep_to
10	7	amod
10	8	nn
10	9	nn
10	12	conj_and
12	15	prep_of
15	14	det
19	5	dep
19	16	punct
19	17	nn
19	18	nn
19	25	rcmod
24	23	advmod
25	21	nsubj
25	22	cop
25	24	advmod
25	28	prep_to
28	27	nn
EOX
Y	1
ROOT	0	0	30	1	FRAG	2	0	30	4	S	1	0	16	2	PP	1	0	5	3	NP	0	0	1	1	NN	0	0	1	1	Mutation	0	0	1	0	IN	0	1	2	1	of	1	1	2	0	NP	2	2	5	3	DT	0	2	3	1	this	2	2	3	0	NN	0	3	4	1	amino	3	3	4	0	NN	0	4	5	1	acid	4	4	5	0	VP	0	5	16	2	VBD	0	5	6	1	led	5	5	6	0	PP	0	6	16	2	TO	0	6	7	1	to	6	6	7	0	NP	0	7	16	3	NP	3	7	11	4	VBN	0	7	8	1	increased	7	7	8	0	NN	0	8	9	1	ERBB	8	8	9	0	NN	0	9	10	1	receptor	9	9	10	0	NN	0	10	11	1	activation	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NP	0	12	16	2	NP	0	12	13	1	NN	0	12	13	1	up-regulation	12	12	13	0	PP	0	13	16	2	IN	0	13	14	1	of	13	13	14	0	NP	1	14	16	2	DT	0	14	15	1	the	14	14	15	0	NN	0	15	16	1	ERBB3	15	15	16	0	:	0	16	17	1	/	16	16	17	0	NP	0	17	29	3	NP	2	17	20	3	NN	0	17	18	1	PI3K/AKT	17	17	18	0	NN	0	18	19	1	signaling	18	18	19	0	NN	0	19	20	1	pathway	19	19	20	0	,	0	20	21	1	,	20	20	21	0	SBAR	1	21	29	2	WHNP	0	21	22	1	WDT	0	21	22	1	which	21	21	22	0	S	0	22	29	1	VP	2	22	29	3	VBD	0	22	23	1	was	22	22	23	0	ADVP	1	23	25	2	RB	0	23	24	1	no	23	23	24	0	RB	0	24	25	1	longer	24	24	25	0	ADJP	0	25	29	2	JJ	0	25	26	1	responsive	25	25	26	0	PP	0	26	29	2	TO	0	26	27	1	to	26	26	27	0	NP	1	27	29	2	NN	0	27	28	1	MEK	27	27	28	0	NN	0	28	29	1	inhibition	28	28	29	0	.	0	29	30	1	.	29	29	30	0
EOS
T	20
Taken	1763	1768	VBN	take	O	_	_
together	1769	1777	RB	together	O	_	_
,	1777	1778	,	,	O	_	_
these	1779	1784	DT	these	O	_	_
results	1785	1792	NNS	result	O	_	_
elucidate	1793	1802	VBP	elucidate	O	_	_
an	1803	1805	DT	a	O	_	_
important	1806	1815	JJ	important	O	_	_
,	1815	1816	,	,	O	_	_
dominant	1817	1825	JJ	dominant	O	_	_
feedback	1826	1834	NN	feedback	O	_	_
network	1835	1842	NN	network	O	_	_
regulating	1843	1853	VBG	regulate	O	_	_
central	1854	1861	JJ	central	O	_	_
oncogenic	1862	1871	JJ	oncogenic	O	_	_
pathways	1872	1880	NNS	pathway	O	_	_
in	1881	1883	IN	in	O	_	_
human	1884	1889	JJ	human	O	_	_
cancer	1890	1896	NN	cancer	O	_	_
.	1896	1897	.	.	O	_	_
D	1
5
0	1	advmod
4	3	det
5	0	vmod
5	4	nsubj
5	11	dobj
11	6	det
11	7	amod
11	9	amod
11	10	nn
11	12	vmod
12	15	dobj
15	13	amod
15	14	amod
15	18	prep_in
18	17	amod
EOX
Y	1
ROOT	0	0	20	1	S	3	0	20	5	S	0	0	2	1	VP	0	0	2	2	VBN	0	0	1	1	Taken	0	0	1	0	ADVP	0	1	2	1	RB	0	1	2	1	together	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	DT	0	3	4	1	these	3	3	4	0	NNS	0	4	5	1	results	4	4	5	0	VP	0	5	19	2	VBP	0	5	6	1	elucidate	5	5	6	0	NP	0	6	19	2	NP	5	6	12	6	DT	0	6	7	1	an	6	6	7	0	JJ	0	7	8	1	important	7	7	8	0	,	0	8	9	1	,	8	8	9	0	JJ	0	9	10	1	dominant	9	9	10	0	NN	0	10	11	1	feedback	10	10	11	0	NN	0	11	12	1	network	11	11	12	0	VP	0	12	19	2	VBG	0	12	13	1	regulating	12	12	13	0	NP	0	13	19	2	NP	2	13	16	3	JJ	0	13	14	1	central	13	13	14	0	JJ	0	14	15	1	oncogenic	14	14	15	0	NNS	0	15	16	1	pathways	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	in	16	16	17	0	NP	1	17	19	2	JJ	0	17	18	1	human	17	17	18	0	NN	0	18	19	1	cancer	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	71
Keywords	1898	1906	NNS	keyword	O	_	_
:	1906	1907	:	:	O	_	_
cancer	1908	1914	NN	cancer	O	_	_
,	1914	1915	,	,	O	_	_
feedback	1916	1924	NN	feedback	O	_	_
,	1924	1925	,	,	O	_	_
ERBB	1926	1930	NN	erbb	B-GENE	_	_
receptors	1931	1940	NNS	receptor	I-GENE	_	_
,	1940	1941	,	,	O	_	_
PI3K	1942	1946	NN	pi3k	B-GENE	_	_
,	1946	1947	,	,	O	_	_
MEK	1948	1951	NN	mek	B-GENE	_	_
INTRODUCTION	1952	1964	NN	introduction	I-GENE	_	_
The	1965	1968	DT	the	O	_	_
phosphatidylinositol	1969	1989	NN	phosphatidylinositol	B-GENE	_	_
3-kinase	1990	1998	NN	3-kinase	I-GENE	_	_
(	1999	2000	CD	(	B-GENE	_	_
PI3K	2000	2004	NN	pi3k	I-GENE	_	_
)	2004	2005	NN	)	O	_	_
,	2005	2006	,	,	O	_	_
RAF	2007	2010	NN	raf	B-GENE	_	_
/	2010	2011	:	/	B-GENE	_	_
MEK/ERK	2011	2018	NN	mek/erk	B-GENE	_	_
mitogen	2019	2026	NN	mitogen	O	_	_
activated	2027	2036	VBN	activate	B-GENE	_	_
protein	2037	2044	NN	protein	I-GENE	_	_
kinase	2045	2051	NN	kinase	I-GENE	_	_
(	2052	2053	CD	(	B-GENE	_	_
MAPK	2053	2057	NN	mapk	I-GENE	_	_
)	2057	2058	NN	)	O	_	_
,	2058	2059	,	,	O	_	_
and	2060	2063	CC	and	O	_	_
mammalian	2064	2073	JJ	mammalian	O	_	_
target	2074	2080	NN	target	O	_	_
of	2081	2083	IN	of	O	_	_
rapamycin	2084	2093	NN	rapamycin	O	_	_
complex	2094	2101	NN	complex	O	_	_
1	2102	2103	CD	1	O	_	_
(	2104	2105	CD	(	O	_	_
mTORC1	2105	2111	NN	mtorc1	O	_	_
)	2111	2112	NN	)	O	_	_
pathways	2113	2121	NNS	pathway	O	_	_
transmit	2122	2130	VBP	transmit	O	_	_
signals	2131	2138	NNS	signal	O	_	_
from	2139	2143	IN	from	O	_	_
receptor	2144	2152	NN	receptor	B-GENE	_	_
tyrosine	2153	2161	NN	tyrosine	I-GENE	_	_
kinases	2162	2169	NNS	kinase	I-GENE	_	_
(	2170	2171	VBP	(	B-GENE	_	_
RTKs	2171	2175	NNS	rtk	I-GENE	_	_
)	2175	2176	CD	)	O	_	_
to	2177	2179	TO	to	O	_	_
downstream	2180	2190	JJ	downstream	O	_	_
effector	2191	2199	NN	effector	O	_	_
networks	2200	2208	NNS	network	O	_	_
regulating	2209	2219	VBG	regulate	O	_	_
cell	2220	2224	NN	cell	O	_	_
growth	2225	2231	NN	growth	O	_	_
,	2231	2232	,	,	O	_	_
metabolism	2233	2243	NN	metabolism	O	_	_
,	2243	2244	,	,	O	_	_
survival	2245	2253	NN	survival	O	_	_
,	2253	2254	,	,	O	_	_
and	2255	2258	CC	and	O	_	_
proliferation	2259	2272	NN	proliferation	O	_	_
(	2273	2274	NN	(	O	_	_
1	2274	2275	CD	1	O	_	_
‚	2275	2276	CD	‚	O	_	_
Äì3	2276	2279	NN	äì3	O	_	_
)	2279	2280	NN	)	O	_	_
.	2280	2281	.	.	O	_	_
D	1
0
0	2	dep
0	21	punct
0	24	dep
0	48	dep
2	4	appos
2	7	appos
2	9	appos
2	12	appos
2	20	appos
7	6	nn
12	11	nn
12	18	dep
18	13	det
18	14	nn
18	15	nn
18	16	num
18	17	nn
23	22	nn
24	23	nsubj
24	29	xcomp
24	48	conj_and
26	25	nn
29	26	nsubj
29	27	num
29	28	nn
33	32	amod
33	36	prep_of
36	35	nn
36	42	rcmod
38	37	number
41	38	num
41	39	nn
41	40	nn
42	41	nsubj
42	43	dobj
42	47	prep_from
47	45	nn
47	46	nn
48	33	nsubj
48	49	dobj
49	50	num
49	54	prep_to
54	52	amod
54	53	nn
54	55	vmod
55	57	dobj
55	59	dobj
55	61	dobj
55	65	dobj
57	56	nn
57	59	conj_and
57	61	conj_and
57	65	conj_and
65	64	nn
65	69	dep
67	66	number
69	67	num
69	68	nn
EOX
Y	1
ROOT	0	0	71	1	FRAG	0	0	71	4	NP	0	0	21	3	NP	0	0	1	1	NNS	0	0	1	1	Keywords	0	0	1	0	:	0	1	2	1	:	1	1	2	0	NP	0	2	21	11	NP	0	2	3	1	NN	0	2	3	1	cancer	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	feedback	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	ERBB	6	6	7	0	NNS	0	7	8	1	receptors	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	PI3K	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	0	11	19	2	NP	1	11	13	2	NN	0	11	12	1	MEK	11	11	12	0	NN	0	12	13	1	INTRODUCTION	12	12	13	0	NP	5	13	19	6	DT	0	13	14	1	The	13	13	14	0	NN	0	14	15	1	phosphatidylinositol	14	14	15	0	NN	0	15	16	1	3-kinase	15	15	16	0	CD	0	16	17	1	(	16	16	17	0	NN	0	17	18	1	PI3K	17	17	18	0	NN	0	18	19	1	)	18	18	19	0	,	0	19	20	1	,	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	RAF	20	20	21	0	:	0	21	22	1	/	21	21	22	0	S	0	22	70	4	S	1	22	30	2	NP	1	22	24	2	NN	0	22	23	1	MEK/ERK	22	22	23	0	NN	0	23	24	1	mitogen	23	23	24	0	VP	0	24	30	2	VBN	0	24	25	1	activated	24	24	25	0	S	1	25	30	2	NP	1	25	27	2	NN	0	25	26	1	protein	25	25	26	0	NN	0	26	27	1	kinase	26	26	27	0	NP	2	27	30	3	CD	0	27	28	1	(	27	27	28	0	NN	0	28	29	1	MAPK	28	28	29	0	NN	0	29	30	1	)	29	29	30	0	,	0	30	31	1	,	30	30	31	0	CC	0	31	32	1	and	31	31	32	0	S	1	32	70	2	NP	0	32	48	2	NP	1	32	34	2	JJ	0	32	33	1	mammalian	32	32	33	0	NN	0	33	34	1	target	33	33	34	0	PP	0	34	48	2	IN	0	34	35	1	of	34	34	35	0	NP	0	35	48	2	NP	1	35	37	2	NN	0	35	36	1	rapamycin	35	35	36	0	NN	0	36	37	1	complex	36	36	37	0	SBAR	0	37	48	1	S	1	37	48	2	NP	3	37	42	4	QP	1	37	39	2	CD	0	37	38	1	1	37	37	38	0	CD	0	38	39	1	(	38	38	39	0	NN	0	39	40	1	mTORC1	39	39	40	0	NN	0	40	41	1	)	40	40	41	0	NNS	0	41	42	1	pathways	41	41	42	0	VP	0	42	48	3	VBP	0	42	43	1	transmit	42	42	43	0	NP	0	43	44	1	NNS	0	43	44	1	signals	43	43	44	0	PP	0	44	48	2	IN	0	44	45	1	from	44	44	45	0	NP	2	45	48	3	NN	0	45	46	1	receptor	45	45	46	0	NN	0	46	47	1	tyrosine	46	46	47	0	NNS	0	47	48	1	kinases	47	47	48	0	VP	0	48	70	2	VBP	0	48	49	1	(	48	48	49	0	NP	0	49	70	2	NP	0	49	51	2	NNS	0	49	50	1	RTKs	49	49	50	0	CD	0	50	51	1	)	50	50	51	0	PP	0	51	70	2	TO	0	51	52	1	to	51	51	52	0	NP	0	52	70	2	NP	2	52	55	3	JJ	0	52	53	1	downstream	52	52	53	0	NN	0	53	54	1	effector	53	53	54	0	NNS	0	54	55	1	networks	54	54	55	0	VP	0	55	70	2	VBG	0	55	56	1	regulating	55	55	56	0	NP	0	56	70	8	NP	1	56	58	2	NN	0	56	57	1	cell	56	56	57	0	NN	0	57	58	1	growth	57	57	58	0	,	0	58	59	1	,	58	58	59	0	NP	0	59	60	1	NN	0	59	60	1	metabolism	59	59	60	0	,	0	60	61	1	,	60	60	61	0	NP	0	61	62	1	NN	0	61	62	1	survival	61	61	62	0	,	0	62	63	1	,	62	62	63	0	CC	0	63	64	1	and	63	63	64	0	NP	0	64	70	2	NP	1	64	66	2	NN	0	64	65	1	proliferation	64	64	65	0	NN	0	65	66	1	(	65	65	66	0	NP	2	66	70	3	QP	1	66	68	2	CD	0	66	67	1	1	66	66	67	0	CD	0	67	68	1	‚	67	67	68	0	NN	0	68	69	1	Äì3	68	68	69	0	NN	0	69	70	1	)	69	69	70	0	.	0	70	71	1	.	70	70	71	0
EOS
T	40
Numerous	2282	2290	JJ	numerous	O	_	_
feedback	2291	2299	NN	feedback	O	_	_
systems	2300	2307	NNS	system	O	_	_
regulating	2308	2318	VBG	regulate	O	_	_
these	2319	2324	DT	these	O	_	_
oncogenic	2325	2334	JJ	oncogenic	O	_	_
pathways	2335	2343	NNS	pathway	O	_	_
have	2344	2348	VBP	have	O	_	_
been	2349	2353	VBN	be	O	_	_
described	2354	2363	VBN	describe	O	_	_
,	2363	2364	,	,	O	_	_
and	2365	2368	CC	and	O	_	_
can	2369	2372	MD	can	O	_	_
potentially	2373	2384	RB	potentially	O	_	_
ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºThe	2385	2436	NNP	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºThe	O	_	_
publisher	2437	2446	NN	publisher	O	_	_
's	2446	2448	POS	's	O	_	_
final	2449	2454	JJ	final	O	_	_
edited	2455	2461	VBN	edit	O	_	_
version	2462	2469	NN	version	O	_	_
of	2470	2472	IN	of	O	_	_
this	2473	2477	DT	this	O	_	_
article	2478	2485	NN	article	O	_	_
is	2486	2488	VBZ	be	O	_	_
available	2489	2498	JJ	available	O	_	_
free	2499	2503	JJ	free	O	_	_
at	2504	2506	IN	at	O	_	_
Cancer	2507	2513	NNP	Cancer	O	_	_
Res	2514	2517	NNP	Res	O	_	_
See	2518	2521	VB	see	O	_	_
other	2522	2527	JJ	other	O	_	_
articles	2528	2536	NNS	article	O	_	_
in	2537	2539	IN	in	O	_	_
PMC	2540	2543	NN	pmc	O	_	_
that	2544	2548	WDT	that	O	_	_
cite	2549	2553	VBP	cite	O	_	_
the	2554	2557	DT	the	O	_	_
published	2558	2567	VBN	publish	O	_	_
article	2568	2575	NN	article	O	_	_
.	2575	2576	.	.	O	_	_
D	1
9
2	0	amod
2	1	nn
2	3	vmod
3	6	dobj
6	4	det
6	5	amod
9	2	nsubjpass
9	7	aux
9	8	auxpass
9	29	conj_and
15	13	advmod
15	14	nn
15	16	possessive
15	17	amod
15	18	vmod
18	25	ccomp
19	22	prep_of
22	21	det
25	19	nsubj
25	23	cop
25	24	amod
25	28	prep_at
28	27	nn
29	12	aux
29	15	nsubj
29	31	dobj
29	33	prep_in
31	30	amod
33	35	rcmod
35	34	nsubj
35	38	dobj
38	36	det
38	37	amod
EOX
Y	1
ROOT	0	0	40	1	S	0	0	40	5	S	1	0	10	2	NP	0	0	7	2	NP	2	0	3	3	JJ	0	0	1	1	Numerous	0	0	1	0	NN	0	1	2	1	feedback	1	1	2	0	NNS	0	2	3	1	systems	2	2	3	0	VP	0	3	7	2	VBG	0	3	4	1	regulating	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	these	4	4	5	0	JJ	0	5	6	1	oncogenic	5	5	6	0	NNS	0	6	7	1	pathways	6	6	7	0	VP	1	7	10	2	VBP	0	7	8	1	have	7	7	8	0	VP	1	8	10	2	VBN	0	8	9	1	been	8	8	9	0	VP	0	9	10	1	VBN	0	9	10	1	described	9	9	10	0	,	0	10	11	1	,	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	SINV	2	12	39	3	MD	0	12	13	1	can	12	12	13	0	NP	0	13	29	2	NP	1	13	18	2	ADVP	0	13	14	1	RB	0	13	14	1	potentially	13	13	14	0	NP	0	14	18	2	NP	1	14	17	3	NNP	0	14	15	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºThe	14	14	15	0	NN	0	15	16	1	publisher	15	15	16	0	POS	0	16	17	1	's	16	16	17	0	JJ	0	17	18	1	final	17	17	18	0	VP	0	18	29	2	VBN	0	18	19	1	edited	18	18	19	0	SBAR	0	19	29	1	S	1	19	29	2	NP	0	19	23	2	NP	0	19	20	1	NN	0	19	20	1	version	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	of	20	20	21	0	NP	1	21	23	2	DT	0	21	22	1	this	21	21	22	0	NN	0	22	23	1	article	22	22	23	0	VP	1	23	29	2	VBZ	0	23	24	1	is	23	23	24	0	ADJP	0	24	29	2	ADJP	1	24	26	2	JJ	0	24	25	1	available	24	24	25	0	JJ	0	25	26	1	free	25	25	26	0	PP	0	26	29	2	IN	0	26	27	1	at	26	26	27	0	NP	1	27	29	2	NNP	0	27	28	1	Cancer	27	27	28	0	NNP	0	28	29	1	Res	28	28	29	0	VP	0	29	39	3	VB	0	29	30	1	See	29	29	30	0	NP	1	30	32	2	JJ	0	30	31	1	other	30	30	31	0	NNS	0	31	32	1	articles	31	31	32	0	PP	0	32	39	2	IN	0	32	33	1	in	32	32	33	0	NP	0	33	39	2	NP	0	33	34	1	NN	0	33	34	1	PMC	33	33	34	0	SBAR	1	34	39	2	WHNP	0	34	35	1	WDT	0	34	35	1	that	34	34	35	0	S	0	35	39	1	VP	0	35	39	2	VBP	0	35	36	1	cite	35	35	36	0	NP	2	36	39	3	DT	0	36	37	1	the	36	36	37	0	VBN	0	37	38	1	published	37	37	38	0	NN	0	38	39	1	article	38	38	39	0	.	0	39	40	1	.	39	39	40	0
EOS
T	32
ÔøºÔøºÔøºÔøºÔøºÔøºÔøº	2577	2598	NNP	ÔøºÔøºÔøºÔøºÔøºÔøºÔøº	O	_	_
MEK	2600	2603	NN	mek	B-GENE	_	_
inhibition	2604	2614	NN	inhibition	O	_	_
leads	2615	2620	VBZ	lead	O	_	_
to	2621	2623	TO	to	O	_	_
PI3K	2624	2628	NN	pi3k	B-GENE	_	_
/	2628	2629	:	/	B-GENE	_	_
AKT	2629	2632	NN	akt	I-GENE	_	_
activation	2633	2643	NN	activation	O	_	_
by	2644	2646	IN	by	O	_	_
relieving	2647	2656	VBG	relieve	O	_	_
a	2657	2658	DT	a	O	_	_
negative	2659	2667	JJ	negative	O	_	_
feedback	2668	2676	NN	feedback	O	_	_
on	2677	2679	IN	on	O	_	_
ERBB	2680	2684	NN	erbb	O	_	_
receptors	2685	2694	NNS	receptor	O	_	_
12	2695	2697	CD	12	O	_	_
/	2697	2698	:	/	O	_	_
8/14	2698	2702	CD	8/14	O	_	_
,	2702	2703	,	,	O	_	_
6:54	2704	2708	CD	6:54	O	_	_
PM	2709	2711	NNP	PM	O	_	_
Ôøºimpact	2712	2721	NNP	Ôøºimpact	O	_	_
the	2722	2725	DT	the	O	_	_
sensitivity	2726	2737	NN	sensitivity	O	_	_
of	2738	2740	IN	of	O	_	_
cancers	2741	2748	NNS	cancer	O	_	_
to	2749	2751	TO	to	O	_	_
kinase	2752	2758	NN	kinase	O	_	_
inhibitors	2759	2769	NNS	inhibitor	O	_	_
.	2769	2770	.	.	O	_	_
D	1
8
2	0	nn
2	1	nn
3	2	nsubj
3	5	prep_to
8	3	dep
8	6	punct
8	7	nn
8	10	prepc_by
10	13	dobj
10	14	prep
13	11	det
13	12	amod
14	16	dep
14	30	prep_to
16	15	nn
16	17	dep
16	18	punct
16	19	dep
19	23	appos
19	27	prep_of
23	21	num
23	22	nn
23	25	dep
25	24	det
30	29	nn
EOX
Y	1
ROOT	0	0	32	1	FRAG	2	0	32	4	S	1	0	6	2	NP	2	0	3	3	NNP	0	0	1	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøº	0	0	1	0	NN	0	1	2	1	MEK	1	1	2	0	NN	0	2	3	1	inhibition	2	2	3	0	VP	0	3	6	2	VBZ	0	3	4	1	leads	3	3	4	0	PP	0	4	6	2	TO	0	4	5	1	to	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	PI3K	5	5	6	0	:	0	6	7	1	/	6	6	7	0	FRAG	0	7	31	2	NP	1	7	9	2	NN	0	7	8	1	AKT	7	7	8	0	NN	0	8	9	1	activation	8	8	9	0	PP	0	9	31	2	IN	0	9	10	1	by	9	9	10	0	S	0	10	31	1	VP	0	10	31	3	VBG	0	10	11	1	relieving	10	10	11	0	NP	2	11	14	3	DT	0	11	12	1	a	11	11	12	0	JJ	0	12	13	1	negative	12	12	13	0	NN	0	13	14	1	feedback	13	13	14	0	PP	0	14	31	2	PP	0	14	28	2	IN	0	14	15	1	on	14	14	15	0	FRAG	0	15	28	3	NP	0	15	18	2	NP	1	15	17	2	NN	0	15	16	1	ERBB	15	15	16	0	NNS	0	16	17	1	receptors	16	16	17	0	NP	0	17	18	1	CD	0	17	18	1	12	17	17	18	0	:	0	18	19	1	/	18	18	19	0	NP	0	19	28	2	NP	0	19	26	3	NP	0	19	20	1	CD	0	19	20	1	8/14	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	0	21	26	2	NP	2	21	24	3	CD	0	21	22	1	6:54	21	21	22	0	NNP	0	22	23	1	PM	22	22	23	0	NNP	0	23	24	1	Ôøºimpact	23	23	24	0	NP	1	24	26	2	DT	0	24	25	1	the	24	24	25	0	NN	0	25	26	1	sensitivity	25	25	26	0	PP	0	26	28	2	IN	0	26	27	1	of	26	26	27	0	NP	0	27	28	1	NNS	0	27	28	1	cancers	27	27	28	0	PP	0	28	31	2	TO	0	28	29	1	to	28	28	29	0	NP	1	29	31	2	NN	0	29	30	1	kinase	29	29	30	0	NNS	0	30	31	1	inhibitors	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	44
For	2771	2774	IN	for	O	_	_
example	2775	2782	NN	example	O	_	_
,	2782	2783	,	,	O	_	_
inhibition	2784	2794	NN	inhibition	O	_	_
of	2795	2797	IN	of	O	_	_
mTORC1	2798	2804	NN	mtorc1	B-GENE	_	_
relieves	2805	2813	VBZ	relieve	O	_	_
proteasomal	2814	2825	JJ	proteasomal	O	_	_
degradation	2826	2837	NN	degradation	O	_	_
of	2838	2840	IN	of	O	_	_
IRS-1	2841	2846	NN	irs-1	B-GENE	_	_
leading	2847	2854	VBG	lead	O	_	_
to	2855	2857	TO	to	O	_	_
feedback	2858	2866	NN	feedback	O	_	_
up-regulation	2867	2880	NN	up-regulation	O	_	_
of	2881	2883	IN	of	O	_	_
IRS-1	2884	2889	NN	irs-1	B-GENE	_	_
/	2889	2890	:	/	B-GENE	_	_
PI3K	2890	2894	NN	pi3k	I-GENE	_	_
/	2894	2895	:	/	B-GENE	_	_
AKT	2895	2898	NNP	AKT	I-GENE	_	_
,	2898	2899	,	,	O	_	_
reducing	2900	2908	VBG	reduce	O	_	_
the	2909	2912	DT	the	O	_	_
efficacy	2913	2921	NN	efficacy	O	_	_
of	2922	2924	IN	of	O	_	_
mTORC1	2925	2931	NN	mtorc1	B-GENE	_	_
inhibitors	2932	2942	NNS	inhibitor	O	_	_
as	2943	2945	IN	as	O	_	_
single	2946	2952	JJ	single	O	_	_
agents	2953	2959	NNS	agent	O	_	_
and	2960	2963	CC	and	O	_	_
prompting	2964	2973	VBG	prompt	O	_	_
the	2974	2977	DT	the	O	_	_
use	2978	2981	NN	use	O	_	_
of	2982	2984	IN	of	O	_	_
combination	2985	2996	NN	combination	O	_	_
therapies	2997	3006	NNS	therapy	O	_	_
(	3007	3008	VBP	(	O	_	_
4	3008	3009	CD	4	O	_	_
‚	3009	3010	CD	‚	O	_	_
Äì6	3010	3013	NN	äì6	O	_	_
)	3013	3014	NN	)	O	_	_
.	3014	3015	.	.	O	_	_
D	1
18
3	5	prep_of
6	1	prep_for
6	3	nsubj
6	8	dobj
8	7	amod
8	10	prep_of
10	11	vmod
11	14	prep_to
14	13	nn
14	16	prep_of
18	6	dep
18	17	punct
18	19	punct
18	38	dep
20	22	dep
20	32	dep
22	24	dobj
22	30	prep_as
22	32	conj_and
24	23	det
24	27	prep_of
27	26	nn
30	29	amod
32	34	dobj
34	33	det
34	37	prep_of
37	36	nn
38	20	nsubj
38	42	dobj
40	39	number
42	40	num
42	41	nn
EOX
Y	1
ROOT	0	0	44	1	FRAG	2	0	44	4	S	3	0	17	4	PP	0	0	2	2	IN	0	0	1	1	For	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	example	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	6	2	NP	0	3	4	1	NN	0	3	4	1	inhibition	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	mTORC1	5	5	6	0	VP	0	6	17	2	VBZ	0	6	7	1	relieves	6	6	7	0	NP	0	7	17	2	NP	1	7	9	2	JJ	0	7	8	1	proteasomal	7	7	8	0	NN	0	8	9	1	degradation	8	8	9	0	PP	0	9	17	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	17	2	NP	0	10	11	1	NN	0	10	11	1	IRS-1	10	10	11	0	VP	0	11	17	2	VBG	0	11	12	1	leading	11	11	12	0	PP	0	12	17	2	TO	0	12	13	1	to	12	12	13	0	NP	0	13	17	2	NP	1	13	15	2	NN	0	13	14	1	feedback	13	13	14	0	NN	0	14	15	1	up-regulation	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	of	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	IRS-1	16	16	17	0	:	0	17	18	1	/	17	17	18	0	FRAG	0	18	43	3	NP	0	18	19	1	NN	0	18	19	1	PI3K	18	18	19	0	:	0	19	20	1	/	19	19	20	0	S	1	20	43	2	NP	0	20	38	2	NP	0	20	21	1	NNP	0	20	21	1	AKT	20	20	21	0	PRN	1	21	38	2	,	0	21	22	1	,	21	21	22	0	S	0	22	38	1	VP	0	22	38	3	VP	0	22	31	3	VBG	0	22	23	1	reducing	22	22	23	0	NP	0	23	28	2	NP	1	23	25	2	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	efficacy	24	24	25	0	PP	0	25	28	2	IN	0	25	26	1	of	25	25	26	0	NP	1	26	28	2	NN	0	26	27	1	mTORC1	26	26	27	0	NNS	0	27	28	1	inhibitors	27	27	28	0	PP	0	28	31	2	IN	0	28	29	1	as	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	single	29	29	30	0	NNS	0	30	31	1	agents	30	30	31	0	CC	0	31	32	1	and	31	31	32	0	VP	0	32	38	2	VBG	0	32	33	1	prompting	32	32	33	0	NP	0	33	38	2	NP	1	33	35	2	DT	0	33	34	1	the	33	33	34	0	NN	0	34	35	1	use	34	34	35	0	PP	0	35	38	2	IN	0	35	36	1	of	35	35	36	0	NP	1	36	38	2	NN	0	36	37	1	combination	36	36	37	0	NNS	0	37	38	1	therapies	37	37	38	0	VP	0	38	43	2	VBP	0	38	39	1	(	38	38	39	0	NP	2	39	43	3	QP	1	39	41	2	CD	0	39	40	1	4	39	39	40	0	CD	0	40	41	1	‚	40	40	41	0	NN	0	41	42	1	Äì6	41	41	42	0	NN	0	42	43	1	)	42	42	43	0	.	0	43	44	1	.	43	43	44	0
EOS
T	50
PI3K	3016	3020	NN	pi3k	O	_	_
and	3021	3024	CC	and	O	_	_
AKT	3025	3028	NN	akt	O	_	_
inhibitors	3029	3039	NNS	inhibitor	O	_	_
relieve	3040	3047	VBP	relieve	O	_	_
a	3048	3049	DT	a	O	_	_
negative	3050	3058	JJ	negative	O	_	_
feedback	3059	3067	NN	feedback	O	_	_
on	3068	3070	IN	on	O	_	_
ERBB	3071	3075	NN	erbb	B-GENE	_	_
receptors	3076	3085	NNS	receptor	I-GENE	_	_
and	3086	3089	CC	and	O	_	_
other	3090	3095	JJ	other	O	_	_
RTKs	3096	3100	NNS	rtk	O	_	_
leading	3101	3108	VBG	lead	O	_	_
to	3109	3111	TO	to	O	_	_
partial	3112	3119	JJ	partial	O	_	_
re-activation	3120	3133	NN	re-activation	O	_	_
of	3134	3136	IN	of	O	_	_
PI3K	3137	3141	NN	pi3k	B-GENE	_	_
/	3141	3142	:	/	B-GENE	_	_
AKT	3142	3145	NN	akt	I-GENE	_	_
signaling	3146	3155	NN	signaling	O	_	_
,	3155	3156	,	,	O	_	_
MEK	3157	3160	NN	mek	B-GENE	_	_
/	3160	3161	:	/	B-GENE	_	_
ERK	3161	3164	NN	erk	I-GENE	_	_
signaling	3165	3174	NN	signaling	O	_	_
,	3174	3175	,	,	O	_	_
and	3176	3179	CC	and	O	_	_
other	3180	3185	JJ	other	O	_	_
downstream	3186	3196	JJ	downstream	O	_	_
pathways	3197	3205	NNS	pathway	O	_	_
,	3205	3206	,	,	O	_	_
potentially	3207	3218	RB	potentially	O	_	_
limiting	3219	3227	VBG	limit	O	_	_
the	3228	3231	DT	the	O	_	_
utility	3232	3239	NN	utility	O	_	_
of	3240	3242	IN	of	O	_	_
PI3K	3243	3247	NN	pi3k	B-GENE	_	_
inhibitors	3248	3258	NNS	inhibitor	O	_	_
as	3259	3261	IN	as	O	_	_
single	3262	3268	JJ	single	O	_	_
agents	3269	3275	NNS	agent	O	_	_
(	3276	3277	VBP	(	O	_	_
7	3277	3278	CD	7	O	_	_
‚	3278	3279	CD	‚	O	_	_
Äì9	3279	3282	NN	äì9	O	_	_
)	3282	3283	NN	)	O	_	_
.	3283	3284	.	.	O	_	_
D	1
4
0	2	conj_and
3	0	nn
3	2	nn
4	3	nsubj
4	7	dobj
4	14	prepc_on
4	35	xcomp
7	5	det
7	6	amod
10	9	nn
10	13	conj_and
13	12	amod
14	10	nsubj
14	13	nsubj
14	17	prep_to
14	27	dobj
14	32	dobj
17	16	amod
17	19	prep_of
19	22	dep
22	20	punct
22	21	nn
22	24	appos
22	25	punct
27	26	nn
27	32	conj_and
27	34	advmod
32	30	amod
32	31	amod
35	37	dobj
35	44	advcl
37	36	det
37	40	prep_of
40	39	nn
43	42	amod
44	41	mark
44	43	nsubj
44	48	dobj
46	45	number
48	46	num
48	47	nn
EOX
Y	1
ROOT	0	0	50	1	S	1	0	50	3	NP	1	0	4	2	NP	0	0	3	3	NN	0	0	1	1	PI3K	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	NN	0	2	3	1	AKT	2	2	3	0	NNS	0	3	4	1	inhibitors	3	3	4	0	VP	0	4	49	4	VBP	0	4	5	1	relieve	4	4	5	0	NP	2	5	8	3	DT	0	5	6	1	a	5	5	6	0	JJ	0	6	7	1	negative	6	6	7	0	NN	0	7	8	1	feedback	7	7	8	0	PP	0	8	35	2	IN	0	8	9	1	on	8	8	9	0	S	1	9	35	2	NP	0	9	14	3	NP	1	9	11	2	NN	0	9	10	1	ERBB	9	9	10	0	NNS	0	10	11	1	receptors	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NP	1	12	14	2	JJ	0	12	13	1	other	12	12	13	0	NNS	0	13	14	1	RTKs	13	13	14	0	VP	0	14	35	3	VBG	0	14	15	1	leading	14	14	15	0	PP	0	15	26	2	TO	0	15	16	1	to	15	15	16	0	NP	0	16	26	2	NP	1	16	18	2	JJ	0	16	17	1	partial	16	16	17	0	NN	0	17	18	1	re-activation	17	17	18	0	PP	0	18	26	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	26	2	NP	0	19	20	1	NN	0	19	20	1	PI3K	19	19	20	0	PRN	1	20	26	3	:	0	20	21	1	/	20	20	21	0	NP	0	21	25	3	NP	1	21	23	2	NN	0	21	22	1	AKT	21	21	22	0	NN	0	22	23	1	signaling	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	0	24	25	1	NN	0	24	25	1	MEK	24	24	25	0	:	0	25	26	1	/	25	25	26	0	NP	0	26	35	6	NP	1	26	28	2	NN	0	26	27	1	ERK	26	26	27	0	NN	0	27	28	1	signaling	27	27	28	0	,	0	28	29	1	,	28	28	29	0	CC	0	29	30	1	and	29	29	30	0	NP	2	30	33	3	JJ	0	30	31	1	other	30	30	31	0	JJ	0	31	32	1	downstream	31	31	32	0	NNS	0	32	33	1	pathways	32	32	33	0	,	0	33	34	1	,	33	33	34	0	ADVP	0	34	35	1	RB	0	34	35	1	potentially	34	34	35	0	S	0	35	49	1	VP	0	35	49	3	VBG	0	35	36	1	limiting	35	35	36	0	NP	0	36	41	2	NP	1	36	38	2	DT	0	36	37	1	the	36	36	37	0	NN	0	37	38	1	utility	37	37	38	0	PP	0	38	41	2	IN	0	38	39	1	of	38	38	39	0	NP	1	39	41	2	NN	0	39	40	1	PI3K	39	39	40	0	NNS	0	40	41	1	inhibitors	40	40	41	0	SBAR	1	41	49	2	IN	0	41	42	1	as	41	41	42	0	S	1	42	49	2	NP	1	42	44	2	JJ	0	42	43	1	single	42	42	43	0	NNS	0	43	44	1	agents	43	43	44	0	VP	0	44	49	2	VBP	0	44	45	1	(	44	44	45	0	NP	2	45	49	3	QP	1	45	47	2	CD	0	45	46	1	7	45	45	46	0	CD	0	46	47	1	‚	46	46	47	0	NN	0	47	48	1	Äì9	47	47	48	0	NN	0	48	49	1	)	48	48	49	0	.	0	49	50	1	.	49	49	50	0
EOS
T	53
Targeted	3285	3293	VBN	target	O	_	_
therapies	3294	3303	NNS	therapy	O	_	_
,	3303	3304	,	,	O	_	_
such	3305	3309	JJ	such	O	_	_
as	3310	3312	IN	as	O	_	_
the	3313	3316	DT	the	O	_	_
EGFR	3317	3321	NN	egfr	B-GENE	_	_
inhibitors	3322	3332	NNS	inhibitor	O	_	_
gefitinib	3333	3342	NN	gefitinib	O	_	_
and	3343	3346	CC	and	O	_	_
erlotinib	3347	3356	NN	erlotinib	O	_	_
,	3356	3357	,	,	O	_	_
are	3358	3361	VBP	be	O	_	_
highly	3362	3368	RB	highly	O	_	_
effective	3369	3378	JJ	effective	O	_	_
when	3379	3383	WRB	when	O	_	_
cells	3384	3389	NNS	cell	O	_	_
are	3390	3393	VBP	be	O	_	_
‚	3394	3395	CD	‚	O	_	_
Äúaddicted	3395	3405	JJ	äúaddicted	O	_	_
‚	3405	3406	NN	‚	O	_	_
Äù	3406	3408	NN	äù	O	_	_
,	3408	3409	,	,	O	_	_
and	3410	3413	CC	and	O	_	_
inhibition	3414	3424	NN	inhibition	O	_	_
of	3425	3427	IN	of	O	_	_
the	3428	3431	DT	the	O	_	_
target	3432	3438	NN	target	O	_	_
leads	3439	3444	VBZ	lead	O	_	_
to	3445	3447	TO	to	O	_	_
down-regulation	3448	3463	NN	down-regulation	O	_	_
of	3464	3466	IN	of	O	_	_
critical	3467	3475	JJ	critical	O	_	_
growth	3476	3482	NN	growth	O	_	_
and	3483	3486	CC	and	O	_	_
survival	3487	3495	NN	survival	O	_	_
signaling	3496	3505	NN	signaling	O	_	_
pathways	3506	3514	NNS	pathway	O	_	_
,	3514	3515	,	,	O	_	_
especially	3516	3526	RB	especially	O	_	_
PI3K	3527	3531	NN	pi3k	B-GENE	_	_
/	3531	3532	:	/	B-GENE	_	_
AKT	3532	3535	NNP	AKT	I-GENE	_	_
and	3536	3539	CC	and	O	_	_
MEK	3540	3543	NN	mek	B-GENE	_	_
/	3543	3544	:	/	B-GENE	_	_
ERK	3544	3547	NN	erk	I-GENE	_	_
(	3548	3549	CD	(	O	_	_
10	3549	3551	CD	10	O	_	_
‚	3551	3552	CD	‚	O	_	_
Äì12	3552	3556	NN	äì12	O	_	_
)	3556	3557	NN	)	O	_	_
.	3557	3558	.	.	O	_	_
D	1
0
0	14	ccomp
0	28	conj_and
1	8	prep_such_as
1	10	prep_such_as
8	5	det
8	6	nn
8	7	nn
8	10	conj_and
14	1	nsubj
14	12	cop
14	13	advmod
14	21	ccomp
21	15	advmod
21	16	nsubj
21	17	cop
21	18	num
21	19	amod
21	20	nn
24	27	prep_of
27	26	det
28	24	nsubj
28	30	prep_to
30	33	prep_of
30	37	prep_of
33	32	amod
33	37	conj_and
33	40	appos
33	42	dep
33	44	dep
33	46	dep
37	35	nn
37	36	nn
40	39	advmod
42	41	punct
42	44	conj_and
42	45	punct
46	47	num
46	51	dep
49	48	number
51	49	num
51	50	nn
EOX
Y	1
ROOT	0	0	53	1	S	0	0	53	6	S	0	0	1	1	VP	0	0	1	1	VBN	0	0	1	1	Targeted	0	0	1	0	S	1	1	22	2	NP	0	1	12	4	NP	0	1	2	1	NNS	0	1	2	1	therapies	1	1	2	0	,	0	2	3	1	,	2	2	3	0	PP	1	3	11	3	JJ	0	3	4	1	such	3	3	4	0	IN	0	4	5	1	as	4	4	5	0	NP	0	5	11	3	NP	3	5	9	4	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	EGFR	6	6	7	0	NNS	0	7	8	1	inhibitors	7	7	8	0	NN	0	8	9	1	gefitinib	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	erlotinib	10	10	11	0	,	0	11	12	1	,	11	11	12	0	VP	1	12	22	2	VBP	0	12	13	1	are	12	12	13	0	ADJP	1	13	22	3	RB	0	13	14	1	highly	13	13	14	0	JJ	0	14	15	1	effective	14	14	15	0	SBAR	1	15	22	2	WHADVP	0	15	16	1	WRB	0	15	16	1	when	15	15	16	0	S	1	16	22	2	NP	0	16	17	1	NNS	0	16	17	1	cells	16	16	17	0	VP	1	17	22	2	VBP	0	17	18	1	are	17	17	18	0	NP	3	18	22	4	CD	0	18	19	1	‚	18	18	19	0	JJ	0	19	20	1	Äúaddicted	19	19	20	0	NN	0	20	21	1	‚	20	20	21	0	NN	0	21	22	1	Äù	21	21	22	0	,	0	22	23	1	,	22	22	23	0	CC	0	23	24	1	and	23	23	24	0	S	1	24	52	2	NP	0	24	28	2	NP	0	24	25	1	NN	0	24	25	1	inhibition	24	24	25	0	PP	0	25	28	2	IN	0	25	26	1	of	25	25	26	0	NP	1	26	28	2	DT	0	26	27	1	the	26	26	27	0	NN	0	27	28	1	target	27	27	28	0	VP	0	28	52	2	VBZ	0	28	29	1	leads	28	28	29	0	PP	0	29	52	2	TO	0	29	30	1	to	29	29	30	0	NP	0	30	52	2	NP	0	30	31	1	NN	0	30	31	1	down-regulation	30	30	31	0	PP	0	31	52	2	IN	0	31	32	1	of	31	31	32	0	NP	0	32	52	5	NP	0	32	38	3	NP	1	32	34	2	JJ	0	32	33	1	critical	32	32	33	0	NN	0	33	34	1	growth	33	33	34	0	CC	0	34	35	1	and	34	34	35	0	NP	2	35	38	3	NN	0	35	36	1	survival	35	35	36	0	NN	0	36	37	1	signaling	36	36	37	0	NNS	0	37	38	1	pathways	37	37	38	0	,	0	38	39	1	,	38	38	39	0	NP	1	39	41	2	RB	0	39	40	1	especially	39	39	40	0	NN	0	40	41	1	PI3K	40	40	41	0	PRN	1	41	46	3	:	0	41	42	1	/	41	41	42	0	NP	0	42	45	3	NP	0	42	43	1	NNP	0	42	43	1	AKT	42	42	43	0	CC	0	43	44	1	and	43	43	44	0	NP	0	44	45	1	NN	0	44	45	1	MEK	44	44	45	0	:	0	45	46	1	/	45	45	46	0	NP	0	46	52	2	NP	0	46	48	2	NN	0	46	47	1	ERK	46	46	47	0	CD	0	47	48	1	(	47	47	48	0	NP	2	48	52	3	QP	1	48	50	2	CD	0	48	49	1	10	48	48	49	0	CD	0	49	50	1	‚	49	49	50	0	NN	0	50	51	1	Äì12	50	50	51	0	NN	0	51	52	1	)	51	51	52	0	.	0	52	53	1	.	52	52	53	0
EOS
T	51
We	3559	3561	PRP	we	O	_	_
recently	3562	3570	RB	recently	O	_	_
found	3571	3576	VBD	find	O	_	_
that	3577	3581	IN	that	O	_	_
treatment	3582	3591	NN	treatment	O	_	_
with	3592	3596	IN	with	O	_	_
a	3597	3598	DT	a	O	_	_
combination	3599	3610	NN	combination	O	_	_
of	3611	3613	IN	of	O	_	_
a	3614	3615	DT	a	O	_	_
MEK	3616	3619	NN	mek	B-GENE	_	_
inhibitor	3620	3629	NN	inhibitor	O	_	_
and	3630	3633	CC	and	O	_	_
a	3634	3635	DT	a	O	_	_
PI3K	3636	3640	NN	pi3k	B-GENE	_	_
inhibitor	3641	3650	NN	inhibitor	O	_	_
led	3651	3654	VBD	lead	O	_	_
to	3655	3657	TO	to	O	_	_
significant	3658	3669	JJ	significant	O	_	_
apoptosis	3670	3679	NN	apoptosis	O	_	_
in	3680	3682	IN	in	O	_	_
EGFR	3683	3687	NN	egfr	B-GENE	_	_
driven	3688	3694	VBN	drive	O	_	_
cancers	3695	3702	NNS	cancer	O	_	_
,	3702	3703	,	,	O	_	_
similar	3704	3711	JJ	similar	O	_	_
to	3712	3714	TO	to	O	_	_
that	3715	3719	DT	that	O	_	_
induced	3720	3727	VBN	induce	O	_	_
by	3728	3730	IN	by	O	_	_
an	3731	3733	DT	a	O	_	_
EGFR	3734	3738	NN	egfr	B-GENE	_	_
TKI	3739	3742	NN	tkus	I-GENE	_	_
,	3742	3743	,	,	O	_	_
whereas	3744	3751	IN	whereas	O	_	_
treatment	3752	3761	NN	treatment	O	_	_
with	3762	3766	IN	with	O	_	_
either	3767	3773	CC	either	O	_	_
pathway	3774	3781	NN	pathway	O	_	_
inhibitor	3782	3791	NN	inhibitor	O	_	_
alone	3792	3797	RB	alone	O	_	_
did	3798	3801	VBD	do	O	_	_
not	3802	3805	RB	not	O	_	_
induce	3806	3812	VB	induce	O	_	_
marked	3813	3819	JJ	marked	O	_	_
cell	3820	3824	NN	cell	O	_	_
death	3825	3830	NN	death	O	_	_
(	3831	3832	CD	(	O	_	_
11	3832	3834	CD	11	O	_	_
)	3834	3835	NN	)	O	_	_
.	3835	3836	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	advmod
2	16	ccomp
4	7	prep_with
7	6	det
7	11	prep_of
7	15	prep_of
11	9	det
11	10	nn
11	15	conj_and
15	13	det
15	14	nn
16	3	mark
16	4	nsubj
16	19	prep_to
16	21	prep_in
19	18	amod
21	22	vmod
22	23	dobj
23	25	amod
23	43	dep
25	27	prep_to
27	28	vmod
28	32	agent
32	30	det
32	31	nn
35	39	prep_with
39	37	advmod
39	38	nn
43	34	mark
43	35	nsubj
43	40	advmod
43	41	aux
43	42	neg
43	46	dobj
46	44	amod
46	45	nn
46	49	dep
48	47	number
49	48	dep
EOX
Y	1
ROOT	0	0	51	1	S	2	0	51	4	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	ADVP	0	1	2	1	RB	0	1	2	1	recently	1	1	2	0	VP	0	2	50	2	VBD	0	2	3	1	found	2	2	3	0	SBAR	1	3	50	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	50	2	NP	0	4	16	2	NP	0	4	5	1	NN	0	4	5	1	treatment	4	4	5	0	PP	0	5	16	2	IN	0	5	6	1	with	5	5	6	0	NP	0	6	16	2	NP	1	6	8	2	DT	0	6	7	1	a	6	6	7	0	NN	0	7	8	1	combination	7	7	8	0	PP	0	8	16	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	16	3	NP	2	9	12	3	DT	0	9	10	1	a	9	9	10	0	NN	0	10	11	1	MEK	10	10	11	0	NN	0	11	12	1	inhibitor	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	NP	2	13	16	3	DT	0	13	14	1	a	13	13	14	0	NN	0	14	15	1	PI3K	14	14	15	0	NN	0	15	16	1	inhibitor	15	15	16	0	VP	0	16	50	3	VBD	0	16	17	1	led	16	16	17	0	PP	0	17	20	2	TO	0	17	18	1	to	17	17	18	0	NP	1	18	20	2	JJ	0	18	19	1	significant	18	18	19	0	NN	0	19	20	1	apoptosis	19	19	20	0	PP	0	20	50	2	IN	0	20	21	1	in	20	20	21	0	NP	0	21	50	2	NP	0	21	22	1	NN	0	21	22	1	EGFR	21	21	22	0	VP	0	22	50	2	VBN	0	22	23	1	driven	22	22	23	0	NP	0	23	50	5	NP	0	23	24	1	NNS	0	23	24	1	cancers	23	23	24	0	,	0	24	25	1	,	24	24	25	0	ADJP	0	25	33	2	JJ	0	25	26	1	similar	25	25	26	0	PP	0	26	33	2	TO	0	26	27	1	to	26	26	27	0	NP	0	27	33	2	NP	0	27	28	1	DT	0	27	28	1	that	27	27	28	0	VP	0	28	33	2	VBN	0	28	29	1	induced	28	28	29	0	PP	0	29	33	2	IN	0	29	30	1	by	29	29	30	0	NP	2	30	33	3	DT	0	30	31	1	an	30	30	31	0	NN	0	31	32	1	EGFR	31	31	32	0	NN	0	32	33	1	TKI	32	32	33	0	,	0	33	34	1	,	33	33	34	0	SBAR	1	34	50	2	IN	0	34	35	1	whereas	34	34	35	0	S	2	35	50	3	NP	0	35	40	2	NP	0	35	36	1	NN	0	35	36	1	treatment	35	35	36	0	PP	0	36	40	2	IN	0	36	37	1	with	36	36	37	0	NP	2	37	40	3	ADVP	0	37	38	1	CC	0	37	38	1	either	37	37	38	0	NN	0	38	39	1	pathway	38	38	39	0	NN	0	39	40	1	inhibitor	39	39	40	0	ADVP	0	40	41	1	RB	0	40	41	1	alone	40	40	41	0	VP	2	41	50	3	VBD	0	41	42	1	did	41	41	42	0	RB	0	42	43	1	not	42	42	43	0	VP	0	43	50	2	VB	0	43	44	1	induce	43	43	44	0	NP	0	44	50	2	NP	2	44	47	3	JJ	0	44	45	1	marked	44	44	45	0	NN	0	45	46	1	cell	45	45	46	0	NN	0	46	47	1	death	46	46	47	0	ADJP	1	47	50	2	QP	1	47	49	2	CD	0	47	48	1	(	47	47	48	0	CD	0	48	49	1	11	48	48	49	0	NN	0	49	50	1	)	49	49	50	0	.	0	50	51	1	.	50	50	51	0
EOS
T	16
In	3837	3839	IN	in	O	_	_
those	3840	3845	DT	those	O	_	_
studies	3846	3853	NNS	study	O	_	_
,	3853	3854	,	,	O	_	_
treatment	3855	3864	NN	treatment	O	_	_
with	3865	3869	IN	with	O	_	_
a	3870	3871	DT	a	O	_	_
single-agent	3872	3884	JJ	single-agent	O	_	_
MEK	3885	3888	NN	mek	B-GENE	_	_
inhibitor	3889	3898	NN	inhibitor	O	_	_
led	3899	3902	VBD	lead	O	_	_
to	3903	3905	TO	to	O	_	_
increased	3906	3915	VBN	increase	O	_	_
AKT	3916	3919	NN	akt	B-GENE	_	_
phosphorylation	3920	3935	NN	phosphorylation	O	_	_
.	3935	3936	.	.	O	_	_
D	1
10
2	1	det
4	9	prep_with
9	6	det
9	7	amod
9	8	nn
10	2	prep_in
10	4	nsubj
10	14	prep_to
14	12	amod
14	13	nn
EOX
Y	1
ROOT	0	0	16	1	S	3	0	16	5	PP	0	0	3	2	IN	0	0	1	1	In	0	0	1	0	NP	1	1	3	2	DT	0	1	2	1	those	1	1	2	0	NNS	0	2	3	1	studies	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	0	4	10	2	NP	0	4	5	1	NN	0	4	5	1	treatment	4	4	5	0	PP	0	5	10	2	IN	0	5	6	1	with	5	5	6	0	NP	3	6	10	4	DT	0	6	7	1	a	6	6	7	0	JJ	0	7	8	1	single-agent	7	7	8	0	NN	0	8	9	1	MEK	8	8	9	0	NN	0	9	10	1	inhibitor	9	9	10	0	VP	0	10	15	2	VBD	0	10	11	1	led	10	10	11	0	PP	0	11	15	2	TO	0	11	12	1	to	11	11	12	0	NP	2	12	15	3	VBN	0	12	13	1	increased	12	12	13	0	NN	0	13	14	1	AKT	13	13	14	0	NN	0	14	15	1	phosphorylation	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	35
Indeed	3937	3943	RB	indeed	O	_	_
,	3943	3944	,	,	O	_	_
several	3945	3952	JJ	several	O	_	_
other	3953	3958	JJ	other	O	_	_
studies	3959	3966	NNS	study	O	_	_
have	3967	3971	VBP	have	O	_	_
shown	3972	3977	VBN	show	O	_	_
that	3978	3982	IN	that	O	_	_
MEK	3983	3986	NN	mek	B-GENE	_	_
inhibition	3987	3997	NN	inhibition	O	_	_
leads	3998	4003	VBZ	lead	O	_	_
to	4004	4006	TO	to	O	_	_
increased	4007	4016	VBN	increase	O	_	_
AKT	4017	4020	NN	akt	O	_	_
activation	4021	4031	NN	activation	O	_	_
,	4031	4032	,	,	O	_	_
often	4033	4038	RB	often	O	_	_
resulting	4039	4048	VBG	result	O	_	_
in	4049	4051	IN	in	O	_	_
reduced	4052	4059	VBN	reduce	O	_	_
efficacy	4060	4068	NN	efficacy	O	_	_
of	4069	4071	IN	of	O	_	_
MEK	4072	4075	NN	mek	B-GENE	_	_
inhibitors	4076	4086	NNS	inhibitor	O	_	_
as	4087	4089	IN	as	O	_	_
single	4090	4096	JJ	single	O	_	_
agents	4097	4103	NNS	agent	O	_	_
(	4104	4105	VBP	(	O	_	_
11	4105	4107	CD	11	O	_	_
,	4107	4108	,	,	O	_	_
13	4109	4111	CD	13	O	_	_
‚	4111	4112	CD	‚	O	_	_
Äì15	4112	4116	NN	äì15	O	_	_
)	4116	4117	NN	)	O	_	_
.	4117	4118	.	.	O	_	_
D	1
6
4	2	amod
4	3	amod
6	0	advmod
6	4	nsubj
6	5	aux
6	10	ccomp
6	27	advcl
9	8	nn
10	7	mark
10	9	nsubj
10	14	prep_to
14	12	amod
14	13	nn
14	17	vmod
17	16	advmod
17	20	prep_in
20	19	amod
20	23	prep_of
23	22	nn
26	25	amod
27	24	mark
27	26	nsubj
27	28	dobj
28	33	appos
31	30	number
33	31	num
33	32	nn
EOX
Y	1
ROOT	0	0	35	1	S	3	0	35	5	ADVP	0	0	1	1	RB	0	0	1	1	Indeed	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	2	2	5	3	JJ	0	2	3	1	several	2	2	3	0	JJ	0	3	4	1	other	3	3	4	0	NNS	0	4	5	1	studies	4	4	5	0	VP	1	5	34	2	VBP	0	5	6	1	have	5	5	6	0	VP	0	6	34	3	VBN	0	6	7	1	shown	6	6	7	0	SBAR	1	7	24	2	IN	0	7	8	1	that	7	7	8	0	S	1	8	24	2	NP	1	8	10	2	NN	0	8	9	1	MEK	8	8	9	0	NN	0	9	10	1	inhibition	9	9	10	0	VP	0	10	24	2	VBZ	0	10	11	1	leads	10	10	11	0	PP	0	11	24	2	TO	0	11	12	1	to	11	11	12	0	NP	0	12	24	3	NP	2	12	15	3	VBN	0	12	13	1	increased	12	12	13	0	NN	0	13	14	1	AKT	13	13	14	0	NN	0	14	15	1	activation	14	14	15	0	,	0	15	16	1	,	15	15	16	0	VP	1	16	24	3	ADVP	0	16	17	1	RB	0	16	17	1	often	16	16	17	0	VBG	0	17	18	1	resulting	17	17	18	0	PP	0	18	24	2	IN	0	18	19	1	in	18	18	19	0	NP	0	19	24	2	NP	1	19	21	2	VBN	0	19	20	1	reduced	19	19	20	0	NN	0	20	21	1	efficacy	20	20	21	0	PP	0	21	24	2	IN	0	21	22	1	of	21	21	22	0	NP	1	22	24	2	NN	0	22	23	1	MEK	22	22	23	0	NNS	0	23	24	1	inhibitors	23	23	24	0	SBAR	1	24	34	2	IN	0	24	25	1	as	24	24	25	0	S	1	25	34	2	NP	1	25	27	2	JJ	0	25	26	1	single	25	25	26	0	NNS	0	26	27	1	agents	26	26	27	0	VP	0	27	34	2	VBP	0	27	28	1	(	27	27	28	0	NP	0	28	34	3	NP	0	28	29	1	CD	0	28	29	1	11	28	28	29	0	,	0	29	30	1	,	29	29	30	0	NP	2	30	34	3	QP	1	30	32	2	CD	0	30	31	1	13	30	30	31	0	CD	0	31	32	1	‚	31	31	32	0	NN	0	32	33	1	Äì15	32	32	33	0	NN	0	33	34	1	)	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	11
However	4119	4126	RB	however	O	_	_
,	4126	4127	,	,	O	_	_
the	4128	4131	DT	the	O	_	_
molecular	4132	4141	JJ	molecular	O	_	_
mechanisms	4142	4152	NNS	mechanism	O	_	_
underlying	4153	4163	VBG	underlie	O	_	_
this	4164	4168	DT	this	O	_	_
feedback	4169	4177	NN	feedback	O	_	_
remain	4178	4184	VBP	remain	O	_	_
unknown	4185	4192	JJ	unknown	O	_	_
.	4192	4193	.	.	O	_	_
D	1
9
4	2	det
4	3	amod
4	5	vmod
5	7	dobj
7	6	det
9	0	advmod
9	4	nsubj
9	8	cop
EOX
Y	1
ROOT	0	0	11	1	S	3	0	11	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	8	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	molecular	3	3	4	0	NNS	0	4	5	1	mechanisms	4	4	5	0	VP	0	5	8	2	VBG	0	5	6	1	underlying	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	this	6	6	7	0	NN	0	7	8	1	feedback	7	7	8	0	VP	1	8	10	2	VBP	0	8	9	1	remain	8	8	9	0	ADJP	0	9	10	1	JJ	0	9	10	1	unknown	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	13
Several	4194	4201	JJ	several	O	_	_
mechanisms	4202	4212	NNS	mechanism	O	_	_
for	4213	4216	IN	for	O	_	_
MEK	4217	4220	NN	mek	B-GENE	_	_
feedback	4221	4229	NN	feedback	O	_	_
regulation	4230	4240	NN	regulation	O	_	_
of	4241	4243	IN	of	O	_	_
AKT	4244	4247	NN	akt	O	_	_
signaling	4248	4257	NN	signaling	O	_	_
have	4258	4262	VBP	have	O	_	_
been	4263	4267	VBN	be	O	_	_
suggested	4268	4277	VBN	suggest	O	_	_
.	4277	4278	.	.	O	_	_
D	1
11
1	0	amod
1	5	prep_for
5	3	nn
5	4	nn
5	8	prep_of
8	7	nn
11	1	nsubjpass
11	9	aux
11	10	auxpass
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	0	0	9	2	NP	1	0	2	2	JJ	0	0	1	1	Several	0	0	1	0	NNS	0	1	2	1	mechanisms	1	1	2	0	PP	0	2	9	2	IN	0	2	3	1	for	2	2	3	0	NP	0	3	9	2	NP	2	3	6	3	NN	0	3	4	1	MEK	3	3	4	0	NN	0	4	5	1	feedback	4	4	5	0	NN	0	5	6	1	regulation	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	of	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	AKT	7	7	8	0	NN	0	8	9	1	signaling	8	8	9	0	VP	1	9	12	2	VBP	0	9	10	1	have	9	9	10	0	VP	1	10	12	2	VBN	0	10	11	1	been	10	10	11	0	VP	0	11	12	1	VBN	0	11	12	1	suggested	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	29
For	4279	4282	IN	for	O	_	_
example	4283	4290	NN	example	O	_	_
,	4290	4291	,	,	O	_	_
ERK-	4292	4296	NN	erk-_NN	O	_	_
mediated	4297	4305	VBD	mediate	O	_	_
serine	4306	4312	NN	serine	O	_	_
phosphorylation	4313	4328	NN	phosphorylation	O	_	_
of	4329	4331	IN	of	O	_	_
the	4332	4335	DT	the	O	_	_
GAB1	4336	4340	NN	gab1	B-GENE	_	_
adaptor	4341	4348	NN	adaptor	I-GENE	_	_
has	4349	4352	VBZ	have	O	_	_
been	4353	4357	VBN	be	O	_	_
shown	4358	4363	VBN	show	O	_	_
to	4364	4366	TO	to	O	_	_
negatively	4367	4377	RB	negatively	O	_	_
regulate	4378	4386	VB	regulate	O	_	_
GAB1-PI3K	4387	4396	NN	gab1-pi3k	B-GENE	_	_
binding	4397	4404	NN	binding	O	_	_
and	4405	4408	CC	and	O	_	_
downstream	4409	4419	JJ	downstream	O	_	_
AKT	4420	4423	NN	akt	O	_	_
signaling	4424	4433	NN	signaling	O	_	_
(	4434	4435	CD	(	O	_	_
16	4435	4437	CD	16	O	_	_
‚	4437	4438	CD	‚	O	_	_
Äì18	4438	4442	NN	äì18	O	_	_
)	4442	4443	NN	)	O	_	_
.	4443	4444	.	.	O	_	_
D	1
4
4	1	prep_for
4	3	nsubj
4	13	ccomp
6	5	nn
6	10	prep_of
10	8	det
10	9	nn
13	6	nsubjpass
13	11	aux
13	12	auxpass
13	16	xcomp
16	14	aux
16	15	advmod
16	18	dobj
16	21	dobj
18	17	nn
18	21	conj_and
21	20	amod
21	27	dep
22	23	number
22	24	number
22	25	number
27	22	num
27	26	nn
EOX
Y	1
ROOT	0	0	29	1	S	3	0	29	5	PP	0	0	2	2	IN	0	0	1	1	For	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	example	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ERK-	3	3	4	0	VP	0	4	28	2	VBD	0	4	5	1	mediated	4	4	5	0	SBAR	0	5	28	1	S	1	5	28	2	NP	0	5	11	2	NP	1	5	7	2	NN	0	5	6	1	serine	5	5	6	0	NN	0	6	7	1	phosphorylation	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	GAB1	9	9	10	0	NN	0	10	11	1	adaptor	10	10	11	0	VP	1	11	28	2	VBZ	0	11	12	1	has	11	11	12	0	VP	1	12	28	2	VBN	0	12	13	1	been	12	12	13	0	VP	0	13	28	2	VBN	0	13	14	1	shown	13	13	14	0	S	0	14	28	1	VP	1	14	28	2	TO	0	14	15	1	to	14	14	15	0	VP	1	15	28	3	ADVP	0	15	16	1	RB	0	15	16	1	negatively	15	15	16	0	VB	0	16	17	1	regulate	16	16	17	0	NP	0	17	28	3	NP	1	17	19	2	NN	0	17	18	1	GAB1-PI3K	17	17	18	0	NN	0	18	19	1	binding	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	NP	0	20	28	2	NP	1	20	22	2	JJ	0	20	21	1	downstream	20	20	21	0	NN	0	21	22	1	AKT	21	21	22	0	NP	2	22	28	3	QP	0	22	26	4	NN	0	22	23	1	signaling	22	22	23	0	CD	0	23	24	1	(	23	23	24	0	CD	0	24	25	1	16	24	24	25	0	CD	0	25	26	1	‚	25	25	26	0	NN	0	26	27	1	Äì18	26	26	27	0	NN	0	27	28	1	)	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	26
MEK	4445	4448	NN	mek	B-GENE	_	_
inhibition	4449	4459	NN	inhibition	O	_	_
can	4460	4463	MD	can	O	_	_
also	4464	4468	RB	also	O	_	_
down-regulate	4469	4482	VB	down-regulate	O	_	_
mTORC1	4483	4489	NN	mtorc1	B-GENE	_	_
signaling	4490	4499	NN	signaling	O	_	_
,	4499	4500	,	,	O	_	_
relieving	4501	4510	VBG	relieve	O	_	_
negative	4511	4519	JJ	negative	O	_	_
feedback	4520	4528	NN	feedback	O	_	_
on	4529	4531	IN	on	O	_	_
IGF-IR	4532	4538	NN	igf-ir	B-GENE	_	_
/	4538	4539	:	/	B-GENE	_	_
IRS	4539	4542	NNP	IRS	I-GENE	_	_
-1	4542	4544	CD	-1	I-GENE	_	_
and	4545	4548	CC	and	O	_	_
activating	4549	4559	VBG	activate	O	_	_
PI3K	4560	4564	NN	pi3k	B-GENE	_	_
/	4564	4565	:	/	B-GENE	_	_
AKT	4565	4568	NN	akt	I-GENE	_	_
signaling	4569	4578	NN	signaling	O	_	_
(	4579	4580	CD	(	O	_	_
19	4580	4582	CD	19	O	_	_
)	4582	4583	NN	)	O	_	_
.	4583	4584	.	.	O	_	_
D	1
4
1	0	nn
4	1	nsubj
4	2	aux
4	3	advmod
4	6	dobj
4	8	vmod
6	5	nn
8	10	dobj
10	9	amod
10	12	prep_on
10	14	dep
10	21	dep
14	13	punct
14	15	num
14	16	prep
14	19	punct
16	18	pobj
18	17	amod
21	20	nn
21	24	dep
23	22	number
24	23	num
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	1	0	2	2	NN	0	0	1	1	MEK	0	0	1	0	NN	0	1	2	1	inhibition	1	1	2	0	VP	2	2	25	3	MD	0	2	3	1	can	2	2	3	0	ADVP	0	3	4	1	RB	0	3	4	1	also	3	3	4	0	VP	0	4	25	4	VB	0	4	5	1	down-regulate	4	4	5	0	NP	1	5	7	2	NN	0	5	6	1	mTORC1	5	5	6	0	NN	0	6	7	1	signaling	6	6	7	0	,	0	7	8	1	,	7	7	8	0	S	0	8	25	1	VP	0	8	25	2	VBG	0	8	9	1	relieving	8	8	9	0	NP	0	9	25	4	NP	1	9	11	2	JJ	0	9	10	1	negative	9	9	10	0	NN	0	10	11	1	feedback	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	on	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	IGF-IR	12	12	13	0	PRN	1	13	20	3	:	0	13	14	1	/	13	13	14	0	NP	0	14	19	2	NP	0	14	16	2	NNP	0	14	15	1	IRS	14	14	15	0	CD	0	15	16	1	-1	15	15	16	0	PP	0	16	19	2	CC	0	16	17	1	and	16	16	17	0	NP	1	17	19	2	VBG	0	17	18	1	activating	17	17	18	0	NN	0	18	19	1	PI3K	18	18	19	0	:	0	19	20	1	/	19	19	20	0	NP	0	20	25	2	NP	1	20	22	2	NN	0	20	21	1	AKT	20	20	21	0	NN	0	21	22	1	signaling	21	21	22	0	NP	1	22	25	2	QP	1	22	24	2	CD	0	22	23	1	(	22	22	23	0	CD	0	23	24	1	19	23	23	24	0	NN	0	24	25	1	)	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	17
ERK	4585	4588	NN	erk	B-GENE	_	_
has	4589	4592	VBZ	have	O	_	_
also	4593	4597	RB	also	O	_	_
been	4598	4602	VBN	be	O	_	_
shown	4603	4608	VBN	show	O	_	_
to	4609	4611	TO	to	O	_	_
directly	4612	4620	RB	directly	O	_	_
regulate	4621	4629	VB	regulate	O	_	_
ERBB	4630	4634	NN	erbb	O	_	_
tyrosine	4635	4643	NN	tyrosine	O	_	_
phosphorylation	4644	4659	NN	phosphorylation	O	_	_
(	4660	4661	CD	(	O	_	_
20	4661	4663	CD	20	O	_	_
,	4663	4664	,	,	O	_	_
21	4665	4667	CD	21	O	_	_
)	4667	4668	NN	)	O	_	_
.	4668	4669	.	.	O	_	_
D	1
4
4	0	nsubjpass
4	1	aux
4	2	advmod
4	3	auxpass
4	7	xcomp
7	5	aux
7	6	advmod
7	10	dobj
10	8	nn
10	9	nn
10	12	amod
12	11	number
12	15	dep
15	14	number
EOX
Y	1
ROOT	0	0	17	1	S	1	0	17	3	NP	0	0	1	1	NN	0	0	1	1	ERK	0	0	1	0	VP	2	1	16	3	VBZ	0	1	2	1	has	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	also	2	2	3	0	VP	1	3	16	2	VBN	0	3	4	1	been	3	3	4	0	VP	0	4	16	2	VBN	0	4	5	1	shown	4	4	5	0	S	0	5	16	1	VP	1	5	16	2	TO	0	5	6	1	to	5	5	6	0	VP	1	6	16	3	ADVP	0	6	7	1	RB	0	6	7	1	directly	6	6	7	0	VB	0	7	8	1	regulate	7	7	8	0	NP	0	8	16	2	NP	2	8	11	3	NN	0	8	9	1	ERBB	8	8	9	0	NN	0	9	10	1	tyrosine	9	9	10	0	NN	0	10	11	1	phosphorylation	10	10	11	0	ADJP	0	11	16	3	ADJP	0	11	13	1	QP	1	11	13	2	CD	0	11	12	1	(	11	11	12	0	CD	0	12	13	1	20	12	12	13	0	,	0	13	14	1	,	13	13	14	0	ADJP	1	14	16	2	CD	0	14	15	1	21	14	14	15	0	NN	0	15	16	1	)	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	28
However	4670	4677	RB	however	O	_	_
,	4677	4678	,	,	O	_	_
it	4679	4681	PRP	it	O	_	_
remains	4682	4689	VBZ	remain	O	_	_
unclear	4690	4697	JJ	unclear	O	_	_
which	4698	4703	WDT	which	O	_	_
mechanisms	4704	4714	NNS	mechanism	O	_	_
,	4714	4715	,	,	O	_	_
if	4716	4718	IN	if	O	_	_
any	4719	4722	DT	any	O	_	_
,	4722	4723	,	,	O	_	_
are	4724	4727	VBP	be	O	_	_
dominant	4728	4736	JJ	dominant	O	_	_
in	4737	4739	IN	in	O	_	_
MEK	4740	4743	NN	mek	B-GENE	_	_
inhibitor	4744	4753	NN	inhibitor	O	_	_
induced	4754	4761	VBD	induce	O	_	_
activation	4762	4772	NN	activation	O	_	_
of	4773	4775	IN	of	O	_	_
AKT	4776	4779	NN	akt	B-GENE	_	_
signaling	4780	4789	NN	signaling	I-GENE	_	_
in	4790	4792	IN	in	I-GENE	_	_
EGFR	4793	4797	NN	egfr	I-GENE	_	_
or	4798	4800	CC	or	O	_	_
HER2-	4801	4806	NN	her2-_NN	O	_	_
driven	4807	4813	VBN	drive	O	_	_
cancers	4814	4821	NNS	cancer	O	_	_
.	4821	4822	.	.	O	_	_
D	1
4
4	0	advmod
4	2	nsubj
4	3	cop
4	12	ccomp
6	8	dep
8	9	dep
12	5	dobj
12	6	nsubj
12	11	cop
12	15	prep_in
15	14	nn
15	16	rcmod
16	17	dobj
16	22	prep_in
16	24	prep_in
17	20	prep_of
20	19	nn
22	24	conj_or
22	25	vmod
25	26	dobj
EOX
Y	1
ROOT	0	0	28	1	S	3	0	28	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	it	2	2	3	0	VP	1	3	27	3	VBZ	0	3	4	1	remains	3	3	4	0	ADJP	0	4	5	1	JJ	0	4	5	1	unclear	4	4	5	0	SBAR	1	5	27	2	WHNP	0	5	6	1	WDT	0	5	6	1	which	5	5	6	0	S	1	6	27	2	NP	0	6	11	2	NP	0	6	7	1	NNS	0	6	7	1	mechanisms	6	6	7	0	PRN	1	7	11	4	,	0	7	8	1	,	7	7	8	0	IN	0	8	9	1	if	8	8	9	0	DT	0	9	10	1	any	9	9	10	0	,	0	10	11	1	,	10	10	11	0	VP	1	11	27	2	VBP	0	11	12	1	are	11	11	12	0	ADJP	0	12	27	2	JJ	0	12	13	1	dominant	12	12	13	0	PP	0	13	27	2	IN	0	13	14	1	in	13	13	14	0	NP	0	14	27	2	NP	1	14	16	2	NN	0	14	15	1	MEK	14	14	15	0	NN	0	15	16	1	inhibitor	15	15	16	0	SBAR	0	16	27	1	S	0	16	27	1	VP	0	16	27	3	VBD	0	16	17	1	induced	16	16	17	0	NP	0	17	21	2	NP	0	17	18	1	NN	0	17	18	1	activation	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	of	18	18	19	0	NP	1	19	21	2	NN	0	19	20	1	AKT	19	19	20	0	NN	0	20	21	1	signaling	20	20	21	0	PP	0	21	27	2	IN	0	21	22	1	in	21	21	22	0	NP	0	22	27	2	NP	0	22	25	3	NN	0	22	23	1	EGFR	22	22	23	0	CC	0	23	24	1	or	23	23	24	0	NN	0	24	25	1	HER2-	24	24	25	0	VP	0	25	27	2	VBN	0	25	26	1	driven	25	25	26	0	NP	0	26	27	1	NNS	0	26	27	1	cancers	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	45
As	4823	4825	IN	as	O	_	_
multiple	4826	4834	JJ	multiple	O	_	_
MEK	4835	4838	NN	mek	O	_	_
and	4839	4842	CC	and	O	_	_
BRAF	4843	4847	NN	braf	O	_	_
inhibitors	4848	4858	NNS	inhibitor	O	_	_
,	4858	4859	,	,	O	_	_
including	4860	4869	VBG	include	O	_	_
the	4870	4873	DT	the	O	_	_
highly	4874	4880	RB	highly	O	_	_
selective	4881	4890	JJ	selective	O	_	_
allosteric	4891	4901	JJ	allosteric	B-GENE	_	_
MEK1	4902	4906	NN	mek1	I-GENE	_	_
/	4906	4907	:	/	I-GENE	_	_
2	4907	4908	CD	2	I-GENE	_	_
inhibitor	4909	4918	NN	inhibitor	O	_	_
,	4918	4919	,	,	O	_	_
AZD6244	4920	4927	NN	azd6244	O	_	_
(	4928	4929	CD	(	O	_	_
22	4929	4931	CD	22	O	_	_
)	4931	4932	NN	)	O	_	_
,	4932	4933	,	,	O	_	_
are	4934	4937	VBP	be	O	_	_
being	4938	4943	VBG	be	O	_	_
developed	4944	4953	VBN	develop	O	_	_
,	4953	4954	,	,	O	_	_
understanding	4955	4968	VBG	understand	O	_	_
the	4969	4972	DT	the	O	_	_
signaling	4973	4982	NN	signaling	O	_	_
feedbacks	4983	4992	NNS	feedback	O	_	_
induced	4993	5000	VBN	induce	O	_	_
by	5001	5003	IN	by	O	_	_
MEK	5004	5007	NN	mek	B-GENE	_	_
inhibitors	5008	5018	NNS	inhibitor	O	_	_
that	5019	5023	WDT	that	O	_	_
may	5024	5027	MD	may	O	_	_
ultimately	5028	5038	RB	ultimately	O	_	_
impact	5039	5045	VB	impact	O	_	_
their	5046	5051	PRP$	they	O	_	_
utility	5052	5059	NN	utility	O	_	_
will	5060	5064	MD	will	O	_	_
become	5065	5071	VB	become	O	_	_
increasingly	5072	5084	RB	increasingly	O	_	_
important	5085	5094	JJ	important	O	_	_
.	5094	5095	.	.	O	_	_
D	1
43
2	1	amod
2	5	conj_and
2	12	prep_including
5	4	nn
10	9	advmod
12	8	det
12	10	amod
12	11	amod
12	15	dep
12	20	dep
15	13	punct
15	14	num
15	17	appos
19	18	number
20	19	dep
24	0	mark
24	2	nsubjpass
24	5	nsubjpass
24	22	aux
24	23	auxpass
26	29	dobj
29	27	det
29	28	nn
29	30	vmod
30	33	agent
33	32	nn
33	37	rcmod
37	34	nsubj
37	35	aux
37	36	advmod
37	39	dobj
39	38	poss
43	24	advcl
43	26	csubj
43	40	aux
43	41	cop
43	42	advmod
EOX
Y	1
ROOT	0	0	45	1	S	3	0	45	5	SBAR	1	0	25	2	IN	0	0	1	1	As	0	0	1	0	S	1	1	25	2	NP	0	1	22	4	NP	0	1	6	3	NP	1	1	3	2	JJ	0	1	2	1	multiple	1	1	2	0	NN	0	2	3	1	MEK	2	2	3	0	CC	0	3	4	1	and	3	3	4	0	NP	1	4	6	2	NN	0	4	5	1	BRAF	4	4	5	0	NNS	0	5	6	1	inhibitors	5	5	6	0	,	0	6	7	1	,	6	6	7	0	PP	0	7	21	2	VBG	0	7	8	1	including	7	7	8	0	NP	0	8	21	2	NP	0	8	18	2	NP	3	8	13	4	DT	0	8	9	1	the	8	8	9	0	ADJP	1	9	11	2	RB	0	9	10	1	highly	9	9	10	0	JJ	0	10	11	1	selective	10	10	11	0	JJ	0	11	12	1	allosteric	11	11	12	0	NN	0	12	13	1	MEK1	12	12	13	0	PRN	1	13	18	2	:	0	13	14	1	/	13	13	14	0	NP	0	14	18	3	NP	1	14	16	2	CD	0	14	15	1	2	14	14	15	0	NN	0	15	16	1	inhibitor	15	15	16	0	,	0	16	17	1	,	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	AZD6244	17	17	18	0	ADJP	1	18	21	2	QP	1	18	20	2	CD	0	18	19	1	(	18	18	19	0	CD	0	19	20	1	22	19	19	20	0	NN	0	20	21	1	)	20	20	21	0	,	0	21	22	1	,	21	21	22	0	VP	1	22	25	2	VBP	0	22	23	1	are	22	22	23	0	VP	1	23	25	2	VBG	0	23	24	1	being	23	23	24	0	VP	0	24	25	1	VBN	0	24	25	1	developed	24	24	25	0	,	0	25	26	1	,	25	25	26	0	S	0	26	40	1	VP	0	26	40	2	VBG	0	26	27	1	understanding	26	26	27	0	NP	0	27	40	2	NP	2	27	30	3	DT	0	27	28	1	the	27	27	28	0	NN	0	28	29	1	signaling	28	28	29	0	NNS	0	29	30	1	feedbacks	29	29	30	0	VP	0	30	40	2	VBN	0	30	31	1	induced	30	30	31	0	PP	0	31	40	2	IN	0	31	32	1	by	31	31	32	0	NP	0	32	40	2	NP	1	32	34	2	NN	0	32	33	1	MEK	32	32	33	0	NNS	0	33	34	1	inhibitors	33	33	34	0	SBAR	1	34	40	2	WHNP	0	34	35	1	WDT	0	34	35	1	that	34	34	35	0	S	0	35	40	1	VP	2	35	40	3	MD	0	35	36	1	may	35	35	36	0	ADVP	0	36	37	1	RB	0	36	37	1	ultimately	36	36	37	0	VP	0	37	40	2	VB	0	37	38	1	impact	37	37	38	0	NP	1	38	40	2	PRP$	0	38	39	1	their	38	38	39	0	NN	0	39	40	1	utility	39	39	40	0	VP	1	40	44	2	MD	0	40	41	1	will	40	40	41	0	VP	1	41	44	2	VB	0	41	42	1	become	41	41	42	0	ADJP	1	42	44	2	RB	0	42	43	1	increasingly	42	42	43	0	JJ	0	43	44	1	important	43	43	44	0	.	0	44	45	1	.	44	44	45	0
EOS
T	25
In	5096	5098	IN	in	O	_	_
this	5099	5103	DT	this	O	_	_
study	5104	5109	NN	study	O	_	_
,	5109	5110	,	,	O	_	_
we	5111	5113	PRP	we	O	_	_
examined	5114	5122	VBD	examine	O	_	_
the	5123	5126	DT	the	O	_	_
molecular	5127	5136	JJ	molecular	O	_	_
mechanism	5137	5146	NN	mechanism	O	_	_
by	5147	5149	IN	by	O	_	_
which	5150	5155	WDT	which	O	_	_
MEK	5156	5159	NN	mek	B-GENE	_	_
inhibition	5160	5170	NN	inhibition	O	_	_
leads	5171	5176	VBZ	lead	O	_	_
to	5177	5179	TO	to	O	_	_
increased	5180	5189	VBN	increase	O	_	_
AKT	5190	5193	NN	akt	B-GENE	_	_
phosphorylation	5194	5209	NN	phosphorylation	O	_	_
in	5210	5212	IN	in	O	_	_
EGFR	5213	5217	NN	egfr	B-GENE	_	_
and	5218	5221	CC	and	O	_	_
HER2	5222	5226	NN	her2	B-GENE	_	_
driven	5227	5233	VBN	drive	O	_	_
cancers	5234	5241	NNS	cancer	O	_	_
.	5241	5242	.	.	O	_	_
D	1
5
2	1	det
5	2	prep_in
5	4	nsubj
5	8	dobj
5	13	prepc_by
8	6	det
8	7	amod
12	11	nn
13	10	dobj
13	12	nsubj
13	17	prep_to
17	15	amod
17	16	nn
17	19	prep_in
17	21	prep_in
19	21	conj_and
19	22	vmod
22	23	dobj
EOX
Y	1
ROOT	0	0	25	1	S	3	0	25	5	PP	0	0	3	2	IN	0	0	1	1	In	0	0	1	0	NP	1	1	3	2	DT	0	1	2	1	this	1	1	2	0	NN	0	2	3	1	study	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	0	4	5	1	PRP	0	4	5	1	we	4	4	5	0	VP	0	5	24	3	VBD	0	5	6	1	examined	5	5	6	0	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	JJ	0	7	8	1	molecular	7	7	8	0	NN	0	8	9	1	mechanism	8	8	9	0	PP	0	9	24	2	IN	0	9	10	1	by	9	9	10	0	SBAR	1	10	24	2	WHNP	0	10	11	1	WDT	0	10	11	1	which	10	10	11	0	S	1	11	24	2	NP	1	11	13	2	NN	0	11	12	1	MEK	11	11	12	0	NN	0	12	13	1	inhibition	12	12	13	0	VP	0	13	24	2	VBZ	0	13	14	1	leads	13	13	14	0	PP	0	14	24	2	TO	0	14	15	1	to	14	14	15	0	NP	0	15	24	2	NP	2	15	18	3	VBN	0	15	16	1	increased	15	15	16	0	NN	0	16	17	1	AKT	16	16	17	0	NN	0	17	18	1	phosphorylation	17	17	18	0	PP	0	18	24	2	IN	0	18	19	1	in	18	18	19	0	NP	0	19	24	2	NP	0	19	22	3	NN	0	19	20	1	EGFR	19	19	20	0	CC	0	20	21	1	and	20	20	21	0	NN	0	21	22	1	HER2	21	21	22	0	VP	0	22	24	2	VBN	0	22	23	1	driven	22	22	23	0	NP	0	23	24	1	NNS	0	23	24	1	cancers	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	28
We	5243	5245	PRP	we	O	_	_
provide	5246	5253	VBP	provide	O	_	_
evidence	5254	5262	NN	evidence	O	_	_
suggesting	5263	5273	VBG	suggest	O	_	_
that	5274	5278	IN	that	O	_	_
this	5279	5283	DT	this	O	_	_
feedback	5284	5292	NN	feedback	O	_	_
occurs	5293	5299	VBZ	occur	O	_	_
at	5300	5302	IN	at	O	_	_
the	5303	5306	DT	the	O	_	_
level	5307	5312	NN	level	O	_	_
of	5313	5315	IN	of	O	_	_
increased	5316	5325	VBN	increase	O	_	_
phosphatidylinositol	5326	5346	NN	phosphatidylinositol	O	_	_
3,4,5-trisphosphate	5347	5366	NN	3,4,5-trisphosphate	O	_	_
(	5367	5368	CD	(	O	_	_
PIP3	5368	5372	NN	pip3	O	_	_
)	5372	5373	NN	)	O	_	_
induced	5374	5381	VBN	induce	O	_	_
by	5382	5384	IN	by	O	_	_
an	5385	5387	DT	a	O	_	_
increased	5388	5397	VBN	increase	O	_	_
association	5398	5409	NN	association	O	_	_
between	5410	5417	IN	between	O	_	_
ERBB3	5418	5423	NN	erbb3	B-GENE	_	_
and	5424	5427	CC	and	O	_	_
PI3K	5428	5432	NN	pi3k	B-GENE	_	_
.	5432	5433	.	.	O	_	_
D	1
1
1	0	nsubj
1	17	xcomp
2	3	vmod
3	7	ccomp
6	5	det
7	4	mark
7	6	nsubj
7	10	prep_at
10	9	det
10	14	prep_of
14	12	amod
14	13	nn
17	2	nsubj
17	15	num
17	16	nn
17	18	vmod
18	22	agent
22	20	det
22	21	amod
22	24	prep_between
22	26	prep_between
24	26	conj_and
EOX
Y	1
ROOT	0	0	28	1	S	1	0	28	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	27	2	VBP	0	1	2	1	provide	1	1	2	0	S	1	2	27	2	NP	0	2	15	2	NP	0	2	3	1	NN	0	2	3	1	evidence	2	2	3	0	VP	0	3	15	2	VBG	0	3	4	1	suggesting	3	3	4	0	SBAR	1	4	15	2	IN	0	4	5	1	that	4	4	5	0	S	1	5	15	2	NP	1	5	7	2	DT	0	5	6	1	this	5	5	6	0	NN	0	6	7	1	feedback	6	6	7	0	VP	0	7	15	2	VBZ	0	7	8	1	occurs	7	7	8	0	PP	0	8	15	2	IN	0	8	9	1	at	8	8	9	0	NP	0	9	15	2	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	level	10	10	11	0	PP	0	11	15	2	IN	0	11	12	1	of	11	11	12	0	NP	2	12	15	3	VBN	0	12	13	1	increased	12	12	13	0	NN	0	13	14	1	phosphatidylinositol	13	13	14	0	NN	0	14	15	1	3,4,5-trisphosphate	14	14	15	0	NP	0	15	27	2	NP	2	15	18	3	CD	0	15	16	1	(	15	15	16	0	NN	0	16	17	1	PIP3	16	16	17	0	NN	0	17	18	1	)	17	17	18	0	VP	0	18	27	2	VBN	0	18	19	1	induced	18	18	19	0	PP	0	19	27	2	IN	0	19	20	1	by	19	19	20	0	NP	0	20	27	2	NP	2	20	23	3	DT	0	20	21	1	an	20	20	21	0	VBN	0	21	22	1	increased	21	21	22	0	NN	0	22	23	1	association	22	22	23	0	PP	0	23	27	2	IN	0	23	24	1	between	23	23	24	0	NP	0	24	27	3	NN	0	24	25	1	ERBB3	24	24	25	0	CC	0	25	26	1	and	25	25	26	0	NN	0	26	27	1	PI3K	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	34
Increased	5434	5443	VBN	increase	O	_	_
ERBB3	5444	5449	NN	erbb3	B-GENE	_	_
activation	5450	5460	NN	activation	O	_	_
results	5461	5468	VBZ	result	O	_	_
from	5469	5473	IN	from	O	_	_
loss	5474	5478	NN	loss	O	_	_
of	5479	5481	IN	of	O	_	_
an	5482	5484	DT	a	O	_	_
inhibitory	5485	5495	JJ	inhibitory	O	_	_
ERK	5496	5499	NN	erk	B-GENE	_	_
dependent	5500	5509	JJ	dependent	O	_	_
threonine	5510	5519	NN	threonine	O	_	_
phosphorylation	5520	5535	NN	phosphorylation	O	_	_
in	5536	5538	IN	in	O	_	_
the	5539	5542	DT	the	O	_	_
conserved	5543	5552	VBN	conserve	O	_	_
JM	5553	5555	NN	jm	O	_	_
domains	5556	5563	NNS	domain	O	_	_
of	5564	5566	IN	of	O	_	_
EGFR	5567	5571	NN	egfr	B-GENE	_	_
and	5572	5575	CC	and	O	_	_
HER2	5576	5580	NN	her2	B-GENE	_	_
,	5580	5581	,	,	O	_	_
previously	5582	5592	RB	previously	O	_	_
found	5593	5598	VBN	find	O	_	_
to	5599	5601	TO	to	O	_	_
regulate	5602	5610	VB	regulate	O	_	_
to	5611	5613	TO	to	O	_	_
EGFR	5614	5618	NN	egfr	B-GENE	_	_
auto-phosphorylation	5619	5639	NN	auto-phosphorylation	O	_	_
(	5640	5641	CD	(	O	_	_
21	5641	5643	CD	21	O	_	_
)	5643	5644	NN	)	O	_	_
.	5644	5645	.	.	O	_	_
D	1
3
2	0	amod
2	1	nn
3	2	nsubj
3	5	prep_from
3	12	dobj
5	9	prep_of
9	7	det
9	8	amod
12	10	amod
12	11	nn
12	14	prep_in
14	15	vmod
15	17	dobj
17	16	nn
17	19	prep_of
17	21	prep_of
17	24	rcmod
19	21	conj_and
24	23	advmod
24	26	xcomp
26	25	aux
26	29	prep_to
29	28	nn
29	32	dep
31	30	number
32	31	dep
EOX
Y	1
ROOT	0	0	34	1	S	1	0	34	3	NP	2	0	3	3	VBN	0	0	1	1	Increased	0	0	1	0	NN	0	1	2	1	ERBB3	1	1	2	0	NN	0	2	3	1	activation	2	2	3	0	VP	0	3	33	3	VBZ	0	3	4	1	results	3	3	4	0	PP	0	4	10	2	IN	0	4	5	1	from	4	4	5	0	NP	0	5	10	2	NP	0	5	6	1	NN	0	5	6	1	loss	5	5	6	0	PP	0	6	10	2	IN	0	6	7	1	of	6	6	7	0	NP	2	7	10	3	DT	0	7	8	1	an	7	7	8	0	JJ	0	8	9	1	inhibitory	8	8	9	0	NN	0	9	10	1	ERK	9	9	10	0	NP	0	10	33	2	NP	2	10	13	3	JJ	0	10	11	1	dependent	10	10	11	0	NN	0	11	12	1	threonine	11	11	12	0	NN	0	12	13	1	phosphorylation	12	12	13	0	PP	0	13	33	2	IN	0	13	14	1	in	13	13	14	0	NP	0	14	33	2	NP	0	14	15	1	DT	0	14	15	1	the	14	14	15	0	VP	0	15	33	2	VBN	0	15	16	1	conserved	15	15	16	0	NP	0	16	33	4	NP	1	16	18	2	NN	0	16	17	1	JM	16	16	17	0	NNS	0	17	18	1	domains	17	17	18	0	PP	0	18	22	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	22	3	NN	0	19	20	1	EGFR	19	19	20	0	CC	0	20	21	1	and	20	20	21	0	NN	0	21	22	1	HER2	21	21	22	0	,	0	22	23	1	,	22	22	23	0	RRC	1	23	33	2	ADVP	0	23	24	1	RB	0	23	24	1	previously	23	23	24	0	VP	0	24	33	2	VBN	0	24	25	1	found	24	24	25	0	S	0	25	33	1	VP	1	25	33	2	TO	0	25	26	1	to	25	25	26	0	VP	0	26	33	2	VB	0	26	27	1	regulate	26	26	27	0	PP	0	27	33	2	TO	0	27	28	1	to	27	27	28	0	NP	0	28	33	2	NP	1	28	30	2	NN	0	28	29	1	EGFR	28	28	29	0	NN	0	29	30	1	auto-phosphorylation	29	29	30	0	ADJP	1	30	33	2	QP	1	30	32	2	CD	0	30	31	1	(	30	30	31	0	CD	0	31	32	1	21	31	31	32	0	NN	0	32	33	1	)	32	32	33	0	.	0	33	34	1	.	33	33	34	0
EOS
T	20
Elucidation	5646	5657	NN	elucidation	O	_	_
of	5658	5660	IN	of	O	_	_
this	5661	5665	DT	this	O	_	_
mechanism	5666	5675	NN	mechanism	O	_	_
provides	5676	5684	VBZ	provide	O	_	_
a	5685	5686	DT	a	O	_	_
greater	5687	5694	JJR	greater	O	_	_
understanding	5695	5708	NN	understanding	O	_	_
of	5709	5711	IN	of	O	_	_
the	5712	5715	DT	the	O	_	_
feedback	5716	5724	NN	feedback	O	_	_
systems	5725	5732	NNS	system	O	_	_
regulating	5733	5743	VBG	regulate	O	_	_
key	5744	5747	JJ	key	O	_	_
pathways	5748	5756	NNS	pathway	O	_	_
that	5757	5761	WDT	that	O	_	_
drive	5762	5767	VBP	drive	O	_	_
human	5768	5773	JJ	human	O	_	_
cancers	5774	5781	NNS	cancer	O	_	_
.	5781	5782	.	.	O	_	_
D	1
4
0	3	prep_of
3	2	det
4	0	nsubj
4	7	dobj
7	5	det
7	6	amod
7	11	prep_of
11	9	det
11	10	nn
11	12	vmod
12	14	dobj
14	13	amod
14	16	rcmod
16	15	nsubj
16	18	dobj
18	17	amod
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	4	2	NP	0	0	1	1	NN	0	0	1	1	Elucidation	0	0	1	0	PP	0	1	4	2	IN	0	1	2	1	of	1	1	2	0	NP	1	2	4	2	DT	0	2	3	1	this	2	2	3	0	NN	0	3	4	1	mechanism	3	3	4	0	VP	0	4	19	2	VBZ	0	4	5	1	provides	4	4	5	0	NP	0	5	19	2	NP	2	5	8	3	DT	0	5	6	1	a	5	5	6	0	JJR	0	6	7	1	greater	6	6	7	0	NN	0	7	8	1	understanding	7	7	8	0	PP	0	8	19	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	19	2	NP	2	9	12	3	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	feedback	10	10	11	0	NNS	0	11	12	1	systems	11	11	12	0	VP	0	12	19	2	VBG	0	12	13	1	regulating	12	12	13	0	NP	0	13	19	2	NP	1	13	15	2	JJ	0	13	14	1	key	13	13	14	0	NNS	0	14	15	1	pathways	14	14	15	0	SBAR	1	15	19	2	WHNP	0	15	16	1	WDT	0	15	16	1	that	15	15	16	0	S	0	16	19	1	VP	0	16	19	2	VBP	0	16	17	1	drive	16	16	17	0	NP	1	17	19	2	JJ	0	17	18	1	human	17	17	18	0	NNS	0	18	19	1	cancers	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	25
MATERIALS	5783	5792	NNS	material	O	_	_
AND	5793	5796	CC	and	O	_	_
METHODS	5797	5804	NNS	method	O	_	_
Cell	5806	5810	NN	cell	O	_	_
culture	5811	5818	NN	culture	O	_	_
reagents	5819	5827	NNS	reagent	O	_	_
and	5828	5831	CC	and	O	_	_
Western	5832	5839	JJ	western	O	_	_
analyses	5840	5848	NNS	analysis	O	_	_
Cell	5849	5853	NN	cell	O	_	_
lines	5854	5859	NNS	line	O	_	_
,	5859	5860	,	,	O	_	_
inhibitors	5861	5871	NNS	inhibitor	O	_	_
,	5871	5872	,	,	O	_	_
and	5873	5876	CC	and	O	_	_
growth	5877	5883	NN	growth	O	_	_
conditions	5884	5894	NNS	condition	O	_	_
are	5895	5898	VBP	be	O	_	_
described	5899	5908	VBN	describe	O	_	_
in	5909	5911	IN	in	O	_	_
Supplemental	5912	5924	NNP	Supplemental	O	_	_
Materials	5925	5934	NNPS	Materials	O	_	_
and	5935	5938	CC	and	O	_	_
Methods	5939	5946	NNS	method	O	_	_
.	5946	5947	.	.	O	_	_
D	1
18
0	2	conj_and
0	8	conj_and
0	12	conj_and
0	16	conj_and
2	5	dep
2	8	conj_and
5	3	nn
5	4	nn
8	7	amod
8	10	dep
10	9	nn
16	15	nn
18	0	nsubjpass
18	2	nsubjpass
18	12	nsubjpass
18	16	nsubjpass
18	17	auxpass
18	21	prep_in
18	23	prep_in
21	20	nn
21	23	conj_and
EOX
Y	1
ROOT	0	0	25	1	S	1	0	25	3	NP	0	0	17	8	NP	0	0	1	1	NNS	0	0	1	1	MATERIALS	0	0	1	0	CC	0	1	2	1	AND	1	1	2	0	NP	0	2	11	3	NP	0	2	6	2	NP	0	2	3	1	NNS	0	2	3	1	METHODS	2	2	3	0	NP	2	3	6	3	NN	0	3	4	1	Cell	3	3	4	0	NN	0	4	5	1	culture	4	4	5	0	NNS	0	5	6	1	reagents	5	5	6	0	CC	0	6	7	1	and	6	6	7	0	NP	0	7	11	2	NP	1	7	9	2	JJ	0	7	8	1	Western	7	7	8	0	NNS	0	8	9	1	analyses	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	Cell	9	9	10	0	NNS	0	10	11	1	lines	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	13	1	NNS	0	12	13	1	inhibitors	12	12	13	0	,	0	13	14	1	,	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	1	15	17	2	NN	0	15	16	1	growth	15	15	16	0	NNS	0	16	17	1	conditions	16	16	17	0	VP	1	17	24	2	VBP	0	17	18	1	are	17	17	18	0	VP	0	18	24	2	VBN	0	18	19	1	described	18	18	19	0	PP	0	19	24	2	IN	0	19	20	1	in	19	19	20	0	NP	0	20	24	3	NP	1	20	22	2	NNP	0	20	21	1	Supplemental	20	20	21	0	NNPS	0	21	22	1	Materials	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	NP	0	23	24	1	NNS	0	23	24	1	Methods	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	21
Cells	5948	5953	NNS	cell	O	_	_
were	5954	5958	VBD	be	O	_	_
lysed	5959	5964	VBN	lyse	O	_	_
in	5965	5967	IN	in	O	_	_
an	5968	5970	DT	a	O	_	_
NP-40	5971	5976	NN	np-40	O	_	_
containing	5977	5987	VBG	contain	O	_	_
buffer	5988	5994	NN	buffer	O	_	_
,	5994	5995	,	,	O	_	_
separated	5996	6005	VBN	separate	O	_	_
by	6006	6008	IN	by	O	_	_
SDS	6009	6012	NN	sd	O	_	_
/	6012	6013	:	/	O	_	_
PAGE	6013	6017	NN	page	O	_	_
,	6017	6018	,	,	O	_	_
and	6019	6022	CC	and	O	_	_
transferred	6023	6034	VBN	transfer	O	_	_
to	6035	6037	TO	to	O	_	_
PVDF	6038	6042	NN	pvdf	O	_	_
membranes	6043	6052	NNS	membrane	O	_	_
.	6052	6053	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	5	prep_in
2	9	conj_and
2	16	conj_and
5	4	det
5	6	vmod
6	7	dobj
9	0	nsubjpass
9	11	prep_by
11	13	dep
13	12	punct
16	0	nsubjpass
16	19	prep_to
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	20	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	20	6	VP	0	2	8	2	VBN	0	2	3	1	lysed	2	2	3	0	PP	0	3	8	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	8	2	NP	1	4	6	2	DT	0	4	5	1	an	4	4	5	0	NN	0	5	6	1	NP-40	5	5	6	0	VP	0	6	8	2	VBG	0	6	7	1	containing	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	buffer	7	7	8	0	,	0	8	9	1	,	8	8	9	0	VP	0	9	14	2	VBN	0	9	10	1	separated	9	9	10	0	PP	0	10	14	2	IN	0	10	11	1	by	10	10	11	0	NP	0	11	14	2	NP	0	11	12	1	NN	0	11	12	1	SDS	11	11	12	0	PRN	1	12	14	2	:	0	12	13	1	/	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	PAGE	13	13	14	0	,	0	14	15	1	,	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	VP	0	16	20	2	VBN	0	16	17	1	transferred	16	16	17	0	PP	0	17	20	2	TO	0	17	18	1	to	17	17	18	0	NP	1	18	20	2	NN	0	18	19	1	PVDF	18	18	19	0	NNS	0	19	20	1	membranes	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	11
Antibody	6054	6062	NN	antibody	O	_	_
binding	6063	6070	NN	binding	O	_	_
was	6071	6074	VBD	be	O	_	_
detected	6075	6083	VBN	detect	O	_	_
using	6084	6089	VBG	use	O	_	_
enhanced	6090	6098	VBN	enhance	O	_	_
chemiluminescence	6099	6116	NN	chemiluminescence	O	_	_
(	6117	6118	CD	(	O	_	_
PerkinElmer	6118	6129	NNP	PerkinElmer	O	_	_
)	6129	6130	CD	)	O	_	_
.	6130	6131	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	6	prep_using
6	5	amod
6	8	dep
8	7	num
8	9	num
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	1	0	2	2	NN	0	0	1	1	Antibody	0	0	1	0	NN	0	1	2	1	binding	1	1	2	0	VP	1	2	10	2	VBD	0	2	3	1	was	2	2	3	0	VP	0	3	10	2	VBN	0	3	4	1	detected	3	3	4	0	PP	0	4	10	2	VBG	0	4	5	1	using	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	VBN	0	5	6	1	enhanced	5	5	6	0	NN	0	6	7	1	chemiluminescence	6	6	7	0	NP	1	7	10	3	CD	0	7	8	1	(	7	7	8	0	NNP	0	8	9	1	PerkinElmer	8	8	9	0	CD	0	9	10	1	)	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	58
Biotin	6132	6138	NNP	Biotin	O	_	_
labeling	6139	6147	NN	labeling	O	_	_
and	6148	6151	CC	and	O	_	_
Immunoprecipitation	6152	6171	NN	immunoprecipitation	O	_	_
HCC827	6172	6178	NN	hcc827	O	_	_
cells	6179	6184	NNS	cell	O	_	_
were	6185	6189	VBD	be	O	_	_
washed	6190	6196	VBN	wash	O	_	_
with	6197	6201	IN	with	O	_	_
PBS	6202	6205	NNP	PBS	O	_	_
and	6206	6209	CC	and	O	_	_
labeled	6210	6217	VBN	label	O	_	_
for	6218	6221	IN	for	O	_	_
1hr	6222	6225	CD	1hr	O	_	_
at	6226	6228	IN	at	O	_	_
4degC	6229	6234	NN	4degc	O	_	_
in	6235	6237	IN	in	O	_	_
0.5	6238	6241	CD	0.5	O	_	_
ug	6241	6243	NN	ug	O	_	_
/	6243	6244	:	/	O	_	_
mL	6244	6246	NN	ml	O	_	_
Sulfo-NHS-LC-Biotin	6247	6266	NN	sulfo-nhs-lc-biotin	O	_	_
(	6267	6268	CD	(	O	_	_
Thermo	6268	6274	NNP	Thermo	O	_	_
ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	6275	6335	NNP	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	O	_	_
MEK	6337	6340	NN	mek	B-GENE	_	_
inhibition	6341	6351	NN	inhibition	O	_	_
leads	6352	6357	VBZ	lead	O	_	_
to	6358	6360	TO	to	O	_	_
PI3K	6361	6365	NN	pi3k	B-GENE	_	_
/	6365	6366	:	/	B-GENE	_	_
AKT	6366	6369	NN	akt	I-GENE	_	_
activation	6370	6380	NN	activation	O	_	_
by	6381	6383	IN	by	O	_	_
relieving	6384	6393	VBG	relieve	O	_	_
a	6394	6395	DT	a	O	_	_
negative	6396	6404	JJ	negative	O	_	_
feedback	6405	6413	NN	feedback	O	_	_
on	6414	6416	IN	on	O	_	_
ERBB	6417	6421	NN	erbb	O	_	_
receptors	6422	6431	NNS	receptor	O	_	_
12	6432	6434	CD	12	O	_	_
/	6434	6435	:	/	O	_	_
8/14	6435	6439	CD	8/14	O	_	_
,	6439	6440	,	,	O	_	_
6:54	6441	6445	CD	6:54	O	_	_
PM	6446	6448	NN	pm	O	_	_
ÔøºScientific	6449	6462	JJ	ôøºscientific	O	_	_
)	6462	6463	CD	)	O	_	_
re	6464	6466	NN	re	O	_	_
suspended	6467	6476	VBN	suspend	O	_	_
in	6477	6479	IN	in	O	_	_
PBS	6480	6483	NNP	PBS	O	_	_
+	6484	6485	CC	+	O	_	_
/	6485	6486	:	/	O	_	_
-	6486	6487	:	-	O	_	_
AZD6244	6487	6494	NN	azd6244	O	_	_
.	6494	6495	.	.	O	_	_
D	1
7
1	0	nn
1	5	conj_and
5	3	nn
5	4	nn
7	1	nsubjpass
7	5	nsubjpass
7	6	auxpass
7	9	prep_with
7	11	conj_and
7	56	dobj
11	1	nsubjpass
11	13	prep_for
11	15	prep_at
15	18	prep_in
18	17	num
18	21	dep
21	19	punct
21	20	nn
21	27	rcmod
26	22	num
26	23	nn
26	24	nn
26	25	nn
27	26	nsubj
27	29	prep_to
29	32	dep
32	30	punct
32	31	nn
32	34	prepc_by
32	54	punct
34	37	dobj
34	40	prep_on
34	53	dep
37	35	det
37	36	amod
40	39	nn
40	50	rcmod
41	43	dep
43	42	punct
43	46	appos
46	45	num
49	47	amod
49	48	num
50	41	dobj
50	49	nsubj
50	52	prep_in
EOX
Y	1
ROOT	0	0	58	1	S	1	0	58	3	NP	0	0	6	3	NP	1	0	2	2	NNP	0	0	1	1	Biotin	0	0	1	0	NN	0	1	2	1	labeling	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NP	2	3	6	3	NN	0	3	4	1	Immunoprecipitation	3	3	4	0	NN	0	4	5	1	HCC827	4	4	5	0	NNS	0	5	6	1	cells	5	5	6	0	VP	1	6	57	2	VBD	0	6	7	1	were	6	6	7	0	VP	0	7	57	4	VP	0	7	10	2	VBN	0	7	8	1	washed	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	with	8	8	9	0	NP	0	9	10	1	NNP	0	9	10	1	PBS	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	VP	0	11	56	3	VBN	0	11	12	1	labeled	11	11	12	0	PP	0	12	14	2	IN	0	12	13	1	for	12	12	13	0	NP	0	13	14	1	CD	0	13	14	1	1hr	13	13	14	0	PP	0	14	56	2	IN	0	14	15	1	at	14	14	15	0	NP	0	15	56	2	NP	0	15	16	1	NN	0	15	16	1	4degC	15	15	16	0	PP	0	16	56	2	IN	0	16	17	1	in	16	16	17	0	NP	0	17	56	2	NP	1	17	19	2	CD	0	17	18	1	0.5	17	17	18	0	NN	0	18	19	1	ug	18	18	19	0	PRN	1	19	56	3	:	0	19	20	1	/	19	19	20	0	NP	0	20	55	2	NP	1	20	22	2	NN	0	20	21	1	mL	20	20	21	0	NN	0	21	22	1	Sulfo-NHS-LC-Biotin	21	21	22	0	SBAR	0	22	55	1	S	1	22	55	2	NP	4	22	27	5	CD	0	22	23	1	(	22	22	23	0	NNP	0	23	24	1	Thermo	23	23	24	0	NNP	0	24	25	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	24	24	25	0	NN	0	25	26	1	MEK	25	25	26	0	NN	0	26	27	1	inhibition	26	26	27	0	VP	0	27	55	2	VBZ	0	27	28	1	leads	27	27	28	0	PP	0	28	55	2	TO	0	28	29	1	to	28	28	29	0	NP	0	29	55	2	NP	0	29	30	1	NN	0	29	30	1	PI3K	29	29	30	0	PRN	1	30	55	3	:	0	30	31	1	/	30	30	31	0	NP	0	31	54	2	NP	1	31	33	2	NN	0	31	32	1	AKT	31	31	32	0	NN	0	32	33	1	activation	32	32	33	0	PP	0	33	54	2	IN	0	33	34	1	by	33	33	34	0	S	0	34	54	2	VP	0	34	53	3	VBG	0	34	35	1	relieving	34	34	35	0	NP	2	35	38	3	DT	0	35	36	1	a	35	35	36	0	JJ	0	36	37	1	negative	36	36	37	0	NN	0	37	38	1	feedback	37	37	38	0	PP	0	38	53	2	IN	0	38	39	1	on	38	38	39	0	NP	0	39	53	2	NP	1	39	41	2	NN	0	39	40	1	ERBB	39	39	40	0	NNS	0	40	41	1	receptors	40	40	41	0	SBAR	1	41	53	2	WHNP	0	41	47	2	NP	0	41	42	1	CD	0	41	42	1	12	41	41	42	0	PRN	1	42	47	2	:	0	42	43	1	/	42	42	43	0	NP	0	43	47	3	NP	0	43	44	1	CD	0	43	44	1	8/14	43	43	44	0	,	0	44	45	1	,	44	44	45	0	NP	1	45	47	2	CD	0	45	46	1	6:54	45	45	46	0	NN	0	46	47	1	PM	46	46	47	0	S	1	47	53	2	NP	2	47	50	3	JJ	0	47	48	1	ÔøºScientific	47	47	48	0	CD	0	48	49	1	)	48	48	49	0	NN	0	49	50	1	re	49	49	50	0	VP	0	50	53	2	VBN	0	50	51	1	suspended	50	50	51	0	PP	0	51	53	2	IN	0	51	52	1	in	51	51	52	0	NP	0	52	53	1	NNP	0	52	53	1	PBS	52	52	53	0	NP	0	53	54	1	CC	0	53	54	1	+	53	53	54	0	:	0	54	55	1	/	54	54	55	0	:	0	55	56	1	-	55	55	56	0	NP	0	56	57	1	NN	0	56	57	1	AZD6244	56	56	57	0	.	0	57	58	1	.	57	57	58	0
EOS
T	7
Labeling	6496	6504	VBG	label	O	_	_
was	6505	6508	VBD	be	O	_	_
quenched	6509	6517	VBN	quench	O	_	_
with	6518	6522	IN	with	O	_	_
100mM	6523	6528	NN	100mm	O	_	_
glycine	6529	6536	NN	glycine	O	_	_
.	6536	6537	.	.	O	_	_
D	1
2
2	0	csubjpass
2	1	auxpass
2	5	prep_with
5	4	nn
EOX
Y	1
ROOT	0	0	7	1	S	1	0	7	3	S	0	0	1	1	VP	0	0	1	1	VBG	0	0	1	1	Labeling	0	0	1	0	VP	1	1	6	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	6	2	VBN	0	2	3	1	quenched	2	2	3	0	PP	0	3	6	2	IN	0	3	4	1	with	3	3	4	0	NP	1	4	6	2	NN	0	4	5	1	100mM	4	4	5	0	NN	0	5	6	1	glycine	5	5	6	0	.	0	6	7	1	.	6	6	7	0
EOS
T	11
Cells	6538	6543	NNS	cell	O	_	_
were	6544	6548	VBD	be	O	_	_
then	6549	6553	RB	then	O	_	_
returned	6554	6562	VBN	return	O	_	_
to	6563	6565	TO	to	O	_	_
media	6566	6571	NNS	media	O	_	_
at	6572	6574	IN	at	O	_	_
37degC	6575	6581	NN	37degc	O	_	_
before	6582	6588	IN	before	O	_	_
lysis	6589	6594	NN	lysis	O	_	_
.	6594	6595	.	.	O	_	_
D	1
3
3	0	nsubjpass
3	1	auxpass
3	2	advmod
3	5	prep_to
3	9	prep_before
5	7	prep_at
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	2	1	10	3	VBD	0	1	2	1	were	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	then	2	2	3	0	VP	0	3	10	3	VBN	0	3	4	1	returned	3	3	4	0	PP	0	4	8	2	TO	0	4	5	1	to	4	4	5	0	NP	0	5	8	2	NP	0	5	6	1	NNS	0	5	6	1	media	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	at	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	37degC	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	before	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	lysis	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	29
Biotin	6596	6602	NNP	Biotin	O	_	_
labeled	6603	6610	VBN	label	O	_	_
cell	6611	6615	NN	cell	O	_	_
surface	6616	6623	NN	surface	O	_	_
proteins	6624	6632	NNS	protein	O	_	_
were	6633	6637	VBD	be	O	_	_
immunoprecipitated	6638	6656	VBN	immunoprecipitate	O	_	_
with	6657	6661	IN	with	O	_	_
NeutrAvidin	6662	6673	NNP	NeutrAvidin	B-GENE	_	_
Agarose	6674	6681	NNP	Agarose	I-GENE	_	_
Resins	6682	6688	NNP	Resins	I-GENE	_	_
(	6689	6690	NNP	(	O	_	_
Thermo	6690	6696	NNP	Thermo	O	_	_
Scientific	6697	6707	NNP	Scientific	O	_	_
)	6707	6708	NN	)	O	_	_
,	6708	6709	,	,	O	_	_
separated	6710	6719	VBN	separate	O	_	_
by	6720	6722	IN	by	O	_	_
SDS	6723	6726	NN	sd	O	_	_
page	6727	6731	NN	page	O	_	_
,	6731	6732	,	,	O	_	_
and	6733	6736	CC	and	O	_	_
immunoblotted	6737	6750	VBN	immunoblot	O	_	_
to	6751	6753	TO	to	O	_	_
detect	6754	6760	VB	detect	O	_	_
the	6761	6764	DT	the	O	_	_
indicated	6765	6774	JJ	indicated	O	_	_
proteins	6775	6783	NNS	protein	O	_	_
.	6783	6784	.	.	O	_	_
D	1
6
0	1	vmod
1	4	dobj
4	2	nn
4	3	nn
6	0	nsubjpass
6	5	auxpass
6	14	prep_with
6	16	conj_and
6	22	conj_and
14	8	nn
14	9	nn
14	10	nn
14	11	nn
14	12	nn
14	13	nn
16	0	nsubjpass
16	19	prep_by
19	18	nn
22	0	nsubjpass
22	24	xcomp
24	23	aux
24	27	dobj
27	25	det
27	26	amod
EOX
Y	1
ROOT	0	0	29	1	S	1	0	29	3	NP	0	0	5	2	NP	0	0	1	1	NNP	0	0	1	1	Biotin	0	0	1	0	VP	0	1	5	2	VBN	0	1	2	1	labeled	1	1	2	0	NP	2	2	5	3	NN	0	2	3	1	cell	2	2	3	0	NN	0	3	4	1	surface	3	3	4	0	NNS	0	4	5	1	proteins	4	4	5	0	VP	1	5	28	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	28	6	VP	0	6	15	2	VBN	0	6	7	1	immunoprecipitated	6	6	7	0	PP	0	7	15	2	IN	0	7	8	1	with	7	7	8	0	NP	6	8	15	7	NNP	0	8	9	1	NeutrAvidin	8	8	9	0	NNP	0	9	10	1	Agarose	9	9	10	0	NNP	0	10	11	1	Resins	10	10	11	0	NNP	0	11	12	1	(	11	11	12	0	NNP	0	12	13	1	Thermo	12	12	13	0	NNP	0	13	14	1	Scientific	13	13	14	0	NN	0	14	15	1	)	14	14	15	0	,	0	15	16	1	,	15	15	16	0	VP	0	16	20	2	VBN	0	16	17	1	separated	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	by	17	17	18	0	NP	1	18	20	2	NN	0	18	19	1	SDS	18	18	19	0	NN	0	19	20	1	page	19	19	20	0	,	0	20	21	1	,	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	VP	0	22	28	2	VBN	0	22	23	1	immunoblotted	22	22	23	0	S	0	23	28	1	VP	1	23	28	2	TO	0	23	24	1	to	23	23	24	0	VP	0	24	28	2	VB	0	24	25	1	detect	24	24	25	0	NP	2	25	28	3	DT	0	25	26	1	the	25	25	26	0	JJ	0	26	27	1	indicated	26	26	27	0	NNS	0	27	28	1	proteins	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	9
Transferrin	6785	6796	NN	transferrin	B-GENE	_	_
receptor	6797	6805	NN	receptor	I-GENE	_	_
was	6806	6809	VBD	be	O	_	_
used	6810	6814	VBN	use	O	_	_
as	6815	6817	IN	as	O	_	_
a	6818	6819	DT	a	O	_	_
loading	6820	6827	VBG	load	O	_	_
control	6828	6835	NN	control	O	_	_
.	6835	6836	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	7	prep_as
7	5	det
7	6	amod
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	1	0	2	2	NN	0	0	1	1	Transferrin	0	0	1	0	NN	0	1	2	1	receptor	1	1	2	0	VP	1	2	8	2	VBD	0	2	3	1	was	2	2	3	0	VP	0	3	8	2	VBN	0	3	4	1	used	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	as	4	4	5	0	NP	2	5	8	3	DT	0	5	6	1	a	5	5	6	0	VBG	0	6	7	1	loading	6	6	7	0	NN	0	7	8	1	control	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	38
Xenograft	6837	6846	NNP	Xenograft	O	_	_
Studies	6847	6854	NNPS	Studies	O	_	_
Xenograft	6855	6864	NNP	Xenograft	O	_	_
studies	6865	6872	NNS	study	O	_	_
were	6873	6877	VBD	be	O	_	_
performed	6878	6887	VBN	perform	O	_	_
in	6888	6890	IN	in	O	_	_
accordance	6891	6901	NN	accordance	O	_	_
with	6902	6906	IN	with	O	_	_
the	6907	6910	DT	the	O	_	_
standards	6911	6920	NNS	standard	O	_	_
of	6921	6923	IN	of	O	_	_
the	6924	6927	DT	the	O	_	_
Institutional	6928	6941	JJ	institutional	O	_	_
Animal	6942	6948	NNP	Animal	O	_	_
Care	6949	6953	NNP	Care	O	_	_
and	6954	6957	CC	and	O	_	_
Use	6958	6961	NNP	Use	O	_	_
Committee	6962	6971	NNP	Committee	O	_	_
(	6972	6973	CD	(	O	_	_
IACUC	6973	6978	NNP	IACUC	O	_	_
)	6978	6979	CD	)	O	_	_
under	6980	6985	IN	under	O	_	_
a	6986	6987	DT	a	O	_	_
protocol	6988	6996	NN	protocol	O	_	_
approved	6997	7005	VBN	approve	O	_	_
by	7006	7008	IN	by	O	_	_
the	7009	7012	DT	the	O	_	_
Animal	7013	7019	NNP	Animal	O	_	_
Care	7020	7024	NNP	Care	O	_	_
and	7025	7028	CC	and	O	_	_
Use	7029	7032	NNP	Use	O	_	_
Committee	7033	7042	NNP	Committee	O	_	_
of	7043	7045	IN	of	O	_	_
Massachusetts	7046	7059	NNP	Massachusetts	O	_	_
General	7060	7067	NNP	General	O	_	_
Hospital	7068	7076	NNP	Hospital	O	_	_
.	7076	7077	.	.	O	_	_
D	1
5
3	0	nn
3	1	nn
3	2	nn
5	3	nsubjpass
5	4	auxpass
5	10	prep_in_accordance_with
5	20	dobj
10	9	det
10	15	prep_of
10	18	prep_of
15	12	det
15	13	amod
15	14	nn
15	18	conj_and
18	17	nn
20	19	num
20	21	num
20	24	prep_under
24	23	det
24	25	vmod
25	29	agent
25	32	agent
29	27	det
29	28	nn
29	32	conj_and
29	36	prep_of
32	31	nn
36	34	nn
36	35	nn
EOX
Y	1
ROOT	0	0	38	1	S	1	0	38	3	NP	3	0	4	4	NNP	0	0	1	1	Xenograft	0	0	1	0	NNPS	0	1	2	1	Studies	1	1	2	0	NNP	0	2	3	1	Xenograft	2	2	3	0	NNS	0	3	4	1	studies	3	3	4	0	VP	1	4	37	2	VBD	0	4	5	1	were	4	4	5	0	VP	0	5	37	3	VBN	0	5	6	1	performed	5	5	6	0	PP	0	6	19	2	IN	0	6	7	1	in	6	6	7	0	NP	0	7	19	2	NP	0	7	8	1	NN	0	7	8	1	accordance	7	7	8	0	PP	0	8	19	2	IN	0	8	9	1	with	8	8	9	0	NP	0	9	19	2	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	NNS	0	10	11	1	standards	10	10	11	0	PP	0	11	19	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	19	3	NP	3	12	16	4	DT	0	12	13	1	the	12	12	13	0	JJ	0	13	14	1	Institutional	13	13	14	0	NNP	0	14	15	1	Animal	14	14	15	0	NNP	0	15	16	1	Care	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	NP	1	17	19	2	NNP	0	17	18	1	Use	17	17	18	0	NNP	0	18	19	1	Committee	18	18	19	0	NP	0	19	37	2	NP	1	19	22	3	CD	0	19	20	1	(	19	19	20	0	NNP	0	20	21	1	IACUC	20	20	21	0	CD	0	21	22	1	)	21	21	22	0	PP	0	22	37	2	IN	0	22	23	1	under	22	22	23	0	NP	0	23	37	2	NP	1	23	25	2	DT	0	23	24	1	a	23	23	24	0	NN	0	24	25	1	protocol	24	24	25	0	VP	0	25	37	2	VBN	0	25	26	1	approved	25	25	26	0	PP	0	26	37	2	IN	0	26	27	1	by	26	26	27	0	NP	0	27	37	2	NP	0	27	33	3	NP	2	27	30	3	DT	0	27	28	1	the	27	27	28	0	NNP	0	28	29	1	Animal	28	28	29	0	NNP	0	29	30	1	Care	29	29	30	0	CC	0	30	31	1	and	30	30	31	0	NP	1	31	33	2	NNP	0	31	32	1	Use	31	31	32	0	NNP	0	32	33	1	Committee	32	32	33	0	PP	0	33	37	2	IN	0	33	34	1	of	33	33	34	0	NP	2	34	37	3	NNP	0	34	35	1	Massachusetts	34	34	35	0	NNP	0	35	36	1	General	35	35	36	0	NNP	0	36	37	1	Hospital	36	36	37	0	.	0	37	38	1	.	37	37	38	0
EOS
T	36
Nude	7078	7082	JJ	nude	O	_	_
mice	7083	7087	NNS	mouse	O	_	_
(	7088	7089	VBP	(	O	_	_
nu	7089	7091	NN	nu	O	_	_
/	7091	7092	:	/	O	_	_
nu	7092	7094	NN	nu	O	_	_
;	7094	7095	:	;	O	_	_
6	7096	7097	CD	6	O	_	_
‚	7097	7098	CD	‚	O	_	_
Äì8	7098	7101	NN	äì8	O	_	_
weeks	7102	7107	NNS	week	O	_	_
old	7108	7111	JJ	old	O	_	_
;	7111	7112	:	;	O	_	_
Charles	7113	7120	NNP	Charles	O	_	_
River	7121	7126	NNP	River	O	_	_
Laboratories	7127	7139	NNPS	Laboratories	O	_	_
)	7139	7140	NN	)	O	_	_
were	7141	7145	VBD	be	O	_	_
injected	7146	7154	VBN	inject	O	_	_
with	7155	7159	IN	with	O	_	_
a	7160	7161	DT	a	O	_	_
suspension	7162	7172	NN	suspension	O	_	_
of	7173	7175	IN	of	O	_	_
5	7176	7177	CD	5	O	_	_
√	7177	7178	CD	√	O	_	_
ó106	7178	7182	NN	ó106	O	_	_
H1975	7183	7188	NN	h1975	O	_	_
cells	7189	7194	NNS	cell	O	_	_
subcutaneously	7195	7209	RB	subcutaneously	O	_	_
into	7210	7214	IN	into	O	_	_
the	7215	7218	DT	the	O	_	_
flank	7219	7224	NN	flank	O	_	_
of	7225	7227	IN	of	O	_	_
each	7228	7232	DT	each	O	_	_
mouse	7233	7238	NN	mouse	O	_	_
.	7238	7239	.	.	O	_	_
D	1
2
1	0	amod
2	1	nsubj
2	3	dobj
2	18	parataxis
3	5	dep
3	11	amod
5	4	punct
8	7	number
10	8	num
10	9	nn
11	10	npadvmod
16	13	nn
16	14	nn
16	15	nn
18	16	nsubjpass
18	17	auxpass
18	21	prep_with
18	28	advmod
18	31	prep_into
21	20	det
21	27	prep_of
24	23	number
27	24	num
27	25	nn
27	26	nn
31	30	det
31	34	prep_of
34	33	det
EOX
Y	1
ROOT	0	0	36	1	S	0	0	36	4	S	1	0	12	2	NP	1	0	2	2	JJ	0	0	1	1	Nude	0	0	1	0	NNS	0	1	2	1	mice	1	1	2	0	VP	0	2	12	2	VBP	0	2	3	1	(	2	2	3	0	NP	0	3	12	3	NP	0	3	4	1	NN	0	3	4	1	nu	3	3	4	0	PRN	1	4	7	3	:	0	4	5	1	/	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	nu	5	5	6	0	:	0	6	7	1	;	6	6	7	0	ADJP	1	7	12	2	NP	2	7	11	3	QP	1	7	9	2	CD	0	7	8	1	6	7	7	8	0	CD	0	8	9	1	‚	8	8	9	0	NN	0	9	10	1	Äì8	9	9	10	0	NNS	0	10	11	1	weeks	10	10	11	0	JJ	0	11	12	1	old	11	11	12	0	:	0	12	13	1	;	12	12	13	0	S	1	13	35	2	NP	3	13	17	4	NNP	0	13	14	1	Charles	13	13	14	0	NNP	0	14	15	1	River	14	14	15	0	NNPS	0	15	16	1	Laboratories	15	15	16	0	NN	0	16	17	1	)	16	16	17	0	VP	1	17	35	2	VBD	0	17	18	1	were	17	17	18	0	VP	0	18	35	3	VBN	0	18	19	1	injected	18	18	19	0	PP	0	19	28	2	IN	0	19	20	1	with	19	19	20	0	NP	0	20	28	2	NP	1	20	22	2	DT	0	20	21	1	a	20	20	21	0	NN	0	21	22	1	suspension	21	21	22	0	PP	0	22	28	2	IN	0	22	23	1	of	22	22	23	0	NP	3	23	28	4	QP	1	23	25	2	CD	0	23	24	1	5	23	23	24	0	CD	0	24	25	1	√	24	24	25	0	NN	0	25	26	1	ó106	25	25	26	0	NN	0	26	27	1	H1975	26	26	27	0	NNS	0	27	28	1	cells	27	27	28	0	PP	1	28	35	3	ADVP	0	28	29	1	RB	0	28	29	1	subcutaneously	28	28	29	0	IN	0	29	30	1	into	29	29	30	0	NP	0	30	35	2	NP	1	30	32	2	DT	0	30	31	1	the	30	30	31	0	NN	0	31	32	1	flank	31	31	32	0	PP	0	32	35	2	IN	0	32	33	1	of	32	32	33	0	NP	1	33	35	2	DT	0	33	34	1	each	33	33	34	0	NN	0	34	35	1	mouse	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	25
Once	7240	7244	RB	once	O	_	_
the	7245	7248	DT	the	O	_	_
mean	7249	7253	JJ	mean	O	_	_
tumor	7254	7259	NN	tumor	O	_	_
volume	7260	7266	NN	volume	O	_	_
reached	7267	7274	VBD	reach	O	_	_
~	7275	7276	CD	~	O	_	_
500mm3	7276	7282	JJ	500mm3	O	_	_
AZD6244	7283	7290	NN	azd6244	O	_	_
was	7291	7294	VBD	be	O	_	_
administered	7295	7307	VBN	administer	O	_	_
by	7308	7310	IN	by	O	_	_
oral	7311	7315	JJ	oral	O	_	_
gavage	7316	7322	NN	gavage	O	_	_
in	7323	7325	IN	in	O	_	_
3	7326	7327	CD	3	O	_	_
doses	7328	7333	NNS	dose	O	_	_
of	7334	7336	IN	of	O	_	_
25mg	7337	7341	JJ	25mg	O	_	_
/	7341	7342	:	/	O	_	_
kg	7342	7344	NN	kg	O	_	_
over	7345	7349	IN	over	O	_	_
30	7350	7352	CD	30	O	_	_
hours	7353	7358	NNS	hour	O	_	_
.	7358	7359	.	.	O	_	_
D	1
5
4	1	det
4	2	amod
4	3	nn
5	0	advmod
5	4	nsubj
5	10	ccomp
8	6	num
8	7	amod
10	8	nsubjpass
10	9	auxpass
10	13	agent
13	12	amod
13	16	prep_in
16	15	num
16	23	prep_of
20	19	punct
20	22	prep_over
23	18	amod
23	20	dep
EOX
Y	1
ROOT	0	0	25	1	S	2	0	25	4	ADVP	0	0	1	1	RB	0	0	1	1	Once	0	0	1	0	NP	3	1	5	4	DT	0	1	2	1	the	1	1	2	0	JJ	0	2	3	1	mean	2	2	3	0	NN	0	3	4	1	tumor	3	3	4	0	NN	0	4	5	1	volume	4	4	5	0	VP	0	5	24	2	VBD	0	5	6	1	reached	5	5	6	0	SBAR	0	6	24	1	S	1	6	24	2	NP	2	6	9	3	CD	0	6	7	1	~	6	6	7	0	JJ	0	7	8	1	500mm3	7	7	8	0	NN	0	8	9	1	AZD6244	8	8	9	0	VP	1	9	24	2	VBD	0	9	10	1	was	9	9	10	0	VP	0	10	24	2	VBN	0	10	11	1	administered	10	10	11	0	PP	0	11	24	2	IN	0	11	12	1	by	11	11	12	0	NP	0	12	24	2	NP	1	12	14	2	JJ	0	12	13	1	oral	12	12	13	0	NN	0	13	14	1	gavage	13	13	14	0	PP	0	14	24	2	IN	0	14	15	1	in	14	14	15	0	NP	0	15	24	2	NP	1	15	17	2	CD	0	15	16	1	3	15	15	16	0	NNS	0	16	17	1	doses	16	16	17	0	PP	0	17	24	2	IN	0	17	18	1	of	17	17	18	0	NP	2	18	24	3	JJ	0	18	19	1	25mg	18	18	19	0	PRN	1	19	23	2	:	0	19	20	1	/	19	19	20	0	NP	0	20	23	2	NP	0	20	21	1	NN	0	20	21	1	kg	20	20	21	0	PP	0	21	23	2	IN	0	21	22	1	over	21	21	22	0	NP	0	22	23	1	CD	0	22	23	1	30	22	22	23	0	NNS	0	23	24	1	hours	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	37
PIP2	7360	7364	NN	pip2	O	_	_
/	7364	7365	:	/	O	_	_
PIP3	7365	7369	NN	pip3	O	_	_
Quantification	7370	7384	NN	quantification	O	_	_
Phospholipids	7385	7398	NNS	phospholipid	O	_	_
were	7399	7403	VBD	be	O	_	_
isolated	7404	7412	VBN	isolate	O	_	_
from	7413	7417	IN	from	O	_	_
cells	7418	7423	NNS	cell	O	_	_
and	7424	7427	CC	and	O	_	_
PIP3	7428	7432	NN	pip3	O	_	_
and	7433	7436	CC	and	O	_	_
PI	7437	7439	NN	pi	O	_	_
(	7439	7440	NN	(	O	_	_
4,5	7440	7443	CD	4,5	O	_	_
)	7443	7444	CD	)	O	_	_
P2	7444	7446	NN	p2	O	_	_
levels	7447	7453	NNS	level	O	_	_
were	7454	7458	VBD	be	O	_	_
measured	7459	7467	VBN	measure	O	_	_
using	7468	7473	VBG	use	O	_	_
ELISA	7474	7479	NN	elisa	O	_	_
kits	7480	7484	NNS	kit	O	_	_
(	7485	7486	CD	(	O	_	_
Echelon	7486	7493	NNP	Echelon	O	_	_
,	7493	7494	,	,	O	_	_
K-2500s	7495	7502	NN	k-2500	O	_	_
and	7503	7506	CC	and	O	_	_
K4500	7507	7512	CD	k4500	O	_	_
)	7512	7513	CD	)	O	_	_
according	7514	7523	VBG	accord	O	_	_
to	7524	7526	TO	to	O	_	_
the	7527	7530	DT	the	O	_	_
manufacturer	7531	7543	NN	manufacturer	O	_	_
's	7543	7545	POS	's	O	_	_
instructions	7546	7558	NNS	instruction	O	_	_
.	7558	7559	.	.	O	_	_
D	1
0
0	1	punct
0	6	dep
4	2	nn
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	8	prep_from
6	13	prep_from
8	13	conj_and
10	12	conj_and
13	10	nn
13	12	nn
13	19	rcmod
13	24	dep
13	26	dep
13	29	dep
15	14	number
17	15	num
17	16	nn
19	17	nsubjpass
19	18	auxpass
19	20	xcomp
20	22	dobj
22	21	nn
24	23	num
24	26	conj_and
24	29	conj_and
29	28	number
29	31	prepc_according_to
29	35	pobj
33	32	det
35	33	poss
EOX
Y	1
ROOT	0	0	37	1	FRAG	0	0	37	4	NP	0	0	1	1	NN	0	0	1	1	PIP2	0	0	1	0	:	0	1	2	1	/	1	1	2	0	S	1	2	36	2	NP	2	2	5	3	NN	0	2	3	1	PIP3	2	2	3	0	NN	0	3	4	1	Quantification	3	3	4	0	NNS	0	4	5	1	Phospholipids	4	4	5	0	VP	1	5	36	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	36	2	VBN	0	6	7	1	isolated	6	6	7	0	PP	0	7	36	2	IN	0	7	8	1	from	7	7	8	0	NP	0	8	36	3	NP	0	8	9	1	NNS	0	8	9	1	cells	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NP	0	10	36	2	NP	0	10	23	2	NP	1	10	14	2	NP	0	10	13	3	NN	0	10	11	1	PIP3	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NN	0	12	13	1	PI	12	12	13	0	NN	0	13	14	1	(	13	13	14	0	SBAR	0	14	23	1	S	1	14	23	2	NP	2	14	18	3	QP	1	14	16	2	CD	0	14	15	1	4,5	14	14	15	0	CD	0	15	16	1	)	15	15	16	0	NN	0	16	17	1	P2	16	16	17	0	NNS	0	17	18	1	levels	17	17	18	0	VP	1	18	23	2	VBD	0	18	19	1	were	18	18	19	0	VP	0	19	23	2	VBN	0	19	20	1	measured	19	19	20	0	S	0	20	23	1	VP	0	20	23	2	VBG	0	20	21	1	using	20	20	21	0	NP	1	21	23	2	NN	0	21	22	1	ELISA	21	21	22	0	NNS	0	22	23	1	kits	22	22	23	0	NP	0	23	36	5	NP	1	23	25	2	CD	0	23	24	1	(	23	23	24	0	NNP	0	24	25	1	Echelon	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NP	0	26	27	1	NN	0	26	27	1	K-2500s	26	26	27	0	CC	0	27	28	1	and	27	27	28	0	NP	0	28	36	2	NP	0	28	30	1	QP	1	28	30	2	CD	0	28	29	1	K4500	28	28	29	0	CD	0	29	30	1	)	29	29	30	0	PP	0	30	36	2	VBG	0	30	31	1	according	30	30	31	0	PP	0	31	36	2	TO	0	31	32	1	to	31	31	32	0	NP	1	32	36	2	NP	1	32	35	3	DT	0	32	33	1	the	32	32	33	0	NN	0	33	34	1	manufacturer	33	33	34	0	POS	0	34	35	1	's	34	34	35	0	NNS	0	35	36	1	instructions	35	35	36	0	.	0	36	37	1	.	36	36	37	0
EOS
T	8
Statistical	7560	7571	JJ	statistical	O	_	_
significance	7572	7584	NN	significance	O	_	_
was	7585	7588	VBD	be	O	_	_
calculated	7589	7599	VBN	calculate	O	_	_
using	7600	7605	VBG	use	O	_	_
a	7606	7607	DT	a	O	_	_
t-test	7608	7614	NN	t-test	O	_	_
.	7614	7615	.	.	O	_	_
D	1
3
1	0	amod
3	1	nsubjpass
3	2	auxpass
3	4	xcomp
4	6	dobj
6	5	det
EOX
Y	1
ROOT	0	0	8	1	S	1	0	8	3	NP	1	0	2	2	JJ	0	0	1	1	Statistical	0	0	1	0	NN	0	1	2	1	significance	1	1	2	0	VP	1	2	7	2	VBD	0	2	3	1	was	2	2	3	0	VP	0	3	7	2	VBN	0	3	4	1	calculated	3	3	4	0	S	0	4	7	1	VP	0	4	7	2	VBG	0	4	5	1	using	4	4	5	0	NP	1	5	7	2	DT	0	5	6	1	a	5	5	6	0	NN	0	6	7	1	t-test	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	32
qRT-PCR	7616	7623	NN	qrt-pcr	O	_	_
RNA	7624	7627	NN	rna	O	_	_
was	7628	7631	VBD	be	O	_	_
isolated	7632	7640	VBN	isolate	O	_	_
using	7641	7646	VBG	use	O	_	_
the	7647	7650	DT	the	O	_	_
RNEasy	7651	7657	NN	rneasy	O	_	_
kit	7658	7661	NN	kit	O	_	_
(	7662	7663	CD	(	O	_	_
Qiagen	7663	7669	NNP	Qiagen	O	_	_
)	7669	7670	NN	)	O	_	_
and	7671	7674	CC	and	O	_	_
cDNA	7675	7679	NN	cdna	O	_	_
was	7680	7683	VBD	be	O	_	_
transcribed	7684	7695	VBN	transcribe	O	_	_
with	7696	7700	IN	with	O	_	_
Superscript	7701	7712	NNP	Superscript	B-GENE	_	_
II	7713	7715	NNP	II	I-GENE	_	_
Reverse	7716	7723	JJ	reverse	I-GENE	_	_
Transcriptase	7724	7737	NN	transcriptase	I-GENE	_	_
(	7738	7739	CD	(	O	_	_
Invitrogen	7739	7749	NNP	Invitrogen	O	_	_
)	7749	7750	NN	)	O	_	_
and	7751	7754	CC	and	O	_	_
used	7755	7759	VBN	use	O	_	_
as	7760	7762	IN	as	O	_	_
a	7763	7764	DT	a	O	_	_
template	7765	7773	NN	template	O	_	_
for	7774	7777	IN	for	O	_	_
PCR	7778	7781	NN	pcr	O	_	_
amplifications	7782	7796	NNS	amplification	O	_	_
.	7796	7797	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	4	xcomp
4	14	ccomp
4	24	ccomp
10	5	det
10	6	nn
10	7	nn
10	8	num
10	9	nn
10	12	conj_and
14	10	nsubjpass
14	12	nsubjpass
14	13	auxpass
14	19	prep_with
14	24	conj_and
19	16	nn
19	17	nn
19	18	amod
19	22	dep
22	20	num
22	21	nn
24	10	nsubjpass
24	27	prep_as
27	26	det
27	30	prep_for
30	29	nn
EOX
Y	1
ROOT	0	0	32	1	S	1	0	32	3	NP	1	0	2	2	NN	0	0	1	1	qRT-PCR	0	0	1	0	NN	0	1	2	1	RNA	1	1	2	0	VP	1	2	31	2	VBD	0	2	3	1	was	2	2	3	0	VP	0	3	31	2	VBN	0	3	4	1	isolated	3	3	4	0	S	0	4	31	1	VP	0	4	31	2	VBG	0	4	5	1	using	4	4	5	0	SBAR	0	5	31	1	S	1	5	31	2	NP	0	5	13	3	NP	5	5	11	6	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	RNEasy	6	6	7	0	NN	0	7	8	1	kit	7	7	8	0	CD	0	8	9	1	(	8	8	9	0	NNP	0	9	10	1	Qiagen	9	9	10	0	NN	0	10	11	1	)	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	cDNA	12	12	13	0	VP	1	13	31	2	VBD	0	13	14	1	was	13	13	14	0	VP	0	14	31	3	VP	0	14	23	2	VBN	0	14	15	1	transcribed	14	14	15	0	PP	0	15	23	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	23	2	NP	3	16	20	4	NNP	0	16	17	1	Superscript	16	16	17	0	NNP	0	17	18	1	II	17	17	18	0	JJ	0	18	19	1	Reverse	18	18	19	0	NN	0	19	20	1	Transcriptase	19	19	20	0	NP	2	20	23	3	CD	0	20	21	1	(	20	20	21	0	NNP	0	21	22	1	Invitrogen	21	21	22	0	NN	0	22	23	1	)	22	22	23	0	CC	0	23	24	1	and	23	23	24	0	VP	0	24	31	2	VBN	0	24	25	1	used	24	24	25	0	PP	0	25	31	2	IN	0	25	26	1	as	25	25	26	0	NP	0	26	31	2	NP	1	26	28	2	DT	0	26	27	1	a	26	26	27	0	NN	0	27	28	1	template	27	27	28	0	PP	0	28	31	2	IN	0	28	29	1	for	28	28	29	0	NP	1	29	31	2	NN	0	29	30	1	PCR	29	29	30	0	NNS	0	30	31	1	amplifications	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	26
The	7798	7801	DT	the	O	_	_
relative	7802	7810	JJ	relative	O	_	_
copy	7811	7815	NN	copy	O	_	_
number	7816	7822	NN	number	O	_	_
for	7823	7826	IN	for	O	_	_
ERBB3	7827	7832	NN	erbb3	O	_	_
and	7833	7836	CC	and	O	_	_
HRG	7837	7840	NN	hrg	O	_	_
was	7841	7844	VBD	be	O	_	_
determined	7845	7855	VBN	determine	O	_	_
using	7856	7861	VBG	use	O	_	_
q-RT-PCR	7862	7870	NN	q-rt-pcr	O	_	_
using	7871	7876	VBG	use	O	_	_
a	7877	7878	DT	a	O	_	_
light-cycler	7879	7891	NN	light-cycler	O	_	_
480	7892	7895	CD	480	O	_	_
(	7896	7897	CD	(	O	_	_
Roche	7897	7902	NNP	Roche	O	_	_
)	7902	7903	CD	)	O	_	_
as	7904	7906	IN	as	O	_	_
previously	7907	7917	RB	previously	O	_	_
described	7918	7927	VBN	describe	O	_	_
(	7928	7929	NN	(	O	_	_
11	7929	7931	CD	11	O	_	_
)	7931	7932	NN	)	O	_	_
.	7932	7933	.	.	O	_	_
D	1
9
3	0	det
3	1	amod
3	2	nn
3	5	prep_for
3	7	prep_for
5	7	conj_and
9	3	nsubjpass
9	8	auxpass
9	10	xcomp
9	21	advcl
10	11	dobj
10	12	vmod
12	14	iobj
12	17	dobj
14	13	det
16	15	number
17	16	num
17	18	num
21	19	mark
21	20	advmod
21	24	dobj
24	22	nn
24	23	num
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	0	0	8	2	NP	3	0	4	4	DT	0	0	1	1	The	0	0	1	0	JJ	0	1	2	1	relative	1	1	2	0	NN	0	2	3	1	copy	2	2	3	0	NN	0	3	4	1	number	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	for	4	4	5	0	NP	0	5	8	3	NN	0	5	6	1	ERBB3	5	5	6	0	CC	0	6	7	1	and	6	6	7	0	NN	0	7	8	1	HRG	7	7	8	0	VP	1	8	25	2	VBD	0	8	9	1	was	8	8	9	0	VP	0	9	25	3	VBN	0	9	10	1	determined	9	9	10	0	S	0	10	19	1	VP	0	10	19	3	VBG	0	10	11	1	using	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	q-RT-PCR	11	11	12	0	S	0	12	19	1	VP	0	12	19	3	VBG	0	12	13	1	using	12	12	13	0	NP	1	13	15	2	DT	0	13	14	1	a	13	13	14	0	NN	0	14	15	1	light-cycler	14	14	15	0	NP	1	15	19	3	QP	1	15	17	2	CD	0	15	16	1	480	15	15	16	0	CD	0	16	17	1	(	16	16	17	0	NNP	0	17	18	1	Roche	17	17	18	0	CD	0	18	19	1	)	18	18	19	0	SBAR	1	19	25	2	IN	0	19	20	1	as	19	19	20	0	S	1	20	25	2	ADVP	0	20	21	1	RB	0	20	21	1	previously	20	20	21	0	VP	0	21	25	2	VBN	0	21	22	1	described	21	21	22	0	NP	2	22	25	3	NN	0	22	23	1	(	22	22	23	0	CD	0	23	24	1	11	23	23	24	0	NN	0	24	25	1	)	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	10
The	7934	7937	DT	the	O	_	_
PCR	7938	7941	NN	pcr	O	_	_
primers	7942	7949	NNS	primer	O	_	_
and	7950	7953	CC	and	O	_	_
conditions	7954	7964	NNS	condition	O	_	_
are	7965	7968	VBP	be	O	_	_
available	7969	7978	JJ	available	O	_	_
upon	7979	7983	IN	upon	O	_	_
request	7984	7991	NN	request	O	_	_
.	7991	7992	.	.	O	_	_
D	1
6
2	0	det
2	1	nn
2	4	conj_and
6	2	nsubj
6	4	nsubj
6	5	cop
6	8	prep_upon
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	2	0	5	5	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	PCR	1	1	2	0	NNS	0	2	3	1	primers	2	2	3	0	CC	0	3	4	1	and	3	3	4	0	NNS	0	4	5	1	conditions	4	4	5	0	VP	1	5	9	2	VBP	0	5	6	1	are	5	5	6	0	ADJP	0	6	9	2	JJ	0	6	7	1	available	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	upon	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	request	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	37
siRNA	7993	7998	NN	sirna	O	_	_
and	7999	8002	CC	and	O	_	_
Transient	8003	8012	JJ	transient	O	_	_
Transfections	8013	8026	NNS	transfection	O	_	_
HCC827	8027	8033	NN	hcc827	O	_	_
and	8034	8037	CC	and	O	_	_
BT-474	8038	8044	NN	bt-474	O	_	_
cells	8045	8050	NNS	cell	O	_	_
were	8051	8055	VBD	be	O	_	_
transfected	8056	8067	VBN	transfect	O	_	_
with	8068	8072	IN	with	O	_	_
50nM	8073	8077	NN	50nm	B-GENE	_	_
ERBB3s4779	8078	8088	NN	erbb3s4779	I-GENE	_	_
silencer	8089	8097	NN	silencer	I-GENE	_	_
select	8098	8104	JJ	select	O	_	_
validated	8105	8114	VBN	validate	O	_	_
siRNA	8115	8120	NN	sirna	O	_	_
or	8121	8123	CC	or	O	_	_
negative	8124	8132	JJ	negative	O	_	_
control	8133	8140	NN	control	O	_	_
(	8141	8142	CD	(	O	_	_
Ambion	8142	8148	NNP	Ambion	O	_	_
)	8148	8149	NN	)	O	_	_
with	8150	8154	IN	with	O	_	_
HiPerFect	8155	8164	NNP	HiPerFect	O	_	_
Transfection	8165	8177	NN	transfection	O	_	_
Reagent	8178	8185	NN	reagent	O	_	_
(	8186	8187	CD	(	O	_	_
Qiagen	8187	8193	NNP	Qiagen	O	_	_
)	8193	8194	CD	)	O	_	_
according	8195	8204	VBG	accord	O	_	_
to	8205	8207	TO	to	O	_	_
manufacturer	8208	8220	NN	manufacturer	O	_	_
‚	8220	8221	CD	‚	O	_	_
Äôs	8221	8224	NNS	äôs	O	_	_
instructions	8225	8237	NNS	instruction	O	_	_
.	8237	8238	.	.	O	_	_
D	1
9
0	2	conj_and
4	0	nn
4	2	nn
4	3	nn
4	7	conj_and
7	6	nn
9	4	nsubjpass
9	7	nsubjpass
9	8	auxpass
9	13	prep_with
9	14	dobj
13	11	nn
13	12	nn
14	15	vmod
14	35	dep
15	16	dobj
15	19	dobj
15	26	prep_with
15	31	prepc_according_to
15	32	pobj
16	19	conj_or
19	18	amod
19	22	dep
22	20	num
22	21	nn
26	24	nn
26	25	nn
26	28	dep
28	27	num
28	29	num
35	33	num
35	34	nn
EOX
Y	1
ROOT	0	0	37	1	S	1	0	37	3	NP	0	0	8	3	NP	2	0	5	3	NP	0	0	3	3	NN	0	0	1	1	siRNA	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	JJ	0	2	3	1	Transient	2	2	3	0	NNS	0	3	4	1	Transfections	3	3	4	0	NN	0	4	5	1	HCC827	4	4	5	0	CC	0	5	6	1	and	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	BT-474	6	6	7	0	NNS	0	7	8	1	cells	7	7	8	0	VP	1	8	36	2	VBD	0	8	9	1	were	8	8	9	0	VP	0	9	36	3	VBN	0	9	10	1	transfected	9	9	10	0	PP	0	10	14	2	IN	0	10	11	1	with	10	10	11	0	NP	2	11	14	3	NN	0	11	12	1	50nM	11	11	12	0	NN	0	12	13	1	ERBB3s4779	12	12	13	0	NN	0	13	14	1	silencer	13	13	14	0	NP	0	14	36	2	NP	0	14	33	2	NP	0	14	15	1	JJ	0	14	15	1	select	14	14	15	0	VP	0	15	33	4	VBN	0	15	16	1	validated	15	15	16	0	NP	0	16	23	3	NP	0	16	17	1	NN	0	16	17	1	siRNA	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	NP	0	18	23	2	NP	1	18	20	2	JJ	0	18	19	1	negative	18	18	19	0	NN	0	19	20	1	control	19	19	20	0	NP	2	20	23	3	CD	0	20	21	1	(	20	20	21	0	NNP	0	21	22	1	Ambion	21	21	22	0	NN	0	22	23	1	)	22	22	23	0	PP	0	23	30	2	IN	0	23	24	1	with	23	23	24	0	NP	0	24	30	2	NP	2	24	27	3	NNP	0	24	25	1	HiPerFect	24	24	25	0	NN	0	25	26	1	Transfection	25	25	26	0	NN	0	26	27	1	Reagent	26	26	27	0	NP	1	27	30	3	CD	0	27	28	1	(	27	27	28	0	NNP	0	28	29	1	Qiagen	28	28	29	0	CD	0	29	30	1	)	29	29	30	0	PP	0	30	33	2	VBG	0	30	31	1	according	30	30	31	0	PP	0	31	33	2	TO	0	31	32	1	to	31	31	32	0	NP	0	32	33	1	NN	0	32	33	1	manufacturer	32	32	33	0	NP	2	33	36	3	CD	0	33	34	1	‚	33	33	34	0	NNS	0	34	35	1	Äôs	34	34	35	0	NNS	0	35	36	1	instructions	35	35	36	0	.	0	36	37	1	.	36	36	37	0
EOS
T	25
Transient	8239	8248	JJ	transient	O	_	_
transfections	8249	8262	NNS	transfection	O	_	_
of	8263	8265	IN	of	O	_	_
CHO-KI	8266	8272	NN	cho-kus	O	_	_
cells	8273	8278	NNS	cell	O	_	_
were	8279	8283	VBD	be	O	_	_
performed	8284	8293	VBN	perform	O	_	_
with	8294	8298	IN	with	O	_	_
TransIT	8299	8306	NN	transit	B-GENE	_	_
¬	8306	8307	CD	¬	I-GENE	_	_
Æ-LT1	8307	8312	NN	æ-lt1	I-GENE	_	_
Transfection	8313	8325	NN	transfection	O	_	_
Reagent	8326	8333	NN	reagent	O	_	_
(	8334	8335	CD	(	O	_	_
MirusBio	8335	8343	NNP	MirusBio	O	_	_
LLC	8344	8347	NNP	LLC	O	_	_
)	8347	8348	CD	)	O	_	_
according	8349	8358	VBG	accord	O	_	_
to	8359	8361	TO	to	O	_	_
the	8362	8365	DT	the	O	_	_
manufacturer	8366	8378	NN	manufacturer	O	_	_
‚	8378	8379	CD	‚	O	_	_
Äôs	8379	8382	NNS	äôs	O	_	_
recommendations	8383	8398	NNS	recommendation	O	_	_
.	8398	8399	.	.	O	_	_
D	1
6
1	0	amod
1	4	prep_of
4	3	nn
6	1	nsubjpass
6	5	auxpass
6	12	prep_with
6	15	dobj
12	8	nn
12	9	num
12	10	nn
12	11	nn
15	13	num
15	14	nn
15	16	num
15	18	prepc_according_to
15	20	pobj
15	23	dep
20	19	det
23	21	num
23	22	nn
EOX
Y	1
ROOT	0	0	25	1	S	1	0	25	3	NP	0	0	5	2	NP	1	0	2	2	JJ	0	0	1	1	Transient	0	0	1	0	NNS	0	1	2	1	transfections	1	1	2	0	PP	0	2	5	2	IN	0	2	3	1	of	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	CHO-KI	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	24	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	24	3	VBN	0	6	7	1	performed	6	6	7	0	PP	0	7	13	2	IN	0	7	8	1	with	7	7	8	0	NP	4	8	13	5	NN	0	8	9	1	TransIT	8	8	9	0	CD	0	9	10	1	¬	9	9	10	0	NN	0	10	11	1	Æ-LT1	10	10	11	0	NN	0	11	12	1	Transfection	11	11	12	0	NN	0	12	13	1	Reagent	12	12	13	0	NP	0	13	24	2	NP	0	13	21	2	NP	2	13	17	4	CD	0	13	14	1	(	13	13	14	0	NNP	0	14	15	1	MirusBio	14	14	15	0	NNP	0	15	16	1	LLC	15	15	16	0	CD	0	16	17	1	)	16	16	17	0	PP	0	17	21	2	VBG	0	17	18	1	according	17	17	18	0	PP	0	18	21	2	TO	0	18	19	1	to	18	18	19	0	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	manufacturer	20	20	21	0	NP	2	21	24	3	CD	0	21	22	1	‚	21	21	22	0	NNS	0	22	23	1	Äôs	22	22	23	0	NNS	0	23	24	1	recommendations	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	19
Wild-type	8400	8409	JJ	wild-type	O	_	_
ERBB3	8410	8415	NN	erbb3	O	_	_
was	8416	8419	VBD	be	O	_	_
co	8420	8422	NN	co	O	_	_
transfected	8423	8434	VBN	transfect	O	_	_
with	8435	8439	IN	with	O	_	_
an	8440	8442	DT	a	O	_	_
equal	8443	8448	JJ	equal	O	_	_
ratio	8449	8454	NN	ratio	O	_	_
of	8455	8457	IN	of	O	_	_
GFP	8458	8461	NN	gfp	B-GENE	_	_
or	8462	8464	CC	or	O	_	_
wild-type	8465	8474	JJ	wild-type	B-GENE	_	_
or	8475	8477	CC	or	I-GENE	_	_
mutant	8478	8484	JJ	mutant	I-GENE	_	_
EGFR	8485	8489	NN	egfr	I-GENE	_	_
or	8490	8492	CC	or	O	_	_
HER2	8493	8497	NN	her2	O	_	_
.	8497	8498	.	.	O	_	_
D	1
3
1	0	amod
3	1	nsubj
3	2	cop
3	4	vmod
4	8	prep_with
4	15	prep_with
8	6	det
8	7	amod
8	10	prep_of
8	15	conj_or
8	17	conj_or
12	14	conj_or
15	12	amod
15	14	amod
15	17	conj_or
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	1	0	2	2	JJ	0	0	1	1	Wild-type	0	0	1	0	NN	0	1	2	1	ERBB3	1	1	2	0	VP	1	2	18	2	VBD	0	2	3	1	was	2	2	3	0	NP	0	3	18	2	NP	0	3	4	1	NN	0	3	4	1	co	3	3	4	0	VP	0	4	18	2	VBN	0	4	5	1	transfected	4	4	5	0	PP	0	5	18	2	IN	0	5	6	1	with	5	5	6	0	NP	0	6	18	3	NP	0	6	11	2	NP	2	6	9	3	DT	0	6	7	1	an	6	6	7	0	JJ	0	7	8	1	equal	7	7	8	0	NN	0	8	9	1	ratio	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	GFP	10	10	11	0	CC	0	11	12	1	or	11	11	12	0	NP	0	12	18	3	NP	1	12	16	2	ADJP	0	12	15	3	JJ	0	12	13	1	wild-type	12	12	13	0	CC	0	13	14	1	or	13	13	14	0	JJ	0	14	15	1	mutant	14	14	15	0	NN	0	15	16	1	EGFR	15	15	16	0	CC	0	16	17	1	or	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	HER2	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	38
shRNA	8499	8504	NN	shrna	O	_	_
,	8504	8505	,	,	O	_	_
DNA	8506	8509	NN	dna	O	_	_
Constructs	8510	8520	NNS	construct	O	_	_
and	8521	8524	CC	and	O	_	_
Lentiviral	8525	8535	JJ	lentiviral	O	_	_
Production	8536	8546	NN	production	O	_	_
HCC827	8547	8553	NN	hcc827	O	_	_
cells	8554	8559	NNS	cell	O	_	_
were	8560	8564	VBD	be	O	_	_
infected	8565	8573	VBN	infect	O	_	_
with	8574	8578	IN	with	O	_	_
shERBB3	8579	8586	NN	sherbb3	O	_	_
as	8587	8589	IN	as	O	_	_
previously	8590	8600	RB	previously	O	_	_
described	8601	8610	VBN	describe	O	_	_
(	8611	8612	NN	(	O	_	_
23	8612	8614	CD	23	O	_	_
,	8614	8615	,	,	O	_	_
24	8616	8618	CD	24	O	_	_
)	8618	8619	NN	)	O	_	_
with	8620	8624	IN	with	O	_	_
tet-on	8625	8631	JJ	tet-on	O	_	_
PLKO	8632	8636	NN	plko	B-GENE	_	_
shERBB3	8637	8644	NN	sherbb3	I-GENE	_	_
or	8645	8647	CC	or	O	_	_
scramble	8648	8656	NN	scramble	O	_	_
shRNA	8657	8662	NN	shrna	O	_	_
knockdown	8663	8672	NN	knockdown	O	_	_
vectors	8673	8680	NNS	vector	O	_	_
(	8681	8682	VBP	(	O	_	_
Addgene	8682	8689	JJ	addgene	O	_	_
)	8689	8690	NN	)	O	_	_
and	8691	8694	CC	and	O	_	_
selected	8695	8703	VBN	select	O	_	_
in	8704	8706	IN	in	O	_	_
puromycin	8707	8716	NN	puromycin	O	_	_
.	8716	8717	.	.	O	_	_
D	1
10
0	3	conj_and
0	8	conj_and
3	2	nn
8	5	amod
8	6	nn
8	7	nn
10	0	nsubjpass
10	3	nsubjpass
10	8	nsubjpass
10	9	auxpass
10	12	prep_with
10	30	advcl
10	34	conj_and
15	14	advmod
15	16	dobj
15	24	prep_with
15	29	prep_with
16	17	num
16	20	amod
20	19	number
24	22	amod
24	23	nn
24	29	conj_or
29	26	nn
29	27	nn
29	28	nn
30	13	mark
30	15	csubj
30	32	dobj
32	31	amod
34	0	nsubjpass
34	36	prep_in
EOX
Y	1
ROOT	0	0	38	1	S	1	0	38	3	NP	0	0	9	5	NP	0	0	1	1	NN	0	0	1	1	shRNA	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	1	2	4	2	NN	0	2	3	1	DNA	2	2	3	0	NNS	0	3	4	1	Constructs	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NP	3	5	9	4	JJ	0	5	6	1	Lentiviral	5	5	6	0	NN	0	6	7	1	Production	6	6	7	0	NN	0	7	8	1	HCC827	7	7	8	0	NNS	0	8	9	1	cells	8	8	9	0	VP	1	9	37	2	VBD	0	9	10	1	were	9	9	10	0	VP	0	10	37	3	VP	0	10	33	3	VBN	0	10	11	1	infected	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	with	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	shERBB3	12	12	13	0	SBAR	1	13	33	2	IN	0	13	14	1	as	13	13	14	0	S	1	14	33	2	S	0	14	30	1	VP	1	14	30	4	ADVP	0	14	15	1	RB	0	14	15	1	previously	14	14	15	0	VBN	0	15	16	1	described	15	15	16	0	NP	0	16	21	3	NP	0	16	18	2	NN	0	16	17	1	(	16	16	17	0	CD	0	17	18	1	23	17	17	18	0	,	0	18	19	1	,	18	18	19	0	ADJP	1	19	21	2	CD	0	19	20	1	24	19	19	20	0	NN	0	20	21	1	)	20	20	21	0	PP	0	21	30	2	IN	0	21	22	1	with	21	21	22	0	NP	0	22	30	3	NP	2	22	25	3	JJ	0	22	23	1	tet-on	22	22	23	0	NN	0	23	24	1	PLKO	23	23	24	0	NN	0	24	25	1	shERBB3	24	24	25	0	CC	0	25	26	1	or	25	25	26	0	NP	3	26	30	4	NN	0	26	27	1	scramble	26	26	27	0	NN	0	27	28	1	shRNA	27	27	28	0	NN	0	28	29	1	knockdown	28	28	29	0	NNS	0	29	30	1	vectors	29	29	30	0	VP	0	30	33	2	VBP	0	30	31	1	(	30	30	31	0	NP	1	31	33	2	JJ	0	31	32	1	Addgene	31	31	32	0	NN	0	32	33	1	)	32	32	33	0	CC	0	33	34	1	and	33	33	34	0	VP	0	34	37	2	VBN	0	34	35	1	selected	34	34	35	0	PP	0	35	37	2	IN	0	35	36	1	in	35	35	36	0	NP	0	36	37	1	NN	0	36	37	1	puromycin	36	36	37	0	.	0	37	38	1	.	37	37	38	0
EOS
T	12
shRNA	8718	8723	NN	shrna	O	_	_
hairpin	8724	8731	NN	hairpin	O	_	_
sequences	8732	8741	NNS	sequence	O	_	_
are	8742	8745	VBP	be	O	_	_
provided	8746	8754	VBN	provide	O	_	_
in	8755	8757	IN	in	O	_	_
the	8758	8761	DT	the	O	_	_
Supplemental	8762	8774	NNP	Supplemental	O	_	_
Materials	8775	8784	NNPS	Materials	O	_	_
and	8785	8788	CC	and	O	_	_
Methods	8789	8796	NNS	method	O	_	_
.	8796	8797	.	.	O	_	_
D	1
4
2	0	nn
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	8	prep_in
4	10	prep_in
8	6	det
8	7	nn
8	10	conj_and
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	2	0	3	3	NN	0	0	1	1	shRNA	0	0	1	0	NN	0	1	2	1	hairpin	1	1	2	0	NNS	0	2	3	1	sequences	2	2	3	0	VP	1	3	11	2	VBP	0	3	4	1	are	3	3	4	0	VP	0	4	11	2	VBN	0	4	5	1	provided	4	4	5	0	PP	0	5	11	2	IN	0	5	6	1	in	5	5	6	0	NP	0	6	11	3	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	NNP	0	7	8	1	Supplemental	7	7	8	0	NNPS	0	8	9	1	Materials	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NP	0	10	11	1	NNS	0	10	11	1	Methods	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	47
Human	8798	8803	JJ	human	B-GENE	_	_
EGFR	8804	8808	NN	egfr	I-GENE	_	_
(	8809	8810	CD	(	O	_	_
wild-type	8810	8819	JJ	wild-type	O	_	_
and	8820	8823	CC	and	O	_	_
exon	8824	8828	NN	exon	O	_	_
19del	8829	8834	NN	19del	O	_	_
)	8834	8835	NN	)	O	_	_
and	8836	8839	CC	and	O	_	_
HER2	8840	8844	NN	her2	B-GENE	_	_
cDNA	8845	8849	NN	cdna	I-GENE	_	_
coding	8850	8856	VBG	code	O	_	_
regions	8857	8864	NNS	region	O	_	_
were	8865	8869	VBD	be	O	_	_
cloned	8870	8876	VBN	clone	O	_	_
into	8877	8881	IN	into	O	_	_
the	8882	8885	DT	the	O	_	_
pENTR	8886	8891	NN	pentr	O	_	_
/	8891	8892	:	/	O	_	_
D-	8892	8894	JJ	d-	O	_	_
TOPO	8895	8899	NN	topo	O	_	_
vector	8900	8906	NN	vector	O	_	_
(	8907	8908	CD	(	O	_	_
Invitrogen	8908	8918	NNP	Invitrogen	O	_	_
)	8918	8919	NN	)	O	_	_
and	8920	8923	CC	and	O	_	_
mutants	8924	8931	NNS	mutant	O	_	_
were	8932	8936	VBD	be	O	_	_
constructed	8937	8948	VBN	construct	O	_	_
with	8949	8953	IN	with	O	_	_
Quick	8954	8959	NNP	Quick	O	_	_
Change	8960	8966	NNP	Change	O	_	_
Site	8967	8971	NN	site	O	_	_
Directed	8972	8980	NNP	Directed	O	_	_
Mutagenesis	8981	8992	NN	mutagenesis	O	_	_
Kit	8993	8996	NN	kit	O	_	_
(	8997	8998	CD	(	O	_	_
Stratagene	8998	9008	NNP	Stratagene	O	_	_
)	9008	9009	CD	)	O	_	_
according	9010	9019	VBG	accord	O	_	_
to	9020	9022	TO	to	O	_	_
the	9023	9026	DT	the	O	_	_
manufacturer	9027	9039	NN	manufacturer	O	_	_
‚	9039	9040	CD	‚	O	_	_
Äôs	9040	9043	NNS	äôs	O	_	_
instructions	9044	9056	NNS	instruction	O	_	_
.	9056	9057	.	.	O	_	_
D	1
1
1	0	amod
1	14	rcmod
1	18	punct
1	28	dep
2	6	dep
3	5	conj_and
6	3	amod
6	5	amod
7	9	conj_and
10	7	nn
10	9	nn
10	11	vmod
11	12	dobj
14	2	dobj
14	10	nsubjpass
14	13	auxpass
14	17	prep_into
17	16	det
24	19	amod
24	20	nn
24	21	nn
24	22	num
24	23	nn
24	26	conj_and
28	24	nsubjpass
28	26	nsubjpass
28	27	auxpass
28	33	prep_with
28	40	prepc_according_to
28	42	pobj
33	30	nn
33	31	nn
33	32	nn
33	35	dep
35	34	nn
35	37	dep
37	36	num
37	38	num
42	41	det
42	45	dep
45	43	num
45	44	nn
EOX
Y	1
ROOT	0	0	47	1	FRAG	0	0	47	4	NP	0	0	18	2	NP	1	0	2	2	JJ	0	0	1	1	Human	0	0	1	0	NN	0	1	2	1	EGFR	1	1	2	0	SBAR	1	2	18	2	WHNP	0	2	7	2	WHNP	0	2	3	1	CD	0	2	3	1	(	2	2	3	0	NP	1	3	7	2	ADJP	0	3	6	3	JJ	0	3	4	1	wild-type	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NN	0	5	6	1	exon	5	5	6	0	NN	0	6	7	1	19del	6	6	7	0	S	1	7	18	2	NP	0	7	13	2	NP	1	7	11	2	NP	0	7	10	3	NN	0	7	8	1	)	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	NN	0	9	10	1	HER2	9	9	10	0	NN	0	10	11	1	cDNA	10	10	11	0	VP	0	11	13	2	VBG	0	11	12	1	coding	11	11	12	0	NP	0	12	13	1	NNS	0	12	13	1	regions	12	12	13	0	VP	1	13	18	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	18	2	VBN	0	14	15	1	cloned	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	into	15	15	16	0	NP	1	16	18	2	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	pENTR	17	17	18	0	:	0	18	19	1	/	18	18	19	0	S	1	19	46	2	NP	0	19	27	3	NP	5	19	25	6	JJ	0	19	20	1	D-	19	19	20	0	NN	0	20	21	1	TOPO	20	20	21	0	NN	0	21	22	1	vector	21	21	22	0	CD	0	22	23	1	(	22	22	23	0	NNP	0	23	24	1	Invitrogen	23	23	24	0	NN	0	24	25	1	)	24	24	25	0	CC	0	25	26	1	and	25	25	26	0	NP	0	26	27	1	NNS	0	26	27	1	mutants	26	26	27	0	VP	1	27	46	2	VBD	0	27	28	1	were	27	27	28	0	VP	0	28	46	3	VBN	0	28	29	1	constructed	28	28	29	0	PP	0	29	39	2	IN	0	29	30	1	with	29	29	30	0	NP	0	30	39	2	NP	3	30	34	4	NNP	0	30	31	1	Quick	30	30	31	0	NNP	0	31	32	1	Change	31	31	32	0	NN	0	32	33	1	Site	32	32	33	0	NNP	0	33	34	1	Directed	33	33	34	0	NP	0	34	39	2	NP	1	34	36	2	NN	0	34	35	1	Mutagenesis	34	34	35	0	NN	0	35	36	1	Kit	35	35	36	0	NP	1	36	39	3	CD	0	36	37	1	(	36	36	37	0	NNP	0	37	38	1	Stratagene	37	37	38	0	CD	0	38	39	1	)	38	38	39	0	PP	0	39	46	2	VBG	0	39	40	1	according	39	39	40	0	PP	0	40	46	2	TO	0	40	41	1	to	40	40	41	0	NP	0	41	46	2	NP	1	41	43	2	DT	0	41	42	1	the	41	41	42	0	NN	0	42	43	1	manufacturer	42	42	43	0	NP	2	43	46	3	CD	0	43	44	1	‚	43	43	44	0	NNS	0	44	45	1	Äôs	44	44	45	0	NNS	0	45	46	1	instructions	45	45	46	0	.	0	46	47	1	.	46	46	47	0
EOS
T	8
All	9058	9061	DT	all	O	_	_
constructs	9062	9072	NNS	construct	O	_	_
were	9073	9077	VBD	be	O	_	_
confirmed	9078	9087	VBN	confirm	O	_	_
by	9088	9090	IN	by	O	_	_
DNA	9091	9094	NN	dna	O	_	_
sequencing	9095	9105	NN	sequencing	O	_	_
.	9105	9106	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	6	agent
6	5	nn
EOX
Y	1
ROOT	0	0	8	1	S	1	0	8	3	NP	1	0	2	2	DT	0	0	1	1	All	0	0	1	0	NNS	0	1	2	1	constructs	1	1	2	0	VP	1	2	7	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	7	2	VBN	0	3	4	1	confirmed	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	by	4	4	5	0	NP	1	5	7	2	NN	0	5	6	1	DNA	5	5	6	0	NN	0	6	7	1	sequencing	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	22
Constructs	9107	9117	NNS	construct	O	_	_
were	9118	9122	VBD	be	O	_	_
cloned	9123	9129	VBN	clone	O	_	_
into	9130	9134	IN	into	O	_	_
the	9135	9138	DT	the	O	_	_
plenti-IRES-GFP	9139	9154	NN	plenti-ires-gfp	O	_	_
lentiviral	9155	9165	NN	lentiviral	O	_	_
vector	9166	9172	NN	vector	O	_	_
(	9173	9174	CD	(	O	_	_
Addgene	9174	9181	NN	addgene	O	_	_
)	9181	9182	NN	)	O	_	_
and	9183	9186	CC	and	O	_	_
infections	9187	9197	NNS	infection	O	_	_
were	9198	9202	VBD	be	O	_	_
performed	9203	9212	VBN	perform	O	_	_
as	9213	9215	IN	as	O	_	_
described	9216	9225	VBN	describe	O	_	_
previously	9226	9236	RB	previously	O	_	_
(	9237	9238	CD	(	O	_	_
25	9238	9240	CD	25	O	_	_
)	9240	9241	NN	)	O	_	_
.	9241	9242	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_into
6	4	det
6	5	nn
6	14	rcmod
10	7	nn
10	8	num
10	9	nn
10	12	conj_and
14	10	nsubjpass
14	12	nsubjpass
14	13	auxpass
14	16	advcl
16	15	mark
16	17	advmod
16	20	dobj
20	18	num
20	19	num
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	1	1	NNS	0	0	1	1	Constructs	0	0	1	0	VP	1	1	21	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	21	2	VBN	0	2	3	1	cloned	2	2	3	0	PP	0	3	21	2	IN	0	3	4	1	into	3	3	4	0	NP	0	4	21	2	NP	2	4	7	3	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	plenti-IRES-GFP	5	5	6	0	NN	0	6	7	1	lentiviral	6	6	7	0	SBAR	0	7	21	1	S	1	7	21	2	NP	0	7	13	3	NP	3	7	11	4	NN	0	7	8	1	vector	7	7	8	0	CD	0	8	9	1	(	8	8	9	0	NN	0	9	10	1	Addgene	9	9	10	0	NN	0	10	11	1	)	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NP	0	12	13	1	NNS	0	12	13	1	infections	12	12	13	0	VP	1	13	21	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	21	2	VBN	0	14	15	1	performed	14	14	15	0	SBAR	1	15	21	2	IN	0	15	16	1	as	15	15	16	0	S	0	16	21	1	VP	0	16	21	3	VBN	0	16	17	1	described	16	16	17	0	ADVP	0	17	18	1	RB	0	17	18	1	previously	17	17	18	0	NP	2	18	21	3	CD	0	18	19	1	(	18	18	19	0	CD	0	19	20	1	25	19	19	20	0	NN	0	20	21	1	)	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	48
Flow	9243	9247	NN	flow	O	_	_
Cytometry	9248	9257	NN	cytometry	O	_	_
ÔøºÔøºÔøºÔøºÔøºÔøº	9258	9276	NN	ôøºôøºôøºôøºôøºôøº	O	_	_
MEK	9278	9281	NN	mek	O	_	_
inhibition	9282	9292	NN	inhibition	O	_	_
leads	9293	9298	VBZ	lead	O	_	_
to	9299	9301	TO	to	O	_	_
PI3K	9302	9306	NN	pi3k	B-GENE	_	_
/	9306	9307	:	/	B-GENE	_	_
AKT	9307	9310	NN	akt	I-GENE	_	_
activation	9311	9321	NN	activation	O	_	_
by	9322	9324	IN	by	O	_	_
relieving	9325	9334	VBG	relieve	O	_	_
a	9335	9336	DT	a	O	_	_
negative	9337	9345	JJ	negative	O	_	_
feedback	9346	9354	NN	feedback	O	_	_
on	9355	9357	IN	on	O	_	_
ERBB	9358	9362	NN	erbb	O	_	_
receptors	9363	9372	NNS	receptor	O	_	_
12	9373	9375	CD	12	O	_	_
/	9375	9376	:	/	O	_	_
8/14	9376	9380	CD	8/14	O	_	_
,	9380	9381	,	,	O	_	_
6:54	9382	9386	CD	6:54	O	_	_
PM	9387	9389	NN	pm	O	_	_
ÔøºBT-474	9390	9399	NN	ôøºbt-474	O	_	_
cells	9400	9405	NNS	cell	O	_	_
were	9406	9410	VBD	be	O	_	_
transfected	9411	9422	VBN	transfect	O	_	_
with	9423	9427	IN	with	O	_	_
ERBB3	9428	9433	NN	erbb3	B-GENE	_	_
siRNA	9434	9439	NN	sirna	I-GENE	_	_
(	9440	9441	CD	(	O	_	_
Ambion	9441	9447	NNP	Ambion	O	_	_
)	9447	9448	NN	)	O	_	_
for	9449	9452	IN	for	O	_	_
48hrs	9453	9458	NNS	48hr	O	_	_
,	9458	9459	,	,	O	_	_
then	9460	9464	RB	then	O	_	_
treated	9465	9472	VBN	treat	O	_	_
with	9473	9477	IN	with	O	_	_
AZD6244	9478	9485	NN	azd6244	O	_	_
or	9486	9488	CC	or	O	_	_
GDC-	9489	9493	JJ	gdc-	O	_	_
0941	9494	9498	NN	0941	O	_	_
for	9499	9502	IN	for	O	_	_
72hrs	9503	9508	NNS	72hr	O	_	_
.	9508	9509	.	.	O	_	_
D	1
28
2	0	nn
2	1	nn
2	5	rcmod
4	3	nn
5	4	nsubj
5	7	prep_to
7	10	dep
7	21	dep
10	8	punct
10	9	nn
10	12	prepc_by
10	20	punct
12	15	dobj
12	18	prep_on
15	13	det
15	14	amod
18	17	nn
18	19	dep
21	26	appos
26	23	num
26	24	nn
26	25	nn
28	2	nsubjpass
28	27	auxpass
28	31	prep_with
28	34	dobj
31	30	nn
34	32	num
34	33	nn
34	36	prep_for
36	39	vmod
39	38	advmod
39	44	prep_with
41	43	conj_or
44	41	nn
44	43	nn
44	46	prep_for
EOX
Y	1
ROOT	0	0	48	1	S	1	0	48	3	NP	0	0	27	2	NP	2	0	3	3	NN	0	0	1	1	Flow	0	0	1	0	NN	0	1	2	1	Cytometry	1	1	2	0	NN	0	2	3	1	ÔøºÔøºÔøºÔøºÔøºÔøº	2	2	3	0	SBAR	0	3	27	1	S	1	3	27	2	NP	1	3	5	2	NN	0	3	4	1	MEK	3	3	4	0	NN	0	4	5	1	inhibition	4	4	5	0	VP	0	5	27	2	VBZ	0	5	6	1	leads	5	5	6	0	PP	0	6	27	2	TO	0	6	7	1	to	6	6	7	0	NP	0	7	27	3	NP	0	7	8	1	NN	0	7	8	1	PI3K	7	7	8	0	PRN	1	8	21	3	:	0	8	9	1	/	8	8	9	0	NP	0	9	20	2	NP	1	9	11	2	NN	0	9	10	1	AKT	9	9	10	0	NN	0	10	11	1	activation	10	10	11	0	PP	0	11	20	2	IN	0	11	12	1	by	11	11	12	0	S	0	12	20	1	VP	0	12	20	3	VBG	0	12	13	1	relieving	12	12	13	0	NP	2	13	16	3	DT	0	13	14	1	a	13	13	14	0	JJ	0	14	15	1	negative	14	14	15	0	NN	0	15	16	1	feedback	15	15	16	0	PP	0	16	20	2	IN	0	16	17	1	on	16	16	17	0	NP	0	17	20	2	NP	1	17	19	2	NN	0	17	18	1	ERBB	17	17	18	0	NNS	0	18	19	1	receptors	18	18	19	0	NP	0	19	20	1	CD	0	19	20	1	12	19	19	20	0	:	0	20	21	1	/	20	20	21	0	NP	0	21	27	3	NP	0	21	22	1	CD	0	21	22	1	8/14	21	21	22	0	,	0	22	23	1	,	22	22	23	0	NP	3	23	27	4	CD	0	23	24	1	6:54	23	23	24	0	NN	0	24	25	1	PM	24	24	25	0	NN	0	25	26	1	ÔøºBT-474	25	25	26	0	NNS	0	26	27	1	cells	26	26	27	0	VP	1	27	47	2	VBD	0	27	28	1	were	27	27	28	0	VP	0	28	47	3	VBN	0	28	29	1	transfected	28	28	29	0	PP	0	29	32	2	IN	0	29	30	1	with	29	29	30	0	NP	1	30	32	2	NN	0	30	31	1	ERBB3	30	30	31	0	NN	0	31	32	1	siRNA	31	31	32	0	NP	0	32	47	2	NP	2	32	35	3	CD	0	32	33	1	(	32	32	33	0	NNP	0	33	34	1	Ambion	33	33	34	0	NN	0	34	35	1	)	34	34	35	0	PP	0	35	47	2	IN	0	35	36	1	for	35	35	36	0	NP	0	36	47	3	NP	0	36	37	1	NNS	0	36	37	1	48hrs	36	36	37	0	,	0	37	38	1	,	37	37	38	0	VP	1	38	47	3	ADVP	0	38	39	1	RB	0	38	39	1	then	38	38	39	0	VBN	0	39	40	1	treated	39	39	40	0	PP	0	40	47	2	IN	0	40	41	1	with	40	40	41	0	NP	0	41	47	2	NP	1	41	45	2	NP	0	41	44	3	NN	0	41	42	1	AZD6244	41	41	42	0	CC	0	42	43	1	or	42	42	43	0	JJ	0	43	44	1	GDC-	43	43	44	0	NN	0	44	45	1	0941	44	44	45	0	PP	0	45	47	2	IN	0	45	46	1	for	45	45	46	0	NP	0	46	47	1	NNS	0	46	47	1	72hrs	46	46	47	0	.	0	47	48	1	.	47	47	48	0
EOS
T	20
Cells	9510	9515	NNS	cell	O	_	_
were	9516	9520	VBD	be	O	_	_
collected	9521	9530	VBN	collect	O	_	_
and	9531	9534	CC	and	O	_	_
stained	9535	9542	VBN	stain	O	_	_
with	9543	9547	IN	with	O	_	_
propidium	9548	9557	NN	propidium	O	_	_
iodide	9558	9564	NN	iodide	O	_	_
(	9565	9566	CD	(	O	_	_
PI	9566	9568	NN	pi	O	_	_
)	9568	9569	NN	)	O	_	_
and	9570	9573	CC	and	O	_	_
AnnexinV	9574	9582	NN	annexinv	O	_	_
as	9583	9585	IN	as	O	_	_
described	9586	9595	VBN	describe	O	_	_
previously	9596	9606	RB	previously	O	_	_
(	9607	9608	CD	(	O	_	_
26	9608	9610	CD	26	O	_	_
)	9610	9611	NN	)	O	_	_
.	9611	9612	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	4	conj_and
2	7	prep_with
2	12	prep_with
4	0	nsubjpass
7	6	nn
7	10	dep
7	12	conj_and
10	8	num
10	9	nn
12	14	dep
14	13	mark
14	15	advmod
14	18	dobj
18	16	num
18	17	num
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	19	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	19	4	VBN	0	2	3	1	collected	2	2	3	0	CC	0	3	4	1	and	3	3	4	0	VBN	0	4	5	1	stained	4	4	5	0	PP	0	5	19	2	IN	0	5	6	1	with	5	5	6	0	NP	0	6	19	3	NP	0	6	11	2	NP	1	6	8	2	NN	0	6	7	1	propidium	6	6	7	0	NN	0	7	8	1	iodide	7	7	8	0	NP	2	8	11	3	CD	0	8	9	1	(	8	8	9	0	NN	0	9	10	1	PI	9	9	10	0	NN	0	10	11	1	)	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NP	0	12	19	2	NP	0	12	13	1	NN	0	12	13	1	AnnexinV	12	12	13	0	SBAR	1	13	19	2	IN	0	13	14	1	as	13	13	14	0	S	0	14	19	1	VP	0	14	19	3	VBN	0	14	15	1	described	14	14	15	0	ADVP	0	15	16	1	RB	0	15	16	1	previously	15	15	16	0	NP	2	16	19	3	CD	0	16	17	1	(	16	16	17	0	CD	0	17	18	1	26	17	17	18	0	NN	0	18	19	1	)	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	15
Cells	9613	9618	NNS	cell	O	_	_
were	9619	9623	VBD	be	O	_	_
analyzed	9624	9632	VBN	analyze	O	_	_
using	9633	9638	VBG	use	O	_	_
a	9639	9640	DT	a	O	_	_
BD	9641	9643	NN	bd	O	_	_
LSR3	9644	9648	NN	lsr3	O	_	_
analytical	9649	9659	JJ	analytical	O	_	_
flow	9660	9664	NN	flow	O	_	_
cytometer	9665	9674	NN	cytometer	O	_	_
(	9675	9676	CD	(	O	_	_
BD	9676	9678	NNP	BD	O	_	_
Biosciences	9679	9690	NNP	Biosciences	O	_	_
)	9690	9691	NN	)	O	_	_
.	9691	9692	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	3	xcomp
3	6	dobj
6	4	det
6	5	nn
6	13	dep
13	7	amod
13	8	nn
13	9	nn
13	10	num
13	11	nn
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	14	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	14	2	VBN	0	2	3	1	analyzed	2	2	3	0	S	0	3	14	1	VP	0	3	14	2	VBG	0	3	4	1	using	3	3	4	0	NP	0	4	14	2	NP	2	4	7	3	DT	0	4	5	1	a	4	4	5	0	NN	0	5	6	1	BD	5	5	6	0	NN	0	6	7	1	LSR3	6	6	7	0	NP	6	7	14	7	JJ	0	7	8	1	analytical	7	7	8	0	NN	0	8	9	1	flow	8	8	9	0	NN	0	9	10	1	cytometer	9	9	10	0	CD	0	10	11	1	(	10	10	11	0	NNP	0	11	12	1	BD	11	11	12	0	NNP	0	12	13	1	Biosciences	12	12	13	0	NN	0	13	14	1	)	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	17
Apoptosis	9693	9702	NN	apoptosis	O	_	_
was	9703	9706	VBD	be	O	_	_
calculated	9707	9717	VBN	calculate	O	_	_
using	9718	9723	VBG	use	O	_	_
the	9724	9727	DT	the	O	_	_
sum	9728	9731	NN	sum	O	_	_
of	9732	9734	IN	of	O	_	_
AnnexinV	9735	9743	NN	annexinv	O	_	_
positive	9744	9752	JJ	positive	O	_	_
and	9753	9756	CC	and	O	_	_
PI	9757	9759	NN	pi	O	_	_
/	9759	9760	:	/	O	_	_
AnnexinV	9760	9768	NN	annexinv	O	_	_
double	9769	9775	JJ	double	O	_	_
positive	9776	9784	JJ	positive	O	_	_
cells	9785	9790	NNS	cell	O	_	_
.	9790	9791	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	3	xcomp
3	8	dep
3	15	dep
5	4	det
5	7	prep_of
8	5	dep
8	15	conj_and
10	12	dep
12	11	punct
15	10	dep
15	13	amod
15	14	amod
EOX
Y	1
ROOT	0	0	17	1	S	1	0	17	3	NP	0	0	1	1	NN	0	0	1	1	Apoptosis	0	0	1	0	VP	1	1	16	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	16	2	VBN	0	2	3	1	calculated	2	2	3	0	S	0	3	16	1	VP	0	3	16	2	VBG	0	3	4	1	using	3	3	4	0	S	0	4	16	3	S	1	4	9	2	NP	0	4	8	2	NP	1	4	6	2	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	sum	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	AnnexinV	7	7	8	0	ADJP	0	8	9	1	JJ	0	8	9	1	positive	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	S	1	10	16	2	NP	0	10	13	2	NP	0	10	11	1	NN	0	10	11	1	PI	10	10	11	0	PRN	1	11	13	2	:	0	11	12	1	/	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	AnnexinV	12	12	13	0	NP	2	13	16	3	JJ	0	13	14	1	double	13	13	14	0	JJ	0	14	15	1	positive	14	14	15	0	NNS	0	15	16	1	cells	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	43
Tandem	9792	9798	NNP	Tandem	O	_	_
mass	9799	9803	NN	mass	O	_	_
spectrometry	9804	9816	NN	spectrometry	O	_	_
(	9817	9818	CD	(	O	_	_
LC	9818	9820	NN	lc	O	_	_
/	9820	9821	:	/	O	_	_
MS/MS	9821	9826	NN	ms/ms	O	_	_
)	9826	9827	CD	)	O	_	_
EGFR	9828	9832	NN	egfr	O	_	_
or	9833	9835	CC	or	O	_	_
HER2	9836	9840	NN	her2	O	_	_
was	9841	9844	VBD	be	O	_	_
immunoprecipitated	9845	9863	VBN	immunoprecipitate	O	_	_
from	9864	9868	IN	from	O	_	_
cells	9869	9874	NNS	cell	O	_	_
treated	9875	9882	VBN	treat	O	_	_
with	9883	9887	IN	with	O	_	_
AZD6244	9888	9895	NN	azd6244	O	_	_
using	9896	9901	VBG	use	O	_	_
anti	9902	9906	JJ	anti	B-GENE	_	_
EGFR	9907	9911	NN	egfr	I-GENE	_	_
antibody	9912	9920	NN	antibody	I-GENE	_	_
(	9921	9922	CD	(	O	_	_
Santa	9922	9927	NNP	Santa	O	_	_
Cruz	9928	9932	NNP	Cruz	O	_	_
)	9932	9933	CD	)	O	_	_
or	9934	9936	CC	or	O	_	_
an	9937	9939	DT	a	O	_	_
anti	9940	9944	JJ	anti	B-GENE	_	_
HER2	9945	9949	NN	her2	I-GENE	_	_
antibody	9950	9958	NN	antibody	I-GENE	_	_
,	9958	9959	,	,	O	_	_
separated	9960	9969	VBN	separate	O	_	_
by	9970	9972	IN	by	O	_	_
SDS	9973	9976	NN	sd	O	_	_
/	9976	9977	:	/	O	_	_
PAGE	9977	9981	NN	page	O	_	_
,	9981	9982	,	,	O	_	_
stained	9983	9990	VBN	stain	O	_	_
with	9991	9995	IN	with	O	_	_
Coomassie	9996	10005	NNP	Coomassie	O	_	_
blue	10006	10010	NN	blue	O	_	_
.	10010	10011	.	.	O	_	_
D	1
38
2	0	nn
2	1	nn
2	4	dep
2	6	dep
2	36	dep
4	3	num
6	5	punct
6	7	num
6	12	rcmod
6	35	punct
8	10	conj_or
12	8	nsubjpass
12	10	nsubjpass
12	11	auxpass
12	14	prep_from
14	15	vmod
15	17	prep_with
15	18	xcomp
18	21	dobj
18	30	dobj
21	19	amod
21	20	nn
21	24	dep
21	30	conj_or
24	22	num
24	23	nn
24	25	num
30	27	det
30	28	amod
30	29	nn
30	32	vmod
32	34	agent
38	2	nsubj
38	41	prep_with
41	40	nn
EOX
Y	1
ROOT	0	0	43	1	S	2	0	43	4	NP	0	0	37	3	NP	0	0	5	2	NP	2	0	3	3	NNP	0	0	1	1	Tandem	0	0	1	0	NN	0	1	2	1	mass	1	1	2	0	NN	0	2	3	1	spectrometry	2	2	3	0	NP	1	3	5	2	CD	0	3	4	1	(	3	3	4	0	NN	0	4	5	1	LC	4	4	5	0	PRN	1	5	36	3	:	0	5	6	1	/	5	5	6	0	NP	0	6	35	2	NP	0	6	8	2	NN	0	6	7	1	MS/MS	6	6	7	0	CD	0	7	8	1	)	7	7	8	0	SBAR	0	8	35	1	S	1	8	35	2	NP	0	8	11	3	NN	0	8	9	1	EGFR	8	8	9	0	CC	0	9	10	1	or	9	9	10	0	NN	0	10	11	1	HER2	10	10	11	0	VP	1	11	35	2	VBD	0	11	12	1	was	11	11	12	0	VP	0	12	35	2	VBN	0	12	13	1	immunoprecipitated	12	12	13	0	PP	0	13	35	2	IN	0	13	14	1	from	13	13	14	0	NP	0	14	35	2	NP	0	14	15	1	NNS	0	14	15	1	cells	14	14	15	0	VP	0	15	35	3	VBN	0	15	16	1	treated	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	with	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	AZD6244	17	17	18	0	S	0	18	35	1	VP	0	18	35	2	VBG	0	18	19	1	using	18	18	19	0	NP	0	19	35	3	NP	0	19	26	2	NP	2	19	22	3	JJ	0	19	20	1	anti	19	19	20	0	NN	0	20	21	1	EGFR	20	20	21	0	NN	0	21	22	1	antibody	21	21	22	0	NP	2	22	26	4	CD	0	22	23	1	(	22	22	23	0	NNP	0	23	24	1	Santa	23	23	24	0	NNP	0	24	25	1	Cruz	24	24	25	0	CD	0	25	26	1	)	25	25	26	0	CC	0	26	27	1	or	26	26	27	0	NP	0	27	35	3	NP	3	27	31	4	DT	0	27	28	1	an	27	27	28	0	JJ	0	28	29	1	anti	28	28	29	0	NN	0	29	30	1	HER2	29	29	30	0	NN	0	30	31	1	antibody	30	30	31	0	,	0	31	32	1	,	31	31	32	0	VP	0	32	35	2	VBN	0	32	33	1	separated	32	32	33	0	PP	0	33	35	2	IN	0	33	34	1	by	33	33	34	0	NP	0	34	35	1	NN	0	34	35	1	SDS	34	34	35	0	:	0	35	36	1	/	35	35	36	0	NP	0	36	37	1	NN	0	36	37	1	PAGE	36	36	37	0	,	0	37	38	1	,	37	37	38	0	VP	0	38	42	2	VBN	0	38	39	1	stained	38	38	39	0	PP	0	39	42	2	IN	0	39	40	1	with	39	39	40	0	NP	1	40	42	2	NNP	0	40	41	1	Coomassie	40	40	41	0	NN	0	41	42	1	blue	41	41	42	0	.	0	42	43	1	.	42	42	43	0
EOS
T	39
Bands	10012	10017	NNS	band	O	_	_
were	10018	10022	VBD	be	O	_	_
excised	10023	10030	VBN	excise	O	_	_
and	10031	10034	CC	and	O	_	_
samples	10035	10042	NNS	sample	O	_	_
were	10043	10047	VBD	be	O	_	_
prepared	10048	10056	VBN	prepare	O	_	_
and	10057	10060	CC	and	O	_	_
analyzed	10061	10069	VBN	analyze	O	_	_
by	10070	10072	IN	by	O	_	_
reversed-phase	10073	10087	JJ	reversed-phase	O	_	_
microcapillary	10088	10102	JJ	microcapillary	O	_	_
/	10102	10103	:	/	O	_	_
tandem	10103	10109	JJ	tandem	O	_	_
mass	10110	10114	NN	mass	O	_	_
spectrometry	10115	10127	NN	spectrometry	O	_	_
(	10128	10129	CD	(	O	_	_
LC	10129	10131	NN	lc	O	_	_
/	10131	10132	:	/	O	_	_
MS/MS	10132	10137	NNP	MS/MS	O	_	_
)	10137	10138	CD	)	O	_	_
as	10139	10141	IN	as	O	_	_
described	10142	10151	VBN	describe	O	_	_
previously	10152	10162	RB	previously	O	_	_
(	10163	10164	CD	(	O	_	_
27	10164	10166	CD	27	O	_	_
‚	10166	10167	CD	‚	O	_	_
Äì29	10167	10171	NN	äì29	O	_	_
)	10171	10172	NN	)	O	_	_
and	10173	10176	CC	and	O	_	_
further	10177	10184	JJ	further	O	_	_
detailed	10185	10193	VBN	detail	O	_	_
in	10194	10196	IN	in	O	_	_
the	10197	10200	DT	the	O	_	_
Supplemental	10201	10213	NNP	Supplemental	O	_	_
Materials	10214	10223	NNPS	Materials	O	_	_
and	10224	10227	CC	and	O	_	_
Methods	10228	10235	NNS	method	O	_	_
.	10235	10236	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	conj_and
2	8	conj_and
6	4	nsubjpass
6	5	auxpass
6	8	conj_and
6	9	prep
6	22	dep
8	4	nsubjpass
9	10	dep
10	11	dep
10	12	punct
10	15	dep
15	13	amod
15	14	nn
15	17	dep
15	18	punct
15	19	dep
17	16	num
19	20	num
19	21	prep
22	23	advmod
22	25	dobj
22	30	dobj
25	24	number
25	28	dep
25	30	conj_and
28	26	num
28	27	nn
30	31	vmod
31	35	prep_in
31	37	prep_in
35	33	det
35	34	nn
35	37	conj_and
EOX
Y	1
ROOT	0	0	39	1	S	0	0	39	4	S	1	0	3	2	NP	0	0	1	1	NNS	0	0	1	1	Bands	0	0	1	0	VP	1	1	3	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	3	1	VBN	0	2	3	1	excised	2	2	3	0	CC	0	3	4	1	and	3	3	4	0	S	1	4	38	2	NP	0	4	5	1	NNS	0	4	5	1	samples	4	4	5	0	VP	1	5	38	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	38	5	VBN	0	6	7	1	prepared	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	VBN	0	8	9	1	analyzed	8	8	9	0	PP	0	9	22	2	IN	0	9	10	1	by	9	9	10	0	FRAG	0	10	22	3	FRAG	0	10	12	2	ADJP	0	10	11	1	JJ	0	10	11	1	reversed-phase	10	10	11	0	ADJP	0	11	12	1	JJ	0	11	12	1	microcapillary	11	11	12	0	:	0	12	13	1	/	12	12	13	0	FRAG	0	13	22	3	NP	0	13	18	2	NP	2	13	16	3	JJ	0	13	14	1	tandem	13	13	14	0	NN	0	14	15	1	mass	14	14	15	0	NN	0	15	16	1	spectrometry	15	15	16	0	NP	1	16	18	2	CD	0	16	17	1	(	16	16	17	0	NN	0	17	18	1	LC	17	17	18	0	:	0	18	19	1	/	18	18	19	0	NP	0	19	22	2	NP	0	19	21	2	NNP	0	19	20	1	MS/MS	19	19	20	0	CD	0	20	21	1	)	20	20	21	0	PP	0	21	22	1	IN	0	21	22	1	as	21	21	22	0	S	0	22	38	1	VP	0	22	38	3	VBN	0	22	23	1	described	22	22	23	0	ADVP	0	23	24	1	RB	0	23	24	1	previously	23	23	24	0	NP	0	24	38	3	NP	0	24	29	2	NP	0	24	26	1	QP	1	24	26	2	CD	0	24	25	1	(	24	24	25	0	CD	0	25	26	1	27	25	25	26	0	NP	2	26	29	3	CD	0	26	27	1	‚	26	26	27	0	NN	0	27	28	1	Äì29	27	27	28	0	NN	0	28	29	1	)	28	28	29	0	CC	0	29	30	1	and	29	29	30	0	NP	0	30	38	2	NP	0	30	31	1	JJ	0	30	31	1	further	30	30	31	0	VP	0	31	38	2	VBN	0	31	32	1	detailed	31	31	32	0	PP	0	32	38	2	IN	0	32	33	1	in	32	32	33	0	NP	0	33	38	3	NP	2	33	36	3	DT	0	33	34	1	the	33	33	34	0	NNP	0	34	35	1	Supplemental	34	34	35	0	NNPS	0	35	36	1	Materials	35	35	36	0	CC	0	36	37	1	and	36	36	37	0	NP	0	37	38	1	NNS	0	37	38	1	Methods	37	37	38	0	.	0	38	39	1	.	38	38	39	0
EOS
T	33
RESULTS	10237	10244	NNS	result	O	_	_
MEK	10246	10249	NN	mek	O	_	_
inhibition	10250	10260	NN	inhibition	O	_	_
leads	10261	10266	VBZ	lead	O	_	_
to	10267	10269	TO	to	O	_	_
activation	10270	10280	NN	activation	O	_	_
of	10281	10283	IN	of	O	_	_
ERBB3	10284	10289	NN	erbb3	B-GENE	_	_
/	10289	10290	:	/	B-GENE	_	_
PI3K/AKT	10290	10298	NN	pi3k/akt	B-GENE	_	_
We	10299	10301	PRP	we	O	_	_
previously	10302	10312	RB	previously	O	_	_
observed	10313	10321	VBD	observe	O	_	_
that	10322	10326	IN	that	O	_	_
AKT	10327	10330	NN	akt	B-GENE	_	_
phosphorylation	10331	10346	NN	phosphorylation	O	_	_
increased	10347	10356	VBN	increase	O	_	_
in	10357	10359	IN	in	O	_	_
response	10360	10368	NN	response	O	_	_
to	10369	10371	TO	to	O	_	_
MEK	10372	10375	NN	mek	B-GENE	_	_
inhibition	10376	10386	NN	inhibition	O	_	_
in	10387	10389	IN	in	O	_	_
HER2	10390	10394	NN	her2	B-GENE	_	_
amplified	10395	10404	VBD	amplify	O	_	_
and	10405	10408	CC	and	O	_	_
EGFR-mutant	10409	10420	JJ	egfr-mutant	O	_	_
cancer	10421	10427	NN	cancer	O	_	_
cells	10428	10433	NNS	cell	O	_	_
(	10434	10435	VBP	(	O	_	_
11	10435	10437	CD	11	O	_	_
)	10437	10438	CD	)	O	_	_
.	10438	10439	.	.	O	_	_
D	1
24
0	3	rcmod
2	1	nn
3	2	nsubj
3	5	prep_to
3	9	dep
3	21	prep_to
5	7	prep_of
9	8	punct
9	12	rcmod
12	10	nsubj
12	11	advmod
12	16	ccomp
15	14	nn
16	13	mark
16	15	nsubj
16	18	prep_in
21	20	nn
21	23	prep_in
24	0	nsubj
24	29	conj_and
28	26	amod
28	27	nn
29	28	nsubj
29	31	dobj
31	30	num
EOX
Y	1
ROOT	0	0	33	1	S	0	0	33	4	S	1	0	25	2	NP	0	0	24	2	NP	0	0	1	1	NNS	0	0	1	1	RESULTS	0	0	1	0	SBAR	0	1	24	1	S	1	1	24	2	NP	1	1	3	2	NN	0	1	2	1	MEK	1	1	2	0	NN	0	2	3	1	inhibition	2	2	3	0	VP	0	3	24	4	VBZ	0	3	4	1	leads	3	3	4	0	PP	0	4	8	2	TO	0	4	5	1	to	4	4	5	0	NP	0	5	8	2	NP	0	5	6	1	NN	0	5	6	1	activation	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	ERBB3	7	7	8	0	PRN	1	8	19	2	:	0	8	9	1	/	8	8	9	0	NP	0	9	19	2	NP	0	9	10	1	NN	0	9	10	1	PI3K/AKT	9	9	10	0	SBAR	0	10	19	1	S	2	10	19	3	NP	0	10	11	1	PRP	0	10	11	1	We	10	10	11	0	ADVP	0	11	12	1	RB	0	11	12	1	previously	11	11	12	0	VP	0	12	19	2	VBD	0	12	13	1	observed	12	12	13	0	SBAR	1	13	19	2	IN	0	13	14	1	that	13	13	14	0	S	1	14	19	2	NP	1	14	16	2	NN	0	14	15	1	AKT	14	14	15	0	NN	0	15	16	1	phosphorylation	15	15	16	0	VP	0	16	19	2	VBN	0	16	17	1	increased	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	in	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	response	18	18	19	0	PP	0	19	24	2	TO	0	19	20	1	to	19	19	20	0	NP	0	20	24	2	NP	1	20	22	2	NN	0	20	21	1	MEK	20	20	21	0	NN	0	21	22	1	inhibition	21	21	22	0	PP	0	22	24	2	IN	0	22	23	1	in	22	22	23	0	NP	0	23	24	1	NN	0	23	24	1	HER2	23	23	24	0	VP	0	24	25	1	VBD	0	24	25	1	amplified	24	24	25	0	CC	0	25	26	1	and	25	25	26	0	S	1	26	32	2	NP	2	26	29	3	JJ	0	26	27	1	EGFR-mutant	26	26	27	0	NN	0	27	28	1	cancer	27	27	28	0	NNS	0	28	29	1	cells	28	28	29	0	VP	0	29	32	2	VBP	0	29	30	1	(	29	29	30	0	NP	1	30	32	2	CD	0	30	31	1	11	30	30	31	0	CD	0	31	32	1	)	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	37
To	10440	10442	TO	to	O	_	_
determine	10443	10452	VB	determine	O	_	_
whether	10453	10460	IN	whether	O	_	_
this	10461	10465	DT	this	O	_	_
potential	10466	10475	JJ	potential	O	_	_
feedback	10476	10484	NN	feedback	O	_	_
is	10485	10487	VBZ	be	O	_	_
observed	10488	10496	VBN	observe	O	_	_
in	10497	10499	IN	in	O	_	_
multiple	10500	10508	JJ	multiple	O	_	_
EGFR	10509	10513	NN	egfr	O	_	_
or	10514	10516	CC	or	O	_	_
HER2	10517	10521	NN	her2	O	_	_
addicted	10522	10530	VBN	addict	O	_	_
cancer	10531	10537	NN	cancer	O	_	_
models	10538	10544	NNS	model	O	_	_
,	10544	10545	,	,	O	_	_
we	10546	10548	PRP	we	O	_	_
treated	10549	10556	VBD	treat	O	_	_
HER2	10557	10561	NN	her2	O	_	_
amplified	10562	10571	VBD	amplify	O	_	_
or	10572	10574	CC	or	O	_	_
EGFR-mutant	10575	10586	JJ	egfr-mutant	O	_	_
cell	10587	10591	NN	cell	O	_	_
lines	10592	10597	NNS	line	O	_	_
with	10598	10602	IN	with	O	_	_
the	10603	10606	DT	the	O	_	_
highly	10607	10613	RB	highly	O	_	_
selective	10614	10623	JJ	selective	O	_	_
allosteric	10624	10634	JJ	allosteric	B-GENE	_	_
MEK1	10635	10639	NN	mek1	I-GENE	_	_
/	10639	10640	:	/	I-GENE	_	_
2	10640	10641	CD	2	I-GENE	_	_
inhibitor	10642	10651	NN	inhibitor	I-GENE	_	_
,	10651	10652	,	,	O	_	_
AZD6244	10653	10660	NN	azd6244	B-GENE	_	_
.	10660	10661	.	.	O	_	_
D	1
18
1	0	aux
1	7	ccomp
5	3	det
5	4	amod
7	2	mark
7	5	nsubjpass
7	6	auxpass
7	10	prep_in
7	12	prep_in
7	15	dobj
10	9	amod
10	12	conj_or
15	13	amod
15	14	nn
18	1	advcl
18	17	nsubj
18	20	ccomp
18	24	ccomp
20	19	nsubj
20	24	conj_or
24	22	amod
24	23	nn
24	30	prep_with
28	27	advmod
30	26	det
30	28	amod
30	29	amod
30	33	dep
33	31	punct
33	32	num
33	35	appos
EOX
Y	1
ROOT	0	0	37	1	S	3	0	37	5	S	0	0	16	1	VP	1	0	16	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	16	2	VB	0	1	2	1	determine	1	1	2	0	SBAR	1	2	16	2	IN	0	2	3	1	whether	2	2	3	0	S	1	3	16	2	NP	2	3	6	3	DT	0	3	4	1	this	3	3	4	0	JJ	0	4	5	1	potential	4	4	5	0	NN	0	5	6	1	feedback	5	5	6	0	VP	1	6	16	2	VBZ	0	6	7	1	is	6	6	7	0	VP	0	7	16	3	VBN	0	7	8	1	observed	7	7	8	0	PP	0	8	13	2	IN	0	8	9	1	in	8	8	9	0	NP	1	9	13	4	JJ	0	9	10	1	multiple	9	9	10	0	NN	0	10	11	1	EGFR	10	10	11	0	CC	0	11	12	1	or	11	11	12	0	NN	0	12	13	1	HER2	12	12	13	0	NP	2	13	16	3	ADJP	0	13	14	1	VBN	0	13	14	1	addicted	13	13	14	0	NN	0	14	15	1	cancer	14	14	15	0	NNS	0	15	16	1	models	15	15	16	0	,	0	16	17	1	,	16	16	17	0	NP	0	17	18	1	PRP	0	17	18	1	we	17	17	18	0	VP	0	18	36	2	VBD	0	18	19	1	treated	18	18	19	0	SBAR	0	19	36	1	S	1	19	36	2	NP	0	19	20	1	NN	0	19	20	1	HER2	19	19	20	0	VP	0	20	36	3	VP	0	20	21	1	VBD	0	20	21	1	amplified	20	20	21	0	CC	0	21	22	1	or	21	21	22	0	VP	0	22	36	2	NP	2	22	25	3	JJ	0	22	23	1	EGFR-mutant	22	22	23	0	NN	0	23	24	1	cell	23	23	24	0	NNS	0	24	25	1	lines	24	24	25	0	PP	0	25	36	2	IN	0	25	26	1	with	25	25	26	0	NP	0	26	36	2	NP	3	26	31	4	DT	0	26	27	1	the	26	26	27	0	ADJP	1	27	29	2	RB	0	27	28	1	highly	27	27	28	0	JJ	0	28	29	1	selective	28	28	29	0	JJ	0	29	30	1	allosteric	29	29	30	0	NN	0	30	31	1	MEK1	30	30	31	0	PRN	1	31	36	2	:	0	31	32	1	/	31	31	32	0	NP	0	32	36	3	NP	1	32	34	2	CD	0	32	33	1	2	32	32	33	0	NN	0	33	34	1	inhibitor	33	33	34	0	,	0	34	35	1	,	34	34	35	0	NP	0	35	36	1	NN	0	35	36	1	AZD6244	35	35	36	0	.	0	36	37	1	.	36	36	37	0
EOS
T	27
This	10662	10666	DT	this	O	_	_
MEK	10667	10670	NN	mek	B-GENE	_	_
inhibitor	10671	10680	NN	inhibitor	O	_	_
was	10681	10684	VBD	be	O	_	_
used	10685	10689	VBN	use	O	_	_
at	10690	10692	IN	at	O	_	_
a	10693	10694	DT	a	O	_	_
concentration	10695	10708	NN	concentration	O	_	_
of	10709	10711	IN	of	O	_	_
2ŒºM	10712	10716	NN	2œºm	O	_	_
,	10716	10717	,	,	O	_	_
which	10718	10723	WDT	which	O	_	_
sufficiently	10724	10736	RB	sufficiently	O	_	_
inhibited	10737	10746	VBD	inhibit	O	_	_
ERK1	10747	10751	NN	erk1	B-GENE	_	_
/	10751	10752	:	/	I-GENE	_	_
2	10752	10753	CD	2	I-GENE	_	_
phosphorylation	10754	10769	NN	phosphorylation	O	_	_
in	10770	10772	IN	in	O	_	_
the	10773	10776	DT	the	O	_	_
HCC827	10777	10783	NN	hcc827	O	_	_
cell	10784	10788	NN	cell	O	_	_
line	10789	10793	NN	line	O	_	_
(	10794	10795	NN	(	O	_	_
Supplemental	10795	10807	NN	supplemental	O	_	_
)	10816	10817	NN	)	O	_	_
.	10817	10818	.	.	O	_	_
D	1
4
2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	7	prep_at
7	6	det
7	9	prep_of
9	13	rcmod
13	11	nsubj
13	12	advmod
13	14	dobj
13	17	dep
17	15	punct
17	16	num
17	25	prep_in
25	19	det
25	20	nn
25	21	nn
25	22	nn
25	23	nn
25	24	nn
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	2	0	3	3	DT	0	0	1	1	This	0	0	1	0	NN	0	1	2	1	MEK	1	1	2	0	NN	0	2	3	1	inhibitor	2	2	3	0	VP	1	3	26	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	26	2	VBN	0	4	5	1	used	4	4	5	0	PP	0	5	26	2	IN	0	5	6	1	at	5	5	6	0	NP	0	6	26	2	NP	1	6	8	2	DT	0	6	7	1	a	6	6	7	0	NN	0	7	8	1	concentration	7	7	8	0	PP	0	8	26	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	26	3	NP	0	9	10	1	NN	0	9	10	1	2ŒºM	9	9	10	0	,	0	10	11	1	,	10	10	11	0	SBAR	1	11	26	2	WHNP	0	11	12	1	WDT	0	11	12	1	which	11	11	12	0	S	1	12	26	2	ADVP	0	12	13	1	RB	0	12	13	1	sufficiently	12	12	13	0	VP	0	13	26	3	VBD	0	13	14	1	inhibited	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ERK1	14	14	15	0	PRN	1	15	26	2	:	0	15	16	1	/	15	15	16	0	NP	0	16	26	2	NP	1	16	18	2	CD	0	16	17	1	2	16	16	17	0	NN	0	17	18	1	phosphorylation	17	17	18	0	PP	0	18	26	2	IN	0	18	19	1	in	18	18	19	0	NP	6	19	26	7	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	HCC827	20	20	21	0	NN	0	21	22	1	cell	21	21	22	0	NN	0	22	23	1	line	22	22	23	0	NN	0	23	24	1	(	23	23	24	0	NN	0	24	25	1	Supplemental	24	24	25	0	NN	0	25	26	1	)	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	18
Similar	10819	10826	JJ	similar	O	_	_
results	10827	10834	NNS	result	O	_	_
were	10835	10839	VBD	be	O	_	_
observed	10840	10848	VBN	observe	O	_	_
using	10849	10854	VBG	use	O	_	_
two	10855	10858	CD	two	O	_	_
distinct	10859	10867	JJ	distinct	O	_	_
allosteric	10868	10878	JJ	allosteric	O	_	_
MEK	10879	10882	NN	mek	B-GENE	_	_
inhibitors	10883	10893	NNS	inhibitor	O	_	_
,	10893	10894	,	,	O	_	_
GSK212	10895	10901	NN	gsk212	O	_	_
and	10902	10905	CC	and	O	_	_
PD0325901	10906	10915	NN	pd0325901	O	_	_
(	10916	10917	CD	(	O	_	_
Supplemental	10917	10929	NNP	Supplemental	O	_	_
)	10938	10939	NN	)	O	_	_
.	10939	10940	.	.	O	_	_
D	1
3
1	0	amod
3	1	nsubjpass
3	2	auxpass
3	4	xcomp
4	9	dobj
9	5	num
9	6	amod
9	7	amod
9	8	nn
9	11	appos
9	13	appos
11	13	conj_and
11	16	dep
16	14	num
16	15	nn
EOX
Y	1
ROOT	0	0	18	1	S	1	0	18	3	NP	1	0	2	2	JJ	0	0	1	1	Similar	0	0	1	0	NNS	0	1	2	1	results	1	1	2	0	VP	1	2	17	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	17	2	VBN	0	3	4	1	observed	3	3	4	0	S	0	4	17	1	VP	0	4	17	2	VBG	0	4	5	1	using	4	4	5	0	NP	0	5	17	3	NP	4	5	10	5	CD	0	5	6	1	two	5	5	6	0	JJ	0	6	7	1	distinct	6	6	7	0	JJ	0	7	8	1	allosteric	7	7	8	0	NN	0	8	9	1	MEK	8	8	9	0	NNS	0	9	10	1	inhibitors	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	0	11	17	2	NP	0	11	14	3	NN	0	11	12	1	GSK212	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	NN	0	13	14	1	PD0325901	13	13	14	0	NP	2	14	17	3	CD	0	14	15	1	(	14	14	15	0	NNP	0	15	16	1	Supplemental	15	15	16	0	NN	0	16	17	1	)	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	42
In	10941	10943	IN	in	O	_	_
each	10944	10948	DT	each	O	_	_
cell	10949	10953	NN	cell	O	_	_
line	10954	10958	NN	line	O	_	_
,	10958	10959	,	,	O	_	_
we	10960	10962	PRP	we	O	_	_
observed	10963	10971	VBD	observe	O	_	_
increased	10972	10981	VBD	increase	O	_	_
AKT	10982	10985	NN	akt	B-GENE	_	_
phosphorylation	10986	11001	NN	phosphorylation	O	_	_
at	11002	11004	IN	at	O	_	_
both	11005	11009	DT	both	O	_	_
S473	11010	11014	NN	s473	O	_	_
and	11015	11018	CC	and	O	_	_
T308	11019	11023	NN	t308	O	_	_
following	11024	11033	VBG	follow	O	_	_
AZD6244	11034	11041	NN	azd6244	O	_	_
treatment	11042	11051	NN	treatment	O	_	_
,	11051	11052	,	,	O	_	_
as	11053	11055	RB	as	O	_	_
well	11056	11060	RB	well	O	_	_
as	11061	11063	IN	as	O	_	_
increased	11064	11073	VBN	increase	O	_	_
phosphorylation	11074	11089	NN	phosphorylation	O	_	_
of	11090	11092	IN	of	O	_	_
several	11093	11100	JJ	several	O	_	_
AKT	11101	11104	NNP	AKT	O	_	_
targets	11105	11112	NNS	target	O	_	_
including	11113	11122	VBG	include	O	_	_
GSK3Œ	11123	11128	NN	gsk3œ	B-GENE	_	_
±	11128	11129	CD	±	I-GENE	_	_
/	11129	11130	:	/	I-GENE	_	_
Œ	11130	11131	NN	œ	I-GENE	_	_
≤	11131	11132	NN	≤	I-GENE	_	_
,	11132	11133	,	,	I-GENE	_	_
ATP	11134	11137	NN	atp	I-GENE	_	_
citrate	11138	11145	NN	citrate	I-GENE	_	_
lyase	11146	11151	NN	lyase	I-GENE	_	_
,	11151	11152	,	,	O	_	_
and	11153	11156	CC	and	O	_	_
PRAS40	11157	11163	NN	pras40	O	_	_
.	11175	11176	.	.	O	_	_
D	1
6
3	1	det
3	2	nn
6	3	prep_in
6	5	nsubj
6	7	ccomp
7	9	dobj
7	12	prep_at
7	14	prep_at
7	23	prep_at
9	8	nn
12	11	preconj
12	14	conj_and
12	17	prep_following
12	23	conj_and
17	16	nn
23	22	amod
23	27	prep_of
27	25	amod
27	26	nn
27	29	prep_including
29	30	num
29	33	dep
29	37	dep
29	40	dep
33	31	punct
33	32	nn
33	37	conj_and
33	40	conj_and
37	35	nn
37	36	nn
EOX
Y	1
ROOT	0	0	42	1	S	3	0	42	5	PP	0	0	4	2	IN	0	0	1	1	In	0	0	1	0	NP	2	1	4	3	DT	0	1	2	1	each	1	1	2	0	NN	0	2	3	1	cell	2	2	3	0	NN	0	3	4	1	line	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	6	1	PRP	0	5	6	1	we	5	5	6	0	VP	0	6	41	2	VBD	0	6	7	1	observed	6	6	7	0	SBAR	0	7	41	1	S	0	7	41	1	VP	0	7	41	3	VBD	0	7	8	1	increased	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	AKT	8	8	9	0	NN	0	9	10	1	phosphorylation	9	9	10	0	PP	0	10	41	2	IN	0	10	11	1	at	10	10	11	0	NP	0	11	41	4	NP	0	11	18	2	NP	1	11	15	4	DT	0	11	12	1	both	11	11	12	0	NN	0	12	13	1	S473	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NN	0	14	15	1	T308	14	14	15	0	PP	0	15	18	2	VBG	0	15	16	1	following	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	AZD6244	16	16	17	0	NN	0	17	18	1	treatment	17	17	18	0	,	0	18	19	1	,	18	18	19	0	CONJP	1	19	22	3	RB	0	19	20	1	as	19	19	20	0	RB	0	20	21	1	well	20	20	21	0	IN	0	21	22	1	as	21	21	22	0	NP	0	22	41	2	NP	1	22	24	2	VBN	0	22	23	1	increased	22	22	23	0	NN	0	23	24	1	phosphorylation	23	23	24	0	PP	0	24	41	2	IN	0	24	25	1	of	24	24	25	0	NP	0	25	41	2	NP	2	25	28	3	JJ	0	25	26	1	several	25	25	26	0	NNP	0	26	27	1	AKT	26	26	27	0	NNS	0	27	28	1	targets	27	27	28	0	PP	0	28	41	2	VBG	0	28	29	1	including	28	28	29	0	NP	0	29	41	2	NP	0	29	31	2	NN	0	29	30	1	GSK3Œ	29	29	30	0	CD	0	30	31	1	±	30	30	31	0	PRN	1	31	41	2	:	0	31	32	1	/	31	31	32	0	NP	0	32	41	6	NP	1	32	34	2	NN	0	32	33	1	Œ	32	32	33	0	NN	0	33	34	1	≤	33	33	34	0	,	0	34	35	1	,	34	34	35	0	NP	2	35	38	3	NN	0	35	36	1	ATP	35	35	36	0	NN	0	36	37	1	citrate	36	36	37	0	NN	0	37	38	1	lyase	37	37	38	0	,	0	38	39	1	,	38	38	39	0	CC	0	39	40	1	and	39	39	40	0	NP	0	40	41	1	NN	0	40	41	1	PRAS40	40	40	41	0	.	0	41	42	1	.	41	41	42	0
EOS
T	23
We	11177	11179	PRP	we	O	_	_
confirmed	11180	11189	VBD	confirm	O	_	_
that	11190	11194	IN	that	O	_	_
these	11195	11200	DT	these	O	_	_
proteins	11201	11209	NNS	protein	O	_	_
were	11210	11214	VBD	be	O	_	_
AKT	11215	11218	NNP	AKT	O	_	_
substrates	11219	11229	NNS	substrate	O	_	_
,	11229	11230	,	,	O	_	_
as	11231	11233	IN	as	O	_	_
co-treatment	11234	11246	NN	co-treatment	O	_	_
with	11247	11251	IN	with	O	_	_
an	11252	11254	DT	a	O	_	_
allosteric	11255	11265	JJ	allosteric	O	_	_
AKT	11266	11269	NN	akt	O	_	_
inhibitor	11270	11279	NN	inhibitor	O	_	_
blocked	11280	11287	VBD	block	O	_	_
their	11288	11293	PRP$	they	O	_	_
phosphorylation	11294	11309	NN	phosphorylation	O	_	_
(	11310	11311	CD	(	O	_	_
Supplemental	11311	11323	NNP	Supplemental	O	_	_
)	11332	11333	NN	)	O	_	_
.	11333	11334	.	.	O	_	_
D	1
16
1	0	nsubj
1	7	ccomp
4	3	det
7	2	mark
7	4	nsubj
7	5	cop
7	6	nn
7	10	prep_as
10	15	prep_with
15	12	det
15	13	amod
15	14	nn
16	1	dep
16	18	dobj
16	21	nsubj
18	17	poss
21	19	num
21	20	nn
EOX
Y	1
ROOT	0	0	23	1	SINV	1	0	23	4	S	1	0	16	2	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	16	2	VBD	0	1	2	1	confirmed	1	1	2	0	SBAR	1	2	16	2	IN	0	2	3	1	that	2	2	3	0	S	1	3	16	2	NP	1	3	5	2	DT	0	3	4	1	these	3	3	4	0	NNS	0	4	5	1	proteins	4	4	5	0	VP	1	5	16	4	VBD	0	5	6	1	were	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	AKT	6	6	7	0	NNS	0	7	8	1	substrates	7	7	8	0	,	0	8	9	1	,	8	8	9	0	PP	0	9	16	2	IN	0	9	10	1	as	9	9	10	0	NP	0	10	16	2	NP	0	10	11	1	NN	0	10	11	1	co-treatment	10	10	11	0	PP	0	11	16	2	IN	0	11	12	1	with	11	11	12	0	NP	3	12	16	4	DT	0	12	13	1	an	12	12	13	0	JJ	0	13	14	1	allosteric	13	13	14	0	NN	0	14	15	1	AKT	14	14	15	0	NN	0	15	16	1	inhibitor	15	15	16	0	VP	0	16	19	2	VBD	0	16	17	1	blocked	16	16	17	0	NP	1	17	19	2	PRP$	0	17	18	1	their	17	17	18	0	NN	0	18	19	1	phosphorylation	18	18	19	0	NP	2	19	22	3	CD	0	19	20	1	(	19	19	20	0	NNP	0	20	21	1	Supplemental	20	20	21	0	NN	0	21	22	1	)	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	21
MEK	11335	11338	NN	mek	B-GENE	_	_
inhibition	11339	11349	NN	inhibition	O	_	_
also	11350	11354	RB	also	O	_	_
led	11355	11358	VBD	lead	O	_	_
to	11359	11361	TO	to	O	_	_
up-	11362	11365	RB	up-	O	_	_
regulation	11366	11376	NN	regulation	O	_	_
of	11377	11379	IN	of	O	_	_
phospho-CRAF	11380	11392	NN	phospho-craf	O	_	_
and	11393	11396	CC	and	O	_	_
phospho-MEK	11397	11408	NN	phospho-mek	B-GENE	_	_
,	11420	11421	,	,	O	_	_
suggesting	11422	11432	VBG	suggest	O	_	_
activation	11433	11443	NN	activation	O	_	_
of	11444	11446	IN	of	O	_	_
a	11447	11448	DT	a	O	_	_
common	11449	11455	JJ	common	O	_	_
upstream	11456	11464	JJ	upstream	O	_	_
signaling	11465	11474	NN	signaling	O	_	_
molecule	11475	11483	NN	molecule	O	_	_
.	11483	11484	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubj
3	2	advmod
3	6	prep_to
3	12	xcomp
6	5	advmod
6	8	prep_of
6	10	prep_of
8	10	conj_and
12	13	dobj
13	19	prep_of
19	15	det
19	16	amod
19	17	amod
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	2	0	21	4	NP	1	0	2	2	NN	0	0	1	1	MEK	0	0	1	0	NN	0	1	2	1	inhibition	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	also	2	2	3	0	VP	0	3	20	4	VBD	0	3	4	1	led	3	3	4	0	PP	0	4	11	2	TO	0	4	5	1	to	4	4	5	0	NP	0	5	11	2	NP	1	5	7	2	ADVP	0	5	6	1	RB	0	5	6	1	up-	5	5	6	0	NN	0	6	7	1	regulation	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	11	3	NN	0	8	9	1	phospho-CRAF	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NN	0	10	11	1	phospho-MEK	10	10	11	0	,	0	11	12	1	,	11	11	12	0	S	0	12	20	1	VP	0	12	20	2	VBG	0	12	13	1	suggesting	12	12	13	0	NP	0	13	20	2	NP	0	13	14	1	NN	0	13	14	1	activation	13	13	14	0	PP	0	14	20	2	IN	0	14	15	1	of	14	14	15	0	NP	4	15	20	5	DT	0	15	16	1	a	15	15	16	0	JJ	0	16	17	1	common	16	16	17	0	JJ	0	17	18	1	upstream	17	17	18	0	NN	0	18	19	1	signaling	18	18	19	0	NN	0	19	20	1	molecule	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	28
This	11485	11489	DT	this	O	_	_
feedback	11490	11498	NN	feedback	O	_	_
also	11499	11503	RB	also	O	_	_
occurred	11504	11512	VBD	occur	O	_	_
in	11513	11515	FW	in	O	_	_
vivo	11516	11520	FW	vivo	O	_	_
,	11520	11521	,	,	O	_	_
as	11522	11524	IN	as	O	_	_
we	11525	11527	PRP	we	O	_	_
observed	11528	11536	VBD	observe	O	_	_
increased	11537	11546	VBD	increase	O	_	_
phospho-AKT	11547	11558	NN	phospho-akt	O	_	_
in	11559	11561	IN	in	O	_	_
an	11562	11564	DT	a	O	_	_
EGFR-	11565	11570	NN	egfr-_NN	B-GENE	_	_
mutant	11571	11577	JJ	mutant	I-GENE	_	_
H1975	11578	11583	NN	h1975	I-GENE	_	_
(	11584	11585	CD	(	B-GENE	_	_
L858R	11585	11590	NN	l858r	I-GENE	_	_
/	11590	11591	:	/	B-GENE	_	_
T790M	11591	11596	NN	t790m	I-GENE	_	_
)	11596	11597	CD	)	O	_	_
xenograft	11598	11607	NN	xenograft	O	_	_
model	11608	11613	NN	model	O	_	_
treated	11614	11621	VBN	treat	O	_	_
with	11622	11626	IN	with	O	_	_
AZD6244	11627	11634	NN	azd6244	O	_	_
.	11646	11647	.	.	O	_	_
D	1
10
1	0	det
3	1	nsubj
3	2	advmod
3	5	advmod
3	9	advcl
5	4	nn
9	7	mark
9	8	nsubj
10	3	dep
10	11	dobj
10	16	prep_in
10	18	nsubj
16	13	det
16	14	nn
16	15	amod
18	17	num
18	20	dep
18	23	dep
20	19	punct
20	21	num
23	22	nn
23	24	vmod
24	26	prep_with
EOX
Y	1
ROOT	0	0	28	1	SINV	1	0	28	4	S	2	0	10	3	NP	1	0	2	2	DT	0	0	1	1	This	0	0	1	0	NN	0	1	2	1	feedback	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	also	2	2	3	0	VP	0	3	10	4	VBD	0	3	4	1	occurred	3	3	4	0	ADVP	1	4	6	2	FW	0	4	5	1	in	4	4	5	0	FW	0	5	6	1	vivo	5	5	6	0	,	0	6	7	1	,	6	6	7	0	SBAR	1	7	10	2	IN	0	7	8	1	as	7	7	8	0	S	1	8	10	2	NP	0	8	9	1	PRP	0	8	9	1	we	8	8	9	0	VP	0	9	10	1	VBD	0	9	10	1	observed	9	9	10	0	VP	0	10	17	3	VBD	0	10	11	1	increased	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	phospho-AKT	11	11	12	0	PP	0	12	17	2	IN	0	12	13	1	in	12	12	13	0	NP	3	13	17	4	DT	0	13	14	1	an	13	13	14	0	NN	0	14	15	1	EGFR-	14	14	15	0	JJ	0	15	16	1	mutant	15	15	16	0	NN	0	16	17	1	H1975	16	16	17	0	NP	0	17	27	3	NP	1	17	19	2	CD	0	17	18	1	(	17	17	18	0	NN	0	18	19	1	L858R	18	18	19	0	PRN	1	19	22	2	:	0	19	20	1	/	19	19	20	0	NP	0	20	22	2	NN	0	20	21	1	T790M	20	20	21	0	CD	0	21	22	1	)	21	21	22	0	NP	0	22	27	2	NP	1	22	24	2	NN	0	22	23	1	xenograft	22	22	23	0	NN	0	23	24	1	model	23	23	24	0	VP	0	24	27	2	VBN	0	24	25	1	treated	24	24	25	0	PP	0	25	27	2	IN	0	25	26	1	with	25	25	26	0	NP	0	26	27	1	NN	0	26	27	1	AZD6244	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	31
MEK	11657	11660	NN	mek	B-GENE	_	_
inhibition	11661	11671	NN	inhibition	O	_	_
leads	11672	11677	VBZ	lead	O	_	_
to	11678	11680	TO	to	O	_	_
feedback	11681	11689	NN	feedback	O	_	_
activation	11690	11700	NN	activation	O	_	_
of	11701	11703	IN	of	O	_	_
ERBB3	11704	11709	NN	erbb3	B-GENE	_	_
/	11709	11710	:	/	B-GENE	_	_
PI3K/AKT	11710	11718	NN	pi3k/akt	B-GENE	_	_
signaling	11719	11728	NN	signaling	O	_	_
Increased	11729	11738	VBN	increase	O	_	_
AKT	11739	11742	NN	akt	B-GENE	_	_
phosphorylation	11743	11758	NN	phosphorylation	O	_	_
suggested	11759	11768	VBD	suggest	O	_	_
a	11769	11770	DT	a	O	_	_
potential	11771	11780	JJ	potential	O	_	_
increase	11781	11789	NN	increase	O	_	_
in	11790	11792	IN	in	O	_	_
the	11793	11796	DT	the	O	_	_
abundance	11797	11806	NN	abundance	O	_	_
of	11807	11809	IN	of	O	_	_
PIP3	11810	11814	NN	pip3	O	_	_
(	11815	11816	CD	(	O	_	_
the	11816	11819	DT	the	O	_	_
lipid	11820	11825	NN	lipid	O	_	_
product	11826	11833	NN	product	O	_	_
of	11834	11836	IN	of	O	_	_
PI3K	11837	11841	NN	pi3k	B-GENE	_	_
)	11841	11842	CD	)	O	_	_
.	11842	11843	.	.	O	_	_
D	1
2
1	0	nn
2	1	nsubj
2	5	prep_to
2	10	dep
2	20	prep_in
5	4	nn
5	7	prep_of
10	8	punct
10	9	nn
10	14	rcmod
13	11	amod
13	12	nn
14	13	nsubj
14	17	dobj
17	15	det
17	16	amod
20	19	det
20	22	prep_of
22	23	num
22	26	dep
26	24	det
26	25	nn
26	28	prep_of
28	29	num
EOX
Y	1
ROOT	0	0	31	1	S	1	0	31	3	NP	1	0	2	2	NN	0	0	1	1	MEK	0	0	1	0	NN	0	1	2	1	inhibition	1	1	2	0	VP	0	2	30	4	VBZ	0	2	3	1	leads	2	2	3	0	PP	0	3	8	2	TO	0	3	4	1	to	3	3	4	0	NP	0	4	8	2	NP	1	4	6	2	NN	0	4	5	1	feedback	4	4	5	0	NN	0	5	6	1	activation	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	ERBB3	7	7	8	0	PRN	1	8	18	2	:	0	8	9	1	/	8	8	9	0	NP	0	9	18	2	NP	1	9	11	2	NN	0	9	10	1	PI3K/AKT	9	9	10	0	NN	0	10	11	1	signaling	10	10	11	0	SBAR	0	11	18	1	S	1	11	18	2	NP	2	11	14	3	VBN	0	11	12	1	Increased	11	11	12	0	NN	0	12	13	1	AKT	12	12	13	0	NN	0	13	14	1	phosphorylation	13	13	14	0	VP	0	14	18	2	VBD	0	14	15	1	suggested	14	14	15	0	NP	2	15	18	3	DT	0	15	16	1	a	15	15	16	0	JJ	0	16	17	1	potential	16	16	17	0	NN	0	17	18	1	increase	17	17	18	0	PP	0	18	30	2	IN	0	18	19	1	in	18	18	19	0	NP	0	19	30	2	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	abundance	20	20	21	0	PP	0	21	30	2	IN	0	21	22	1	of	21	21	22	0	NP	0	22	30	2	NP	0	22	24	2	NN	0	22	23	1	PIP3	22	22	23	0	CD	0	23	24	1	(	23	23	24	0	NP	0	24	30	2	NP	2	24	27	3	DT	0	24	25	1	the	24	24	25	0	NN	0	25	26	1	lipid	25	25	26	0	NN	0	26	27	1	product	26	26	27	0	PP	0	27	30	2	IN	0	27	28	1	of	27	27	28	0	NP	0	28	30	2	NN	0	28	29	1	PI3K	28	28	29	0	CD	0	29	30	1	)	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	27
Therefore	11844	11853	RB	therefore	O	_	_
,	11853	11854	,	,	O	_	_
EGFR	11855	11859	NN	egfr	B-GENE	_	_
driven	11860	11866	VBN	drive	O	_	_
HCC827	11867	11873	NN	hcc827	O	_	_
and	11874	11877	CC	and	O	_	_
HER2	11878	11882	NN	her2	O	_	_
driven	11883	11889	VBN	drive	O	_	_
MDA-MB-453	11890	11900	NN	mda-mb-453	O	_	_
cells	11901	11906	NNS	cell	O	_	_
were	11907	11911	VBD	be	O	_	_
treated	11912	11919	VBN	treat	O	_	_
with	11920	11924	IN	with	O	_	_
a	11925	11926	DT	a	O	_	_
MEK	11927	11930	NN	mek	B-GENE	_	_
inhibitor	11931	11940	NN	inhibitor	O	_	_
,	11940	11941	,	,	O	_	_
lipids	11942	11948	NNS	lipid	O	_	_
were	11949	11953	VBD	be	O	_	_
isolated	11954	11962	VBN	isolate	O	_	_
,	11962	11963	,	,	O	_	_
and	11964	11967	CC	and	O	_	_
PIP3	11968	11972	NN	pip3	O	_	_
levels	11973	11979	NNS	level	O	_	_
were	11980	11984	VBD	be	O	_	_
quantified	11985	11995	VBN	quantify	O	_	_
.	11995	11996	.	.	O	_	_
D	1
11
2	3	vmod
3	4	dobj
3	6	dobj
4	6	conj_and
4	7	vmod
7	9	dobj
9	8	nn
11	0	advmod
11	2	nsubjpass
11	10	auxpass
11	15	prep_with
11	19	dep
11	25	conj_and
15	13	det
15	14	nn
19	17	nsubjpass
19	18	auxpass
23	22	nn
25	23	nsubjpass
25	24	auxpass
EOX
Y	1
ROOT	0	0	27	1	S	2	0	27	7	ADVP	0	0	1	1	RB	0	0	1	1	Therefore	0	0	1	0	,	0	1	2	1	,	1	1	2	0	S	1	2	16	2	NP	0	2	10	2	NP	0	2	3	1	NN	0	2	3	1	EGFR	2	2	3	0	VP	0	3	10	2	VBN	0	3	4	1	driven	3	3	4	0	NP	0	4	10	2	NP	0	4	7	3	NN	0	4	5	1	HCC827	4	4	5	0	CC	0	5	6	1	and	5	5	6	0	NN	0	6	7	1	HER2	6	6	7	0	VP	0	7	10	2	VBN	0	7	8	1	driven	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	MDA-MB-453	8	8	9	0	NNS	0	9	10	1	cells	9	9	10	0	VP	1	10	16	2	VBD	0	10	11	1	were	10	10	11	0	VP	0	11	16	2	VBN	0	11	12	1	treated	11	11	12	0	PP	0	12	16	2	IN	0	12	13	1	with	12	12	13	0	NP	2	13	16	3	DT	0	13	14	1	a	13	13	14	0	NN	0	14	15	1	MEK	14	14	15	0	NN	0	15	16	1	inhibitor	15	15	16	0	PRN	1	16	21	3	,	0	16	17	1	,	16	16	17	0	S	1	17	20	2	NP	0	17	18	1	NNS	0	17	18	1	lipids	17	17	18	0	VP	1	18	20	2	VBD	0	18	19	1	were	18	18	19	0	VP	0	19	20	1	VBN	0	19	20	1	isolated	19	19	20	0	,	0	20	21	1	,	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	S	1	22	26	2	NP	1	22	24	2	NN	0	22	23	1	PIP3	22	22	23	0	NNS	0	23	24	1	levels	23	23	24	0	VP	1	24	26	2	VBD	0	24	25	1	were	24	24	25	0	VP	0	25	26	1	VBN	0	25	26	1	quantified	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	12
In	11997	11999	IN	in	O	_	_
both	12000	12004	DT	both	O	_	_
cell	12005	12009	NN	cell	O	_	_
lines	12010	12015	NNS	line	O	_	_
,	12015	12016	,	,	O	_	_
AZD6244	12017	12024	NN	azd6244	O	_	_
induced	12025	12032	VBD	induce	O	_	_
significant	12033	12044	JJ	significant	O	_	_
increases	12045	12054	NNS	increase	O	_	_
in	12055	12057	IN	in	O	_	_
PIP3	12058	12062	NN	pip3	O	_	_
.	12074	12075	.	.	O	_	_
D	1
6
3	1	det
3	2	nn
6	3	prep_in
6	5	nsubj
6	8	dobj
6	10	prep_in
8	7	amod
EOX
Y	1
ROOT	0	0	12	1	S	3	0	12	5	PP	0	0	4	2	IN	0	0	1	1	In	0	0	1	0	NP	2	1	4	3	DT	0	1	2	1	both	1	1	2	0	NN	0	2	3	1	cell	2	2	3	0	NNS	0	3	4	1	lines	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	AZD6244	5	5	6	0	VP	0	6	11	3	VBD	0	6	7	1	induced	6	6	7	0	NP	1	7	9	2	JJ	0	7	8	1	significant	7	7	8	0	NNS	0	8	9	1	increases	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	in	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	PIP3	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	22
We	12076	12078	PRP	we	O	_	_
did	12079	12082	VBD	do	O	_	_
not	12083	12086	RB	not	O	_	_
observe	12087	12094	VB	observe	O	_	_
any	12095	12098	DT	any	O	_	_
change	12099	12105	NN	change	O	_	_
in	12106	12108	IN	in	O	_	_
expression	12109	12119	NN	expression	O	_	_
of	12120	12122	IN	of	O	_	_
the	12123	12126	DT	the	O	_	_
PTEN	12127	12131	NNP	PTEN	B-GENE	_	_
phosphatase	12132	12143	NN	phosphatase	I-GENE	_	_
responsible	12144	12155	JJ	responsible	O	_	_
for	12156	12159	IN	for	O	_	_
de	12160	12162	FW	de	O	_	_
phosphorylating	12163	12178	VBG	phosphorylate	O	_	_
PIP3	12179	12183	NN	pip3	O	_	_
,	12183	12184	,	,	O	_	_
following	12185	12194	VBG	follow	O	_	_
MEK	12195	12198	NN	mek	B-GENE	_	_
inhibition	12199	12209	NN	inhibition	O	_	_
.	12221	12222	.	.	O	_	_
D	1
3
3	0	nsubj
3	1	aux
3	2	neg
3	12	xcomp
5	4	det
5	7	prep_in
7	11	prep_of
11	9	det
11	10	nn
12	5	nsubj
12	14	prep_for
14	15	vmod
15	16	dobj
16	20	prep_following
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	2	1	21	3	VBD	0	1	2	1	did	1	1	2	0	RB	0	2	3	1	not	2	2	3	0	VP	0	3	21	2	VB	0	3	4	1	observe	3	3	4	0	S	1	4	21	2	NP	0	4	12	2	NP	1	4	6	2	DT	0	4	5	1	any	4	4	5	0	NN	0	5	6	1	change	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	in	6	6	7	0	NP	0	7	12	2	NP	0	7	8	1	NN	0	7	8	1	expression	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	of	8	8	9	0	NP	2	9	12	3	DT	0	9	10	1	the	9	9	10	0	NNP	0	10	11	1	PTEN	10	10	11	0	NN	0	11	12	1	phosphatase	11	11	12	0	ADJP	0	12	21	2	JJ	0	12	13	1	responsible	12	12	13	0	PP	0	13	21	2	IN	0	13	14	1	for	13	13	14	0	NP	0	14	21	2	NP	0	14	15	1	FW	0	14	15	1	de	14	14	15	0	VP	0	15	21	2	VBG	0	15	16	1	phosphorylating	15	15	16	0	NP	0	16	21	3	NP	0	16	17	1	NN	0	16	17	1	PIP3	16	16	17	0	,	0	17	18	1	,	17	17	18	0	PP	0	18	21	2	VBG	0	18	19	1	following	18	18	19	0	NP	1	19	21	2	NN	0	19	20	1	MEK	19	19	20	0	NN	0	20	21	1	inhibition	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	27
To	12223	12225	TO	to	O	_	_
determine	12226	12235	VB	determine	O	_	_
if	12236	12238	IN	if	O	_	_
MEK	12239	12242	NN	mek	B-GENE	_	_
inhibition	12243	12253	NN	inhibition	O	_	_
led	12254	12257	VBD	lead	O	_	_
to	12258	12260	TO	to	O	_	_
activation	12261	12271	NN	activation	O	_	_
of	12272	12274	IN	of	O	_	_
PI3K	12275	12279	NN	pi3k	B-GENE	_	_
,	12279	12280	,	,	O	_	_
we	12281	12283	PRP	we	O	_	_
immunoprecipitated	12284	12302	VBD	immunoprecipitate	O	_	_
the	12303	12306	DT	the	O	_	_
p85	12307	12310	NN	p85	B-GENE	_	_
regulatory	12311	12321	JJ	regulatory	I-GENE	_	_
subunit	12322	12329	NN	subunit	I-GENE	_	_
of	12330	12332	IN	of	I-GENE	_	_
PI3K	12333	12337	NN	pi3k	I-GENE	_	_
and	12338	12341	CC	and	O	_	_
assessed	12342	12350	VBN	assess	O	_	_
the	12351	12354	DT	the	O	_	_
abundance	12355	12364	NN	abundance	O	_	_
of	12365	12367	IN	of	O	_	_
bound	12368	12373	VBN	bind	O	_	_
adaptors	12374	12382	NNS	adaptor	O	_	_
.	12382	12383	.	.	O	_	_
D	1
12
1	0	aux
1	5	advcl
4	3	nn
5	2	mark
5	4	nsubj
5	7	prep_to
7	9	prep_of
12	1	advcl
12	11	nsubj
12	16	dobj
12	20	conj_and
16	13	det
16	14	nn
16	15	amod
16	18	prep_of
20	11	nsubj
20	22	dobj
22	21	det
22	25	prep_of
25	24	amod
EOX
Y	1
ROOT	0	0	27	1	S	3	0	27	5	S	0	0	10	1	VP	1	0	10	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	10	2	VB	0	1	2	1	determine	1	1	2	0	SBAR	1	2	10	2	IN	0	2	3	1	if	2	2	3	0	S	1	3	10	2	NP	1	3	5	2	NN	0	3	4	1	MEK	3	3	4	0	NN	0	4	5	1	inhibition	4	4	5	0	VP	0	5	10	2	VBD	0	5	6	1	led	5	5	6	0	PP	0	6	10	2	TO	0	6	7	1	to	6	6	7	0	NP	0	7	10	2	NP	0	7	8	1	NN	0	7	8	1	activation	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	PI3K	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	0	11	12	1	PRP	0	11	12	1	we	11	11	12	0	VP	0	12	26	3	VP	0	12	19	2	VBD	0	12	13	1	immunoprecipitated	12	12	13	0	NP	0	13	19	2	NP	3	13	17	4	DT	0	13	14	1	the	13	13	14	0	NN	0	14	15	1	p85	14	14	15	0	JJ	0	15	16	1	regulatory	15	15	16	0	NN	0	16	17	1	subunit	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	PI3K	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	VP	0	20	26	2	VBN	0	20	21	1	assessed	20	20	21	0	NP	0	21	26	2	NP	1	21	23	2	DT	0	21	22	1	the	21	21	22	0	NN	0	22	23	1	abundance	22	22	23	0	PP	0	23	26	2	IN	0	23	24	1	of	23	23	24	0	NP	1	24	26	2	ADJP	0	24	25	1	VBN	0	24	25	1	bound	24	24	25	0	NNS	0	25	26	1	adaptors	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	29
PI3K	12384	12388	NN	pi3k	B-GENE	_	_
consists	12389	12397	VBZ	consist	O	_	_
of	12398	12400	IN	of	O	_	_
a	12401	12402	DT	a	O	_	_
p110	12403	12407	NN	p110	B-GENE	_	_
catalytic	12408	12417	JJ	catalytic	O	_	_
subunit	12418	12425	NN	subunit	O	_	_
and	12426	12429	CC	and	O	_	_
a	12430	12431	DT	a	O	_	_
p85	12432	12435	NN	p85	B-GENE	_	_
regulatory	12436	12446	JJ	regulatory	I-GENE	_	_
subunit	12447	12454	NN	subunit	I-GENE	_	_
,	12454	12455	,	,	O	_	_
and	12456	12459	CC	and	O	_	_
is	12460	12462	VBZ	be	O	_	_
activated	12463	12472	VBN	activate	O	_	_
when	12473	12477	WRB	when	O	_	_
p85	12478	12481	NN	p85	B-GENE	_	_
SH2	12482	12485	NN	sh2	B-GENE	_	_
domains	12486	12493	NNS	domain	O	_	_
bind	12494	12498	VBP	bind	O	_	_
to	12499	12501	TO	to	O	_	_
tyrosine	12502	12510	NN	tyrosine	O	_	_
phosphorylated	12511	12525	JJ	phosphorylated	O	_	_
proteins	12526	12534	NNS	protein	O	_	_
with	12535	12539	IN	with	O	_	_
YXXM	12540	12544	NN	yxxm	O	_	_
motifs	12545	12551	NNS	motif	O	_	_
.	12551	12552	.	.	O	_	_
D	1
1
1	0	nsubj
1	6	prep_of
1	11	prep_of
1	15	conj_and
6	3	det
6	4	nn
6	5	amod
6	11	conj_and
11	8	det
11	9	nn
11	10	amod
15	0	nsubjpass
15	14	auxpass
15	20	advcl
19	17	nn
19	18	nn
20	16	advmod
20	19	nsubj
20	24	prep_to
20	27	prep_with
24	22	nn
24	23	amod
27	26	nn
EOX
Y	1
ROOT	0	0	29	1	S	1	0	29	3	NP	0	0	1	1	NN	0	0	1	1	PI3K	0	0	1	0	VP	0	1	28	4	VP	0	1	12	2	VBZ	0	1	2	1	consists	1	1	2	0	PP	0	2	12	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	12	3	NP	3	3	7	4	DT	0	3	4	1	a	3	3	4	0	NN	0	4	5	1	p110	4	4	5	0	JJ	0	5	6	1	catalytic	5	5	6	0	NN	0	6	7	1	subunit	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	NP	3	8	12	4	DT	0	8	9	1	a	8	8	9	0	NN	0	9	10	1	p85	9	9	10	0	JJ	0	10	11	1	regulatory	10	10	11	0	NN	0	11	12	1	subunit	11	11	12	0	,	0	12	13	1	,	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	VP	1	14	28	2	VBZ	0	14	15	1	is	14	14	15	0	VP	0	15	28	2	VBN	0	15	16	1	activated	15	15	16	0	SBAR	1	16	28	2	WHADVP	0	16	17	1	WRB	0	16	17	1	when	16	16	17	0	S	1	17	28	2	NP	2	17	20	3	NN	0	17	18	1	p85	17	17	18	0	NN	0	18	19	1	SH2	18	18	19	0	NNS	0	19	20	1	domains	19	19	20	0	VP	0	20	28	3	VBP	0	20	21	1	bind	20	20	21	0	PP	0	21	25	2	TO	0	21	22	1	to	21	21	22	0	NP	2	22	25	3	NN	0	22	23	1	tyrosine	22	22	23	0	JJ	0	23	24	1	phosphorylated	23	23	24	0	NNS	0	24	25	1	proteins	24	24	25	0	PP	0	25	28	2	IN	0	25	26	1	with	25	25	26	0	NP	1	26	28	2	NN	0	26	27	1	YXXM	26	26	27	0	NNS	0	27	28	1	motifs	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	41
Treatment	12553	12562	NN	treatment	O	_	_
with	12563	12567	IN	with	O	_	_
AZD6244	12568	12575	NN	azd6244	O	_	_
ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	12576	12627	NN	ôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøº	O	_	_
MEK	12629	12632	NN	mek	B-GENE	_	_
inhibition	12633	12643	NN	inhibition	O	_	_
leads	12644	12649	VBZ	lead	O	_	_
to	12650	12652	TO	to	O	_	_
PI3K	12653	12657	NN	pi3k	B-GENE	_	_
/	12657	12658	:	/	B-GENE	_	_
AKT	12658	12661	NN	akt	I-GENE	_	_
activation	12662	12672	NN	activation	O	_	_
by	12673	12675	IN	by	O	_	_
relieving	12676	12685	VBG	relieve	O	_	_
a	12686	12687	DT	a	O	_	_
negative	12688	12696	JJ	negative	O	_	_
feedback	12697	12705	NN	feedback	O	_	_
on	12706	12708	IN	on	O	_	_
ERBB	12709	12713	NN	erbb	O	_	_
receptors	12714	12723	NNS	receptor	O	_	_
12	12724	12726	CD	12	O	_	_
/	12726	12727	:	/	O	_	_
8/14	12727	12731	CD	8/14	O	_	_
,	12731	12732	,	,	O	_	_
6:54	12733	12737	CD	6:54	O	_	_
PM	12738	12740	NN	pm	O	_	_
Ôøºincreased	12741	12753	VBD	ôøºincreased	O	_	_
the	12754	12757	DT	the	O	_	_
association	12758	12769	NN	association	O	_	_
between	12770	12777	IN	between	O	_	_
PI3K	12778	12782	NN	pi3k	B-GENE	_	_
and	12783	12786	CC	and	O	_	_
tyrosine	12787	12795	NN	tyrosine	O	_	_
phosphorylated	12796	12810	JJ	phosphorylated	O	_	_
adaptors	12811	12819	NNS	adaptor	O	_	_
,	12819	12820	,	,	O	_	_
including	12821	12830	VBG	include	O	_	_
ERBB3	12831	12836	NN	erbb3	B-GENE	_	_
and	12837	12840	CC	and	O	_	_
GAB1	12841	12845	NN	gab1	B-GENE	_	_
.	12858	12859	.	.	O	_	_
D	1
11
0	5	prep_with
5	2	nn
5	3	nn
5	4	nn
6	0	nsubj
6	8	prep_to
11	6	dep
11	9	punct
11	10	nn
11	13	prepc_by
13	16	dobj
13	19	prep_on
16	14	det
16	15	amod
19	18	nn
19	26	rcmod
20	22	dep
22	21	punct
22	25	appos
25	24	num
26	20	nsubj
26	28	iobj
26	34	dobj
28	27	det
28	30	prep_between
28	32	prep_between
30	32	conj_and
34	33	amod
34	37	prep_including
34	39	prep_including
37	39	conj_and
EOX
Y	1
ROOT	0	0	41	1	FRAG	2	0	41	4	S	1	0	9	2	NP	0	0	6	2	NP	0	0	1	1	NN	0	0	1	1	Treatment	0	0	1	0	PP	0	1	6	2	IN	0	1	2	1	with	1	1	2	0	NP	3	2	6	4	NN	0	2	3	1	AZD6244	2	2	3	0	NN	0	3	4	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	3	3	4	0	NN	0	4	5	1	MEK	4	4	5	0	NN	0	5	6	1	inhibition	5	5	6	0	VP	0	6	9	2	VBZ	0	6	7	1	leads	6	6	7	0	PP	0	7	9	2	TO	0	7	8	1	to	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	PI3K	8	8	9	0	:	0	9	10	1	/	9	9	10	0	FRAG	0	10	40	2	NP	1	10	12	2	NN	0	10	11	1	AKT	10	10	11	0	NN	0	11	12	1	activation	11	11	12	0	PP	0	12	40	2	IN	0	12	13	1	by	12	12	13	0	S	0	13	40	1	VP	0	13	40	3	VBG	0	13	14	1	relieving	13	13	14	0	NP	2	14	17	3	DT	0	14	15	1	a	14	14	15	0	JJ	0	15	16	1	negative	15	15	16	0	NN	0	16	17	1	feedback	16	16	17	0	PP	0	17	40	2	IN	0	17	18	1	on	17	17	18	0	NP	0	18	40	2	NP	1	18	20	2	NN	0	18	19	1	ERBB	18	18	19	0	NNS	0	19	20	1	receptors	19	19	20	0	SBAR	1	20	40	2	WHNP	0	20	26	2	NP	0	20	21	1	CD	0	20	21	1	12	20	20	21	0	PRN	1	21	26	2	:	0	21	22	1	/	21	21	22	0	NP	0	22	26	3	NP	0	22	23	1	CD	0	22	23	1	8/14	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	1	24	26	2	CD	0	24	25	1	6:54	24	24	25	0	NN	0	25	26	1	PM	25	25	26	0	S	0	26	40	1	VP	0	26	40	3	VBD	0	26	27	1	Ôøºincreased	26	26	27	0	NP	0	27	33	2	NP	1	27	29	2	DT	0	27	28	1	the	27	27	28	0	NN	0	28	29	1	association	28	28	29	0	PP	0	29	33	2	IN	0	29	30	1	between	29	29	30	0	NP	0	30	33	3	NN	0	30	31	1	PI3K	30	30	31	0	CC	0	31	32	1	and	31	31	32	0	NN	0	32	33	1	tyrosine	32	32	33	0	NP	0	33	40	3	NP	1	33	35	2	JJ	0	33	34	1	phosphorylated	33	33	34	0	NNS	0	34	35	1	adaptors	34	34	35	0	,	0	35	36	1	,	35	35	36	0	PP	0	36	40	2	VBG	0	36	37	1	including	36	36	37	0	NP	0	37	40	3	NN	0	37	38	1	ERBB3	37	37	38	0	CC	0	38	39	1	and	38	38	39	0	NN	0	39	40	1	GAB1	39	39	40	0	.	0	40	41	1	.	40	40	41	0
EOS
T	20
These	12860	12865	DT	these	O	_	_
results	12866	12873	NNS	result	O	_	_
suggest	12874	12881	VBP	suggest	O	_	_
that	12882	12886	IN	that	O	_	_
MEK	12887	12890	NN	mek	B-GENE	_	_
inhibition	12891	12901	NN	inhibition	O	_	_
leads	12902	12907	VBZ	lead	O	_	_
to	12908	12910	TO	to	O	_	_
an	12911	12913	DT	a	O	_	_
increase	12914	12922	NN	increase	O	_	_
in	12923	12925	IN	in	O	_	_
the	12926	12929	DT	the	O	_	_
phospho-tyrosine	12930	12946	JJ	phospho-tyrosine	O	_	_
signaling	12947	12956	NN	signaling	O	_	_
cascades	12957	12965	NNS	cascade	O	_	_
that	12966	12970	WDT	that	O	_	_
directly	12971	12979	RB	directly	O	_	_
activate	12980	12988	VBP	activate	O	_	_
PI3K	12989	12993	NN	pi3k	B-GENE	_	_
.	12993	12994	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	6	ccomp
5	4	nn
6	3	mark
6	5	nsubj
6	9	prep_to
9	8	det
9	14	prep_in
14	11	det
14	12	amod
14	13	nn
14	17	rcmod
17	15	nsubj
17	16	advmod
17	18	dobj
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	results	1	1	2	0	VP	0	2	19	2	VBP	0	2	3	1	suggest	2	2	3	0	SBAR	1	3	19	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	19	2	NP	1	4	6	2	NN	0	4	5	1	MEK	4	4	5	0	NN	0	5	6	1	inhibition	5	5	6	0	VP	0	6	19	2	VBZ	0	6	7	1	leads	6	6	7	0	PP	0	7	19	2	TO	0	7	8	1	to	7	7	8	0	NP	0	8	19	2	NP	1	8	10	2	DT	0	8	9	1	an	8	8	9	0	NN	0	9	10	1	increase	9	9	10	0	PP	0	10	19	2	IN	0	10	11	1	in	10	10	11	0	NP	0	11	19	2	NP	3	11	15	4	DT	0	11	12	1	the	11	11	12	0	JJ	0	12	13	1	phospho-tyrosine	12	12	13	0	NN	0	13	14	1	signaling	13	13	14	0	NNS	0	14	15	1	cascades	14	14	15	0	SBAR	1	15	19	2	WHNP	0	15	16	1	WDT	0	15	16	1	that	15	15	16	0	S	1	16	19	2	ADVP	0	16	17	1	RB	0	16	17	1	directly	16	16	17	0	VP	0	17	19	2	VBP	0	17	18	1	activate	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	PI3K	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	22
In	12995	12997	IN	in	O	_	_
EGFR	12998	13002	NN	egfr	O	_	_
and	13003	13006	CC	and	O	_	_
HER2	13007	13011	NN	her2	O	_	_
driven	13012	13018	VBN	drive	O	_	_
cancers	13019	13026	NNS	cancer	O	_	_
,	13026	13027	,	,	O	_	_
ERBB3	13028	13033	NN	erbb3	O	_	_
is	13034	13036	VBZ	be	O	_	_
a	13037	13038	DT	a	O	_	_
primary	13039	13046	JJ	primary	O	_	_
activator	13047	13056	NN	activator	O	_	_
of	13057	13059	IN	of	O	_	_
PI3K	13060	13064	NN	pi3k	B-GENE	_	_
/	13064	13065	:	/	B-GENE	_	_
AKT	13065	13068	NNP	AKT	I-GENE	_	_
(	13069	13070	CD	(	O	_	_
24	13070	13072	CD	24	O	_	_
,	13072	13073	,	,	O	_	_
30	13074	13076	CD	30	O	_	_
)	13076	13077	NN	)	O	_	_
.	13077	13078	.	.	O	_	_
D	1
11
1	3	conj_and
1	4	vmod
4	5	dobj
11	1	prep_in
11	3	prep_in
11	7	nsubj
11	8	cop
11	9	det
11	10	amod
11	13	prep_of
13	15	dep
13	17	amod
15	14	punct
17	16	number
17	20	dep
20	19	number
EOX
Y	1
ROOT	0	0	22	1	S	3	0	22	5	PP	0	0	6	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	6	2	NP	0	1	4	3	NN	0	1	2	1	EGFR	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NN	0	3	4	1	HER2	3	3	4	0	VP	0	4	6	2	VBN	0	4	5	1	driven	4	4	5	0	NP	0	5	6	1	NNS	0	5	6	1	cancers	5	5	6	0	,	0	6	7	1	,	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	ERBB3	7	7	8	0	VP	1	8	21	2	VBZ	0	8	9	1	is	8	8	9	0	NP	0	9	21	2	NP	2	9	12	3	DT	0	9	10	1	a	9	9	10	0	JJ	0	10	11	1	primary	10	10	11	0	NN	0	11	12	1	activator	11	11	12	0	PP	0	12	21	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	21	2	NP	0	13	16	2	NP	0	13	14	1	NN	0	13	14	1	PI3K	13	13	14	0	PRN	1	14	16	2	:	0	14	15	1	/	14	14	15	0	NP	0	15	16	1	NNP	0	15	16	1	AKT	15	15	16	0	ADJP	0	16	21	3	ADJP	0	16	18	1	QP	1	16	18	2	CD	0	16	17	1	(	16	16	17	0	CD	0	17	18	1	24	17	17	18	0	,	0	18	19	1	,	18	18	19	0	ADJP	1	19	21	2	CD	0	19	20	1	30	19	19	20	0	NN	0	20	21	1	)	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	23
We	13079	13081	PRP	we	O	_	_
observed	13082	13090	VBD	observe	O	_	_
increased	13091	13100	VBD	increase	O	_	_
ERBB3	13101	13106	NN	erbb3	B-GENE	_	_
binding	13107	13114	NN	binding	O	_	_
to	13115	13117	TO	to	O	_	_
PI3K	13118	13122	NN	pi3k	B-GENE	_	_
following	13123	13132	VBG	follow	O	_	_
MEK	13133	13136	NN	mek	O	_	_
inhibition	13137	13147	NN	inhibition	O	_	_
,	13159	13160	,	,	O	_	_
and	13161	13164	CC	and	O	_	_
accordingly	13165	13176	RB	accordingly	O	_	_
,	13176	13177	,	,	O	_	_
MEK	13178	13181	NN	mek	B-GENE	_	_
inhibition	13182	13192	NN	inhibition	O	_	_
substantially	13193	13206	RB	substantially	O	_	_
increased	13207	13216	VBD	increase	O	_	_
tyrosine	13217	13225	NN	tyrosine	O	_	_
phosphorylated	13226	13240	JJ	phosphorylated	O	_	_
ERBB3	13241	13246	NN	erbb3	B-GENE	_	_
levels	13247	13253	NNS	level	O	_	_
.	13265	13266	.	.	O	_	_
D	1
1
1	0	nsubj
1	2	ccomp
1	17	conj_and
2	4	dobj
2	6	prep_to
4	3	nn
6	9	prep_following
9	8	nn
15	14	nn
17	12	advmod
17	15	nsubj
17	16	advmod
17	21	dobj
21	18	nn
21	19	amod
21	20	nn
EOX
Y	1
ROOT	0	0	23	1	S	0	0	23	5	S	1	0	10	2	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	10	2	VBD	0	1	2	1	observed	1	1	2	0	SBAR	0	2	10	1	S	0	2	10	1	VP	0	2	10	3	VBD	0	2	3	1	increased	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	ERBB3	3	3	4	0	NN	0	4	5	1	binding	4	4	5	0	PP	0	5	10	2	TO	0	5	6	1	to	5	5	6	0	NP	0	6	10	2	NP	0	6	7	1	NN	0	6	7	1	PI3K	6	6	7	0	PP	0	7	10	2	VBG	0	7	8	1	following	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	MEK	8	8	9	0	NN	0	9	10	1	inhibition	9	9	10	0	,	0	10	11	1	,	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	S	4	12	22	5	ADVP	0	12	13	1	RB	0	12	13	1	accordingly	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	1	14	16	2	NN	0	14	15	1	MEK	14	14	15	0	NN	0	15	16	1	inhibition	15	15	16	0	ADVP	0	16	17	1	RB	0	16	17	1	substantially	16	16	17	0	VP	0	17	22	2	VBD	0	17	18	1	increased	17	17	18	0	NP	3	18	22	4	NN	0	18	19	1	tyrosine	18	18	19	0	JJ	0	19	20	1	phosphorylated	19	19	20	0	NN	0	20	21	1	ERBB3	20	20	21	0	NNS	0	21	22	1	levels	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	16
In	13267	13269	IN	in	O	_	_
some	13270	13274	DT	some	O	_	_
cell	13275	13279	NN	cell	O	_	_
lines	13280	13285	NNS	line	O	_	_
,	13285	13286	,	,	O	_	_
we	13287	13289	PRP	we	O	_	_
observed	13290	13298	VBD	observe	O	_	_
an	13299	13301	DT	a	O	_	_
increase	13302	13310	NN	increase	O	_	_
in	13311	13313	IN	in	O	_	_
total	13314	13319	JJ	total	O	_	_
ERBB3	13320	13325	NN	erbb3	B-GENE	_	_
along	13326	13331	IN	along	O	_	_
with	13332	13336	IN	with	O	_	_
phospho-ERBB3	13337	13350	NN	phospho-erbb3	O	_	_
.	13362	13363	.	.	O	_	_
D	1
6
3	1	det
3	2	nn
6	3	prep_in
6	5	nsubj
6	8	dobj
6	11	prep_in
6	13	prepc_along_with
6	14	pobj
8	7	det
11	10	amod
EOX
Y	1
ROOT	0	0	16	1	S	3	0	16	5	PP	0	0	4	2	IN	0	0	1	1	In	0	0	1	0	NP	2	1	4	3	DT	0	1	2	1	some	1	1	2	0	NN	0	2	3	1	cell	2	2	3	0	NNS	0	3	4	1	lines	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	6	1	PRP	0	5	6	1	we	5	5	6	0	VP	0	6	15	4	VBD	0	6	7	1	observed	6	6	7	0	NP	1	7	9	2	DT	0	7	8	1	an	7	7	8	0	NN	0	8	9	1	increase	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	in	9	9	10	0	NP	1	10	12	2	JJ	0	10	11	1	total	10	10	11	0	NN	0	11	12	1	ERBB3	11	11	12	0	PP	0	12	15	2	IN	0	12	13	1	along	12	12	13	0	PP	0	13	15	2	IN	0	13	14	1	with	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	phospho-ERBB3	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	40
Of	13364	13366	IN	of	O	_	_
note	13367	13371	NN	note	O	_	_
,	13371	13372	,	,	O	_	_
we	13373	13375	PRP	we	O	_	_
did	13376	13379	VBD	do	O	_	_
not	13380	13383	RB	not	O	_	_
observe	13384	13391	VB	observe	O	_	_
a	13392	13393	DT	a	O	_	_
change	13394	13400	NN	change	O	_	_
in	13401	13403	IN	in	O	_	_
expression	13404	13414	NN	expression	O	_	_
of	13415	13417	IN	of	O	_	_
the	13418	13421	DT	the	O	_	_
E3-ubiquitin	13422	13434	NN	e3-ubiquitin	B-GENE	_	_
ligase	13435	13441	NN	ligase	I-GENE	_	_
,	13441	13442	,	,	O	_	_
neuregulin	13443	13453	NN	neuregulin	B-GENE	_	_
receptor	13454	13462	NN	receptor	I-GENE	_	_
degradation	13463	13474	NN	degradation	I-GENE	_	_
protein	13475	13482	NN	protein	I-GENE	_	_
1	13483	13484	CD	1	I-GENE	_	_
(	13485	13486	CD	(	B-GENE	_	_
NRDP1	13486	13491	NN	nrdp1	I-GENE	_	_
)	13491	13492	NN	)	O	_	_
,	13492	13493	,	,	O	_	_
which	13494	13499	WDT	which	O	_	_
can	13500	13503	MD	can	O	_	_
control	13504	13511	VB	control	O	_	_
the	13512	13515	DT	the	O	_	_
steady	13516	13522	JJ	steady	O	_	_
state	13523	13528	NN	state	O	_	_
levels	13529	13535	NNS	level	O	_	_
of	13536	13538	IN	of	O	_	_
ERBB3	13539	13544	NN	erbb3	O	_	_
(	13545	13546	CD	(	O	_	_
31	13546	13548	CD	31	O	_	_
,	13548	13549	,	,	O	_	_
32	13550	13552	CD	32	O	_	_
)	13552	13553	NN	)	O	_	_
.	13565	13566	.	.	O	_	_
D	1
6
6	1	prep_of
6	3	nsubj
6	4	aux
6	5	neg
6	23	dobj
8	10	prep_in
10	14	prep_of
14	12	det
14	13	nn
14	19	appos
19	16	nn
19	17	nn
19	18	nn
19	21	dep
21	20	number
23	7	det
23	8	dep
23	22	nn
23	27	rcmod
27	25	nsubj
27	26	aux
27	31	dobj
31	28	det
31	29	amod
31	30	nn
31	33	prep_of
33	35	amod
35	34	number
35	38	dep
38	37	number
EOX
Y	1
ROOT	0	0	40	1	S	3	0	40	5	PP	0	0	2	2	IN	0	0	1	1	Of	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	note	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	4	1	PRP	0	3	4	1	we	3	3	4	0	VP	2	4	39	3	VBD	0	4	5	1	did	4	4	5	0	RB	0	5	6	1	not	5	5	6	0	VP	0	6	39	2	VB	0	6	7	1	observe	6	6	7	0	NP	0	7	39	3	NP	3	7	24	4	DT	0	7	8	1	a	7	7	8	0	NAC	0	8	22	2	NN	0	8	9	1	change	8	8	9	0	PP	0	9	22	2	IN	0	9	10	1	in	9	9	10	0	NP	0	10	22	2	NP	0	10	11	1	NN	0	10	11	1	expression	10	10	11	0	PP	0	11	22	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	22	3	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	E3-ubiquitin	13	13	14	0	NN	0	14	15	1	ligase	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NP	0	16	22	2	NP	3	16	20	4	NN	0	16	17	1	neuregulin	16	16	17	0	NN	0	17	18	1	receptor	17	17	18	0	NN	0	18	19	1	degradation	18	18	19	0	NN	0	19	20	1	protein	19	19	20	0	NP	0	20	22	1	QP	1	20	22	2	CD	0	20	21	1	1	20	20	21	0	CD	0	21	22	1	(	21	21	22	0	NN	0	22	23	1	NRDP1	22	22	23	0	NN	0	23	24	1	)	23	23	24	0	,	0	24	25	1	,	24	24	25	0	SBAR	1	25	39	2	WHNP	0	25	26	1	WDT	0	25	26	1	which	25	25	26	0	S	0	26	39	1	VP	1	26	39	2	MD	0	26	27	1	can	26	26	27	0	VP	0	27	39	2	VB	0	27	28	1	control	27	27	28	0	NP	0	28	39	2	NP	3	28	32	4	DT	0	28	29	1	the	28	28	29	0	JJ	0	29	30	1	steady	29	29	30	0	NN	0	30	31	1	state	30	30	31	0	NNS	0	31	32	1	levels	31	31	32	0	PP	0	32	39	2	IN	0	32	33	1	of	32	32	33	0	NP	0	33	39	2	NP	0	33	34	1	NN	0	33	34	1	ERBB3	33	33	34	0	ADJP	0	34	39	3	ADJP	0	34	36	1	QP	1	34	36	2	CD	0	34	35	1	(	34	34	35	0	CD	0	35	36	1	31	35	35	36	0	,	0	36	37	1	,	36	36	37	0	ADJP	1	37	39	2	CD	0	37	38	1	32	37	37	38	0	NN	0	38	39	1	)	38	38	39	0	.	0	39	40	1	.	39	39	40	0
EOS
T	28
There	13567	13572	EX	there	O	_	_
was	13573	13576	VBD	be	O	_	_
also	13577	13581	RB	also	O	_	_
no	13582	13584	DT	no	O	_	_
increase	13585	13593	NN	increase	O	_	_
in	13594	13596	IN	in	O	_	_
ERBB3	13597	13602	NN	erbb3	B-GENE	_	_
mRNA	13603	13607	NN	mrna	I-GENE	_	_
levels	13608	13614	NNS	level	O	_	_
following	13615	13624	VBG	follow	O	_	_
AZD6244	13625	13632	NN	azd6244	O	_	_
treatment	13633	13642	NN	treatment	O	_	_
(	13643	13644	CD	(	O	_	_
Supplemental	13644	13656	NNP	Supplemental	O	_	_
)	13665	13666	NN	)	O	_	_
,	13666	13667	,	,	O	_	_
suggesting	13668	13678	VBG	suggest	O	_	_
that	13679	13683	IN	that	O	_	_
any	13684	13687	DT	any	O	_	_
increase	13688	13696	NN	increase	O	_	_
in	13697	13699	IN	in	O	_	_
ERBB3	13700	13705	NN	erbb3	B-GENE	_	_
protein	13706	13713	NN	protein	I-GENE	_	_
levels	13714	13720	NNS	level	O	_	_
is	13721	13723	VBZ	be	O	_	_
post	13724	13728	JJ	post	O	_	_
transcriptional	13729	13744	JJ	transcriptional	O	_	_
.	13744	13745	.	.	O	_	_
D	1
1
1	0	expl
1	2	advmod
1	4	nsubj
1	16	vmod
4	3	det
4	8	prep_in
8	6	nn
8	7	nn
8	11	prep_following
11	10	nn
11	14	dep
14	12	num
14	13	nn
16	26	ccomp
19	18	det
19	23	prep_in
23	21	nn
23	22	nn
26	17	mark
26	19	nsubj
26	24	cop
26	25	amod
EOX
Y	1
ROOT	0	0	28	1	S	1	0	28	3	NP	0	0	1	1	EX	0	0	1	1	There	0	0	1	0	VP	2	1	27	5	VBD	0	1	2	1	was	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	also	2	2	3	0	NP	0	3	15	2	NP	1	3	5	2	DT	0	3	4	1	no	3	3	4	0	NN	0	4	5	1	increase	4	4	5	0	PP	0	5	15	2	IN	0	5	6	1	in	5	5	6	0	NP	0	6	15	2	NP	2	6	9	3	NN	0	6	7	1	ERBB3	6	6	7	0	NN	0	7	8	1	mRNA	7	7	8	0	NNS	0	8	9	1	levels	8	8	9	0	PP	0	9	15	2	VBG	0	9	10	1	following	9	9	10	0	NP	0	10	15	2	NP	1	10	12	2	NN	0	10	11	1	AZD6244	10	10	11	0	NN	0	11	12	1	treatment	11	11	12	0	NP	2	12	15	3	CD	0	12	13	1	(	12	12	13	0	NNP	0	13	14	1	Supplemental	13	13	14	0	NN	0	14	15	1	)	14	14	15	0	,	0	15	16	1	,	15	15	16	0	S	0	16	27	1	VP	0	16	27	2	VBG	0	16	17	1	suggesting	16	16	17	0	SBAR	1	17	27	2	IN	0	17	18	1	that	17	17	18	0	S	1	18	27	2	NP	0	18	24	2	NP	1	18	20	2	DT	0	18	19	1	any	18	18	19	0	NN	0	19	20	1	increase	19	19	20	0	PP	0	20	24	2	IN	0	20	21	1	in	20	20	21	0	NP	2	21	24	3	NN	0	21	22	1	ERBB3	21	21	22	0	NN	0	22	23	1	protein	22	22	23	0	NNS	0	23	24	1	levels	23	23	24	0	VP	1	24	27	2	VBZ	0	24	25	1	is	24	24	25	0	ADJP	1	25	27	2	JJ	0	25	26	1	post	25	25	26	0	JJ	0	26	27	1	transcriptional	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	21
To	13746	13748	TO	to	O	_	_
assess	13749	13755	VB	assess	O	_	_
the	13756	13759	DT	the	O	_	_
kinetics	13760	13768	NNS	kinetics	O	_	_
of	13769	13771	IN	of	O	_	_
this	13772	13776	DT	this	O	_	_
feedback	13777	13785	NN	feedback	O	_	_
response	13786	13794	NN	response	O	_	_
,	13794	13795	,	,	O	_	_
we	13796	13798	PRP	we	O	_	_
treated	13799	13806	VBD	treat	O	_	_
the	13807	13810	DT	the	O	_	_
HCC827	13811	13817	NN	hcc827	O	_	_
cells	13818	13823	NNS	cell	O	_	_
with	13824	13828	IN	with	O	_	_
AZD6244	13829	13836	NN	azd6244	O	_	_
over	13837	13841	IN	over	O	_	_
a	13842	13843	DT	a	O	_	_
time	13844	13848	NN	time	O	_	_
course	13849	13855	NN	course	O	_	_
.	13855	13856	.	.	O	_	_
D	1
10
1	0	aux
1	3	dobj
3	2	det
3	7	prep_of
7	5	det
7	6	nn
10	1	advcl
10	9	nsubj
10	13	dobj
10	15	prep_with
10	19	prep_over
13	11	det
13	12	nn
19	17	det
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	3	0	21	5	S	0	0	8	1	VP	1	0	8	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	8	2	VB	0	1	2	1	assess	1	1	2	0	NP	0	2	8	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NNS	0	3	4	1	kinetics	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	of	4	4	5	0	NP	2	5	8	3	DT	0	5	6	1	this	5	5	6	0	NN	0	6	7	1	feedback	6	6	7	0	NN	0	7	8	1	response	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	0	9	10	1	PRP	0	9	10	1	we	9	9	10	0	VP	0	10	20	4	VBD	0	10	11	1	treated	10	10	11	0	NP	2	11	14	3	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	HCC827	12	12	13	0	NNS	0	13	14	1	cells	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	with	14	14	15	0	NP	0	15	16	1	NN	0	15	16	1	AZD6244	15	15	16	0	PP	0	16	20	2	IN	0	16	17	1	over	16	16	17	0	NP	2	17	20	3	DT	0	17	18	1	a	17	17	18	0	NN	0	18	19	1	time	18	18	19	0	NN	0	19	20	1	course	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	28
Phoshosphorylation	13857	13875	NN	phoshosphorylation	O	_	_
of	13876	13878	IN	of	O	_	_
ERBB3	13879	13884	NN	erbb3	O	_	_
and	13885	13888	CC	and	O	_	_
AKT	13889	13892	NN	akt	O	_	_
,	13892	13893	,	,	O	_	_
as	13894	13896	RB	as	O	_	_
well	13897	13901	RB	well	O	_	_
as	13902	13904	IN	as	O	_	_
downstream	13905	13915	JJ	downstream	O	_	_
substrates	13916	13926	NNS	substrate	O	_	_
,	13926	13927	,	,	O	_	_
increased	13928	13937	VBN	increase	O	_	_
after	13938	13943	RB	after	O	_	_
just	13944	13948	RB	just	O	_	_
one	13949	13952	CD	one	O	_	_
hour	13953	13957	NN	hour	O	_	_
of	13958	13960	IN	of	O	_	_
MEK	13961	13964	NN	mek	B-GENE	_	_
inhibition	13965	13975	NN	inhibition	O	_	_
and	13976	13979	CC	and	O	_	_
continued	13980	13989	VBD	continue	O	_	_
to	13990	13992	TO	to	O	_	_
accumulate	13993	14003	VB	accumulate	O	_	_
for	14004	14007	IN	for	O	_	_
24	14008	14010	CD	24	O	_	_
hours	14011	14016	NNS	hour	O	_	_
.	14028	14029	.	.	O	_	_
D	1
12
0	2	prep_of
0	4	prep_of
0	10	conj_and
2	4	conj_and
10	9	amod
12	0	nsubj
12	10	nsubj
12	13	prep
12	21	conj_and
13	16	pobj
16	14	advmod
16	15	num
16	19	prep_of
19	18	nn
21	0	nsubj
21	23	xcomp
23	22	aux
23	26	prep_for
26	25	num
EOX
Y	1
ROOT	0	0	28	1	S	1	0	28	3	NP	0	0	12	5	NP	0	0	5	2	NP	0	0	1	1	NN	0	0	1	1	Phoshosphorylation	0	0	1	0	PP	0	1	5	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	5	3	NN	0	2	3	1	ERBB3	2	2	3	0	CC	0	3	4	1	and	3	3	4	0	NN	0	4	5	1	AKT	4	4	5	0	,	0	5	6	1	,	5	5	6	0	CONJP	1	6	9	3	RB	0	6	7	1	as	6	6	7	0	RB	0	7	8	1	well	7	7	8	0	IN	0	8	9	1	as	8	8	9	0	NP	1	9	11	2	JJ	0	9	10	1	downstream	9	9	10	0	NNS	0	10	11	1	substrates	10	10	11	0	,	0	11	12	1	,	11	11	12	0	VP	0	12	27	3	VP	0	12	20	2	VBN	0	12	13	1	increased	12	12	13	0	PP	0	13	20	2	RB	0	13	14	1	after	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	RB	0	14	15	1	just	14	14	15	0	CD	0	15	16	1	one	15	15	16	0	NN	0	16	17	1	hour	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	of	17	17	18	0	NP	1	18	20	2	NN	0	18	19	1	MEK	18	18	19	0	NN	0	19	20	1	inhibition	19	19	20	0	CC	0	20	21	1	and	20	20	21	0	VP	0	21	27	2	VBD	0	21	22	1	continued	21	21	22	0	S	0	22	27	1	VP	1	22	27	2	TO	0	22	23	1	to	22	22	23	0	VP	0	23	27	2	VB	0	23	24	1	accumulate	23	23	24	0	PP	0	24	27	2	IN	0	24	25	1	for	24	24	25	0	NP	1	25	27	2	CD	0	25	26	1	24	25	25	26	0	NNS	0	26	27	1	hours	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	35
To	14030	14032	TO	to	O	_	_
determine	14033	14042	VB	determine	O	_	_
if	14043	14045	IN	if	O	_	_
the	14046	14049	DT	the	O	_	_
feedback	14050	14058	NN	feedback	O	_	_
activation	14059	14069	NN	activation	O	_	_
of	14070	14072	IN	of	O	_	_
ERBB3	14073	14078	NN	erbb3	B-GENE	_	_
occurs	14079	14085	VBZ	occur	O	_	_
on	14086	14088	IN	on	O	_	_
the	14089	14092	DT	the	O	_	_
plasma	14093	14099	NN	plasma	O	_	_
membrane	14100	14108	NN	membrane	O	_	_
,	14108	14109	,	,	O	_	_
we	14110	14112	PRP	we	O	_	_
biotin	14113	14119	VBP	biotin	O	_	_
labeled	14120	14127	VBN	label	O	_	_
the	14128	14131	DT	the	O	_	_
surface	14132	14139	NN	surface	O	_	_
of	14140	14142	IN	of	O	_	_
HCC827	14143	14149	NN	hcc827	O	_	_
cells	14150	14155	NNS	cell	O	_	_
in	14156	14158	IN	in	O	_	_
the	14159	14162	DT	the	O	_	_
presence	14163	14171	NN	presence	O	_	_
or	14172	14174	CC	or	O	_	_
absence	14175	14182	NN	absence	O	_	_
of	14183	14185	IN	of	O	_	_
AZD6244	14186	14193	NN	azd6244	O	_	_
and	14194	14197	CC	and	O	_	_
immunoprecipitated	14198	14216	VBD	immunoprecipitate	O	_	_
the	14217	14220	DT	the	O	_	_
labeled	14221	14228	JJ	labeled	O	_	_
proteins	14229	14237	NNS	protein	O	_	_
.	14237	14238	.	.	O	_	_
D	1
15
1	0	aux
1	8	advcl
5	3	det
5	4	nn
5	7	prep_of
8	2	mark
8	5	nsubj
8	12	prep_on
12	10	det
12	11	nn
15	1	advcl
15	14	nsubj
15	16	ccomp
15	30	ccomp
16	18	dobj
16	24	prep_in
16	26	prep_in
16	30	conj_and
18	17	det
18	21	prep_of
21	20	nn
24	23	det
24	26	conj_or
24	28	prep_of
30	33	dobj
33	31	det
33	32	amod
EOX
Y	1
ROOT	0	0	35	1	S	3	0	35	5	S	0	0	13	1	VP	1	0	13	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	13	2	VB	0	1	2	1	determine	1	1	2	0	SBAR	1	2	13	2	IN	0	2	3	1	if	2	2	3	0	S	1	3	13	2	NP	0	3	8	2	NP	2	3	6	3	DT	0	3	4	1	the	3	3	4	0	NN	0	4	5	1	feedback	4	4	5	0	NN	0	5	6	1	activation	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	ERBB3	7	7	8	0	VP	0	8	13	2	VBZ	0	8	9	1	occurs	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	on	9	9	10	0	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	plasma	11	11	12	0	NN	0	12	13	1	membrane	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	0	14	15	1	PRP	0	14	15	1	we	14	14	15	0	VP	0	15	34	2	VBP	0	15	16	1	biotin	15	15	16	0	S	0	16	34	1	VP	0	16	34	3	VP	0	16	29	3	VBN	0	16	17	1	labeled	16	16	17	0	NP	0	17	22	2	NP	1	17	19	2	DT	0	17	18	1	the	17	17	18	0	NN	0	18	19	1	surface	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	of	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	HCC827	20	20	21	0	NNS	0	21	22	1	cells	21	21	22	0	PP	0	22	29	2	IN	0	22	23	1	in	22	22	23	0	NP	0	23	29	2	NP	1	23	27	4	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	presence	24	24	25	0	CC	0	25	26	1	or	25	25	26	0	NN	0	26	27	1	absence	26	26	27	0	PP	0	27	29	2	IN	0	27	28	1	of	27	27	28	0	NP	0	28	29	1	NN	0	28	29	1	AZD6244	28	28	29	0	CC	0	29	30	1	and	29	29	30	0	VP	0	30	34	2	VBD	0	30	31	1	immunoprecipitated	30	30	31	0	NP	2	31	34	3	DT	0	31	32	1	the	31	31	32	0	JJ	0	32	33	1	labeled	32	32	33	0	NNS	0	33	34	1	proteins	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	21
After	14239	14244	IN	after	O	_	_
just	14245	14249	RB	just	O	_	_
one	14250	14253	CD	one	O	_	_
hour	14254	14258	NN	hour	O	_	_
of	14259	14261	IN	of	O	_	_
MEK	14262	14265	NN	mek	B-GENE	_	_
inhibition	14266	14276	NN	inhibition	O	_	_
during	14277	14283	IN	during	O	_	_
biotin	14284	14290	NN	biotin	O	_	_
labeling	14291	14299	NN	labeling	O	_	_
,	14299	14300	,	,	O	_	_
surface	14301	14308	NN	surface	O	_	_
levels	14309	14315	NNS	level	O	_	_
of	14316	14318	IN	of	O	_	_
the	14319	14322	DT	the	O	_	_
activated	14323	14332	VBN	activate	O	_	_
receptor	14333	14341	NN	receptor	O	_	_
were	14342	14346	VBD	be	O	_	_
substantially	14347	14360	RB	substantially	O	_	_
elevated	14361	14369	JJ	elevated	O	_	_
.	14381	14382	.	.	O	_	_
D	1
19
3	1	advmod
3	2	num
3	6	prep_of
6	5	nn
6	9	prep_during
9	8	nn
12	11	nn
12	16	prep_of
16	14	det
16	15	amod
19	3	prep_after
19	12	nsubj
19	17	cop
19	18	advmod
EOX
Y	1
ROOT	0	0	21	1	S	3	0	21	5	PP	0	0	10	2	IN	0	0	1	1	After	0	0	1	0	NP	0	1	10	2	NP	2	1	4	3	RB	0	1	2	1	just	1	1	2	0	CD	0	2	3	1	one	2	2	3	0	NN	0	3	4	1	hour	3	3	4	0	PP	0	4	10	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	NN	0	5	6	1	MEK	5	5	6	0	NN	0	6	7	1	inhibition	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	during	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	biotin	8	8	9	0	NN	0	9	10	1	labeling	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	0	11	17	2	NP	1	11	13	2	NN	0	11	12	1	surface	11	11	12	0	NNS	0	12	13	1	levels	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	of	13	13	14	0	NP	2	14	17	3	DT	0	14	15	1	the	14	14	15	0	VBN	0	15	16	1	activated	15	15	16	0	NN	0	16	17	1	receptor	16	16	17	0	VP	1	17	20	2	VBD	0	17	18	1	were	17	17	18	0	ADJP	1	18	20	2	RB	0	18	19	1	substantially	18	18	19	0	JJ	0	19	20	1	elevated	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	12
Total	14383	14388	JJ	total	O	_	_
ERBB3	14389	14394	NN	erbb3	B-GENE	_	_
on	14395	14397	IN	on	O	_	_
the	14398	14401	DT	the	O	_	_
cell	14402	14406	NN	cell	O	_	_
surface	14407	14414	NN	surface	O	_	_
also	14415	14419	RB	also	O	_	_
increased	14420	14429	VBD	increase	O	_	_
following	14430	14439	VBG	follow	O	_	_
AZD6244	14440	14447	NN	azd6244	O	_	_
treatment	14448	14457	NN	treatment	O	_	_
.	14457	14458	.	.	O	_	_
D	1
7
1	0	amod
1	5	prep_on
5	3	det
5	4	nn
7	1	nsubj
7	6	advmod
7	10	prep_following
10	9	nn
EOX
Y	1
ROOT	0	0	12	1	S	2	0	12	4	NP	0	0	6	2	NP	1	0	2	2	JJ	0	0	1	1	Total	0	0	1	0	NN	0	1	2	1	ERBB3	1	1	2	0	PP	0	2	6	2	IN	0	2	3	1	on	2	2	3	0	NP	2	3	6	3	DT	0	3	4	1	the	3	3	4	0	NN	0	4	5	1	cell	4	4	5	0	NN	0	5	6	1	surface	5	5	6	0	ADVP	0	6	7	1	RB	0	6	7	1	also	6	6	7	0	VP	0	7	11	2	VBD	0	7	8	1	increased	7	7	8	0	PP	0	8	11	2	VBG	0	8	9	1	following	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	AZD6244	9	9	10	0	NN	0	10	11	1	treatment	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	30
MEK	14459	14462	NN	mek	B-GENE	_	_
inhibition	14463	14473	NN	inhibition	O	_	_
did	14474	14477	VBD	do	O	_	_
not	14478	14481	RB	not	O	_	_
seem	14482	14486	VB	seem	O	_	_
to	14487	14489	TO	to	O	_	_
significantly	14490	14503	RB	significantly	O	_	_
affect	14504	14510	VB	affect	O	_	_
the	14511	14514	DT	the	O	_	_
kinetics	14515	14523	NNS	kinetics	O	_	_
of	14524	14526	IN	of	O	_	_
loss	14527	14531	NN	loss	O	_	_
of	14532	14534	IN	of	O	_	_
ERBB3	14535	14540	NN	erbb3	O	_	_
on	14541	14543	IN	on	O	_	_
the	14544	14547	DT	the	O	_	_
cell	14548	14552	NN	cell	O	_	_
surface	14553	14560	NN	surface	O	_	_
,	14572	14573	,	,	O	_	_
suggesting	14574	14584	VBG	suggest	O	_	_
that	14585	14589	IN	that	O	_	_
receptor	14590	14598	NN	receptor	O	_	_
internalization	14599	14614	NN	internalization	O	_	_
or	14615	14617	CC	or	O	_	_
cycling	14618	14625	NN	cycling	O	_	_
was	14626	14629	VBD	be	O	_	_
not	14630	14633	RB	not	O	_	_
significantly	14634	14647	RB	significantly	O	_	_
affected	14648	14656	VBN	affect	O	_	_
.	14656	14657	.	.	O	_	_
D	1
4
1	0	nn
4	1	nsubj
4	2	aux
4	3	neg
4	7	xcomp
7	5	aux
7	6	advmod
7	9	dobj
7	17	prep_on
7	19	vmod
9	8	det
9	11	prep_of
11	13	prep_of
17	15	det
17	16	nn
19	28	ccomp
22	21	nn
22	24	conj_or
28	20	mark
28	22	nsubjpass
28	24	nsubjpass
28	25	auxpass
28	26	neg
28	27	advmod
EOX
Y	1
ROOT	0	0	30	1	S	1	0	30	3	NP	1	0	2	2	NN	0	0	1	1	MEK	0	0	1	0	NN	0	1	2	1	inhibition	1	1	2	0	VP	2	2	29	3	VBD	0	2	3	1	did	2	2	3	0	RB	0	3	4	1	not	3	3	4	0	VP	0	4	29	2	VB	0	4	5	1	seem	4	4	5	0	S	0	5	29	1	VP	2	5	29	3	TO	0	5	6	1	to	5	5	6	0	ADVP	0	6	7	1	RB	0	6	7	1	significantly	6	6	7	0	VP	0	7	29	5	VB	0	7	8	1	affect	7	7	8	0	NP	0	8	14	2	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NNS	0	9	10	1	kinetics	9	9	10	0	PP	0	10	14	2	IN	0	10	11	1	of	10	10	11	0	NP	0	11	14	2	NP	0	11	12	1	NN	0	11	12	1	loss	11	11	12	0	PP	0	12	14	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	ERBB3	13	13	14	0	PP	0	14	18	2	IN	0	14	15	1	on	14	14	15	0	NP	2	15	18	3	DT	0	15	16	1	the	15	15	16	0	NN	0	16	17	1	cell	16	16	17	0	NN	0	17	18	1	surface	17	17	18	0	,	0	18	19	1	,	18	18	19	0	S	0	19	29	1	VP	0	19	29	2	VBG	0	19	20	1	suggesting	19	19	20	0	SBAR	1	20	29	2	IN	0	20	21	1	that	20	20	21	0	S	1	21	29	2	NP	0	21	25	3	NP	1	21	23	2	NN	0	21	22	1	receptor	21	21	22	0	NN	0	22	23	1	internalization	22	22	23	0	CC	0	23	24	1	or	23	23	24	0	NP	0	24	25	1	NN	0	24	25	1	cycling	24	24	25	0	VP	2	25	29	3	VBD	0	25	26	1	was	25	25	26	0	RB	0	26	27	1	not	26	26	27	0	ADJP	1	27	29	2	RB	0	27	28	1	significantly	27	27	28	0	VBN	0	28	29	1	affected	28	28	29	0	.	0	29	30	1	.	29	29	30	0
EOS
T	15
These	14658	14663	DT	these	O	_	_
data	14664	14668	NNS	datum	O	_	_
demonstrate	14669	14680	VBP	demonstrate	O	_	_
that	14681	14685	IN	that	O	_	_
feedback	14686	14694	NN	feedback	O	_	_
activation	14695	14705	NN	activation	O	_	_
of	14706	14708	IN	of	O	_	_
ERBB3	14709	14714	NN	erbb3	B-GENE	_	_
occurs	14715	14721	VBZ	occur	O	_	_
rapidly	14722	14729	RB	rapidly	O	_	_
on	14730	14732	IN	on	O	_	_
the	14733	14736	DT	the	O	_	_
plasma	14737	14743	NN	plasma	O	_	_
membrane	14744	14752	NN	membrane	O	_	_
.	14752	14753	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	8	ccomp
5	4	nn
5	7	prep_of
8	3	mark
8	5	nsubj
8	9	advmod
8	13	prep_on
13	11	det
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	data	1	1	2	0	VP	0	2	14	2	VBP	0	2	3	1	demonstrate	2	2	3	0	SBAR	1	3	14	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	14	2	NP	0	4	8	2	NP	1	4	6	2	NN	0	4	5	1	feedback	4	4	5	0	NN	0	5	6	1	activation	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	ERBB3	7	7	8	0	VP	0	8	14	3	VBZ	0	8	9	1	occurs	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	rapidly	9	9	10	0	PP	0	10	14	2	IN	0	10	11	1	on	10	10	11	0	NP	2	11	14	3	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	plasma	12	12	13	0	NN	0	13	14	1	membrane	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	58
Feedback	14763	14771	NN	feedback	O	_	_
activation	14772	14782	NN	activation	O	_	_
and	14783	14786	CC	and	O	_	_
increased	14787	14796	VBD	increase	O	_	_
surface	14797	14804	NN	surface	O	_	_
localization	14805	14817	NN	localization	O	_	_
of	14818	14820	IN	of	O	_	_
ERBB3	14821	14826	NN	erbb3	B-GENE	_	_
occurs	14827	14833	VBZ	occur	O	_	_
within	14834	14840	IN	within	O	_	_
one	14841	14844	CD	one	O	_	_
hour	14845	14849	NN	hour	O	_	_
of	14850	14852	IN	of	O	_	_
treatment	14853	14862	NN	treatment	O	_	_
with	14863	14867	IN	with	O	_	_
AZD6244	14868	14875	NN	azd6244	O	_	_
Knockdown	14876	14885	NN	knockdown	O	_	_
of	14886	14888	IN	of	O	_	_
ERBB3	14889	14894	NN	erbb3	O	_	_
abrogates	14895	14904	VBZ	abrogate	O	_	_
MEK	14905	14908	NN	mek	B-GENE	_	_
/	14908	14909	:	/	B-GENE	_	_
ERK	14909	14912	NN	erk	I-GENE	_	_
feedback	14913	14921	NN	feedback	O	_	_
on	14922	14924	IN	on	O	_	_
AKT	14925	14928	NNP	AKT	O	_	_
and	14929	14932	CC	and	O	_	_
downstream	14933	14943	JJ	downstream	O	_	_
substrates	14944	14954	NNS	substrate	O	_	_
To	14955	14957	TO	to	O	_	_
determine	14958	14967	VB	determine	O	_	_
if	14968	14970	IN	if	O	_	_
increased	14971	14980	VBN	increase	O	_	_
ERBB3	14981	14986	NN	erbb3	B-GENE	_	_
phosphorylation	14987	15002	NN	phosphorylation	O	_	_
caused	15003	15009	VBD	cause	O	_	_
the	15010	15013	DT	the	O	_	_
increase	15014	15022	NN	increase	O	_	_
in	15023	15025	IN	in	O	_	_
AKT	15026	15029	NN	akt	O	_	_
phosphorylation	15030	15045	NN	phosphorylation	O	_	_
following	15046	15055	VBG	follow	O	_	_
MEK	15056	15059	NN	mek	B-GENE	_	_
inhibition	15060	15070	NN	inhibition	O	_	_
,	15070	15071	,	,	O	_	_
we	15072	15074	PRP	we	O	_	_
suppressed	15075	15085	VBD	suppress	O	_	_
expression	15086	15096	NN	expression	O	_	_
of	15097	15099	IN	of	O	_	_
ERBB3	15100	15105	NN	erbb3	O	_	_
using	15106	15111	VBG	use	O	_	_
a	15112	15113	DT	a	O	_	_
Tet	15114	15117	NNP	Tet	O	_	_
inducible	15118	15127	JJ	inducible	O	_	_
shERBB3	15128	15135	NN	sherbb3	B-GENE	_	_
hairpin	15136	15143	NN	hairpin	I-GENE	_	_
construct	15144	15153	NN	construct	I-GENE	_	_
.	15153	15154	.	.	O	_	_
D	1
46
1	3	conj_and
3	8	ccomp
5	4	nn
5	7	prep_of
8	5	nsubj
8	11	prep_within
8	15	prep_with
11	10	num
11	13	prep_of
16	0	nn
16	1	nn
16	3	nn
16	18	prep_of
19	16	nsubj
19	30	xcomp
20	23	dep
23	21	punct
23	22	nn
23	25	prep_on
23	28	prep_on
25	28	conj_and
28	27	amod
30	20	nsubj
30	29	aux
30	35	advcl
34	32	amod
34	33	nn
35	31	mark
35	34	nsubj
35	37	dobj
35	40	prep_in
37	36	det
40	39	nn
40	43	prep_following
43	42	nn
46	19	ccomp
46	45	nsubj
46	47	dobj
47	49	prep_of
49	50	vmod
50	56	dobj
56	51	det
56	52	nn
56	53	amod
56	54	nn
56	55	nn
EOX
Y	1
ROOT	0	0	58	1	S	3	0	58	5	S	1	0	44	2	NP	0	0	19	2	NP	2	0	17	3	NN	0	0	1	1	Feedback	0	0	1	0	NP	0	1	16	3	NP	0	1	2	1	NN	0	1	2	1	activation	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	S	0	3	16	1	VP	0	3	16	2	VBD	0	3	4	1	increased	3	3	4	0	SBAR	0	4	16	1	S	1	4	16	2	NP	0	4	8	2	NP	1	4	6	2	NN	0	4	5	1	surface	4	4	5	0	NN	0	5	6	1	localization	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	ERBB3	7	7	8	0	VP	0	8	16	3	VBZ	0	8	9	1	occurs	8	8	9	0	PP	0	9	14	2	IN	0	9	10	1	within	9	9	10	0	NP	0	10	14	2	NP	1	10	12	2	CD	0	10	11	1	one	10	10	11	0	NN	0	11	12	1	hour	11	11	12	0	PP	0	12	14	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	treatment	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	with	14	14	15	0	NP	0	15	16	1	NN	0	15	16	1	AZD6244	15	15	16	0	NN	0	16	17	1	Knockdown	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	ERBB3	18	18	19	0	VP	0	19	44	2	VBZ	0	19	20	1	abrogates	19	19	20	0	S	1	20	44	2	NP	0	20	29	2	NP	0	20	21	1	NN	0	20	21	1	MEK	20	20	21	0	PRN	1	21	29	2	:	0	21	22	1	/	21	21	22	0	NP	0	22	29	2	NP	1	22	24	2	NN	0	22	23	1	ERK	22	22	23	0	NN	0	23	24	1	feedback	23	23	24	0	PP	0	24	29	2	IN	0	24	25	1	on	24	24	25	0	NP	0	25	29	3	NP	0	25	26	1	NNP	0	25	26	1	AKT	25	25	26	0	CC	0	26	27	1	and	26	26	27	0	NP	1	27	29	2	JJ	0	27	28	1	downstream	27	27	28	0	NNS	0	28	29	1	substrates	28	28	29	0	VP	1	29	44	2	TO	0	29	30	1	To	29	29	30	0	VP	0	30	44	2	VB	0	30	31	1	determine	30	30	31	0	SBAR	1	31	44	2	IN	0	31	32	1	if	31	31	32	0	S	1	32	44	2	NP	2	32	35	3	VBN	0	32	33	1	increased	32	32	33	0	NN	0	33	34	1	ERBB3	33	33	34	0	NN	0	34	35	1	phosphorylation	34	34	35	0	VP	0	35	44	3	VBD	0	35	36	1	caused	35	35	36	0	NP	1	36	38	2	DT	0	36	37	1	the	36	36	37	0	NN	0	37	38	1	increase	37	37	38	0	PP	0	38	44	2	IN	0	38	39	1	in	38	38	39	0	NP	0	39	44	2	NP	1	39	41	2	NN	0	39	40	1	AKT	39	39	40	0	NN	0	40	41	1	phosphorylation	40	40	41	0	PP	0	41	44	2	VBG	0	41	42	1	following	41	41	42	0	NP	1	42	44	2	NN	0	42	43	1	MEK	42	42	43	0	NN	0	43	44	1	inhibition	43	43	44	0	,	0	44	45	1	,	44	44	45	0	NP	0	45	46	1	PRP	0	45	46	1	we	45	45	46	0	VP	0	46	57	2	VBD	0	46	47	1	suppressed	46	46	47	0	NP	0	47	57	2	NP	0	47	48	1	NN	0	47	48	1	expression	47	47	48	0	PP	0	48	57	2	IN	0	48	49	1	of	48	48	49	0	NP	0	49	57	2	NP	0	49	50	1	NN	0	49	50	1	ERBB3	49	49	50	0	VP	0	50	57	2	VBG	0	50	51	1	using	50	50	51	0	NP	5	51	57	6	DT	0	51	52	1	a	51	51	52	0	NNP	0	52	53	1	Tet	52	52	53	0	JJ	0	53	54	1	inducible	53	53	54	0	NN	0	54	55	1	shERBB3	54	54	55	0	NN	0	55	56	1	hairpin	55	55	56	0	NN	0	56	57	1	construct	56	56	57	0	.	0	57	58	1	.	57	57	58	0
EOS
T	25
Following	15155	15164	VBG	follow	O	_	_
treatment	15165	15174	NN	treatment	O	_	_
with	15175	15179	IN	with	O	_	_
doxycycline	15180	15191	NN	doxycycline	O	_	_
there	15192	15197	EX	there	O	_	_
was	15198	15201	VBD	be	O	_	_
effective	15202	15211	JJ	effective	O	_	_
knockdown	15212	15221	NN	knockdown	O	_	_
of	15222	15224	IN	of	O	_	_
ERBB3	15225	15230	NN	erbb3	B-GENE	_	_
,	15230	15231	,	,	O	_	_
and	15232	15235	CC	and	O	_	_
this	15236	15240	DT	this	O	_	_
abrogated	15241	15250	VBD	abrogate	O	_	_
the	15251	15254	DT	the	O	_	_
increase	15255	15263	NN	increase	O	_	_
in	15264	15266	IN	in	O	_	_
AKT	15267	15270	NN	akt	O	_	_
signaling	15271	15280	NN	signaling	O	_	_
normally	15281	15289	RB	normally	O	_	_
observed	15290	15298	VBN	observe	O	_	_
following	15299	15308	VBG	follow	O	_	_
MEK	15309	15312	NN	mek	O	_	_
inhibition	15313	15323	NN	inhibition	O	_	_
.	15335	15336	.	.	O	_	_
D	1
5
1	3	prep_with
5	1	prep_following
5	4	expl
5	7	nsubj
5	13	conj_and
7	6	amod
7	9	prep_of
13	12	nsubj
13	15	dobj
15	14	det
15	18	prep_in
18	17	nn
18	20	vmod
20	19	advmod
20	23	prep_following
23	22	nn
EOX
Y	1
ROOT	0	0	25	1	S	0	0	25	5	S	2	0	10	3	PP	0	0	4	2	VBG	0	0	1	1	Following	0	0	1	0	NP	0	1	4	2	NP	0	1	2	1	NN	0	1	2	1	treatment	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	with	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	doxycycline	3	3	4	0	NP	0	4	5	1	EX	0	4	5	1	there	4	4	5	0	VP	1	5	10	2	VBD	0	5	6	1	was	5	5	6	0	NP	0	6	10	2	NP	1	6	8	2	JJ	0	6	7	1	effective	6	6	7	0	NN	0	7	8	1	knockdown	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	ERBB3	9	9	10	0	,	0	10	11	1	,	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	S	1	12	24	2	NP	0	12	13	1	DT	0	12	13	1	this	12	12	13	0	VP	0	13	24	2	VBD	0	13	14	1	abrogated	13	13	14	0	NP	0	14	24	2	NP	1	14	16	2	DT	0	14	15	1	the	14	14	15	0	NN	0	15	16	1	increase	15	15	16	0	PP	0	16	24	2	IN	0	16	17	1	in	16	16	17	0	NP	0	17	24	2	NP	1	17	19	2	NN	0	17	18	1	AKT	17	17	18	0	NN	0	18	19	1	signaling	18	18	19	0	VP	1	19	24	3	ADVP	0	19	20	1	RB	0	19	20	1	normally	19	19	20	0	VBN	0	20	21	1	observed	20	20	21	0	PP	0	21	24	2	VBG	0	21	22	1	following	21	21	22	0	NP	1	22	24	2	NN	0	22	23	1	MEK	22	22	23	0	NN	0	23	24	1	inhibition	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	22
In	15337	15339	IN	in	O	_	_
HER2	15340	15344	NN	her2	O	_	_
amplified	15345	15354	VBD	amplify	O	_	_
BT-474	15355	15361	NN	bt-474	O	_	_
cells	15362	15367	NNS	cell	O	_	_
with	15368	15372	IN	with	O	_	_
abrogated	15373	15382	VBN	abrogate	O	_	_
ERBB3	15383	15388	NN	erbb3	B-GENE	_	_
expression	15389	15399	NN	expression	O	_	_
,	15399	15400	,	,	O	_	_
the	15401	15404	DT	the	O	_	_
increase	15405	15413	NN	increase	O	_	_
in	15414	15416	IN	in	O	_	_
AKT	15417	15420	NN	akt	O	_	_
signaling	15421	15430	NN	signaling	O	_	_
following	15431	15440	VBG	follow	O	_	_
MEK	15441	15444	NN	mek	B-GENE	_	_
inhibition	15445	15455	NN	inhibition	O	_	_
was	15456	15459	VBD	be	O	_	_
also	15460	15464	RB	also	O	_	_
attenuated	15465	15475	VBN	attenuate	O	_	_
.	15488	15489	.	.	O	_	_
D	1
20
4	1	nn
4	2	amod
4	3	nn
4	6	prepc_with
6	8	dobj
8	7	nn
11	10	det
11	14	prep_in
14	13	nn
14	17	prep_following
17	16	nn
20	4	prep_in
20	11	nsubjpass
20	18	auxpass
20	19	advmod
EOX
Y	1
ROOT	0	0	22	1	S	3	0	22	5	PP	0	0	9	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	9	2	NP	3	1	5	4	NN	0	1	2	1	HER2	1	1	2	0	VBD	0	2	3	1	amplified	2	2	3	0	NN	0	3	4	1	BT-474	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	with	5	5	6	0	S	0	6	9	1	VP	0	6	9	2	VBN	0	6	7	1	abrogated	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	ERBB3	7	7	8	0	NN	0	8	9	1	expression	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	18	2	NP	1	10	12	2	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	increase	11	11	12	0	PP	0	12	18	2	IN	0	12	13	1	in	12	12	13	0	NP	0	13	18	2	NP	1	13	15	2	NN	0	13	14	1	AKT	13	13	14	0	NN	0	14	15	1	signaling	14	14	15	0	PP	0	15	18	2	VBG	0	15	16	1	following	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	MEK	16	16	17	0	NN	0	17	18	1	inhibition	17	17	18	0	VP	1	18	21	2	VBD	0	18	19	1	was	18	18	19	0	VP	1	19	21	2	ADVP	0	19	20	1	RB	0	19	20	1	also	19	19	20	0	VBN	0	20	21	1	attenuated	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	36
In	15490	15492	IN	in	O	_	_
contrast	15493	15501	NN	contrast	O	_	_
to	15502	15504	TO	to	O	_	_
HCC827	15505	15511	NN	hcc827	O	_	_
cells	15512	15517	NNS	cell	O	_	_
,	15517	15518	,	,	O	_	_
we	15519	15521	PRP	we	O	_	_
observed	15522	15530	VBD	observe	O	_	_
significant	15531	15542	JJ	significant	O	_	_
down-regulation	15543	15558	NN	down-regulation	O	_	_
of	15559	15561	IN	of	O	_	_
basal	15562	15567	JJ	basal	O	_	_
AKT	15568	15571	NN	akt	O	_	_
phosphorylation	15572	15587	NN	phosphorylation	O	_	_
in	15588	15590	IN	in	O	_	_
BT-474	15591	15597	NN	bt-474	O	_	_
cells	15598	15603	NNS	cell	O	_	_
following	15604	15613	VBG	follow	O	_	_
ERBB3	15614	15619	NN	erbb3	O	_	_
knockdown	15620	15629	NN	knockdown	O	_	_
,	15641	15642	,	,	O	_	_
indicating	15643	15653	VBG	indicate	O	_	_
the	15654	15657	DT	the	O	_	_
sole	15658	15662	JJ	sole	O	_	_
reliance	15663	15671	NN	reliance	O	_	_
on	15672	15674	IN	on	O	_	_
ERBB3	15675	15680	NN	erbb3	O	_	_
for	15681	15684	IN	for	O	_	_
PI3K	15685	15689	NN	pi3k	B-GENE	_	_
activation	15690	15700	NN	activation	O	_	_
in	15701	15703	IN	in	O	_	_
this	15704	15708	DT	this	O	_	_
HER2	15709	15713	NN	her2	O	_	_
amplified	15714	15723	VBD	amplify	O	_	_
cancer	15724	15730	NN	cancer	O	_	_
.	15730	15731	.	.	O	_	_
D	1
7
1	4	prep_to
4	3	nn
7	1	prep_in
7	6	nsubj
7	9	dobj
7	21	vmod
9	8	amod
9	13	prep_of
13	11	amod
13	12	nn
13	16	prep_in
16	15	nn
16	19	prep_following
19	18	nn
21	24	dobj
21	26	prep_on
21	33	advcl
24	22	det
24	23	amod
29	28	nn
29	32	prep_in
32	31	det
33	27	mark
33	29	nsubj
33	34	dobj
EOX
Y	1
ROOT	0	0	36	1	S	3	0	36	5	PP	0	0	5	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	5	2	NP	0	1	2	1	NN	0	1	2	1	contrast	1	1	2	0	PP	0	2	5	2	TO	0	2	3	1	to	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	HCC827	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	7	1	PRP	0	6	7	1	we	6	6	7	0	VP	0	7	35	4	VBD	0	7	8	1	observed	7	7	8	0	NP	0	8	20	2	NP	1	8	10	2	JJ	0	8	9	1	significant	8	8	9	0	NN	0	9	10	1	down-regulation	9	9	10	0	PP	0	10	20	2	IN	0	10	11	1	of	10	10	11	0	NP	0	11	20	2	NP	2	11	14	3	JJ	0	11	12	1	basal	11	11	12	0	NN	0	12	13	1	AKT	12	12	13	0	NN	0	13	14	1	phosphorylation	13	13	14	0	PP	0	14	20	2	IN	0	14	15	1	in	14	14	15	0	NP	0	15	20	2	NP	1	15	17	2	NN	0	15	16	1	BT-474	15	15	16	0	NNS	0	16	17	1	cells	16	16	17	0	PP	0	17	20	2	VBG	0	17	18	1	following	17	17	18	0	NP	1	18	20	2	NN	0	18	19	1	ERBB3	18	18	19	0	NN	0	19	20	1	knockdown	19	19	20	0	,	0	20	21	1	,	20	20	21	0	S	0	21	35	1	VP	0	21	35	4	VBG	0	21	22	1	indicating	21	21	22	0	NP	2	22	25	3	DT	0	22	23	1	the	22	22	23	0	JJ	0	23	24	1	sole	23	23	24	0	NN	0	24	25	1	reliance	24	24	25	0	PP	0	25	27	2	IN	0	25	26	1	on	25	25	26	0	NP	0	26	27	1	NN	0	26	27	1	ERBB3	26	26	27	0	SBAR	1	27	35	2	IN	0	27	28	1	for	27	27	28	0	S	1	28	35	2	NP	0	28	33	2	NP	1	28	30	2	NN	0	28	29	1	PI3K	28	28	29	0	NN	0	29	30	1	activation	29	29	30	0	PP	0	30	33	2	IN	0	30	31	1	in	30	30	31	0	NP	1	31	33	2	DT	0	31	32	1	this	31	31	32	0	NN	0	32	33	1	HER2	32	32	33	0	VP	0	33	35	2	VBD	0	33	34	1	amplified	33	33	34	0	NP	0	34	35	1	NN	0	34	35	1	cancer	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	17
In	15732	15734	IN	in	O	_	_
contrast	15735	15743	NN	contrast	O	_	_
,	15743	15744	,	,	O	_	_
EGFR-mutant	15745	15756	JJ	egfr-mutant	B-GENE	_	_
cancers	15757	15764	NNS	cancer	O	_	_
also	15765	15769	RB	also	O	_	_
utilize	15770	15777	VBP	utilize	O	_	_
GAB1	15778	15782	NN	gab1	B-GENE	_	_
to	15783	15785	TO	to	O	_	_
activate	15786	15794	VB	activate	O	_	_
PI3K	15795	15799	NN	pi3k	B-GENE	_	_
(	15813	15814	NN	(	O	_	_
24	15814	15816	CD	24	O	_	_
,	15816	15817	,	,	O	_	_
33	15818	15820	CD	33	O	_	_
)	15820	15821	NN	)	O	_	_
.	15821	15822	.	.	O	_	_
D	1
6
4	3	amod
6	1	prep_in
6	4	nsubj
6	5	advmod
6	7	dobj
7	9	vmod
7	15	amod
9	8	aux
9	11	dobj
11	10	nn
11	12	num
15	14	number
EOX
Y	1
ROOT	0	0	17	1	S	4	0	17	6	PP	0	0	2	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	contrast	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	JJ	0	3	4	1	EGFR-mutant	3	3	4	0	NNS	0	4	5	1	cancers	4	4	5	0	ADVP	0	5	6	1	RB	0	5	6	1	also	5	5	6	0	VP	0	6	16	2	VBP	0	6	7	1	utilize	6	6	7	0	NP	0	7	16	3	NP	0	7	13	2	NN	0	7	8	1	GAB1	7	7	8	0	S	0	8	13	1	VP	1	8	13	2	TO	0	8	9	1	to	8	8	9	0	VP	0	9	13	2	VB	0	9	10	1	activate	9	9	10	0	NP	1	10	13	3	NN	0	10	11	1	PI3K	10	10	11	0	NN	0	11	12	1	(	11	11	12	0	CD	0	12	13	1	24	12	12	13	0	,	0	13	14	1	,	13	13	14	0	ADJP	1	14	16	2	CD	0	14	15	1	33	14	14	15	0	NN	0	15	16	1	)	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	57
Suppression	15832	15843	NN	suppression	O	_	_
of	15844	15846	IN	of	O	_	_
ERBB3	15847	15852	NN	erbb3	B-GENE	_	_
expression	15853	15863	NN	expression	O	_	_
abrogates	15864	15873	VBZ	abrogate	O	_	_
MEK	15874	15877	NN	mek	B-GENE	_	_
/	15877	15878	:	/	B-GENE	_	_
ERK	15878	15881	NN	erk	I-GENE	_	_
feedback	15882	15890	NN	feedback	O	_	_
on	15891	15893	IN	on	O	_	_
PI3K	15894	15898	NN	pi3k	B-GENE	_	_
/	15898	15899	:	/	B-GENE	_	_
AKT	15899	15902	NN	akt	I-GENE	_	_
signaling	15903	15912	NN	signaling	O	_	_
ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	15913	15985	NNP	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	O	_	_
MEK	15987	15990	NN	mek	B-GENE	_	_
inhibition	15991	16001	NN	inhibition	O	_	_
leads	16002	16007	VBZ	lead	O	_	_
to	16008	16010	TO	to	O	_	_
PI3K	16011	16015	NN	pi3k	B-GENE	_	_
/	16015	16016	:	/	B-GENE	_	_
AKT	16016	16019	NN	akt	I-GENE	_	_
activation	16020	16030	NN	activation	O	_	_
by	16031	16033	IN	by	O	_	_
relieving	16034	16043	VBG	relieve	O	_	_
a	16044	16045	DT	a	O	_	_
negative	16046	16054	JJ	negative	O	_	_
feedback	16055	16063	NN	feedback	O	_	_
on	16064	16066	IN	on	O	_	_
ERBB	16067	16071	NN	erbb	O	_	_
receptors	16072	16081	NNS	receptor	O	_	_
12	16082	16084	CD	12	O	_	_
/	16084	16085	:	/	O	_	_
8/14	16085	16089	CD	8/14	O	_	_
,	16089	16090	,	,	O	_	_
6:54	16091	16095	CD	6:54	O	_	_
PM	16096	16098	NN	pm	O	_	_
ÔøºWe	16099	16104	NN	ôøºwe	O	_	_
suspected	16105	16114	VBN	suspect	O	_	_
that	16115	16119	IN	that	O	_	_
knockdown	16120	16129	NN	knockdown	O	_	_
of	16130	16132	IN	of	O	_	_
ERBB3	16133	16138	NN	erbb3	B-GENE	_	_
may	16139	16142	MD	may	O	_	_
increase	16143	16151	VB	increase	O	_	_
the	16152	16155	DT	the	O	_	_
efficacy	16156	16164	NN	efficacy	O	_	_
of	16165	16167	IN	of	O	_	_
MEK	16168	16171	NN	mek	B-GENE	_	_
inhibition	16172	16182	NN	inhibition	O	_	_
by	16183	16185	IN	by	O	_	_
suppressing	16186	16197	VBG	suppress	O	_	_
PI3K	16198	16202	NN	pi3k	B-GENE	_	_
/	16202	16203	:	/	B-GENE	_	_
AKT	16203	16206	NN	akt	I-GENE	_	_
signaling	16207	16216	NN	signaling	O	_	_
.	16216	16217	.	.	O	_	_
D	1
4
0	3	prep_of
3	2	nn
4	0	nsubj
4	14	dobj
5	8	dep
8	6	punct
8	7	nn
8	10	prep_on
8	11	punct
14	5	nn
14	12	nn
14	13	nn
14	17	rcmod
14	22	dep
14	55	dep
16	15	nn
17	16	nsubj
17	19	prep_to
22	20	punct
22	21	nn
22	24	prepc_by
22	53	punct
24	27	dobj
24	30	prep_on
27	25	det
27	26	amod
30	29	nn
30	38	rcmod
31	33	dep
33	32	punct
33	37	appos
37	35	num
37	36	nn
38	31	nsubj
38	44	ccomp
40	42	prep_of
44	39	mark
44	40	nsubj
44	43	aux
44	46	dobj
44	51	prepc_by
46	45	det
46	49	prep_of
49	48	nn
51	52	dobj
55	54	nn
EOX
Y	1
ROOT	0	0	57	1	S	1	0	57	3	NP	0	0	4	2	NP	0	0	1	1	NN	0	0	1	1	Suppression	0	0	1	0	PP	0	1	4	2	IN	0	1	2	1	of	1	1	2	0	NP	1	2	4	2	NN	0	2	3	1	ERBB3	2	2	3	0	NN	0	3	4	1	expression	3	3	4	0	VP	0	4	56	2	VBZ	0	4	5	1	abrogates	4	4	5	0	NP	0	5	56	3	NP	0	5	20	2	NP	3	5	15	4	NP	0	5	12	2	NP	0	5	6	1	NN	0	5	6	1	MEK	5	5	6	0	PRN	1	6	12	3	:	0	6	7	1	/	6	6	7	0	NP	0	7	11	2	NP	1	7	9	2	NN	0	7	8	1	ERK	7	7	8	0	NN	0	8	9	1	feedback	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	on	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	PI3K	10	10	11	0	:	0	11	12	1	/	11	11	12	0	NN	0	12	13	1	AKT	12	12	13	0	NN	0	13	14	1	signaling	13	13	14	0	NNP	0	14	15	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	14	14	15	0	SBAR	0	15	20	1	S	1	15	20	2	NP	1	15	17	2	NN	0	15	16	1	MEK	15	15	16	0	NN	0	16	17	1	inhibition	16	16	17	0	VP	0	17	20	2	VBZ	0	17	18	1	leads	17	17	18	0	PP	0	18	20	2	TO	0	18	19	1	to	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	PI3K	19	19	20	0	PRN	1	20	54	3	:	0	20	21	1	/	20	20	21	0	NP	0	21	53	2	NP	1	21	23	2	NN	0	21	22	1	AKT	21	21	22	0	NN	0	22	23	1	activation	22	22	23	0	PP	0	23	53	2	IN	0	23	24	1	by	23	23	24	0	S	0	24	53	1	VP	0	24	53	3	VBG	0	24	25	1	relieving	24	24	25	0	NP	2	25	28	3	DT	0	25	26	1	a	25	25	26	0	JJ	0	26	27	1	negative	26	26	27	0	NN	0	27	28	1	feedback	27	27	28	0	PP	0	28	53	2	IN	0	28	29	1	on	28	28	29	0	NP	0	29	53	2	NP	1	29	31	2	NN	0	29	30	1	ERBB	29	29	30	0	NNS	0	30	31	1	receptors	30	30	31	0	SBAR	1	31	53	2	WHNP	0	31	38	2	NP	0	31	32	1	CD	0	31	32	1	12	31	31	32	0	PRN	1	32	38	2	:	0	32	33	1	/	32	32	33	0	NP	0	33	38	3	NP	0	33	34	1	CD	0	33	34	1	8/14	33	33	34	0	,	0	34	35	1	,	34	34	35	0	NP	2	35	38	3	CD	0	35	36	1	6:54	35	35	36	0	NN	0	36	37	1	PM	36	36	37	0	NN	0	37	38	1	ÔøºWe	37	37	38	0	S	0	38	53	1	VP	0	38	53	2	VBN	0	38	39	1	suspected	38	38	39	0	SBAR	1	39	53	2	IN	0	39	40	1	that	39	39	40	0	S	1	40	53	2	NP	0	40	43	2	NP	0	40	41	1	NN	0	40	41	1	knockdown	40	40	41	0	PP	0	41	43	2	IN	0	41	42	1	of	41	41	42	0	NP	0	42	43	1	NN	0	42	43	1	ERBB3	42	42	43	0	VP	1	43	53	2	MD	0	43	44	1	may	43	43	44	0	VP	0	44	53	3	VB	0	44	45	1	increase	44	44	45	0	NP	0	45	50	2	NP	1	45	47	2	DT	0	45	46	1	the	45	45	46	0	NN	0	46	47	1	efficacy	46	46	47	0	PP	0	47	50	2	IN	0	47	48	1	of	47	47	48	0	NP	1	48	50	2	NN	0	48	49	1	MEK	48	48	49	0	NN	0	49	50	1	inhibition	49	49	50	0	PP	0	50	53	2	IN	0	50	51	1	by	50	50	51	0	S	0	51	53	1	VP	0	51	53	2	VBG	0	51	52	1	suppressing	51	51	52	0	NP	0	52	53	1	NN	0	52	53	1	PI3K	52	52	53	0	:	0	53	54	1	/	53	53	54	0	NP	1	54	56	2	NN	0	54	55	1	AKT	54	54	55	0	NN	0	55	56	1	signaling	55	55	56	0	.	0	56	57	1	.	56	56	57	0
EOS
T	20
Treatment	16218	16227	NN	treatment	O	_	_
with	16228	16232	IN	with	O	_	_
ERBB3	16233	16238	NN	erbb3	B-GENE	_	_
siRNA	16239	16244	NN	sirna	I-GENE	_	_
induced	16245	16252	VBD	induce	O	_	_
similar	16253	16260	JJ	similar	O	_	_
levels	16261	16267	NNS	level	O	_	_
of	16268	16270	IN	of	O	_	_
cell	16271	16275	NN	cell	O	_	_
death	16276	16281	NN	death	O	_	_
compared	16282	16290	VBN	compare	O	_	_
to	16291	16293	TO	to	O	_	_
treatment	16294	16303	NN	treatment	O	_	_
with	16304	16308	IN	with	O	_	_
a	16309	16310	DT	a	O	_	_
PI3K	16311	16315	NN	pi3k	B-GENE	_	_
inhibitor	16316	16325	NN	inhibitor	O	_	_
,	16325	16326	,	,	O	_	_
GDC-0941	16327	16335	NN	gdc-0941	O	_	_
.	16347	16348	.	.	O	_	_
D	1
4
0	3	prep_with
3	2	nn
4	0	nsubj
4	6	dobj
4	11	prepc_compared_to
4	12	pobj
6	5	amod
6	9	prep_of
9	8	nn
12	16	prep_with
16	14	det
16	15	nn
16	18	appos
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	4	2	NP	0	0	1	1	NN	0	0	1	1	Treatment	0	0	1	0	PP	0	1	4	2	IN	0	1	2	1	with	1	1	2	0	NP	1	2	4	2	NN	0	2	3	1	ERBB3	2	2	3	0	NN	0	3	4	1	siRNA	3	3	4	0	VP	0	4	19	3	VBD	0	4	5	1	induced	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	JJ	0	5	6	1	similar	5	5	6	0	NNS	0	6	7	1	levels	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	of	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	cell	8	8	9	0	NN	0	9	10	1	death	9	9	10	0	PP	0	10	19	2	VBN	0	10	11	1	compared	10	10	11	0	PP	0	11	19	2	TO	0	11	12	1	to	11	11	12	0	NP	0	12	19	2	NP	0	12	13	1	NN	0	12	13	1	treatment	12	12	13	0	PP	0	13	19	2	IN	0	13	14	1	with	13	13	14	0	NP	0	14	19	3	NP	2	14	17	3	DT	0	14	15	1	a	14	14	15	0	NN	0	15	16	1	PI3K	15	15	16	0	NN	0	16	17	1	inhibitor	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	GDC-0941	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	26
Indeed	16349	16355	RB	indeed	O	_	_
,	16355	16356	,	,	O	_	_
combining	16357	16366	VBG	combine	O	_	_
ERBB3	16367	16372	NN	erbb3	B-GENE	_	_
siRNA	16373	16378	NN	sirna	I-GENE	_	_
with	16379	16383	IN	with	O	_	_
AZD6244	16384	16391	NN	azd6244	O	_	_
increased	16392	16401	VBD	increase	O	_	_
the	16402	16405	DT	the	O	_	_
cell	16406	16410	NN	cell	O	_	_
death	16411	16416	NN	death	O	_	_
response	16417	16425	NN	response	O	_	_
,	16425	16426	,	,	O	_	_
approaching	16427	16438	VBG	approach	O	_	_
the	16439	16442	DT	the	O	_	_
level	16443	16448	NN	level	O	_	_
of	16449	16451	IN	of	O	_	_
apoptosis	16452	16461	NN	apoptosis	O	_	_
achieved	16462	16470	VBN	achieve	O	_	_
with	16471	16475	IN	with	O	_	_
GDC-0941	16476	16484	NN	gdc-0941	O	_	_
in	16485	16487	IN	in	O	_	_
combination	16488	16499	NN	combination	O	_	_
with	16500	16504	IN	with	O	_	_
AZD6244	16505	16512	NN	azd6244	O	_	_
.	16524	16525	.	.	O	_	_
D	1
2
2	0	advmod
2	4	dobj
2	6	prep_with
2	7	dep
4	3	nn
7	11	dobj
7	13	vmod
11	8	det
11	9	nn
11	10	nn
13	15	dobj
15	14	det
15	17	prep_of
17	18	vmod
18	20	prep_with
18	24	prep_with
20	22	prep_in
EOX
Y	1
ROOT	0	0	26	1	S	2	0	26	5	ADVP	0	0	1	1	RB	0	0	1	1	Indeed	0	0	1	0	,	0	1	2	1	,	1	1	2	0	VP	0	2	7	3	VBG	0	2	3	1	combining	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	ERBB3	3	3	4	0	NN	0	4	5	1	siRNA	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	with	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	AZD6244	6	6	7	0	VP	0	7	25	4	VBD	0	7	8	1	increased	7	7	8	0	NP	3	8	12	4	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	cell	9	9	10	0	NN	0	10	11	1	death	10	10	11	0	NN	0	11	12	1	response	11	11	12	0	,	0	12	13	1	,	12	12	13	0	S	0	13	25	1	VP	0	13	25	2	VBG	0	13	14	1	approaching	13	13	14	0	NP	0	14	25	2	NP	1	14	16	2	DT	0	14	15	1	the	14	14	15	0	NN	0	15	16	1	level	15	15	16	0	PP	0	16	25	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	25	2	NP	0	17	18	1	NN	0	17	18	1	apoptosis	17	17	18	0	VP	0	18	25	3	VBN	0	18	19	1	achieved	18	18	19	0	PP	0	19	23	2	IN	0	19	20	1	with	19	19	20	0	NP	0	20	23	2	NP	0	20	21	1	NN	0	20	21	1	GDC-0941	20	20	21	0	PP	0	21	23	2	IN	0	21	22	1	in	21	21	22	0	NP	0	22	23	1	NN	0	22	23	1	combination	22	22	23	0	PP	0	23	25	2	IN	0	23	24	1	with	23	23	24	0	NP	0	24	25	1	NN	0	24	25	1	AZD6244	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	59
These	16526	16531	DT	these	O	_	_
data	16532	16536	NNS	datum	O	_	_
indicate	16537	16545	VBP	indicate	O	_	_
that	16546	16550	IN	that	O	_	_
ERBB3	16551	16556	NN	erbb3	B-GENE	_	_
plays	16557	16562	VBZ	play	O	_	_
a	16563	16564	DT	a	O	_	_
significant	16565	16576	JJ	significant	O	_	_
role	16577	16581	NN	role	O	_	_
in	16582	16584	IN	in	O	_	_
MEK	16585	16588	NN	mek	B-GENE	_	_
feedback	16589	16597	NN	feedback	I-GENE	_	_
on	16598	16600	IN	on	O	_	_
PI3K	16601	16605	NN	pi3k	B-GENE	_	_
/	16605	16606	:	/	B-GENE	_	_
AKT	16606	16609	NN	akt	I-GENE	_	_
signaling	16610	16619	NN	signaling	O	_	_
in	16620	16622	IN	in	O	_	_
EGFR	16623	16627	NN	egfr	B-GENE	_	_
and	16628	16631	CC	and	O	_	_
HER2	16632	16636	NN	her2	O	_	_
driven	16637	16643	VBN	drive	O	_	_
cell	16644	16648	NN	cell	O	_	_
lines	16649	16654	NNS	line	O	_	_
,	16654	16655	,	,	O	_	_
suggesting	16656	16666	VBG	suggest	O	_	_
that	16667	16671	IN	that	O	_	_
combination	16672	16683	NN	combination	O	_	_
therapies	16684	16693	NNS	therapy	O	_	_
targeting	16694	16703	VBG	target	O	_	_
MEK	16704	16707	NN	mek	B-GENE	_	_
and	16708	16711	CC	and	O	_	_
ERBB3	16712	16717	NN	erbb3	B-GENE	_	_
or	16718	16720	CC	or	O	_	_
MEK	16721	16724	NN	mek	B-GENE	_	_
and	16725	16728	CC	and	O	_	_
PI3K	16729	16733	NN	pi3k	B-GENE	_	_
may	16734	16737	MD	may	O	_	_
block	16738	16743	VB	block	O	_	_
feedback	16744	16752	NN	feedback	O	_	_
activation	16753	16763	NN	activation	O	_	_
of	16764	16766	IN	of	O	_	_
ERBB3	16767	16772	NN	erbb3	B-GENE	_	_
/	16772	16773	:	/	B-GENE	_	_
PI3K/AKT	16773	16781	NN	pi3k/akt	B-GENE	_	_
signaling	16782	16791	NN	signaling	O	_	_
and	16792	16795	CC	and	O	_	_
thus	16796	16800	RB	thus	O	_	_
be	16801	16803	VB	be	O	_	_
more	16804	16808	RBR	more	O	_	_
effective	16809	16818	JJ	effective	O	_	_
than	16819	16823	IN	than	O	_	_
treatment	16824	16833	NN	treatment	O	_	_
with	16834	16838	IN	with	O	_	_
a	16839	16840	DT	a	O	_	_
MEK	16841	16844	NN	mek	B-GENE	_	_
inhibitor	16845	16854	NN	inhibitor	O	_	_
alone	16855	16860	RB	alone	O	_	_
.	16860	16861	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	5	ccomp
2	50	ccomp
5	3	mark
5	4	nsubj
5	8	xcomp
5	47	advmod
5	50	conj_and
8	6	det
8	7	amod
8	11	prep_in
8	16	dep
8	45	dep
11	10	nn
11	13	prep_on
16	14	punct
16	15	nn
16	18	prep_in
16	20	prep_in
16	21	vmod
16	43	punct
18	20	conj_and
21	23	dobj
21	25	vmod
23	22	nn
25	38	ccomp
28	27	nn
28	29	vmod
29	30	dobj
29	32	dobj
29	34	dobj
30	32	conj_and
30	34	conj_or
30	36	conj_or
34	36	conj_and
38	26	mark
38	28	nsubj
38	37	aux
38	40	dobj
40	39	nn
40	42	prep_of
45	44	nn
50	4	nsubj
50	48	cop
50	49	advmod
50	52	prep_than
50	57	advmod
52	56	prep_with
56	54	det
56	55	nn
EOX
Y	1
ROOT	0	0	59	1	S	1	0	59	3	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	data	1	1	2	0	VP	0	2	58	2	VBP	0	2	3	1	indicate	2	2	3	0	SBAR	1	3	58	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	58	2	NP	0	4	5	1	NN	0	4	5	1	ERBB3	4	4	5	0	VP	0	5	58	4	VP	0	5	46	2	VBZ	0	5	6	1	plays	5	5	6	0	S	0	6	46	1	NP	0	6	46	3	NP	0	6	14	2	NP	2	6	9	3	DT	0	6	7	1	a	6	6	7	0	JJ	0	7	8	1	significant	7	7	8	0	NN	0	8	9	1	role	8	8	9	0	PP	0	9	14	2	IN	0	9	10	1	in	9	9	10	0	NP	0	10	14	2	NP	1	10	12	2	NN	0	10	11	1	MEK	10	10	11	0	NN	0	11	12	1	feedback	11	11	12	0	PP	0	12	14	2	IN	0	12	13	1	on	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	PI3K	13	13	14	0	PRN	1	14	44	3	:	0	14	15	1	/	14	14	15	0	NP	0	15	43	3	NP	1	15	17	2	NN	0	15	16	1	AKT	15	15	16	0	NN	0	16	17	1	signaling	16	16	17	0	PP	0	17	21	2	IN	0	17	18	1	in	17	17	18	0	NP	0	18	21	3	NN	0	18	19	1	EGFR	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	NN	0	20	21	1	HER2	20	20	21	0	VP	0	21	43	4	VBN	0	21	22	1	driven	21	21	22	0	NP	1	22	24	2	NN	0	22	23	1	cell	22	22	23	0	NNS	0	23	24	1	lines	23	23	24	0	,	0	24	25	1	,	24	24	25	0	S	0	25	43	1	VP	0	25	43	2	VBG	0	25	26	1	suggesting	25	25	26	0	SBAR	1	26	43	2	IN	0	26	27	1	that	26	26	27	0	S	1	27	43	2	NP	0	27	37	2	NP	1	27	29	2	NN	0	27	28	1	combination	27	27	28	0	NNS	0	28	29	1	therapies	28	28	29	0	VP	0	29	37	2	VBG	0	29	30	1	targeting	29	29	30	0	NP	0	30	37	3	NP	0	30	33	3	NN	0	30	31	1	MEK	30	30	31	0	CC	0	31	32	1	and	31	31	32	0	NN	0	32	33	1	ERBB3	32	32	33	0	CC	0	33	34	1	or	33	33	34	0	NP	0	34	37	3	NN	0	34	35	1	MEK	34	34	35	0	CC	0	35	36	1	and	35	35	36	0	NN	0	36	37	1	PI3K	36	36	37	0	VP	1	37	43	2	MD	0	37	38	1	may	37	37	38	0	VP	0	38	43	2	VB	0	38	39	1	block	38	38	39	0	NP	0	39	43	2	NP	1	39	41	2	NN	0	39	40	1	feedback	39	39	40	0	NN	0	40	41	1	activation	40	40	41	0	PP	0	41	43	2	IN	0	41	42	1	of	41	41	42	0	NP	0	42	43	1	NN	0	42	43	1	ERBB3	42	42	43	0	:	0	43	44	1	/	43	43	44	0	NP	1	44	46	2	NN	0	44	45	1	PI3K/AKT	44	44	45	0	NN	0	45	46	1	signaling	45	45	46	0	CC	0	46	47	1	and	46	46	47	0	ADVP	0	47	48	1	RB	0	47	48	1	thus	47	47	48	0	VP	1	48	58	3	VB	0	48	49	1	be	48	48	49	0	ADJP	1	49	57	3	RBR	0	49	50	1	more	49	49	50	0	JJ	0	50	51	1	effective	50	50	51	0	PP	0	51	57	2	IN	0	51	52	1	than	51	51	52	0	NP	0	52	57	2	NP	0	52	53	1	NN	0	52	53	1	treatment	52	52	53	0	PP	0	53	57	2	IN	0	53	54	1	with	53	53	54	0	NP	2	54	57	3	DT	0	54	55	1	a	54	54	55	0	NN	0	55	56	1	MEK	55	55	56	0	NN	0	56	57	1	inhibitor	56	56	57	0	ADVP	0	57	58	1	RB	0	57	58	1	alone	57	57	58	0	.	0	58	59	1	.	58	58	59	0
EOS
T	37
MEK	16862	16865	NN	mek	B-GENE	_	_
inhibition	16866	16876	NN	inhibition	O	_	_
results	16877	16884	VBZ	result	O	_	_
in	16885	16887	IN	in	O	_	_
feedback	16888	16896	NN	feedback	O	_	_
activation	16897	16907	NN	activation	O	_	_
of	16908	16910	IN	of	O	_	_
ERBB3	16911	16916	NN	erbb3	B-GENE	_	_
in	16917	16919	IN	in	O	_	_
KRAS-mutant	16920	16931	JJ	kras-mutant	O	_	_
cell	16932	16936	NN	cell	O	_	_
lines	16937	16942	NNS	line	O	_	_
with	16943	16947	IN	with	O	_	_
low	16948	16951	JJ	low	O	_	_
basal	16952	16957	JJ	basal	O	_	_
levels	16958	16964	NNS	level	O	_	_
of	16965	16967	IN	of	O	_	_
phospho-ERBB3	16968	16981	NN	phospho-erbb3	O	_	_
We	16982	16984	PRP	we	O	_	_
next	16985	16989	IN	next	O	_	_
determined	16990	17000	VBN	determine	O	_	_
whether	17001	17008	IN	whether	O	_	_
MEK	17009	17012	NN	mek	B-GENE	_	_
feedback	17013	17021	NN	feedback	I-GENE	_	_
on	17022	17024	IN	on	O	_	_
ERBB3	17025	17030	NN	erbb3	B-GENE	_	_
also	17031	17035	RB	also	O	_	_
occurs	17036	17042	VBZ	occur	O	_	_
in	17043	17045	IN	in	O	_	_
cancers	17046	17053	NNS	cancer	O	_	_
not	17054	17057	RB	not	O	_	_
addicted	17058	17066	VBN	addict	O	_	_
to	17067	17069	TO	to	O	_	_
EGFR	17070	17074	NN	egfr	O	_	_
or	17075	17077	CC	or	O	_	_
HER2	17078	17082	NN	her2	O	_	_
.	17082	17083	.	.	O	_	_
D	1
2
1	0	nn
2	1	nsubj
2	5	prep_in
2	15	prep_with
2	33	prep_to
2	35	prep_to
5	4	nn
5	7	prep_of
7	11	prep_in
11	9	amod
11	10	nn
15	13	amod
15	14	amod
15	17	prep_of
17	20	rcmod
20	18	nsubj
20	19	advmod
20	27	ccomp
23	22	nn
23	25	prep_on
27	21	mark
27	23	nsubj
27	26	advmod
27	29	prep_in
29	31	amod
31	30	neg
33	35	conj_or
EOX
Y	1
ROOT	0	0	37	1	S	1	0	37	3	NP	1	0	2	2	NN	0	0	1	1	MEK	0	0	1	0	NN	0	1	2	1	inhibition	1	1	2	0	VP	0	2	36	4	VBZ	0	2	3	1	results	2	2	3	0	PP	0	3	12	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	12	2	NP	1	4	6	2	NN	0	4	5	1	feedback	4	4	5	0	NN	0	5	6	1	activation	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	12	2	NP	0	7	8	1	NN	0	7	8	1	ERBB3	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	in	8	8	9	0	NP	2	9	12	3	JJ	0	9	10	1	KRAS-mutant	9	9	10	0	NN	0	10	11	1	cell	10	10	11	0	NNS	0	11	12	1	lines	11	11	12	0	PP	0	12	32	2	IN	0	12	13	1	with	12	12	13	0	NP	0	13	32	2	NP	2	13	16	3	JJ	0	13	14	1	low	13	13	14	0	JJ	0	14	15	1	basal	14	14	15	0	NNS	0	15	16	1	levels	15	15	16	0	PP	0	16	32	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	32	2	NP	0	17	18	1	NN	0	17	18	1	phospho-ERBB3	17	17	18	0	SBAR	0	18	32	1	S	1	18	32	2	NP	0	18	19	1	PRP	0	18	19	1	We	18	18	19	0	VP	1	19	32	3	ADVP	0	19	20	1	IN	0	19	20	1	next	19	19	20	0	VBN	0	20	21	1	determined	20	20	21	0	SBAR	1	21	32	2	IN	0	21	22	1	whether	21	21	22	0	S	2	22	32	3	NP	0	22	26	2	NP	1	22	24	2	NN	0	22	23	1	MEK	22	22	23	0	NN	0	23	24	1	feedback	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	on	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	ERBB3	25	25	26	0	ADVP	0	26	27	1	RB	0	26	27	1	also	26	26	27	0	VP	0	27	32	2	VBZ	0	27	28	1	occurs	27	27	28	0	PP	0	28	32	2	IN	0	28	29	1	in	28	28	29	0	NP	0	29	32	2	NP	0	29	30	1	NNS	0	29	30	1	cancers	29	29	30	0	ADJP	1	30	32	2	RB	0	30	31	1	not	30	30	31	0	VBN	0	31	32	1	addicted	31	31	32	0	PP	0	32	36	2	TO	0	32	33	1	to	32	32	33	0	NP	0	33	36	3	NN	0	33	34	1	EGFR	33	33	34	0	CC	0	34	35	1	or	34	34	35	0	NN	0	35	36	1	HER2	35	35	36	0	.	0	36	37	1	.	36	36	37	0
EOS
T	20
We	17084	17086	PRP	we	O	_	_
treated	17087	17094	VBD	treat	O	_	_
a	17095	17096	DT	a	O	_	_
panel	17097	17102	NN	panel	O	_	_
of	17103	17105	IN	of	O	_	_
KRAS-mutant	17106	17117	JJ	kras-mutant	O	_	_
cell	17118	17122	NN	cell	O	_	_
lines	17123	17128	NNS	line	O	_	_
,	17128	17129	,	,	O	_	_
which	17130	17135	WDT	which	O	_	_
have	17136	17140	VBP	have	O	_	_
low	17141	17144	JJ	low	O	_	_
basal	17145	17150	JJ	basal	O	_	_
levels	17151	17157	NNS	level	O	_	_
of	17158	17160	IN	of	O	_	_
phospho-ERBB3	17161	17174	NN	phospho-erbb3	O	_	_
,	17174	17175	,	,	O	_	_
with	17176	17180	IN	with	O	_	_
AZD6244	17181	17188	NN	azd6244	O	_	_
.	17188	17189	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	dobj
1	18	prep_with
3	2	det
3	7	prep_of
7	5	amod
7	6	nn
7	10	rcmod
10	9	nsubj
10	13	dobj
13	11	amod
13	12	amod
13	15	prep_of
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	19	3	VBD	0	1	2	1	treated	1	1	2	0	NP	0	2	17	2	NP	1	2	4	2	DT	0	2	3	1	a	2	2	3	0	NN	0	3	4	1	panel	3	3	4	0	PP	0	4	17	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	17	4	NP	2	5	8	3	JJ	0	5	6	1	KRAS-mutant	5	5	6	0	NN	0	6	7	1	cell	6	6	7	0	NNS	0	7	8	1	lines	7	7	8	0	,	0	8	9	1	,	8	8	9	0	SBAR	1	9	16	2	WHNP	0	9	10	1	WDT	0	9	10	1	which	9	9	10	0	S	0	10	16	1	VP	0	10	16	2	VBP	0	10	11	1	have	10	10	11	0	NP	0	11	16	2	NP	2	11	14	3	JJ	0	11	12	1	low	11	11	12	0	JJ	0	12	13	1	basal	12	12	13	0	NNS	0	13	14	1	levels	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	of	14	14	15	0	NP	0	15	16	1	NN	0	15	16	1	phospho-ERBB3	15	15	16	0	,	0	16	17	1	,	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	with	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	AZD6244	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	32
Surprisingly	17190	17202	RB	surprisingly	O	_	_
,	17202	17203	,	,	O	_	_
MEK	17204	17207	NN	mek	B-GENE	_	_
inhibition	17208	17218	NN	inhibition	O	_	_
led	17219	17222	VBD	lead	O	_	_
to	17223	17225	TO	to	O	_	_
significant	17226	17237	JJ	significant	O	_	_
activation	17238	17248	NN	activation	O	_	_
of	17249	17251	IN	of	O	_	_
ERBB3	17252	17257	NN	erbb3	B-GENE	_	_
,	17257	17258	,	,	O	_	_
but	17259	17262	CC	but	O	_	_
in	17263	17265	IN	in	O	_	_
contrast	17266	17274	NN	contrast	O	_	_
to	17275	17277	TO	to	O	_	_
EGFR-mutant	17278	17289	JJ	egfr-mutant	B-GENE	_	_
and	17290	17293	CC	and	O	_	_
HER2-	17294	17299	NN	her2-_NN	O	_	_
amplified	17300	17309	VBD	amplify	O	_	_
cancers	17310	17317	NNS	cancer	O	_	_
,	17317	17318	,	,	O	_	_
the	17319	17322	DT	the	O	_	_
increased	17323	17332	VBN	increase	O	_	_
ERBB3	17333	17338	NN	erbb3	B-GENE	_	_
activation	17339	17349	NN	activation	O	_	_
did	17350	17353	VBD	do	O	_	_
not	17354	17357	RB	not	O	_	_
translate	17358	17367	VB	translate	O	_	_
to	17368	17370	TO	to	O	_	_
increased	17371	17380	VBN	increase	O	_	_
phospho-AKT	17381	17392	NN	phospho-akt	O	_	_
.	17404	17405	.	.	O	_	_
D	1
27
3	2	nn
4	3	nsubj
4	7	prep_to
4	12	conj_but
4	15	prep_to
4	19	prep_to
7	6	amod
7	9	prep_of
12	13	pobj
15	19	conj_and
19	17	nn
19	18	amod
24	21	det
24	22	amod
24	23	nn
27	0	advmod
27	4	parataxis
27	12	parataxis
27	24	nsubj
27	25	aux
27	26	neg
27	30	prep_to
30	29	amod
EOX
Y	1
ROOT	0	0	32	1	S	3	0	32	5	ADVP	0	0	1	1	RB	0	0	1	1	Surprisingly	0	0	1	0	PRN	1	1	21	3	,	0	1	2	1	,	1	1	2	0	S	1	2	20	2	NP	1	2	4	2	NN	0	2	3	1	MEK	2	2	3	0	NN	0	3	4	1	inhibition	3	3	4	0	VP	0	4	20	5	VP	0	4	10	2	VBD	0	4	5	1	led	4	4	5	0	PP	0	5	10	2	TO	0	5	6	1	to	5	5	6	0	NP	0	6	10	2	NP	1	6	8	2	JJ	0	6	7	1	significant	6	6	7	0	NN	0	7	8	1	activation	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	ERBB3	9	9	10	0	,	0	10	11	1	,	10	10	11	0	CC	0	11	12	1	but	11	11	12	0	PP	0	12	14	2	IN	0	12	13	1	in	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	contrast	13	13	14	0	PP	0	14	20	2	TO	0	14	15	1	to	14	14	15	0	NP	0	15	20	3	NP	0	15	16	1	JJ	0	15	16	1	EGFR-mutant	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	NP	2	17	20	3	NN	0	17	18	1	HER2-	17	17	18	0	VBD	0	18	19	1	amplified	18	18	19	0	NNS	0	19	20	1	cancers	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	3	21	25	4	DT	0	21	22	1	the	21	21	22	0	VBN	0	22	23	1	increased	22	22	23	0	NN	0	23	24	1	ERBB3	23	23	24	0	NN	0	24	25	1	activation	24	24	25	0	VP	2	25	31	3	VBD	0	25	26	1	did	25	25	26	0	RB	0	26	27	1	not	26	26	27	0	VP	0	27	31	2	VB	0	27	28	1	translate	27	27	28	0	PP	0	28	31	2	TO	0	28	29	1	to	28	28	29	0	NP	1	29	31	2	VBN	0	29	30	1	increased	29	29	30	0	NN	0	30	31	1	phospho-AKT	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	22
Similar	17406	17413	JJ	similar	O	_	_
to	17414	17416	TO	to	O	_	_
the	17417	17420	DT	the	O	_	_
EGFR	17421	17425	NN	egfr	B-GENE	_	_
and	17426	17429	CC	and	O	_	_
HER2	17430	17434	NN	her2	O	_	_
driven	17435	17441	VBN	drive	O	_	_
models	17442	17448	NNS	model	O	_	_
,	17448	17449	,	,	O	_	_
we	17450	17452	PRP	we	O	_	_
also	17453	17457	RB	also	O	_	_
observed	17458	17466	VBD	observe	O	_	_
up-regulation	17467	17480	NN	up-regulation	O	_	_
of	17481	17483	IN	of	O	_	_
phospho-CRAF	17484	17496	NN	phospho-craf	O	_	_
and	17497	17500	CC	and	O	_	_
phospho-	17501	17509	JJ	phospho-	O	_	_
MEK	17510	17513	NN	mek	O	_	_
following	17514	17523	VBG	follow	O	_	_
MEK	17524	17527	NN	mek	O	_	_
inhibition	17528	17538	NN	inhibition	O	_	_
.	17538	17539	.	.	O	_	_
D	1
11
0	3	prep_to
0	5	prep_to
3	2	det
3	5	conj_and
3	6	vmod
6	7	dobj
11	0	ccomp
11	9	nsubj
11	10	advmod
11	12	dobj
12	17	prep_of
14	16	conj_and
17	14	nn
17	16	nn
17	20	prep_following
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	4	0	22	6	S	0	0	8	1	ADJP	0	0	8	2	JJ	0	0	1	1	Similar	0	0	1	0	PP	0	1	8	2	TO	0	1	2	1	to	1	1	2	0	NP	0	2	8	2	NP	1	2	6	4	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	EGFR	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NN	0	5	6	1	HER2	5	5	6	0	VP	0	6	8	2	VBN	0	6	7	1	driven	6	6	7	0	NP	0	7	8	1	NNS	0	7	8	1	models	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	0	9	10	1	PRP	0	9	10	1	we	9	9	10	0	ADVP	0	10	11	1	RB	0	10	11	1	also	10	10	11	0	VP	0	11	21	2	VBD	0	11	12	1	observed	11	11	12	0	NP	0	12	21	2	NP	0	12	13	1	NN	0	12	13	1	up-regulation	12	12	13	0	PP	0	13	21	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	21	2	NP	1	14	18	2	NP	0	14	17	3	NN	0	14	15	1	phospho-CRAF	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	JJ	0	16	17	1	phospho-	16	16	17	0	NN	0	17	18	1	MEK	17	17	18	0	PP	0	18	21	2	VBG	0	18	19	1	following	18	18	19	0	NP	1	19	21	2	NN	0	19	20	1	MEK	19	19	20	0	NN	0	20	21	1	inhibition	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	45
We	17540	17542	PRP	we	O	_	_
suspect	17543	17550	VBP	suspect	O	_	_
that	17551	17555	IN	that	O	_	_
increased	17556	17565	VBN	increase	O	_	_
ERBB3	17566	17571	NN	erbb3	B-GENE	_	_
phosphorylation	17572	17587	NN	phosphorylation	O	_	_
did	17588	17591	VBD	do	O	_	_
not	17592	17595	RB	not	O	_	_
drive	17596	17601	VB	drive	O	_	_
PI3K	17602	17606	NN	pi3k	O	_	_
in	17607	17609	IN	in	O	_	_
these	17610	17615	DT	these	O	_	_
KRAS-mutant	17616	17627	JJ	kras-mutant	O	_	_
cell	17628	17632	NN	cell	O	_	_
lines	17633	17638	NNS	line	O	_	_
because	17639	17646	IN	because	O	_	_
they	17647	17651	PRP	they	O	_	_
express	17652	17659	VBP	express	O	_	_
significantly	17660	17673	RB	significantly	O	_	_
less	17674	17678	JJR	less	O	_	_
EGFR	17679	17683	NN	egfr	B-GENE	_	_
and	17684	17687	CC	and	O	_	_
HER2	17688	17692	NN	her2	B-GENE	_	_
,	17692	17693	,	,	O	_	_
resulting	17694	17703	VBG	result	O	_	_
in	17704	17706	IN	in	O	_	_
markedly	17707	17715	RB	markedly	O	_	_
lower	17716	17721	JJR	lower	O	_	_
levels	17722	17728	NNS	level	O	_	_
of	17729	17731	IN	of	O	_	_
phospho-ERBB3	17732	17745	NN	phospho-erbb3	O	_	_
compared	17746	17754	VBN	compare	O	_	_
to	17755	17757	TO	to	O	_	_
those	17758	17763	DT	those	O	_	_
observed	17764	17772	VBN	observe	O	_	_
in	17773	17775	IN	in	O	_	_
EGFR	17776	17780	NN	egfr	B-GENE	_	_
and	17781	17784	CC	and	O	_	_
HER2	17785	17789	NN	her2	O	_	_
driven	17790	17796	VBN	drive	O	_	_
models	17797	17803	NNS	model	O	_	_
(	17804	17805	VBP	(	O	_	_
Supplemental	17805	17817	NNP	Supplemental	O	_	_
)	17826	17827	CD	)	O	_	_
.	17827	17828	.	.	O	_	_
D	1
1
1	0	nsubj
1	8	ccomp
5	3	amod
5	4	nn
8	2	mark
8	5	nsubj
8	6	aux
8	7	neg
8	9	dobj
8	14	prep_in
8	17	advcl
14	11	det
14	12	amod
14	13	nn
17	15	mark
17	16	nsubj
17	20	dobj
17	22	dobj
17	24	vmod
19	18	advmod
20	19	amod
20	22	conj_and
24	28	prep_in
24	32	prepc_compared_to
24	33	pobj
27	26	advmod
28	27	amod
28	30	prep_of
33	34	vmod
34	36	prep_in
34	38	prep_in
36	38	conj_and
36	39	vmod
39	41	ccomp
41	40	nsubj
41	42	dobj
42	43	num
EOX
Y	1
ROOT	0	0	45	1	S	1	0	45	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	44	2	VBP	0	1	2	1	suspect	1	1	2	0	SBAR	1	2	44	2	IN	0	2	3	1	that	2	2	3	0	S	1	3	44	2	NP	2	3	6	3	VBN	0	3	4	1	increased	3	3	4	0	NN	0	4	5	1	ERBB3	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	VP	2	6	44	3	VBD	0	6	7	1	did	6	6	7	0	RB	0	7	8	1	not	7	7	8	0	VP	0	8	44	4	VB	0	8	9	1	drive	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	PI3K	9	9	10	0	PP	0	10	15	2	IN	0	10	11	1	in	10	10	11	0	NP	3	11	15	4	DT	0	11	12	1	these	11	11	12	0	JJ	0	12	13	1	KRAS-mutant	12	12	13	0	NN	0	13	14	1	cell	13	13	14	0	NNS	0	14	15	1	lines	14	14	15	0	SBAR	1	15	44	2	IN	0	15	16	1	because	15	15	16	0	S	1	16	44	2	NP	0	16	17	1	PRP	0	16	17	1	they	16	16	17	0	VP	0	17	44	4	VBP	0	17	18	1	express	17	17	18	0	NP	1	18	23	4	ADJP	1	18	20	2	RB	0	18	19	1	significantly	18	18	19	0	JJR	0	19	20	1	less	19	19	20	0	NN	0	20	21	1	EGFR	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	NN	0	22	23	1	HER2	22	22	23	0	,	0	23	24	1	,	23	23	24	0	S	0	24	44	1	VP	0	24	44	3	VBG	0	24	25	1	resulting	24	24	25	0	PP	0	25	31	2	IN	0	25	26	1	in	25	25	26	0	NP	0	26	31	2	NP	1	26	29	2	ADJP	1	26	28	2	RB	0	26	27	1	markedly	26	26	27	0	JJR	0	27	28	1	lower	27	27	28	0	NNS	0	28	29	1	levels	28	28	29	0	PP	0	29	31	2	IN	0	29	30	1	of	29	29	30	0	NP	0	30	31	1	NN	0	30	31	1	phospho-ERBB3	30	30	31	0	PP	0	31	44	2	VBN	0	31	32	1	compared	31	31	32	0	PP	0	32	44	2	TO	0	32	33	1	to	32	32	33	0	NP	0	33	44	2	NP	0	33	34	1	DT	0	33	34	1	those	33	33	34	0	VP	0	34	44	2	VBN	0	34	35	1	observed	34	34	35	0	PP	0	35	44	2	IN	0	35	36	1	in	35	35	36	0	NP	0	36	44	2	NP	0	36	39	3	NN	0	36	37	1	EGFR	36	36	37	0	CC	0	37	38	1	and	37	37	38	0	NN	0	38	39	1	HER2	38	38	39	0	VP	0	39	44	2	VBN	0	39	40	1	driven	39	39	40	0	SBAR	0	40	44	1	S	1	40	44	2	NP	0	40	41	1	NNS	0	40	41	1	models	40	40	41	0	VP	0	41	44	2	VBP	0	41	42	1	(	41	41	42	0	NP	0	42	44	2	NNP	0	42	43	1	Supplemental	42	42	43	0	CD	0	43	44	1	)	43	43	44	0	.	0	44	45	1	.	44	44	45	0
EOS
T	22
Indeed	17829	17835	RB	indeed	O	_	_
,	17835	17836	,	,	O	_	_
we	17837	17839	PRP	we	O	_	_
recently	17840	17848	RB	recently	O	_	_
reported	17849	17857	VBD	report	O	_	_
that	17858	17862	IN	that	O	_	_
IGF-IR	17863	17869	NN	igf-ir	B-GENE	_	_
/	17869	17870	:	/	B-GENE	_	_
IRS	17870	17873	NNP	IRS	I-GENE	_	_
signaling	17874	17883	NN	signaling	O	_	_
is	17884	17886	VBZ	be	O	_	_
the	17887	17890	DT	the	O	_	_
major	17891	17896	JJ	major	O	_	_
PI3K	17897	17901	NN	pi3k	O	_	_
input	17902	17907	NN	input	O	_	_
in	17908	17910	IN	in	O	_	_
these	17911	17916	DT	these	O	_	_
cells	17917	17922	NNS	cell	O	_	_
(	17923	17924	VBP	(	O	_	_
19	17924	17926	CD	19	O	_	_
)	17926	17927	CD	)	O	_	_
.	17927	17928	.	.	O	_	_
D	1
4
4	0	advmod
4	2	nsubj
4	3	advmod
4	18	ccomp
6	14	dep
9	8	nn
14	7	punct
14	9	nsubj
14	10	cop
14	11	det
14	12	amod
14	13	nn
14	17	prep_in
17	16	det
18	5	mark
18	6	nsubj
18	20	dobj
20	19	num
EOX
Y	1
ROOT	0	0	22	1	S	4	0	22	6	ADVP	0	0	1	1	RB	0	0	1	1	Indeed	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	we	2	2	3	0	ADVP	0	3	4	1	RB	0	3	4	1	recently	3	3	4	0	VP	0	4	21	2	VBD	0	4	5	1	reported	4	4	5	0	SBAR	1	5	21	2	IN	0	5	6	1	that	5	5	6	0	S	1	6	21	2	NP	0	6	18	2	NP	0	6	7	1	NN	0	6	7	1	IGF-IR	6	6	7	0	PRN	1	7	18	2	:	0	7	8	1	/	7	7	8	0	S	1	8	18	2	NP	1	8	10	2	NNP	0	8	9	1	IRS	8	8	9	0	NN	0	9	10	1	signaling	9	9	10	0	VP	1	10	18	2	VBZ	0	10	11	1	is	10	10	11	0	NP	0	11	18	2	NP	3	11	15	4	DT	0	11	12	1	the	11	11	12	0	JJ	0	12	13	1	major	12	12	13	0	NN	0	13	14	1	PI3K	13	13	14	0	NN	0	14	15	1	input	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	in	15	15	16	0	NP	1	16	18	2	DT	0	16	17	1	these	16	16	17	0	NNS	0	17	18	1	cells	17	17	18	0	VP	0	18	21	2	VBP	0	18	19	1	(	18	18	19	0	NP	1	19	21	2	CD	0	19	20	1	19	19	19	20	0	CD	0	20	21	1	)	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	53
Thus	17929	17933	RB	thus	O	_	_
,	17933	17934	,	,	O	_	_
the	17935	17938	DT	the	O	_	_
feedback	17939	17947	NN	feedback	O	_	_
from	17948	17952	IN	from	O	_	_
MEK	17953	17956	NN	mek	B-GENE	_	_
inhibition	17957	17967	NN	inhibition	O	_	_
to	17968	17970	TO	to	O	_	_
activation	17971	17981	NN	activation	O	_	_
of	17982	17984	IN	of	O	_	_
ERBB3	17985	17990	NN	erbb3	B-GENE	_	_
appears	17991	17998	VBZ	appear	O	_	_
to	17999	18001	TO	to	O	_	_
be	18002	18004	VB	be	O	_	_
conserved	18005	18014	VBN	conserve	O	_	_
in	18015	18017	IN	in	O	_	_
all	18018	18021	DT	all	O	_	_
three	18022	18027	CD	three	O	_	_
of	18028	18030	IN	of	O	_	_
the	18031	18034	DT	the	O	_	_
models	18035	18041	NNS	model	O	_	_
we	18042	18044	PRP	we	O	_	_
tested	18045	18051	VBD	test	O	_	_
,	18051	18052	,	,	O	_	_
including	18053	18062	VBG	include	O	_	_
EGFR-mutant	18063	18074	JJ	egfr-mutant	B-GENE	_	_
,	18074	18075	,	,	O	_	_
HER2	18076	18080	NN	her2	O	_	_
amplified	18081	18090	VBD	amplify	O	_	_
,	18090	18091	,	,	O	_	_
and	18092	18095	CC	and	O	_	_
KRAS-mutant	18096	18107	JJ	kras-mutant	O	_	_
cancers	18108	18115	NNS	cancer	O	_	_
,	18115	18116	,	,	O	_	_
but	18117	18120	CC	but	O	_	_
results	18121	18128	VBZ	result	O	_	_
in	18129	18131	IN	in	O	_	_
increased	18132	18141	VBN	increase	O	_	_
PI3K	18142	18146	NN	pi3k	B-GENE	_	_
/	18146	18147	:	/	B-GENE	_	_
AKT	18147	18150	NN	akt	I-GENE	_	_
signaling	18151	18160	NN	signaling	O	_	_
only	18161	18165	RB	only	O	_	_
in	18166	18168	IN	in	O	_	_
cells	18169	18174	NNS	cell	O	_	_
that	18175	18179	WDT	that	O	_	_
express	18180	18187	VBP	express	O	_	_
sufficient	18188	18198	JJ	sufficient	O	_	_
absolute	18199	18207	JJ	absolute	O	_	_
levels	18208	18214	NNS	level	O	_	_
of	18215	18217	IN	of	O	_	_
phospho-ERBB3	18218	18231	NN	phospho-erbb3	O	_	_
.	18231	18232	.	.	O	_	_
D	1
11
3	2	det
3	6	prep_from
6	5	nn
6	8	prep_to
8	10	prep_of
11	0	advmod
11	3	nsubj
11	14	xcomp
11	35	conj_but
14	12	aux
14	13	auxpass
14	17	prep_in
17	16	quantmod
17	20	prep_of
17	25	prep_including
20	19	det
20	22	rcmod
22	21	nsubj
25	27	appos
25	32	appos
27	28	vmod
27	32	conj_and
32	31	amod
35	3	nsubj
35	38	prep_in
35	44	prep_in
38	37	amod
38	41	dep
38	44	conj_only
41	39	punct
41	40	nn
44	46	rcmod
46	45	nsubj
46	49	dobj
49	47	amod
49	48	amod
49	51	prep_of
EOX
Y	1
ROOT	0	0	53	1	S	3	0	53	5	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	11	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	feedback	3	3	4	0	PP	0	4	11	2	IN	0	4	5	1	from	4	4	5	0	NP	0	5	11	2	NP	1	5	7	2	NN	0	5	6	1	MEK	5	5	6	0	NN	0	6	7	1	inhibition	6	6	7	0	PP	0	7	11	2	TO	0	7	8	1	to	7	7	8	0	NP	0	8	11	2	NP	0	8	9	1	NN	0	8	9	1	activation	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	ERBB3	10	10	11	0	VP	0	11	52	4	VP	0	11	33	2	VBZ	0	11	12	1	appears	11	11	12	0	S	0	12	33	1	VP	1	12	33	2	TO	0	12	13	1	to	12	12	13	0	VP	1	13	33	2	VB	0	13	14	1	be	13	13	14	0	VP	0	14	33	2	VBN	0	14	15	1	conserved	14	14	15	0	PP	0	15	33	2	IN	0	15	16	1	in	15	15	16	0	NP	0	16	33	4	NP	0	16	18	1	QP	1	16	18	2	DT	0	16	17	1	all	16	16	17	0	CD	0	17	18	1	three	17	17	18	0	PP	0	18	23	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	23	2	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NNS	0	20	21	1	models	20	20	21	0	SBAR	0	21	23	1	S	1	21	23	2	NP	0	21	22	1	PRP	0	21	22	1	we	21	21	22	0	VP	0	22	23	1	VBD	0	22	23	1	tested	22	22	23	0	,	0	23	24	1	,	23	23	24	0	PP	0	24	33	2	VBG	0	24	25	1	including	24	24	25	0	NP	0	25	33	3	NP	0	25	26	1	JJ	0	25	26	1	EGFR-mutant	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	0	27	33	4	NP	0	27	29	2	NP	0	27	28	1	NN	0	27	28	1	HER2	27	27	28	0	VP	0	28	29	1	VBD	0	28	29	1	amplified	28	28	29	0	,	0	29	30	1	,	29	29	30	0	CC	0	30	31	1	and	30	30	31	0	NP	1	31	33	2	JJ	0	31	32	1	KRAS-mutant	31	31	32	0	NNS	0	32	33	1	cancers	32	32	33	0	,	0	33	34	1	,	33	33	34	0	CC	0	34	35	1	but	34	34	35	0	VP	0	35	52	2	VBZ	0	35	36	1	results	35	35	36	0	PP	0	36	52	2	IN	0	36	37	1	in	36	36	37	0	NP	0	37	52	3	NP	0	37	42	2	NP	1	37	39	2	VBN	0	37	38	1	increased	37	37	38	0	NN	0	38	39	1	PI3K	38	38	39	0	PRN	1	39	42	2	:	0	39	40	1	/	39	39	40	0	NP	1	40	42	2	NN	0	40	41	1	AKT	40	40	41	0	NN	0	41	42	1	signaling	41	41	42	0	CONJP	0	42	44	2	RB	0	42	43	1	only	42	42	43	0	IN	0	43	44	1	in	43	43	44	0	NP	0	44	52	2	NP	0	44	45	1	NNS	0	44	45	1	cells	44	44	45	0	SBAR	1	45	52	2	WHNP	0	45	46	1	WDT	0	45	46	1	that	45	45	46	0	S	0	46	52	1	VP	0	46	52	2	VBP	0	46	47	1	express	46	46	47	0	NP	0	47	52	2	NP	2	47	50	3	JJ	0	47	48	1	sufficient	47	47	48	0	JJ	0	48	49	1	absolute	48	48	49	0	NNS	0	49	50	1	levels	49	49	50	0	PP	0	50	52	2	IN	0	50	51	1	of	50	50	51	0	NP	0	51	52	1	NN	0	51	52	1	phospho-ERBB3	51	51	52	0	.	0	52	53	1	.	52	52	53	0
EOS
T	58
MEK	18242	18245	NN	mek	B-GENE	_	_
/	18245	18246	:	/	B-GENE	_	_
ERK	18246	18249	NN	erk	I-GENE	_	_
feedback	18250	18258	NN	feedback	O	_	_
on	18259	18261	IN	on	O	_	_
ERBB3	18262	18267	NN	erbb3	O	_	_
occurs	18268	18274	VBZ	occur	O	_	_
in	18275	18277	IN	in	O	_	_
KRAS-mutant	18278	18289	JJ	kras-mutant	O	_	_
cell	18290	18294	NN	cell	O	_	_
lines	18295	18300	NNS	line	O	_	_
and	18301	18304	CC	and	O	_	_
is	18305	18307	VBZ	be	O	_	_
distinct	18308	18316	JJ	distinct	O	_	_
from	18317	18321	IN	from	O	_	_
TORC1	18322	18327	NN	torc1	B-GENE	_	_
feedback	18328	18336	NN	feedback	I-GENE	_	_
on	18337	18339	IN	on	O	_	_
IRS-1	18340	18345	NN	irs-1	B-GENE	_	_
The	18346	18349	DT	the	O	_	_
feedback	18350	18358	NN	feedback	O	_	_
observed	18359	18367	VBN	observe	O	_	_
in	18368	18370	IN	in	O	_	_
EGFR	18371	18375	NN	egfr	B-GENE	_	_
and	18376	18379	CC	and	O	_	_
HER2	18380	18384	NN	her2	B-GENE	_	_
driven	18385	18391	VBN	drive	O	_	_
cancers	18392	18399	NNS	cancer	O	_	_
is	18400	18402	VBZ	be	O	_	_
distinct	18403	18411	JJ	distinct	O	_	_
from	18412	18416	IN	from	O	_	_
a	18417	18418	DT	a	O	_	_
well	18419	18423	RB	well	O	_	_
described	18424	18433	VBN	describe	O	_	_
feedback	18434	18442	NN	feedback	O	_	_
mechanism	18443	18452	NN	mechanism	O	_	_
in	18453	18455	IN	in	O	_	_
which	18456	18461	WDT	which	O	_	_
mTORC1	18462	18468	NN	mtorc1	B-GENE	_	_
inhibition	18469	18479	NN	inhibition	O	_	_
leads	18480	18485	VBZ	lead	O	_	_
to	18486	18488	TO	to	O	_	_
increased	18489	18498	VBN	increase	O	_	_
IRS-1	18499	18504	NN	irs-1	B-GENE	_	_
expression	18505	18515	NN	expression	O	_	_
and	18516	18519	CC	and	O	_	_
up-regulation	18520	18533	NN	up-regulation	O	_	_
of	18534	18536	IN	of	O	_	_
IGF-IR	18537	18543	NN	igf-ir	B-GENE	_	_
/	18543	18544	:	/	B-GENE	_	_
IRS	18544	18547	NNP	IRS	I-GENE	_	_
signaling	18548	18557	NN	signaling	O	_	_
(	18558	18559	CD	(	O	_	_
5	18559	18560	CD	5	O	_	_
,	18560	18561	,	,	O	_	_
6	18562	18563	CD	6	O	_	_
)	18563	18564	NN	)	O	_	_
.	18564	18565	.	.	O	_	_
D	1
0
0	1	punct
0	6	dep
0	13	dep
3	2	nn
3	5	prep_on
6	3	nsubj
6	10	prep_in
6	13	conj_and
6	20	dobj
10	8	amod
10	9	nn
13	3	nsubj
13	12	cop
13	16	prep_from
13	18	prep_on
16	15	nn
20	19	det
20	21	vmod
20	40	rcmod
21	23	prep_in
21	25	prep_in
23	25	conj_and
23	26	vmod
26	29	ccomp
29	27	nsubj
29	28	cop
29	35	prep_from
33	32	advmod
35	31	det
35	33	amod
35	34	nn
39	38	nn
40	37	prep_in
40	39	nsubj
40	44	prep_to
40	46	prep_to
44	42	amod
44	43	nn
44	46	conj_and
46	48	prep_of
48	51	dep
48	53	amod
51	49	punct
51	50	nn
53	52	number
53	56	dep
56	55	number
EOX
Y	1
ROOT	0	0	58	1	FRAG	0	0	58	4	NP	0	0	1	1	NN	0	0	1	1	MEK	0	0	1	0	:	0	1	2	1	/	1	1	2	0	S	1	2	57	2	NP	0	2	6	2	NP	1	2	4	2	NN	0	2	3	1	ERK	2	2	3	0	NN	0	3	4	1	feedback	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	on	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	ERBB3	5	5	6	0	VP	0	6	57	4	VP	0	6	11	2	VBZ	0	6	7	1	occurs	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	in	7	7	8	0	NP	2	8	11	3	JJ	0	8	9	1	KRAS-mutant	8	8	9	0	NN	0	9	10	1	cell	9	9	10	0	NNS	0	10	11	1	lines	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	VP	1	12	19	3	VBZ	0	12	13	1	is	12	12	13	0	ADJP	0	13	17	2	JJ	0	13	14	1	distinct	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	from	14	14	15	0	NP	1	15	17	2	NN	0	15	16	1	TORC1	15	15	16	0	NN	0	16	17	1	feedback	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	on	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	IRS-1	18	18	19	0	NP	0	19	57	3	NP	1	19	21	2	DT	0	19	20	1	The	19	19	20	0	NN	0	20	21	1	feedback	20	20	21	0	VP	0	21	36	2	VBN	0	21	22	1	observed	21	21	22	0	PP	0	22	36	2	IN	0	22	23	1	in	22	22	23	0	NP	0	23	36	2	NP	0	23	26	3	NN	0	23	24	1	EGFR	23	23	24	0	CC	0	24	25	1	and	24	24	25	0	NN	0	25	26	1	HER2	25	25	26	0	VP	0	26	36	2	VBN	0	26	27	1	driven	26	26	27	0	SBAR	0	27	36	1	S	1	27	36	2	NP	0	27	28	1	NNS	0	27	28	1	cancers	27	27	28	0	VP	1	28	36	2	VBZ	0	28	29	1	is	28	28	29	0	ADJP	0	29	36	2	JJ	0	29	30	1	distinct	29	29	30	0	PP	0	30	36	2	IN	0	30	31	1	from	30	30	31	0	NP	3	31	36	4	DT	0	31	32	1	a	31	31	32	0	ADJP	1	32	34	2	RB	0	32	33	1	well	32	32	33	0	VBN	0	33	34	1	described	33	33	34	0	NN	0	34	35	1	feedback	34	34	35	0	NN	0	35	36	1	mechanism	35	35	36	0	SBAR	1	36	57	2	WHPP	0	36	38	2	IN	0	36	37	1	in	36	36	37	0	WHNP	0	37	38	1	WDT	0	37	38	1	which	37	37	38	0	S	1	38	57	2	NP	1	38	40	2	NN	0	38	39	1	mTORC1	38	38	39	0	NN	0	39	40	1	inhibition	39	39	40	0	VP	0	40	57	2	VBZ	0	40	41	1	leads	40	40	41	0	PP	0	41	57	2	TO	0	41	42	1	to	41	41	42	0	NP	0	42	57	3	NP	2	42	45	3	VBN	0	42	43	1	increased	42	42	43	0	NN	0	43	44	1	IRS-1	43	43	44	0	NN	0	44	45	1	expression	44	44	45	0	CC	0	45	46	1	and	45	45	46	0	NP	0	46	57	2	NP	0	46	47	1	NN	0	46	47	1	up-regulation	46	46	47	0	PP	0	47	57	2	IN	0	47	48	1	of	47	47	48	0	NP	0	48	57	2	NP	0	48	52	2	NP	0	48	49	1	NN	0	48	49	1	IGF-IR	48	48	49	0	PRN	1	49	52	2	:	0	49	50	1	/	49	49	50	0	NP	1	50	52	2	NNP	0	50	51	1	IRS	50	50	51	0	NN	0	51	52	1	signaling	51	51	52	0	ADJP	0	52	57	3	ADJP	0	52	54	1	QP	1	52	54	2	CD	0	52	53	1	(	52	52	53	0	CD	0	53	54	1	5	53	53	54	0	,	0	54	55	1	,	54	54	55	0	ADJP	1	55	57	2	CD	0	55	56	1	6	55	55	56	0	NN	0	56	57	1	)	56	56	57	0	.	0	57	58	1	.	57	57	58	0
EOS
T	49
In	18566	18568	IN	in	O	_	_
the	18569	18572	DT	the	O	_	_
KRAS-mutant	18573	18584	JJ	kras-mutant	O	_	_
cell	18585	18589	NN	cell	O	_	_
lines	18590	18595	NNS	line	O	_	_
that	18596	18600	WDT	that	O	_	_
we	18601	18603	PRP	we	O	_	_
analyzed	18604	18612	VBD	analyze	O	_	_
,	18612	18613	,	,	O	_	_
which	18614	18619	WDT	which	O	_	_
primarily	18620	18629	RB	primarily	O	_	_
use	18630	18633	VBP	use	O	_	_
IGF-1R	18634	18640	NN	igf-1r	B-GENE	_	_
/	18640	18641	:	/	B-GENE	_	_
IRS	18641	18644	NNP	IRS	I-GENE	_	_
to	18645	18647	TO	to	O	_	_
activate	18648	18656	VB	activate	O	_	_
PI3K	18657	18661	NN	pi3k	O	_	_
(	18662	18663	NN	(	O	_	_
19	18663	18665	CD	19	O	_	_
)	18665	18666	NN	)	O	_	_
,	18666	18667	,	,	O	_	_
treatment	18668	18677	NN	treatment	O	_	_
with	18678	18682	IN	with	O	_	_
the	18683	18686	DT	the	O	_	_
mTORC1	18687	18693	NN	mtorc1	B-GENE	_	_
inhibitor	18694	18703	NN	inhibitor	O	_	_
rapamycin	18704	18713	NN	rapamycin	O	_	_
led	18714	18717	VBD	lead	O	_	_
to	18718	18720	TO	to	O	_	_
feedback	18721	18729	NN	feedback	O	_	_
activation	18730	18740	NN	activation	O	_	_
of	18741	18743	IN	of	O	_	_
AKT	18744	18747	NN	akt	B-GENE	_	_
signaling	18748	18757	NN	signaling	O	_	_
that	18758	18762	WDT	that	O	_	_
was	18763	18766	VBD	be	O	_	_
blocked	18767	18774	VBN	block	O	_	_
by	18775	18777	IN	by	O	_	_
co-treatment	18778	18790	NN	co-treatment	O	_	_
with	18791	18795	IN	with	O	_	_
the	18796	18799	DT	the	O	_	_
IGF-IR	18800	18806	NN	igf-ir	B-GENE	_	_
/	18806	18807	:	/	B-GENE	_	_
IR	18807	18809	NNP	IR	I-GENE	_	_
inhibitor	18810	18819	NN	inhibitor	O	_	_
,	18819	18820	,	,	O	_	_
NVP-AEW541	18821	18831	NN	nvp-aew541	O	_	_
.	18846	18847	.	.	O	_	_
D	1
28
4	1	det
4	2	amod
4	3	nn
4	7	rcmod
4	11	rcmod
7	5	dobj
7	6	nsubj
11	9	nsubj
11	10	advmod
11	16	xcomp
12	14	dep
14	13	punct
16	12	nsubj
16	15	aux
16	18	dobj
18	17	nn
18	20	amod
20	19	number
22	27	prep_with
27	24	det
27	25	nn
27	26	nn
28	4	prep_in
28	22	nsubj
28	31	prep_to
31	30	nn
31	34	prep_of
31	37	rcmod
34	33	nn
37	35	nsubjpass
37	36	auxpass
37	39	agent
37	42	prep_with
42	41	det
42	45	dep
45	43	punct
45	44	nn
45	47	appos
EOX
Y	1
ROOT	0	0	49	1	S	3	0	49	5	PP	0	0	21	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	21	4	NP	3	1	5	4	DT	0	1	2	1	the	1	1	2	0	JJ	0	2	3	1	KRAS-mutant	2	2	3	0	NN	0	3	4	1	cell	3	3	4	0	NNS	0	4	5	1	lines	4	4	5	0	SBAR	1	5	8	2	WHNP	0	5	6	1	WDT	0	5	6	1	that	5	5	6	0	S	1	6	8	2	NP	0	6	7	1	PRP	0	6	7	1	we	6	6	7	0	VP	0	7	8	1	VBD	0	7	8	1	analyzed	7	7	8	0	,	0	8	9	1	,	8	8	9	0	SBAR	1	9	21	2	WHNP	0	9	10	1	WDT	0	9	10	1	which	9	9	10	0	S	1	10	21	2	ADVP	0	10	11	1	RB	0	10	11	1	primarily	10	10	11	0	VP	0	11	21	2	VBP	0	11	12	1	use	11	11	12	0	S	1	12	21	2	NP	0	12	15	2	NP	0	12	13	1	NN	0	12	13	1	IGF-1R	12	12	13	0	PRN	1	13	15	2	:	0	13	14	1	/	13	13	14	0	NP	0	14	15	1	NNP	0	14	15	1	IRS	14	14	15	0	VP	1	15	21	2	TO	0	15	16	1	to	15	15	16	0	VP	0	16	21	2	VB	0	16	17	1	activate	16	16	17	0	NP	0	17	21	2	NP	1	17	19	2	NN	0	17	18	1	PI3K	17	17	18	0	NN	0	18	19	1	(	18	18	19	0	ADJP	1	19	21	2	CD	0	19	20	1	19	19	19	20	0	NN	0	20	21	1	)	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	0	22	28	2	NP	0	22	23	1	NN	0	22	23	1	treatment	22	22	23	0	PP	0	23	28	2	IN	0	23	24	1	with	23	23	24	0	NP	3	24	28	4	DT	0	24	25	1	the	24	24	25	0	NN	0	25	26	1	mTORC1	25	25	26	0	NN	0	26	27	1	inhibitor	26	26	27	0	NN	0	27	28	1	rapamycin	27	27	28	0	VP	0	28	48	2	VBD	0	28	29	1	led	28	28	29	0	PP	0	29	48	2	TO	0	29	30	1	to	29	29	30	0	NP	0	30	48	3	NP	1	30	32	2	NN	0	30	31	1	feedback	30	30	31	0	NN	0	31	32	1	activation	31	31	32	0	PP	0	32	35	2	IN	0	32	33	1	of	32	32	33	0	NP	1	33	35	2	NN	0	33	34	1	AKT	33	33	34	0	NN	0	34	35	1	signaling	34	34	35	0	SBAR	1	35	48	2	WHNP	0	35	36	1	WDT	0	35	36	1	that	35	35	36	0	S	0	36	48	1	VP	1	36	48	2	VBD	0	36	37	1	was	36	36	37	0	VP	0	37	48	3	VBN	0	37	38	1	blocked	37	37	38	0	PP	0	38	40	2	IN	0	38	39	1	by	38	38	39	0	NP	0	39	40	1	NN	0	39	40	1	co-treatment	39	39	40	0	PP	0	40	48	2	IN	0	40	41	1	with	40	40	41	0	NP	0	41	48	2	NP	1	41	43	2	DT	0	41	42	1	the	41	41	42	0	NN	0	42	43	1	IGF-IR	42	42	43	0	PRN	1	43	48	2	:	0	43	44	1	/	43	43	44	0	NP	0	44	48	3	NP	1	44	46	2	NNP	0	44	45	1	IR	44	44	45	0	NN	0	45	46	1	inhibitor	45	45	46	0	,	0	46	47	1	,	46	46	47	0	NP	0	47	48	1	NN	0	47	48	1	NVP-AEW541	47	47	48	0	.	0	48	49	1	.	48	48	49	0
EOS
T	23
In	18848	18850	IN	in	O	_	_
contrast	18851	18859	NN	contrast	O	_	_
,	18859	18860	,	,	O	_	_
MEK	18861	18864	NN	mek	B-GENE	_	_
inhibitor	18865	18874	NN	inhibitor	O	_	_
induced	18875	18882	VBD	induce	O	_	_
activation	18883	18893	NN	activation	O	_	_
of	18894	18896	IN	of	O	_	_
ERBB3	18897	18902	NN	erbb3	B-GENE	_	_
in	18903	18905	IN	in	O	_	_
the	18906	18909	DT	the	O	_	_
KRAS-mutant	18910	18921	JJ	kras-mutant	O	_	_
cancers	18922	18929	NNS	cancer	O	_	_
was	18930	18933	VBD	be	O	_	_
blocked	18934	18941	VBN	block	O	_	_
by	18942	18944	IN	by	O	_	_
gefitinib	18945	18954	NN	gefitinib	O	_	_
,	18954	18955	,	,	O	_	_
but	18956	18959	CC	but	O	_	_
not	18960	18963	RB	not	O	_	_
by	18964	18966	IN	by	O	_	_
NVP-AEW541	18967	18977	NN	nvp-aew541	O	_	_
.	18990	18991	.	.	O	_	_
D	1
5
4	3	nn
5	1	prep_in
5	4	nsubj
5	14	ccomp
6	8	prep_of
8	12	prep_in
12	10	det
12	11	amod
14	6	nsubjpass
14	13	auxpass
14	16	agent
14	19	neg
14	21	agent
16	21	conj_but
EOX
Y	1
ROOT	0	0	23	1	S	3	0	23	5	PP	0	0	2	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	contrast	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	MEK	3	3	4	0	NN	0	4	5	1	inhibitor	4	4	5	0	VP	0	5	22	2	VBD	0	5	6	1	induced	5	5	6	0	SBAR	0	6	22	1	S	1	6	22	2	NP	0	6	13	2	NP	0	6	7	1	NN	0	6	7	1	activation	6	6	7	0	PP	0	7	13	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	13	2	NP	0	8	9	1	NN	0	8	9	1	ERBB3	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	in	9	9	10	0	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	JJ	0	11	12	1	KRAS-mutant	11	11	12	0	NNS	0	12	13	1	cancers	12	12	13	0	VP	1	13	22	2	VBD	0	13	14	1	was	13	13	14	0	VP	0	14	22	2	VBN	0	14	15	1	blocked	14	14	15	0	PP	0	15	22	4	PP	0	15	17	2	IN	0	15	16	1	by	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	gefitinib	16	16	17	0	,	0	17	18	1	,	17	17	18	0	CC	0	18	19	1	but	18	18	19	0	PP	1	19	22	3	RB	0	19	20	1	not	19	19	20	0	IN	0	20	21	1	by	20	20	21	0	NP	0	21	22	1	NN	0	21	22	1	NVP-AEW541	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	22
Accordingly	18992	19003	RB	accordingly	O	_	_
,	19003	19004	,	,	O	_	_
NVP-AEW541	19005	19015	NN	nvp-aew541	O	_	_
failed	19016	19022	VBD	fail	O	_	_
to	19023	19025	TO	to	O	_	_
abrogate	19026	19034	VB	abrogate	O	_	_
AZD6244	19035	19042	NN	azd6244	O	_	_
induced	19043	19050	JJ	induced	O	_	_
activation	19051	19061	NN	activation	O	_	_
of	19062	19064	IN	of	O	_	_
phospho-AKT	19065	19076	NN	phospho-akt	B-GENE	_	_
in	19077	19079	IN	in	I-GENE	_	_
EGFR	19080	19084	NN	egfr	I-GENE	_	_
and	19085	19088	CC	and	O	_	_
HER2	19089	19093	NN	her2	O	_	_
driven	19094	19100	VBN	drive	O	_	_
cell	19101	19105	NN	cell	O	_	_
lines	19106	19111	NNS	line	O	_	_
(	19112	19113	VBP	(	O	_	_
Supplemental	19113	19125	NNP	Supplemental	O	_	_
)	19134	19135	CD	)	O	_	_
.	19135	19136	.	.	O	_	_
D	1
3
3	0	advmod
3	2	nsubj
3	5	xcomp
5	4	aux
5	8	dobj
5	12	prep_in
5	14	prep_in
8	6	nn
8	7	amod
8	10	prep_of
12	14	conj_and
12	15	vmod
15	18	ccomp
17	16	nn
18	17	nsubj
18	19	dobj
19	20	num
EOX
Y	1
ROOT	0	0	22	1	S	3	0	22	5	ADVP	0	0	1	1	RB	0	0	1	1	Accordingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	NVP-AEW541	2	2	3	0	VP	0	3	21	2	VBD	0	3	4	1	failed	3	3	4	0	S	0	4	21	1	VP	1	4	21	2	TO	0	4	5	1	to	4	4	5	0	VP	0	5	21	3	VB	0	5	6	1	abrogate	5	5	6	0	NP	0	6	11	2	NP	2	6	9	3	NN	0	6	7	1	AZD6244	6	6	7	0	JJ	0	7	8	1	induced	7	7	8	0	NN	0	8	9	1	activation	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	phospho-AKT	10	10	11	0	PP	0	11	21	2	IN	0	11	12	1	in	11	11	12	0	NP	0	12	21	2	NP	0	12	15	3	NN	0	12	13	1	EGFR	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NN	0	14	15	1	HER2	14	14	15	0	VP	0	15	21	2	VBN	0	15	16	1	driven	15	15	16	0	SBAR	0	16	21	1	S	1	16	21	2	NP	1	16	18	2	NN	0	16	17	1	cell	16	16	17	0	NNS	0	17	18	1	lines	17	17	18	0	VP	0	18	21	2	VBP	0	18	19	1	(	18	18	19	0	NP	0	19	21	2	NNP	0	19	20	1	Supplemental	19	19	20	0	CD	0	20	21	1	)	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	73
Of	19137	19139	IN	of	O	_	_
note	19140	19144	NN	note	O	_	_
,	19144	19145	,	,	O	_	_
we	19146	19148	PRP	we	O	_	_
have	19149	19153	VBP	have	O	_	_
also	19154	19158	RB	also	O	_	_
previously	19159	19169	RB	previously	O	_	_
observed	19170	19178	VBN	observe	O	_	_
cancers	19179	19186	NNS	cancer	O	_	_
in	19187	19189	IN	in	O	_	_
which	19190	19195	WDT	which	O	_	_
MEK	19196	19199	NN	mek	B-GENE	_	_
inhibition	19200	19210	NN	inhibition	O	_	_
leads	19211	19216	VBZ	lead	O	_	_
to	19217	19219	TO	to	O	_	_
inhibition	19220	19230	NN	inhibition	O	_	_
of	19231	19233	IN	of	O	_	_
downstream	19234	19244	JJ	downstream	O	_	_
phospho-S6	19245	19255	NN	phospho-s6	O	_	_
,	19255	19256	,	,	O	_	_
resulting	19257	19266	VBG	result	O	_	_
in	19267	19269	IN	in	O	_	_
feedback	19270	19278	NN	feedback	O	_	_
activation	19279	19289	NN	activation	O	_	_
of	19290	19292	IN	of	O	_	_
IGF-	19293	19297	JJ	igf-	B-GENE	_	_
IR	19298	19300	NN	ir	I-GENE	_	_
/	19300	19301	:	/	B-GENE	_	_
IRS	19301	19304	NNP	IRS	I-GENE	_	_
-1	19304	19306	CD	-1	I-GENE	_	_
/	19306	19307	:	/	B-GENE	_	_
AKT	19307	19310	NN	akt	I-GENE	_	_
signaling	19311	19320	NN	signaling	O	_	_
independent	19321	19332	JJ	independent	O	_	_
of	19333	19335	IN	of	O	_	_
ERBB3	19336	19341	NN	erbb3	B-GENE	_	_
in	19342	19344	IN	in	O	_	_
both	19345	19349	CC	both	O	_	_
KRAS	19350	19354	NNP	KRAS	O	_	_
wild-type	19355	19364	JJ	wild-type	O	_	_
and	19365	19368	CC	and	O	_	_
mutant	19369	19375	JJ	mutant	O	_	_
cancers	19376	19383	NNS	cancer	O	_	_
(	19384	19385	VBP	(	O	_	_
19	19385	19387	CD	19	O	_	_
)	19387	19388	CD	)	O	_	_
,	19388	19389	,	,	O	_	_
suggesting	19390	19400	VBG	suggest	O	_	_
that	19401	19405	IN	that	O	_	_
cancers	19406	19413	NNS	cancer	O	_	_
not	19414	19417	RB	not	O	_	_
driven	19418	19424	VBN	drive	O	_	_
by	19425	19427	IN	by	O	_	_
EGFR	19428	19432	NN	egfr	B-GENE	_	_
or	19433	19435	CC	or	O	_	_
HER2	19436	19440	NN	her2	B-GENE	_	_
may	19441	19444	MD	may	O	_	_
have	19445	19449	VB	have	O	_	_
alternate	19450	19459	JJ	alternate	O	_	_
,	19459	19460	,	,	O	_	_
ERBB3	19461	19466	NN	erbb3	O	_	_
independent	19467	19478	JJ	independent	O	_	_
,	19478	19479	,	,	O	_	_
mechanisms	19480	19490	NNS	mechanism	O	_	_
of	19491	19493	IN	of	O	_	_
MEK-	19494	19498	NN	mek-_NN	B-GENE	_	_
inhibitor	19499	19508	NN	inhibitor	O	_	_
induced	19509	19516	VBD	induce	O	_	_
feedback	19517	19525	NN	feedback	O	_	_
activation	19526	19536	NN	activation	O	_	_
of	19537	19539	IN	of	O	_	_
AKT	19540	19543	NN	akt	O	_	_
.	19543	19544	.	.	O	_	_
D	1
7
7	1	prep_of
7	3	nsubj
7	4	aux
7	5	advmod
7	6	advmod
7	8	dobj
7	61	ccomp
7	67	ccomp
8	13	rcmod
12	11	nn
13	10	prep_in
13	12	nsubj
13	15	prep_to
13	36	prep
15	18	prep_of
15	20	vmod
18	17	amod
20	23	prep_in
23	22	nn
23	26	prep_of
26	25	amod
26	28	dep
28	27	punct
28	29	dep
28	30	punct
28	32	dep
32	31	nn
32	33	amod
32	35	prep_of
36	37	dep
36	38	conj
38	43	rcmod
39	41	conj_and
42	39	amod
42	41	amod
43	42	nsubj
43	45	dobj
43	47	vmod
45	44	num
47	57	ccomp
49	51	vmod
51	50	neg
51	53	agent
51	55	agent
53	55	conj_or
57	48	mark
57	49	nsubj
57	56	aux
57	58	dobj
61	60	dep
63	66	prep_of
66	65	nn
67	63	nsubj
67	69	dobj
69	68	nn
69	71	prep_of
EOX
Y	1
ROOT	0	0	73	1	S	0	0	73	6	S	3	0	59	4	PP	0	0	2	2	IN	0	0	1	1	Of	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	note	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	4	1	PRP	0	3	4	1	we	3	3	4	0	VP	2	4	59	3	VBP	0	4	5	1	have	4	4	5	0	ADVP	0	5	6	1	RB	0	5	6	1	also	5	5	6	0	VP	1	6	59	3	ADVP	0	6	7	1	RB	0	6	7	1	previously	6	6	7	0	VBN	0	7	8	1	observed	7	7	8	0	NP	0	8	59	2	NP	0	8	9	1	NNS	0	8	9	1	cancers	8	8	9	0	SBAR	1	9	59	2	WHPP	0	9	11	2	IN	0	9	10	1	in	9	9	10	0	WHNP	0	10	11	1	WDT	0	10	11	1	which	10	10	11	0	S	1	11	59	2	NP	1	11	13	2	NN	0	11	12	1	MEK	11	11	12	0	NN	0	12	13	1	inhibition	12	12	13	0	VP	0	13	59	2	VBZ	0	13	14	1	leads	13	13	14	0	PP	0	14	59	2	PP	0	14	36	2	TO	0	14	15	1	to	14	14	15	0	NP	0	15	36	4	NP	0	15	16	1	NN	0	15	16	1	inhibition	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	of	16	16	17	0	NP	1	17	19	2	JJ	0	17	18	1	downstream	17	17	18	0	NN	0	18	19	1	phospho-S6	18	18	19	0	,	0	19	20	1	,	19	19	20	0	VP	0	20	36	2	VBG	0	20	21	1	resulting	20	20	21	0	PP	0	21	36	2	IN	0	21	22	1	in	21	21	22	0	NP	0	22	36	2	NP	1	22	24	2	NN	0	22	23	1	feedback	22	22	23	0	NN	0	23	24	1	activation	23	23	24	0	PP	0	24	36	2	IN	0	24	25	1	of	24	24	25	0	NP	0	25	36	2	NP	1	25	27	2	JJ	0	25	26	1	IGF-	25	25	26	0	NN	0	26	27	1	IR	26	26	27	0	PRN	1	27	36	2	:	0	27	28	1	/	27	27	28	0	FRAG	0	28	36	3	NP	0	28	30	2	NP	0	28	29	1	NNP	0	28	29	1	IRS	28	28	29	0	NP	0	29	30	1	CD	0	29	30	1	-1	29	29	30	0	:	0	30	31	1	/	30	30	31	0	NP	0	31	36	3	NP	1	31	33	2	NN	0	31	32	1	AKT	31	31	32	0	NN	0	32	33	1	signaling	32	32	33	0	ADJP	0	33	34	1	JJ	0	33	34	1	independent	33	33	34	0	PP	0	34	36	2	IN	0	34	35	1	of	34	34	35	0	NP	0	35	36	1	NN	0	35	36	1	ERBB3	35	35	36	0	PP	0	36	59	3	IN	0	36	37	1	in	36	36	37	0	CC	0	37	38	1	both	37	37	38	0	NP	0	38	59	2	NP	0	38	39	1	NNP	0	38	39	1	KRAS	38	38	39	0	SBAR	0	39	59	1	S	1	39	59	2	NP	1	39	43	2	ADJP	0	39	42	3	JJ	0	39	40	1	wild-type	39	39	40	0	CC	0	40	41	1	and	40	40	41	0	JJ	0	41	42	1	mutant	41	41	42	0	NNS	0	42	43	1	cancers	42	42	43	0	VP	0	43	59	4	VBP	0	43	44	1	(	43	43	44	0	NP	1	44	46	2	CD	0	44	45	1	19	44	44	45	0	CD	0	45	46	1	)	45	45	46	0	,	0	46	47	1	,	46	46	47	0	S	0	47	59	1	VP	0	47	59	2	VBG	0	47	48	1	suggesting	47	47	48	0	SBAR	1	48	59	2	IN	0	48	49	1	that	48	48	49	0	S	1	49	59	2	NP	0	49	56	2	NP	0	49	50	1	NNS	0	49	50	1	cancers	49	49	50	0	VP	1	50	56	3	RB	0	50	51	1	not	50	50	51	0	VBN	0	51	52	1	driven	51	51	52	0	PP	0	52	56	2	IN	0	52	53	1	by	52	52	53	0	NP	0	53	56	3	NN	0	53	54	1	EGFR	53	53	54	0	CC	0	54	55	1	or	54	54	55	0	NN	0	55	56	1	HER2	55	55	56	0	VP	1	56	59	2	MD	0	56	57	1	may	56	56	57	0	VP	0	57	59	2	VB	0	57	58	1	have	57	57	58	0	NP	0	58	59	1	JJ	0	58	59	1	alternate	58	58	59	0	,	0	59	60	1	,	59	59	60	0	S	1	60	62	2	NP	0	60	61	1	NN	0	60	61	1	ERBB3	60	60	61	0	ADJP	0	61	62	1	JJ	0	61	62	1	independent	61	61	62	0	,	0	62	63	1	,	62	62	63	0	S	1	63	72	2	NP	0	63	67	2	NP	0	63	64	1	NNS	0	63	64	1	mechanisms	63	63	64	0	PP	0	64	67	2	IN	0	64	65	1	of	64	64	65	0	NP	1	65	67	2	NN	0	65	66	1	MEK-	65	65	66	0	NN	0	66	67	1	inhibitor	66	66	67	0	VP	0	67	72	2	VBD	0	67	68	1	induced	67	67	68	0	NP	0	68	72	2	NP	1	68	70	2	NN	0	68	69	1	feedback	68	68	69	0	NN	0	69	70	1	activation	69	69	70	0	PP	0	70	72	2	IN	0	70	71	1	of	70	70	71	0	NP	0	71	72	1	NN	0	71	72	1	AKT	71	71	72	0	.	0	72	73	1	.	72	72	73	0
EOS
T	50
Our	19545	19548	PRP$	we	O	_	_
data	19549	19553	NNS	datum	O	_	_
suggest	19554	19561	VBP	suggest	O	_	_
that	19562	19566	IN	that	O	_	_
the	19567	19570	DT	the	O	_	_
effect	19571	19577	NN	effect	O	_	_
of	19578	19580	IN	of	O	_	_
MEK	19581	19584	NN	mek	B-GENE	_	_
inhibition	19585	19595	NN	inhibition	O	_	_
on	19596	19598	IN	on	O	_	_
ERBB3	19599	19604	NN	erbb3	B-GENE	_	_
is	19605	19607	VBZ	be	O	_	_
a	19608	19609	DT	a	O	_	_
ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	19610	19658	NNP	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	O	_	_
MEK	19660	19663	NN	mek	B-GENE	_	_
inhibition	19664	19674	NN	inhibition	O	_	_
leads	19675	19680	VBZ	lead	O	_	_
to	19681	19683	TO	to	O	_	_
PI3K	19684	19688	NN	pi3k	B-GENE	_	_
/	19688	19689	:	/	B-GENE	_	_
AKT	19689	19692	NN	akt	I-GENE	_	_
activation	19693	19703	NN	activation	O	_	_
by	19704	19706	IN	by	O	_	_
relieving	19707	19716	VBG	relieve	O	_	_
a	19717	19718	DT	a	O	_	_
negative	19719	19727	JJ	negative	O	_	_
feedback	19728	19736	NN	feedback	O	_	_
on	19737	19739	IN	on	O	_	_
ERBB	19740	19744	NN	erbb	O	_	_
receptors	19745	19754	NNS	receptor	O	_	_
12	19755	19757	CD	12	O	_	_
/	19757	19758	:	/	O	_	_
8/14	19758	19762	CD	8/14	O	_	_
,	19762	19763	,	,	O	_	_
6:54	19764	19768	CD	6:54	O	_	_
PM	19769	19771	NNP	PM	O	_	_
Ôøºnovel	19772	19780	NNP	Ôøºnovel	O	_	_
feedback	19781	19789	NN	feedback	O	_	_
mechanism	19790	19799	NN	mechanism	O	_	_
,	19799	19800	,	,	O	_	_
distinct	19801	19809	JJ	distinct	O	_	_
from	19810	19814	IN	from	O	_	_
mTORC1	19815	19821	NN	mtorc1	O	_	_
feedback	19822	19830	NN	feedback	O	_	_
on	19831	19833	IN	on	O	_	_
IGF-IR	19834	19840	NN	igf-ir	B-GENE	_	_
/	19840	19841	:	/	B-GENE	_	_
IRS	19841	19844	NNP	IRS	I-GENE	_	_
-1	19844	19846	CD	-1	I-GENE	_	_
.	19846	19847	.	.	O	_	_
D	1
2
1	0	poss
2	1	nsubj
2	15	ccomp
5	4	det
5	8	prep_of
8	7	nn
8	10	prep_on
15	3	mark
15	5	nsubj
15	11	cop
15	12	det
15	13	nn
15	14	nn
15	16	rcmod
15	21	dep
15	47	dep
16	18	prep_to
21	19	punct
21	20	nn
21	23	prepc_by
21	46	punct
23	26	dobj
23	29	prep_on
23	30	dobj
26	24	det
26	25	amod
29	28	nn
30	32	dep
30	45	prep_on
32	31	punct
32	38	appos
32	40	dep
38	34	num
38	35	nn
38	36	nn
38	37	nn
40	43	prep_from
43	42	nn
47	48	num
EOX
Y	1
ROOT	0	0	50	1	S	1	0	50	3	NP	1	0	2	2	PRP$	0	0	1	1	Our	0	0	1	0	NNS	0	1	2	1	data	1	1	2	0	VP	0	2	49	2	VBP	0	2	3	1	suggest	2	2	3	0	SBAR	1	3	49	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	49	2	NP	0	4	11	2	NP	1	4	6	2	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	effect	5	5	6	0	PP	0	6	11	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	11	2	NP	1	7	9	2	NN	0	7	8	1	MEK	7	7	8	0	NN	0	8	9	1	inhibition	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	on	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	ERBB3	10	10	11	0	VP	1	11	49	2	VBZ	0	11	12	1	is	11	11	12	0	NP	0	12	49	3	NP	0	12	19	2	NP	3	12	16	4	DT	0	12	13	1	a	12	12	13	0	NNP	0	13	14	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	13	13	14	0	NN	0	14	15	1	MEK	14	14	15	0	NN	0	15	16	1	inhibition	15	15	16	0	SBAR	0	16	19	1	S	0	16	19	1	VP	0	16	19	2	VBZ	0	16	17	1	leads	16	16	17	0	PP	0	17	19	2	TO	0	17	18	1	to	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	PI3K	18	18	19	0	PRN	1	19	47	3	:	0	19	20	1	/	19	19	20	0	NP	0	20	46	2	NP	1	20	22	2	NN	0	20	21	1	AKT	20	20	21	0	NN	0	21	22	1	activation	21	21	22	0	PP	0	22	46	2	IN	0	22	23	1	by	22	22	23	0	S	0	23	46	1	VP	0	23	46	4	VBG	0	23	24	1	relieving	23	23	24	0	NP	2	24	27	3	DT	0	24	25	1	a	24	24	25	0	JJ	0	25	26	1	negative	25	25	26	0	NN	0	26	27	1	feedback	26	26	27	0	PP	0	27	30	2	IN	0	27	28	1	on	27	27	28	0	NP	1	28	30	2	NN	0	28	29	1	ERBB	28	28	29	0	NNS	0	29	30	1	receptors	29	29	30	0	NP	0	30	46	2	NP	0	30	44	2	NP	0	30	31	1	CD	0	30	31	1	12	30	30	31	0	PRN	1	31	44	4	:	0	31	32	1	/	31	31	32	0	NP	0	32	39	3	NP	0	32	33	1	CD	0	32	33	1	8/14	32	32	33	0	,	0	33	34	1	,	33	33	34	0	NP	4	34	39	5	CD	0	34	35	1	6:54	34	34	35	0	NNP	0	35	36	1	PM	35	35	36	0	NNP	0	36	37	1	Ôøºnovel	36	36	37	0	NN	0	37	38	1	feedback	37	37	38	0	NN	0	38	39	1	mechanism	38	38	39	0	,	0	39	40	1	,	39	39	40	0	ADJP	0	40	44	2	JJ	0	40	41	1	distinct	40	40	41	0	PP	0	41	44	2	IN	0	41	42	1	from	41	41	42	0	NP	1	42	44	2	NN	0	42	43	1	mTORC1	42	42	43	0	NN	0	43	44	1	feedback	43	43	44	0	PP	0	44	46	2	IN	0	44	45	1	on	44	44	45	0	NP	0	45	46	1	NN	0	45	46	1	IGF-IR	45	45	46	0	:	0	46	47	1	/	46	46	47	0	NP	0	47	49	2	NNP	0	47	48	1	IRS	47	47	48	0	CD	0	48	49	1	-1	48	48	49	0	.	0	49	50	1	.	49	49	50	0
EOS
T	42
A	19848	19849	DT	a	O	_	_
model	19850	19855	NN	model	O	_	_
describing	19856	19866	VBG	describe	O	_	_
these	19867	19872	DT	these	O	_	_
findings	19873	19881	NNS	finding	O	_	_
is	19882	19884	VBZ	be	O	_	_
shown	19885	19890	VBN	show	O	_	_
in	19891	19893	IN	in	O	_	_
MEK	19905	19908	NN	mek	B-GENE	_	_
inhibition	19909	19919	NN	inhibition	O	_	_
results	19920	19927	VBZ	result	O	_	_
in	19928	19930	IN	in	O	_	_
increased	19931	19940	VBN	increase	O	_	_
tyrosine	19941	19949	NN	tyrosine	O	_	_
phosphorylation	19950	19965	NN	phosphorylation	O	_	_
of	19966	19968	IN	of	O	_	_
ERBB3	19969	19974	NN	erbb3	B-GENE	_	_
due	19975	19978	JJ	due	O	_	_
to	19979	19981	TO	to	O	_	_
inhibition	19982	19992	NN	inhibition	O	_	_
of	19993	19995	IN	of	O	_	_
ERK	19996	19999	NN	erk	B-GENE	_	_
mediated	20000	20008	VBD	mediate	O	_	_
threonine	20009	20018	NN	threonine	O	_	_
phosphorylation	20019	20034	NN	phosphorylation	O	_	_
of	20035	20037	IN	of	O	_	_
EGFR	20038	20042	NN	egfr	B-GENE	_	_
and	20043	20046	CC	and	O	_	_
HER2	20047	20051	NN	her2	B-GENE	_	_
We	20052	20054	PRP	we	O	_	_
investigated	20055	20067	VBD	investigate	O	_	_
the	20068	20071	DT	the	O	_	_
mechanism	20072	20081	NN	mechanism	O	_	_
leading	20082	20089	VBG	lead	O	_	_
to	20090	20092	TO	to	O	_	_
increased	20093	20102	VBN	increase	O	_	_
ERBB3	20103	20108	NN	erbb3	B-GENE	_	_
phosphorylation	20109	20124	NN	phosphorylation	O	_	_
following	20125	20134	VBG	follow	O	_	_
MEK	20135	20138	NN	mek	B-GENE	_	_
inhibition	20139	20149	NN	inhibition	O	_	_
.	20149	20150	.	.	O	_	_
D	1
10
1	0	det
1	2	vmod
2	6	ccomp
4	3	det
6	4	nsubjpass
6	5	auxpass
6	9	prep_in
9	8	nn
10	1	nsubj
10	22	advcl
14	12	amod
14	13	nn
14	16	prep_of
16	19	prep_due_to
19	21	prep_of
22	11	mark
22	14	nsubj
22	24	dobj
24	23	nn
24	26	prep_of
24	28	prep_of
24	30	rcmod
26	28	conj_and
30	29	nsubj
30	32	dobj
32	31	det
32	33	vmod
33	40	prep_to
40	35	amod
40	36	nn
40	37	nn
40	38	amod
40	39	nn
EOX
Y	1
ROOT	0	0	42	1	S	1	0	42	3	NP	0	0	10	2	NP	1	0	2	2	DT	0	0	1	1	A	0	0	1	0	NN	0	1	2	1	model	1	1	2	0	VP	0	2	10	2	VBG	0	2	3	1	describing	2	2	3	0	SBAR	0	3	10	1	S	1	3	10	2	NP	1	3	5	2	DT	0	3	4	1	these	3	3	4	0	NNS	0	4	5	1	findings	4	4	5	0	VP	1	5	10	2	VBZ	0	5	6	1	is	5	5	6	0	VP	0	6	10	2	VBN	0	6	7	1	shown	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	in	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	MEK	8	8	9	0	NN	0	9	10	1	inhibition	9	9	10	0	VP	0	10	41	2	VBZ	0	10	11	1	results	10	10	11	0	SBAR	1	11	41	2	IN	0	11	12	1	in	11	11	12	0	S	1	12	41	2	NP	0	12	22	2	NP	2	12	15	3	VBN	0	12	13	1	increased	12	12	13	0	NN	0	13	14	1	tyrosine	13	13	14	0	NN	0	14	15	1	phosphorylation	14	14	15	0	PP	0	15	22	2	IN	0	15	16	1	of	15	15	16	0	NP	0	16	22	2	NP	0	16	17	1	NN	0	16	17	1	ERBB3	16	16	17	0	ADJP	0	17	22	2	JJ	0	17	18	1	due	17	17	18	0	PP	0	18	22	2	TO	0	18	19	1	to	18	18	19	0	NP	0	19	22	2	NP	0	19	20	1	NN	0	19	20	1	inhibition	19	19	20	0	PP	0	20	22	2	IN	0	20	21	1	of	20	20	21	0	NP	0	21	22	1	NN	0	21	22	1	ERK	21	21	22	0	VP	0	22	41	2	VBD	0	22	23	1	mediated	22	22	23	0	NP	0	23	41	3	NP	1	23	25	2	NN	0	23	24	1	threonine	23	23	24	0	NN	0	24	25	1	phosphorylation	24	24	25	0	PP	0	25	29	2	IN	0	25	26	1	of	25	25	26	0	NP	0	26	29	3	NN	0	26	27	1	EGFR	26	26	27	0	CC	0	27	28	1	and	27	27	28	0	NN	0	28	29	1	HER2	28	28	29	0	SBAR	0	29	41	1	S	1	29	41	2	NP	0	29	30	1	PRP	0	29	30	1	We	29	29	30	0	VP	0	30	41	2	VBD	0	30	31	1	investigated	30	30	31	0	NP	0	31	41	2	NP	1	31	33	2	DT	0	31	32	1	the	31	31	32	0	NN	0	32	33	1	mechanism	32	32	33	0	VP	0	33	41	2	VBG	0	33	34	1	leading	33	33	34	0	PP	0	34	41	2	TO	0	34	35	1	to	34	34	35	0	NP	5	35	41	6	VBN	0	35	36	1	increased	35	35	36	0	NN	0	36	37	1	ERBB3	36	36	37	0	NN	0	37	38	1	phosphorylation	37	37	38	0	VBG	0	38	39	1	following	38	38	39	0	NN	0	39	40	1	MEK	39	39	40	0	NN	0	40	41	1	inhibition	40	40	41	0	.	0	41	42	1	.	41	41	42	0
EOS
T	31
HRG	20151	20154	NN	hrg	O	_	_
ligand	20155	20161	NN	ligand	O	_	_
expression	20162	20172	NN	expression	O	_	_
was	20173	20176	VBD	be	O	_	_
not	20177	20180	RB	not	O	_	_
increased	20181	20190	VBN	increase	O	_	_
with	20191	20195	IN	with	O	_	_
AZD6244	20196	20203	NN	azd6244	O	_	_
(	20204	20205	CD	(	O	_	_
Supplemental	20205	20217	NNP	Supplemental	O	_	_
)	20226	20227	NN	)	O	_	_
;	20227	20228	:	;	O	_	_
however	20229	20236	RB	however	O	_	_
,	20236	20237	,	,	O	_	_
MEK	20238	20241	NN	mek	B-GENE	_	_
inhibitor	20242	20251	NN	inhibitor	O	_	_
induced	20252	20259	VBD	induce	O	_	_
feedback	20260	20268	NN	feedback	O	_	_
activation	20269	20279	NN	activation	O	_	_
of	20280	20282	IN	of	O	_	_
AKT	20283	20286	NNP	AKT	B-GENE	_	_
required	20287	20295	VBD	require	O	_	_
EGFR	20296	20300	NN	egfr	B-GENE	_	_
or	20301	20303	CC	or	O	_	_
HER2	20304	20308	NN	her2	B-GENE	_	_
kinase	20309	20315	NN	kinase	I-GENE	_	_
activity	20316	20324	NN	activity	O	_	_
(	20325	20326	CD	(	O	_	_
Supplemental	20326	20338	NNP	Supplemental	O	_	_
)	20347	20348	NN	)	O	_	_
.	20348	20349	.	.	O	_	_
D	1
21
2	0	nn
2	1	nn
5	2	nsubjpass
5	3	auxpass
5	4	neg
5	10	prep_with
5	16	parataxis
10	7	nn
10	8	num
10	9	nn
15	14	nn
16	12	advmod
16	15	nsubj
16	18	dobj
18	17	nn
18	20	prep_of
21	5	dep
21	26	dobj
21	29	nsubj
22	24	conj_or
26	22	nn
26	24	nn
26	25	nn
29	27	num
29	28	nn
EOX
Y	1
ROOT	0	0	31	1	SINV	1	0	31	4	S	0	0	21	3	S	1	0	11	2	NP	2	0	3	3	NN	0	0	1	1	HRG	0	0	1	0	NN	0	1	2	1	ligand	1	1	2	0	NN	0	2	3	1	expression	2	2	3	0	VP	2	3	11	3	VBD	0	3	4	1	was	3	3	4	0	RB	0	4	5	1	not	4	4	5	0	VP	0	5	11	2	VBN	0	5	6	1	increased	5	5	6	0	PP	0	6	11	2	IN	0	6	7	1	with	6	6	7	0	NP	3	7	11	4	NN	0	7	8	1	AZD6244	7	7	8	0	CD	0	8	9	1	(	8	8	9	0	NNP	0	9	10	1	Supplemental	9	9	10	0	NN	0	10	11	1	)	10	10	11	0	:	0	11	12	1	;	11	11	12	0	S	3	12	21	4	ADVP	0	12	13	1	RB	0	12	13	1	however	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	1	14	16	2	NN	0	14	15	1	MEK	14	14	15	0	NN	0	15	16	1	inhibitor	15	15	16	0	VP	0	16	21	2	VBD	0	16	17	1	induced	16	16	17	0	NP	0	17	21	2	NP	1	17	19	2	NN	0	17	18	1	feedback	17	17	18	0	NN	0	18	19	1	activation	18	18	19	0	PP	0	19	21	2	IN	0	19	20	1	of	19	19	20	0	NP	0	20	21	1	NNP	0	20	21	1	AKT	20	20	21	0	VP	0	21	27	2	VBD	0	21	22	1	required	21	21	22	0	NP	2	22	27	3	NP	0	22	25	3	NN	0	22	23	1	EGFR	22	22	23	0	CC	0	23	24	1	or	23	23	24	0	NN	0	24	25	1	HER2	24	24	25	0	NN	0	25	26	1	kinase	25	25	26	0	NN	0	26	27	1	activity	26	26	27	0	NP	2	27	30	3	CD	0	27	28	1	(	27	27	28	0	NNP	0	28	29	1	Supplemental	28	28	29	0	NN	0	29	30	1	)	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	20
Indeed	20350	20356	RB	indeed	O	_	_
,	20356	20357	,	,	O	_	_
even	20358	20362	RB	even	O	_	_
in	20363	20365	IN	in	O	_	_
KRAS-mutant	20366	20377	JJ	kras-mutant	O	_	_
SW1463	20378	20384	NN	sw1463	O	_	_
cells	20385	20390	NNS	cell	O	_	_
,	20390	20391	,	,	O	_	_
MEK	20392	20395	NN	mek	B-GENE	_	_
feedback	20396	20404	NN	feedback	I-GENE	_	_
on	20405	20407	IN	on	O	_	_
ERBB3	20408	20413	NN	erbb3	B-GENE	_	_
was	20414	20417	VBD	be	O	_	_
still	20418	20423	RB	still	O	_	_
dependent	20424	20433	JJ	dependent	O	_	_
on	20434	20436	IN	on	O	_	_
EGFR	20437	20441	NN	egfr	B-GENE	_	_
kinase	20442	20448	NN	kinase	I-GENE	_	_
activity	20449	20457	NN	activity	O	_	_
.	20470	20471	.	.	O	_	_
D	1
14
6	4	amod
6	5	nn
9	8	nn
9	11	prep_on
14	0	advmod
14	2	advmod
14	6	prep_in
14	9	nsubj
14	12	cop
14	13	advmod
14	18	prep_on
18	16	nn
18	17	nn
EOX
Y	1
ROOT	0	0	20	1	S	5	0	20	7	ADVP	0	0	1	1	RB	0	0	1	1	Indeed	0	0	1	0	,	0	1	2	1	,	1	1	2	0	PP	1	2	7	3	RB	0	2	3	1	even	2	2	3	0	IN	0	3	4	1	in	3	3	4	0	NP	2	4	7	3	JJ	0	4	5	1	KRAS-mutant	4	4	5	0	NN	0	5	6	1	SW1463	5	5	6	0	NNS	0	6	7	1	cells	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	0	8	12	2	NP	1	8	10	2	NN	0	8	9	1	MEK	8	8	9	0	NN	0	9	10	1	feedback	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	on	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	ERBB3	11	11	12	0	VP	2	12	19	3	VBD	0	12	13	1	was	12	12	13	0	ADVP	0	13	14	1	RB	0	13	14	1	still	13	13	14	0	ADJP	0	14	19	2	JJ	0	14	15	1	dependent	14	14	15	0	PP	0	15	19	2	IN	0	15	16	1	on	15	15	16	0	NP	2	16	19	3	NN	0	16	17	1	EGFR	16	16	17	0	NN	0	17	18	1	kinase	17	17	18	0	NN	0	18	19	1	activity	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	26
Because	20472	20479	IN	because	O	_	_
EGFR	20480	20484	NN	egfr	B-GENE	_	_
and	20485	20488	CC	and	O	_	_
HER2	20489	20493	NN	her2	B-GENE	_	_
inhibition	20494	20504	NN	inhibition	O	_	_
blocked	20505	20512	VBD	block	O	_	_
MEK	20513	20516	NN	mek	B-GENE	_	_
feedback	20517	20525	NN	feedback	O	_	_
activation	20526	20536	NN	activation	O	_	_
of	20537	20539	IN	of	O	_	_
ERBB3	20540	20545	NN	erbb3	B-GENE	_	_
/	20545	20546	:	/	B-GENE	_	_
PI3K/AKT	20546	20554	NN	pi3k/akt	B-GENE	_	_
,	20554	20555	,	,	O	_	_
we	20556	20558	PRP	we	O	_	_
investigated	20559	20571	VBD	investigate	O	_	_
whether	20572	20579	IN	whether	O	_	_
MEK	20580	20583	NN	mek	B-GENE	_	_
inhibition	20584	20594	NN	inhibition	O	_	_
affected	20595	20603	VBD	affect	O	_	_
the	20604	20607	DT	the	O	_	_
activation	20608	20618	NN	activation	O	_	_
of	20619	20621	IN	of	O	_	_
these	20622	20627	DT	these	O	_	_
receptors	20628	20637	NNS	receptor	O	_	_
.	20637	20638	.	.	O	_	_
D	1
15
1	3	conj_and
4	1	nn
4	3	nn
5	0	mark
5	4	nsubj
5	8	dobj
8	6	nn
8	7	nn
8	10	prep_of
10	12	dep
12	11	punct
15	5	advcl
15	14	nsubj
15	19	ccomp
18	17	nn
19	16	mark
19	18	nsubj
19	21	dobj
21	20	det
21	24	prep_of
24	23	det
EOX
Y	1
ROOT	0	0	26	1	S	3	0	26	5	SBAR	1	0	13	2	IN	0	0	1	1	Because	0	0	1	0	S	1	1	13	2	NP	1	1	5	2	NP	0	1	4	3	NN	0	1	2	1	EGFR	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NN	0	3	4	1	HER2	3	3	4	0	NN	0	4	5	1	inhibition	4	4	5	0	VP	0	5	13	2	VBD	0	5	6	1	blocked	5	5	6	0	NP	0	6	13	2	NP	2	6	9	3	NN	0	6	7	1	MEK	6	6	7	0	NN	0	7	8	1	feedback	7	7	8	0	NN	0	8	9	1	activation	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	13	2	NP	0	10	11	1	NN	0	10	11	1	ERBB3	10	10	11	0	PRN	1	11	13	2	:	0	11	12	1	/	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	PI3K/AKT	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	0	14	15	1	PRP	0	14	15	1	we	14	14	15	0	VP	0	15	25	2	VBD	0	15	16	1	investigated	15	15	16	0	SBAR	1	16	25	2	IN	0	16	17	1	whether	16	16	17	0	S	1	17	25	2	NP	1	17	19	2	NN	0	17	18	1	MEK	17	17	18	0	NN	0	18	19	1	inhibition	18	18	19	0	VP	0	19	25	2	VBD	0	19	20	1	affected	19	19	20	0	NP	0	20	25	2	NP	1	20	22	2	DT	0	20	21	1	the	20	20	21	0	NN	0	21	22	1	activation	21	21	22	0	PP	0	22	25	2	IN	0	22	23	1	of	22	22	23	0	NP	1	23	25	2	DT	0	23	24	1	these	23	23	24	0	NNS	0	24	25	1	receptors	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	24
Treatment	20639	20648	NN	treatment	O	_	_
of	20649	20651	IN	of	O	_	_
HCC827	20652	20658	NN	hcc827	O	_	_
and	20659	20662	CC	and	O	_	_
BT-474	20663	20669	NN	bt-474	O	_	_
cells	20670	20675	NNS	cell	O	_	_
with	20676	20680	IN	with	O	_	_
AZD6244	20681	20688	NN	azd6244	O	_	_
resulted	20689	20697	VBD	result	O	_	_
in	20698	20700	IN	in	O	_	_
increased	20701	20710	VBN	increase	O	_	_
tyrosine	20711	20719	NN	tyrosine	O	_	_
phosphorylation	20720	20735	NN	phosphorylation	O	_	_
of	20736	20738	IN	of	O	_	_
both	20739	20743	CC	both	O	_	_
EGFR	20744	20748	NN	egfr	B-GENE	_	_
and	20749	20752	CC	and	O	_	_
HER2	20753	20757	NN	her2	B-GENE	_	_
,	20757	20758	,	,	O	_	_
indicative	20759	20769	JJ	indicative	O	_	_
of	20770	20772	IN	of	O	_	_
receptor	20773	20781	NN	receptor	O	_	_
activation	20782	20792	NN	activation	O	_	_
.	20804	20805	.	.	O	_	_
D	1
8
0	5	prep_of
2	4	conj_and
5	2	nn
5	4	nn
5	7	prep_with
8	0	nsubj
8	12	prep_in
12	10	amod
12	11	nn
12	15	prep_of
12	17	prep_of
15	14	preconj
15	17	conj_and
15	22	dep
19	21	prep_of
22	19	amod
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	0	0	8	2	NP	0	0	1	1	NN	0	0	1	1	Treatment	0	0	1	0	PP	0	1	8	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	8	2	NP	1	2	6	2	NP	0	2	5	3	NN	0	2	3	1	HCC827	2	2	3	0	CC	0	3	4	1	and	3	3	4	0	NN	0	4	5	1	BT-474	4	4	5	0	NNS	0	5	6	1	cells	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	with	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	AZD6244	7	7	8	0	VP	0	8	23	2	VBD	0	8	9	1	resulted	8	8	9	0	PP	0	9	23	2	IN	0	9	10	1	in	9	9	10	0	NP	0	10	23	2	NP	2	10	13	3	VBN	0	10	11	1	increased	10	10	11	0	NN	0	11	12	1	tyrosine	11	11	12	0	NN	0	12	13	1	phosphorylation	12	12	13	0	PP	0	13	23	2	IN	0	13	14	1	of	13	13	14	0	NP	1	14	23	4	CC	0	14	15	1	both	14	14	15	0	NP	0	15	18	3	NN	0	15	16	1	EGFR	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	NN	0	17	18	1	HER2	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	1	19	23	2	ADJP	0	19	22	2	JJ	0	19	20	1	indicative	19	19	20	0	PP	0	20	22	2	IN	0	20	21	1	of	20	20	21	0	NP	0	21	22	1	NN	0	21	22	1	receptor	21	21	22	0	NN	0	22	23	1	activation	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	19
It	20806	20808	PRP	it	O	_	_
has	20809	20812	VBZ	have	O	_	_
been	20813	20817	VBN	be	O	_	_
reported	20818	20826	VBN	report	O	_	_
that	20827	20831	IN	that	O	_	_
activation	20832	20842	NN	activation	O	_	_
of	20843	20845	IN	of	O	_	_
EGFR	20846	20850	NN	egfr	B-GENE	_	_
involves	20851	20859	VBZ	involve	O	_	_
the	20860	20863	DT	the	O	_	_
formation	20864	20873	NN	formation	O	_	_
of	20874	20876	IN	of	O	_	_
an	20877	20879	DT	a	O	_	_
asymmetric	20880	20890	JJ	asymmetric	O	_	_
dimer	20891	20896	NN	dimer	O	_	_
(	20897	20898	NN	(	O	_	_
34	20898	20900	CD	34	O	_	_
)	20900	20901	NN	)	O	_	_
.	20901	20902	.	.	O	_	_
D	1
3
3	0	nsubjpass
3	1	aux
3	2	auxpass
3	8	ccomp
5	7	prep_of
8	4	mark
8	5	nsubj
8	10	dobj
10	9	det
10	15	prep_of
15	12	det
15	13	amod
15	14	nn
15	17	amod
17	16	number
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	18	2	VBZ	0	1	2	1	has	1	1	2	0	VP	1	2	18	2	VBN	0	2	3	1	been	2	2	3	0	VP	0	3	18	2	VBN	0	3	4	1	reported	3	3	4	0	SBAR	1	4	18	2	IN	0	4	5	1	that	4	4	5	0	S	1	5	18	2	NP	0	5	8	2	NP	0	5	6	1	NN	0	5	6	1	activation	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	EGFR	7	7	8	0	VP	0	8	18	2	VBZ	0	8	9	1	involves	8	8	9	0	NP	0	9	18	2	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	formation	10	10	11	0	PP	0	11	18	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	18	2	NP	3	12	16	4	DT	0	12	13	1	an	12	12	13	0	JJ	0	13	14	1	asymmetric	13	13	14	0	NN	0	14	15	1	dimer	14	14	15	0	NN	0	15	16	1	(	15	15	16	0	ADJP	1	16	18	2	CD	0	16	17	1	34	16	16	17	0	NN	0	17	18	1	)	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	49
Formation	20903	20912	NN	formation	O	_	_
of	20913	20915	IN	of	O	_	_
the	20916	20919	DT	the	O	_	_
active	20920	20926	JJ	active	O	_	_
RTK	20927	20930	NN	rtk	O	_	_
dimer	20931	20936	NN	dimer	O	_	_
is	20937	20939	VBZ	be	O	_	_
facilitated	20940	20951	VBN	facilitate	O	_	_
by	20952	20954	IN	by	O	_	_
stabilizing	20955	20966	VBG	stabilize	O	_	_
contacts	20967	20975	NNS	contact	O	_	_
made	20976	20980	VBN	make	O	_	_
between	20981	20988	IN	between	O	_	_
the	20989	20992	DT	the	O	_	_
juxtamembrane	20993	21006	NN	juxtamembrane	O	_	_
(	21007	21008	CD	(	O	_	_
JM	21008	21010	NN	jm	O	_	_
)	21010	21011	NN	)	O	_	_
domain	21012	21018	NN	domain	O	_	_
of	21019	21021	IN	of	O	_	_
the	21022	21025	DT	the	O	_	_
‚	21026	21027	NN	‚	O	_	_
Äúreceiver	21027	21037	NN	äúreceiver	O	_	_
/	21037	21038	:	/	O	_	_
acceptor	21038	21046	NN	acceptor	O	_	_
‚	21046	21047	CD	‚	O	_	_
Äù	21047	21049	NN	äù	O	_	_
kinase	21050	21056	NN	kinase	O	_	_
and	21057	21060	CC	and	O	_	_
the	21061	21064	DT	the	O	_	_
C-terminal	21065	21075	JJ	c-terminal	O	_	_
lobe	21076	21080	NN	lobe	O	_	_
of	21081	21083	IN	of	O	_	_
the	21084	21087	DT	the	O	_	_
‚	21088	21089	NN	‚	O	_	_
Äúactivator	21089	21100	NN	äúactivator	O	_	_
/	21100	21101	:	/	O	_	_
donor	21101	21106	NN	donor	O	_	_
‚	21106	21107	NN	‚	O	_	_
Äù	21107	21109	NN	äù	O	_	_
kinase	21110	21116	NN	kinase	O	_	_
(	21117	21118	CD	(	O	_	_
21	21118	21120	CD	21	O	_	_
,	21120	21121	,	,	O	_	_
34	21122	21124	CD	34	O	_	_
,	21124	21125	,	,	O	_	_
35	21126	21128	CD	35	O	_	_
)	21128	21129	NN	)	O	_	_
.	21129	21130	.	.	O	_	_
D	1
7
0	5	prep_of
5	2	det
5	3	amod
5	4	nn
7	0	nsubjpass
7	6	auxpass
7	9	agent
9	10	dobj
10	11	vmod
11	18	prep_between
18	13	det
18	14	nn
18	15	num
18	16	nn
18	17	nn
18	19	prep
19	21	dep
21	20	det
21	22	dep
21	23	punct
21	27	dep
21	31	dep
21	36	punct
21	40	dep
27	24	nn
27	25	num
27	26	nn
27	31	conj_and
27	35	prep_of
31	29	det
31	30	amod
35	33	det
35	34	nn
40	37	nn
40	38	nn
40	39	nn
40	42	dep
42	41	num
42	44	amod
42	47	appos
47	46	num
EOX
Y	1
ROOT	0	0	49	1	S	1	0	49	3	NP	0	0	6	2	NP	0	0	1	1	NN	0	0	1	1	Formation	0	0	1	0	PP	0	1	6	2	IN	0	1	2	1	of	1	1	2	0	NP	3	2	6	4	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	active	3	3	4	0	NN	0	4	5	1	RTK	4	4	5	0	NN	0	5	6	1	dimer	5	5	6	0	VP	1	6	48	2	VBZ	0	6	7	1	is	6	6	7	0	VP	0	7	48	2	VBN	0	7	8	1	facilitated	7	7	8	0	PP	0	8	48	2	IN	0	8	9	1	by	8	8	9	0	S	0	9	48	1	VP	0	9	48	2	VBG	0	9	10	1	stabilizing	9	9	10	0	NP	0	10	48	2	NP	0	10	11	1	NNS	0	10	11	1	contacts	10	10	11	0	VP	0	11	48	2	VBN	0	11	12	1	made	11	11	12	0	PP	0	12	48	2	IN	0	12	13	1	between	12	12	13	0	NP	0	13	48	2	NP	5	13	19	6	DT	0	13	14	1	the	13	13	14	0	NN	0	14	15	1	juxtamembrane	14	14	15	0	CD	0	15	16	1	(	15	15	16	0	NN	0	16	17	1	JM	16	16	17	0	NN	0	17	18	1	)	17	17	18	0	NN	0	18	19	1	domain	18	18	19	0	PP	0	19	48	2	IN	0	19	20	1	of	19	19	20	0	FRAG	0	20	48	3	FRAG	0	20	36	3	NP	0	20	23	2	NP	1	20	22	2	DT	0	20	21	1	the	20	20	21	0	NN	0	21	22	1	‚	21	21	22	0	NP	0	22	23	1	NN	0	22	23	1	Äúreceiver	22	22	23	0	:	0	23	24	1	/	23	23	24	0	NP	0	24	36	2	NP	0	24	32	3	NP	3	24	28	4	NN	0	24	25	1	acceptor	24	24	25	0	CD	0	25	26	1	‚	25	25	26	0	NN	0	26	27	1	Äù	26	26	27	0	NN	0	27	28	1	kinase	27	27	28	0	CC	0	28	29	1	and	28	28	29	0	NP	2	29	32	3	DT	0	29	30	1	the	29	29	30	0	JJ	0	30	31	1	C-terminal	30	30	31	0	NN	0	31	32	1	lobe	31	31	32	0	PP	0	32	36	2	IN	0	32	33	1	of	32	32	33	0	NP	2	33	36	3	DT	0	33	34	1	the	33	33	34	0	NN	0	34	35	1	‚	34	34	35	0	NN	0	35	36	1	Äúactivator	35	35	36	0	:	0	36	37	1	/	36	36	37	0	FRAG	0	37	48	2	NP	3	37	41	4	NN	0	37	38	1	donor	37	37	38	0	NN	0	38	39	1	‚	38	38	39	0	NN	0	39	40	1	Äù	39	39	40	0	NN	0	40	41	1	kinase	40	40	41	0	NP	0	41	48	5	NP	1	41	43	2	CD	0	41	42	1	(	41	41	42	0	CD	0	42	43	1	21	42	42	43	0	,	0	43	44	1	,	43	43	44	0	NP	0	44	45	1	CD	0	44	45	1	34	44	44	45	0	,	0	45	46	1	,	45	45	46	0	NP	1	46	48	2	CD	0	46	47	1	35	46	46	47	0	NN	0	47	48	1	)	47	47	48	0	.	0	48	49	1	.	48	48	49	0
EOS
T	28
Threonine	21131	21140	NN	threonine	O	_	_
669	21141	21144	CD	669	O	_	_
of	21145	21147	IN	of	O	_	_
EGFR	21148	21152	NN	egfr	B-GENE	_	_
,	21152	21153	,	,	O	_	_
a	21154	21155	DT	a	O	_	_
putative	21156	21164	JJ	putative	O	_	_
MAPK	21165	21169	NN	mapk	O	_	_
target	21170	21176	NN	target	O	_	_
site	21177	21181	NN	site	O	_	_
,	21181	21182	,	,	O	_	_
is	21183	21185	VBZ	be	O	_	_
conserved	21186	21195	VBN	conserve	O	_	_
within	21196	21202	IN	within	O	_	_
the	21203	21206	DT	the	O	_	_
JM	21207	21209	NN	jm	O	_	_
domains	21210	21217	NNS	domain	O	_	_
of	21218	21220	IN	of	O	_	_
EGFR	21221	21225	NN	egfr	B-GENE	_	_
,	21225	21226	,	,	O	_	_
HER2	21227	21231	NN	her2	B-GENE	_	_
,	21231	21232	,	,	O	_	_
and	21233	21236	CC	and	O	_	_
ERBB4	21237	21242	NN	erbb4	O	_	_
(	21243	21244	CD	(	O	_	_
21	21244	21246	CD	21	O	_	_
)	21246	21247	NN	)	O	_	_
.	21247	21248	.	.	O	_	_
D	1
12
0	1	num
0	3	prep_of
0	9	appos
9	5	det
9	6	amod
9	7	nn
9	8	nn
12	0	nsubjpass
12	11	auxpass
12	16	prep_within
16	14	det
16	15	nn
16	18	prep_of
16	20	prep_of
16	23	prep_of
18	20	conj_and
18	23	conj_and
18	26	dep
25	24	number
26	25	dep
EOX
Y	1
ROOT	0	0	28	1	S	1	0	28	3	NP	0	0	11	4	NP	0	0	4	2	NP	0	0	2	2	NN	0	0	1	1	Threonine	0	0	1	0	CD	0	1	2	1	669	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	EGFR	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	4	5	10	5	DT	0	5	6	1	a	5	5	6	0	JJ	0	6	7	1	putative	6	6	7	0	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	target	8	8	9	0	NN	0	9	10	1	site	9	9	10	0	,	0	10	11	1	,	10	10	11	0	VP	1	11	27	2	VBZ	0	11	12	1	is	11	11	12	0	VP	0	12	27	2	VBN	0	12	13	1	conserved	12	12	13	0	PP	0	13	27	2	IN	0	13	14	1	within	13	13	14	0	NP	0	14	27	2	NP	2	14	17	3	DT	0	14	15	1	the	14	14	15	0	NN	0	15	16	1	JM	15	15	16	0	NNS	0	16	17	1	domains	16	16	17	0	PP	0	17	27	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	27	2	NP	0	18	24	6	NN	0	18	19	1	EGFR	18	18	19	0	,	0	19	20	1	,	19	19	20	0	NN	0	20	21	1	HER2	20	20	21	0	,	0	21	22	1	,	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	NN	0	23	24	1	ERBB4	23	23	24	0	ADJP	1	24	27	2	QP	1	24	26	2	CD	0	24	25	1	(	24	24	25	0	CD	0	25	26	1	21	25	25	26	0	NN	0	26	27	1	)	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	29
When	21249	21253	WRB	when	O	_	_
overexpressed	21254	21267	VBN	overexpress	O	_	_
in	21268	21270	IN	in	O	_	_
CHO-KI	21271	21277	NN	cho-kus	O	_	_
cells	21278	21283	NNS	cell	O	_	_
,	21283	21284	,	,	O	_	_
mutation	21285	21293	NN	mutation	O	_	_
of	21294	21296	IN	of	O	_	_
this	21297	21301	DT	this	O	_	_
threonine	21302	21311	NN	threonine	O	_	_
site	21312	21316	NN	site	O	_	_
has	21317	21320	VBZ	have	O	_	_
been	21321	21325	VBN	be	O	_	_
shown	21326	21331	VBN	show	O	_	_
to	21332	21334	TO	to	O	_	_
augment	21335	21342	VB	augment	O	_	_
EGFR	21343	21347	NN	egfr	B-GENE	_	_
tyrosine	21348	21356	NN	tyrosine	O	_	_
phosphorylation	21357	21372	NN	phosphorylation	O	_	_
(	21373	21374	CD	(	O	_	_
20	21374	21376	CD	20	O	_	_
,	21376	21377	,	,	O	_	_
21	21378	21380	CD	21	O	_	_
,	21380	21381	,	,	O	_	_
36	21382	21384	CD	36	O	_	_
,	21384	21385	,	,	O	_	_
37	21386	21388	CD	37	O	_	_
)	21388	21389	NN	)	O	_	_
.	21389	21390	.	.	O	_	_
D	1
13
1	0	advmod
1	4	prep_in
4	3	nn
6	10	prep_of
10	8	det
10	9	nn
13	1	advcl
13	6	nsubjpass
13	11	aux
13	12	auxpass
13	15	xcomp
15	14	aux
15	18	dobj
18	16	nn
18	17	nn
18	20	dep
18	22	appos
20	19	number
22	24	amod
22	27	appos
27	26	num
EOX
Y	1
ROOT	0	0	29	1	S	3	0	29	5	SBAR	1	0	5	2	WHADVP	0	0	1	1	WRB	0	0	1	1	When	0	0	1	0	S	0	1	5	1	VP	0	1	5	2	VBN	0	1	2	1	overexpressed	1	1	2	0	PP	0	2	5	2	IN	0	2	3	1	in	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	CHO-KI	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	11	2	NP	0	6	7	1	NN	0	6	7	1	mutation	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	2	8	11	3	DT	0	8	9	1	this	8	8	9	0	NN	0	9	10	1	threonine	9	9	10	0	NN	0	10	11	1	site	10	10	11	0	VP	1	11	28	2	VBZ	0	11	12	1	has	11	11	12	0	VP	1	12	28	2	VBN	0	12	13	1	been	12	12	13	0	VP	0	13	28	2	VBN	0	13	14	1	shown	13	13	14	0	S	0	14	28	1	VP	1	14	28	2	TO	0	14	15	1	to	14	14	15	0	VP	0	15	28	2	VB	0	15	16	1	augment	15	15	16	0	NP	0	16	28	3	NP	0	16	21	2	NP	2	16	19	3	NN	0	16	17	1	EGFR	16	16	17	0	NN	0	17	18	1	tyrosine	17	17	18	0	NN	0	18	19	1	phosphorylation	18	18	19	0	NP	0	19	21	1	QP	1	19	21	2	CD	0	19	20	1	(	19	19	20	0	CD	0	20	21	1	20	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	0	22	28	5	NP	0	22	23	1	CD	0	22	23	1	21	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	0	24	25	1	CD	0	24	25	1	36	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NP	1	26	28	2	CD	0	26	27	1	37	26	26	27	0	NN	0	27	28	1	)	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	21
However	21391	21398	RB	however	O	_	_
,	21398	21399	,	,	O	_	_
the	21400	21403	DT	the	O	_	_
physiological	21404	21417	JJ	physiological	O	_	_
consequences	21418	21430	NNS	consequence	O	_	_
of	21431	21433	IN	of	O	_	_
EGFR	21434	21438	NN	egfr	B-GENE	_	_
T669	21439	21443	NN	t669	O	_	_
phosphorylation	21444	21459	NN	phosphorylation	O	_	_
in	21460	21462	IN	in	O	_	_
cancer	21463	21469	NN	cancer	O	_	_
models	21470	21476	NNS	model	O	_	_
and	21477	21480	CC	and	O	_	_
on	21481	21483	IN	on	O	_	_
ERBB3	21484	21489	NN	erbb3	B-GENE	_	_
/	21489	21490	:	/	B-GENE	_	_
PI3K/AKT	21490	21498	NN	pi3k/akt	B-GENE	_	_
signaling	21499	21508	NN	signaling	O	_	_
remained	21509	21517	VBD	remain	O	_	_
unknown	21518	21525	JJ	unknown	O	_	_
.	21525	21526	.	.	O	_	_
D	1
19
4	2	det
4	3	amod
4	8	prep_of
8	6	nn
8	7	nn
8	8	conj_and
8	11	prep_in
8	14	prep_on
11	10	nn
14	17	dep
17	15	punct
17	16	nn
19	0	advmod
19	4	nsubj
19	18	cop
EOX
Y	1
ROOT	0	0	21	1	S	3	0	21	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	18	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	physiological	3	3	4	0	NNS	0	4	5	1	consequences	4	4	5	0	PP	0	5	18	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	18	2	NP	2	6	9	3	NN	0	6	7	1	EGFR	6	6	7	0	NN	0	7	8	1	T669	7	7	8	0	NN	0	8	9	1	phosphorylation	8	8	9	0	PP	0	9	18	3	PP	0	9	12	2	IN	0	9	10	1	in	9	9	10	0	NP	1	10	12	2	NN	0	10	11	1	cancer	10	10	11	0	NNS	0	11	12	1	models	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	PP	0	13	18	2	IN	0	13	14	1	on	13	13	14	0	NP	0	14	18	2	NP	0	14	15	1	NN	0	14	15	1	ERBB3	14	14	15	0	PRN	1	15	18	2	:	0	15	16	1	/	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	PI3K/AKT	16	16	17	0	NN	0	17	18	1	signaling	17	17	18	0	VP	1	18	20	2	VBD	0	18	19	1	remained	18	18	19	0	ADJP	0	19	20	1	JJ	0	19	20	1	unknown	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	62
MEK	21536	21539	NN	mek	B-GENE	_	_
inhibition	21540	21550	NN	inhibition	O	_	_
blocks	21551	21557	VBZ	block	O	_	_
phosphorylation	21558	21573	NN	phosphorylation	O	_	_
of	21574	21576	IN	of	O	_	_
a	21577	21578	DT	a	O	_	_
direct	21579	21585	JJ	direct	O	_	_
ERK	21586	21589	NN	erk	B-GENE	_	_
target	21590	21596	NN	target	O	_	_
site	21597	21601	NN	site	O	_	_
in	21602	21604	IN	in	O	_	_
the	21605	21608	DT	the	O	_	_
conserved	21609	21618	VBN	conserve	O	_	_
JM	21619	21621	NN	jm	O	_	_
domains	21622	21629	NNS	domain	O	_	_
of	21630	21632	IN	of	O	_	_
EGFR	21633	21637	NN	egfr	B-GENE	_	_
and	21638	21641	CC	and	O	_	_
HER2	21642	21646	NN	her2	O	_	_
We	21647	21649	PRP	we	O	_	_
hypothesized	21650	21662	VBD	hypothesize	O	_	_
that	21663	21667	IN	that	O	_	_
the	21668	21671	DT	the	O	_	_
MEK	21672	21675	NN	mek	B-GENE	_	_
/	21675	21676	:	/	B-GENE	_	_
ERK	21676	21679	NN	erk	I-GENE	_	_
pathway	21680	21687	NN	pathway	O	_	_
may	21688	21691	MD	may	O	_	_
suppress	21692	21700	VB	suppress	O	_	_
trans-phosphorylation	21701	21722	NN	trans-phosphorylation	O	_	_
of	21723	21725	IN	of	O	_	_
ERBB3	21726	21731	NN	erbb3	B-GENE	_	_
by	21732	21734	IN	by	O	_	_
directly	21735	21743	RB	directly	O	_	_
phosphorylating	21744	21759	VBG	phosphorylate	O	_	_
the	21760	21763	DT	the	O	_	_
JM	21764	21766	NN	jm	B-GENE	_	_
domains	21767	21774	NNS	domain	I-GENE	_	_
of	21775	21777	IN	of	O	_	_
EGFR	21778	21782	NN	egfr	B-GENE	_	_
and	21783	21786	CC	and	O	_	_
HER2	21787	21791	NN	her2	B-GENE	_	_
,	21791	21792	,	,	O	_	_
and	21793	21796	CC	and	O	_	_
that	21797	21801	IN	that	O	_	_
this	21802	21806	DT	this	O	_	_
could	21807	21812	MD	could	O	_	_
be	21813	21815	VB	be	O	_	_
a	21816	21817	DT	a	O	_	_
dominant	21818	21826	JJ	dominant	O	_	_
MEK	21827	21830	NN	mek	B-GENE	_	_
inhibitor	21831	21840	NN	inhibitor	O	_	_
induced	21841	21848	VBD	induce	O	_	_
feedback	21849	21857	NN	feedback	O	_	_
leading	21858	21865	VBG	lead	O	_	_
to	21866	21868	TO	to	O	_	_
AKT	21869	21872	NN	akt	B-GENE	_	_
activation	21873	21883	NN	activation	O	_	_
in	21884	21886	IN	in	O	_	_
these	21887	21892	DT	these	O	_	_
cancers	21893	21900	NNS	cancer	O	_	_
.	21900	21901	.	.	O	_	_
D	1
2
1	0	nn
2	1	nsubj
2	52	ccomp
3	9	prep_of
9	5	det
9	6	amod
9	7	nn
9	8	nn
9	11	prep_in
11	12	vmod
12	14	dobj
12	20	ccomp
12	51	ccomp
14	13	nn
14	16	prep_of
14	18	prep_of
16	18	conj_and
20	19	nsubj
20	23	dep
20	51	conj_and
23	21	mark
23	22	det
23	24	punct
23	28	dep
26	25	nn
28	26	nsubj
28	27	aux
28	29	dobj
28	34	prepc_by
29	31	prep_of
34	33	advmod
34	37	dobj
37	35	det
37	36	nn
37	39	prep_of
37	41	prep_of
39	41	conj_and
51	44	mark
51	45	nsubj
51	46	aux
51	47	cop
51	48	det
51	49	amod
51	50	nn
52	3	nsubj
52	53	dobj
52	57	prep_to
53	54	amod
57	56	nn
57	60	prep_in
60	59	det
EOX
Y	1
ROOT	0	0	62	1	S	1	0	62	3	NP	1	0	2	2	NN	0	0	1	1	MEK	0	0	1	0	NN	0	1	2	1	inhibition	1	1	2	0	VP	0	2	61	2	VBZ	0	2	3	1	blocks	2	2	3	0	SBAR	0	3	61	1	S	1	3	61	2	NP	0	3	52	2	NP	0	3	4	1	NN	0	3	4	1	phosphorylation	3	3	4	0	PP	0	4	52	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	52	2	NP	4	5	10	5	DT	0	5	6	1	a	5	5	6	0	JJ	0	6	7	1	direct	6	6	7	0	NN	0	7	8	1	ERK	7	7	8	0	NN	0	8	9	1	target	8	8	9	0	NN	0	9	10	1	site	9	9	10	0	PP	0	10	52	2	IN	0	10	11	1	in	10	10	11	0	NP	0	11	52	2	NP	0	11	12	1	DT	0	11	12	1	the	11	11	12	0	VP	0	12	52	3	VBN	0	12	13	1	conserved	12	12	13	0	NP	0	13	19	2	NP	1	13	15	2	NN	0	13	14	1	JM	13	13	14	0	NNS	0	14	15	1	domains	14	14	15	0	PP	0	15	19	2	IN	0	15	16	1	of	15	15	16	0	NP	0	16	19	3	NN	0	16	17	1	EGFR	16	16	17	0	CC	0	17	18	1	and	17	17	18	0	NN	0	18	19	1	HER2	18	18	19	0	SBAR	0	19	52	4	SBAR	0	19	42	1	S	1	19	42	2	NP	0	19	20	1	PRP	0	19	20	1	We	19	19	20	0	VP	0	20	42	2	VBD	0	20	21	1	hypothesized	20	20	21	0	SBAR	1	21	42	2	IN	0	21	22	1	that	21	21	22	0	FRAG	0	22	42	3	NP	1	22	24	2	DT	0	22	23	1	the	22	22	23	0	NN	0	23	24	1	MEK	23	23	24	0	:	0	24	25	1	/	24	24	25	0	S	1	25	42	2	NP	1	25	27	2	NN	0	25	26	1	ERK	25	25	26	0	NN	0	26	27	1	pathway	26	26	27	0	VP	1	27	42	2	MD	0	27	28	1	may	27	27	28	0	VP	0	28	42	3	VB	0	28	29	1	suppress	28	28	29	0	NP	0	29	32	2	NP	0	29	30	1	NN	0	29	30	1	trans-phosphorylation	29	29	30	0	PP	0	30	32	2	IN	0	30	31	1	of	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	ERBB3	31	31	32	0	PP	0	32	42	2	IN	0	32	33	1	by	32	32	33	0	S	1	33	42	2	ADVP	0	33	34	1	RB	0	33	34	1	directly	33	33	34	0	VP	0	34	42	2	VBG	0	34	35	1	phosphorylating	34	34	35	0	NP	0	35	42	2	NP	2	35	38	3	DT	0	35	36	1	the	35	35	36	0	NN	0	36	37	1	JM	36	36	37	0	NNS	0	37	38	1	domains	37	37	38	0	PP	0	38	42	2	IN	0	38	39	1	of	38	38	39	0	NP	0	39	42	3	NN	0	39	40	1	EGFR	39	39	40	0	CC	0	40	41	1	and	40	40	41	0	NN	0	41	42	1	HER2	41	41	42	0	,	0	42	43	1	,	42	42	43	0	CC	0	43	44	1	and	43	43	44	0	SBAR	1	44	52	2	IN	0	44	45	1	that	44	44	45	0	S	1	45	52	2	NP	0	45	46	1	DT	0	45	46	1	this	45	45	46	0	VP	1	46	52	2	MD	0	46	47	1	could	46	46	47	0	VP	1	47	52	2	VB	0	47	48	1	be	47	47	48	0	NP	3	48	52	4	DT	0	48	49	1	a	48	48	49	0	JJ	0	49	50	1	dominant	49	49	50	0	NN	0	50	51	1	MEK	50	50	51	0	NN	0	51	52	1	inhibitor	51	51	52	0	VP	0	52	61	3	VBD	0	52	53	1	induced	52	52	53	0	NP	0	53	55	2	NN	0	53	54	1	feedback	53	53	54	0	VBG	0	54	55	1	leading	54	54	55	0	PP	0	55	61	2	TO	0	55	56	1	to	55	55	56	0	NP	0	56	61	2	NP	1	56	58	2	NN	0	56	57	1	AKT	56	56	57	0	NN	0	57	58	1	activation	57	57	58	0	PP	0	58	61	2	IN	0	58	59	1	in	58	58	59	0	NP	1	59	61	2	DT	0	59	60	1	these	59	59	60	0	NNS	0	60	61	1	cancers	60	60	61	0	.	0	61	62	1	.	61	61	62	0
EOS
T	28
We	21902	21904	PRP	we	O	_	_
used	21905	21909	VBD	use	O	_	_
tandem	21910	21916	JJ	tandem	O	_	_
mass	21917	21921	NN	mass	O	_	_
spectrometry	21922	21934	NN	spectrometry	O	_	_
to	21935	21937	TO	to	O	_	_
measure	21938	21945	VB	measure	O	_	_
the	21946	21949	DT	the	O	_	_
effects	21950	21957	NNS	effect	O	_	_
of	21958	21960	IN	of	O	_	_
AZD6244	21961	21968	NN	azd6244	O	_	_
on	21969	21971	IN	on	O	_	_
phosphorylation	21972	21987	NN	phosphorylation	O	_	_
of	21988	21990	IN	of	O	_	_
this	21991	21995	DT	this	O	_	_
JM	21996	21998	NN	jm	O	_	_
domain	21999	22005	NN	domain	O	_	_
threonine	22006	22015	NN	threonine	O	_	_
residue	22016	22023	NN	residue	O	_	_
in	22024	22026	IN	in	O	_	_
both	22027	22031	CC	both	O	_	_
EGFR-mutant	22032	22043	JJ	egfr-mutant	B-GENE	_	_
and	22044	22047	CC	and	O	_	_
HER2	22048	22052	NN	her2	O	_	_
amplified	22053	22062	VBD	amplify	O	_	_
cancer	22063	22069	NN	cancer	O	_	_
models	22070	22076	NNS	model	O	_	_
.	22076	22077	.	.	O	_	_
D	1
1
1	0	nsubj
1	4	dobj
1	6	xcomp
4	2	amod
4	3	nn
6	5	aux
6	8	dobj
6	12	prep_on
6	24	advcl
8	7	det
8	10	prep_of
12	18	prep_of
18	14	det
18	15	nn
18	16	nn
18	17	nn
21	20	preconj
21	23	conj_and
24	19	mark
24	21	nsubj
24	23	nsubj
24	26	dobj
26	25	nn
EOX
Y	1
ROOT	0	0	28	1	S	1	0	28	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	27	3	VBD	0	1	2	1	used	1	1	2	0	NP	2	2	5	3	JJ	0	2	3	1	tandem	2	2	3	0	NN	0	3	4	1	mass	3	3	4	0	NN	0	4	5	1	spectrometry	4	4	5	0	S	0	5	27	1	VP	1	5	27	2	TO	0	5	6	1	to	5	5	6	0	VP	0	6	27	4	VB	0	6	7	1	measure	6	6	7	0	NP	0	7	11	2	NP	1	7	9	2	DT	0	7	8	1	the	7	7	8	0	NNS	0	8	9	1	effects	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	AZD6244	10	10	11	0	PP	0	11	19	2	IN	0	11	12	1	on	11	11	12	0	NP	0	12	19	2	NP	0	12	13	1	NN	0	12	13	1	phosphorylation	12	12	13	0	PP	0	13	19	2	IN	0	13	14	1	of	13	13	14	0	NP	4	14	19	5	DT	0	14	15	1	this	14	14	15	0	NN	0	15	16	1	JM	15	15	16	0	NN	0	16	17	1	domain	16	16	17	0	NN	0	17	18	1	threonine	17	17	18	0	NN	0	18	19	1	residue	18	18	19	0	SBAR	1	19	27	2	IN	0	19	20	1	in	19	19	20	0	S	1	20	27	2	NP	1	20	24	4	CC	0	20	21	1	both	20	20	21	0	NP	0	21	22	1	JJ	0	21	22	1	EGFR-mutant	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	NP	0	23	24	1	NN	0	23	24	1	HER2	23	23	24	0	VP	0	24	27	2	VBD	0	24	25	1	amplified	24	24	25	0	NP	1	25	27	2	NN	0	25	26	1	cancer	25	25	26	0	NNS	0	26	27	1	models	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	35
Targeting	22078	22087	NN	targeting	O	_	_
both	22088	22092	CC	both	O	_	_
the	22093	22096	DT	the	O	_	_
phosphorylated	22097	22111	VBN	phosphorylate	O	_	_
and	22112	22115	CC	and	O	_	_
non	22116	22119	JJ	non	O	_	_
phosphorylated	22120	22134	VBN	phosphorylate	O	_	_
peptide	22135	22142	NN	peptide	O	_	_
forms	22143	22148	NNS	form	O	_	_
,	22148	22149	,	,	O	_	_
we	22150	22152	PRP	we	O	_	_
detected	22153	22161	VBD	detect	O	_	_
a	22162	22163	DT	a	O	_	_
66	22164	22166	CD	66	O	_	_
%	22166	22167	NN	%	O	_	_
average	22168	22175	JJ	average	O	_	_
decrease	22176	22184	NN	decrease	O	_	_
in	22185	22187	IN	in	O	_	_
EGFR	22188	22192	NN	egfr	B-GENE	_	_
T669	22193	22197	NN	t669	O	_	_
phosphorylation	22198	22213	NN	phosphorylation	O	_	_
and	22214	22217	CC	and	O	_	_
a	22218	22219	DT	a	O	_	_
75	22220	22222	CD	75	O	_	_
%	22222	22223	NN	%	O	_	_
decrease	22224	22232	NN	decrease	O	_	_
in	22233	22235	IN	in	O	_	_
HER2	22236	22240	NN	her2	B-GENE	_	_
T677	22241	22245	NN	t677	I-GENE	_	_
phosphorylation	22246	22261	NN	phosphorylation	O	_	_
upon	22262	22266	IN	upon	O	_	_
treatment	22267	22276	NN	treatment	O	_	_
with	22277	22281	IN	with	O	_	_
AZD6244	22282	22289	NN	azd6244	O	_	_
.	22324	22325	.	.	O	_	_
D	1
11
0	1	dep
0	2	conj
0	3	dep
0	5	dep
3	5	conj_and
6	0	nsubj
6	8	dobj
8	7	nn
11	6	vmod
11	10	nsubj
11	16	dobj
11	20	prep_in
11	25	prep_in
11	31	prep_upon
11	33	prep_with
14	13	number
16	12	det
16	14	amod
16	15	amod
20	18	nn
20	19	nn
20	25	conj_and
24	23	number
25	22	det
25	24	amod
25	29	prep_in
29	27	nn
29	28	nn
EOX
Y	1
ROOT	0	0	35	1	S	3	0	35	5	S	1	0	9	2	NP	0	0	6	2	NP	0	0	3	3	NN	0	0	1	1	Targeting	0	0	1	0	CC	0	1	2	1	both	1	1	2	0	DT	0	2	3	1	the	2	2	3	0	UCP	0	3	6	3	VP	0	3	4	1	VBN	0	3	4	1	phosphorylated	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	ADJP	0	5	6	1	JJ	0	5	6	1	non	5	5	6	0	VP	0	6	9	2	VBN	0	6	7	1	phosphorylated	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	peptide	7	7	8	0	NNS	0	8	9	1	forms	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	11	1	PRP	0	10	11	1	we	10	10	11	0	VP	0	11	34	5	VBD	0	11	12	1	detected	11	11	12	0	NP	3	12	17	4	DT	0	12	13	1	a	12	12	13	0	ADJP	1	13	15	2	CD	0	13	14	1	66	13	13	14	0	NN	0	14	15	1	%	14	14	15	0	JJ	0	15	16	1	average	15	15	16	0	NN	0	16	17	1	decrease	16	16	17	0	PP	0	17	30	2	IN	0	17	18	1	in	17	17	18	0	NP	0	18	30	3	NP	2	18	21	3	NN	0	18	19	1	EGFR	18	18	19	0	NN	0	19	20	1	T669	19	19	20	0	NN	0	20	21	1	phosphorylation	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	NP	0	22	30	2	NP	2	22	26	3	DT	0	22	23	1	a	22	22	23	0	ADJP	1	23	25	2	CD	0	23	24	1	75	23	23	24	0	NN	0	24	25	1	%	24	24	25	0	NN	0	25	26	1	decrease	25	25	26	0	PP	0	26	30	2	IN	0	26	27	1	in	26	26	27	0	NP	2	27	30	3	NN	0	27	28	1	HER2	27	27	28	0	NN	0	28	29	1	T677	28	28	29	0	NN	0	29	30	1	phosphorylation	29	29	30	0	PP	0	30	32	2	IN	0	30	31	1	upon	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	treatment	31	31	32	0	PP	0	32	34	2	IN	0	32	33	1	with	32	32	33	0	NP	0	33	34	1	NN	0	33	34	1	AZD6244	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	21
Phospho	22326	22333	NN	phospho	O	_	_
specific	22334	22342	JJ	specific	O	_	_
antibodies	22343	22353	NNS	antibody	O	_	_
confirmed	22354	22363	VBD	confirm	O	_	_
that	22364	22368	IN	that	O	_	_
treatment	22369	22378	NN	treatment	O	_	_
with	22379	22383	IN	with	O	_	_
AZD6244	22384	22391	NN	azd6244	O	_	_
inhibited	22392	22401	VBD	inhibit	O	_	_
phosphorylation	22402	22417	NN	phosphorylation	O	_	_
of	22418	22420	IN	of	O	_	_
T669	22421	22425	NN	t669	O	_	_
of	22426	22428	IN	of	O	_	_
EGFR	22429	22433	NN	egfr	B-GENE	_	_
and	22434	22437	CC	and	O	_	_
the	22438	22441	DT	the	O	_	_
analogous	22442	22451	JJ	analogous	O	_	_
T677	22452	22456	NN	t677	O	_	_
of	22457	22459	IN	of	O	_	_
HER2	22460	22464	NN	her2	O	_	_
.	22477	22478	.	.	O	_	_
D	1
3
2	0	nn
2	1	amod
3	2	nsubj
3	8	ccomp
5	7	prep_with
8	4	mark
8	5	nsubj
8	9	dobj
9	11	prep_of
9	17	prep_of
11	13	prep_of
11	17	conj_and
17	15	det
17	16	amod
17	19	prep_of
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	2	0	3	3	NN	0	0	1	1	Phospho	0	0	1	0	JJ	0	1	2	1	specific	1	1	2	0	NNS	0	2	3	1	antibodies	2	2	3	0	VP	0	3	20	2	VBD	0	3	4	1	confirmed	3	3	4	0	SBAR	1	4	20	2	IN	0	4	5	1	that	4	4	5	0	S	1	5	20	2	NP	0	5	8	2	NP	0	5	6	1	NN	0	5	6	1	treatment	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	with	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	AZD6244	7	7	8	0	VP	0	8	20	2	VBD	0	8	9	1	inhibited	8	8	9	0	NP	0	9	20	2	NP	0	9	10	1	NN	0	9	10	1	phosphorylation	9	9	10	0	PP	0	10	20	2	IN	0	10	11	1	of	10	10	11	0	NP	0	11	20	3	NP	0	11	14	2	NP	0	11	12	1	NN	0	11	12	1	T669	11	11	12	0	PP	0	12	14	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	EGFR	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	0	15	20	2	NP	2	15	18	3	DT	0	15	16	1	the	15	15	16	0	ADJP	0	16	17	1	JJ	0	16	17	1	analogous	16	16	17	0	NN	0	17	18	1	T677	17	17	18	0	PP	0	18	20	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	HER2	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	28
Together	22479	22487	RB	together	O	_	_
these	22488	22493	DT	these	O	_	_
data	22494	22498	NNS	datum	O	_	_
indicate	22499	22507	VBP	indicate	O	_	_
that	22508	22512	IN	that	O	_	_
loss	22513	22517	NN	loss	O	_	_
of	22518	22520	IN	of	O	_	_
this	22521	22525	DT	this	O	_	_
inhibitory	22526	22536	JJ	inhibitory	O	_	_
threonine	22537	22546	NN	threonine	O	_	_
phosphorylation	22547	22562	NN	phosphorylation	O	_	_
on	22563	22565	IN	on	O	_	_
the	22566	22569	DT	the	O	_	_
JM	22570	22572	NN	jm	O	_	_
domains	22573	22580	NNS	domain	O	_	_
of	22581	22583	IN	of	O	_	_
EGFR	22584	22588	NN	egfr	B-GENE	_	_
and	22589	22592	CC	and	O	_	_
HER2	22593	22597	NN	her2	B-GENE	_	_
occurs	22598	22604	VBZ	occur	O	_	_
in	22605	22607	IN	in	O	_	_
cancer	22608	22614	NN	cancer	O	_	_
cell	22615	22619	NN	cell	O	_	_
lines	22620	22625	NNS	line	O	_	_
following	22626	22635	VBG	follow	O	_	_
MEK	22636	22639	NN	mek	O	_	_
inhibition	22640	22650	NN	inhibition	O	_	_
.	22650	22651	.	.	O	_	_
D	1
3
2	1	det
3	0	advmod
3	2	nsubj
3	19	ccomp
5	10	prep_of
10	7	det
10	8	amod
10	9	nn
10	14	prep_on
14	12	det
14	13	nn
14	16	prep_of
14	18	prep_of
16	18	conj_and
19	4	mark
19	5	nsubj
19	23	prep_in
23	21	nn
23	22	nn
23	26	prep_following
26	25	nn
EOX
Y	1
ROOT	0	0	28	1	S	2	0	28	4	ADVP	0	0	1	1	RB	0	0	1	1	Together	0	0	1	0	NP	1	1	3	2	DT	0	1	2	1	these	1	1	2	0	NNS	0	2	3	1	data	2	2	3	0	VP	0	3	27	2	VBP	0	3	4	1	indicate	3	3	4	0	SBAR	1	4	27	2	IN	0	4	5	1	that	4	4	5	0	S	1	5	27	2	NP	0	5	19	2	NP	0	5	6	1	NN	0	5	6	1	loss	5	5	6	0	PP	0	6	19	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	19	2	NP	3	7	11	4	DT	0	7	8	1	this	7	7	8	0	JJ	0	8	9	1	inhibitory	8	8	9	0	NN	0	9	10	1	threonine	9	9	10	0	NN	0	10	11	1	phosphorylation	10	10	11	0	PP	0	11	19	2	IN	0	11	12	1	on	11	11	12	0	NP	0	12	19	2	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	JM	13	13	14	0	NNS	0	14	15	1	domains	14	14	15	0	PP	0	15	19	2	IN	0	15	16	1	of	15	15	16	0	NP	0	16	19	3	NN	0	16	17	1	EGFR	16	16	17	0	CC	0	17	18	1	and	17	17	18	0	NN	0	18	19	1	HER2	18	18	19	0	VP	0	19	27	2	VBZ	0	19	20	1	occurs	19	19	20	0	PP	0	20	27	2	IN	0	20	21	1	in	20	20	21	0	NP	0	21	27	2	NP	2	21	24	3	NN	0	21	22	1	cancer	21	21	22	0	NN	0	22	23	1	cell	22	22	23	0	NNS	0	23	24	1	lines	23	23	24	0	PP	0	24	27	2	VBG	0	24	25	1	following	24	24	25	0	NP	1	25	27	2	NN	0	25	26	1	MEK	25	25	26	0	NN	0	26	27	1	inhibition	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	45
Mutation	22652	22660	NN	mutation	O	_	_
of	22661	22663	IN	of	O	_	_
T669	22664	22668	NN	t669	O	_	_
and	22669	22672	CC	and	O	_	_
T677	22673	22677	NN	t677	O	_	_
abrogates	22678	22687	VBZ	abrogate	O	_	_
MEK	22688	22691	NN	mek	B-GENE	_	_
inhibitor	22692	22701	NN	inhibitor	O	_	_
induced	22702	22709	VBD	induce	O	_	_
suppression	22710	22721	NN	suppression	O	_	_
of	22722	22724	IN	of	O	_	_
ERBB3	22725	22730	NN	erbb3	B-GENE	_	_
activation	22731	22741	NN	activation	O	_	_
We	22742	22744	PRP	we	O	_	_
hypothesized	22745	22757	VBD	hypothesize	O	_	_
that	22758	22762	IN	that	O	_	_
MEK	22763	22766	NN	mek	B-GENE	_	_
inhibition	22767	22777	NN	inhibition	O	_	_
activates	22778	22787	VBZ	activate	O	_	_
AKT	22788	22791	NN	akt	O	_	_
by	22792	22794	IN	by	O	_	_
inhibiting	22795	22805	VBG	inhibit	O	_	_
ERK	22806	22809	NN	erk	B-GENE	_	_
activity	22810	22818	NN	activity	O	_	_
,	22818	22819	,	,	O	_	_
which	22820	22825	WDT	which	O	_	_
blocks	22826	22832	VBZ	block	O	_	_
an	22833	22835	DT	a	O	_	_
inhibitory	22836	22846	JJ	inhibitory	O	_	_
threonine	22847	22856	NN	threonine	O	_	_
phosphorylation	22857	22872	NN	phosphorylation	O	_	_
on	22873	22875	IN	on	O	_	_
the	22876	22879	DT	the	O	_	_
JM	22880	22882	NN	jm	O	_	_
domains	22883	22890	NNS	domain	O	_	_
of	22891	22893	IN	of	O	_	_
EGFR	22894	22898	NN	egfr	B-GENE	_	_
and	22899	22902	CC	and	O	_	_
HER2	22903	22907	NN	her2	B-GENE	_	_
,	22907	22908	,	,	O	_	_
thereby	22909	22916	RB	thereby	O	_	_
increasing	22917	22927	VBG	increase	O	_	_
ERBB3	22928	22933	NN	erbb3	B-GENE	_	_
phosphorylation	22934	22949	NN	phosphorylation	O	_	_
.	22949	22950	.	.	O	_	_
D	1
5
0	2	prep_of
0	4	prep_of
2	4	conj_and
5	0	nsubj
5	8	ccomp
7	6	nn
8	7	nsubj
8	9	dobj
9	12	prep_of
9	14	rcmod
12	11	nn
14	13	nsubj
14	18	ccomp
17	16	nn
18	15	mark
18	17	nsubj
18	19	dobj
18	23	prep_by
23	21	amod
23	22	nn
23	26	rcmod
26	25	nsubj
26	30	dobj
26	34	prep_on
26	41	vmod
30	27	det
30	28	amod
30	29	nn
34	32	det
34	33	nn
34	36	prep_of
34	38	prep_of
36	38	conj_and
41	40	advmod
41	43	dobj
43	42	nn
EOX
Y	1
ROOT	0	0	45	1	S	1	0	45	3	NP	0	0	5	2	NP	0	0	1	1	NN	0	0	1	1	Mutation	0	0	1	0	PP	0	1	5	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	5	3	NN	0	2	3	1	T669	2	2	3	0	CC	0	3	4	1	and	3	3	4	0	NN	0	4	5	1	T677	4	4	5	0	VP	0	5	44	2	VBZ	0	5	6	1	abrogates	5	5	6	0	SBAR	0	6	44	1	S	1	6	44	2	NP	1	6	8	2	NN	0	6	7	1	MEK	6	6	7	0	NN	0	7	8	1	inhibitor	7	7	8	0	VP	0	8	44	2	VBD	0	8	9	1	induced	8	8	9	0	NP	0	9	44	3	NP	0	9	10	1	NN	0	9	10	1	suppression	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	of	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	ERBB3	11	11	12	0	NN	0	12	13	1	activation	12	12	13	0	SBAR	0	13	44	1	S	1	13	44	2	NP	0	13	14	1	PRP	0	13	14	1	We	13	13	14	0	VP	0	14	44	2	VBD	0	14	15	1	hypothesized	14	14	15	0	SBAR	1	15	44	2	IN	0	15	16	1	that	15	15	16	0	S	1	16	44	2	NP	1	16	18	2	NN	0	16	17	1	MEK	16	16	17	0	NN	0	17	18	1	inhibition	17	17	18	0	VP	0	18	44	3	VBZ	0	18	19	1	activates	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	AKT	19	19	20	0	PP	0	20	44	2	IN	0	20	21	1	by	20	20	21	0	NP	0	21	44	3	NP	2	21	24	3	VBG	0	21	22	1	inhibiting	21	21	22	0	NN	0	22	23	1	ERK	22	22	23	0	NN	0	23	24	1	activity	23	23	24	0	,	0	24	25	1	,	24	24	25	0	SBAR	1	25	44	2	WHNP	0	25	26	1	WDT	0	25	26	1	which	25	25	26	0	S	0	26	44	1	VP	0	26	44	5	VBZ	0	26	27	1	blocks	26	26	27	0	NP	3	27	31	4	DT	0	27	28	1	an	27	27	28	0	JJ	0	28	29	1	inhibitory	28	28	29	0	NN	0	29	30	1	threonine	29	29	30	0	NN	0	30	31	1	phosphorylation	30	30	31	0	PP	0	31	39	2	IN	0	31	32	1	on	31	31	32	0	NP	0	32	39	2	NP	2	32	35	3	DT	0	32	33	1	the	32	32	33	0	NN	0	33	34	1	JM	33	33	34	0	NNS	0	34	35	1	domains	34	34	35	0	PP	0	35	39	2	IN	0	35	36	1	of	35	35	36	0	NP	0	36	39	3	NN	0	36	37	1	EGFR	36	36	37	0	CC	0	37	38	1	and	37	37	38	0	NN	0	38	39	1	HER2	38	38	39	0	,	0	39	40	1	,	39	39	40	0	S	1	40	44	2	ADVP	0	40	41	1	RB	0	40	41	1	thereby	40	40	41	0	VP	0	41	44	2	VBG	0	41	42	1	increasing	41	41	42	0	NP	1	42	44	2	NN	0	42	43	1	ERBB3	42	42	43	0	NN	0	43	44	1	phosphorylation	43	43	44	0	.	0	44	45	1	.	44	44	45	0
EOS
T	53
To	22951	22953	TO	to	O	_	_
test	22954	22958	VB	test	O	_	_
this	22959	22963	DT	this	O	_	_
hypothesis	22964	22974	NN	hypothesis	O	_	_
,	22974	22975	,	,	O	_	_
we	22976	22978	PRP	we	O	_	_
transiently	22979	22990	RB	transiently	O	_	_
transfected	22991	23002	VBD	transfect	O	_	_
CHO-KI	23003	23009	NN	cho-kus	O	_	_
cells	23010	23015	NNS	cell	O	_	_
,	23015	23016	,	,	O	_	_
which	23017	23022	WDT	which	O	_	_
do	23023	23025	VBP	do	O	_	_
not	23026	23029	RB	not	O	_	_
express	23030	23037	VB	express	O	_	_
ERBB	23038	23042	NN	erbb	B-GENE	_	_
receptors	23043	23052	NNS	receptor	I-GENE	_	_
ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	23053	23113	NNP	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	O	_	_
MEK	23115	23118	NN	mek	B-GENE	_	_
inhibition	23119	23129	NN	inhibition	O	_	_
leads	23130	23135	VBZ	lead	O	_	_
to	23136	23138	TO	to	O	_	_
PI3K	23139	23143	NN	pi3k	B-GENE	_	_
/	23143	23144	:	/	B-GENE	_	_
AKT	23144	23147	NN	akt	I-GENE	_	_
activation	23148	23158	NN	activation	O	_	_
by	23159	23161	IN	by	O	_	_
relieving	23162	23171	VBG	relieve	O	_	_
a	23172	23173	DT	a	O	_	_
negative	23174	23182	JJ	negative	O	_	_
feedback	23183	23191	NN	feedback	O	_	_
on	23192	23194	IN	on	O	_	_
ERBB	23195	23199	NN	erbb	O	_	_
receptors	23200	23209	NNS	receptor	O	_	_
12	23210	23212	CD	12	O	_	_
/	23212	23213	:	/	O	_	_
8/14	23213	23217	CD	8/14	O	_	_
,	23217	23218	,	,	O	_	_
6:54	23219	23223	CD	6:54	O	_	_
PM	23224	23226	NNP	PM	O	_	_
Ôøºendogenously	23227	23242	NNP	Ôøºendogenously	O	_	_
,	23242	23243	,	,	O	_	_
with	23244	23248	IN	with	O	_	_
wild-type	23249	23258	JJ	wild-type	O	_	_
ERBB3	23259	23264	NN	erbb3	O	_	_
with	23265	23269	IN	with	O	_	_
either	23270	23276	CC	either	O	_	_
wild-type	23277	23286	JJ	wild-type	B-GENE	_	_
EGFR	23287	23291	NN	egfr	I-GENE	_	_
or	23292	23294	CC	or	O	_	_
EGFR	23295	23299	NN	egfr	B-GENE	_	_
T669A	23300	23305	NN	t669a	I-GENE	_	_
.	23305	23306	.	.	O	_	_
D	1
7
1	0	aux
1	3	dobj
3	2	det
7	1	advcl
7	5	nsubj
7	6	advmod
7	9	dobj
9	8	nn
9	14	rcmod
14	11	nsubj
14	12	aux
14	13	neg
14	16	dobj
16	15	nn
16	20	rcmod
19	17	nn
19	18	nn
20	19	nsubj
20	22	prep_to
20	25	dep
20	36	dep
20	44	prep_with
20	45	prep
25	23	punct
25	24	nn
25	27	prepc_by
25	35	punct
27	30	dobj
27	33	prep_on
30	28	det
30	29	amod
33	32	nn
33	34	dep
36	40	appos
40	38	num
40	39	nn
44	43	amod
45	46	dep
45	48	conj
45	51	conj
48	47	amod
48	51	conj_or
51	50	nn
EOX
Y	1
ROOT	0	0	53	1	S	4	0	53	6	S	0	0	4	1	VP	1	0	4	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	4	2	VB	0	1	2	1	test	1	1	2	0	NP	1	2	4	2	DT	0	2	3	1	this	2	2	3	0	NN	0	3	4	1	hypothesis	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	6	1	PRP	0	5	6	1	we	5	5	6	0	ADVP	0	6	7	1	RB	0	6	7	1	transiently	6	6	7	0	VP	0	7	52	2	VBD	0	7	8	1	transfected	7	7	8	0	NP	0	8	52	3	NP	1	8	10	2	NN	0	8	9	1	CHO-KI	8	8	9	0	NNS	0	9	10	1	cells	9	9	10	0	,	0	10	11	1	,	10	10	11	0	SBAR	1	11	52	2	WHNP	0	11	12	1	WDT	0	11	12	1	which	11	11	12	0	S	0	12	52	1	VP	2	12	52	3	VBP	0	12	13	1	do	12	12	13	0	RB	0	13	14	1	not	13	13	14	0	VP	0	14	52	2	VB	0	14	15	1	express	14	14	15	0	NP	0	15	52	2	NP	1	15	17	2	NN	0	15	16	1	ERBB	15	15	16	0	NNS	0	16	17	1	receptors	16	16	17	0	SBAR	0	17	52	1	S	1	17	52	2	NP	2	17	20	3	NNP	0	17	18	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	17	17	18	0	NN	0	18	19	1	MEK	18	18	19	0	NN	0	19	20	1	inhibition	19	19	20	0	VP	0	20	52	4	VBZ	0	20	21	1	leads	20	20	21	0	PP	0	21	23	2	TO	0	21	22	1	to	21	21	22	0	NP	0	22	23	1	NN	0	22	23	1	PI3K	22	22	23	0	PRN	1	23	36	4	:	0	23	24	1	/	23	23	24	0	NP	1	24	26	2	NN	0	24	25	1	AKT	24	24	25	0	NN	0	25	26	1	activation	25	25	26	0	PP	0	26	35	2	IN	0	26	27	1	by	26	26	27	0	S	0	27	35	1	VP	0	27	35	3	VBG	0	27	28	1	relieving	27	27	28	0	NP	2	28	31	3	DT	0	28	29	1	a	28	28	29	0	JJ	0	29	30	1	negative	29	29	30	0	NN	0	30	31	1	feedback	30	30	31	0	PP	0	31	35	2	IN	0	31	32	1	on	31	31	32	0	NP	0	32	35	2	NP	1	32	34	2	NN	0	32	33	1	ERBB	32	32	33	0	NNS	0	33	34	1	receptors	33	33	34	0	NP	0	34	35	1	CD	0	34	35	1	12	34	34	35	0	:	0	35	36	1	/	35	35	36	0	PP	0	36	52	2	PP	1	36	45	2	NP	0	36	42	4	NP	0	36	37	1	CD	0	36	37	1	8/14	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	2	38	41	3	CD	0	38	39	1	6:54	38	38	39	0	NNP	0	39	40	1	PM	39	39	40	0	NNP	0	40	41	1	Ôøºendogenously	40	40	41	0	,	0	41	42	1	,	41	41	42	0	PP	0	42	45	2	IN	0	42	43	1	with	42	42	43	0	NP	1	43	45	2	JJ	0	43	44	1	wild-type	43	43	44	0	NN	0	44	45	1	ERBB3	44	44	45	0	PP	0	45	52	3	IN	0	45	46	1	with	45	45	46	0	CC	0	46	47	1	either	46	46	47	0	NP	0	47	52	3	NP	1	47	49	2	JJ	0	47	48	1	wild-type	47	47	48	0	NN	0	48	49	1	EGFR	48	48	49	0	CC	0	49	50	1	or	49	49	50	0	NP	1	50	52	2	NN	0	50	51	1	EGFR	50	50	51	0	NN	0	51	52	1	T669A	51	51	52	0	.	0	52	53	1	.	52	52	53	0
EOS
T	32
In	23307	23309	IN	in	O	_	_
cells	23310	23315	NNS	cell	O	_	_
transfected	23316	23327	VBN	transfect	O	_	_
with	23328	23332	IN	with	O	_	_
wild-type	23333	23342	JJ	wild-type	B-GENE	_	_
EGFR	23343	23347	NN	egfr	I-GENE	_	_
,	23347	23348	,	,	O	_	_
MEK	23349	23352	NN	mek	B-GENE	_	_
inhibition	23353	23363	NN	inhibition	O	_	_
led	23364	23367	VBD	lead	O	_	_
to	23368	23370	TO	to	O	_	_
feedback	23371	23379	NN	feedback	O	_	_
activation	23380	23390	NN	activation	O	_	_
of	23391	23393	IN	of	O	_	_
phospho-ERBB3	23394	23407	NN	phospho-erbb3	B-GENE	_	_
and	23408	23411	CC	and	O	_	_
phosho-EGFR	23412	23423	NN	phosho-egfr	B-GENE	_	_
,	23423	23424	,	,	O	_	_
recapitulating	23425	23439	VBG	recapitulate	O	_	_
the	23440	23443	DT	the	O	_	_
results	23444	23451	NNS	result	O	_	_
we	23452	23454	PRP	we	O	_	_
had	23455	23458	VBD	have	O	_	_
observed	23459	23467	VBN	observe	O	_	_
in	23468	23470	IN	in	O	_	_
our	23471	23474	PRP$	we	O	_	_
panel	23475	23480	NN	panel	O	_	_
of	23481	23483	IN	of	O	_	_
cancer	23484	23490	NN	cancer	O	_	_
cell	23491	23495	NN	cell	O	_	_
lines	23496	23501	NNS	line	O	_	_
.	23513	23514	.	.	O	_	_
D	1
9
1	2	vmod
2	5	prep_with
5	4	amod
8	7	nn
9	1	prep_in
9	8	nsubj
9	12	prep_to
9	18	xcomp
12	11	nn
12	14	prep_of
12	16	prep_of
14	16	conj_and
18	20	dobj
20	19	det
20	23	rcmod
23	21	nsubj
23	22	aux
23	26	prep_in
26	25	poss
26	30	prep_of
30	28	nn
30	29	nn
EOX
Y	1
ROOT	0	0	32	1	S	3	0	32	5	PP	0	0	6	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	6	2	NP	0	1	2	1	NNS	0	1	2	1	cells	1	1	2	0	VP	0	2	6	2	VBN	0	2	3	1	transfected	2	2	3	0	PP	0	3	6	2	IN	0	3	4	1	with	3	3	4	0	NP	1	4	6	2	JJ	0	4	5	1	wild-type	4	4	5	0	NN	0	5	6	1	EGFR	5	5	6	0	,	0	6	7	1	,	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	MEK	7	7	8	0	NN	0	8	9	1	inhibition	8	8	9	0	VP	0	9	31	4	VBD	0	9	10	1	led	9	9	10	0	PP	0	10	17	2	TO	0	10	11	1	to	10	10	11	0	NP	0	11	17	2	NP	1	11	13	2	NN	0	11	12	1	feedback	11	11	12	0	NN	0	12	13	1	activation	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	17	3	NN	0	14	15	1	phospho-ERBB3	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	NN	0	16	17	1	phosho-EGFR	16	16	17	0	,	0	17	18	1	,	17	17	18	0	S	0	18	31	1	VP	0	18	31	2	VBG	0	18	19	1	recapitulating	18	18	19	0	NP	0	19	31	2	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NNS	0	20	21	1	results	20	20	21	0	SBAR	0	21	31	1	S	1	21	31	2	NP	0	21	22	1	PRP	0	21	22	1	we	21	21	22	0	VP	1	22	31	2	VBD	0	22	23	1	had	22	22	23	0	VP	0	23	31	2	VBN	0	23	24	1	observed	23	23	24	0	PP	0	24	31	2	IN	0	24	25	1	in	24	24	25	0	NP	0	25	31	2	NP	1	25	27	2	PRP$	0	25	26	1	our	25	25	26	0	NN	0	26	27	1	panel	26	26	27	0	PP	0	27	31	2	IN	0	27	28	1	of	27	27	28	0	NP	2	28	31	3	NN	0	28	29	1	cancer	28	28	29	0	NN	0	29	30	1	cell	29	29	30	0	NNS	0	30	31	1	lines	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	23
In	23515	23517	IN	in	O	_	_
contrast	23518	23526	NN	contrast	O	_	_
,	23526	23527	,	,	O	_	_
the	23528	23531	DT	the	O	_	_
EGFR	23532	23536	NN	egfr	B-GENE	_	_
T669A	23537	23542	NN	t669a	O	_	_
mutant	23543	23549	NN	mutant	O	_	_
increased	23550	23559	VBD	increase	O	_	_
both	23560	23564	CC	both	O	_	_
basal	23565	23570	JJ	basal	O	_	_
EGFR	23571	23575	NN	egfr	B-GENE	_	_
and	23576	23579	CC	and	O	_	_
ERBB3	23580	23585	NN	erbb3	B-GENE	_	_
tyrosine	23586	23594	NN	tyrosine	O	_	_
phosphorylation	23595	23610	NN	phosphorylation	O	_	_
that	23611	23615	WDT	that	O	_	_
was	23616	23619	VBD	be	O	_	_
not	23620	23623	RB	not	O	_	_
augmented	23624	23633	VBN	augment	O	_	_
by	23634	23636	IN	by	O	_	_
MEK	23637	23640	NN	mek	B-GENE	_	_
inhibition	23641	23651	NN	inhibition	O	_	_
.	23651	23652	.	.	O	_	_
D	1
7
6	3	det
6	4	nn
6	5	nn
7	1	prep_in
7	6	nsubj
7	8	prep
8	10	pobj
8	14	pobj
10	9	amod
10	14	conj_and
10	18	rcmod
14	12	nn
14	13	nn
18	15	nsubjpass
18	16	auxpass
18	17	neg
18	21	agent
21	20	nn
EOX
Y	1
ROOT	0	0	23	1	S	3	0	23	5	PP	0	0	2	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	contrast	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	3	3	7	4	DT	0	3	4	1	the	3	3	4	0	NN	0	4	5	1	EGFR	4	4	5	0	NN	0	5	6	1	T669A	5	5	6	0	NN	0	6	7	1	mutant	6	6	7	0	VP	0	7	22	2	VBD	0	7	8	1	increased	7	7	8	0	PP	0	8	22	2	CC	0	8	9	1	both	8	8	9	0	NP	0	9	22	2	NP	0	9	15	3	NP	1	9	11	2	JJ	0	9	10	1	basal	9	9	10	0	NN	0	10	11	1	EGFR	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NP	2	12	15	3	NN	0	12	13	1	ERBB3	12	12	13	0	NN	0	13	14	1	tyrosine	13	13	14	0	NN	0	14	15	1	phosphorylation	14	14	15	0	SBAR	1	15	22	2	WHNP	0	15	16	1	WDT	0	15	16	1	that	15	15	16	0	S	0	16	22	1	VP	2	16	22	3	VBD	0	16	17	1	was	16	16	17	0	RB	0	17	18	1	not	17	17	18	0	VP	0	18	22	2	VBN	0	18	19	1	augmented	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	by	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	MEK	20	20	21	0	NN	0	21	22	1	inhibition	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	49
As	23653	23655	IN	as	O	_	_
a	23656	23657	DT	a	O	_	_
control	23658	23665	NN	control	O	_	_
,	23665	23666	,	,	O	_	_
we	23667	23669	PRP	we	O	_	_
treated	23670	23677	VBD	treat	O	_	_
CHO-KI	23678	23684	NN	cho-kus	O	_	_
cells	23685	23690	NNS	cell	O	_	_
expressing	23691	23701	VBG	express	O	_	_
EGFR	23702	23706	NN	egfr	B-GENE	_	_
T669A	23707	23712	NN	t669a	I-GENE	_	_
with	23713	23717	IN	with	O	_	_
HRG	23718	23721	NN	hrg	O	_	_
ligand	23722	23728	NN	ligand	O	_	_
to	23729	23731	TO	to	O	_	_
induce	23732	23738	VB	induce	O	_	_
maximal	23739	23746	JJ	maximal	O	_	_
ERBB3	23747	23752	NN	erbb3	B-GENE	_	_
phosphorylation	23753	23768	NN	phosphorylation	O	_	_
,	23780	23781	,	,	O	_	_
indicating	23782	23792	VBG	indicate	O	_	_
that	23793	23797	IN	that	O	_	_
the	23798	23801	DT	the	O	_	_
lack	23802	23806	NN	lack	O	_	_
of	23807	23809	IN	of	O	_	_
induction	23810	23819	NN	induction	O	_	_
of	23820	23822	IN	of	O	_	_
phospho-ERBB3	23823	23836	NN	phospho-erbb3	O	_	_
in	23837	23839	IN	in	O	_	_
EGFR	23840	23844	NN	egfr	B-GENE	_	_
T669A	23845	23850	NN	t669a	O	_	_
expressing	23851	23861	NN	expressing	O	_	_
cells	23862	23867	NNS	cell	O	_	_
following	23868	23877	VBG	follow	O	_	_
MEK	23878	23881	NN	mek	B-GENE	_	_
inhibition	23882	23892	NN	inhibition	O	_	_
was	23893	23896	VBD	be	O	_	_
not	23897	23900	RB	not	O	_	_
simply	23901	23907	RB	simply	O	_	_
due	23908	23911	JJ	due	O	_	_
to	23912	23914	TO	to	O	_	_
the	23915	23918	DT	the	O	_	_
saturation	23919	23929	NN	saturation	O	_	_
of	23930	23932	IN	of	O	_	_
the	23933	23936	DT	the	O	_	_
system	23937	23943	NN	system	O	_	_
with	23944	23948	IN	with	O	_	_
phospho-ERBB3	23949	23962	NN	phospho-erbb3	O	_	_
.	23962	23963	.	.	O	_	_
D	1
5
2	1	det
5	2	prep_as
5	4	nsubj
5	7	dobj
5	20	vmod
7	6	nn
7	8	vmod
8	10	dobj
8	13	prep_with
8	15	xcomp
10	9	nn
13	12	nn
15	14	aux
15	18	dobj
18	16	amod
18	17	nn
20	39	ccomp
23	22	det
23	25	prep_of
25	27	prep_of
27	32	prep_in
32	29	nn
32	30	nn
32	31	nn
32	35	prep_following
35	34	nn
39	21	mark
39	23	nsubj
39	36	cop
39	37	neg
39	38	advmod
39	42	prep_to
42	41	det
42	45	prep_of
45	44	det
45	47	prep_with
EOX
Y	1
ROOT	0	0	49	1	S	3	0	49	5	PP	0	0	3	2	IN	0	0	1	1	As	0	0	1	0	NP	1	1	3	2	DT	0	1	2	1	a	1	1	2	0	NN	0	2	3	1	control	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	0	4	5	1	PRP	0	4	5	1	we	4	4	5	0	VP	0	5	48	4	VBD	0	5	6	1	treated	5	5	6	0	NP	0	6	19	2	NP	1	6	8	2	NN	0	6	7	1	CHO-KI	6	6	7	0	NNS	0	7	8	1	cells	7	7	8	0	VP	0	8	19	4	VBG	0	8	9	1	expressing	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	EGFR	9	9	10	0	NN	0	10	11	1	T669A	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	with	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	HRG	12	12	13	0	NN	0	13	14	1	ligand	13	13	14	0	S	0	14	19	1	VP	1	14	19	2	TO	0	14	15	1	to	14	14	15	0	VP	0	15	19	2	VB	0	15	16	1	induce	15	15	16	0	NP	2	16	19	3	JJ	0	16	17	1	maximal	16	16	17	0	NN	0	17	18	1	ERBB3	17	17	18	0	NN	0	18	19	1	phosphorylation	18	18	19	0	,	0	19	20	1	,	19	19	20	0	S	0	20	48	1	VP	0	20	48	2	VBG	0	20	21	1	indicating	20	20	21	0	SBAR	1	21	48	2	IN	0	21	22	1	that	21	21	22	0	S	1	22	48	2	NP	0	22	36	2	NP	1	22	24	2	DT	0	22	23	1	the	22	22	23	0	NN	0	23	24	1	lack	23	23	24	0	PP	0	24	36	2	IN	0	24	25	1	of	24	24	25	0	NP	0	25	36	2	NP	0	25	26	1	NN	0	25	26	1	induction	25	25	26	0	PP	0	26	36	2	IN	0	26	27	1	of	26	26	27	0	NP	0	27	36	2	NP	0	27	28	1	NN	0	27	28	1	phospho-ERBB3	27	27	28	0	PP	0	28	36	2	IN	0	28	29	1	in	28	28	29	0	NP	0	29	36	2	NP	3	29	33	4	NN	0	29	30	1	EGFR	29	29	30	0	NN	0	30	31	1	T669A	30	30	31	0	NN	0	31	32	1	expressing	31	31	32	0	NNS	0	32	33	1	cells	32	32	33	0	PP	0	33	36	2	VBG	0	33	34	1	following	33	33	34	0	NP	1	34	36	2	NN	0	34	35	1	MEK	34	34	35	0	NN	0	35	36	1	inhibition	35	35	36	0	VP	3	36	48	4	VBD	0	36	37	1	was	36	36	37	0	RB	0	37	38	1	not	37	37	38	0	ADVP	0	38	39	1	RB	0	38	39	1	simply	38	38	39	0	ADJP	0	39	48	2	JJ	0	39	40	1	due	39	39	40	0	PP	0	40	48	2	TO	0	40	41	1	to	40	40	41	0	NP	0	41	48	2	NP	1	41	43	2	DT	0	41	42	1	the	41	41	42	0	NN	0	42	43	1	saturation	42	42	43	0	PP	0	43	48	2	IN	0	43	44	1	of	43	43	44	0	NP	0	44	48	2	NP	1	44	46	2	DT	0	44	45	1	the	44	44	45	0	NN	0	45	46	1	system	45	45	46	0	PP	0	46	48	2	IN	0	46	47	1	with	46	46	47	0	NP	0	47	48	1	NN	0	47	48	1	phospho-ERBB3	47	47	48	0	.	0	48	49	1	.	48	48	49	0
EOS
T	19
We	23964	23966	PRP	we	O	_	_
observed	23967	23975	VBD	observe	O	_	_
analogous	23976	23985	JJ	analogous	O	_	_
results	23986	23993	NNS	result	O	_	_
in	23994	23996	IN	in	O	_	_
CHO-KI	23997	24003	NN	cho-kus	O	_	_
cells	24004	24009	NNS	cell	O	_	_
expressing	24010	24020	VBG	express	O	_	_
wild-type	24021	24030	JJ	wild-type	O	_	_
ERBB3	24031	24036	NN	erbb3	O	_	_
in	24037	24039	IN	in	O	_	_
combination	24040	24051	NN	combination	O	_	_
with	24052	24056	IN	with	O	_	_
wild-type	24057	24066	JJ	wild-type	O	_	_
or	24067	24069	CC	or	O	_	_
T677A	24070	24075	NN	t677a	O	_	_
mutant	24076	24082	JJ	mutant	O	_	_
HER2	24083	24087	NN	her2	O	_	_
.	24099	24100	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	dobj
1	6	prep_in
1	7	xcomp
3	2	amod
6	5	nn
7	9	dobj
7	11	prep_in
7	13	prep_with
7	17	prep_with
9	8	amod
13	17	conj_or
17	15	nn
17	16	amod
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	18	4	VBD	0	1	2	1	observed	1	1	2	0	NP	1	2	4	2	JJ	0	2	3	1	analogous	2	2	3	0	NNS	0	3	4	1	results	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	in	4	4	5	0	NP	1	5	7	2	NN	0	5	6	1	CHO-KI	5	5	6	0	NNS	0	6	7	1	cells	6	6	7	0	S	0	7	18	1	VP	0	7	18	4	VBG	0	7	8	1	expressing	7	7	8	0	NP	1	8	10	2	JJ	0	8	9	1	wild-type	8	8	9	0	NN	0	9	10	1	ERBB3	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	in	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	combination	11	11	12	0	PP	0	12	18	2	IN	0	12	13	1	with	12	12	13	0	NP	0	13	18	3	NP	0	13	14	1	JJ	0	13	14	1	wild-type	13	13	14	0	CC	0	14	15	1	or	14	14	15	0	NP	2	15	18	3	NN	0	15	16	1	T677A	15	15	16	0	JJ	0	16	17	1	mutant	16	16	17	0	NN	0	17	18	1	HER2	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	31
Together	24101	24109	RB	together	O	_	_
these	24110	24115	DT	these	O	_	_
results	24116	24123	NNS	result	O	_	_
support	24124	24131	VBP	support	O	_	_
the	24132	24135	DT	the	O	_	_
hypothesis	24136	24146	NN	hypothesis	O	_	_
that	24147	24151	IN	that	O	_	_
inhibition	24152	24162	NN	inhibition	O	_	_
of	24163	24165	IN	of	O	_	_
ERK	24166	24169	NN	erk	B-GENE	_	_
mediated	24170	24178	VBD	mediate	O	_	_
phosphorylation	24179	24194	NN	phosphorylation	O	_	_
of	24195	24197	IN	of	O	_	_
a	24198	24199	DT	a	O	_	_
conserved	24200	24209	VBN	conserve	O	_	_
JM	24210	24212	NN	jm	O	_	_
domain	24213	24219	NN	domain	O	_	_
threonine	24220	24229	NN	threonine	O	_	_
residue	24230	24237	NN	residue	O	_	_
leads	24238	24243	VBZ	lead	O	_	_
to	24244	24246	TO	to	O	_	_
feedback	24247	24255	NN	feedback	O	_	_
activation	24256	24266	NN	activation	O	_	_
of	24267	24269	IN	of	O	_	_
EGFR	24270	24274	NN	egfr	B-GENE	_	_
,	24274	24275	,	,	O	_	_
HER2	24276	24280	NN	her2	B-GENE	_	_
,	24280	24281	,	,	O	_	_
and	24282	24285	CC	and	O	_	_
ERBB3	24286	24291	NN	erbb3	O	_	_
.	24302	24303	.	.	O	_	_
D	1
3
2	1	det
3	0	advmod
3	2	nsubj
3	5	dobj
3	10	ccomp
5	4	det
7	9	prep_of
10	6	mark
10	7	nsubj
10	19	ccomp
11	18	prep_of
14	17	dobj
17	15	nn
17	16	nn
18	13	det
18	14	dep
19	11	nsubj
19	22	prep_to
22	21	nn
22	24	prep_of
22	26	prep_of
22	29	prep_of
24	26	conj_and
24	29	conj_and
EOX
Y	1
ROOT	0	0	31	1	S	2	0	31	4	ADVP	0	0	1	1	RB	0	0	1	1	Together	0	0	1	0	NP	1	1	3	2	DT	0	1	2	1	these	1	1	2	0	NNS	0	2	3	1	results	2	2	3	0	VP	0	3	30	3	VBP	0	3	4	1	support	3	3	4	0	NP	1	4	6	2	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	hypothesis	5	5	6	0	SBAR	1	6	30	2	IN	0	6	7	1	that	6	6	7	0	S	1	7	30	2	NP	0	7	10	2	NP	0	7	8	1	NN	0	7	8	1	inhibition	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	ERK	9	9	10	0	VP	0	10	30	2	VBD	0	10	11	1	mediated	10	10	11	0	SBAR	0	11	30	1	S	1	11	30	2	NP	0	11	19	2	NP	0	11	12	1	NN	0	11	12	1	phosphorylation	11	11	12	0	PP	0	12	19	2	IN	0	12	13	1	of	12	12	13	0	NP	2	13	19	3	DT	0	13	14	1	a	13	13	14	0	S	0	14	18	1	VP	0	14	18	2	VBN	0	14	15	1	conserved	14	14	15	0	NP	2	15	18	3	NN	0	15	16	1	JM	15	15	16	0	NN	0	16	17	1	domain	16	16	17	0	NN	0	17	18	1	threonine	17	17	18	0	NN	0	18	19	1	residue	18	18	19	0	VP	0	19	30	2	VBZ	0	19	20	1	leads	19	19	20	0	PP	0	20	30	2	TO	0	20	21	1	to	20	20	21	0	NP	0	21	30	2	NP	1	21	23	2	NN	0	21	22	1	feedback	21	21	22	0	NN	0	22	23	1	activation	22	22	23	0	PP	0	23	30	2	IN	0	23	24	1	of	23	23	24	0	NP	0	24	30	6	NP	0	24	25	1	NN	0	24	25	1	EGFR	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NP	0	26	27	1	NN	0	26	27	1	HER2	26	26	27	0	,	0	27	28	1	,	27	27	28	0	CC	0	28	29	1	and	28	28	29	0	NP	0	29	30	1	NN	0	29	30	1	ERBB3	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	88
T669A	24313	24318	NN	t669a	O	_	_
mutation	24319	24327	NN	mutation	O	_	_
of	24328	24330	IN	of	O	_	_
EGFR	24331	24335	NN	egfr	B-GENE	_	_
or	24336	24338	CC	or	O	_	_
T677A	24339	24344	NN	t677a	O	_	_
mutation	24345	24353	NN	mutation	O	_	_
of	24354	24356	IN	of	O	_	_
HER2	24357	24361	NN	her2	B-GENE	_	_
blocks	24362	24368	VBZ	block	I-GENE	_	_
MEK	24369	24372	NN	mek	I-GENE	_	_
feedback	24373	24381	NN	feedback	I-GENE	_	_
activation	24382	24392	NN	activation	I-GENE	_	_
of	24393	24395	IN	of	I-GENE	_	_
ERBB	24396	24400	NN	erbb	I-GENE	_	_
receptors	24401	24410	NNS	receptor	I-GENE	_	_
Model	24420	24425	NNP	Model	O	_	_
of	24426	24428	IN	of	O	_	_
MEK	24429	24432	NN	mek	B-GENE	_	_
inhibitor	24433	24442	NN	inhibitor	O	_	_
induced	24443	24450	VBD	induce	O	_	_
feedback	24451	24459	NN	feedback	O	_	_
on	24460	24462	IN	on	O	_	_
ERBB	24463	24467	NN	erbb	B-GENE	_	_
receptor	24468	24476	NN	receptor	I-GENE	_	_
signaling	24477	24486	NN	signaling	O	_	_
pathways	24487	24495	NNS	pathway	O	_	_
To	24496	24498	TO	to	O	_	_
determine	24499	24508	VB	determine	O	_	_
if	24509	24511	IN	if	O	_	_
this	24512	24516	DT	this	O	_	_
feedback	24517	24525	NN	feedback	O	_	_
model	24526	24531	NN	model	O	_	_
explains	24532	24540	VBZ	explain	O	_	_
the	24541	24544	DT	the	O	_	_
activation	24545	24555	NN	activation	O	_	_
of	24556	24558	IN	of	O	_	_
PI3K	24559	24563	NN	pi3k	B-GENE	_	_
signaling	24564	24573	NN	signaling	O	_	_
in	24574	24576	IN	in	O	_	_
EGFR-mutant	24577	24588	JJ	egfr-mutant	B-GENE	_	_
cancers	24589	24596	NNS	cancer	O	_	_
,	24596	24597	,	,	O	_	_
we	24598	24600	PRP	we	O	_	_
used	24601	24605	VBD	use	O	_	_
shRNA	24606	24611	NN	shrna	O	_	_
to	24612	24614	TO	to	O	_	_
knockdown	24615	24624	VB	knockdown	O	_	_
endogenous	24625	24635	JJ	endogenous	O	_	_
EGFR	24636	24640	NN	egfr	O	_	_
(	24641	24642	NN	(	O	_	_
which	24642	24647	WDT	which	O	_	_
carries	24648	24655	VBZ	carry	O	_	_
an	24656	24658	DT	a	O	_	_
exon	24659	24663	NN	exon	O	_	_
19	24664	24666	CD	19	O	_	_
deletion	24667	24675	NN	deletion	O	_	_
)	24675	24676	NN	)	O	_	_
in	24677	24679	IN	in	O	_	_
the	24680	24683	DT	the	O	_	_
HCC827	24684	24690	NN	hcc827	B-GENE	_	_
NSCLC	24691	24696	NN	nsclc	I-GENE	_	_
cell	24697	24701	NN	cell	O	_	_
line	24702	24706	NN	line	O	_	_
and	24707	24710	CC	and	O	_	_
replaced	24711	24719	VBN	replace	O	_	_
with	24720	24724	IN	with	O	_	_
either	24725	24731	CC	either	O	_	_
EGFR	24732	24736	NN	egfr	O	_	_
(	24737	24738	CD	(	O	_	_
exon	24738	24742	NN	exon	O	_	_
19del	24743	24748	NN	19del	O	_	_
)	24748	24749	CD	)	O	_	_
wild-type	24750	24759	JJ	wild-type	O	_	_
at	24760	24762	IN	at	O	_	_
T669	24763	24767	NN	t669	O	_	_
,	24767	24768	,	,	O	_	_
or	24769	24771	CC	or	O	_	_
EGFR	24772	24776	NN	egfr	O	_	_
(	24777	24778	CD	(	O	_	_
exon	24778	24782	NN	exon	O	_	_
19del	24783	24788	NN	19del	O	_	_
)	24788	24789	CD	)	O	_	_
carrying	24790	24798	VBG	carry	O	_	_
a	24799	24800	DT	a	O	_	_
T669A	24801	24806	NN	t669a	O	_	_
mutation	24807	24815	NN	mutation	O	_	_
.	24815	24816	.	.	O	_	_
D	1
44
1	0	nn
1	6	prep_of
3	5	conj_or
6	3	nn
6	5	nn
6	8	prep_of
9	1	nsubj
9	12	dobj
12	10	nn
12	11	nn
12	15	prep_of
12	20	rcmod
15	14	nn
16	19	prep_of
19	18	nn
20	16	nsubj
20	21	dobj
20	26	prep_on
20	28	xcomp
26	23	nn
26	24	nn
26	25	nn
28	27	aux
28	33	advcl
32	30	det
32	31	nn
33	29	mark
33	32	nsubj
33	35	dobj
35	34	det
35	38	prep_of
38	37	nn
38	41	prep_in
41	40	amod
44	9	ccomp
44	43	nsubj
44	45	dobj
44	47	xcomp
47	46	aux
47	50	dobj
50	48	amod
50	49	nn
50	52	rcmod
50	65	rcmod
52	51	nsubj
52	57	dobj
52	65	conj_and
57	53	det
57	54	nn
57	55	num
57	56	nn
57	63	prep_in
63	59	det
63	60	nn
63	61	nn
63	62	nn
65	51	nsubj
65	83	prepc_with
71	67	preconj
71	68	nn
71	69	num
71	70	nn
71	73	amod
71	75	prep_at
71	81	conj_or
73	72	number
81	78	nn
81	79	num
81	80	nn
83	71	nsubj
83	81	nsubj
83	82	advmod
83	86	dobj
86	84	det
86	85	nn
EOX
Y	1
ROOT	0	0	88	1	S	3	0	88	5	S	1	0	42	2	NP	0	0	9	2	NP	1	0	2	2	NN	0	0	1	1	T669A	0	0	1	0	NN	0	1	2	1	mutation	1	1	2	0	PP	0	2	9	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	9	2	NP	1	3	7	2	NP	0	3	6	3	NN	0	3	4	1	EGFR	3	3	4	0	CC	0	4	5	1	or	4	4	5	0	NN	0	5	6	1	T677A	5	5	6	0	NN	0	6	7	1	mutation	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	HER2	8	8	9	0	VP	0	9	42	2	VBZ	0	9	10	1	blocks	9	9	10	0	NP	0	10	42	3	NP	2	10	13	3	NN	0	10	11	1	MEK	10	10	11	0	NN	0	11	12	1	feedback	11	11	12	0	NN	0	12	13	1	activation	12	12	13	0	PP	0	13	16	2	IN	0	13	14	1	of	13	13	14	0	NP	1	14	16	2	NN	0	14	15	1	ERBB	14	14	15	0	NNS	0	15	16	1	receptors	15	15	16	0	SBAR	0	16	42	1	S	1	16	42	2	NP	0	16	20	2	NP	0	16	17	1	NNP	0	16	17	1	Model	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	of	17	17	18	0	NP	1	18	20	2	NN	0	18	19	1	MEK	18	18	19	0	NN	0	19	20	1	inhibitor	19	19	20	0	VP	0	20	42	4	VBD	0	20	21	1	induced	20	20	21	0	NP	0	21	22	1	NN	0	21	22	1	feedback	21	21	22	0	PP	0	22	27	2	IN	0	22	23	1	on	22	22	23	0	NP	3	23	27	4	NN	0	23	24	1	ERBB	23	23	24	0	NN	0	24	25	1	receptor	24	24	25	0	NN	0	25	26	1	signaling	25	25	26	0	NNS	0	26	27	1	pathways	26	26	27	0	S	0	27	42	1	VP	1	27	42	2	TO	0	27	28	1	To	27	27	28	0	VP	0	28	42	2	VB	0	28	29	1	determine	28	28	29	0	SBAR	1	29	42	2	IN	0	29	30	1	if	29	29	30	0	S	1	30	42	2	NP	2	30	33	3	DT	0	30	31	1	this	30	30	31	0	NN	0	31	32	1	feedback	31	31	32	0	NN	0	32	33	1	model	32	32	33	0	VP	0	33	42	2	VBZ	0	33	34	1	explains	33	33	34	0	NP	0	34	42	2	NP	1	34	36	2	DT	0	34	35	1	the	34	34	35	0	NN	0	35	36	1	activation	35	35	36	0	PP	0	36	42	2	IN	0	36	37	1	of	36	36	37	0	NP	0	37	42	2	NP	1	37	39	2	NN	0	37	38	1	PI3K	37	37	38	0	NN	0	38	39	1	signaling	38	38	39	0	PP	0	39	42	2	IN	0	39	40	1	in	39	39	40	0	NP	1	40	42	2	JJ	0	40	41	1	EGFR-mutant	40	40	41	0	NNS	0	41	42	1	cancers	41	41	42	0	,	0	42	43	1	,	42	42	43	0	NP	0	43	44	1	PRP	0	43	44	1	we	43	43	44	0	VP	0	44	87	3	VBD	0	44	45	1	used	44	44	45	0	NP	0	45	46	1	NN	0	45	46	1	shRNA	45	45	46	0	S	0	46	87	1	VP	1	46	87	2	TO	0	46	47	1	to	46	46	47	0	VP	0	47	87	2	VB	0	47	48	1	knockdown	47	47	48	0	NP	0	48	87	2	NP	2	48	51	3	JJ	0	48	49	1	endogenous	48	48	49	0	NN	0	49	50	1	EGFR	49	49	50	0	NN	0	50	51	1	(	50	50	51	0	SBAR	1	51	87	2	WHNP	0	51	52	1	WDT	0	51	52	1	which	51	51	52	0	S	0	52	87	1	VP	0	52	87	3	VP	0	52	64	2	VBZ	0	52	53	1	carries	52	52	53	0	NP	0	53	64	2	NP	4	53	58	5	DT	0	53	54	1	an	53	53	54	0	NN	0	54	55	1	exon	54	54	55	0	CD	0	55	56	1	19	55	55	56	0	NN	0	56	57	1	deletion	56	56	57	0	NN	0	57	58	1	)	57	57	58	0	PP	0	58	64	2	IN	0	58	59	1	in	58	58	59	0	NP	4	59	64	5	DT	0	59	60	1	the	59	59	60	0	NN	0	60	61	1	HCC827	60	60	61	0	NN	0	61	62	1	NSCLC	61	61	62	0	NN	0	62	63	1	cell	62	62	63	0	NN	0	63	64	1	line	63	63	64	0	CC	0	64	65	1	and	64	64	65	0	VP	0	65	87	2	VBN	0	65	66	1	replaced	65	65	66	0	PP	0	66	87	2	IN	0	66	67	1	with	66	66	67	0	S	1	67	87	2	NP	1	67	82	5	CC	0	67	68	1	either	67	67	68	0	NP	0	68	76	2	NP	0	68	74	2	NP	3	68	72	4	NN	0	68	69	1	EGFR	68	68	69	0	CD	0	69	70	1	(	69	69	70	0	NN	0	70	71	1	exon	70	70	71	0	NN	0	71	72	1	19del	71	71	72	0	ADJP	1	72	74	2	CD	0	72	73	1	)	72	72	73	0	JJ	0	73	74	1	wild-type	73	73	74	0	PP	0	74	76	2	IN	0	74	75	1	at	74	74	75	0	NP	0	75	76	1	NN	0	75	76	1	T669	75	75	76	0	,	0	76	77	1	,	76	76	77	0	CC	0	77	78	1	or	77	77	78	0	NP	3	78	82	4	NN	0	78	79	1	EGFR	78	78	79	0	CD	0	79	80	1	(	79	79	80	0	NN	0	80	81	1	exon	80	80	81	0	NN	0	81	82	1	19del	81	81	82	0	VP	1	82	87	3	ADVP	0	82	83	1	CD	0	82	83	1	)	82	82	83	0	VBG	0	83	84	1	carrying	83	83	84	0	NP	2	84	87	3	DT	0	84	85	1	a	84	84	85	0	NN	0	85	86	1	T669A	85	85	86	0	NN	0	86	87	1	mutation	86	86	87	0	.	0	87	88	1	.	87	87	88	0
EOS
T	24
Of	24817	24819	IN	of	O	_	_
note	24820	24824	NN	note	O	_	_
,	24824	24825	,	,	O	_	_
this	24826	24830	DT	this	O	_	_
is	24831	24833	VBZ	be	O	_	_
the	24834	24837	DT	the	O	_	_
same	24838	24842	JJ	same	O	_	_
EGFR-mutant	24843	24854	JJ	egfr-mutant	O	_	_
cell	24855	24859	NN	cell	O	_	_
line	24860	24864	NN	line	O	_	_
in	24865	24867	IN	in	O	_	_
which	24868	24873	WDT	which	O	_	_
we	24874	24876	PRP	we	O	_	_
observed	24877	24885	VBD	observe	O	_	_
that	24886	24890	IN	that	O	_	_
EGFR	24891	24895	NN	egfr	B-GENE	_	_
T669	24896	24900	NN	t669	I-GENE	_	_
is	24901	24903	VBZ	be	O	_	_
phosphorylated	24904	24918	VBN	phosphorylate	O	_	_
in	24919	24921	IN	in	O	_	_
MEK	24922	24925	NN	mek	B-GENE	_	_
dependent	24926	24935	JJ	dependent	O	_	_
manner	24936	24942	NN	manner	O	_	_
.	24977	24978	.	.	O	_	_
D	1
9
9	1	prep_of
9	3	nsubj
9	4	cop
9	5	det
9	6	amod
9	7	amod
9	8	nn
9	13	rcmod
13	11	prep_in
13	12	nsubj
13	18	ccomp
16	15	nn
18	14	mark
18	16	nsubjpass
18	17	auxpass
18	22	prep_in
22	20	nn
22	21	amod
EOX
Y	1
ROOT	0	0	24	1	S	3	0	24	5	PP	0	0	2	2	IN	0	0	1	1	Of	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	note	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	4	1	DT	0	3	4	1	this	3	3	4	0	VP	1	4	23	2	VBZ	0	4	5	1	is	4	4	5	0	NP	0	5	23	2	NP	4	5	10	5	DT	0	5	6	1	the	5	5	6	0	JJ	0	6	7	1	same	6	6	7	0	JJ	0	7	8	1	EGFR-mutant	7	7	8	0	NN	0	8	9	1	cell	8	8	9	0	NN	0	9	10	1	line	9	9	10	0	SBAR	1	10	23	2	WHPP	0	10	12	2	IN	0	10	11	1	in	10	10	11	0	WHNP	0	11	12	1	WDT	0	11	12	1	which	11	11	12	0	S	1	12	23	2	NP	0	12	13	1	PRP	0	12	13	1	we	12	12	13	0	VP	0	13	23	2	VBD	0	13	14	1	observed	13	13	14	0	SBAR	1	14	23	2	IN	0	14	15	1	that	14	14	15	0	S	1	15	23	2	NP	1	15	17	2	NN	0	15	16	1	EGFR	15	15	16	0	NN	0	16	17	1	T669	16	16	17	0	VP	1	17	23	2	VBZ	0	17	18	1	is	17	17	18	0	VP	0	18	23	2	VBN	0	18	19	1	phosphorylated	18	18	19	0	PP	0	19	23	2	IN	0	19	20	1	in	19	19	20	0	NP	2	20	23	3	NN	0	20	21	1	MEK	20	20	21	0	JJ	0	21	22	1	dependent	21	21	22	0	NN	0	22	23	1	manner	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	27
When	24979	24983	WRB	when	O	_	_
endogenous	24984	24994	JJ	endogenous	O	_	_
EGFR	24995	24999	NN	egfr	O	_	_
was	25000	25003	VBD	be	O	_	_
replaced	25004	25012	VBN	replace	O	_	_
with	25013	25017	IN	with	O	_	_
EGFR	25018	25022	NN	egfr	B-GENE	_	_
(	25023	25024	CD	(	I-GENE	_	_
exon19del	25024	25033	NN	exon19del	I-GENE	_	_
)	25033	25034	CD	)	I-GENE	_	_
wild-type	25035	25044	JJ	wild-type	O	_	_
at	25045	25047	IN	at	O	_	_
T669	25048	25052	NN	t669	O	_	_
,	25052	25053	,	,	O	_	_
MEK	25054	25057	NN	mek	B-GENE	_	_
inhibition	25058	25068	NN	inhibition	O	_	_
led	25069	25072	VBD	lead	O	_	_
to	25073	25075	TO	to	O	_	_
significant	25076	25087	JJ	significant	O	_	_
feedback	25088	25096	NN	feedback	O	_	_
activation	25097	25107	NN	activation	O	_	_
of	25108	25110	IN	of	O	_	_
ERBB3	25111	25116	NN	erbb3	B-GENE	_	_
/	25116	25117	:	/	B-GENE	_	_
PI3K/AKT	25117	25125	NN	pi3k/akt	B-GENE	_	_
signaling	25126	25135	NN	signaling	O	_	_
.	25147	25148	.	.	O	_	_
D	1
16
2	1	amod
4	0	advmod
4	2	nsubjpass
4	3	auxpass
4	6	prep_with
4	12	prep_at
6	7	num
6	10	amod
8	9	num
10	8	npadvmod
15	14	nn
16	4	advcl
16	15	nsubj
16	25	dep
20	17	dep
20	18	amod
20	19	nn
20	22	prep_of
25	20	dep
25	23	punct
25	24	nn
EOX
Y	1
ROOT	0	0	27	1	S	3	0	27	5	SBAR	1	0	13	2	WHADVP	0	0	1	1	WRB	0	0	1	1	When	0	0	1	0	S	1	1	13	2	NP	1	1	3	2	JJ	0	1	2	1	endogenous	1	1	2	0	NN	0	2	3	1	EGFR	2	2	3	0	VP	1	3	13	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	13	3	VBN	0	4	5	1	replaced	4	4	5	0	PP	0	5	11	2	IN	0	5	6	1	with	5	5	6	0	NP	0	6	11	2	NP	0	6	8	2	NN	0	6	7	1	EGFR	6	6	7	0	CD	0	7	8	1	(	7	7	8	0	ADJP	1	8	11	2	NP	0	8	10	2	NN	0	8	9	1	exon19del	8	8	9	0	CD	0	9	10	1	)	9	9	10	0	JJ	0	10	11	1	wild-type	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	at	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	T669	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	1	14	16	2	NN	0	14	15	1	MEK	14	14	15	0	NN	0	15	16	1	inhibition	15	15	16	0	VP	0	16	26	2	VBD	0	16	17	1	led	16	16	17	0	SBAR	0	17	26	1	FRAG	2	17	26	3	X	1	17	23	2	X	0	17	18	1	TO	0	17	18	1	to	17	17	18	0	NP	0	18	23	2	NP	2	18	21	3	JJ	0	18	19	1	significant	18	18	19	0	NN	0	19	20	1	feedback	19	19	20	0	NN	0	20	21	1	activation	20	20	21	0	PP	0	21	23	2	IN	0	21	22	1	of	21	21	22	0	NP	0	22	23	1	NN	0	22	23	1	ERBB3	22	22	23	0	:	0	23	24	1	/	23	23	24	0	NP	1	24	26	2	NN	0	24	25	1	PI3K/AKT	24	24	25	0	NN	0	25	26	1	signaling	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	38
However	25149	25156	RB	however	O	_	_
,	25156	25157	,	,	O	_	_
replacement	25158	25169	NN	replacement	O	_	_
with	25170	25174	IN	with	O	_	_
the	25175	25178	DT	the	O	_	_
EGFR	25179	25183	NN	egfr	B-GENE	_	_
(	25184	25185	CD	(	B-GENE	_	_
exon19	25185	25191	NN	exon19	I-GENE	_	_
del	25192	25195	DT	del	O	_	_
)	25195	25196	CD	)	O	_	_
T669A	25197	25202	NN	t669a	O	_	_
mutant	25203	25209	NN	mutant	O	_	_
led	25210	25213	VBD	lead	O	_	_
to	25214	25216	TO	to	O	_	_
increased	25217	25226	VBN	increase	O	_	_
tyrosine	25227	25235	NN	tyrosine	O	_	_
phosphorylation	25236	25251	NN	phosphorylation	O	_	_
of	25252	25254	IN	of	O	_	_
both	25255	25259	CC	both	O	_	_
EGFR	25260	25264	NN	egfr	B-GENE	_	_
and	25265	25268	CC	and	O	_	_
ERBB3	25269	25274	NN	erbb3	B-GENE	_	_
,	25274	25275	,	,	O	_	_
and	25276	25279	CC	and	O	_	_
activation	25280	25290	NN	activation	O	_	_
of	25291	25293	IN	of	O	_	_
PI3K	25294	25298	NN	pi3k	B-GENE	_	_
/	25298	25299	:	/	B-GENE	_	_
AKT	25299	25302	NN	akt	I-GENE	_	_
signaling	25303	25312	NN	signaling	O	_	_
,	25312	25313	,	,	O	_	_
mimicking	25314	25323	VBG	mimic	O	_	_
the	25324	25327	DT	the	O	_	_
effect	25328	25334	NN	effect	O	_	_
of	25335	25337	IN	of	O	_	_
MEK	25338	25341	NN	mek	B-GENE	_	_
inhibition	25342	25352	NN	inhibition	O	_	_
.	25364	25365	.	.	O	_	_
D	1
12
2	7	prep_with
7	4	det
7	5	nn
7	6	num
7	11	dep
11	8	det
11	9	num
11	10	nn
12	0	advmod
12	2	nsubj
12	16	prep_to
12	24	prep_to
12	31	xcomp
16	14	amod
16	15	nn
16	19	prep_of
16	21	prep_of
16	24	conj_and
19	18	preconj
19	21	conj_and
24	26	prep_of
26	29	dep
29	27	punct
29	28	nn
31	33	dobj
33	32	det
33	36	prep_of
36	35	nn
EOX
Y	1
ROOT	0	0	38	1	S	3	0	38	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	12	2	NP	0	2	3	1	NN	0	2	3	1	replacement	2	2	3	0	PP	0	3	12	2	IN	0	3	4	1	with	3	3	4	0	NP	0	4	12	2	NP	3	4	8	4	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	EGFR	5	5	6	0	CD	0	6	7	1	(	6	6	7	0	NN	0	7	8	1	exon19	7	7	8	0	NP	3	8	12	4	DT	0	8	9	1	del	8	8	9	0	CD	0	9	10	1	)	9	9	10	0	NN	0	10	11	1	T669A	10	10	11	0	NN	0	11	12	1	mutant	11	11	12	0	VP	0	12	37	4	VBD	0	12	13	1	led	12	12	13	0	PP	0	13	30	2	TO	0	13	14	1	to	13	13	14	0	NP	0	14	30	4	NP	0	14	22	2	NP	2	14	17	3	VBN	0	14	15	1	increased	14	14	15	0	NN	0	15	16	1	tyrosine	15	15	16	0	NN	0	16	17	1	phosphorylation	16	16	17	0	PP	0	17	22	2	IN	0	17	18	1	of	17	17	18	0	NP	1	18	22	4	CC	0	18	19	1	both	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	EGFR	19	19	20	0	CC	0	20	21	1	and	20	20	21	0	NP	0	21	22	1	NN	0	21	22	1	ERBB3	21	21	22	0	,	0	22	23	1	,	22	22	23	0	CC	0	23	24	1	and	23	23	24	0	NP	0	24	30	2	NP	0	24	25	1	NN	0	24	25	1	activation	24	24	25	0	PP	0	25	30	2	IN	0	25	26	1	of	25	25	26	0	NP	0	26	30	2	NP	0	26	27	1	NN	0	26	27	1	PI3K	26	26	27	0	PRN	1	27	30	2	:	0	27	28	1	/	27	27	28	0	NP	1	28	30	2	NN	0	28	29	1	AKT	28	28	29	0	NN	0	29	30	1	signaling	29	29	30	0	,	0	30	31	1	,	30	30	31	0	S	0	31	37	1	VP	0	31	37	2	VBG	0	31	32	1	mimicking	31	31	32	0	NP	0	32	37	2	NP	1	32	34	2	DT	0	32	33	1	the	32	32	33	0	NN	0	33	34	1	effect	33	33	34	0	PP	0	34	37	2	IN	0	34	35	1	of	34	34	35	0	NP	1	35	37	2	NN	0	35	36	1	MEK	35	35	36	0	NN	0	36	37	1	inhibition	36	36	37	0	.	0	37	38	1	.	37	37	38	0
EOS
T	21
As	25366	25368	IN	as	O	_	_
expected	25369	25377	VBN	expect	O	_	_
,	25377	25378	,	,	O	_	_
addition	25379	25387	NN	addition	O	_	_
of	25388	25390	IN	of	O	_	_
AZD6244	25391	25398	NN	azd6244	O	_	_
failed	25399	25405	VBD	fail	O	_	_
to	25406	25408	TO	to	O	_	_
further	25409	25416	JJ	further	O	_	_
augment	25417	25424	VBP	augment	O	_	_
ERBB3	25425	25430	NN	erbb3	O	_	_
and	25431	25434	CC	and	O	_	_
AKT	25435	25438	NN	akt	B-GENE	_	_
phosphorylation	25439	25454	NN	phosphorylation	O	_	_
in	25455	25457	IN	in	O	_	_
cells	25458	25463	NNS	cell	O	_	_
expressing	25464	25474	VBG	express	O	_	_
the	25475	25478	DT	the	O	_	_
669A	25479	25483	NN	669a	B-GENE	_	_
mutant	25484	25490	NN	mutant	I-GENE	_	_
.	25490	25491	.	.	O	_	_
D	1
6
1	0	mark
3	5	prep_of
6	1	advcl
6	3	nsubj
6	8	prep_to
8	9	rcmod
9	13	dobj
9	15	prep_in
10	12	conj_and
13	10	nn
13	12	nn
15	16	vmod
16	19	dobj
19	17	det
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	3	0	21	5	SBAR	1	0	2	2	IN	0	0	1	1	As	0	0	1	0	S	0	1	2	1	VP	0	1	2	1	VBN	0	1	2	1	expected	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	6	2	NP	0	3	4	1	NN	0	3	4	1	addition	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	AZD6244	5	5	6	0	VP	0	6	20	2	VBD	0	6	7	1	failed	6	6	7	0	PP	0	7	20	2	TO	0	7	8	1	to	7	7	8	0	NP	0	8	20	2	NP	0	8	9	1	JJ	0	8	9	1	further	8	8	9	0	SBAR	0	9	20	1	S	0	9	20	1	VP	0	9	20	3	VBP	0	9	10	1	augment	9	9	10	0	NP	1	10	14	2	NP	0	10	13	3	NN	0	10	11	1	ERBB3	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NN	0	12	13	1	AKT	12	12	13	0	NN	0	13	14	1	phosphorylation	13	13	14	0	PP	0	14	20	2	IN	0	14	15	1	in	14	14	15	0	NP	0	15	20	2	NP	0	15	16	1	NNS	0	15	16	1	cells	15	15	16	0	VP	0	16	20	2	VBG	0	16	17	1	expressing	16	16	17	0	NP	2	17	20	3	DT	0	17	18	1	the	17	17	18	0	NN	0	18	19	1	669A	18	18	19	0	NN	0	19	20	1	mutant	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	21
These	25492	25497	DT	these	O	_	_
results	25498	25505	NNS	result	O	_	_
demonstrate	25506	25517	VBP	demonstrate	O	_	_
that	25518	25522	IN	that	O	_	_
EGFR	25523	25527	NN	egfr	B-GENE	_	_
T669	25528	25532	NN	t669	O	_	_
phosphorylation	25533	25548	NN	phosphorylation	O	_	_
is	25549	25551	VBZ	be	O	_	_
necessary	25552	25561	JJ	necessary	O	_	_
for	25562	25565	IN	for	O	_	_
MEK	25566	25569	NN	mek	B-GENE	_	_
/	25569	25570	:	/	B-GENE	_	_
ERK	25570	25573	NN	erk	I-GENE	_	_
to	25574	25576	TO	to	O	_	_
suppress	25577	25585	VB	suppress	O	_	_
EGFR	25586	25590	NN	egfr	B-GENE	_	_
mediated	25591	25599	JJ	mediated	O	_	_
activation	25600	25610	NN	activation	O	_	_
of	25611	25613	IN	of	O	_	_
ERBB3	25614	25619	NN	erbb3	B-GENE	_	_
.	25619	25620	.	.	O	_	_
D	1
12
1	0	det
2	1	nsubj
2	8	ccomp
6	4	nn
6	5	nn
8	3	mark
8	6	nsubj
8	7	cop
8	10	prep_for
12	2	dep
12	11	punct
12	14	dep
14	13	aux
14	17	dobj
17	15	nn
17	16	amod
17	19	prep_of
EOX
Y	1
ROOT	0	0	21	1	FRAG	2	0	21	4	S	1	0	11	2	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	results	1	1	2	0	VP	0	2	11	2	VBP	0	2	3	1	demonstrate	2	2	3	0	SBAR	1	3	11	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	11	2	NP	2	4	7	3	NN	0	4	5	1	EGFR	4	4	5	0	NN	0	5	6	1	T669	5	5	6	0	NN	0	6	7	1	phosphorylation	6	6	7	0	VP	1	7	11	2	VBZ	0	7	8	1	is	7	7	8	0	ADJP	0	8	11	2	JJ	0	8	9	1	necessary	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	for	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	MEK	10	10	11	0	:	0	11	12	1	/	11	11	12	0	FRAG	0	12	20	2	NP	0	12	13	1	NN	0	12	13	1	ERK	12	12	13	0	S	0	13	20	1	VP	1	13	20	2	TO	0	13	14	1	to	13	13	14	0	VP	0	14	20	2	VB	0	14	15	1	suppress	14	14	15	0	NP	0	15	20	2	NP	2	15	18	3	NN	0	15	16	1	EGFR	15	15	16	0	JJ	0	16	17	1	mediated	16	16	17	0	NN	0	17	18	1	activation	17	17	18	0	PP	0	18	20	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	ERBB3	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	27
This	25621	25625	DT	this	O	_	_
supports	25626	25634	VBZ	support	O	_	_
the	25635	25638	DT	the	O	_	_
hypothesis	25639	25649	NN	hypothesis	O	_	_
that	25650	25654	IN	that	O	_	_
a	25655	25656	DT	a	O	_	_
dominant	25657	25665	JJ	dominant	B-GENE	_	_
ERK	25666	25669	NN	erk	I-GENE	_	_
feedback	25670	25678	NN	feedback	I-GENE	_	_
on	25679	25681	IN	on	O	_	_
ERBB3	25682	25687	NN	erbb3	B-GENE	_	_
/	25687	25688	:	/	B-GENE	_	_
PI3K/AKT	25688	25696	NN	pi3k/akt	B-GENE	_	_
is	25697	25699	VBZ	be	O	_	_
mediated	25700	25708	VBN	mediate	O	_	_
though	25709	25715	IN	though	O	_	_
phosphorylation	25716	25731	NN	phosphorylation	O	_	_
of	25732	25734	IN	of	O	_	_
T669	25735	25739	NN	t669	O	_	_
on	25740	25742	IN	on	O	_	_
EGFR	25743	25747	NN	egfr	O	_	_
(	25748	25749	CD	(	O	_	_
or	25749	25751	CC	or	O	_	_
T677	25752	25756	NN	t677	B-GENE	_	_
HER2	25757	25761	NN	her2	I-GENE	_	_
)	25761	25762	NN	)	O	_	_
.	25762	25763	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	dobj
1	14	ccomp
3	2	det
8	5	det
8	6	amod
8	7	nn
8	10	prep_on
10	12	dep
12	11	punct
14	4	mark
14	8	nsubjpass
14	13	auxpass
14	16	advcl
16	15	mark
16	18	prep_of
16	19	dep
19	20	pobj
19	25	pobj
20	21	num
20	25	conj_or
25	23	nn
25	24	nn
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	0	1	26	3	VBZ	0	1	2	1	supports	1	1	2	0	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	hypothesis	3	3	4	0	SBAR	1	4	26	2	IN	0	4	5	1	that	4	4	5	0	S	1	5	26	2	NP	0	5	13	2	NP	3	5	9	4	DT	0	5	6	1	a	5	5	6	0	JJ	0	6	7	1	dominant	6	6	7	0	NN	0	7	8	1	ERK	7	7	8	0	NN	0	8	9	1	feedback	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	on	9	9	10	0	NP	0	10	13	2	NP	0	10	11	1	NN	0	10	11	1	ERBB3	10	10	11	0	PRN	1	11	13	2	:	0	11	12	1	/	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	PI3K/AKT	12	12	13	0	VP	1	13	26	2	VBZ	0	13	14	1	is	13	13	14	0	VP	0	14	26	2	VBN	0	14	15	1	mediated	14	14	15	0	SBAR	1	15	26	2	IN	0	15	16	1	though	15	15	16	0	S	0	16	26	2	NP	0	16	19	2	NP	0	16	17	1	NN	0	16	17	1	phosphorylation	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	T669	18	18	19	0	PP	0	19	26	2	IN	0	19	20	1	on	19	19	20	0	NP	0	20	26	3	NP	0	20	22	2	NN	0	20	21	1	EGFR	20	20	21	0	CD	0	21	22	1	(	21	21	22	0	CC	0	22	23	1	or	22	22	23	0	NP	2	23	26	3	NN	0	23	24	1	T677	23	23	24	0	NN	0	24	25	1	HER2	24	24	25	0	NN	0	25	26	1	)	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	20
DISCUSSION	25764	25774	NN	discussion	O	_	_
RAF	25775	25778	NN	raf	O	_	_
and	25779	25782	CC	and	O	_	_
MEK	25783	25786	NN	mek	B-GENE	_	_
inhibitors	25787	25797	NNS	inhibitor	O	_	_
are	25798	25801	VBP	be	O	_	_
being	25802	25807	VBG	be	O	_	_
developed	25808	25817	VBN	develop	O	_	_
as	25818	25820	IN	as	O	_	_
treatments	25821	25831	NNS	treatment	O	_	_
for	25832	25835	IN	for	O	_	_
cancers	25836	25843	NNS	cancer	O	_	_
with	25844	25848	IN	with	O	_	_
activation	25849	25859	NN	activation	O	_	_
of	25860	25862	IN	of	O	_	_
RAF	25863	25866	NN	raf	B-GENE	_	_
/	25866	25867	:	/	B-GENE	_	_
MEK/ERK	25867	25874	NN	mek/erk	B-GENE	_	_
signaling	25875	25884	NN	signaling	O	_	_
.	25884	25885	.	.	O	_	_
D	1
7
1	0	nn
1	4	conj_and
4	3	nn
7	1	nsubjpass
7	4	nsubjpass
7	5	aux
7	6	auxpass
7	9	prep_as
7	13	prep_with
9	11	prep_for
13	15	prep_of
15	18	dep
18	16	punct
18	17	nn
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	5	3	NP	1	0	2	2	NN	0	0	1	1	DISCUSSION	0	0	1	0	NN	0	1	2	1	RAF	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	MEK	3	3	4	0	NNS	0	4	5	1	inhibitors	4	4	5	0	VP	1	5	19	2	VBP	0	5	6	1	are	5	5	6	0	VP	1	6	19	2	VBG	0	6	7	1	being	6	6	7	0	VP	0	7	19	3	VBN	0	7	8	1	developed	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	as	8	8	9	0	NP	0	9	12	2	NP	0	9	10	1	NNS	0	9	10	1	treatments	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	for	10	10	11	0	NP	0	11	12	1	NNS	0	11	12	1	cancers	11	11	12	0	PP	0	12	19	2	IN	0	12	13	1	with	12	12	13	0	NP	0	13	19	2	NP	0	13	14	1	NN	0	13	14	1	activation	13	13	14	0	PP	0	14	19	2	IN	0	14	15	1	of	14	14	15	0	NP	0	15	19	2	NP	0	15	16	1	NN	0	15	16	1	RAF	15	15	16	0	PRN	1	16	19	2	:	0	16	17	1	/	16	16	17	0	NP	1	17	19	2	NN	0	17	18	1	MEK/ERK	17	17	18	0	NN	0	18	19	1	signaling	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	23
However	25886	25893	RB	however	O	_	_
,	25893	25894	,	,	O	_	_
with	25895	25899	IN	with	O	_	_
the	25900	25903	DT	the	O	_	_
exception	25904	25913	NN	exception	O	_	_
of	25914	25916	IN	of	O	_	_
BRAF-mutant	25917	25928	JJ	braf-mutant	O	_	_
melanomas	25929	25938	NNS	melanoma	O	_	_
,	25938	25939	,	,	O	_	_
the	25940	25943	DT	the	O	_	_
efficacy	25944	25952	NN	efficacy	O	_	_
of	25953	25955	IN	of	O	_	_
these	25956	25961	DT	these	O	_	_
drugs	25962	25967	NNS	drug	O	_	_
as	25968	25970	IN	as	O	_	_
single	25971	25977	JJ	single	O	_	_
agents	25978	25984	NNS	agent	O	_	_
has	25985	25988	VBZ	have	O	_	_
been	25989	25993	VBN	be	O	_	_
underwhelming	25994	26007	VBG	underwhelm	O	_	_
to	26008	26010	TO	to	O	_	_
date	26011	26015	NN	date	O	_	_
.	26015	26016	.	.	O	_	_
D	1
19
4	3	det
4	7	prep_of
7	6	amod
10	9	det
10	13	prep_of
13	12	det
13	16	prep_as
16	15	amod
19	0	advmod
19	4	prep_with
19	10	nsubj
19	17	aux
19	18	aux
19	21	prep_to
EOX
Y	1
ROOT	0	0	23	1	S	5	0	23	7	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	PP	0	2	8	2	IN	0	2	3	1	with	2	2	3	0	NP	0	3	8	2	NP	1	3	5	2	DT	0	3	4	1	the	3	3	4	0	NN	0	4	5	1	exception	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	of	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	BRAF-mutant	6	6	7	0	NNS	0	7	8	1	melanomas	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	0	9	17	2	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	efficacy	10	10	11	0	PP	0	11	17	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	17	2	NP	1	12	14	2	DT	0	12	13	1	these	12	12	13	0	NNS	0	13	14	1	drugs	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	as	14	14	15	0	NP	1	15	17	2	JJ	0	15	16	1	single	15	15	16	0	NNS	0	16	17	1	agents	16	16	17	0	VP	1	17	22	2	VBZ	0	17	18	1	has	17	17	18	0	VP	1	18	22	2	VBN	0	18	19	1	been	18	18	19	0	VP	0	19	22	2	VBG	0	19	20	1	underwhelming	19	19	20	0	PP	0	20	22	2	TO	0	20	21	1	to	20	20	21	0	NP	0	21	22	1	NN	0	21	22	1	date	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	33
Although	26017	26025	IN	although	O	_	_
there	26026	26031	EX	there	O	_	_
are	26032	26035	VBP	be	O	_	_
several	26036	26043	JJ	several	O	_	_
potential	26044	26053	JJ	potential	O	_	_
reasons	26054	26061	NNS	reason	O	_	_
for	26062	26065	IN	for	O	_	_
this	26066	26070	DT	this	O	_	_
lack	26071	26075	NN	lack	O	_	_
of	26076	26078	IN	of	O	_	_
efficacy	26079	26087	NN	efficacy	O	_	_
,	26087	26088	,	,	O	_	_
feedback	26089	26097	NN	feedback	O	_	_
activation	26098	26108	NN	activation	O	_	_
of	26109	26111	IN	of	O	_	_
parallel	26112	26120	JJ	parallel	O	_	_
oncogenic	26121	26130	JJ	oncogenic	O	_	_
pathways	26131	26139	NNS	pathway	O	_	_
including	26140	26149	VBG	include	O	_	_
PI3K	26150	26154	NN	pi3k	O	_	_
/	26154	26155	:	/	O	_	_
AKT	26155	26158	NNP	AKT	O	_	_
has	26159	26162	VBZ	have	O	_	_
been	26163	26167	VBN	be	O	_	_
invoked	26168	26175	VBN	invoke	O	_	_
(	26176	26177	CD	(	O	_	_
11	26177	26179	CD	11	O	_	_
,	26179	26180	,	,	O	_	_
13	26181	26183	CD	13	O	_	_
‚	26183	26184	CD	‚	O	_	_
Äì15	26184	26188	NN	äì15	O	_	_
)	26188	26189	NN	)	O	_	_
.	26189	26190	.	.	O	_	_
D	1
24
2	0	mark
2	1	expl
2	5	nsubj
5	3	amod
5	4	amod
5	8	prep_for
8	7	det
8	10	prep_of
13	12	nn
13	17	prep_of
17	15	amod
17	16	amod
17	19	prep_including
19	21	dep
21	20	punct
24	2	advcl
24	13	nsubjpass
24	22	aux
24	23	auxpass
24	26	dobj
26	25	number
26	31	appos
29	28	number
31	29	num
31	30	nn
EOX
Y	1
ROOT	0	0	33	1	S	3	0	33	5	SBAR	1	0	11	2	IN	0	0	1	1	Although	0	0	1	0	S	1	1	11	2	NP	0	1	2	1	EX	0	1	2	1	there	1	1	2	0	VP	1	2	11	2	VBP	0	2	3	1	are	2	2	3	0	NP	0	3	11	2	NP	2	3	6	3	JJ	0	3	4	1	several	3	3	4	0	JJ	0	4	5	1	potential	4	4	5	0	NNS	0	5	6	1	reasons	5	5	6	0	PP	0	6	11	2	IN	0	6	7	1	for	6	6	7	0	NP	0	7	11	2	NP	1	7	9	2	DT	0	7	8	1	this	7	7	8	0	NN	0	8	9	1	lack	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	efficacy	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	22	2	NP	1	12	14	2	NN	0	12	13	1	feedback	12	12	13	0	NN	0	13	14	1	activation	13	13	14	0	PP	0	14	22	2	IN	0	14	15	1	of	14	14	15	0	NP	0	15	22	2	NP	2	15	18	3	JJ	0	15	16	1	parallel	15	15	16	0	JJ	0	16	17	1	oncogenic	16	16	17	0	NNS	0	17	18	1	pathways	17	17	18	0	PP	0	18	22	2	VBG	0	18	19	1	including	18	18	19	0	NP	0	19	22	2	NP	0	19	20	1	NN	0	19	20	1	PI3K	19	19	20	0	PRN	1	20	22	2	:	0	20	21	1	/	20	20	21	0	NP	0	21	22	1	NNP	0	21	22	1	AKT	21	21	22	0	VP	1	22	32	2	VBZ	0	22	23	1	has	22	22	23	0	VP	1	23	32	2	VBN	0	23	24	1	been	23	23	24	0	VP	0	24	32	2	VBN	0	24	25	1	invoked	24	24	25	0	NP	0	25	32	3	NP	0	25	27	1	QP	1	25	27	2	CD	0	25	26	1	(	25	25	26	0	CD	0	26	27	1	11	26	26	27	0	,	0	27	28	1	,	27	27	28	0	NP	2	28	32	3	QP	1	28	30	2	CD	0	28	29	1	13	28	28	29	0	CD	0	29	30	1	‚	29	29	30	0	NN	0	30	31	1	Äì15	30	30	31	0	NN	0	31	32	1	)	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	23
This	26191	26195	DT	this	O	_	_
idea	26196	26200	NN	idea	O	_	_
is	26201	26203	VBZ	be	O	_	_
analogous	26204	26213	JJ	analogous	O	_	_
to	26214	26216	TO	to	O	_	_
findings	26217	26225	NNS	finding	O	_	_
that	26226	26230	IN	that	O	_	_
mTORC1	26231	26237	NN	mtorc1	B-GENE	_	_
inhibitors	26238	26248	NNS	inhibitor	O	_	_
are	26249	26252	VBP	be	O	_	_
limited	26253	26260	VBN	limit	O	_	_
by	26261	26263	IN	by	O	_	_
feedback	26264	26272	NN	feedback	O	_	_
activation	26273	26283	NN	activation	O	_	_
of	26284	26286	IN	of	O	_	_
PI3K	26287	26291	NN	pi3k	B-GENE	_	_
signaling	26292	26301	NN	signaling	O	_	_
(	26302	26303	CD	(	O	_	_
4	26303	26304	CD	4	O	_	_
,	26304	26305	,	,	O	_	_
6	26306	26307	CD	6	O	_	_
)	26307	26308	NN	)	O	_	_
.	26308	26309	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubj
3	2	cop
3	5	prep_to
3	10	ccomp
8	7	nn
10	6	mark
10	8	nsubjpass
10	9	auxpass
10	13	agent
13	12	nn
13	16	prep_of
16	15	nn
16	18	amod
18	17	number
18	21	dep
21	20	number
EOX
Y	1
ROOT	0	0	23	1	S	1	0	23	3	NP	1	0	2	2	DT	0	0	1	1	This	0	0	1	0	NN	0	1	2	1	idea	1	1	2	0	VP	1	2	22	3	VBZ	0	2	3	1	is	2	2	3	0	ADJP	0	3	6	2	JJ	0	3	4	1	analogous	3	3	4	0	PP	0	4	6	2	TO	0	4	5	1	to	4	4	5	0	NP	0	5	6	1	NNS	0	5	6	1	findings	5	5	6	0	SBAR	1	6	22	2	IN	0	6	7	1	that	6	6	7	0	S	1	7	22	2	NP	1	7	9	2	NN	0	7	8	1	mTORC1	7	7	8	0	NNS	0	8	9	1	inhibitors	8	8	9	0	VP	1	9	22	2	VBP	0	9	10	1	are	9	9	10	0	VP	0	10	22	2	VBN	0	10	11	1	limited	10	10	11	0	PP	0	11	22	2	IN	0	11	12	1	by	11	11	12	0	NP	0	12	22	2	NP	1	12	14	2	NN	0	12	13	1	feedback	12	12	13	0	NN	0	13	14	1	activation	13	13	14	0	PP	0	14	22	2	IN	0	14	15	1	of	14	14	15	0	NP	0	15	22	2	NP	1	15	17	2	NN	0	15	16	1	PI3K	15	15	16	0	NN	0	16	17	1	signaling	16	16	17	0	ADJP	0	17	22	3	ADJP	0	17	19	1	QP	1	17	19	2	CD	0	17	18	1	(	17	17	18	0	CD	0	18	19	1	4	18	18	19	0	,	0	19	20	1	,	19	19	20	0	ADJP	1	20	22	2	CD	0	20	21	1	6	20	20	21	0	NN	0	21	22	1	)	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	61
In	26310	26312	IN	in	O	_	_
this	26313	26317	DT	this	O	_	_
study	26318	26323	NN	study	O	_	_
,	26323	26324	,	,	O	_	_
we	26325	26327	PRP	we	O	_	_
observe	26328	26335	VBP	observe	O	_	_
that	26336	26340	IN	that	O	_	_
MEK-inhibitor	26341	26354	NN	mek-inhibitor	B-GENE	_	_
induced	26355	26362	VBD	induce	O	_	_
activation	26363	26373	NN	activation	O	_	_
of	26374	26376	IN	of	O	_	_
PI3K	26377	26381	NN	pi3k	B-GENE	_	_
/	26381	26382	:	/	B-GENE	_	_
AKT	26382	26385	NN	akt	I-GENE	_	_
occurs	26386	26392	VBZ	occur	O	_	_
in	26393	26395	IN	in	O	_	_
multiple	26396	26404	JJ	multiple	O	_	_
ERBB	26405	26409	NN	erbb	O	_	_
driven	26410	26416	VBN	drive	O	_	_
cancer	26417	26423	NN	cancer	O	_	_
ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	26424	26481	NN	ôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøº	O	_	_
ÔøºÔøºMEK	26483	26492	NN	ôøºôøºmek	B-GENE	_	_
inhibition	26493	26503	NN	inhibition	O	_	_
leads	26504	26509	VBZ	lead	O	_	_
to	26510	26512	TO	to	O	_	_
PI3K	26513	26517	NN	pi3k	B-GENE	_	_
/	26517	26518	:	/	B-GENE	_	_
AKT	26518	26521	NN	akt	I-GENE	_	_
activation	26522	26532	NN	activation	O	_	_
by	26533	26535	IN	by	O	_	_
relieving	26536	26545	VBG	relieve	O	_	_
a	26546	26547	DT	a	O	_	_
negative	26548	26556	JJ	negative	O	_	_
feedback	26557	26565	NN	feedback	O	_	_
on	26566	26568	IN	on	O	_	_
ERBB	26569	26573	NN	erbb	O	_	_
receptors	26574	26583	NNS	receptor	O	_	_
12	26584	26586	CD	12	O	_	_
/	26586	26587	:	/	O	_	_
8/14	26587	26591	CD	8/14	O	_	_
,	26591	26592	,	,	O	_	_
6:54	26593	26597	CD	6:54	O	_	_
PM	26598	26600	NNP	PM	O	_	_
Ôøºmodels	26601	26610	NNP	Ôøºmodels	O	_	_
via	26611	26614	IN	via	O	_	_
loss	26615	26619	NN	loss	O	_	_
of	26620	26622	IN	of	O	_	_
an	26623	26625	DT	a	O	_	_
inhibitory	26626	26636	JJ	inhibitory	O	_	_
threonine	26637	26646	NN	threonine	O	_	_
phosphorylation	26647	26662	NN	phosphorylation	O	_	_
in	26663	26665	IN	in	O	_	_
the	26666	26669	DT	the	O	_	_
conserved	26670	26679	VBN	conserve	O	_	_
JM	26680	26682	NN	jm	O	_	_
domains	26683	26690	NNS	domain	O	_	_
of	26691	26693	IN	of	O	_	_
EGFR	26694	26698	NN	egfr	B-GENE	_	_
and	26699	26702	CC	and	O	_	_
HER2	26703	26707	NN	her2	B-GENE	_	_
.	26707	26708	.	.	O	_	_
D	1
5
2	1	det
5	2	prep_in
5	4	nsubj
5	8	ccomp
8	6	mark
8	7	nsubj
8	9	dobj
8	52	prep_in
9	11	prep_of
9	14	dep
14	12	punct
14	13	nsubj
14	17	prep_in
14	43	dep
17	16	amod
17	18	vmod
18	20	iobj
18	22	dobj
20	19	nn
22	21	nn
22	23	rcmod
22	28	dep
22	39	dep
23	25	prep_to
28	26	punct
28	27	nn
28	30	prepc_by
28	38	punct
30	33	dobj
30	36	prep_on
33	31	det
33	32	amod
36	35	nn
36	37	dep
43	41	num
43	42	nn
43	45	prep_via
43	50	prep_of
50	47	det
50	48	amod
50	49	nn
52	53	vmod
53	55	dobj
55	54	nn
55	57	prep_of
55	59	prep_of
57	59	conj_and
EOX
Y	1
ROOT	0	0	61	1	S	3	0	61	5	PP	0	0	3	2	IN	0	0	1	1	In	0	0	1	0	NP	1	1	3	2	DT	0	1	2	1	this	1	1	2	0	NN	0	2	3	1	study	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	0	4	5	1	PRP	0	4	5	1	we	4	4	5	0	VP	0	5	60	2	VBP	0	5	6	1	observe	5	5	6	0	SBAR	1	6	60	2	IN	0	6	7	1	that	6	6	7	0	S	1	7	60	2	NP	0	7	8	1	NN	0	7	8	1	MEK-inhibitor	7	7	8	0	VP	0	8	60	3	VBD	0	8	9	1	induced	8	8	9	0	NP	0	9	51	3	NP	0	9	10	1	NN	0	9	10	1	activation	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	of	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	PI3K	11	11	12	0	PRN	1	12	51	4	:	0	12	13	1	/	12	12	13	0	S	1	13	40	2	NP	0	13	14	1	NN	0	13	14	1	AKT	13	13	14	0	VP	0	14	40	2	VBZ	0	14	15	1	occurs	14	14	15	0	PP	0	15	40	2	IN	0	15	16	1	in	15	15	16	0	NP	0	16	40	2	NP	1	16	18	2	JJ	0	16	17	1	multiple	16	16	17	0	NN	0	17	18	1	ERBB	17	17	18	0	VP	0	18	40	3	VBN	0	18	19	1	driven	18	18	19	0	NP	1	19	21	2	NN	0	19	20	1	cancer	19	19	20	0	NN	0	20	21	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	20	20	21	0	NP	0	21	40	3	NP	0	21	26	2	NP	1	21	23	2	NN	0	21	22	1	ÔøºÔøºMEK	21	21	22	0	NN	0	22	23	1	inhibition	22	22	23	0	SBAR	0	23	26	1	S	0	23	26	1	VP	0	23	26	2	VBZ	0	23	24	1	leads	23	23	24	0	PP	0	24	26	2	TO	0	24	25	1	to	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	PI3K	25	25	26	0	PRN	1	26	39	3	:	0	26	27	1	/	26	26	27	0	NP	0	27	38	2	NP	1	27	29	2	NN	0	27	28	1	AKT	27	27	28	0	NN	0	28	29	1	activation	28	28	29	0	PP	0	29	38	2	IN	0	29	30	1	by	29	29	30	0	S	0	30	38	1	VP	0	30	38	3	VBG	0	30	31	1	relieving	30	30	31	0	NP	2	31	34	3	DT	0	31	32	1	a	31	31	32	0	JJ	0	32	33	1	negative	32	32	33	0	NN	0	33	34	1	feedback	33	33	34	0	PP	0	34	38	2	IN	0	34	35	1	on	34	34	35	0	NP	0	35	38	2	NP	1	35	37	2	NN	0	35	36	1	ERBB	35	35	36	0	NNS	0	36	37	1	receptors	36	36	37	0	NP	0	37	38	1	CD	0	37	38	1	12	37	37	38	0	:	0	38	39	1	/	38	38	39	0	NP	0	39	40	1	CD	0	39	40	1	8/14	39	39	40	0	,	0	40	41	1	,	40	40	41	0	NP	0	41	51	3	NP	2	41	44	3	CD	0	41	42	1	6:54	41	41	42	0	NNP	0	42	43	1	PM	42	42	43	0	NNP	0	43	44	1	Ôøºmodels	43	43	44	0	PP	0	44	46	2	IN	0	44	45	1	via	44	44	45	0	NP	0	45	46	1	NN	0	45	46	1	loss	45	45	46	0	PP	0	46	51	2	IN	0	46	47	1	of	46	46	47	0	NP	3	47	51	4	DT	0	47	48	1	an	47	47	48	0	JJ	0	48	49	1	inhibitory	48	48	49	0	NN	0	49	50	1	threonine	49	49	50	0	NN	0	50	51	1	phosphorylation	50	50	51	0	PP	0	51	60	2	IN	0	51	52	1	in	51	51	52	0	NP	0	52	60	2	NP	0	52	53	1	DT	0	52	53	1	the	52	52	53	0	VP	0	53	60	2	VBN	0	53	54	1	conserved	53	53	54	0	NP	0	54	60	2	NP	1	54	56	2	NN	0	54	55	1	JM	54	54	55	0	NNS	0	55	56	1	domains	55	55	56	0	PP	0	56	60	2	IN	0	56	57	1	of	56	56	57	0	NP	0	57	60	3	NN	0	57	58	1	EGFR	57	57	58	0	CC	0	58	59	1	and	58	58	59	0	NN	0	59	60	1	HER2	59	59	60	0	.	0	60	61	1	.	60	60	61	0
EOS
T	23
Phosphorylation	26709	26724	NN	phosphorylation	O	_	_
of	26725	26727	IN	of	O	_	_
this	26728	26732	DT	this	O	_	_
threonine	26733	26742	NN	threonine	O	_	_
residue	26743	26750	NN	residue	O	_	_
has	26751	26754	VBZ	have	O	_	_
been	26755	26759	VBN	be	O	_	_
shown	26760	26765	VBN	show	O	_	_
to	26766	26768	TO	to	O	_	_
impair	26769	26775	VB	impair	O	_	_
EGFR	26776	26780	NN	egfr	B-GENE	_	_
activation	26781	26791	NN	activation	O	_	_
,	26791	26792	,	,	O	_	_
likely	26793	26799	RB	likely	O	_	_
through	26800	26807	IN	through	O	_	_
disruption	26808	26818	NN	disruption	O	_	_
of	26819	26821	IN	of	O	_	_
receptor	26822	26830	NN	receptor	O	_	_
dimerization	26831	26843	NN	dimerization	O	_	_
(	26844	26845	CD	(	O	_	_
21	26845	26847	CD	21	O	_	_
)	26847	26848	NN	)	O	_	_
.	26848	26849	.	.	O	_	_
D	1
7
0	4	prep_of
4	2	det
4	3	nn
7	0	nsubjpass
7	5	aux
7	6	auxpass
7	9	xcomp
9	8	aux
9	11	dobj
11	10	nn
11	21	rcmod
13	15	prep_through
15	18	prep_of
18	17	nn
20	19	number
21	13	advmod
21	20	num
EOX
Y	1
ROOT	0	0	23	1	S	1	0	23	3	NP	0	0	5	2	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	5	2	IN	0	1	2	1	of	1	1	2	0	NP	2	2	5	3	DT	0	2	3	1	this	2	2	3	0	NN	0	3	4	1	threonine	3	3	4	0	NN	0	4	5	1	residue	4	4	5	0	VP	1	5	22	2	VBZ	0	5	6	1	has	5	5	6	0	VP	1	6	22	2	VBN	0	6	7	1	been	6	6	7	0	VP	0	7	22	2	VBN	0	7	8	1	shown	7	7	8	0	S	0	8	22	1	VP	1	8	22	2	TO	0	8	9	1	to	8	8	9	0	VP	0	9	22	2	VB	0	9	10	1	impair	9	9	10	0	NP	0	10	22	3	NP	1	10	12	2	NN	0	10	11	1	EGFR	10	10	11	0	NN	0	11	12	1	activation	11	11	12	0	,	0	12	13	1	,	12	12	13	0	RRC	1	13	22	2	ADVP	0	13	19	2	RB	0	13	14	1	likely	13	13	14	0	PP	0	14	19	2	IN	0	14	15	1	through	14	14	15	0	NP	0	15	19	2	NP	0	15	16	1	NN	0	15	16	1	disruption	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	of	16	16	17	0	NP	1	17	19	2	NN	0	17	18	1	receptor	17	17	18	0	NN	0	18	19	1	dimerization	18	18	19	0	NP	1	19	22	2	QP	1	19	21	2	CD	0	19	20	1	(	19	19	20	0	CD	0	20	21	1	21	20	20	21	0	NN	0	21	22	1	)	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	19
Our	26850	26853	PRP$	we	O	_	_
findings	26854	26862	NNS	finding	O	_	_
suggest	26863	26870	VBP	suggest	O	_	_
that	26871	26875	IN	that	O	_	_
direct	26876	26882	JJ	direct	O	_	_
ERK	26883	26886	NN	erk	B-GENE	_	_
mediated	26887	26895	VBD	mediate	O	_	_
phosphorylation	26896	26911	NN	phosphorylation	O	_	_
of	26912	26914	IN	of	O	_	_
EGFR	26915	26919	NN	egfr	B-GENE	_	_
T669	26920	26924	NN	t669	I-GENE	_	_
and	26925	26928	CC	and	O	_	_
HER2	26929	26933	NN	her2	O	_	_
T677	26934	26938	NN	t677	O	_	_
suppresses	26939	26949	VBZ	suppress	O	_	_
activation	26950	26960	NN	activation	O	_	_
of	26961	26963	IN	of	O	_	_
ERBB3	26964	26969	NN	erbb3	B-GENE	_	_
.	26969	26970	.	.	O	_	_
D	1
2
1	0	poss
2	1	nsubj
2	6	ccomp
5	4	amod
6	3	mark
6	5	nsubj
6	14	ccomp
7	10	prep_of
7	13	prep_of
10	9	nn
10	13	conj_and
13	12	nn
14	7	nsubj
14	15	dobj
15	17	prep_of
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	1	0	2	2	PRP$	0	0	1	1	Our	0	0	1	0	NNS	0	1	2	1	findings	1	1	2	0	VP	0	2	18	2	VBP	0	2	3	1	suggest	2	2	3	0	SBAR	1	3	18	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	18	2	NP	1	4	6	2	JJ	0	4	5	1	direct	4	4	5	0	NN	0	5	6	1	ERK	5	5	6	0	VP	0	6	18	2	VBD	0	6	7	1	mediated	6	6	7	0	SBAR	0	7	18	1	S	1	7	18	2	NP	0	7	14	2	NP	0	7	8	1	NN	0	7	8	1	phosphorylation	7	7	8	0	PP	0	8	14	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	14	3	NP	1	9	11	2	NN	0	9	10	1	EGFR	9	9	10	0	NN	0	10	11	1	T669	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	HER2	12	12	13	0	NN	0	13	14	1	T677	13	13	14	0	VP	0	14	18	2	VBZ	0	14	15	1	suppresses	14	14	15	0	NP	0	15	18	2	NP	0	15	16	1	NN	0	15	16	1	activation	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	ERBB3	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	30
These	26971	26976	DT	these	O	_	_
findings	26977	26985	NNS	finding	O	_	_
agree	26986	26991	VBP	agree	O	_	_
with	26992	26996	IN	with	O	_	_
those	26997	27002	DT	those	O	_	_
by	27003	27005	IN	by	O	_	_
Li	27006	27008	NNP	Li	O	_	_
and	27009	27012	CC	and	O	_	_
colleagues	27013	27023	NNS	colleague	O	_	_
who	27024	27027	WP	who	O	_	_
observed	27028	27036	VBD	observe	O	_	_
that	27037	27041	IN	that	O	_	_
MEK	27042	27045	NN	mek	B-GENE	_	_
inhibition	27046	27056	NN	inhibition	O	_	_
failed	27057	27063	VBD	fail	O	_	_
to	27064	27066	TO	to	O	_	_
increase	27067	27075	VB	increase	O	_	_
phosphorylation	27076	27091	NN	phosphorylation	O	_	_
of	27092	27094	IN	of	O	_	_
EGFR	27095	27099	NN	egfr	B-GENE	_	_
T669A	27100	27105	NN	t669a	I-GENE	_	_
homodimers	27106	27116	NNS	homodimer	I-GENE	_	_
expressed	27117	27126	VBN	express	O	_	_
in	27127	27129	IN	in	O	_	_
CHO-KI	27130	27136	NN	cho-kus	O	_	_
cells	27137	27142	NNS	cell	O	_	_
(	27143	27144	VBP	(	O	_	_
20	27144	27146	CD	20	O	_	_
)	27146	27147	CD	)	O	_	_
.	27147	27148	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	4	prep_with
2	6	prep_by
2	26	conj_and
8	10	rcmod
10	9	nsubj
10	14	ccomp
13	12	nn
14	11	mark
14	13	nsubj
14	16	xcomp
16	15	aux
16	17	dobj
17	21	prep_of
21	19	nn
21	20	nn
21	22	vmod
22	25	prep_in
25	24	nn
26	8	nsubj
26	28	dobj
28	27	number
EOX
Y	1
ROOT	0	0	30	1	S	0	0	30	4	S	1	0	7	2	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	findings	1	1	2	0	VP	0	2	7	3	VBP	0	2	3	1	agree	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	with	3	3	4	0	NP	0	4	5	1	DT	0	4	5	1	those	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	by	5	5	6	0	NP	0	6	7	1	NNP	0	6	7	1	Li	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	S	1	8	29	2	NP	0	8	26	2	NP	0	8	9	1	NNS	0	8	9	1	colleagues	8	8	9	0	SBAR	1	9	26	2	WHNP	0	9	10	1	WP	0	9	10	1	who	9	9	10	0	S	0	10	26	1	VP	0	10	26	2	VBD	0	10	11	1	observed	10	10	11	0	SBAR	1	11	26	2	IN	0	11	12	1	that	11	11	12	0	S	1	12	26	2	NP	1	12	14	2	NN	0	12	13	1	MEK	12	12	13	0	NN	0	13	14	1	inhibition	13	13	14	0	VP	0	14	26	2	VBD	0	14	15	1	failed	14	14	15	0	S	0	15	26	1	VP	1	15	26	2	TO	0	15	16	1	to	15	15	16	0	VP	0	16	26	2	VB	0	16	17	1	increase	16	16	17	0	NP	0	17	26	2	NP	0	17	18	1	NN	0	17	18	1	phosphorylation	17	17	18	0	PP	0	18	26	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	26	2	NP	2	19	22	3	NN	0	19	20	1	EGFR	19	19	20	0	NN	0	20	21	1	T669A	20	20	21	0	NNS	0	21	22	1	homodimers	21	21	22	0	VP	0	22	26	2	VBN	0	22	23	1	expressed	22	22	23	0	PP	0	23	26	2	IN	0	23	24	1	in	23	23	24	0	NP	1	24	26	2	NN	0	24	25	1	CHO-KI	24	24	25	0	NNS	0	25	26	1	cells	25	25	26	0	VP	0	26	29	2	VBP	0	26	27	1	(	26	26	27	0	NP	0	27	29	1	QP	1	27	29	2	CD	0	27	28	1	20	27	27	28	0	CD	0	28	29	1	)	28	28	29	0	.	0	29	30	1	.	29	29	30	0
EOS
T	28
In	27149	27151	IN	in	O	_	_
this	27152	27156	DT	this	O	_	_
study	27157	27162	NN	study	O	_	_
,	27162	27163	,	,	O	_	_
we	27164	27166	PRP	we	O	_	_
extend	27167	27173	VBP	extend	O	_	_
previous	27174	27182	JJ	previous	O	_	_
findings	27183	27191	NNS	finding	O	_	_
by	27192	27194	IN	by	O	_	_
directly	27195	27203	RB	directly	O	_	_
showing	27204	27211	VBG	show	O	_	_
the	27212	27215	DT	the	O	_	_
effects	27216	27223	NNS	effect	O	_	_
of	27224	27226	IN	of	O	_	_
EGFR	27227	27231	NN	egfr	B-GENE	_	_
T669A	27232	27237	NN	t669a	I-GENE	_	_
on	27238	27240	IN	on	O	_	_
ERBB3	27241	27246	NN	erbb3	B-GENE	_	_
/	27246	27247	:	/	B-GENE	_	_
PI3K/AKT	27247	27255	NN	pi3k/akt	B-GENE	_	_
signaling	27256	27265	NN	signaling	O	_	_
in	27266	27268	IN	in	O	_	_
an	27269	27271	DT	a	O	_	_
EGFR-mutant	27272	27283	JJ	egfr-mutant	O	_	_
cancer	27284	27290	NN	cancer	O	_	_
cell	27291	27295	NN	cell	O	_	_
line	27296	27300	NN	line	O	_	_
.	27300	27301	.	.	O	_	_
D	1
5
2	1	det
5	2	prep_in
5	4	nsubj
5	7	dobj
5	10	prepc_by
7	6	amod
10	9	advmod
10	12	dobj
10	17	prep_on
12	11	det
12	15	prep_of
15	14	nn
17	20	dep
20	18	punct
20	19	nn
20	26	prep_in
26	22	det
26	23	amod
26	24	nn
26	25	nn
EOX
Y	1
ROOT	0	0	28	1	S	3	0	28	5	PP	0	0	3	2	IN	0	0	1	1	In	0	0	1	0	NP	1	1	3	2	DT	0	1	2	1	this	1	1	2	0	NN	0	2	3	1	study	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	0	4	5	1	PRP	0	4	5	1	we	4	4	5	0	VP	0	5	27	3	VBP	0	5	6	1	extend	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	previous	6	6	7	0	NNS	0	7	8	1	findings	7	7	8	0	PP	0	8	27	2	IN	0	8	9	1	by	8	8	9	0	S	1	9	27	2	ADVP	0	9	10	1	RB	0	9	10	1	directly	9	9	10	0	VP	0	10	27	3	VBG	0	10	11	1	showing	10	10	11	0	NP	0	11	16	2	NP	1	11	13	2	DT	0	11	12	1	the	11	11	12	0	NNS	0	12	13	1	effects	12	12	13	0	PP	0	13	16	2	IN	0	13	14	1	of	13	13	14	0	NP	1	14	16	2	NN	0	14	15	1	EGFR	14	14	15	0	NN	0	15	16	1	T669A	15	15	16	0	PP	0	16	27	2	IN	0	16	17	1	on	16	16	17	0	NP	0	17	27	2	NP	0	17	18	1	NN	0	17	18	1	ERBB3	17	17	18	0	PRN	1	18	27	2	:	0	18	19	1	/	18	18	19	0	NP	0	19	27	2	NP	1	19	21	2	NN	0	19	20	1	PI3K/AKT	19	19	20	0	NN	0	20	21	1	signaling	20	20	21	0	PP	0	21	27	2	IN	0	21	22	1	in	21	21	22	0	NP	4	22	27	5	DT	0	22	23	1	an	22	22	23	0	JJ	0	23	24	1	EGFR-mutant	23	23	24	0	NN	0	24	25	1	cancer	24	24	25	0	NN	0	25	26	1	cell	25	25	26	0	NN	0	26	27	1	line	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	60
Furthermore	27302	27313	RB	furthermore	O	_	_
,	27313	27314	,	,	O	_	_
we	27315	27317	PRP	we	O	_	_
show	27318	27322	VBP	show	O	_	_
that	27323	27327	IN	that	O	_	_
although	27328	27336	IN	although	O	_	_
multiple	27337	27345	JJ	multiple	O	_	_
mechanisms	27346	27356	NNS	mechanism	O	_	_
for	27357	27360	IN	for	O	_	_
MAPK	27361	27365	NN	mapk	O	_	_
feedback	27366	27374	NN	feedback	O	_	_
regulation	27375	27385	NN	regulation	O	_	_
of	27386	27388	IN	of	O	_	_
AKT	27389	27392	NN	akt	O	_	_
signaling	27393	27402	NN	signaling	O	_	_
have	27403	27407	VBP	have	O	_	_
been	27408	27412	VBN	be	O	_	_
proposed	27413	27421	VBN	propose	O	_	_
,	27421	27422	,	,	O	_	_
T669A	27423	27428	NN	t669a	O	_	_
mutation	27429	27437	NN	mutation	O	_	_
of	27438	27440	IN	of	O	_	_
EGFR	27441	27445	NN	egfr	B-GENE	_	_
is	27446	27448	VBZ	be	O	_	_
sufficient	27449	27459	JJ	sufficient	O	_	_
to	27460	27462	TO	to	O	_	_
block	27463	27468	VB	block	O	_	_
MEK	27469	27472	NN	mek	B-GENE	_	_
inhibitor-	27473	27483	NN	inhibitor-_NN	O	_	_
induced	27484	27491	VBD	induce	O	_	_
feedback	27492	27500	NN	feedback	O	_	_
activation	27501	27511	NN	activation	O	_	_
of	27512	27514	IN	of	O	_	_
PI3K	27515	27519	NN	pi3k	B-GENE	_	_
/	27519	27520	:	/	B-GENE	_	_
AKT	27520	27523	NNP	AKT	I-GENE	_	_
,	27523	27524	,	,	O	_	_
suggesting	27525	27535	VBG	suggest	O	_	_
that	27536	27540	IN	that	O	_	_
the	27541	27544	DT	the	O	_	_
feedback	27545	27553	NN	feedback	O	_	_
we	27554	27556	PRP	we	O	_	_
describe	27557	27565	VBP	describe	O	_	_
herein	27566	27572	RB	herein	O	_	_
is	27573	27575	VBZ	be	O	_	_
one	27576	27579	CD	one	O	_	_
of	27580	27582	IN	of	O	_	_
the	27583	27586	DT	the	O	_	_
dominant	27587	27595	JJ	dominant	O	_	_
mechanisms	27596	27606	NNS	mechanism	O	_	_
regulating	27607	27617	VBG	regulate	O	_	_
AKT	27618	27621	NN	akt	O	_	_
activation	27622	27632	NN	activation	O	_	_
in	27633	27635	IN	in	O	_	_
EGFR	27636	27640	NN	egfr	B-GENE	_	_
and	27641	27644	CC	and	O	_	_
HER	27645	27648	NN	her	O	_	_
driven	27649	27655	VBN	drive	O	_	_
cancers	27656	27663	NNS	cancer	O	_	_
.	27663	27664	.	.	O	_	_
D	1
3
3	0	advmod
3	2	nsubj
3	24	ccomp
7	6	amod
7	11	prep_for
11	9	nn
11	10	nn
11	14	prep_of
14	13	nn
17	5	mark
17	7	nsubjpass
17	15	aux
17	16	auxpass
20	19	nn
20	22	prep_of
24	4	mark
24	17	advcl
24	20	nsubj
24	23	cop
24	26	xcomp
26	25	aux
26	29	ccomp
28	27	nn
29	28	nsubj
29	31	dobj
29	37	vmod
31	30	nn
31	33	prep_of
33	35	dep
35	34	punct
37	45	ccomp
40	39	det
40	42	rcmod
42	41	nsubj
42	43	advmod
45	38	mark
45	40	nsubj
45	44	cop
45	49	prep_of
49	47	det
49	48	amod
49	50	vmod
50	52	dobj
50	54	prep_in
50	56	prep_in
52	51	nn
54	56	conj_and
54	57	vmod
57	58	dobj
EOX
Y	1
ROOT	0	0	60	1	S	3	0	60	5	ADVP	0	0	1	1	RB	0	0	1	1	Furthermore	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	we	2	2	3	0	VP	0	3	59	2	VBP	0	3	4	1	show	3	3	4	0	SBAR	1	4	59	2	IN	0	4	5	1	that	4	4	5	0	S	3	5	59	4	SBAR	1	5	18	2	IN	0	5	6	1	although	5	5	6	0	S	1	6	18	2	NP	0	6	15	2	NP	1	6	8	2	JJ	0	6	7	1	multiple	6	6	7	0	NNS	0	7	8	1	mechanisms	7	7	8	0	PP	0	8	15	2	IN	0	8	9	1	for	8	8	9	0	NP	0	9	15	2	NP	2	9	12	3	NN	0	9	10	1	MAPK	9	9	10	0	NN	0	10	11	1	feedback	10	10	11	0	NN	0	11	12	1	regulation	11	11	12	0	PP	0	12	15	2	IN	0	12	13	1	of	12	12	13	0	NP	1	13	15	2	NN	0	13	14	1	AKT	13	13	14	0	NN	0	14	15	1	signaling	14	14	15	0	VP	1	15	18	2	VBP	0	15	16	1	have	15	15	16	0	VP	1	16	18	2	VBN	0	16	17	1	been	16	16	17	0	VP	0	17	18	1	VBN	0	17	18	1	proposed	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	0	19	23	2	NP	1	19	21	2	NN	0	19	20	1	T669A	19	19	20	0	NN	0	20	21	1	mutation	20	20	21	0	PP	0	21	23	2	IN	0	21	22	1	of	21	21	22	0	NP	0	22	23	1	NN	0	22	23	1	EGFR	22	22	23	0	VP	1	23	59	2	VBZ	0	23	24	1	is	23	23	24	0	ADJP	0	24	59	2	JJ	0	24	25	1	sufficient	24	24	25	0	S	0	25	59	1	VP	1	25	59	2	TO	0	25	26	1	to	25	25	26	0	VP	0	26	59	2	VB	0	26	27	1	block	26	26	27	0	SBAR	0	27	59	1	S	1	27	59	2	NP	1	27	29	2	NN	0	27	28	1	MEK	27	27	28	0	NN	0	28	29	1	inhibitor-	28	28	29	0	VP	0	29	59	4	VBD	0	29	30	1	induced	29	29	30	0	NP	0	30	36	2	NP	1	30	32	2	NN	0	30	31	1	feedback	30	30	31	0	NN	0	31	32	1	activation	31	31	32	0	PP	0	32	36	2	IN	0	32	33	1	of	32	32	33	0	NP	0	33	36	2	NP	0	33	34	1	NN	0	33	34	1	PI3K	33	33	34	0	PRN	1	34	36	2	:	0	34	35	1	/	34	34	35	0	NP	0	35	36	1	NNP	0	35	36	1	AKT	35	35	36	0	,	0	36	37	1	,	36	36	37	0	S	0	37	59	1	VP	0	37	59	2	VBG	0	37	38	1	suggesting	37	37	38	0	SBAR	1	38	59	2	IN	0	38	39	1	that	38	38	39	0	S	1	39	59	2	NP	0	39	44	2	NP	1	39	41	2	DT	0	39	40	1	the	39	39	40	0	NN	0	40	41	1	feedback	40	40	41	0	SBAR	0	41	44	1	S	1	41	44	2	NP	0	41	42	1	PRP	0	41	42	1	we	41	41	42	0	VP	0	42	44	2	VBP	0	42	43	1	describe	42	42	43	0	ADVP	0	43	44	1	RB	0	43	44	1	herein	43	43	44	0	VP	1	44	59	2	VBZ	0	44	45	1	is	44	44	45	0	NP	0	45	59	2	NP	0	45	46	1	CD	0	45	46	1	one	45	45	46	0	PP	0	46	59	2	IN	0	46	47	1	of	46	46	47	0	NP	0	47	59	2	NP	2	47	50	3	DT	0	47	48	1	the	47	47	48	0	JJ	0	48	49	1	dominant	48	48	49	0	NNS	0	49	50	1	mechanisms	49	49	50	0	VP	0	50	59	3	VBG	0	50	51	1	regulating	50	50	51	0	NP	1	51	53	2	NN	0	51	52	1	AKT	51	51	52	0	NN	0	52	53	1	activation	52	52	53	0	PP	0	53	59	2	IN	0	53	54	1	in	53	53	54	0	NP	0	54	59	2	NP	0	54	57	3	NN	0	54	55	1	EGFR	54	54	55	0	CC	0	55	56	1	and	55	55	56	0	NN	0	56	57	1	HER	56	56	57	0	VP	0	57	59	2	VBN	0	57	58	1	driven	57	57	58	0	NP	0	58	59	1	NNS	0	58	59	1	cancers	58	58	59	0	.	0	59	60	1	.	59	59	60	0
EOS
T	21
In	27665	27667	IN	in	O	_	_
addition	27668	27676	NN	addition	O	_	_
to	27677	27679	TO	to	O	_	_
increased	27680	27689	VBN	increase	O	_	_
ERBB3	27690	27695	NN	erbb3	B-GENE	_	_
tyrosine	27696	27704	NN	tyrosine	O	_	_
phosphorylation	27705	27720	NN	phosphorylation	O	_	_
,	27720	27721	,	,	O	_	_
we	27722	27724	PRP	we	O	_	_
also	27725	27729	RB	also	O	_	_
observe	27730	27737	VBP	observe	O	_	_
increased	27738	27747	VBN	increase	O	_	_
expression	27748	27758	NN	expression	O	_	_
of	27759	27761	IN	of	O	_	_
total	27762	27767	JJ	total	B-GENE	_	_
ERBB3	27768	27773	NN	erbb3	I-GENE	_	_
protein	27774	27781	NN	protein	I-GENE	_	_
following	27782	27791	VBG	follow	O	_	_
MEK	27792	27795	NN	mek	O	_	_
inhibition	27796	27806	NN	inhibition	O	_	_
.	27806	27807	.	.	O	_	_
D	1
10
6	3	amod
6	4	nn
6	5	nn
10	6	prep_in_addition_to
10	8	nsubj
10	9	advmod
10	12	dobj
12	11	amod
12	16	prep_of
16	14	amod
16	15	nn
16	19	prep_following
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	4	0	21	6	PP	0	0	7	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	7	2	NP	0	1	2	1	NN	0	1	2	1	addition	1	1	2	0	PP	0	2	7	2	TO	0	2	3	1	to	2	2	3	0	NP	3	3	7	4	VBN	0	3	4	1	increased	3	3	4	0	NN	0	4	5	1	ERBB3	4	4	5	0	NN	0	5	6	1	tyrosine	5	5	6	0	NN	0	6	7	1	phosphorylation	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	0	8	9	1	PRP	0	8	9	1	we	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	also	9	9	10	0	VP	0	10	20	2	VBP	0	10	11	1	observe	10	10	11	0	NP	0	11	20	2	NP	1	11	13	2	VBN	0	11	12	1	increased	11	11	12	0	NN	0	12	13	1	expression	12	12	13	0	PP	0	13	20	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	JJ	0	14	15	1	total	14	14	15	0	NN	0	15	16	1	ERBB3	15	15	16	0	NN	0	16	17	1	protein	16	16	17	0	PP	0	17	20	2	VBG	0	17	18	1	following	17	17	18	0	NP	1	18	20	2	NN	0	18	19	1	MEK	18	18	19	0	NN	0	19	20	1	inhibition	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	22
This	27808	27812	DT	this	O	_	_
increase	27813	27821	NN	increase	O	_	_
appears	27822	27829	VBZ	appear	O	_	_
to	27830	27832	TO	to	O	_	_
be	27833	27835	VB	be	O	_	_
post	27836	27840	JJ	post	O	_	_
transcriptional	27841	27856	JJ	transcriptional	O	_	_
as	27857	27859	IN	as	O	_	_
no	27860	27862	DT	no	O	_	_
change	27863	27869	NN	change	O	_	_
in	27870	27872	IN	in	O	_	_
ERBB3	27873	27878	NN	erbb3	B-GENE	_	_
mRNA	27879	27883	NN	mrna	I-GENE	_	_
levels	27884	27890	NNS	level	O	_	_
was	27891	27894	VBD	be	O	_	_
observed	27895	27903	VBN	observe	O	_	_
with	27904	27908	IN	with	O	_	_
AZD6244	27909	27916	NN	azd6244	O	_	_
(	27917	27918	CD	(	O	_	_
Supplemental	27918	27930	NNP	Supplemental	O	_	_
)	27939	27940	NN	)	O	_	_
.	27940	27941	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	6	xcomp
6	3	aux
6	4	cop
6	5	amod
6	15	dep
9	8	det
9	13	prep_in
13	11	nn
13	12	nn
15	7	mark
15	9	nsubjpass
15	14	auxpass
15	20	prep_with
20	17	nn
20	18	num
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	1	0	2	2	DT	0	0	1	1	This	0	0	1	0	NN	0	1	2	1	increase	1	1	2	0	VP	0	2	21	2	VBZ	0	2	3	1	appears	2	2	3	0	S	0	3	21	1	VP	1	3	21	2	TO	0	3	4	1	to	3	3	4	0	VP	1	4	21	2	VB	0	4	5	1	be	4	4	5	0	ADJP	0	5	21	2	ADJP	1	5	7	2	JJ	0	5	6	1	post	5	5	6	0	JJ	0	6	7	1	transcriptional	6	6	7	0	SBAR	1	7	21	2	IN	0	7	8	1	as	7	7	8	0	S	1	8	21	2	NP	0	8	14	2	NP	1	8	10	2	DT	0	8	9	1	no	8	8	9	0	NN	0	9	10	1	change	9	9	10	0	PP	0	10	14	2	IN	0	10	11	1	in	10	10	11	0	NP	2	11	14	3	NN	0	11	12	1	ERBB3	11	11	12	0	NN	0	12	13	1	mRNA	12	12	13	0	NNS	0	13	14	1	levels	13	13	14	0	VP	1	14	21	2	VBD	0	14	15	1	was	14	14	15	0	VP	0	15	21	2	VBN	0	15	16	1	observed	15	15	16	0	PP	0	16	21	2	IN	0	16	17	1	with	16	16	17	0	NP	3	17	21	4	NN	0	17	18	1	AZD6244	17	17	18	0	CD	0	18	19	1	(	18	18	19	0	NNP	0	19	20	1	Supplemental	19	19	20	0	NN	0	20	21	1	)	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	15
We	27942	27944	PRP	we	O	_	_
were	27945	27949	VBD	be	O	_	_
unable	27950	27956	JJ	unable	O	_	_
to	27957	27959	TO	to	O	_	_
definitively	27960	27972	RB	definitively	O	_	_
determine	27973	27982	VB	determine	O	_	_
the	27983	27986	DT	the	O	_	_
mechanism	27987	27996	NN	mechanism	O	_	_
for	27997	28000	IN	for	O	_	_
increased	28001	28010	VBN	increase	O	_	_
expression	28011	28021	NN	expression	O	_	_
of	28022	28024	IN	of	O	_	_
total	28025	28030	JJ	total	O	_	_
ERBB3	28031	28036	NN	erbb3	O	_	_
.	28036	28037	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
2	5	xcomp
5	3	aux
5	4	advmod
5	7	dobj
7	6	det
7	10	prep_for
10	9	amod
10	13	prep_of
13	12	amod
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	1	1	14	2	VBD	0	1	2	1	were	1	1	2	0	ADJP	0	2	14	2	JJ	0	2	3	1	unable	2	2	3	0	S	0	3	14	1	VP	1	3	14	2	TO	0	3	4	1	to	3	3	4	0	VP	1	4	14	3	ADVP	0	4	5	1	RB	0	4	5	1	definitively	4	4	5	0	VB	0	5	6	1	determine	5	5	6	0	NP	0	6	14	2	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	mechanism	7	7	8	0	PP	0	8	14	2	IN	0	8	9	1	for	8	8	9	0	NP	0	9	14	2	NP	1	9	11	2	VBN	0	9	10	1	increased	9	9	10	0	NN	0	10	11	1	expression	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	of	11	11	12	0	NP	1	12	14	2	JJ	0	12	13	1	total	12	12	13	0	NN	0	13	14	1	ERBB3	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	20
However	28038	28045	RB	however	O	_	_
,	28045	28046	,	,	O	_	_
we	28047	28049	PRP	we	O	_	_
observed	28050	28058	VBD	observe	O	_	_
that	28059	28063	IN	that	O	_	_
increased	28064	28073	VBN	increase	O	_	_
ERBB3	28074	28079	NN	erbb3	B-GENE	_	_
expression	28080	28090	NN	expression	O	_	_
was	28091	28094	VBD	be	O	_	_
not	28095	28098	RB	not	O	_	_
solely	28099	28105	RB	solely	O	_	_
a	28106	28107	DT	a	O	_	_
result	28108	28114	NN	result	O	_	_
of	28115	28117	IN	of	O	_	_
increased	28118	28127	VBN	increase	O	_	_
tyrosine	28128	28136	NN	tyrosine	O	_	_
phosphorylation	28137	28152	NN	phosphorylation	O	_	_
of	28153	28155	IN	of	O	_	_
ERBB3	28156	28161	NN	erbb3	B-GENE	_	_
.	28173	28174	.	.	O	_	_
D	1
3
3	0	advmod
3	2	nsubj
3	12	ccomp
7	5	amod
7	6	nn
12	4	mark
12	7	nsubj
12	8	cop
12	9	neg
12	10	advmod
12	11	det
12	16	prep_of
16	14	amod
16	15	nn
16	18	prep_of
EOX
Y	1
ROOT	0	0	20	1	S	3	0	20	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	we	2	2	3	0	VP	0	3	19	2	VBD	0	3	4	1	observed	3	3	4	0	SBAR	1	4	19	2	IN	0	4	5	1	that	4	4	5	0	S	1	5	19	2	NP	2	5	8	3	VBN	0	5	6	1	increased	5	5	6	0	NN	0	6	7	1	ERBB3	6	6	7	0	NN	0	7	8	1	expression	7	7	8	0	VP	3	8	19	4	VBD	0	8	9	1	was	8	8	9	0	RB	0	9	10	1	not	9	9	10	0	ADVP	0	10	11	1	RB	0	10	11	1	solely	10	10	11	0	NP	0	11	19	2	NP	1	11	13	2	DT	0	11	12	1	a	11	11	12	0	NN	0	12	13	1	result	12	12	13	0	PP	0	13	19	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	19	2	NP	2	14	17	3	VBN	0	14	15	1	increased	14	14	15	0	NN	0	15	16	1	tyrosine	15	15	16	0	NN	0	16	17	1	phosphorylation	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	ERBB3	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	26
Interestingly	28175	28188	RB	interestingly	O	_	_
,	28188	28189	,	,	O	_	_
inhibition	28190	28200	NN	inhibition	O	_	_
of	28201	28203	IN	of	O	_	_
ERK	28204	28207	NN	erk	B-GENE	_	_
mediated	28208	28216	VBD	mediate	O	_	_
phosphorylation	28217	28232	NN	phosphorylation	O	_	_
of	28233	28235	IN	of	O	_	_
the	28236	28239	DT	the	O	_	_
threonine	28240	28249	NN	threonine	O	_	_
JM	28250	28252	NN	jm	O	_	_
domain	28253	28259	NN	domain	O	_	_
sites	28260	28265	NNS	site	O	_	_
appeared	28266	28274	VBD	appear	O	_	_
to	28275	28277	TO	to	O	_	_
be	28278	28280	VB	be	O	_	_
necessary	28281	28290	JJ	necessary	O	_	_
for	28291	28294	IN	for	O	_	_
both	28295	28299	DT	both	O	_	_
increased	28300	28309	VBN	increase	O	_	_
phospho-	28310	28318	NN	phospho-_NN	O	_	_
and	28319	28322	CC	and	O	_	_
total	28323	28328	JJ	total	O	_	_
ERBB3	28329	28334	NN	erbb3	B-GENE	_	_
levels	28335	28341	NNS	level	O	_	_
.	28341	28342	.	.	O	_	_
D	1
5
2	4	prep_of
5	0	advmod
5	2	nsubj
5	6	dobj
6	10	prep_of
6	13	rcmod
10	8	det
10	9	nn
12	11	nn
13	12	nsubj
13	16	xcomp
16	14	aux
16	15	cop
16	20	prep_for
16	24	prep_for
20	18	det
20	19	amod
20	24	conj_and
24	22	amod
24	23	nn
EOX
Y	1
ROOT	0	0	26	1	S	3	0	26	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	5	2	NP	0	2	3	1	NN	0	2	3	1	inhibition	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	ERK	4	4	5	0	VP	0	5	25	2	VBD	0	5	6	1	mediated	5	5	6	0	NP	0	6	25	3	NP	0	6	7	1	NN	0	6	7	1	phosphorylation	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	threonine	9	9	10	0	NN	0	10	11	1	JM	10	10	11	0	SBAR	0	11	25	1	S	1	11	25	2	NP	1	11	13	2	NN	0	11	12	1	domain	11	11	12	0	NNS	0	12	13	1	sites	12	12	13	0	VP	0	13	25	2	VBD	0	13	14	1	appeared	13	13	14	0	S	0	14	25	1	VP	1	14	25	2	TO	0	14	15	1	to	14	14	15	0	VP	1	15	25	2	VB	0	15	16	1	be	15	15	16	0	ADJP	0	16	25	2	JJ	0	16	17	1	necessary	16	16	17	0	PP	0	17	25	2	IN	0	17	18	1	for	17	17	18	0	NP	0	18	25	3	NP	2	18	21	3	DT	0	18	19	1	both	18	18	19	0	VBN	0	19	20	1	increased	19	19	20	0	NN	0	20	21	1	phospho-	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	NP	2	22	25	3	JJ	0	22	23	1	total	22	22	23	0	NN	0	23	24	1	ERBB3	23	23	24	0	NNS	0	24	25	1	levels	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	30
For	28343	28346	IN	for	O	_	_
example	28347	28354	NN	example	O	_	_
,	28354	28355	,	,	O	_	_
expression	28356	28366	NN	expression	O	_	_
of	28367	28369	IN	of	O	_	_
T669A	28370	28375	NN	t669a	B-GENE	_	_
EGFR	28376	28380	NN	egfr	I-GENE	_	_
in	28381	28383	IN	in	O	_	_
CHO-KI	28384	28390	NN	cho-kus	O	_	_
cells	28391	28396	NNS	cell	O	_	_
and	28397	28400	CC	and	O	_	_
HCC827	28401	28407	NN	hcc827	O	_	_
cells	28408	28413	NNS	cell	O	_	_
led	28414	28417	VBD	lead	O	_	_
to	28418	28420	TO	to	O	_	_
increased	28421	28430	VBN	increase	O	_	_
basal	28431	28436	JJ	basal	O	_	_
ERBB3	28437	28442	NN	erbb3	O	_	_
expression	28443	28453	NN	expression	O	_	_
and	28454	28457	CC	and	O	_	_
phosphorylation	28458	28473	NN	phosphorylation	O	_	_
,	28473	28474	,	,	O	_	_
which	28475	28480	WDT	which	O	_	_
was	28481	28484	VBD	be	O	_	_
not	28485	28488	RB	not	O	_	_
further	28489	28496	JJ	further	O	_	_
augmented	28497	28506	JJ	augmented	O	_	_
by	28507	28509	IN	by	O	_	_
AZD6244	28510	28517	NN	azd6244	O	_	_
.	28528	28529	.	.	O	_	_
D	1
13
3	6	prep_of
6	5	nn
6	9	prep_in
6	12	prep_in
9	8	nn
9	12	conj_and
12	11	nn
13	1	prep_for
13	3	nsubj
13	18	prep_to
13	20	prep_to
18	15	amod
18	16	amod
18	17	nn
18	20	conj_and
20	26	rcmod
26	22	nsubj
26	23	cop
26	24	neg
26	25	amod
26	28	prep_by
EOX
Y	1
ROOT	0	0	30	1	S	3	0	30	5	PP	0	0	2	2	IN	0	0	1	1	For	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	example	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	13	2	NP	0	3	4	1	NN	0	3	4	1	expression	3	3	4	0	PP	0	4	13	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	13	2	NP	1	5	7	2	NN	0	5	6	1	T669A	5	5	6	0	NN	0	6	7	1	EGFR	6	6	7	0	PP	0	7	13	2	IN	0	7	8	1	in	7	7	8	0	NP	0	8	13	3	NP	1	8	10	2	NN	0	8	9	1	CHO-KI	8	8	9	0	NNS	0	9	10	1	cells	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	HCC827	11	11	12	0	NNS	0	12	13	1	cells	12	12	13	0	VP	0	13	29	2	VBD	0	13	14	1	led	13	13	14	0	PP	0	14	29	2	TO	0	14	15	1	to	14	14	15	0	NP	0	15	29	3	NP	3	15	19	4	VBN	0	15	16	1	increased	15	15	16	0	JJ	0	16	17	1	basal	16	16	17	0	NN	0	17	18	1	ERBB3	17	17	18	0	NN	0	18	19	1	expression	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	NP	0	20	29	3	NP	0	20	21	1	NN	0	20	21	1	phosphorylation	20	20	21	0	,	0	21	22	1	,	21	21	22	0	SBAR	1	22	29	2	WHNP	0	22	23	1	WDT	0	22	23	1	which	22	22	23	0	S	0	23	29	1	VP	2	23	29	3	VBD	0	23	24	1	was	23	23	24	0	RB	0	24	25	1	not	24	24	25	0	ADJP	0	25	29	2	ADJP	1	25	27	2	JJ	0	25	26	1	further	25	25	26	0	JJ	0	26	27	1	augmented	26	26	27	0	PP	0	27	29	2	IN	0	27	28	1	by	27	27	28	0	NP	0	28	29	1	NN	0	28	29	1	AZD6244	28	28	29	0	.	0	29	30	1	.	29	29	30	0
EOS
T	38
This	28530	28534	DT	this	O	_	_
suggests	28535	28543	VBZ	suggest	O	_	_
that	28544	28548	IN	that	O	_	_
the	28549	28552	DT	the	O	_	_
increases	28553	28562	NNS	increase	O	_	_
in	28563	28565	IN	in	O	_	_
both	28566	28570	DT	both	O	_	_
phosho-	28571	28578	JJ	phosho-	O	_	_
and	28579	28582	CC	and	O	_	_
total	28583	28588	JJ	total	O	_	_
ERBB3	28589	28594	NN	erbb3	B-GENE	_	_
are	28595	28598	VBP	be	O	_	_
the	28599	28602	DT	the	O	_	_
result	28603	28609	NN	result	O	_	_
of	28610	28612	IN	of	O	_	_
increased	28613	28622	VBN	increase	O	_	_
dimer	28623	28628	NN	dimer	O	_	_
formation	28629	28638	NN	formation	O	_	_
between	28639	28646	IN	between	O	_	_
EGFR	28647	28651	NN	egfr	B-GENE	_	_
and	28652	28655	CC	and	O	_	_
ERBB3	28656	28661	NN	erbb3	B-GENE	_	_
,	28661	28662	,	,	O	_	_
which	28663	28668	WDT	which	O	_	_
results	28669	28676	VBZ	result	O	_	_
from	28677	28681	IN	from	O	_	_
loss	28682	28686	NN	loss	O	_	_
of	28687	28689	IN	of	O	_	_
inhibitory	28690	28700	JJ	inhibitory	O	_	_
threonine	28701	28710	NN	threonine	O	_	_
phosphorylation	28711	28726	NN	phosphorylation	O	_	_
within	28727	28733	IN	within	O	_	_
the	28734	28737	DT	the	O	_	_
JM	28738	28740	NN	jm	O	_	_
domain	28741	28747	NN	domain	O	_	_
of	28748	28750	IN	of	O	_	_
EGFR	28751	28755	NN	egfr	B-GENE	_	_
.	28755	28756	.	.	O	_	_
D	1
1
1	0	nsubj
1	13	ccomp
4	3	det
4	10	prep_in
7	9	conj_and
10	6	det
10	7	amod
10	9	amod
13	2	mark
13	4	nsubj
13	11	cop
13	12	det
13	17	prep_of
17	15	amod
17	16	nn
17	19	prep_between
17	21	prep_between
19	21	conj_and
19	24	rcmod
24	23	nsubj
24	26	prep_from
24	34	prep_within
26	30	prep_of
30	28	amod
30	29	nn
34	32	det
34	33	nn
34	36	prep_of
EOX
Y	1
ROOT	0	0	38	1	S	1	0	38	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	0	1	37	2	VBZ	0	1	2	1	suggests	1	1	2	0	SBAR	1	2	37	2	IN	0	2	3	1	that	2	2	3	0	S	1	3	37	2	NP	0	3	11	2	NP	1	3	5	2	DT	0	3	4	1	the	3	3	4	0	NNS	0	4	5	1	increases	4	4	5	0	PP	0	5	11	2	IN	0	5	6	1	in	5	5	6	0	NP	2	6	11	3	DT	0	6	7	1	both	6	6	7	0	ADJP	0	7	10	3	JJ	0	7	8	1	phosho-	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	JJ	0	9	10	1	total	9	9	10	0	NN	0	10	11	1	ERBB3	10	10	11	0	VP	1	11	37	2	VBP	0	11	12	1	are	11	11	12	0	NP	0	12	37	2	NP	1	12	14	2	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	result	13	13	14	0	PP	0	14	37	2	IN	0	14	15	1	of	14	14	15	0	NP	0	15	37	2	NP	2	15	18	3	VBN	0	15	16	1	increased	15	15	16	0	NN	0	16	17	1	dimer	16	16	17	0	NN	0	17	18	1	formation	17	17	18	0	PP	0	18	37	2	IN	0	18	19	1	between	18	18	19	0	NP	0	19	37	3	NP	0	19	22	3	NN	0	19	20	1	EGFR	19	19	20	0	CC	0	20	21	1	and	20	20	21	0	NN	0	21	22	1	ERBB3	21	21	22	0	,	0	22	23	1	,	22	22	23	0	SBAR	1	23	37	2	WHNP	0	23	24	1	WDT	0	23	24	1	which	23	23	24	0	S	0	24	37	1	VP	0	24	37	3	VBZ	0	24	25	1	results	24	24	25	0	PP	0	25	31	2	IN	0	25	26	1	from	25	25	26	0	NP	0	26	31	2	NP	0	26	27	1	NN	0	26	27	1	loss	26	26	27	0	PP	0	27	31	2	IN	0	27	28	1	of	27	27	28	0	NP	2	28	31	3	JJ	0	28	29	1	inhibitory	28	28	29	0	NN	0	29	30	1	threonine	29	29	30	0	NN	0	30	31	1	phosphorylation	30	30	31	0	PP	0	31	37	2	IN	0	31	32	1	within	31	31	32	0	NP	0	32	37	2	NP	2	32	35	3	DT	0	32	33	1	the	32	32	33	0	NN	0	33	34	1	JM	33	33	34	0	NN	0	34	35	1	domain	34	34	35	0	PP	0	35	37	2	IN	0	35	36	1	of	35	35	36	0	NP	0	36	37	1	NN	0	36	37	1	EGFR	36	36	37	0	.	0	37	38	1	.	37	37	38	0
EOS
T	37
Although	28757	28765	IN	although	O	_	_
we	28766	28768	PRP	we	O	_	_
believe	28769	28776	VBP	believe	O	_	_
that	28777	28781	IN	that	O	_	_
the	28782	28785	DT	the	O	_	_
data	28786	28790	NNS	datum	O	_	_
support	28791	28798	VBP	support	O	_	_
such	28799	28803	JJ	such	O	_	_
a	28804	28805	DT	a	O	_	_
model	28806	28811	NN	model	O	_	_
,	28811	28812	,	,	O	_	_
it	28813	28815	PRP	it	O	_	_
remains	28816	28823	VBZ	remain	O	_	_
possible	28824	28832	JJ	possible	O	_	_
that	28833	28837	IN	that	O	_	_
phosphorylation	28838	28853	NN	phosphorylation	O	_	_
of	28854	28856	IN	of	O	_	_
the	28857	28860	DT	the	O	_	_
EGFR	28861	28865	NN	egfr	B-GENE	_	_
JM	28866	28868	NN	jm	I-GENE	_	_
domain	28869	28875	NN	domain	I-GENE	_	_
affects	28876	28883	VBZ	affect	O	_	_
tyrosine	28884	28892	NN	tyrosine	O	_	_
phosphorylated	28893	28907	JJ	phosphorylated	O	_	_
and	28908	28911	CC	and	O	_	_
total	28912	28917	JJ	total	O	_	_
ERBB3	28918	28923	NN	erbb3	B-GENE	_	_
levels	28924	28930	NNS	level	O	_	_
via	28931	28934	IN	via	O	_	_
a	28935	28936	DT	a	O	_	_
mechanism	28937	28946	NN	mechanism	O	_	_
not	28947	28950	RB	not	O	_	_
linked	28951	28957	VBN	link	O	_	_
to	28958	28960	TO	to	O	_	_
heterodimer	28961	28972	NN	heterodimer	O	_	_
formation	28973	28982	NN	formation	O	_	_
.	28982	28983	.	.	O	_	_
D	1
13
2	0	mark
2	1	nsubj
2	6	ccomp
5	4	det
6	3	mark
6	5	nsubj
6	7	prep
7	9	dep
9	8	det
13	2	advcl
13	11	nsubj
13	12	cop
13	21	ccomp
15	20	prep_of
20	17	det
20	18	nn
20	19	nn
21	14	mark
21	15	nsubj
21	23	dobj
21	27	dobj
21	30	prep_via
23	22	npadvmod
23	27	conj_and
27	25	amod
27	26	nn
30	29	det
30	32	vmod
32	31	neg
32	35	prep_to
35	34	nn
EOX
Y	1
ROOT	0	0	37	1	S	3	0	37	5	SBAR	1	0	10	2	IN	0	0	1	1	Although	0	0	1	0	S	1	1	10	2	NP	0	1	2	1	PRP	0	1	2	1	we	1	1	2	0	VP	0	2	10	2	VBP	0	2	3	1	believe	2	2	3	0	SBAR	1	3	10	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	10	2	NP	1	4	6	2	DT	0	4	5	1	the	4	4	5	0	NNS	0	5	6	1	data	5	5	6	0	VP	0	6	10	2	VBP	0	6	7	1	support	6	6	7	0	PP	0	7	10	2	JJ	0	7	8	1	such	7	7	8	0	NP	1	8	10	2	DT	0	8	9	1	a	8	8	9	0	NN	0	9	10	1	model	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	0	11	12	1	PRP	0	11	12	1	it	11	11	12	0	VP	1	12	36	3	VBZ	0	12	13	1	remains	12	12	13	0	ADJP	0	13	14	1	JJ	0	13	14	1	possible	13	13	14	0	SBAR	1	14	36	2	IN	0	14	15	1	that	14	14	15	0	S	1	15	36	2	NP	0	15	21	2	NP	0	15	16	1	NN	0	15	16	1	phosphorylation	15	15	16	0	PP	0	16	21	2	IN	0	16	17	1	of	16	16	17	0	NP	3	17	21	4	DT	0	17	18	1	the	17	17	18	0	NN	0	18	19	1	EGFR	18	18	19	0	NN	0	19	20	1	JM	19	19	20	0	NN	0	20	21	1	domain	20	20	21	0	VP	0	21	36	3	VBZ	0	21	22	1	affects	21	21	22	0	NP	0	22	28	3	ADJP	1	22	24	2	NN	0	22	23	1	tyrosine	22	22	23	0	JJ	0	23	24	1	phosphorylated	23	23	24	0	CC	0	24	25	1	and	24	24	25	0	NP	2	25	28	3	JJ	0	25	26	1	total	25	25	26	0	NN	0	26	27	1	ERBB3	26	26	27	0	NNS	0	27	28	1	levels	27	27	28	0	PP	0	28	36	2	IN	0	28	29	1	via	28	28	29	0	NP	0	29	36	2	NP	1	29	31	2	DT	0	29	30	1	a	29	29	30	0	NN	0	30	31	1	mechanism	30	30	31	0	VP	1	31	36	3	RB	0	31	32	1	not	31	31	32	0	VBN	0	32	33	1	linked	32	32	33	0	PP	0	33	36	2	TO	0	33	34	1	to	33	33	34	0	NP	1	34	36	2	NN	0	34	35	1	heterodimer	34	34	35	0	NN	0	35	36	1	formation	35	35	36	0	.	0	36	37	1	.	36	36	37	0
EOS
T	24
Overall	28984	28991	RB	overall	O	_	_
,	28991	28992	,	,	O	_	_
this	28993	28997	DT	this	O	_	_
study	28998	29003	NN	study	O	_	_
suggests	29004	29012	VBZ	suggest	O	_	_
that	29013	29017	IN	that	O	_	_
combining	29018	29027	VBG	combine	O	_	_
MEK	29028	29031	NN	mek	B-GENE	_	_
inhibitors	29032	29042	NNS	inhibitor	O	_	_
with	29043	29047	IN	with	O	_	_
either	29048	29054	CC	either	O	_	_
ERBB	29055	29059	NN	erbb	O	_	_
or	29060	29062	CC	or	O	_	_
PI3K	29063	29067	NN	pi3k	O	_	_
inhibitors	29068	29078	NNS	inhibitor	O	_	_
,	29078	29079	,	,	O	_	_
may	29080	29083	MD	may	O	_	_
be	29084	29086	VB	be	O	_	_
effective	29087	29096	JJ	effective	O	_	_
strategies	29097	29107	NNS	strategy	O	_	_
in	29108	29110	IN	in	O	_	_
the	29111	29114	DT	the	O	_	_
clinic	29115	29121	NN	clinic	O	_	_
.	29121	29122	.	.	O	_	_
D	1
4
3	2	det
4	0	advmod
4	3	nsubj
4	19	ccomp
6	8	dobj
6	11	prep_with
6	14	prep_with
8	7	nn
11	10	preconj
11	14	conj_or
14	13	nn
19	5	mark
19	6	dep
19	16	aux
19	17	cop
19	18	amod
19	22	prep_in
22	21	det
EOX
Y	1
ROOT	0	0	24	1	S	3	0	24	5	ADVP	0	0	1	1	RB	0	0	1	1	Overall	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	1	2	4	2	DT	0	2	3	1	this	2	2	3	0	NN	0	3	4	1	study	3	3	4	0	VP	0	4	23	2	VBZ	0	4	5	1	suggests	4	4	5	0	SBAR	1	5	23	2	IN	0	5	6	1	that	5	5	6	0	S	2	6	23	3	S	0	6	15	1	VP	0	6	15	3	VBG	0	6	7	1	combining	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	MEK	7	7	8	0	NNS	0	8	9	1	inhibitors	8	8	9	0	PP	0	9	15	2	IN	0	9	10	1	with	9	9	10	0	NP	1	10	15	4	CC	0	10	11	1	either	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	ERBB	11	11	12	0	CC	0	12	13	1	or	12	12	13	0	NP	1	13	15	2	NN	0	13	14	1	PI3K	13	13	14	0	NNS	0	14	15	1	inhibitors	14	14	15	0	,	0	15	16	1	,	15	15	16	0	VP	1	16	23	2	MD	0	16	17	1	may	16	16	17	0	VP	1	17	23	2	VB	0	17	18	1	be	17	17	18	0	NP	0	18	23	2	NP	1	18	20	2	JJ	0	18	19	1	effective	18	18	19	0	NNS	0	19	20	1	strategies	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	in	20	20	21	0	NP	1	21	23	2	DT	0	21	22	1	the	21	21	22	0	NN	0	22	23	1	clinic	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	42
Although	29123	29131	IN	although	O	_	_
there	29132	29137	EX	there	O	_	_
are	29138	29141	VBP	be	O	_	_
currently	29142	29151	RB	currently	O	_	_
no	29152	29154	DT	no	O	_	_
approved	29155	29163	VBN	approve	O	_	_
therapies	29164	29173	NNS	therapy	O	_	_
targeting	29174	29183	VBG	target	O	_	_
ERBB3	29184	29189	NN	erbb3	B-GENE	_	_
,	29189	29190	,	,	O	_	_
development	29191	29202	NN	development	O	_	_
of	29203	29205	IN	of	O	_	_
anti	29206	29210	JJ	anti	B-GENE	_	_
ERBB3	29211	29216	NN	erbb3	I-GENE	_	_
antibodies	29217	29227	NNS	antibody	I-GENE	_	_
is	29228	29230	VBZ	be	O	_	_
underway	29231	29239	NN	underway	O	_	_
and	29240	29243	CC	and	O	_	_
our	29244	29247	PRP$	we	O	_	_
data	29248	29252	NNS	datum	O	_	_
suggests	29253	29261	VBZ	suggest	O	_	_
the	29262	29265	DT	the	O	_	_
possible	29266	29274	JJ	possible	O	_	_
utility	29275	29282	NN	utility	O	_	_
of	29283	29285	IN	of	O	_	_
combining	29286	29295	VBG	combine	O	_	_
these	29296	29301	DT	these	O	_	_
antibodies	29302	29312	NNS	antibody	O	_	_
with	29313	29317	IN	with	O	_	_
MEK	29318	29321	NN	mek	B-GENE	_	_
inhibitors	29322	29332	NNS	inhibitor	O	_	_
to	29333	29335	TO	to	O	_	_
block	29336	29341	VB	block	O	_	_
feedback	29342	29350	NN	feedback	O	_	_
activation	29351	29361	NN	activation	O	_	_
of	29362	29364	IN	of	O	_	_
AKT	29365	29368	NNP	AKT	O	_	_
in	29369	29371	IN	in	O	_	_
multiple	29372	29380	JJ	multiple	O	_	_
cancer	29381	29387	NN	cancer	O	_	_
models	29388	29394	NNS	model	O	_	_
.	29394	29395	.	.	O	_	_
D	1
16
2	0	mark
2	1	expl
2	3	advmod
2	6	nsubj
6	4	det
6	5	amod
6	7	vmod
7	8	dobj
10	14	prep_of
14	12	amod
14	13	nn
16	2	advcl
16	10	nsubj
16	15	cop
16	20	conj_and
19	18	poss
20	19	nsubj
20	23	dobj
23	21	det
23	22	amod
23	25	prepc_of
25	27	dobj
25	30	prep_with
25	32	xcomp
27	26	det
30	29	nn
32	31	aux
32	34	dobj
32	40	prep_in
34	33	nn
34	36	prep_of
40	38	amod
40	39	nn
EOX
Y	1
ROOT	0	0	42	1	S	2	0	42	6	SBAR	1	0	9	2	IN	0	0	1	1	Although	0	0	1	0	S	1	1	9	2	NP	0	1	2	1	EX	0	1	2	1	there	1	1	2	0	VP	2	2	9	3	VBP	0	2	3	1	are	2	2	3	0	ADVP	0	3	4	1	RB	0	3	4	1	currently	3	3	4	0	NP	0	4	9	2	NP	2	4	7	3	DT	0	4	5	1	no	4	4	5	0	VBN	0	5	6	1	approved	5	5	6	0	NNS	0	6	7	1	therapies	6	6	7	0	VP	0	7	9	2	VBG	0	7	8	1	targeting	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	ERBB3	8	8	9	0	,	0	9	10	1	,	9	9	10	0	S	1	10	17	2	NP	0	10	15	2	NP	0	10	11	1	NN	0	10	11	1	development	10	10	11	0	PP	0	11	15	2	IN	0	11	12	1	of	11	11	12	0	NP	2	12	15	3	JJ	0	12	13	1	anti	12	12	13	0	NN	0	13	14	1	ERBB3	13	13	14	0	NNS	0	14	15	1	antibodies	14	14	15	0	VP	1	15	17	2	VBZ	0	15	16	1	is	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	underway	16	16	17	0	CC	0	17	18	1	and	17	17	18	0	S	1	18	41	2	NP	1	18	20	2	PRP$	0	18	19	1	our	18	18	19	0	NNS	0	19	20	1	data	19	19	20	0	VP	0	20	41	2	VBZ	0	20	21	1	suggests	20	20	21	0	NP	0	21	41	2	NP	2	21	24	3	DT	0	21	22	1	the	21	21	22	0	JJ	0	22	23	1	possible	22	22	23	0	NN	0	23	24	1	utility	23	23	24	0	PP	0	24	41	2	IN	0	24	25	1	of	24	24	25	0	S	0	25	41	1	VP	0	25	41	4	VBG	0	25	26	1	combining	25	25	26	0	NP	1	26	28	2	DT	0	26	27	1	these	26	26	27	0	NNS	0	27	28	1	antibodies	27	27	28	0	PP	0	28	31	2	IN	0	28	29	1	with	28	28	29	0	NP	1	29	31	2	NN	0	29	30	1	MEK	29	29	30	0	NNS	0	30	31	1	inhibitors	30	30	31	0	S	0	31	41	1	VP	1	31	41	2	TO	0	31	32	1	to	31	31	32	0	VP	0	32	41	3	VB	0	32	33	1	block	32	32	33	0	NP	0	33	37	2	NP	1	33	35	2	NN	0	33	34	1	feedback	33	33	34	0	NN	0	34	35	1	activation	34	34	35	0	PP	0	35	37	2	IN	0	35	36	1	of	35	35	36	0	NP	0	36	37	1	NNP	0	36	37	1	AKT	36	36	37	0	PP	0	37	41	2	IN	0	37	38	1	in	37	37	38	0	NP	2	38	41	3	JJ	0	38	39	1	multiple	38	38	39	0	NN	0	39	40	1	cancer	39	39	40	0	NNS	0	40	41	1	models	40	40	41	0	.	0	41	42	1	.	41	41	42	0
EOS
T	32
Interestingly	29396	29409	RB	interestingly	O	_	_
,	29409	29410	,	,	O	_	_
we	29411	29413	PRP	we	O	_	_
also	29414	29418	RB	also	O	_	_
observed	29419	29427	VBD	observe	O	_	_
feedback	29428	29436	NN	feedback	O	_	_
activation	29437	29447	NN	activation	O	_	_
of	29448	29450	IN	of	O	_	_
ERBB3	29451	29456	NN	erbb3	B-GENE	_	_
following	29457	29466	VBG	follow	O	_	_
MEK	29467	29470	NN	mek	B-GENE	_	_
inhibition	29471	29481	NN	inhibition	O	_	_
in	29482	29484	IN	in	O	_	_
KRAS-mutant	29485	29496	JJ	kras-mutant	O	_	_
cancers	29497	29504	NNS	cancer	O	_	_
that	29505	29509	WDT	that	O	_	_
express	29510	29517	VBP	express	O	_	_
low	29518	29521	JJ	low	O	_	_
basal	29522	29527	JJ	basal	O	_	_
levels	29528	29534	NNS	level	O	_	_
of	29535	29537	IN	of	O	_	_
phospho-ERBB3	29538	29551	NN	phospho-erbb3	O	_	_
and	29552	29555	CC	and	O	_	_
therefore	29556	29565	RB	therefore	O	_	_
do	29566	29568	VBP	do	O	_	_
not	29569	29572	RB	not	O	_	_
use	29573	29576	VB	use	O	_	_
ERBB3	29577	29582	NN	erbb3	B-GENE	_	_
to	29583	29585	TO	to	O	_	_
activate	29586	29594	VB	activate	O	_	_
PI3K	29595	29599	NN	pi3k	B-GENE	_	_
.	29599	29600	.	.	O	_	_
D	1
4
4	0	advmod
4	2	nsubj
4	3	advmod
4	6	dobj
4	11	prep_following
6	5	nn
6	8	prep_of
11	10	nn
11	14	prep_in
11	16	rcmod
11	26	rcmod
14	13	amod
16	15	nsubj
16	19	dobj
16	26	conj_and
19	17	amod
19	18	amod
19	21	prep_of
26	15	nsubj
26	23	advmod
26	24	aux
26	25	neg
26	27	dobj
26	29	xcomp
29	28	aux
29	30	dobj
EOX
Y	1
ROOT	0	0	32	1	S	4	0	32	6	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	we	2	2	3	0	ADVP	0	3	4	1	RB	0	3	4	1	also	3	3	4	0	VP	0	4	31	3	VBD	0	4	5	1	observed	4	4	5	0	NP	0	5	9	2	NP	1	5	7	2	NN	0	5	6	1	feedback	5	5	6	0	NN	0	6	7	1	activation	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	ERBB3	8	8	9	0	PP	0	9	31	2	VBG	0	9	10	1	following	9	9	10	0	NP	0	10	31	3	NP	1	10	12	2	NN	0	10	11	1	MEK	10	10	11	0	NN	0	11	12	1	inhibition	11	11	12	0	PP	0	12	15	2	IN	0	12	13	1	in	12	12	13	0	NP	1	13	15	2	JJ	0	13	14	1	KRAS-mutant	13	13	14	0	NNS	0	14	15	1	cancers	14	14	15	0	SBAR	1	15	31	2	WHNP	0	15	16	1	WDT	0	15	16	1	that	15	15	16	0	S	0	16	31	1	VP	0	16	31	3	VP	0	16	22	2	VBP	0	16	17	1	express	16	16	17	0	NP	0	17	22	2	NP	2	17	20	3	JJ	0	17	18	1	low	17	17	18	0	JJ	0	18	19	1	basal	18	18	19	0	NNS	0	19	20	1	levels	19	19	20	0	PP	0	20	22	2	IN	0	20	21	1	of	20	20	21	0	NP	0	21	22	1	NN	0	21	22	1	phospho-ERBB3	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	VP	3	23	31	4	ADVP	0	23	24	1	RB	0	23	24	1	therefore	23	23	24	0	VBP	0	24	25	1	do	24	24	25	0	RB	0	25	26	1	not	25	25	26	0	VP	0	26	31	3	VB	0	26	27	1	use	26	26	27	0	NP	0	27	28	1	NN	0	27	28	1	ERBB3	27	27	28	0	S	0	28	31	1	VP	1	28	31	2	TO	0	28	29	1	to	28	28	29	0	VP	0	29	31	2	VB	0	29	30	1	activate	29	29	30	0	NP	0	30	31	1	NN	0	30	31	1	PI3K	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	40
This	29601	29605	DT	this	O	_	_
observation	29606	29617	NN	observation	O	_	_
suggests	29618	29626	VBZ	suggest	O	_	_
that	29627	29631	IN	that	O	_	_
MEK	29632	29635	NN	mek	B-GENE	_	_
feedback	29636	29644	NN	feedback	I-GENE	_	_
on	29645	29647	IN	on	O	_	_
ERBB3	29648	29653	NN	erbb3	B-GENE	_	_
occurs	29654	29660	VBZ	occur	O	_	_
in	29661	29663	IN	in	O	_	_
a	29664	29665	DT	a	O	_	_
range	29666	29671	NN	range	O	_	_
of	29672	29674	IN	of	O	_	_
cancers	29675	29682	NNS	cancer	O	_	_
,	29682	29683	,	,	O	_	_
regardless	29684	29694	RB	regardless	O	_	_
of	29695	29697	IN	of	O	_	_
dependence	29698	29708	NN	dependence	O	_	_
on	29709	29711	IN	on	O	_	_
ERBB	29712	29716	NN	erbb	O	_	_
signaling	29717	29726	NN	signaling	O	_	_
,	29726	29727	,	,	O	_	_
and	29728	29731	CC	and	O	_	_
highlights	29732	29742	VBZ	highlight	O	_	_
another	29743	29750	DT	another	O	_	_
potential	29751	29760	JJ	potential	O	_	_
complication	29761	29773	NN	complication	O	_	_
for	29774	29777	IN	for	O	_	_
patients	29778	29786	NNS	patient	O	_	_
treated	29787	29794	VBN	treat	O	_	_
exclusively	29795	29806	RB	exclusively	O	_	_
with	29807	29811	IN	with	O	_	_
inhibitors	29812	29822	NNS	inhibitor	O	_	_
of	29823	29825	IN	of	O	_	_
the	29826	29829	DT	the	O	_	_
RAF	29830	29833	NN	raf	B-GENE	_	_
/	29833	29834	:	/	B-GENE	_	_
MEK/ERK	29834	29841	NN	mek/erk	B-GENE	_	_
pathway	29842	29849	NN	pathway	O	_	_
.	29849	29850	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	8	ccomp
2	23	ccomp
5	4	nn
5	7	prep_on
8	3	mark
8	5	nsubj
8	11	prep_in
8	20	prep_on
8	23	conj_and
11	10	det
11	13	prep_of
13	17	prep_regardless_of
20	19	nn
23	5	nsubj
23	26	dobj
23	28	prep_for
26	24	det
26	25	amod
28	29	vmod
29	30	advmod
29	32	prep_with
32	35	prep_of
35	34	det
35	38	dep
38	36	punct
38	37	nn
EOX
Y	1
ROOT	0	0	40	1	S	1	0	40	3	NP	1	0	2	2	DT	0	0	1	1	This	0	0	1	0	NN	0	1	2	1	observation	1	1	2	0	VP	0	2	39	2	VBZ	0	2	3	1	suggests	2	2	3	0	SBAR	1	3	39	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	39	2	NP	0	4	8	2	NP	1	4	6	2	NN	0	4	5	1	MEK	4	4	5	0	NN	0	5	6	1	feedback	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	on	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	ERBB3	7	7	8	0	VP	0	8	39	4	VP	0	8	21	3	VBZ	0	8	9	1	occurs	8	8	9	0	PP	0	9	18	2	IN	0	9	10	1	in	9	9	10	0	NP	0	10	18	2	NP	1	10	12	2	DT	0	10	11	1	a	10	10	11	0	NN	0	11	12	1	range	11	11	12	0	PP	0	12	18	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	18	3	NP	0	13	14	1	NNS	0	13	14	1	cancers	13	13	14	0	,	0	14	15	1	,	14	14	15	0	ADVP	0	15	18	2	RB	0	15	16	1	regardless	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	dependence	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	on	18	18	19	0	NP	1	19	21	2	NN	0	19	20	1	ERBB	19	19	20	0	NN	0	20	21	1	signaling	20	20	21	0	,	0	21	22	1	,	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	VP	0	23	39	3	VBZ	0	23	24	1	highlights	23	23	24	0	NP	2	24	27	3	DT	0	24	25	1	another	24	24	25	0	JJ	0	25	26	1	potential	25	25	26	0	NN	0	26	27	1	complication	26	26	27	0	PP	0	27	39	2	IN	0	27	28	1	for	27	27	28	0	NP	0	28	39	2	NP	0	28	29	1	NNS	0	28	29	1	patients	28	28	29	0	VP	0	29	39	2	VBN	0	29	30	1	treated	29	29	30	0	PP	1	30	39	3	RB	0	30	31	1	exclusively	30	30	31	0	IN	0	31	32	1	with	31	31	32	0	NP	0	32	39	2	NP	0	32	33	1	NNS	0	32	33	1	inhibitors	32	32	33	0	PP	0	33	39	2	IN	0	33	34	1	of	33	33	34	0	NP	0	34	39	2	NP	1	34	36	2	DT	0	34	35	1	the	34	34	35	0	NN	0	35	36	1	RAF	35	35	36	0	PRN	1	36	39	2	:	0	36	37	1	/	36	36	37	0	NP	1	37	39	2	NN	0	37	38	1	MEK/ERK	37	37	38	0	NN	0	38	39	1	pathway	38	38	39	0	.	0	39	40	1	.	39	39	40	0
EOS
T	32
For	29851	29854	IN	for	O	_	_
example	29855	29862	NN	example	O	_	_
,	29862	29863	,	,	O	_	_
in	29864	29866	IN	in	O	_	_
KRAS-mutant	29867	29878	JJ	kras-mutant	O	_	_
cancers	29879	29886	NNS	cancer	O	_	_
that	29887	29891	WDT	that	O	_	_
initially	29892	29901	RB	initially	O	_	_
respond	29902	29909	VBP	respond	O	_	_
to	29910	29912	TO	to	O	_	_
single	29913	29919	JJ	single	O	_	_
agent	29920	29925	NN	agent	O	_	_
RAF	29926	29929	NN	raf	O	_	_
/	29929	29930	:	/	B-GENE	_	_
MEK	29930	29933	NN	mek	I-GENE	_	_
inhibitors	29934	29944	NNS	inhibitor	O	_	_
,	29944	29945	,	,	O	_	_
chronic	29946	29953	JJ	chronic	O	_	_
inhibition	29954	29964	NN	inhibition	O	_	_
of	29965	29967	IN	of	O	_	_
this	29968	29972	DT	this	O	_	_
pathway	29973	29980	NN	pathway	O	_	_
may	29981	29984	MD	may	O	_	_
lead	29985	29989	VB	lead	O	_	_
to	29990	29992	TO	to	O	_	_
persistent	29993	30003	JJ	persistent	O	_	_
activation	30004	30014	NN	activation	O	_	_
of	30015	30017	IN	of	O	_	_
EGFR	30018	30022	NN	egfr	B-GENE	_	_
or	30023	30025	CC	or	O	_	_
HER2	30026	30030	NN	her2	B-GENE	_	_
.	30030	30031	.	.	O	_	_
D	1
23
5	4	amod
5	8	rcmod
8	6	nsubj
8	7	advmod
8	12	prep_to
12	10	amod
12	11	nn
12	15	dep
15	13	punct
15	14	nn
18	17	amod
18	21	prep_of
21	20	det
23	1	prep_for
23	5	prep_in
23	18	nsubj
23	22	aux
23	26	prep_to
26	25	amod
26	28	prep_of
26	30	prep_of
28	30	conj_or
EOX
Y	1
ROOT	0	0	32	1	S	5	0	32	7	PP	0	0	2	2	IN	0	0	1	1	For	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	example	1	1	2	0	,	0	2	3	1	,	2	2	3	0	PP	0	3	16	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	16	2	NP	1	4	6	2	JJ	0	4	5	1	KRAS-mutant	4	4	5	0	NNS	0	5	6	1	cancers	5	5	6	0	SBAR	1	6	16	2	WHNP	0	6	7	1	WDT	0	6	7	1	that	6	6	7	0	S	1	7	16	2	ADVP	0	7	8	1	RB	0	7	8	1	initially	7	7	8	0	VP	0	8	16	2	VBP	0	8	9	1	respond	8	8	9	0	PP	0	9	16	2	TO	0	9	10	1	to	9	9	10	0	NP	0	10	16	2	NP	2	10	13	3	JJ	0	10	11	1	single	10	10	11	0	NN	0	11	12	1	agent	11	11	12	0	NN	0	12	13	1	RAF	12	12	13	0	PRN	1	13	16	2	:	0	13	14	1	/	13	13	14	0	NP	1	14	16	2	NN	0	14	15	1	MEK	14	14	15	0	NNS	0	15	16	1	inhibitors	15	15	16	0	,	0	16	17	1	,	16	16	17	0	NP	0	17	22	2	NP	1	17	19	2	JJ	0	17	18	1	chronic	17	17	18	0	NN	0	18	19	1	inhibition	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	of	19	19	20	0	NP	1	20	22	2	DT	0	20	21	1	this	20	20	21	0	NN	0	21	22	1	pathway	21	21	22	0	VP	1	22	31	2	MD	0	22	23	1	may	22	22	23	0	VP	0	23	31	2	VB	0	23	24	1	lead	23	23	24	0	PP	0	24	31	2	TO	0	24	25	1	to	24	24	25	0	NP	0	25	31	2	NP	1	25	27	2	JJ	0	25	26	1	persistent	25	25	26	0	NN	0	26	27	1	activation	26	26	27	0	PP	0	27	31	2	IN	0	27	28	1	of	27	27	28	0	NP	0	28	31	3	NN	0	28	29	1	EGFR	28	28	29	0	CC	0	29	30	1	or	29	29	30	0	NN	0	30	31	1	HER2	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	21
Therefore	30032	30041	RB	therefore	O	_	_
,	30041	30042	,	,	O	_	_
these	30043	30048	DT	these	O	_	_
data	30049	30053	NNS	datum	O	_	_
suggest	30054	30061	VBP	suggest	O	_	_
that	30062	30066	IN	that	O	_	_
activation	30067	30077	NN	activation	O	_	_
of	30078	30080	IN	of	O	_	_
ERBB	30081	30085	NN	erbb	B-GENE	_	_
signaling	30086	30095	NN	signaling	O	_	_
may	30096	30099	MD	may	O	_	_
lead	30100	30104	VB	lead	O	_	_
to	30105	30107	TO	to	O	_	_
resistance	30108	30118	NN	resistance	O	_	_
to	30119	30121	TO	to	O	_	_
single-agent	30122	30134	JJ	single-agent	O	_	_
RAF	30135	30138	NN	raf	O	_	_
or	30139	30141	CC	or	O	_	_
MEK	30142	30145	NN	mek	B-GENE	_	_
inhibitors	30146	30156	NNS	inhibitor	O	_	_
.	30156	30157	.	.	O	_	_
D	1
4
3	2	det
4	0	advmod
4	3	nsubj
4	11	ccomp
6	9	prep_of
9	8	nn
11	5	mark
11	6	nsubj
11	10	aux
11	13	prep_to
11	16	prep_to
11	19	prep_to
16	15	amod
16	19	conj_or
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	3	0	21	5	ADVP	0	0	1	1	RB	0	0	1	1	Therefore	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	1	2	4	2	DT	0	2	3	1	these	2	2	3	0	NNS	0	3	4	1	data	3	3	4	0	VP	0	4	20	2	VBP	0	4	5	1	suggest	4	4	5	0	SBAR	1	5	20	2	IN	0	5	6	1	that	5	5	6	0	S	1	6	20	2	NP	0	6	10	2	NP	0	6	7	1	NN	0	6	7	1	activation	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	of	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	ERBB	8	8	9	0	NN	0	9	10	1	signaling	9	9	10	0	VP	1	10	20	2	MD	0	10	11	1	may	10	10	11	0	VP	0	11	20	3	VB	0	11	12	1	lead	11	11	12	0	PP	0	12	14	2	TO	0	12	13	1	to	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	resistance	13	13	14	0	PP	0	14	20	2	TO	0	14	15	1	to	14	14	15	0	NP	0	15	20	3	NP	1	15	17	2	JJ	0	15	16	1	single-agent	15	15	16	0	NN	0	16	17	1	RAF	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	NP	1	18	20	2	NN	0	18	19	1	MEK	18	18	19	0	NNS	0	19	20	1	inhibitors	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	8
Supplementary	30158	30171	NNP	Supplementary	O	_	_
Material	30172	30180	NNP	Material	O	_	_
ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº1	30181	30218	NNP	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº1	O	_	_
Click	30219	30224	VB	click	O	_	_
here	30225	30229	RB	here	O	_	_
to	30230	30232	TO	to	O	_	_
view	30233	30237	VB	view	O	_	_
.	30237	30238	.	.	O	_	_
D	1
3
2	0	nn
2	1	nn
3	2	nsubj
3	4	advmod
3	6	xcomp
6	5	aux
EOX
Y	1
ROOT	0	0	8	1	S	1	0	8	3	NP	2	0	3	3	NNP	0	0	1	1	Supplementary	0	0	1	0	NNP	0	1	2	1	Material	1	1	2	0	NNP	0	2	3	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº1	2	2	3	0	VP	0	3	7	3	VB	0	3	4	1	Click	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	here	4	4	5	0	S	0	5	7	1	VP	1	5	7	2	TO	0	5	6	1	to	5	5	6	0	VP	0	6	7	1	VB	0	6	7	1	view	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	34
(	30238	30239	NN	(	O	_	_
310K	30239	30243	NN	310k	O	_	_
,	30243	30244	,	,	O	_	_
docx	30245	30249	NN	docx	O	_	_
)	30249	30250	CD	)	O	_	_
Ôøº	30251	30254	NN	ôøº	O	_	_
MEK	30256	30259	NN	mek	B-GENE	_	_
inhibition	30260	30270	NN	inhibition	O	_	_
leads	30271	30276	VBZ	lead	O	_	_
to	30277	30279	TO	to	O	_	_
PI3K	30280	30284	NN	pi3k	B-GENE	_	_
/	30284	30285	:	/	B-GENE	_	_
AKT	30285	30288	NN	akt	I-GENE	_	_
activation	30289	30299	NN	activation	O	_	_
by	30300	30302	IN	by	O	_	_
relieving	30303	30312	VBG	relieve	O	_	_
a	30313	30314	DT	a	O	_	_
negative	30315	30323	JJ	negative	O	_	_
feedback	30324	30332	NN	feedback	O	_	_
on	30333	30335	IN	on	O	_	_
ERBB	30336	30340	NN	erbb	O	_	_
receptors	30341	30350	NNS	receptor	O	_	_
12	30351	30353	CD	12	O	_	_
/	30353	30354	:	/	O	_	_
8/14	30354	30358	CD	8/14	O	_	_
,	30358	30359	,	,	O	_	_
6:54	30360	30364	CD	6:54	O	_	_
PM	30365	30367	NN	pm	O	_	_
ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº2	30368	30414	NN	ôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøº2	O	_	_
Click	30415	30420	VB	click	O	_	_
here	30421	30425	RB	here	O	_	_
to	30426	30428	TO	to	O	_	_
view	30429	30433	VB	view	O	_	_
.	30433	30434	.	.	O	_	_
D	1
13
1	0	nn
1	6	appos
6	3	nn
6	4	num
6	5	nn
6	7	dep
8	1	nsubj
8	10	prep_to
13	8	dep
13	11	punct
13	12	nn
13	15	prepc_by
15	18	dobj
15	21	prep_on
18	16	det
18	17	amod
21	20	nn
21	29	rcmod
22	24	dep
24	23	punct
24	28	appos
28	26	num
28	27	nn
29	22	nsubj
29	30	advmod
29	32	xcomp
32	31	aux
EOX
Y	1
ROOT	0	0	34	1	FRAG	2	0	34	4	S	1	0	11	2	NP	0	0	8	3	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	310K	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	8	2	NP	3	3	7	4	NN	0	3	4	1	docx	3	3	4	0	CD	0	4	5	1	)	4	4	5	0	NN	0	5	6	1	Ôøº	5	5	6	0	NN	0	6	7	1	MEK	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	inhibition	7	7	8	0	VP	0	8	11	2	VBZ	0	8	9	1	leads	8	8	9	0	PP	0	9	11	2	TO	0	9	10	1	to	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	PI3K	10	10	11	0	:	0	11	12	1	/	11	11	12	0	FRAG	0	12	33	2	NP	1	12	14	2	NN	0	12	13	1	AKT	12	12	13	0	NN	0	13	14	1	activation	13	13	14	0	PP	0	14	33	2	IN	0	14	15	1	by	14	14	15	0	S	0	15	33	1	VP	0	15	33	3	VBG	0	15	16	1	relieving	15	15	16	0	NP	2	16	19	3	DT	0	16	17	1	a	16	16	17	0	JJ	0	17	18	1	negative	17	17	18	0	NN	0	18	19	1	feedback	18	18	19	0	PP	0	19	33	2	IN	0	19	20	1	on	19	19	20	0	NP	0	20	33	2	NP	1	20	22	2	NN	0	20	21	1	ERBB	20	20	21	0	NNS	0	21	22	1	receptors	21	21	22	0	SBAR	1	22	33	2	WHNP	0	22	29	2	NP	0	22	23	1	CD	0	22	23	1	12	22	22	23	0	PRN	1	23	29	2	:	0	23	24	1	/	23	23	24	0	NP	0	24	29	3	NP	0	24	25	1	CD	0	24	25	1	8/14	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NP	2	26	29	3	CD	0	26	27	1	6:54	26	26	27	0	NN	0	27	28	1	PM	27	27	28	0	NN	0	28	29	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº2	28	28	29	0	S	0	29	33	1	VP	0	29	33	3	VB	0	29	30	1	Click	29	29	30	0	ADVP	0	30	31	1	RB	0	30	31	1	here	30	30	31	0	S	0	31	33	1	VP	1	31	33	2	TO	0	31	32	1	to	31	31	32	0	VP	0	32	33	1	VB	0	32	33	1	view	32	32	33	0	.	0	33	34	1	.	33	33	34	0
EOS
T	41
(	30434	30435	NN	(	O	_	_
36K	30435	30438	NN	36k	O	_	_
,	30438	30439	,	,	O	_	_
docx	30440	30444	NN	docx	O	_	_
)	30444	30445	CD	)	O	_	_
ÔøºÔøºÔøºACKNOWLEDGEMENTS	30446	30471	NN	ôøºôøºôøºacknowledgements	O	_	_
We	30472	30474	PRP	we	O	_	_
thank	30475	30480	VBP	thank	O	_	_
Min	30481	30484	NNP	Min	O	_	_
Yuan	30485	30489	NNP	Yuan	O	_	_
and	30490	30493	CC	and	O	_	_
Susanne	30494	30501	NNP	Susanne	O	_	_
Breitkopf	30502	30511	NNP	Breitkopf	O	_	_
for	30512	30515	IN	for	O	_	_
help	30516	30520	NN	help	O	_	_
with	30521	30525	IN	with	O	_	_
mass	30526	30530	NN	mass	O	_	_
spectrometry	30531	30543	NN	spectrometry	O	_	_
,	30543	30544	,	,	O	_	_
Mike	30545	30549	NNP	Mike	O	_	_
Rothernberg	30550	30561	NNP	Rothernberg	O	_	_
and	30562	30565	CC	and	O	_	_
Cyril	30566	30571	NNP	Cyril	O	_	_
Benes	30572	30577	NNP	Benes	O	_	_
for	30578	30581	IN	for	O	_	_
helpful	30582	30589	JJ	helpful	O	_	_
discussions	30590	30601	NNS	discussion	O	_	_
,	30601	30602	,	,	O	_	_
and	30603	30606	CC	and	O	_	_
Zachary	30607	30614	NNP	Zachary	O	_	_
Morris	30615	30621	NNP	Morris	O	_	_
and	30622	30625	CC	and	O	_	_
Andrea	30626	30632	NNP	Andrea	O	_	_
McClatchey	30633	30643	NNP	McClatchey	O	_	_
for	30644	30647	IN	for	O	_	_
assistance	30648	30658	NN	assistance	O	_	_
with	30659	30663	IN	with	O	_	_
biotin	30664	30670	NN	biotin	O	_	_
labeling	30671	30679	NN	labeling	O	_	_
experiments	30680	30691	NNS	experiment	O	_	_
.	30691	30692	.	.	O	_	_
D	1
1
1	0	nn
1	5	appos
5	3	nn
5	4	num
5	7	rcmod
7	6	nsubj
7	9	dobj
7	12	dobj
7	20	dobj
7	30	dobj
7	33	dobj
7	39	prep_with
9	8	nn
9	12	conj_and
9	14	prep_for
9	20	conj_and
9	23	conj_and
9	30	conj_and
9	33	conj_and
12	11	nn
14	17	prep_with
17	16	nn
20	19	nn
20	23	conj_and
20	26	prep_for
23	22	nn
26	25	amod
30	29	nn
33	32	nn
33	35	prep_for
39	37	nn
39	38	nn
EOX
Y	1
ROOT	0	0	41	1	NP	0	0	41	4	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	36K	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	40	2	NP	2	3	6	3	NN	0	3	4	1	docx	3	3	4	0	CD	0	4	5	1	)	4	4	5	0	NN	0	5	6	1	ÔøºÔøºÔøºACKNOWLEDGEMENTS	5	5	6	0	SBAR	0	6	40	1	S	1	6	40	2	NP	0	6	7	1	PRP	0	6	7	1	We	6	6	7	0	VP	0	7	40	3	VBP	0	7	8	1	thank	7	7	8	0	NP	0	8	36	8	NP	0	8	18	2	NP	0	8	13	3	NP	1	8	10	2	NNP	0	8	9	1	Min	8	8	9	0	NNP	0	9	10	1	Yuan	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	NP	1	11	13	2	NNP	0	11	12	1	Susanne	11	11	12	0	NNP	0	12	13	1	Breitkopf	12	12	13	0	PP	0	13	18	2	IN	0	13	14	1	for	13	13	14	0	NP	0	14	18	2	NP	0	14	15	1	NN	0	14	15	1	help	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	with	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	mass	16	16	17	0	NN	0	17	18	1	spectrometry	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	0	19	27	2	NP	0	19	24	3	NP	1	19	21	2	NNP	0	19	20	1	Mike	19	19	20	0	NNP	0	20	21	1	Rothernberg	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	NP	1	22	24	2	NNP	0	22	23	1	Cyril	22	22	23	0	NNP	0	23	24	1	Benes	23	23	24	0	PP	0	24	27	2	IN	0	24	25	1	for	24	24	25	0	NP	1	25	27	2	JJ	0	25	26	1	helpful	25	25	26	0	NNS	0	26	27	1	discussions	26	26	27	0	,	0	27	28	1	,	27	27	28	0	CC	0	28	29	1	and	28	28	29	0	NP	1	29	31	2	NNP	0	29	30	1	Zachary	29	29	30	0	NNP	0	30	31	1	Morris	30	30	31	0	CC	0	31	32	1	and	31	31	32	0	NP	0	32	36	2	NP	1	32	34	2	NNP	0	32	33	1	Andrea	32	32	33	0	NNP	0	33	34	1	McClatchey	33	33	34	0	PP	0	34	36	2	IN	0	34	35	1	for	34	34	35	0	NP	0	35	36	1	NN	0	35	36	1	assistance	35	35	36	0	PP	0	36	40	2	IN	0	36	37	1	with	36	36	37	0	NP	2	37	40	3	NN	0	37	38	1	biotin	37	37	38	0	NN	0	38	39	1	labeling	38	38	39	0	NNS	0	39	40	1	experiments	39	39	40	0	.	0	40	41	1	.	40	40	41	0
EOS
T	122
GRANT	30693	30698	JJ	grant	O	_	_
SUPPORT	30699	30706	NNP	SUPPORT	O	_	_
Financial	30707	30716	NNP	Financial	O	_	_
Support	30717	30724	NN	support	O	_	_
:	30724	30725	:	:	O	_	_
This	30726	30730	DT	this	O	_	_
study	30731	30736	NN	study	O	_	_
is	30737	30739	VBZ	be	O	_	_
supported	30740	30749	VBN	support	O	_	_
by	30750	30752	IN	by	O	_	_
the	30753	30756	DT	the	O	_	_
NIH	30757	30760	NNP	NIH	O	_	_
Gastrointestinal	30761	30777	JJ	gastrointestinal	O	_	_
Cancer	30778	30784	NN	cancer	O	_	_
SPORE	30785	30790	NN	spore	O	_	_
P50	30791	30794	NN	p50	O	_	_
CA127003	30795	30803	NN	ca127003	O	_	_
(	30804	30805	CD	(	O	_	_
J.A.E.	30805	30811	NNP	J.A.E.	O	_	_
)	30811	30812	CD	)	O	_	_
,	30812	30813	,	,	O	_	_
K08	30814	30817	CD	k08	O	_	_
grant	30818	30823	NN	grant	O	_	_
CA120060-01	30824	30835	NN	ca120060-01	O	_	_
(	30836	30837	CD	(	O	_	_
J.A.E.	30837	30843	NNP	J.A.E.	O	_	_
)	30843	30844	CD	)	O	_	_
,	30844	30845	,	,	O	_	_
R01CA137008-01	30846	30860	NN	r01ca137008-01	O	_	_
(	30861	30862	CD	(	O	_	_
J.A.E.	30862	30868	NNP	J.A.E.	O	_	_
)	30868	30869	CD	)	O	_	_
,	30869	30870	,	,	O	_	_
R01CA140594	30871	30882	NN	r01ca140594	O	_	_
(	30883	30884	CD	(	O	_	_
J.A.E.	30884	30890	NNP	J.A.E.	O	_	_
)	30890	30891	CD	)	O	_	_
,	30891	30892	,	,	O	_	_
1U01CA141457-01	30893	30908	NN	1u01ca141457-01	O	_	_
(	30909	30910	CD	(	O	_	_
J.A.E.	30910	30916	NNP	J.A.E.	O	_	_
)	30916	30917	CD	)	O	_	_
,	30917	30918	,	,	O	_	_
Lung	30919	30923	NN	lung	B-GENE	_	_
SPORE	30924	30929	NN	spore	I-GENE	_	_
P50CA090578	30930	30941	NN	p50ca090578	I-GENE	_	_
(	30942	30943	CD	(	O	_	_
J.A.E.	30943	30949	NNP	J.A.E.	O	_	_
)	30949	30950	CD	)	O	_	_
,	30950	30951	,	,	O	_	_
the	30952	30955	DT	the	O	_	_
V	30956	30957	NN	v	O	_	_
Foundation	30958	30968	NNP	Foundation	O	_	_
(	30969	30970	CD	(	O	_	_
J.A.E.	30970	30976	NNP	J.A.E.	O	_	_
)	30976	30977	CD	)	O	_	_
,	30977	30978	,	,	O	_	_
American	30979	30987	NNP	American	O	_	_
Cancer	30988	30994	NNP	Cancer	O	_	_
Society	30995	31002	NNP	Society	O	_	_
RSG-06-102-01-CCE	31003	31020	NN	rsg-06-102-01-cce	O	_	_
(	31021	31022	CD	(	O	_	_
J.A.E.	31022	31028	NNP	J.A.E.	O	_	_
)	31028	31029	CD	)	O	_	_
,	31029	31030	,	,	O	_	_
the	31031	31034	DT	the	O	_	_
Ellison	31035	31042	NNP	Ellison	O	_	_
Foundation	31043	31053	NNP	Foundation	O	_	_
Scholar	31054	31061	NNP	Scholar	O	_	_
Award	31062	31067	NN	award	O	_	_
(	31068	31069	CD	(	O	_	_
J.A.E.	31069	31075	NNP	J.A.E.	O	_	_
)	31075	31076	CD	)	O	_	_
,	31076	31077	,	,	O	_	_
the	31078	31081	DT	the	O	_	_
American	31082	31090	JJ	american	O	_	_
Lung	31091	31095	NN	lung	O	_	_
Cancer	31096	31102	NNP	Cancer	O	_	_
Association	31103	31114	NNP	Association	O	_	_
Lung	31115	31119	NN	lung	O	_	_
Cancer	31120	31126	NN	cancer	O	_	_
Discovery	31127	31136	NNP	Discovery	O	_	_
Award	31137	31142	NN	award	O	_	_
(	31143	31144	CD	(	O	_	_
J.A.E.	31144	31150	NNP	J.A.E.	O	_	_
)	31150	31151	CD	)	O	_	_
,	31151	31152	,	,	O	_	_
NIH	31153	31156	NNP	NIH	O	_	_
5P01CA120964-04	31157	31172	NN	5p01ca120964-04	O	_	_
(	31173	31174	CD	(	O	_	_
J.M.A.	31174	31180	NNP	J.M.A.	O	_	_
)	31180	31181	CD	)	O	_	_
,	31181	31182	,	,	O	_	_
NIH	31183	31186	NNP	NIH	O	_	_
DF	31187	31189	NN	df	O	_	_
/	31189	31190	:	/	O	_	_
HCC	31190	31193	NNP	HCC	O	_	_
Cancer	31194	31200	NNP	Cancer	O	_	_
Center	31201	31207	NNP	Center	O	_	_
Support	31208	31215	NN	support	O	_	_
Grant	31216	31221	NNP	Grant	O	_	_
5P30CA006516-46	31222	31237	NNP	5P30CA006516-46	O	_	_
(	31238	31239	CD	(	O	_	_
J.M.A.	31239	31245	NNP	J.M.A.	O	_	_
)	31245	31246	CD	)	O	_	_
,	31246	31247	,	,	O	_	_
R01CA80195	31248	31258	NN	r01ca80195	O	_	_
(	31259	31260	CD	(	O	_	_
C.L.A.	31260	31266	NNP	C.L.A.	O	_	_
)	31266	31267	NN	)	O	_	_
and	31268	31271	CC	and	O	_	_
Vanderbilt	31272	31282	NNP	Vanderbilt	O	_	_
Breast	31283	31289	NN	breast	O	_	_
Cancer	31290	31296	NN	cancer	O	_	_
SPORE	31297	31302	NN	spore	O	_	_
P50	31303	31306	NN	p50	O	_	_
CA98131	31307	31314	NN	ca98131	O	_	_
(	31315	31316	CD	(	O	_	_
C.	31316	31318	NNP	C.	O	_	_
L.A.	31319	31323	NNP	L.A.	O	_	_
)	31323	31324	NNP	)	O	_	_
.	31324	31325	.	.	O	_	_
D	1

121	0	dep
121	1	dep
121	2	dep
121	3	dep
121	5	dep
121	6	dep
121	7	dep
121	8	dep
121	9	dep
121	10	dep
121	11	dep
121	12	dep
121	13	dep
121	14	dep
121	15	dep
121	16	dep
121	18	dep
121	21	dep
121	22	dep
121	23	dep
121	25	dep
121	28	dep
121	30	dep
121	33	dep
121	35	dep
121	38	dep
121	40	dep
121	43	dep
121	44	dep
121	45	dep
121	47	dep
121	50	dep
121	51	dep
121	52	dep
121	54	dep
121	57	dep
121	58	dep
121	59	dep
121	60	dep
121	62	dep
121	65	dep
121	66	dep
121	67	dep
121	68	dep
121	69	dep
121	71	dep
121	74	dep
121	75	dep
121	76	dep
121	77	dep
121	78	dep
121	79	dep
121	80	dep
121	81	dep
121	82	dep
121	84	dep
121	87	dep
121	88	dep
121	90	dep
121	93	dep
121	94	dep
121	95	dep
121	96	dep
121	97	dep
121	98	dep
121	99	dep
121	100	dep
121	101	dep
121	103	dep
121	106	dep
121	108	dep
121	110	dep
121	111	dep
121	112	dep
121	113	dep
121	114	dep
121	115	dep
121	116	dep
121	118	dep
121	119	dep
EOX
Y	1
X	121	0	122	122	X	0	0	1	1	GRANT	0	0	1	0	X	0	1	2	1	SUPPORT	1	1	2	0	X	0	2	3	1	Financial	2	2	3	0	X	0	3	4	1	Support	3	3	4	0	X	0	4	5	1	:	4	4	5	0	X	0	5	6	1	This	5	5	6	0	X	0	6	7	1	study	6	6	7	0	X	0	7	8	1	is	7	7	8	0	X	0	8	9	1	supported	8	8	9	0	X	0	9	10	1	by	9	9	10	0	X	0	10	11	1	the	10	10	11	0	X	0	11	12	1	NIH	11	11	12	0	X	0	12	13	1	Gastrointestinal	12	12	13	0	X	0	13	14	1	Cancer	13	13	14	0	X	0	14	15	1	SPORE	14	14	15	0	X	0	15	16	1	P50	15	15	16	0	X	0	16	17	1	CA127003	16	16	17	0	X	0	17	18	1	-LRB-	17	17	18	0	X	0	18	19	1	J.A.E.	18	18	19	0	X	0	19	20	1	-RRB-	19	19	20	0	X	0	20	21	1	,	20	20	21	0	X	0	21	22	1	K08	21	21	22	0	X	0	22	23	1	grant	22	22	23	0	X	0	23	24	1	CA120060-01	23	23	24	0	X	0	24	25	1	-LRB-	24	24	25	0	X	0	25	26	1	J.A.E.	25	25	26	0	X	0	26	27	1	-RRB-	26	26	27	0	X	0	27	28	1	,	27	27	28	0	X	0	28	29	1	R01CA137008-01	28	28	29	0	X	0	29	30	1	-LRB-	29	29	30	0	X	0	30	31	1	J.A.E.	30	30	31	0	X	0	31	32	1	-RRB-	31	31	32	0	X	0	32	33	1	,	32	32	33	0	X	0	33	34	1	R01CA140594	33	33	34	0	X	0	34	35	1	-LRB-	34	34	35	0	X	0	35	36	1	J.A.E.	35	35	36	0	X	0	36	37	1	-RRB-	36	36	37	0	X	0	37	38	1	,	37	37	38	0	X	0	38	39	1	1U01CA141457-01	38	38	39	0	X	0	39	40	1	-LRB-	39	39	40	0	X	0	40	41	1	J.A.E.	40	40	41	0	X	0	41	42	1	-RRB-	41	41	42	0	X	0	42	43	1	,	42	42	43	0	X	0	43	44	1	Lung	43	43	44	0	X	0	44	45	1	SPORE	44	44	45	0	X	0	45	46	1	P50CA090578	45	45	46	0	X	0	46	47	1	-LRB-	46	46	47	0	X	0	47	48	1	J.A.E.	47	47	48	0	X	0	48	49	1	-RRB-	48	48	49	0	X	0	49	50	1	,	49	49	50	0	X	0	50	51	1	the	50	50	51	0	X	0	51	52	1	V	51	51	52	0	X	0	52	53	1	Foundation	52	52	53	0	X	0	53	54	1	-LRB-	53	53	54	0	X	0	54	55	1	J.A.E.	54	54	55	0	X	0	55	56	1	-RRB-	55	55	56	0	X	0	56	57	1	,	56	56	57	0	X	0	57	58	1	American	57	57	58	0	X	0	58	59	1	Cancer	58	58	59	0	X	0	59	60	1	Society	59	59	60	0	X	0	60	61	1	RSG-06-102-01-CCE	60	60	61	0	X	0	61	62	1	-LRB-	61	61	62	0	X	0	62	63	1	J.A.E.	62	62	63	0	X	0	63	64	1	-RRB-	63	63	64	0	X	0	64	65	1	,	64	64	65	0	X	0	65	66	1	the	65	65	66	0	X	0	66	67	1	Ellison	66	66	67	0	X	0	67	68	1	Foundation	67	67	68	0	X	0	68	69	1	Scholar	68	68	69	0	X	0	69	70	1	Award	69	69	70	0	X	0	70	71	1	-LRB-	70	70	71	0	X	0	71	72	1	J.A.E.	71	71	72	0	X	0	72	73	1	-RRB-	72	72	73	0	X	0	73	74	1	,	73	73	74	0	X	0	74	75	1	the	74	74	75	0	X	0	75	76	1	American	75	75	76	0	X	0	76	77	1	Lung	76	76	77	0	X	0	77	78	1	Cancer	77	77	78	0	X	0	78	79	1	Association	78	78	79	0	X	0	79	80	1	Lung	79	79	80	0	X	0	80	81	1	Cancer	80	80	81	0	X	0	81	82	1	Discovery	81	81	82	0	X	0	82	83	1	Award	82	82	83	0	X	0	83	84	1	-LRB-	83	83	84	0	X	0	84	85	1	J.A.E.	84	84	85	0	X	0	85	86	1	-RRB-	85	85	86	0	X	0	86	87	1	,	86	86	87	0	X	0	87	88	1	NIH	87	87	88	0	X	0	88	89	1	5P01CA120964-04	88	88	89	0	X	0	89	90	1	-LRB-	89	89	90	0	X	0	90	91	1	J.M.A.	90	90	91	0	X	0	91	92	1	-RRB-	91	91	92	0	X	0	92	93	1	,	92	92	93	0	X	0	93	94	1	NIH	93	93	94	0	X	0	94	95	1	DF	94	94	95	0	X	0	95	96	1	/	95	95	96	0	X	0	96	97	1	HCC	96	96	97	0	X	0	97	98	1	Cancer	97	97	98	0	X	0	98	99	1	Center	98	98	99	0	X	0	99	100	1	Support	99	99	100	0	X	0	100	101	1	Grant	100	100	101	0	X	0	101	102	1	5P30CA006516-46	101	101	102	0	X	0	102	103	1	-LRB-	102	102	103	0	X	0	103	104	1	J.M.A.	103	103	104	0	X	0	104	105	1	-RRB-	104	104	105	0	X	0	105	106	1	,	105	105	106	0	X	0	106	107	1	R01CA80195	106	106	107	0	X	0	107	108	1	-LRB-	107	107	108	0	X	0	108	109	1	C.L.A.	108	108	109	0	X	0	109	110	1	-RRB-	109	109	110	0	X	0	110	111	1	and	110	110	111	0	X	0	111	112	1	Vanderbilt	111	111	112	0	X	0	112	113	1	Breast	112	112	113	0	X	0	113	114	1	Cancer	113	113	114	0	X	0	114	115	1	SPORE	114	114	115	0	X	0	115	116	1	P50	115	115	116	0	X	0	116	117	1	CA98131	116	116	117	0	X	0	117	118	1	-LRB-	117	117	118	0	X	0	118	119	1	C.	118	118	119	0	X	0	119	120	1	L.A.	119	119	120	0	X	0	120	121	1	-RRB-	120	120	121	0	X	0	121	122	1	.	121	121	122	0
EOS
T	25
Footnotes	31326	31335	NNS	footnote	O	_	_
Conflict	31337	31345	NN	conflict	O	_	_
of	31346	31348	IN	of	O	_	_
Interest	31349	31357	NN	interest	O	_	_
Statement	31358	31367	NN	statement	O	_	_
:	31367	31368	:	:	O	_	_
J.A.E	31369	31374	NN	j.a.e	O	_	_
receives	31375	31383	VBZ	receive	O	_	_
research	31384	31392	NN	research	O	_	_
support	31393	31400	NN	support	O	_	_
from	31401	31405	IN	from	O	_	_
AstraZeneca	31406	31417	NNP	AstraZeneca	O	_	_
and	31418	31421	CC	and	O	_	_
GalaxoSmithKline	31422	31438	NNP	GalaxoSmithKline	O	_	_
and	31439	31442	CC	and	O	_	_
consults	31443	31451	NNS	consult	O	_	_
for	31452	31455	IN	for	O	_	_
AstraZeneca	31456	31467	NNP	AstraZeneca	O	_	_
,	31467	31468	,	,	O	_	_
GalaxoSmithKline	31469	31485	NNP	GalaxoSmithKline	O	_	_
,	31485	31486	,	,	O	_	_
Novartis	31487	31495	NNP	Novartis	O	_	_
and	31496	31499	CC	and	O	_	_
Genentech	31500	31509	NNP	Genentech	O	_	_
.	31509	31510	.	.	O	_	_
D	1
1
1	0	nn
1	4	prep_of
1	6	dep
4	3	nn
6	7	rcmod
7	9	dobj
7	15	dobj
9	8	nn
9	11	prep_from
9	13	prep_from
9	15	conj_and
11	13	conj_and
15	17	prep_for
15	19	prep_for
15	21	prep_for
15	23	prep_for
17	19	conj_and
17	21	conj_and
17	23	conj_and
EOX
Y	1
ROOT	0	0	25	1	NP	0	0	25	4	NP	0	0	5	2	NP	1	0	2	2	NNS	0	0	1	1	Footnotes	0	0	1	0	NN	0	1	2	1	Conflict	1	1	2	0	PP	0	2	5	2	IN	0	2	3	1	of	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	Interest	3	3	4	0	NN	0	4	5	1	Statement	4	4	5	0	:	0	5	6	1	:	5	5	6	0	NP	0	6	24	2	NP	0	6	7	1	NN	0	6	7	1	J.A.E	6	6	7	0	SBAR	0	7	24	1	S	0	7	24	1	VP	0	7	24	2	VBZ	0	7	8	1	receives	7	7	8	0	NP	0	8	24	3	NP	0	8	14	2	NP	1	8	10	2	NN	0	8	9	1	research	8	8	9	0	NN	0	9	10	1	support	9	9	10	0	PP	0	10	14	2	IN	0	10	11	1	from	10	10	11	0	NP	0	11	14	3	NNP	0	11	12	1	AstraZeneca	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	NNP	0	13	14	1	GalaxoSmithKline	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	0	15	24	2	NP	0	15	16	1	NNS	0	15	16	1	consults	15	15	16	0	PP	0	16	24	2	IN	0	16	17	1	for	16	16	17	0	NP	0	17	24	7	NNP	0	17	18	1	AstraZeneca	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NNP	0	19	20	1	GalaxoSmithKline	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NNP	0	21	22	1	Novartis	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	NNP	0	23	24	1	Genentech	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	3
REFERENCES	31511	31521	NNS	reference	O	_	_
1	31523	31524	CD	1	O	_	_
.	31524	31525	.	.	O	_	_
D	1
0
0	1	num
EOX
Y	1
ROOT	0	0	3	1	NP	0	0	3	3	NNS	0	0	1	1	REFERENCES	0	0	1	0	CD	0	1	2	1	1	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	3
Engelman	31526	31534	NNP	Engelman	O	_	_
JA	31535	31537	NNP	JA	O	_	_
.	31537	31538	.	.	O	_	_
D	1
1
1	0	nn
EOX
Y	1
ROOT	0	0	3	1	NP	1	0	3	3	NNP	0	0	1	1	Engelman	0	0	1	0	NNP	0	1	2	1	JA	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	12
Targeting	31539	31548	NN	targeting	O	_	_
PI3K	31549	31553	NN	pi3k	O	_	_
signalling	31554	31564	NN	signalling	O	_	_
in	31565	31567	IN	in	O	_	_
cancer	31568	31574	NN	cancer	O	_	_
:	31574	31575	:	:	O	_	_
opportunities	31576	31589	NNS	opportunity	O	_	_
,	31589	31590	,	,	O	_	_
challenges	31591	31601	NNS	challenge	O	_	_
and	31602	31605	CC	and	O	_	_
limitations	31606	31617	NNS	limitation	O	_	_
.	31617	31618	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
2	4	prep_in
2	6	dep
2	8	dep
2	10	dep
6	8	conj_and
6	10	conj_and
EOX
Y	1
ROOT	0	0	12	1	NP	0	0	12	4	NP	0	0	5	2	NP	2	0	3	3	NN	0	0	1	1	Targeting	0	0	1	0	NN	0	1	2	1	PI3K	1	1	2	0	NN	0	2	3	1	signalling	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	cancer	4	4	5	0	:	0	5	6	1	:	5	5	6	0	NP	0	6	11	5	NP	0	6	7	1	NNS	0	6	7	1	opportunities	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	0	8	9	1	NNS	0	8	9	1	challenges	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NP	0	10	11	1	NNS	0	10	11	1	limitations	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	4
Nat	31619	31622	NNP	Nat	B-GENE	_	_
Rev	31623	31626	NN	rev	I-GENE	_	_
Cancer	31627	31633	NN	cancer	I-GENE	_	_
.	31633	31634	.	.	O	_	_
D	1
0
0	2	dep
2	1	nn
EOX
Y	1
ROOT	0	0	4	1	NP	0	0	4	3	NP	0	0	1	1	NNP	0	0	1	1	Nat	0	0	1	0	NP	1	1	3	2	NN	0	1	2	1	Rev	1	1	2	0	NN	0	2	3	1	Cancer	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	6
2009	31635	31639	CD	2009	O	_	_
;	31639	31640	:	;	O	_	_
9:550	31640	31645	CD	9:550	O	_	_
‚	31645	31646	CD	‚	O	_	_
Äì562	31646	31651	NN	äì562	O	_	_
.	31651	31652	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2009	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	9:550	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì562	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
2	31653	31654	LS	2	O	_	_
.	31654	31655	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	S	0	0	2	2	VP	0	0	1	1	LS	0	0	1	1	2	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	6
Guertin	31656	31663	NNP	Guertin	O	_	_
DA	31664	31666	NNP	DA	O	_	_
,	31666	31667	,	,	O	_	_
Sabatini	31668	31676	NNP	Sabatini	O	_	_
DM	31677	31679	NN	dm	O	_	_
.	31679	31680	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	1	0	2	2	NNP	0	0	1	1	Guertin	0	0	1	0	NNP	0	1	2	1	DA	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Sabatini	3	3	4	0	NN	0	4	5	1	DM	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	8
Defining	31681	31689	VBG	define	O	_	_
the	31690	31693	DT	the	O	_	_
role	31694	31698	NN	role	O	_	_
of	31699	31701	IN	of	O	_	_
mTOR	31702	31706	NN	mtor	B-GENE	_	_
in	31707	31709	IN	in	O	_	_
cancer	31710	31716	NN	cancer	O	_	_
.	31716	31717	.	.	O	_	_
D	1
0
0	2	dobj
0	6	prep_in
2	1	det
2	4	prep_of
EOX
Y	1
ROOT	0	0	8	1	S	0	0	8	2	VP	0	0	7	3	VBG	0	0	1	1	Defining	0	0	1	0	NP	0	1	5	2	NP	1	1	3	2	DT	0	1	2	1	the	1	1	2	0	NN	0	2	3	1	role	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	mTOR	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	in	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	cancer	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	3
Cancer	31718	31724	NN	cancer	O	_	_
Cell	31725	31729	NN	cell	O	_	_
.	31729	31730	.	.	O	_	_
D	1
0
0	1	dep
EOX
Y	1
ROOT	0	0	3	1	NP	0	0	3	3	NP	0	0	1	1	NN	0	0	1	1	Cancer	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	Cell	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	6
2007	31731	31735	CD	2007	O	_	_
;	31735	31736	:	;	O	_	_
12:9	31736	31740	CD	12:9	O	_	_
‚	31740	31741	CD	‚	O	_	_
Äì22	31741	31745	NN	äì22	O	_	_
.	31745	31746	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2007	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	12:9	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì22	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
3	31747	31748	LS	3	O	_	_
.	31748	31749	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	S	0	0	2	2	VP	0	0	1	1	LS	0	0	1	1	3	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	13
Montagut	31750	31758	NN	montagut	O	_	_
C	31759	31760	NN	c	O	_	_
,	31760	31761	,	,	O	_	_
Settleman	31762	31771	NNP	Settleman	O	_	_
J.	31772	31774	NNP	J.	O	_	_
Targeting	31775	31784	NN	targeting	O	_	_
the	31785	31788	DT	the	O	_	_
RAF-MEK-ERK	31789	31800	NN	raf-mek-erk	B-GENE	_	_
pathway	31801	31808	NN	pathway	O	_	_
in	31809	31811	IN	in	O	_	_
cancer	31812	31818	NN	cancer	O	_	_
therapy	31819	31826	NN	therapy	O	_	_
.	31826	31827	.	.	O	_	_
D	1
1
1	0	nn
1	5	appos
5	3	nn
5	4	nn
5	8	dep
8	6	det
8	7	nn
8	11	prep_in
11	10	nn
EOX
Y	1
ROOT	0	0	13	1	NP	0	0	13	4	NP	1	0	2	2	NN	0	0	1	1	Montagut	0	0	1	0	NN	0	1	2	1	C	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	12	2	NP	2	3	6	3	NNP	0	3	4	1	Settleman	3	3	4	0	NNP	0	4	5	1	J.	4	4	5	0	NN	0	5	6	1	Targeting	5	5	6	0	NP	0	6	12	2	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	RAF-MEK-ERK	7	7	8	0	NN	0	8	9	1	pathway	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	in	9	9	10	0	NP	1	10	12	2	NN	0	10	11	1	cancer	10	10	11	0	NN	0	11	12	1	therapy	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	3
Cancer	31828	31834	NNP	Cancer	O	_	_
Lett	31835	31839	NNP	Lett	O	_	_
.	31839	31840	.	.	O	_	_
D	1
1
1	0	nn
EOX
Y	1
ROOT	0	0	3	1	NP	1	0	3	3	NNP	0	0	1	1	Cancer	0	0	1	0	NNP	0	1	2	1	Lett	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	6
2009	31841	31845	CD	2009	O	_	_
;	31845	31846	:	;	O	_	_
283:125	31846	31853	CD	283:125	O	_	_
‚	31853	31854	CD	‚	O	_	_
Äì134	31854	31859	NN	äì134	O	_	_
.	31859	31860	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2009	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	283:125	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì134	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
4	31861	31862	LS	4	O	_	_
.	31862	31863	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	S	0	0	2	2	VP	0	0	1	1	LS	0	0	1	1	4	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Sun	31864	31867	NNP	Sun	B-GENE	_	_
S	31868	31869	NN	s	I-GENE	_	_
,	31869	31870	,	,	O	_	_
LM	31871	31873	NN	lm	B-GENE	_	_
R	31874	31875	NN	r	I-GENE	_	_
,	31875	31876	,	,	O	_	_
X	31877	31878	NN	x	B-GENE	_	_
W	31879	31880	NN	w	I-GENE	_	_
,	31880	31881	,	,	O	_	_
Z	31882	31883	NN	z	B-GENE	_	_
Z	31884	31885	NN	z	I-GENE	_	_
,	31885	31886	,	,	O	_	_
P	31887	31888	NN	p	B-GENE	_	_
Y	31889	31890	NN	y	I-GENE	_	_
,	31890	31891	,	,	O	_	_
H	31892	31893	NN	h	B-GENE	_	_
F	31894	31895	NN	f	I-GENE	_	_
,	31895	31896	,	,	O	_	_
et	31897	31899	FW	et	O	_	_
al.	31900	31902	FW	al.	O	_	_
.	31902	31903	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	4	NP	1	0	2	2	NNP	0	0	1	1	Sun	0	0	1	0	NN	0	1	2	1	S	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	20	11	NP	1	3	5	2	NN	0	3	4	1	LM	3	3	4	0	NN	0	4	5	1	R	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	X	6	6	7	0	NN	0	7	8	1	W	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	0	9	11	2	NN	0	9	10	1	Z	9	9	10	0	NN	0	10	11	1	Z	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	P	12	12	13	0	NN	0	13	14	1	Y	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NN	0	15	16	1	H	15	15	16	0	NN	0	16	17	1	F	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	16
Activation	31904	31914	NN	activation	O	_	_
of	31915	31917	IN	of	O	_	_
Akt	31918	31921	NN	akt	B-GENE	_	_
and	31922	31925	CC	and	O	_	_
eIF4E	31926	31931	NN	eif4e	B-GENE	_	_
survival	31932	31940	NN	survival	O	_	_
pathways	31941	31949	NNS	pathway	O	_	_
by	31950	31952	IN	by	O	_	_
rapamycin-	31953	31963	NN	rapamycin-_NN	O	_	_
mediated	31964	31972	VBD	mediate	O	_	_
mammalian	31973	31982	JJ	mammalian	O	_	_
target	31983	31989	NN	target	O	_	_
of	31990	31992	IN	of	O	_	_
rapamycin	31993	32002	NN	rapamycin	O	_	_
inhibition	32003	32013	NN	inhibition	O	_	_
.	32013	32014	.	.	O	_	_
D	1
9
0	6	prep_of
0	8	prep_by
2	4	conj_and
6	2	nn
6	4	nn
6	5	nn
9	0	nsubj
9	11	dobj
11	10	amod
11	14	prep_of
14	13	nn
EOX
Y	1
ROOT	0	0	16	1	S	1	0	16	3	NP	0	0	9	3	NP	0	0	1	1	NN	0	0	1	1	Activation	0	0	1	0	PP	0	1	7	2	IN	0	1	2	1	of	1	1	2	0	NP	2	2	7	3	NP	0	2	5	3	NN	0	2	3	1	Akt	2	2	3	0	CC	0	3	4	1	and	3	3	4	0	NN	0	4	5	1	eIF4E	4	4	5	0	NN	0	5	6	1	survival	5	5	6	0	NNS	0	6	7	1	pathways	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	rapamycin-	8	8	9	0	VP	0	9	15	2	VBD	0	9	10	1	mediated	9	9	10	0	NP	0	10	15	2	NP	1	10	12	2	JJ	0	10	11	1	mammalian	10	10	11	0	NN	0	11	12	1	target	11	11	12	0	PP	0	12	15	2	IN	0	12	13	1	of	12	12	13	0	NP	1	13	15	2	NN	0	13	14	1	rapamycin	13	13	14	0	NN	0	14	15	1	inhibition	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	3
Cancer	32015	32021	NNP	Cancer	O	_	_
Research	32022	32030	NNP	Research	O	_	_
.	32030	32031	.	.	O	_	_
D	1
1
1	0	nn
EOX
Y	1
ROOT	0	0	3	1	NP	1	0	3	3	NNP	0	0	1	1	Cancer	0	0	1	0	NNP	0	1	2	1	Research	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	6
2005	32032	32036	CD	2005	O	_	_
;	32036	32037	:	;	O	_	_
65:7052	32037	32044	CD	65:7052	O	_	_
‚	32044	32045	CD	‚	O	_	_
Äì7058	32045	32051	NN	äì7058	O	_	_
.	32051	32052	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2005	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	65:7052	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì7058	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
5	32053	32054	CD	5	O	_	_
.	32054	32055	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	5	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	9
Carracedo	32056	32065	NNP	Carracedo	O	_	_
A	32066	32067	NNP	A	O	_	_
,	32067	32068	,	,	O	_	_
Baselga	32069	32076	NNP	Baselga	O	_	_
J	32077	32078	NNP	J	O	_	_
,	32078	32079	,	,	O	_	_
Pandolfi	32080	32088	NNP	Pandolfi	O	_	_
PP	32089	32091	NNP	PP	O	_	_
.	32091	32092	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
7	6	nn
EOX
Y	1
ROOT	0	0	9	1	NP	0	0	9	4	NP	1	0	2	2	NNP	0	0	1	1	Carracedo	0	0	1	0	NNP	0	1	2	1	A	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	8	3	NP	1	3	5	2	NNP	0	3	4	1	Baselga	3	3	4	0	NNP	0	4	5	1	J	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Pandolfi	6	6	7	0	NNP	0	7	8	1	PP	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	12
Deconstructing	32093	32107	VBG	deconstruct	O	_	_
feedback	32108	32116	NN	feedback	O	_	_
signaling	32117	32126	NN	signaling	O	_	_
networks	32127	32135	NNS	network	O	_	_
to	32136	32138	TO	to	O	_	_
improve	32139	32146	VB	improve	O	_	_
anticancer	32147	32157	JJ	anticancer	O	_	_
therapy	32158	32165	NN	therapy	O	_	_
with	32166	32170	IN	with	O	_	_
mTORC1	32171	32177	NN	mtorc1	B-GENE	_	_
inhibitors	32178	32188	NNS	inhibitor	O	_	_
.	32188	32189	.	.	O	_	_
D	1
0
0	3	dobj
0	5	xcomp
3	1	nn
3	2	nn
5	4	aux
5	7	dobj
5	10	prep_with
7	6	amod
10	9	nn
EOX
Y	1
ROOT	0	0	12	1	S	0	0	12	2	VP	0	0	11	3	VBG	0	0	1	1	Deconstructing	0	0	1	0	NP	2	1	4	3	NN	0	1	2	1	feedback	1	1	2	0	NN	0	2	3	1	signaling	2	2	3	0	NNS	0	3	4	1	networks	3	3	4	0	S	0	4	11	1	VP	1	4	11	2	TO	0	4	5	1	to	4	4	5	0	VP	0	5	11	3	VB	0	5	6	1	improve	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	anticancer	6	6	7	0	NN	0	7	8	1	therapy	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	with	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	mTORC1	9	9	10	0	NNS	0	10	11	1	inhibitors	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	3
Cell	32190	32194	NN	cell	O	_	_
Cycle	32195	32200	NN	cycle	O	_	_
.	32200	32201	.	.	O	_	_
D	1
0
0	1	dep
EOX
Y	1
ROOT	0	0	3	1	NP	0	0	3	3	NP	0	0	1	1	NN	0	0	1	1	Cell	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	Cycle	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	6
2008	32202	32206	CD	2008	O	_	_
;	32206	32207	:	;	O	_	_
7:3805	32207	32213	CD	7:3805	O	_	_
‚	32213	32214	CD	‚	O	_	_
Äì3809	32214	32220	NN	äì3809	O	_	_
.	32220	32221	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2008	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	7:3805	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì3809	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
6	32222	32223	CD	6	O	_	_
.	32223	32224	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	6	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	32
O'Reilly	32225	32233	NNP	O'Reilly	O	_	_
KE	32234	32236	NNP	KE	O	_	_
,	32236	32237	,	,	O	_	_
Rojo	32238	32242	NNP	Rojo	O	_	_
F	32243	32244	NN	f	O	_	_
,	32244	32245	,	,	O	_	_
She	32246	32249	PRP	she	O	_	_
QB	32250	32252	NN	qb	O	_	_
,	32252	32253	,	,	O	_	_
Solit	32254	32259	NN	solit	O	_	_
D	32260	32261	NN	d	O	_	_
,	32261	32262	,	,	O	_	_
Mills	32263	32268	NNP	Mills	O	_	_
GB	32269	32271	NNP	GB	O	_	_
,	32271	32272	,	,	O	_	_
Smith	32273	32278	NNP	Smith	O	_	_
D	32279	32280	NNP	D	O	_	_
,	32280	32281	,	,	O	_	_
et	32282	32284	FW	et	O	_	_
al.	32285	32288	FW	al.	O	_	_
mTOR	32289	32293	NN	mtor	O	_	_
inhibition	32294	32304	NN	inhibition	O	_	_
induces	32305	32312	VBZ	induce	O	_	_
upstream	32313	32321	JJ	upstream	O	_	_
receptor	32322	32330	NN	receptor	B-GENE	_	_
tyrosine	32331	32339	NN	tyrosine	I-GENE	_	_
kinase	32340	32346	NN	kinase	I-GENE	_	_
signaling	32347	32356	NN	signaling	O	_	_
and	32357	32360	CC	and	O	_	_
activates	32361	32370	VBZ	activate	O	_	_
Akt	32371	32374	NN	akt	B-GENE	_	_
.	32374	32375	.	.	O	_	_
D	1
22
1	0	nn
1	4	appos
1	7	appos
1	10	appos
1	13	appos
1	16	appos
1	21	appos
4	3	nn
7	6	dep
10	9	nn
13	12	nn
16	15	nn
21	18	nn
21	19	nn
21	20	nn
22	1	nsubj
22	27	dobj
22	29	conj_and
27	23	amod
27	24	nn
27	25	nn
27	26	nn
29	1	nsubj
29	30	dobj
EOX
Y	1
ROOT	0	0	32	1	S	1	0	32	3	NP	0	0	22	13	NP	1	0	2	2	NNP	0	0	1	1	O'Reilly	0	0	1	0	NNP	0	1	2	1	KE	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Rojo	3	3	4	0	NN	0	4	5	1	F	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	PRP	0	6	7	1	She	6	6	7	0	NN	0	7	8	1	QB	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	Solit	9	9	10	0	NN	0	10	11	1	D	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Mills	12	12	13	0	NNP	0	13	14	1	GB	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Smith	15	15	16	0	NNP	0	16	17	1	D	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	3	18	22	4	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	NN	0	20	21	1	mTOR	20	20	21	0	NN	0	21	22	1	inhibition	21	21	22	0	VP	0	22	31	3	VP	0	22	28	2	VBZ	0	22	23	1	induces	22	22	23	0	NP	4	23	28	5	JJ	0	23	24	1	upstream	23	23	24	0	NN	0	24	25	1	receptor	24	24	25	0	NN	0	25	26	1	tyrosine	25	25	26	0	NN	0	26	27	1	kinase	26	26	27	0	NN	0	27	28	1	signaling	27	27	28	0	CC	0	28	29	1	and	28	28	29	0	VP	0	29	31	2	VBZ	0	29	30	1	activates	29	29	30	0	NP	0	30	31	1	NN	0	30	31	1	Akt	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	3
Cancer	32376	32382	NN	cancer	O	_	_
Res	32383	32386	NNP	Res	O	_	_
.	32386	32387	.	.	O	_	_
D	1
0
0	1	appos
EOX
Y	1
ROOT	0	0	3	1	NP	0	0	3	3	NP	0	0	1	1	NN	0	0	1	1	Cancer	0	0	1	0	NP	0	1	2	1	NNP	0	1	2	1	Res	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	6
2006	32388	32392	CD	2006	O	_	_
;	32392	32393	:	;	O	_	_
66:1500	32393	32400	CD	66:1500	O	_	_
‚	32400	32401	CD	‚	O	_	_
Äì1508	32401	32407	NN	äì1508	O	_	_
.	32407	32408	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2006	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	66:1500	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì1508	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
7	32409	32410	CD	7	O	_	_
.	32410	32411	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	7	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Chandarlapaty	32412	32425	NNP	Chandarlapaty	O	_	_
S	32426	32427	NNP	S	O	_	_
,	32427	32428	,	,	O	_	_
Sawai	32429	32434	NNP	Sawai	O	_	_
A	32435	32436	NNP	A	O	_	_
,	32436	32437	,	,	O	_	_
Scaltriti	32438	32447	NNP	Scaltriti	O	_	_
M	32448	32449	NNP	M	O	_	_
,	32449	32450	,	,	O	_	_
Rodrik-Outmezguine	32451	32469	NNP	Rodrik-Outmezguine	O	_	_
V	32470	32471	NNP	V	O	_	_
,	32471	32472	,	,	O	_	_
Grbovic-Huezo	32473	32486	NNP	Grbovic-Huezo	O	_	_
O	32487	32488	NNP	O	O	_	_
,	32488	32489	,	,	O	_	_
Serra	32490	32495	NNP	Serra	O	_	_
V	32496	32497	NNP	V	O	_	_
,	32497	32498	,	,	O	_	_
et	32499	32501	FW	et	O	_	_
al.	32502	32504	FW	al.	O	_	_
.	32504	32505	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	4	NP	1	0	2	2	NNP	0	0	1	1	Chandarlapaty	0	0	1	0	NNP	0	1	2	1	S	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	20	11	NP	1	3	5	2	NNP	0	3	4	1	Sawai	3	3	4	0	NNP	0	4	5	1	A	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Scaltriti	6	6	7	0	NNP	0	7	8	1	M	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Rodrik-Outmezguine	9	9	10	0	NNP	0	10	11	1	V	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Grbovic-Huezo	12	12	13	0	NNP	0	13	14	1	O	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Serra	15	15	16	0	NNP	0	16	17	1	V	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	36
AKT	32506	32509	NNP	AKT	O	_	_
ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	32510	32546	NNP	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	O	_	_
MEK	32548	32551	NN	mek	B-GENE	_	_
inhibition	32552	32562	NN	inhibition	O	_	_
leads	32563	32568	VBZ	lead	O	_	_
to	32569	32571	TO	to	O	_	_
PI3K	32572	32576	NN	pi3k	B-GENE	_	_
/	32576	32577	:	/	B-GENE	_	_
AKT	32577	32580	NN	akt	I-GENE	_	_
activation	32581	32591	NN	activation	O	_	_
by	32592	32594	IN	by	O	_	_
relieving	32595	32604	VBG	relieve	O	_	_
a	32605	32606	DT	a	O	_	_
negative	32607	32615	JJ	negative	O	_	_
feedback	32616	32624	NN	feedback	O	_	_
on	32625	32627	IN	on	O	_	_
ERBB	32628	32632	NN	erbb	O	_	_
receptors	32633	32642	NNS	receptor	O	_	_
12	32643	32645	CD	12	O	_	_
/	32645	32646	:	/	O	_	_
8/14	32646	32650	CD	8/14	O	_	_
,	32650	32651	,	,	O	_	_
6:54	32652	32656	CD	6:54	O	_	_
PM	32657	32659	NNP	PM	O	_	_
Ôøºinhibition	32660	32673	NNP	Ôøºinhibition	O	_	_
relieves	32674	32682	VBZ	relieve	O	_	_
feedback	32683	32691	NN	feedback	O	_	_
suppression	32692	32703	NN	suppression	O	_	_
of	32704	32706	IN	of	O	_	_
receptor	32707	32715	NN	receptor	B-GENE	_	_
tyrosine	32716	32724	NN	tyrosine	I-GENE	_	_
kinase	32725	32731	NN	kinase	I-GENE	_	_
expression	32732	32742	NN	expression	O	_	_
and	32743	32746	CC	and	O	_	_
activity	32747	32755	NN	activity	O	_	_
.	32755	32756	.	.	O	_	_
D	1
9
1	0	nn
1	3	dep
3	2	nn
4	1	nsubj
4	6	prep_to
9	4	dep
9	7	punct
9	8	nn
9	11	prepc_by
11	14	dobj
11	17	prep_on
14	12	det
14	13	amod
17	16	nn
17	25	rcmod
18	20	dep
20	19	punct
20	22	amod
24	23	nn
25	18	dobj
25	24	nsubj
25	27	dobj
27	26	nn
27	32	prep_of
27	34	prep_of
32	29	nn
32	30	nn
32	31	nn
32	34	conj_and
EOX
Y	1
ROOT	0	0	36	1	FRAG	2	0	36	4	S	1	0	7	2	NP	0	0	4	2	NP	1	0	2	2	NNP	0	0	1	1	AKT	0	0	1	0	NNP	0	1	2	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	1	1	2	0	NP	1	2	4	2	NN	0	2	3	1	MEK	2	2	3	0	NN	0	3	4	1	inhibition	3	3	4	0	VP	0	4	7	2	VBZ	0	4	5	1	leads	4	4	5	0	PP	0	5	7	2	TO	0	5	6	1	to	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	PI3K	6	6	7	0	:	0	7	8	1	/	7	7	8	0	FRAG	0	8	35	2	NP	1	8	10	2	NN	0	8	9	1	AKT	8	8	9	0	NN	0	9	10	1	activation	9	9	10	0	PP	0	10	35	2	IN	0	10	11	1	by	10	10	11	0	S	0	11	35	1	VP	0	11	35	3	VBG	0	11	12	1	relieving	11	11	12	0	NP	2	12	15	3	DT	0	12	13	1	a	12	12	13	0	JJ	0	13	14	1	negative	13	13	14	0	NN	0	14	15	1	feedback	14	14	15	0	PP	0	15	35	2	IN	0	15	16	1	on	15	15	16	0	NP	0	16	35	2	NP	1	16	18	2	NN	0	16	17	1	ERBB	16	16	17	0	NNS	0	17	18	1	receptors	17	17	18	0	SBAR	1	18	35	2	WHNP	0	18	23	2	NP	0	18	19	1	CD	0	18	19	1	12	18	18	19	0	PRN	1	19	23	2	:	0	19	20	1	/	19	19	20	0	NP	0	20	23	3	NP	0	20	21	1	CD	0	20	21	1	8/14	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	0	22	23	1	CD	0	22	23	1	6:54	22	22	23	0	S	1	23	35	2	NP	1	23	25	2	NNP	0	23	24	1	PM	23	23	24	0	NNP	0	24	25	1	Ôøºinhibition	24	24	25	0	VP	0	25	35	2	VBZ	0	25	26	1	relieves	25	25	26	0	NP	0	26	35	2	NP	1	26	28	2	NN	0	26	27	1	feedback	26	26	27	0	NN	0	27	28	1	suppression	27	27	28	0	PP	0	28	35	2	IN	0	28	29	1	of	28	28	29	0	NP	0	29	35	3	NP	3	29	33	4	NN	0	29	30	1	receptor	29	29	30	0	NN	0	30	31	1	tyrosine	30	30	31	0	NN	0	31	32	1	kinase	31	31	32	0	NN	0	32	33	1	expression	32	32	33	0	CC	0	33	34	1	and	33	33	34	0	NP	0	34	35	1	NN	0	34	35	1	activity	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	3
Cancer	32757	32763	NN	cancer	O	_	_
Cell	32764	32768	NN	cell	O	_	_
.	32768	32769	.	.	O	_	_
D	1
0
0	1	dep
EOX
Y	1
ROOT	0	0	3	1	NP	0	0	3	3	NP	0	0	1	1	NN	0	0	1	1	Cancer	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	Cell	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	6
2011	32770	32774	CD	2011	O	_	_
;	32774	32775	:	;	O	_	_
19:58	32775	32780	CD	19:58	O	_	_
‚	32780	32781	CD	‚	O	_	_
Äì71	32781	32785	NN	äì71	O	_	_
.	32785	32786	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2011	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	19:58	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì71	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
8	32787	32788	CD	8	O	_	_
.	32788	32789	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	8	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	15
Chakrabarty	32790	32801	NNP	Chakrabarty	O	_	_
A	32802	32803	NNP	A	O	_	_
,	32803	32804	,	,	O	_	_
Sanchez	32805	32812	NNP	Sanchez	O	_	_
V	32813	32814	NNP	V	O	_	_
,	32814	32815	,	,	O	_	_
Kuba	32816	32820	NNP	Kuba	O	_	_
MG	32821	32823	NN	mg	O	_	_
,	32823	32824	,	,	O	_	_
Rinehart	32825	32833	NNP	Rinehart	O	_	_
C	32834	32835	NNP	C	O	_	_
,	32835	32836	,	,	O	_	_
Arteaga	32837	32844	NNP	Arteaga	O	_	_
CL	32845	32847	NN	cl	O	_	_
.	32847	32848	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
1	7	appos
1	10	appos
1	13	appos
4	3	nn
7	6	nn
10	9	nn
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	NP	0	0	15	10	NP	1	0	2	2	NNP	0	0	1	1	Chakrabarty	0	0	1	0	NNP	0	1	2	1	A	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Sanchez	3	3	4	0	NNP	0	4	5	1	V	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Kuba	6	6	7	0	NN	0	7	8	1	MG	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Rinehart	9	9	10	0	NNP	0	10	11	1	C	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Arteaga	12	12	13	0	NN	0	13	14	1	CL	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	22
Breast	32849	32855	NN	breast	O	_	_
Cancer	32856	32862	NN	cancer	O	_	_
Special	32863	32870	JJ	special	O	_	_
Feature	32871	32878	NN	feature	O	_	_
:	32878	32879	:	:	O	_	_
Feedback	32880	32888	NN	feedback	O	_	_
upregulation	32889	32901	NN	upregulation	O	_	_
of	32902	32904	IN	of	O	_	_
HER3	32905	32909	NN	her3	B-GENE	_	_
(	32910	32911	CD	(	B-GENE	_	_
ErbB3	32911	32916	NN	erbb3	I-GENE	_	_
)	32916	32917	NN	)	O	_	_
expression	32918	32928	NN	expression	O	_	_
and	32929	32932	CC	and	O	_	_
activity	32933	32941	NN	activity	O	_	_
attenuates	32942	32952	VBZ	attenuate	O	_	_
antitumor	32953	32962	JJ	antitumor	O	_	_
effect	32963	32969	NN	effect	O	_	_
of	32970	32972	IN	of	O	_	_
PI3K	32973	32977	NN	pi3k	B-GENE	_	_
inhibitors	32978	32988	NNS	inhibitor	O	_	_
.	32988	32989	.	.	O	_	_
D	1
15
1	0	nn
1	3	dep
1	6	conj_and
1	14	conj_and
3	2	amod
6	5	nn
6	12	prep_of
12	8	nn
12	9	num
12	10	nn
12	11	nn
15	1	nsubj
15	6	nsubj
15	14	nsubj
15	17	dobj
17	16	amod
17	20	prep_of
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	15	5	NP	0	0	4	2	NP	1	0	2	2	NN	0	0	1	1	Breast	0	0	1	0	NN	0	1	2	1	Cancer	1	1	2	0	NP	1	2	4	2	JJ	0	2	3	1	Special	2	2	3	0	NN	0	3	4	1	Feature	3	3	4	0	:	0	4	5	1	:	4	4	5	0	NP	0	5	13	2	NP	1	5	7	2	NN	0	5	6	1	Feedback	5	5	6	0	NN	0	6	7	1	upregulation	6	6	7	0	PP	0	7	13	2	IN	0	7	8	1	of	7	7	8	0	NP	4	8	13	5	NN	0	8	9	1	HER3	8	8	9	0	CD	0	9	10	1	(	9	9	10	0	NN	0	10	11	1	ErbB3	10	10	11	0	NN	0	11	12	1	)	11	11	12	0	NN	0	12	13	1	expression	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	activity	14	14	15	0	VP	0	15	21	2	VBZ	0	15	16	1	attenuates	15	15	16	0	NP	0	16	21	2	NP	1	16	18	2	JJ	0	16	17	1	antitumor	16	16	17	0	NN	0	17	18	1	effect	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	of	18	18	19	0	NP	1	19	21	2	NN	0	19	20	1	PI3K	19	19	20	0	NNS	0	20	21	1	inhibitors	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	14
Proceedings	32990	33001	NNP	Proceedings	O	_	_
of	33002	33004	IN	of	O	_	_
the	33005	33008	DT	the	O	_	_
National	33009	33017	NNP	National	O	_	_
Academy	33018	33025	NNP	Academy	O	_	_
of	33026	33028	IN	of	O	_	_
Sciences	33029	33037	NNPS	Sciences	O	_	_
of	33038	33040	IN	of	O	_	_
the	33041	33044	DT	the	O	_	_
United	33045	33051	NNP	United	O	_	_
States	33052	33058	NNPS	States	O	_	_
of	33059	33061	IN	of	O	_	_
America	33062	33069	NNP	America	O	_	_
.	33069	33070	.	.	O	_	_
D	1
0
0	4	prep_of
0	10	prep_of
0	12	prep_of
4	2	det
4	3	nn
4	6	prep_of
10	8	det
10	9	nn
EOX
Y	1
ROOT	0	0	14	1	NP	0	0	14	5	NP	0	0	1	1	NNP	0	0	1	1	Proceedings	0	0	1	0	PP	0	1	7	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	7	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	NNP	0	3	4	1	National	3	3	4	0	NNP	0	4	5	1	Academy	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NNPS	0	6	7	1	Sciences	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NNP	0	9	10	1	United	9	9	10	0	NNPS	0	10	11	1	States	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	13	1	NNP	0	12	13	1	America	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	3
2011	33071	33075	CD	2011	O	_	_
9	33076	33077	CD	9	O	_	_
.	33077	33078	.	.	O	_	_
D	1
1
1	0	num
EOX
Y	1
ROOT	0	0	3	1	FRAG	0	0	3	2	NP	1	0	2	2	CD	0	0	1	1	2011	0	0	1	0	CD	0	1	2	1	9	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	21
Serra	33079	33084	NNP	Serra	O	_	_
V	33085	33086	NNP	V	O	_	_
,	33086	33087	,	,	O	_	_
Scaltriti	33088	33097	NNP	Scaltriti	O	_	_
M	33098	33099	NNP	M	O	_	_
,	33099	33100	,	,	O	_	_
Prudkin	33101	33108	NNP	Prudkin	B-GENE	_	_
L	33109	33110	NNP	L	I-GENE	_	_
,	33110	33111	,	,	O	_	_
Eichhorn	33112	33120	NNP	Eichhorn	O	_	_
PJ	33121	33123	NNP	PJ	O	_	_
,	33123	33124	,	,	O	_	_
Ibrahim	33125	33132	NNP	Ibrahim	O	_	_
YH	33133	33135	NNP	YH	O	_	_
,	33135	33136	,	,	O	_	_
Chandarlapaty	33137	33150	NNP	Chandarlapaty	O	_	_
S	33151	33152	NN	s	O	_	_
,	33152	33153	,	,	O	_	_
et	33154	33156	FW	et	O	_	_
al.	33157	33159	FW	al.	O	_	_
.	33159	33160	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	4	NP	1	0	2	2	NNP	0	0	1	1	Serra	0	0	1	0	NNP	0	1	2	1	V	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	20	11	NP	1	3	5	2	NNP	0	3	4	1	Scaltriti	3	3	4	0	NNP	0	4	5	1	M	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Prudkin	6	6	7	0	NNP	0	7	8	1	L	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Eichhorn	9	9	10	0	NNP	0	10	11	1	PJ	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Ibrahim	12	12	13	0	NNP	0	13	14	1	YH	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Chandarlapaty	15	15	16	0	NN	0	16	17	1	S	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	17
PI3K	33161	33165	NN	pi3k	O	_	_
inhibition	33166	33176	NN	inhibition	O	_	_
results	33177	33184	VBZ	result	O	_	_
in	33185	33187	IN	in	O	_	_
enhanced	33188	33196	VBN	enhance	O	_	_
HER	33197	33200	NN	her	B-GENE	_	_
signaling	33201	33210	NN	signaling	O	_	_
and	33211	33214	CC	and	O	_	_
acquired	33215	33223	VBD	acquire	O	_	_
ERK	33224	33227	NN	erk	B-GENE	_	_
dependency	33228	33238	NN	dependency	O	_	_
in	33239	33241	IN	in	O	_	_
HER2	33242	33246	NN	her2	O	_	_
overexpressing	33247	33261	VBG	overexpress	O	_	_
breast	33262	33268	NN	breast	O	_	_
cancer	33269	33275	NN	cancer	O	_	_
.	33275	33276	.	.	O	_	_
D	1
2
1	0	nn
2	1	nsubj
2	6	prep_in
2	8	conj_and
6	4	amod
6	5	nn
8	1	nsubj
8	10	dobj
8	12	prep_in
10	9	nn
12	13	vmod
13	15	dobj
15	14	nn
EOX
Y	1
ROOT	0	0	17	1	S	1	0	17	3	NP	1	0	2	2	NN	0	0	1	1	PI3K	0	0	1	0	NN	0	1	2	1	inhibition	1	1	2	0	VP	0	2	16	3	VP	0	2	7	2	VBZ	0	2	3	1	results	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	in	3	3	4	0	NP	2	4	7	3	VBN	0	4	5	1	enhanced	4	4	5	0	NN	0	5	6	1	HER	5	5	6	0	NN	0	6	7	1	signaling	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	VP	0	8	16	3	VBD	0	8	9	1	acquired	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	ERK	9	9	10	0	NN	0	10	11	1	dependency	10	10	11	0	PP	0	11	16	2	IN	0	11	12	1	in	11	11	12	0	NP	0	12	16	2	NP	0	12	13	1	NN	0	12	13	1	HER2	12	12	13	0	VP	0	13	16	2	VBG	0	13	14	1	overexpressing	13	13	14	0	NP	1	14	16	2	NN	0	14	15	1	breast	14	14	15	0	NN	0	15	16	1	cancer	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	2
Oncogene	33277	33285	NN	oncogene	O	_	_
.	33285	33286	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	NP	0	0	2	2	NN	0	0	1	1	Oncogene	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	6
2011	33287	33291	CD	2011	O	_	_
;	33291	33292	:	;	O	_	_
30:2547	33292	33299	CD	30:2547	O	_	_
‚	33299	33300	CD	‚	O	_	_
Äì2557	33300	33306	NN	äì2557	O	_	_
.	33306	33307	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2011	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	30:2547	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì2557	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
10	33308	33310	CD	10	O	_	_
.	33310	33311	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	10	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	15
Engelman	33312	33320	NNP	Engelman	O	_	_
JA	33321	33323	NNP	JA	O	_	_
,	33323	33324	,	,	O	_	_
Settleman	33325	33334	NNP	Settleman	O	_	_
J.	33335	33337	NNP	J.	O	_	_
Acquired	33338	33346	VBD	acquire	O	_	_
resistance	33347	33357	NN	resistance	O	_	_
to	33358	33360	TO	to	O	_	_
tyrosine	33361	33369	NN	tyrosine	B-GENE	_	_
kinase	33370	33376	NN	kinase	I-GENE	_	_
inhibitors	33377	33387	NNS	inhibitor	O	_	_
during	33388	33394	IN	during	O	_	_
cancer	33395	33401	NN	cancer	O	_	_
therapy	33402	33409	NN	therapy	O	_	_
.	33409	33410	.	.	O	_	_
D	1
5
1	0	nn
4	3	nn
5	1	nsubj
5	4	nsubj
5	6	dobj
5	10	prep_to
5	13	prep_during
10	8	nn
10	9	nn
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	3	0	15	5	NP	1	0	2	2	NNP	0	0	1	1	Engelman	0	0	1	0	NNP	0	1	2	1	JA	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Settleman	3	3	4	0	NNP	0	4	5	1	J.	4	4	5	0	VP	0	5	14	4	VBD	0	5	6	1	Acquired	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	resistance	6	6	7	0	PP	0	7	11	2	TO	0	7	8	1	to	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	tyrosine	8	8	9	0	NN	0	9	10	1	kinase	9	9	10	0	NNS	0	10	11	1	inhibitors	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	during	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	cancer	12	12	13	0	NN	0	13	14	1	therapy	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	5
Curr	33411	33415	NNP	Curr	O	_	_
Opin	33416	33420	NNP	Opin	O	_	_
Genet	33421	33426	NNP	Genet	O	_	_
Dev	33427	33430	NNP	Dev	O	_	_
.	33430	33431	.	.	O	_	_
D	1
3
3	0	nn
3	1	nn
3	2	nn
EOX
Y	1
ROOT	0	0	5	1	NP	3	0	5	5	NNP	0	0	1	1	Curr	0	0	1	0	NNP	0	1	2	1	Opin	1	1	2	0	NNP	0	2	3	1	Genet	2	2	3	0	NNP	0	3	4	1	Dev	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	6
2008	33432	33436	CD	2008	O	_	_
;	33436	33437	:	;	O	_	_
18:73	33437	33442	CD	18:73	O	_	_
‚	33442	33443	CD	‚	O	_	_
Äì79	33443	33447	NN	äì79	O	_	_
.	33447	33448	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2008	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	18:73	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì79	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
11	33449	33451	CD	11	O	_	_
.	33451	33452	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	11	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Faber	33453	33458	NNP	Faber	O	_	_
AC	33459	33461	NN	ac	O	_	_
,	33461	33462	,	,	O	_	_
Li	33463	33465	NNP	Li	O	_	_
D	33466	33467	NNP	D	O	_	_
,	33467	33468	,	,	O	_	_
Song	33469	33473	NN	song	O	_	_
Y	33474	33475	NN	y	O	_	_
,	33475	33476	,	,	O	_	_
Liang	33477	33482	NNP	Liang	O	_	_
MC	33483	33485	NNP	MC	O	_	_
,	33485	33486	,	,	O	_	_
Yeap	33487	33491	NNP	Yeap	O	_	_
BY	33492	33494	NNP	BY	O	_	_
,	33494	33495	,	,	O	_	_
Bronson	33496	33503	NNP	Bronson	O	_	_
RT	33504	33506	NN	rt	O	_	_
,	33506	33507	,	,	O	_	_
et	33508	33510	FW	et	O	_	_
al.	33511	33513	FW	al.	O	_	_
.	33513	33514	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	4	NP	1	0	2	2	NNP	0	0	1	1	Faber	0	0	1	0	NN	0	1	2	1	AC	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	20	11	NP	1	3	5	2	NNP	0	3	4	1	Li	3	3	4	0	NNP	0	4	5	1	D	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	Song	6	6	7	0	NN	0	7	8	1	Y	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Liang	9	9	10	0	NNP	0	10	11	1	MC	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Yeap	12	12	13	0	NNP	0	13	14	1	BY	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Bronson	15	15	16	0	NN	0	16	17	1	RT	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	14
Differential	33515	33527	JJ	differential	O	_	_
induction	33528	33537	NN	induction	O	_	_
of	33538	33540	IN	of	O	_	_
apoptosis	33541	33550	NN	apoptosis	O	_	_
in	33551	33553	IN	in	O	_	_
HER2	33554	33558	NN	her2	B-GENE	_	_
and	33559	33562	CC	and	O	_	_
EGFR	33563	33567	NN	egfr	B-GENE	_	_
addicted	33568	33576	VBD	addict	O	_	_
cancers	33577	33584	NNS	cancer	O	_	_
following	33585	33594	VBG	follow	O	_	_
PI3K	33595	33599	NN	pi3k	O	_	_
inhibition	33600	33610	NN	inhibition	O	_	_
.	33610	33611	.	.	O	_	_
D	1
8
1	0	amod
1	3	prep_of
3	5	prep_in
3	7	prep_in
5	7	conj_and
8	1	nsubj
8	9	dobj
9	12	prep_following
12	11	nn
EOX
Y	1
ROOT	0	0	14	1	S	1	0	14	3	NP	0	0	8	2	NP	1	0	2	2	JJ	0	0	1	1	Differential	0	0	1	0	NN	0	1	2	1	induction	1	1	2	0	PP	0	2	8	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	8	2	NP	0	3	4	1	NN	0	3	4	1	apoptosis	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	in	4	4	5	0	NP	0	5	8	3	NN	0	5	6	1	HER2	5	5	6	0	CC	0	6	7	1	and	6	6	7	0	NN	0	7	8	1	EGFR	7	7	8	0	VP	0	8	13	2	VBD	0	8	9	1	addicted	8	8	9	0	NP	0	9	13	2	NP	0	9	10	1	NNS	0	9	10	1	cancers	9	9	10	0	PP	0	10	13	2	VBG	0	10	11	1	following	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	PI3K	11	11	12	0	NN	0	12	13	1	inhibition	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	14
Proceedings	33612	33623	NNP	Proceedings	O	_	_
of	33624	33626	IN	of	O	_	_
the	33627	33630	DT	the	O	_	_
National	33631	33639	NNP	National	O	_	_
Academy	33640	33647	NNP	Academy	O	_	_
of	33648	33650	IN	of	O	_	_
Sciences	33651	33659	NNPS	Sciences	O	_	_
of	33660	33662	IN	of	O	_	_
the	33663	33666	DT	the	O	_	_
United	33667	33673	NNP	United	O	_	_
States	33674	33680	NNPS	States	O	_	_
of	33681	33683	IN	of	O	_	_
America	33684	33691	NNP	America	O	_	_
.	33691	33692	.	.	O	_	_
D	1
0
0	4	prep_of
0	10	prep_of
0	12	prep_of
4	2	det
4	3	nn
4	6	prep_of
10	8	det
10	9	nn
EOX
Y	1
ROOT	0	0	14	1	NP	0	0	14	5	NP	0	0	1	1	NNP	0	0	1	1	Proceedings	0	0	1	0	PP	0	1	7	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	7	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	NNP	0	3	4	1	National	3	3	4	0	NNP	0	4	5	1	Academy	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NNPS	0	6	7	1	Sciences	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NNP	0	9	10	1	United	9	9	10	0	NNPS	0	10	11	1	States	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	13	1	NNP	0	12	13	1	America	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	6
2009	33693	33697	CD	2009	O	_	_
;	33697	33698	:	;	O	_	_
106:19503	33698	33707	CD	106:19503	O	_	_
‚	33707	33708	CD	‚	O	_	_
Äì19508	33708	33715	NN	äì19508	O	_	_
.	33715	33716	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2009	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	106:19503	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì19508	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
12	33717	33719	CD	12	O	_	_
.	33719	33720	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	12	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Ono	33721	33724	NNP	Ono	O	_	_
M	33725	33726	NNP	M	O	_	_
,	33726	33727	,	,	O	_	_
Hirata	33728	33734	NNP	Hirata	O	_	_
A	33735	33736	NNP	A	O	_	_
,	33736	33737	,	,	O	_	_
Kometani	33738	33746	NNP	Kometani	O	_	_
T	33747	33748	NN	t	O	_	_
,	33748	33749	,	,	O	_	_
Miyagawa	33750	33758	NNP	Miyagawa	O	_	_
M	33759	33760	NNP	M	O	_	_
,	33760	33761	,	,	O	_	_
Ueda	33762	33766	NNP	Ueda	O	_	_
S	33767	33768	NN	s	O	_	_
,	33768	33769	,	,	O	_	_
Kinoshita	33770	33779	NN	kinoshita	O	_	_
H	33780	33781	NN	h	O	_	_
,	33781	33782	,	,	O	_	_
et	33783	33785	FW	et	O	_	_
al.	33786	33788	FW	al.	O	_	_
.	33788	33789	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	4	NP	1	0	2	2	NNP	0	0	1	1	Ono	0	0	1	0	NNP	0	1	2	1	M	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	20	11	NP	1	3	5	2	NNP	0	3	4	1	Hirata	3	3	4	0	NNP	0	4	5	1	A	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Kometani	6	6	7	0	NN	0	7	8	1	T	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Miyagawa	9	9	10	0	NNP	0	10	11	1	M	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Ueda	12	12	13	0	NN	0	13	14	1	S	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NN	0	15	16	1	Kinoshita	15	15	16	0	NN	0	16	17	1	H	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	45
Sensitivity	33790	33801	NN	sensitivity	O	_	_
to	33802	33804	TO	to	O	_	_
gefitinib	33805	33814	VB	gefitinib	O	_	_
(	33815	33816	CD	(	O	_	_
Iressa	33816	33822	NNP	Iressa	O	_	_
,	33822	33823	,	,	O	_	_
ZD1839	33824	33830	NN	zd1839	O	_	_
)	33830	33831	NN	)	O	_	_
in	33832	33834	IN	in	O	_	_
non	33835	33838	JJ	non	O	_	_
small	33839	33844	JJ	small	O	_	_
cell	33845	33849	NN	cell	O	_	_
lung	33850	33854	NN	lung	O	_	_
cancer	33855	33861	NN	cancer	O	_	_
cell	33862	33866	NN	cell	O	_	_
lines	33867	33872	NNS	line	O	_	_
correlates	33873	33883	VBZ	correlate	O	_	_
with	33884	33888	IN	with	O	_	_
dependence	33889	33899	NN	dependence	O	_	_
on	33900	33902	IN	on	O	_	_
the	33903	33906	DT	the	O	_	_
epidermal	33907	33916	JJ	epidermal	B-GENE	_	_
growth	33917	33923	NN	growth	I-GENE	_	_
factor	33924	33930	NN	factor	I-GENE	_	_
(	33931	33932	CD	(	I-GENE	_	_
EGF	33932	33935	NN	egf	I-GENE	_	_
)	33935	33936	NN	)	I-GENE	_	_
receptor	33937	33945	NN	receptor	I-GENE	_	_
/	33945	33946	:	/	I-GENE	_	_
extracellular	33946	33959	JJ	extracellular	I-GENE	_	_
signal	33960	33966	NN	signal	I-GENE	_	_
regulated	33967	33976	VBN	regulate	I-GENE	_	_
kinase	33977	33983	NN	kinase	I-GENE	_	_
1	33984	33985	CD	1	I-GENE	_	_
/	33985	33986	:	/	I-GENE	_	_
2	33986	33987	CD	2	I-GENE	_	_
and	33988	33991	CC	and	O	_	_
EGF	33992	33995	NN	egf	B-GENE	_	_
receptor	33996	34004	NN	receptor	I-GENE	_	_
/	34004	34005	:	/	B-GENE	_	_
Akt	34005	34008	NN	akt	I-GENE	_	_
pathway	34009	34016	NN	pathway	O	_	_
for	34017	34020	IN	for	O	_	_
proliferation	34021	34034	NN	proliferation	O	_	_
.	34034	34035	.	.	O	_	_
D	1
0
0	2	vmod
0	28	punct
0	31	dep
2	1	aux
2	16	xcomp
6	3	num
6	4	nn
7	15	prep_in
15	9	amod
15	10	amod
15	11	nn
15	12	nn
15	13	nn
15	14	nn
16	6	nsubj
16	7	dep
16	18	prep_with
16	23	prep_on
16	27	nsubj
23	20	det
23	21	amod
23	22	nn
27	24	num
27	25	nn
27	26	nn
30	29	amod
31	30	nsubj
31	41	xcomp
32	33	num
32	35	dep
32	38	dep
35	34	punct
35	38	conj_and
35	39	punct
38	37	nn
41	32	nsubj
41	40	nn
41	43	prep_for
EOX
Y	1
ROOT	0	0	45	1	FRAG	0	0	45	4	NP	0	0	28	2	NP	0	0	1	1	NN	0	0	1	1	Sensitivity	0	0	1	0	SBAR	0	1	28	1	S	0	1	28	1	VP	1	1	28	2	TO	0	1	2	1	to	1	1	2	0	VP	0	2	28	2	VB	0	2	3	1	gefitinib	2	2	3	0	S	2	3	28	3	NP	3	3	7	4	CD	0	3	4	1	(	3	3	4	0	NNP	0	4	5	1	Iressa	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NN	0	6	7	1	ZD1839	6	6	7	0	ADJP	0	7	16	2	NN	0	7	8	1	)	7	7	8	0	PP	0	8	16	2	IN	0	8	9	1	in	8	8	9	0	NP	6	9	16	7	JJ	0	9	10	1	non	9	9	10	0	JJ	0	10	11	1	small	10	10	11	0	NN	0	11	12	1	cell	11	11	12	0	NN	0	12	13	1	lung	12	12	13	0	NN	0	13	14	1	cancer	13	13	14	0	NN	0	14	15	1	cell	14	14	15	0	NNS	0	15	16	1	lines	15	15	16	0	SBAR	0	16	28	1	SINV	0	16	28	2	VP	0	16	24	3	VBZ	0	16	17	1	correlates	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	with	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	dependence	18	18	19	0	PP	0	19	24	2	IN	0	19	20	1	on	19	19	20	0	NP	3	20	24	4	DT	0	20	21	1	the	20	20	21	0	JJ	0	21	22	1	epidermal	21	21	22	0	NN	0	22	23	1	growth	22	22	23	0	NN	0	23	24	1	factor	23	23	24	0	NP	3	24	28	4	CD	0	24	25	1	(	24	24	25	0	NN	0	25	26	1	EGF	25	25	26	0	NN	0	26	27	1	)	26	26	27	0	NN	0	27	28	1	receptor	27	27	28	0	:	0	28	29	1	/	28	28	29	0	S	1	29	44	2	NP	1	29	31	2	JJ	0	29	30	1	extracellular	29	29	30	0	NN	0	30	31	1	signal	30	30	31	0	VP	0	31	44	2	VBN	0	31	32	1	regulated	31	31	32	0	S	1	32	44	2	NP	0	32	40	2	NP	0	32	34	2	NN	0	32	33	1	kinase	32	32	33	0	CD	0	33	34	1	1	33	33	34	0	PRN	1	34	40	3	:	0	34	35	1	/	34	34	35	0	NP	0	35	39	3	NP	0	35	36	1	CD	0	35	36	1	2	35	35	36	0	CC	0	36	37	1	and	36	36	37	0	NP	1	37	39	2	NN	0	37	38	1	EGF	37	37	38	0	NN	0	38	39	1	receptor	38	38	39	0	:	0	39	40	1	/	39	39	40	0	NP	0	40	44	2	NP	1	40	42	2	NN	0	40	41	1	Akt	40	40	41	0	NN	0	41	42	1	pathway	41	41	42	0	PP	0	42	44	2	IN	0	42	43	1	for	42	42	43	0	NP	0	43	44	1	NN	0	43	44	1	proliferation	43	43	44	0	.	0	44	45	1	.	44	44	45	0
EOS
T	4
Mol	34036	34039	NNP	Mol	O	_	_
Cancer	34040	34046	NNP	Cancer	O	_	_
Ther	34047	34051	NNP	Ther	O	_	_
.	34051	34052	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
EOX
Y	1
ROOT	0	0	4	1	NP	2	0	4	4	NNP	0	0	1	1	Mol	0	0	1	0	NNP	0	1	2	1	Cancer	1	1	2	0	NNP	0	2	3	1	Ther	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	6
2004	34053	34057	CD	2004	O	_	_
;	34057	34058	:	;	O	_	_
3:465	34058	34063	CD	3:465	O	_	_
‚	34063	34064	CD	‚	O	_	_
Äì472	34064	34069	NN	äì472	O	_	_
.	34069	34070	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2004	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	3:465	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì472	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
13	34071	34073	CD	13	O	_	_
.	34073	34074	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	13	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Hoeflich	34075	34083	NNP	Hoeflich	O	_	_
KP	34084	34086	NNP	KP	O	_	_
,	34086	34087	,	,	O	_	_
O'Brien	34088	34095	NNP	O'Brien	O	_	_
C	34096	34097	NNP	C	O	_	_
,	34097	34098	,	,	O	_	_
Boyd	34099	34103	NNP	Boyd	O	_	_
Z	34104	34105	NNP	Z	O	_	_
,	34105	34106	,	,	O	_	_
Cavet	34107	34112	NNP	Cavet	O	_	_
G	34113	34114	NNP	G	O	_	_
,	34114	34115	,	,	O	_	_
Guerrero	34116	34124	NNP	Guerrero	O	_	_
S	34125	34126	NNP	S	O	_	_
,	34126	34127	,	,	O	_	_
Jung	34128	34132	NNP	Jung	O	_	_
K	34133	34134	NNP	K	O	_	_
,	34134	34135	,	,	O	_	_
et	34136	34138	FW	et	O	_	_
al.	34139	34141	FW	al.	O	_	_
.	34141	34142	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	4	NP	1	0	2	2	NNP	0	0	1	1	Hoeflich	0	0	1	0	NNP	0	1	2	1	KP	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	20	11	NP	1	3	5	2	NNP	0	3	4	1	O'Brien	3	3	4	0	NNP	0	4	5	1	C	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Boyd	6	6	7	0	NNP	0	7	8	1	Z	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Cavet	9	9	10	0	NNP	0	10	11	1	G	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Guerrero	12	12	13	0	NNP	0	13	14	1	S	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Jung	15	15	16	0	NNP	0	16	17	1	K	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	17
In	34143	34145	FW	in	O	_	_
vivo	34146	34150	FW	vivo	O	_	_
antitumor	34151	34160	NN	antitumor	O	_	_
activity	34161	34169	NN	activity	O	_	_
of	34170	34172	IN	of	O	_	_
MEK	34173	34176	NN	mek	B-GENE	_	_
and	34177	34180	CC	and	O	_	_
phosphatidylinositol	34181	34201	NN	phosphatidylinositol	B-GENE	_	_
3-kinase	34202	34210	NN	3-kinase	I-GENE	_	_
inhibitors	34211	34221	NNS	inhibitor	O	_	_
in	34222	34224	IN	in	O	_	_
basal	34225	34230	JJ	basal	O	_	_
like	34231	34235	IN	like	O	_	_
breast	34236	34242	NN	breast	O	_	_
cancer	34243	34249	NN	cancer	O	_	_
models	34250	34256	NNS	model	O	_	_
.	34256	34257	.	.	O	_	_
D	1
3
3	0	nn
3	1	nn
3	2	nn
3	9	prep_of
3	15	prep_in
5	7	conj_and
9	5	nn
9	7	nn
9	8	nn
11	13	prep_like
15	11	amod
15	14	nn
EOX
Y	1
ROOT	0	0	17	1	NP	0	0	17	4	NP	3	0	4	4	FW	0	0	1	1	In	0	0	1	0	FW	0	1	2	1	vivo	1	1	2	0	NN	0	2	3	1	antitumor	2	2	3	0	NN	0	3	4	1	activity	3	3	4	0	PP	0	4	10	2	IN	0	4	5	1	of	4	4	5	0	NP	2	5	10	3	NP	0	5	8	3	NN	0	5	6	1	MEK	5	5	6	0	CC	0	6	7	1	and	6	6	7	0	NN	0	7	8	1	phosphatidylinositol	7	7	8	0	NN	0	8	9	1	3-kinase	8	8	9	0	NNS	0	9	10	1	inhibitors	9	9	10	0	PP	0	10	16	2	IN	0	10	11	1	in	10	10	11	0	NP	2	11	16	3	ADJP	0	11	14	2	JJ	0	11	12	1	basal	11	11	12	0	PP	0	12	14	2	IN	0	12	13	1	like	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	breast	13	13	14	0	NN	0	14	15	1	cancer	14	14	15	0	NNS	0	15	16	1	models	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	4
Clin	34258	34262	NNP	Clin	O	_	_
Cancer	34263	34269	NNP	Cancer	O	_	_
Res	34270	34273	NNP	Res	O	_	_
.	34273	34274	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
EOX
Y	1
ROOT	0	0	4	1	NP	2	0	4	4	NNP	0	0	1	1	Clin	0	0	1	0	NNP	0	1	2	1	Cancer	1	1	2	0	NNP	0	2	3	1	Res	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	7
2009	34275	34279	CD	2009	O	_	_
;	34279	34280	:	;	O	_	_
15:4649	34280	34287	CD	15:4649	O	_	_
‚	34287	34288	CD	‚	O	_	_
Äì	34288	34290	NN	äì	O	_	_
4664	34291	34295	CD	4664	O	_	_
.	34295	34296	.	.	O	_	_
D	1
0
0	3	dep
3	2	number
3	4	dep
4	5	num
EOX
Y	1
ROOT	0	0	7	1	NP	0	0	7	4	NP	0	0	1	1	CD	0	0	1	1	2009	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	0	2	6	2	NP	0	2	4	1	QP	1	2	4	2	CD	0	2	3	1	15:4649	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NP	0	4	6	2	NN	0	4	5	1	Äì	4	4	5	0	CD	0	5	6	1	4664	5	5	6	0	.	0	6	7	1	.	6	6	7	0
EOS
T	2
14	34297	34299	CD	14	O	_	_
.	34299	34300	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	14	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Mirzoeva	34301	34309	NNP	Mirzoeva	O	_	_
OK	34310	34312	UH	ok	O	_	_
,	34312	34313	,	,	O	_	_
Das	34314	34317	NN	da	O	_	_
D	34318	34319	NN	d	O	_	_
,	34319	34320	,	,	O	_	_
Heiser	34321	34327	NNP	Heiser	O	_	_
LM	34328	34330	NNP	LM	O	_	_
,	34330	34331	,	,	O	_	_
Bhattacharya	34332	34344	NNP	Bhattacharya	O	_	_
S	34345	34346	NN	s	O	_	_
,	34346	34347	,	,	O	_	_
Siwak	34348	34353	NN	siwak	O	_	_
D	34354	34355	NN	d	O	_	_
,	34355	34356	,	,	O	_	_
Gendelman	34357	34366	NN	gendelman	O	_	_
R	34367	34368	NN	r	O	_	_
,	34368	34369	,	,	O	_	_
et	34370	34372	FW	et	O	_	_
al.	34373	34375	FW	al.	O	_	_
.	34375	34376	.	.	O	_	_
D	1
0
0	1	rcmod
0	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	4	NP	0	0	2	2	NP	0	0	1	1	NNP	0	0	1	1	Mirzoeva	0	0	1	0	SBAR	0	1	2	1	S	0	1	2	1	VP	0	1	2	1	ADVP	0	1	2	1	UH	0	1	2	1	OK	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	20	11	NP	1	3	5	2	NN	0	3	4	1	Das	3	3	4	0	NN	0	4	5	1	D	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Heiser	6	6	7	0	NNP	0	7	8	1	LM	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Bhattacharya	9	9	10	0	NN	0	10	11	1	S	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	Siwak	12	12	13	0	NN	0	13	14	1	D	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NN	0	15	16	1	Gendelman	15	15	16	0	NN	0	16	17	1	R	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	25
Basal	34377	34382	JJ	basal	O	_	_
subtype	34383	34390	NN	subtype	O	_	_
and	34391	34394	CC	and	O	_	_
MAPK	34395	34399	NN	mapk	B-GENE	_	_
/	34399	34400	:	/	I-GENE	_	_
ERK	34400	34403	NN	erk	I-GENE	_	_
kinase	34404	34410	NN	kinase	I-GENE	_	_
(	34411	34412	CD	(	B-GENE	_	_
MEK	34412	34415	NN	mek	I-GENE	_	_
)	34415	34416	SYM	)	O	_	_
-	34416	34417	:	-	O	_	_
phosphoinositide	34417	34433	NN	phosphoinositide	O	_	_
3-kinase	34434	34442	NN	3-kinase	O	_	_
feedback	34443	34451	NN	feedback	O	_	_
signaling	34452	34461	NN	signaling	O	_	_
determine	34462	34471	VBP	determine	O	_	_
susceptibility	34472	34486	NN	susceptibility	O	_	_
of	34487	34489	IN	of	O	_	_
breast	34490	34496	NN	breast	O	_	_
cancer	34497	34503	NN	cancer	O	_	_
cells	34504	34509	NNS	cell	O	_	_
to	34510	34512	TO	to	O	_	_
MEK	34513	34516	NN	mek	B-GENE	_	_
inhibition	34517	34527	NN	inhibition	O	_	_
.	34527	34528	.	.	O	_	_
D	1
1
1	0	amod
1	3	conj_and
3	6	dep
3	12	dep
6	4	punct
6	5	nn
6	8	dep
8	7	num
12	9	dep
12	11	nn
12	15	rcmod
14	13	nn
15	14	nsubj
15	16	dobj
15	23	prep_to
16	20	prep_of
20	18	nn
20	19	nn
23	22	nn
EOX
Y	1
ROOT	0	0	25	1	S	0	0	25	1	NP	0	0	25	3	NP	1	0	2	2	JJ	0	0	1	1	Basal	0	0	1	0	NN	0	1	2	1	subtype	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NP	0	3	25	3	NP	0	3	4	1	NN	0	3	4	1	MAPK	3	3	4	0	PRN	1	4	9	2	:	0	4	5	1	/	4	4	5	0	NP	0	5	9	2	NP	1	5	7	2	NN	0	5	6	1	ERK	5	5	6	0	NN	0	6	7	1	kinase	6	6	7	0	NP	1	7	9	2	CD	0	7	8	1	(	7	7	8	0	NN	0	8	9	1	MEK	8	8	9	0	SBAR	0	9	25	1	FRAG	2	9	25	4	X	0	9	10	1	SYM	0	9	10	1	)	9	9	10	0	:	0	10	11	1	-	10	10	11	0	NP	0	11	24	2	NP	1	11	13	2	NN	0	11	12	1	phosphoinositide	11	11	12	0	NN	0	12	13	1	3-kinase	12	12	13	0	SBAR	0	13	24	1	S	1	13	24	2	NP	1	13	15	2	NN	0	13	14	1	feedback	13	13	14	0	NN	0	14	15	1	signaling	14	14	15	0	VP	0	15	24	3	VBP	0	15	16	1	determine	15	15	16	0	NP	0	16	21	2	NP	0	16	17	1	NN	0	16	17	1	susceptibility	16	16	17	0	PP	0	17	21	2	IN	0	17	18	1	of	17	17	18	0	NP	2	18	21	3	NN	0	18	19	1	breast	18	18	19	0	NN	0	19	20	1	cancer	19	19	20	0	NNS	0	20	21	1	cells	20	20	21	0	PP	0	21	24	2	TO	0	21	22	1	to	21	21	22	0	NP	1	22	24	2	NN	0	22	23	1	MEK	22	22	23	0	NN	0	23	24	1	inhibition	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	3
Cancer	34529	34535	NN	cancer	O	_	_
Res	34536	34539	NNP	Res	O	_	_
.	34539	34540	.	.	O	_	_
D	1
0
0	1	appos
EOX
Y	1
ROOT	0	0	3	1	NP	0	0	3	3	NP	0	0	1	1	NN	0	0	1	1	Cancer	0	0	1	0	NP	0	1	2	1	NNP	0	1	2	1	Res	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	6
2009	34541	34545	CD	2009	O	_	_
;	34545	34546	:	;	O	_	_
69:565	34546	34552	CD	69:565	O	_	_
‚	34552	34553	CD	‚	O	_	_
Äì572	34553	34558	NN	äì572	O	_	_
.	34558	34559	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2009	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	69:565	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì572	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
15	34560	34562	CD	15	O	_	_
.	34562	34563	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	15	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	22
Yoon	34564	34568	NNP	Yoon	O	_	_
YK	34569	34571	NNP	YK	O	_	_
,	34571	34572	,	,	O	_	_
Kim	34573	34576	NNP	Kim	B-GENE	_	_
HP	34577	34579	NNP	HP	I-GENE	_	_
,	34579	34580	,	,	O	_	_
Han	34581	34584	NNP	Han	B-GENE	_	_
SW	34585	34587	NNP	SW	I-GENE	_	_
,	34587	34588	,	,	O	_	_
Hur	34589	34592	NNP	Hur	B-GENE	_	_
HS	34593	34595	NN	h	I-GENE	_	_
,	34595	34596	,	,	O	_	_
Oh	34597	34599	UH	oh	O	_	_
do	34600	34602	VBP	do	O	_	_
Y	34603	34604	NN	y	O	_	_
,	34604	34605	,	,	O	_	_
Im	34606	34608	NN	im	O	_	_
SA	34609	34611	NNP	SA	O	_	_
,	34611	34612	,	,	O	_	_
et	34613	34615	FW	et	O	_	_
al.	34616	34618	FW	al.	O	_	_
.	34618	34619	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
1	7	appos
1	10	appos
1	13	dep
1	17	dep
4	3	nn
7	6	nn
10	9	nn
13	12	dep
13	14	nsubj
17	16	nn
17	20	appos
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	0	0	22	2	VP	0	0	21	1	NP	0	0	21	3	NP	0	0	11	7	NP	1	0	2	2	NNP	0	0	1	1	Yoon	0	0	1	0	NNP	0	1	2	1	YK	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Kim	3	3	4	0	NNP	0	4	5	1	HP	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Han	6	6	7	0	NNP	0	7	8	1	SW	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Hur	9	9	10	0	NN	0	10	11	1	HS	10	10	11	0	PRN	1	11	16	3	,	0	11	12	1	,	11	11	12	0	SINV	1	12	15	3	FRAG	0	12	13	1	INTJ	0	12	13	1	UH	0	12	13	1	Oh	12	12	13	0	VP	0	13	14	1	VBP	0	13	14	1	do	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	Y	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NP	0	16	21	3	NP	1	16	18	2	NN	0	16	17	1	Im	16	16	17	0	NNP	0	17	18	1	SA	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	1	19	21	2	FW	0	19	20	1	et	19	19	20	0	FW	0	20	21	1	al.	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	25
Combination	34620	34631	NN	combination	O	_	_
of	34632	34634	IN	of	O	_	_
EGFR	34635	34639	NN	egfr	B-GENE	_	_
and	34640	34643	CC	and	O	_	_
MEK1	34644	34648	NN	mek1	B-GENE	_	_
/	34648	34649	:	/	I-GENE	_	_
2	34649	34650	CD	2	I-GENE	_	_
inhibitor	34651	34660	NN	inhibitor	O	_	_
shows	34661	34666	VBZ	show	O	_	_
synergistic	34667	34678	JJ	synergistic	O	_	_
effects	34679	34686	NNS	effect	O	_	_
by	34687	34689	IN	by	O	_	_
suppressing	34690	34701	VBG	suppress	O	_	_
EGFR	34702	34706	NN	egfr	B-GENE	_	_
/	34706	34707	:	/	B-GENE	_	_
HER3	34707	34711	NN	her3	I-GENE	_	_
dependent	34712	34721	JJ	dependent	O	_	_
AKT	34722	34725	NN	akt	O	_	_
activation	34726	34736	NN	activation	O	_	_
in	34737	34739	IN	in	O	_	_
human	34740	34745	JJ	human	O	_	_
gastric	34746	34753	JJ	gastric	O	_	_
cancer	34754	34760	NN	cancer	O	_	_
cells	34761	34766	NNS	cell	O	_	_
.	34766	34767	.	.	O	_	_
D	1
0
0	2	prep_of
0	4	prep_of
0	5	punct
0	8	dep
2	4	conj_and
7	6	num
8	7	nsubj
8	10	dobj
8	13	prep_by
10	9	amod
13	12	amod
13	18	dep
18	14	punct
18	15	dep
18	16	amod
18	17	nn
18	23	prep_in
23	20	amod
23	21	amod
23	22	nn
EOX
Y	1
ROOT	0	0	25	1	FRAG	0	0	25	4	NP	0	0	5	2	NP	0	0	1	1	NN	0	0	1	1	Combination	0	0	1	0	PP	0	1	5	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	5	3	NN	0	2	3	1	EGFR	2	2	3	0	CC	0	3	4	1	and	3	3	4	0	NN	0	4	5	1	MEK1	4	4	5	0	:	0	5	6	1	/	5	5	6	0	S	1	6	24	2	NP	1	6	8	2	CD	0	6	7	1	2	6	6	7	0	NN	0	7	8	1	inhibitor	7	7	8	0	VP	0	8	24	3	VBZ	0	8	9	1	shows	8	8	9	0	NP	1	9	11	2	JJ	0	9	10	1	synergistic	9	9	10	0	NNS	0	10	11	1	effects	10	10	11	0	PP	0	11	24	2	IN	0	11	12	1	by	11	11	12	0	NP	0	12	24	2	NP	1	12	14	2	VBG	0	12	13	1	suppressing	12	12	13	0	NN	0	13	14	1	EGFR	13	13	14	0	PRN	1	14	24	2	:	0	14	15	1	/	14	14	15	0	S	1	15	24	2	NP	0	15	16	1	NN	0	15	16	1	HER3	15	15	16	0	NP	0	16	24	2	NP	2	16	19	3	JJ	0	16	17	1	dependent	16	16	17	0	NN	0	17	18	1	AKT	17	17	18	0	NN	0	18	19	1	activation	18	18	19	0	PP	0	19	24	2	IN	0	19	20	1	in	19	19	20	0	NP	3	20	24	4	JJ	0	20	21	1	human	20	20	21	0	JJ	0	21	22	1	gastric	21	21	22	0	NN	0	22	23	1	cancer	22	22	23	0	NNS	0	23	24	1	cells	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	4
Mol	34768	34771	NNP	Mol	O	_	_
Cancer	34772	34778	NNP	Cancer	O	_	_
Ther	34779	34783	NNP	Ther	O	_	_
.	34783	34784	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
EOX
Y	1
ROOT	0	0	4	1	NP	2	0	4	4	NNP	0	0	1	1	Mol	0	0	1	0	NNP	0	1	2	1	Cancer	1	1	2	0	NNP	0	2	3	1	Ther	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	6
2009	34785	34789	CD	2009	O	_	_
;	34789	34790	:	;	O	_	_
8:2526	34790	34796	CD	8:2526	O	_	_
‚	34796	34797	CD	‚	O	_	_
Äì2536	34797	34803	NN	äì2536	O	_	_
.	34803	34804	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2009	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	8:2526	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì2536	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
16	34805	34807	CD	16	O	_	_
.	34807	34808	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	16	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Lehr	34809	34813	NNP	Lehr	O	_	_
S	34814	34815	NN	s	O	_	_
,	34815	34816	,	,	O	_	_
Kotzka	34817	34823	FW	kotzka	O	_	_
J	34824	34825	NN	j	O	_	_
,	34825	34826	,	,	O	_	_
Avci	34827	34831	NNP	Avci	O	_	_
H	34832	34833	NNP	H	O	_	_
,	34833	34834	,	,	O	_	_
Sickmann	34835	34843	NNP	Sickmann	O	_	_
A	34844	34845	NNP	A	O	_	_
,	34845	34846	,	,	O	_	_
Meyer	34847	34852	NNP	Meyer	O	_	_
HE	34853	34855	PRP	he	O	_	_
,	34855	34856	,	,	O	_	_
Herkner	34857	34864	NNP	Herkner	O	_	_
A	34865	34866	NNP	A	O	_	_
,	34866	34867	,	,	O	_	_
et	34868	34870	FW	et	O	_	_
al.	34871	34873	FW	al.	O	_	_
.	34873	34874	.	.	O	_	_
D	1
0
0	1	nn
0	3	dep
0	4	dep
4	7	appos
4	10	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
16	12	nn
16	13	dep
16	15	dep
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	3	NP	0	0	4	4	NP	0	0	1	1	NNP	0	0	1	1	Lehr	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	S	1	1	2	0	,	0	2	3	1	,	2	2	3	0	FW	0	3	4	1	Kotzka	3	3	4	0	NP	0	4	20	9	NP	0	4	5	1	NN	0	4	5	1	J	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Avci	6	6	7	0	NNP	0	7	8	1	H	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Sickmann	9	9	10	0	NNP	0	10	11	1	A	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	4	12	17	5	NNP	0	12	13	1	Meyer	12	12	13	0	PRP	0	13	14	1	HE	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NNP	0	15	16	1	Herkner	15	15	16	0	NNP	0	16	17	1	A	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	10
Identification	34875	34889	NN	identification	O	_	_
of	34890	34892	IN	of	O	_	_
major	34893	34898	JJ	major	O	_	_
ERK	34899	34902	NN	erk	B-GENE	_	_
related	34903	34910	JJ	related	O	_	_
phosphorylation	34911	34926	NN	phosphorylation	O	_	_
sites	34927	34932	NNS	site	O	_	_
in	34933	34935	IN	in	O	_	_
Gab1	34936	34940	NN	gab1	B-GENE	_	_
.	34940	34941	.	.	O	_	_
D	1
4
0	3	prep_of
3	2	amod
4	0	nsubj
4	6	dobj
6	5	nn
6	8	prep_in
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	4	2	NP	0	0	1	1	NN	0	0	1	1	Identification	0	0	1	0	PP	0	1	4	2	IN	0	1	2	1	of	1	1	2	0	NP	1	2	4	2	JJ	0	2	3	1	major	2	2	3	0	NN	0	3	4	1	ERK	3	3	4	0	VP	0	4	9	2	JJ	0	4	5	1	related	4	4	5	0	NP	0	5	9	2	NP	1	5	7	2	NN	0	5	6	1	phosphorylation	5	5	6	0	NNS	0	6	7	1	sites	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	in	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	Gab1	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	2
Biochemistry	34942	34954	NNP	Biochemistry	O	_	_
.	34954	34955	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	NNP	0	0	1	1	Biochemistry	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	6
2004	34956	34960	CD	2004	O	_	_
;	34960	34961	:	;	O	_	_
43:12133	34961	34969	CD	43:12133	O	_	_
‚	34969	34970	CD	‚	O	_	_
Äì12140	34970	34977	NN	äì12140	O	_	_
.	34977	34978	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2004	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	43:12133	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì12140	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
17	34979	34981	CD	17	O	_	_
.	34981	34982	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	17	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	18
Roshan	34983	34989	NNP	Roshan	O	_	_
B	34990	34991	NNP	B	O	_	_
,	34991	34992	,	,	O	_	_
Kjelsberg	34993	35002	NNP	Kjelsberg	O	_	_
C	35003	35004	NNP	C	O	_	_
,	35004	35005	,	,	O	_	_
Spokes	35006	35012	NNP	Spokes	O	_	_
K	35013	35014	NNP	K	O	_	_
,	35014	35015	,	,	O	_	_
Eldred	35016	35022	NNP	Eldred	O	_	_
A	35023	35024	NNP	A	O	_	_
,	35024	35025	,	,	O	_	_
Crovello	35026	35034	NNP	Crovello	O	_	_
CS	35035	35037	NNP	CS	O	_	_
,	35037	35038	,	,	O	_	_
Cantley	35039	35046	NNP	Cantley	O	_	_
LG	35047	35049	NNP	LG	O	_	_
.	35049	35050	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
EOX
Y	1
ROOT	0	0	18	1	NP	0	0	18	4	NP	1	0	2	2	NNP	0	0	1	1	Roshan	0	0	1	0	NNP	0	1	2	1	B	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	17	9	NP	1	3	5	2	NNP	0	3	4	1	Kjelsberg	3	3	4	0	NNP	0	4	5	1	C	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Spokes	6	6	7	0	NNP	0	7	8	1	K	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Eldred	9	9	10	0	NNP	0	10	11	1	A	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Crovello	12	12	13	0	NNP	0	13	14	1	CS	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Cantley	15	15	16	0	NNP	0	16	17	1	LG	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	11
Activated	35051	35060	VBN	activate	O	_	_
ERK2	35061	35065	NN	erk2	B-GENE	_	_
interacts	35066	35075	VBZ	interact	O	_	_
with	35076	35080	IN	with	O	_	_
and	35081	35084	CC	and	O	_	_
phosphorylates	35085	35099	VBZ	phosphorylate	O	_	_
the	35100	35103	DT	the	O	_	_
docking	35104	35111	NN	docking	O	_	_
protein	35112	35119	NN	protein	O	_	_
GAB1	35120	35124	NN	gab1	O	_	_
.	35124	35125	.	.	O	_	_
D	1
2
0	1	dobj
2	0	csubj
2	3	prep
2	5	conj_and
5	0	csubj
5	9	dobj
9	6	det
9	7	nn
9	8	nn
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	S	0	0	2	1	VP	0	0	2	2	VBN	0	0	1	1	Activated	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	ERK2	1	1	2	0	VP	0	2	10	3	VP	0	2	4	2	VBZ	0	2	3	1	interacts	2	2	3	0	PP	0	3	4	1	IN	0	3	4	1	with	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	VP	0	5	10	2	VBZ	0	5	6	1	phosphorylates	5	5	6	0	NP	3	6	10	4	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	docking	7	7	8	0	NN	0	8	9	1	protein	8	8	9	0	NN	0	9	10	1	GAB1	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	4
J	35126	35127	NNP	J	O	_	_
Biol	35128	35132	NNP	Biol	O	_	_
Chem	35133	35137	NNP	Chem	O	_	_
.	35137	35138	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
EOX
Y	1
ROOT	0	0	4	1	NP	2	0	4	4	NNP	0	0	1	1	J	0	0	1	0	NNP	0	1	2	1	Biol	1	1	2	0	NNP	0	2	3	1	Chem	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	6
1999	35139	35143	CD	1999	O	_	_
;	35143	35144	:	;	O	_	_
274:36362	35144	35153	CD	274:36362	O	_	_
‚	35153	35154	CD	‚	O	_	_
Äì36368	35154	35161	NN	äì36368	O	_	_
.	35161	35162	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	1999	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	274:36362	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì36368	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
18	35163	35165	CD	18	O	_	_
.	35165	35166	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	18	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	9
Yu	35167	35169	NNP	Yu	O	_	_
CF	35170	35172	NN	cf	O	_	_
,	35172	35173	,	,	O	_	_
Liu	35174	35177	NNP	Liu	O	_	_
ZX	35178	35180	NNP	ZX	O	_	_
,	35180	35181	,	,	O	_	_
Cantley	35182	35189	NNP	Cantley	O	_	_
LG	35190	35192	NNP	LG	O	_	_
.	35192	35193	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
7	6	nn
EOX
Y	1
ROOT	0	0	9	1	NP	0	0	9	4	NP	1	0	2	2	NNP	0	0	1	1	Yu	0	0	1	0	NN	0	1	2	1	CF	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	8	3	NP	1	3	5	2	NNP	0	3	4	1	Liu	3	3	4	0	NNP	0	4	5	1	ZX	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Cantley	6	6	7	0	NNP	0	7	8	1	LG	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	16
ERK	35194	35197	NN	erk	B-GENE	_	_
negatively	35198	35208	RB	negatively	O	_	_
regulates	35209	35218	VBZ	regulate	O	_	_
the	35219	35222	DT	the	O	_	_
epidermal	35223	35232	JJ	epidermal	B-GENE	_	_
growth	35233	35239	NN	growth	I-GENE	_	_
factor	35240	35246	NN	factor	I-GENE	_	_
mediated	35247	35255	JJ	mediated	O	_	_
interaction	35256	35267	NN	interaction	O	_	_
of	35268	35270	IN	of	O	_	_
Gab1	35271	35275	NN	gab1	B-GENE	_	_
and	35276	35279	CC	and	O	_	_
the	35280	35283	DT	the	O	_	_
phosphatidylinositol	35284	35304	NN	phosphatidylinositol	B-GENE	_	_
3-kinase	35305	35313	NN	3-kinase	I-GENE	_	_
.	35313	35314	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	advmod
2	8	dobj
8	3	det
8	4	amod
8	5	nn
8	6	nn
8	7	amod
8	10	prep_of
8	14	prep_of
10	14	conj_and
14	12	det
14	13	nn
EOX
Y	1
ROOT	0	0	16	1	S	2	0	16	4	NP	0	0	1	1	NN	0	0	1	1	ERK	0	0	1	0	ADVP	0	1	2	1	RB	0	1	2	1	negatively	1	1	2	0	VP	0	2	15	2	VBZ	0	2	3	1	regulates	2	2	3	0	NP	0	3	15	2	NP	5	3	9	6	DT	0	3	4	1	the	3	3	4	0	JJ	0	4	5	1	epidermal	4	4	5	0	NN	0	5	6	1	growth	5	5	6	0	NN	0	6	7	1	factor	6	6	7	0	JJ	0	7	8	1	mediated	7	7	8	0	NN	0	8	9	1	interaction	8	8	9	0	PP	0	9	15	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	15	3	NP	0	10	11	1	NN	0	10	11	1	Gab1	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	phosphatidylinositol	13	13	14	0	NN	0	14	15	1	3-kinase	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	4
J	35315	35316	NNP	J	O	_	_
Biol	35317	35321	NNP	Biol	O	_	_
Chem	35322	35326	NNP	Chem	O	_	_
.	35326	35327	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
EOX
Y	1
ROOT	0	0	4	1	NP	2	0	4	4	NNP	0	0	1	1	J	0	0	1	0	NNP	0	1	2	1	Biol	1	1	2	0	NNP	0	2	3	1	Chem	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	6
2002	35328	35332	CD	2002	O	_	_
;	35332	35333	:	;	O	_	_
277:19382	35333	35342	CD	277:19382	O	_	_
‚	35342	35343	CD	‚	O	_	_
Äì19388	35343	35350	NN	äì19388	O	_	_
.	35350	35351	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2002	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	277:19382	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì19388	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
19	35352	35354	CD	19	O	_	_
.	35354	35355	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	19	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Ebi	35356	35359	NN	ebus	B-GENE	_	_
H	35360	35361	NN	h	I-GENE	_	_
,	35361	35362	,	,	O	_	_
Corcoran	35363	35371	NNP	Corcoran	O	_	_
RB	35372	35374	NN	rb	O	_	_
,	35374	35375	,	,	O	_	_
Singh	35376	35381	NNP	Singh	O	_	_
A	35382	35383	NNP	A	O	_	_
,	35383	35384	,	,	O	_	_
Chen	35385	35389	NNP	Chen	O	_	_
Z	35390	35391	NNP	Z	O	_	_
,	35391	35392	,	,	O	_	_
Song	35393	35397	NN	song	O	_	_
Y	35398	35399	NN	y	O	_	_
,	35399	35400	,	,	O	_	_
Lifshits	35401	35409	VBZ	lifshit	O	_	_
E	35410	35411	NN	e	O	_	_
,	35411	35412	,	,	O	_	_
et	35413	35415	FW	et	O	_	_
al.	35416	35418	FW	al.	O	_	_
.	35418	35419	.	.	O	_	_
D	1
15
1	0	nn
1	4	appos
1	7	appos
1	10	appos
1	13	appos
4	3	nn
7	6	nn
10	9	nn
13	12	nn
15	1	nsubj
15	16	dobj
16	19	appos
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	15	10	NP	1	0	2	2	NN	0	0	1	1	Ebi	0	0	1	0	NN	0	1	2	1	H	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Corcoran	3	3	4	0	NN	0	4	5	1	RB	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Singh	6	6	7	0	NNP	0	7	8	1	A	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Chen	9	9	10	0	NNP	0	10	11	1	Z	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	Song	12	12	13	0	NN	0	13	14	1	Y	13	13	14	0	,	0	14	15	1	,	14	14	15	0	VP	0	15	20	2	VBZ	0	15	16	1	Lifshits	15	15	16	0	NP	0	16	20	3	NP	0	16	17	1	NN	0	16	17	1	E	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	16
Receptor	35420	35428	NN	receptor	B-GENE	_	_
tyrosine	35429	35437	NN	tyrosine	I-GENE	_	_
kinases	35438	35445	NNS	kinase	I-GENE	_	_
exert	35446	35451	VBP	exert	O	_	_
dominant	35452	35460	JJ	dominant	O	_	_
control	35461	35468	NN	control	O	_	_
over	35469	35473	IN	over	O	_	_
PI3K	35474	35478	NN	pi3k	B-GENE	_	_
signaling	35479	35488	NN	signaling	O	_	_
in	35489	35491	IN	in	O	_	_
human	35492	35497	JJ	human	B-GENE	_	_
KRAS	35498	35502	NNP	KRAS	I-GENE	_	_
mutant	35503	35509	JJ	mutant	I-GENE	_	_
colorectal	35510	35520	JJ	colorectal	I-GENE	_	_
cancers	35521	35528	NNS	cancer	I-GENE	_	_
.	35528	35529	.	.	O	_	_
D	1
3
2	0	nn
2	1	nn
3	2	nsubj
3	14	xcomp
5	4	amod
5	8	prep_over
8	7	nn
8	11	prep_in
11	10	amod
14	5	nsubj
14	12	amod
14	13	amod
EOX
Y	1
ROOT	0	0	16	1	S	1	0	16	3	NP	2	0	3	3	NN	0	0	1	1	Receptor	0	0	1	0	NN	0	1	2	1	tyrosine	1	1	2	0	NNS	0	2	3	1	kinases	2	2	3	0	VP	0	3	15	2	VBP	0	3	4	1	exert	3	3	4	0	S	1	4	15	2	NP	0	4	12	2	NP	1	4	6	2	JJ	0	4	5	1	dominant	4	4	5	0	NN	0	5	6	1	control	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	over	6	6	7	0	NP	0	7	12	2	NP	1	7	9	2	NN	0	7	8	1	PI3K	7	7	8	0	NN	0	8	9	1	signaling	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	in	9	9	10	0	NP	1	10	12	2	JJ	0	10	11	1	human	10	10	11	0	NNP	0	11	12	1	KRAS	11	11	12	0	NP	2	12	15	3	JJ	0	12	13	1	mutant	12	12	13	0	JJ	0	13	14	1	colorectal	13	13	14	0	NNS	0	14	15	1	cancers	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	6
The	35530	35533	DT	the	O	_	_
Journal	35534	35541	NNP	Journal	O	_	_
of	35542	35544	IN	of	O	_	_
clinical	35545	35553	JJ	clinical	O	_	_
investigation	35554	35567	NN	investigation	O	_	_
.	35567	35568	.	.	O	_	_
D	1
1
1	0	det
1	4	prep_of
4	3	amod
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNP	0	1	2	1	Journal	1	1	2	0	PP	0	2	5	2	IN	0	2	3	1	of	2	2	3	0	NP	1	3	5	2	JJ	0	3	4	1	clinical	3	3	4	0	NN	0	4	5	1	investigation	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	6
2011	35569	35573	CD	2011	O	_	_
;	35573	35574	:	;	O	_	_
121:4311	35574	35582	CD	121:4311	O	_	_
‚	35582	35583	CD	‚	O	_	_
Äì4321	35583	35589	NN	äì4321	O	_	_
.	35589	35590	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2011	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	121:4311	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì4321	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	25
ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	35591	35651	NNP	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	O	_	_
MEK	35653	35656	NN	mek	B-GENE	_	_
inhibition	35657	35667	NN	inhibition	O	_	_
leads	35668	35673	VBZ	lead	O	_	_
to	35674	35676	TO	to	O	_	_
PI3K	35677	35681	NN	pi3k	B-GENE	_	_
/	35681	35682	:	/	B-GENE	_	_
AKT	35682	35685	NN	akt	I-GENE	_	_
activation	35686	35696	NN	activation	O	_	_
by	35697	35699	IN	by	O	_	_
relieving	35700	35709	VBG	relieve	O	_	_
a	35710	35711	DT	a	O	_	_
negative	35712	35720	JJ	negative	O	_	_
feedback	35721	35729	NN	feedback	O	_	_
on	35730	35732	IN	on	O	_	_
ERBB	35733	35737	NN	erbb	O	_	_
receptors	35738	35747	NNS	receptor	O	_	_
12	35748	35750	CD	12	O	_	_
/	35750	35751	:	/	O	_	_
8/14	35751	35755	CD	8/14	O	_	_
,	35755	35756	,	,	O	_	_
6:54	35757	35761	CD	6:54	O	_	_
PM	35762	35764	NN	pm	O	_	_
Ôøº20	35765	35770	NN	ôøº20	O	_	_
.	35770	35771	.	.	O	_	_
D	1
8
2	0	nn
2	1	nn
3	2	nsubj
3	5	prep_to
8	3	dep
8	6	punct
8	7	nn
8	10	prepc_by
10	13	dobj
10	16	prep_on
10	19	dep
13	11	det
13	12	amod
16	15	nn
16	17	dep
19	18	punct
19	23	appos
23	21	num
23	22	nn
EOX
Y	1
ROOT	0	0	25	1	FRAG	2	0	25	4	S	1	0	6	2	NP	2	0	3	3	NNP	0	0	1	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	0	0	1	0	NN	0	1	2	1	MEK	1	1	2	0	NN	0	2	3	1	inhibition	2	2	3	0	VP	0	3	6	2	VBZ	0	3	4	1	leads	3	3	4	0	PP	0	4	6	2	TO	0	4	5	1	to	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	PI3K	5	5	6	0	:	0	6	7	1	/	6	6	7	0	FRAG	0	7	24	2	NP	1	7	9	2	NN	0	7	8	1	AKT	7	7	8	0	NN	0	8	9	1	activation	8	8	9	0	PP	0	9	24	2	IN	0	9	10	1	by	9	9	10	0	S	0	10	24	1	VP	0	10	24	4	VBG	0	10	11	1	relieving	10	10	11	0	NP	2	11	14	3	DT	0	11	12	1	a	11	11	12	0	JJ	0	12	13	1	negative	12	12	13	0	NN	0	13	14	1	feedback	13	13	14	0	PP	0	14	18	2	IN	0	14	15	1	on	14	14	15	0	NP	0	15	18	2	NP	1	15	17	2	NN	0	15	16	1	ERBB	15	15	16	0	NNS	0	16	17	1	receptors	16	16	17	0	NP	0	17	18	1	CD	0	17	18	1	12	17	17	18	0	PRN	1	18	24	2	:	0	18	19	1	/	18	18	19	0	NP	0	19	24	3	NP	0	19	20	1	CD	0	19	20	1	8/14	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	2	21	24	3	CD	0	21	22	1	6:54	21	21	22	0	NN	0	22	23	1	PM	22	22	23	0	NN	0	23	24	1	Ôøº20	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	12
Li	35772	35774	NNP	Li	O	_	_
X	35775	35776	NNP	X	O	_	_
,	35776	35777	,	,	O	_	_
Huang	35778	35783	NNP	Huang	O	_	_
Y	35784	35785	NN	y	O	_	_
,	35785	35786	,	,	O	_	_
Jiang	35787	35792	NNP	Jiang	O	_	_
J	35793	35794	NNP	J	O	_	_
,	35794	35795	,	,	O	_	_
Frank	35796	35801	NNP	Frank	O	_	_
SJ	35802	35804	NNP	SJ	O	_	_
.	35804	35805	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
1	7	appos
1	10	appos
4	3	nn
7	6	nn
10	9	nn
EOX
Y	1
ROOT	0	0	12	1	NP	0	0	12	8	NP	1	0	2	2	NNP	0	0	1	1	Li	0	0	1	0	NNP	0	1	2	1	X	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Huang	3	3	4	0	NN	0	4	5	1	Y	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Jiang	6	6	7	0	NNP	0	7	8	1	J	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Frank	9	9	10	0	NNP	0	10	11	1	SJ	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	13
ERK	35806	35809	NN	erk	O	_	_
dependent	35810	35819	JJ	dependent	O	_	_
threonine	35820	35829	NN	threonine	O	_	_
phosphorylation	35830	35845	NN	phosphorylation	O	_	_
of	35846	35848	IN	of	O	_	_
EGF	35849	35852	NN	egf	B-GENE	_	_
receptor	35853	35861	NN	receptor	I-GENE	_	_
modulates	35862	35871	VBZ	modulate	O	_	_
receptor	35872	35880	NN	receptor	O	_	_
downregulation	35881	35895	NN	downregulation	O	_	_
and	35896	35899	CC	and	O	_	_
signaling	35900	35909	NN	signaling	O	_	_
.	35909	35910	.	.	O	_	_
D	1
7
1	0	npadvmod
3	1	amod
3	2	nn
3	6	prep_of
6	5	nn
7	3	nsubj
7	9	dobj
7	11	dobj
9	8	nn
9	11	conj_and
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	0	0	7	2	NP	2	0	4	3	ADJP	1	0	2	2	NP	0	0	1	1	NN	0	0	1	1	ERK	0	0	1	0	JJ	0	1	2	1	dependent	1	1	2	0	NN	0	2	3	1	threonine	2	2	3	0	NN	0	3	4	1	phosphorylation	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	of	4	4	5	0	NP	1	5	7	2	NN	0	5	6	1	EGF	5	5	6	0	NN	0	6	7	1	receptor	6	6	7	0	VP	0	7	12	2	VBZ	0	7	8	1	modulates	7	7	8	0	NP	1	8	12	4	NN	0	8	9	1	receptor	8	8	9	0	NN	0	9	10	1	downregulation	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	NN	0	11	12	1	signaling	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	3
Cell	35911	35915	NN	cell	O	_	_
Signal	35916	35922	NN	signal	O	_	_
.	35922	35923	.	.	O	_	_
D	1
1
1	0	nsubj
EOX
Y	1
ROOT	0	0	3	1	S	1	0	3	3	NP	0	0	1	1	NN	0	0	1	1	Cell	0	0	1	0	VP	0	1	2	1	NN	0	1	2	1	Signal	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	6
2008	35924	35928	CD	2008	O	_	_
;	35928	35929	:	;	O	_	_
20:2145	35929	35936	CD	20:2145	O	_	_
‚	35936	35937	CD	‚	O	_	_
Äì2155	35937	35943	NN	äì2155	O	_	_
.	35943	35944	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2008	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	20:2145	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì2155	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
21	35945	35947	CD	21	O	_	_
.	35947	35948	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	21	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	22
Red	35949	35952	NNP	Red	O	_	_
Brewer	35953	35959	NNP	Brewer	O	_	_
M	35960	35961	NN	m	O	_	_
,	35961	35962	,	,	O	_	_
Choi	35963	35967	NNP	Choi	O	_	_
SH	35968	35970	NNP	SH	O	_	_
,	35970	35971	,	,	O	_	_
Alvarado	35972	35980	NNP	Alvarado	O	_	_
D	35981	35982	NNP	D	O	_	_
,	35982	35983	,	,	O	_	_
Moravcevic	35984	35994	NNP	Moravcevic	O	_	_
K	35995	35996	NNP	K	O	_	_
,	35996	35997	,	,	O	_	_
Pozzi	35998	36003	NNP	Pozzi	O	_	_
A	36004	36005	NNP	A	O	_	_
,	36005	36006	,	,	O	_	_
Lemmon	36007	36013	NNP	Lemmon	O	_	_
MA	36014	36016	NNP	MA	O	_	_
,	36016	36017	,	,	O	_	_
et	36018	36020	FW	et	O	_	_
al.	36021	36023	FW	al.	O	_	_
.	36023	36024	.	.	O	_	_
D	1
1
1	0	nn
1	2	dep
2	5	appos
2	8	appos
2	11	appos
2	14	appos
2	17	appos
2	20	appos
5	4	nn
8	7	nn
11	10	nn
14	13	nn
17	16	nn
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	NP	0	0	22	3	NP	1	0	2	2	NNP	0	0	1	1	Red	0	0	1	0	NNP	0	1	2	1	Brewer	1	1	2	0	NP	0	2	21	13	NP	0	2	3	1	NN	0	2	3	1	M	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	1	4	6	2	NNP	0	4	5	1	Choi	4	4	5	0	NNP	0	5	6	1	SH	5	5	6	0	,	0	6	7	1	,	6	6	7	0	NP	1	7	9	2	NNP	0	7	8	1	Alvarado	7	7	8	0	NNP	0	8	9	1	D	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	1	10	12	2	NNP	0	10	11	1	Moravcevic	10	10	11	0	NNP	0	11	12	1	K	11	11	12	0	,	0	12	13	1	,	12	12	13	0	NP	1	13	15	2	NNP	0	13	14	1	Pozzi	13	13	14	0	NNP	0	14	15	1	A	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NP	1	16	18	2	NNP	0	16	17	1	Lemmon	16	16	17	0	NNP	0	17	18	1	MA	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	1	19	21	2	FW	0	19	20	1	et	19	19	20	0	FW	0	20	21	1	al.	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	13
The	36025	36028	DT	the	O	_	_
juxtamembrane	36029	36042	NN	juxtamembrane	O	_	_
region	36043	36049	NN	region	O	_	_
of	36050	36052	IN	of	O	_	_
the	36053	36056	DT	the	O	_	_
EGF	36057	36060	NN	egf	B-GENE	_	_
receptor	36061	36069	NN	receptor	I-GENE	_	_
functions	36070	36079	NNS	function	O	_	_
as	36080	36082	IN	as	O	_	_
an	36083	36085	DT	a	O	_	_
activation	36086	36096	NN	activation	O	_	_
domain	36097	36103	NN	domain	O	_	_
.	36103	36104	.	.	O	_	_
D	1
2
2	0	det
2	1	nn
2	7	prep_of
2	11	prep_as
7	4	det
7	5	nn
7	6	nn
11	9	det
11	10	nn
EOX
Y	1
ROOT	0	0	13	1	NP	0	0	13	4	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	juxtamembrane	1	1	2	0	NN	0	2	3	1	region	2	2	3	0	PP	0	3	8	2	IN	0	3	4	1	of	3	3	4	0	NP	3	4	8	4	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	EGF	5	5	6	0	NN	0	6	7	1	receptor	6	6	7	0	NNS	0	7	8	1	functions	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	as	8	8	9	0	NP	2	9	12	3	DT	0	9	10	1	an	9	9	10	0	NN	0	10	11	1	activation	10	10	11	0	NN	0	11	12	1	domain	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	3
Mol	36105	36108	NNP	Mol	O	_	_
Cell	36109	36113	NN	cell	O	_	_
.	36113	36114	.	.	O	_	_
D	1
0
0	1	dep
EOX
Y	1
ROOT	0	0	3	1	NP	0	0	3	3	NP	0	0	1	1	NNP	0	0	1	1	Mol	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	Cell	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	6
2009	36115	36119	CD	2009	O	_	_
;	36119	36120	:	;	O	_	_
34:641	36120	36126	CD	34:641	O	_	_
‚	36126	36127	CD	‚	O	_	_
Äì651	36127	36132	NN	äì651	O	_	_
.	36132	36133	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2009	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	34:641	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì651	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
22	36134	36136	CD	22	O	_	_
.	36136	36137	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	22	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Yeh	36138	36141	NNP	Yeh	O	_	_
TC	36142	36144	NNP	TC	O	_	_
,	36144	36145	,	,	O	_	_
Marsh	36146	36151	NNP	Marsh	O	_	_
V	36152	36153	NNP	V	O	_	_
,	36153	36154	,	,	O	_	_
Bernat	36155	36161	NNP	Bernat	O	_	_
BA	36162	36164	NN	ba	O	_	_
,	36164	36165	,	,	O	_	_
Ballard	36166	36173	NNP	Ballard	O	_	_
J	36174	36175	NNP	J	O	_	_
,	36175	36176	,	,	O	_	_
Colwell	36177	36184	NNP	Colwell	O	_	_
H	36185	36186	NNP	H	O	_	_
,	36186	36187	,	,	O	_	_
Evans	36188	36193	NNP	Evans	O	_	_
RJ	36194	36196	NN	rj	O	_	_
,	36196	36197	,	,	O	_	_
et	36198	36200	FW	et	O	_	_
al.	36201	36203	FW	al.	O	_	_
.	36203	36204	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	4	NP	1	0	2	2	NNP	0	0	1	1	Yeh	0	0	1	0	NNP	0	1	2	1	TC	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	20	11	NP	1	3	5	2	NNP	0	3	4	1	Marsh	3	3	4	0	NNP	0	4	5	1	V	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Bernat	6	6	7	0	NN	0	7	8	1	BA	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Ballard	9	9	10	0	NNP	0	10	11	1	J	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Colwell	12	12	13	0	NNP	0	13	14	1	H	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Evans	15	15	16	0	NN	0	16	17	1	RJ	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	24
Biological	36205	36215	JJ	biological	O	_	_
characterization	36216	36232	NN	characterization	O	_	_
of	36233	36235	IN	of	O	_	_
ARRY-	36236	36241	NN	arry-_NN	O	_	_
142886	36242	36248	CD	142886	O	_	_
(	36249	36250	CD	(	O	_	_
AZD6244	36250	36257	NN	azd6244	O	_	_
)	36257	36258	NN	)	O	_	_
,	36258	36259	,	,	O	_	_
a	36260	36261	DT	a	O	_	_
potent	36262	36268	JJ	potent	O	_	_
,	36268	36269	,	,	O	_	_
highly	36270	36276	RB	highly	O	_	_
selective	36277	36286	JJ	selective	O	_	_
mitogen	36287	36294	NN	mitogen	B-GENE	_	_
activated	36295	36304	VBN	activate	I-GENE	_	_
protein	36305	36312	NN	protein	I-GENE	_	_
kinase	36313	36319	NN	kinase	I-GENE	_	_
kinase	36320	36326	NN	kinase	I-GENE	_	_
1	36327	36328	CD	1	I-GENE	_	_
/	36328	36329	:	/	I-GENE	_	_
2	36329	36330	CD	2	I-GENE	_	_
inhibitor	36331	36340	NN	inhibitor	O	_	_
.	36340	36341	.	.	O	_	_
D	1
15
1	0	amod
1	3	prep_of
3	7	dep
3	14	appos
5	4	number
7	5	num
7	6	nn
13	10	amod
13	12	advmod
14	9	det
14	13	amod
15	1	nsubj
15	18	xcomp
17	16	nn
18	17	nsubj
18	19	num
18	22	dep
22	20	punct
22	21	num
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	0	0	15	2	NP	1	0	2	2	JJ	0	0	1	1	Biological	0	0	1	0	NN	0	1	2	1	characterization	1	1	2	0	PP	0	2	15	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	15	3	NP	0	3	8	2	NP	0	3	4	1	NN	0	3	4	1	ARRY-	3	3	4	0	NP	2	4	8	3	QP	1	4	6	2	CD	0	4	5	1	142886	4	4	5	0	CD	0	5	6	1	(	5	5	6	0	NN	0	6	7	1	AZD6244	6	6	7	0	NN	0	7	8	1	)	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	2	9	15	3	DT	0	9	10	1	a	9	9	10	0	ADJP	3	10	14	4	JJ	0	10	11	1	potent	10	10	11	0	,	0	11	12	1	,	11	11	12	0	RB	0	12	13	1	highly	12	12	13	0	JJ	0	13	14	1	selective	13	13	14	0	NN	0	14	15	1	mitogen	14	14	15	0	VP	0	15	23	2	VBN	0	15	16	1	activated	15	15	16	0	S	1	16	23	2	NP	1	16	18	2	NN	0	16	17	1	protein	16	16	17	0	NN	0	17	18	1	kinase	17	17	18	0	NP	0	18	23	2	NP	0	18	20	2	NN	0	18	19	1	kinase	18	18	19	0	CD	0	19	20	1	1	19	19	20	0	PRN	1	20	23	2	:	0	20	21	1	/	20	20	21	0	NP	1	21	23	2	CD	0	21	22	1	2	21	21	22	0	NN	0	22	23	1	inhibitor	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	4
Clin	36342	36346	NNP	Clin	O	_	_
Cancer	36347	36353	NNP	Cancer	O	_	_
Res	36354	36357	NNP	Res	O	_	_
.	36357	36358	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
EOX
Y	1
ROOT	0	0	4	1	NP	2	0	4	4	NNP	0	0	1	1	Clin	0	0	1	0	NNP	0	1	2	1	Cancer	1	1	2	0	NNP	0	2	3	1	Res	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	6
2007	36359	36363	CD	2007	O	_	_
;	36363	36364	:	;	O	_	_
13:1576	36364	36371	CD	13:1576	O	_	_
‚	36371	36372	CD	‚	O	_	_
Äì1583	36372	36378	NN	äì1583	O	_	_
.	36378	36379	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2007	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	13:1576	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì1583	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
23	36380	36382	CD	23	O	_	_
.	36382	36383	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	23	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	26
Rothenberg	36384	36394	NNP	Rothenberg	O	_	_
SM	36395	36397	NNP	SM	O	_	_
,	36397	36398	,	,	O	_	_
Engelman	36399	36407	NNP	Engelman	O	_	_
JA	36408	36410	NNP	JA	O	_	_
,	36410	36411	,	,	O	_	_
Le	36412	36414	NNP	Le	O	_	_
S	36415	36416	NN	s	O	_	_
,	36416	36417	,	,	O	_	_
Riese	36418	36423	NNP	Riese	O	_	_
DJ	36424	36426	NNP	DJ	O	_	_
,	36426	36427	,	,	O	_	_
2nd	36428	36431	JJ	2nd	O	_	_
,	36431	36432	,	,	O	_	_
Haber	36433	36438	NNP	Haber	O	_	_
DA	36439	36441	NNP	DA	O	_	_
,	36441	36442	,	,	O	_	_
Settleman	36443	36452	NNP	Settleman	O	_	_
J.	36453	36455	NNP	J.	O	_	_
Modeling	36456	36464	NNP	Modeling	O	_	_
oncogene	36465	36473	NN	oncogene	O	_	_
addiction	36474	36483	NN	addiction	O	_	_
using	36484	36489	VBG	use	O	_	_
RNA	36490	36493	NN	rna	O	_	_
interference	36494	36506	NN	interference	O	_	_
.	36506	36507	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
1	7	appos
1	10	appos
1	12	appos
1	15	appos
1	21	appos
1	22	vmod
4	3	nn
7	6	nn
10	9	nn
15	14	nn
21	17	nn
21	18	nn
21	19	nn
21	20	nn
22	24	dobj
24	23	nn
EOX
Y	1
ROOT	0	0	26	1	NP	0	0	26	3	NP	0	0	22	13	NP	1	0	2	2	NNP	0	0	1	1	Rothenberg	0	0	1	0	NNP	0	1	2	1	SM	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Engelman	3	3	4	0	NNP	0	4	5	1	JA	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Le	6	6	7	0	NN	0	7	8	1	S	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Riese	9	9	10	0	NNP	0	10	11	1	DJ	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	13	1	JJ	0	12	13	1	2nd	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	1	14	16	2	NNP	0	14	15	1	Haber	14	14	15	0	NNP	0	15	16	1	DA	15	15	16	0	,	0	16	17	1	,	16	16	17	0	NP	4	17	22	5	NNP	0	17	18	1	Settleman	17	17	18	0	NNP	0	18	19	1	J.	18	18	19	0	NNP	0	19	20	1	Modeling	19	19	20	0	NN	0	20	21	1	oncogene	20	20	21	0	NN	0	21	22	1	addiction	21	21	22	0	VP	0	22	25	2	VBG	0	22	23	1	using	22	22	23	0	NP	1	23	25	2	NN	0	23	24	1	RNA	23	23	24	0	NN	0	24	25	1	interference	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	13
Proc	36508	36512	NNP	Proc	O	_	_
Natl	36513	36517	NNP	Natl	O	_	_
Acad	36518	36522	NNP	Acad	O	_	_
Sci	36523	36526	NNP	Sci	O	_	_
U	36527	36528	NNP	U	O	_	_
S	36529	36530	NNP	S	O	_	_
A.	36531	36533	NNP	A.	O	_	_
2008	36534	36538	CD	2008	O	_	_
;	36538	36539	:	;	O	_	_
105:12480	36539	36548	CD	105:12480	O	_	_
‚	36548	36549	CD	‚	O	_	_
Äì12484	36549	36556	NN	äì12484	O	_	_
.	36556	36557	.	.	O	_	_
D	1
6
6	0	nn
6	1	nn
6	2	nn
6	3	nn
6	4	nn
6	5	nn
6	7	num
6	11	dep
10	9	number
11	10	num
EOX
Y	1
ROOT	0	0	13	1	NP	0	0	13	4	NP	6	0	8	8	NNP	0	0	1	1	Proc	0	0	1	0	NNP	0	1	2	1	Natl	1	1	2	0	NNP	0	2	3	1	Acad	2	2	3	0	NNP	0	3	4	1	Sci	3	3	4	0	NNP	0	4	5	1	U	4	4	5	0	NNP	0	5	6	1	S	5	5	6	0	NNP	0	6	7	1	A.	6	6	7	0	CD	0	7	8	1	2008	7	7	8	0	:	0	8	9	1	;	8	8	9	0	NP	1	9	12	2	QP	1	9	11	2	CD	0	9	10	1	105:12480	9	9	10	0	CD	0	10	11	1	‚	10	10	11	0	NN	0	11	12	1	Äì12484	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	2
24	36558	36560	CD	24	O	_	_
.	36560	36561	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	24	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Engelman	36562	36570	NNP	Engelman	O	_	_
JA	36571	36573	NNP	JA	O	_	_
,	36573	36574	,	,	O	_	_
Janne	36575	36580	NNP	Janne	O	_	_
PA	36581	36583	NN	pa	O	_	_
,	36583	36584	,	,	O	_	_
Mermel	36585	36591	NNP	Mermel	O	_	_
C	36592	36593	NNP	C	O	_	_
,	36593	36594	,	,	O	_	_
Pearlberg	36595	36604	NNP	Pearlberg	O	_	_
J	36605	36606	NNP	J	O	_	_
,	36606	36607	,	,	O	_	_
Mukohara	36608	36616	NNP	Mukohara	O	_	_
T	36617	36618	NN	t	O	_	_
,	36618	36619	,	,	O	_	_
Fleet	36620	36625	NNP	Fleet	O	_	_
C	36626	36627	NNP	C	O	_	_
,	36627	36628	,	,	O	_	_
et	36629	36631	FW	et	O	_	_
al.	36632	36634	FW	al.	O	_	_
.	36634	36635	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	4	NP	1	0	2	2	NNP	0	0	1	1	Engelman	0	0	1	0	NNP	0	1	2	1	JA	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	20	11	NP	1	3	5	2	NNP	0	3	4	1	Janne	3	3	4	0	NN	0	4	5	1	PA	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Mermel	6	6	7	0	NNP	0	7	8	1	C	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Pearlberg	9	9	10	0	NNP	0	10	11	1	J	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Mukohara	12	12	13	0	NN	0	13	14	1	T	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Fleet	15	15	16	0	NNP	0	16	17	1	C	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	16
ErbB-3	36636	36642	NN	erbb-3	B-GENE	_	_
mediates	36643	36651	VBZ	mediate	O	_	_
phosphoinositide	36652	36668	NN	phosphoinositide	B-GENE	_	_
3-kinase	36669	36677	NN	3-kinase	I-GENE	_	_
activity	36678	36686	NN	activity	O	_	_
in	36687	36689	IN	in	O	_	_
gefitinib	36690	36699	NN	gefitinib	O	_	_
sensitive	36700	36709	JJ	sensitive	O	_	_
non	36710	36713	JJ	non	O	_	_
small	36714	36719	JJ	small	O	_	_
cell	36720	36724	NN	cell	O	_	_
lung	36725	36729	NN	lung	O	_	_
cancer	36730	36736	NN	cancer	O	_	_
cell	36737	36741	NN	cell	O	_	_
lines	36742	36747	NNS	line	O	_	_
.	36747	36748	.	.	O	_	_
D	1
1
1	0	nsubj
1	4	dobj
4	2	nn
4	3	nn
4	6	prep_in
6	14	dep
14	7	amod
14	8	amod
14	9	amod
14	10	nn
14	11	nn
14	12	nn
14	13	nn
EOX
Y	1
ROOT	0	0	16	1	S	1	0	16	3	NP	0	0	1	1	NN	0	0	1	1	ErbB-3	0	0	1	0	VP	0	1	15	2	VBZ	0	1	2	1	mediates	1	1	2	0	NP	0	2	15	2	NP	2	2	5	3	NN	0	2	3	1	phosphoinositide	2	2	3	0	NN	0	3	4	1	3-kinase	3	3	4	0	NN	0	4	5	1	activity	4	4	5	0	PP	0	5	15	2	IN	0	5	6	1	in	5	5	6	0	NP	0	6	15	2	NP	0	6	7	1	NN	0	6	7	1	gefitinib	6	6	7	0	NP	7	7	15	8	JJ	0	7	8	1	sensitive	7	7	8	0	JJ	0	8	9	1	non	8	8	9	0	JJ	0	9	10	1	small	9	9	10	0	NN	0	10	11	1	cell	10	10	11	0	NN	0	11	12	1	lung	11	11	12	0	NN	0	12	13	1	cancer	12	12	13	0	NN	0	13	14	1	cell	13	13	14	0	NNS	0	14	15	1	lines	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	14
Proceedings	36749	36760	NNP	Proceedings	O	_	_
of	36761	36763	IN	of	O	_	_
the	36764	36767	DT	the	O	_	_
National	36768	36776	NNP	National	O	_	_
Academy	36777	36784	NNP	Academy	O	_	_
of	36785	36787	IN	of	O	_	_
Sciences	36788	36796	NNPS	Sciences	O	_	_
of	36797	36799	IN	of	O	_	_
the	36800	36803	DT	the	O	_	_
United	36804	36810	NNP	United	O	_	_
States	36811	36817	NNPS	States	O	_	_
of	36818	36820	IN	of	O	_	_
America	36821	36828	NNP	America	O	_	_
.	36828	36829	.	.	O	_	_
D	1
0
0	4	prep_of
0	10	prep_of
0	12	prep_of
4	2	det
4	3	nn
4	6	prep_of
10	8	det
10	9	nn
EOX
Y	1
ROOT	0	0	14	1	NP	0	0	14	5	NP	0	0	1	1	NNP	0	0	1	1	Proceedings	0	0	1	0	PP	0	1	7	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	7	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	NNP	0	3	4	1	National	3	3	4	0	NNP	0	4	5	1	Academy	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NNPS	0	6	7	1	Sciences	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NNP	0	9	10	1	United	9	9	10	0	NNPS	0	10	11	1	States	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	13	1	NNP	0	12	13	1	America	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	6
2005	36830	36834	CD	2005	O	_	_
;	36834	36835	:	;	O	_	_
102:3788	36835	36843	CD	102:3788	O	_	_
‚	36843	36844	CD	‚	O	_	_
Äì3793	36844	36850	NN	äì3793	O	_	_
.	36850	36851	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2005	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	102:3788	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì3793	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
25	36852	36854	CD	25	O	_	_
.	36854	36855	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	25	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Engelman	36856	36864	NNP	Engelman	O	_	_
JA	36865	36867	NNP	JA	O	_	_
,	36867	36868	,	,	O	_	_
Mukohara	36869	36877	NNP	Mukohara	O	_	_
T	36878	36879	NN	t	O	_	_
,	36879	36880	,	,	O	_	_
Zejnullahu	36881	36891	NN	zejnullahu	O	_	_
K	36892	36893	NN	k	O	_	_
,	36893	36894	,	,	O	_	_
Lifshits	36895	36903	VBZ	lifshit	O	_	_
E	36904	36905	NN	e	O	_	_
,	36905	36906	,	,	O	_	_
Borras	36907	36913	NNP	Borras	O	_	_
AM	36914	36916	NNP	AM	O	_	_
,	36916	36917	,	,	O	_	_
Gale	36918	36922	NNP	Gale	O	_	_
CM	36923	36925	NN	cm	O	_	_
,	36925	36926	,	,	O	_	_
et	36927	36929	FW	et	O	_	_
al.	36930	36932	FW	al.	O	_	_
.	36932	36933	.	.	O	_	_
D	1
9
1	0	nn
1	4	appos
4	3	nn
4	7	appos
7	6	nn
9	1	nsubj
9	10	dobj
10	13	appos
10	16	appos
10	19	appos
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	9	4	NP	1	0	2	2	NNP	0	0	1	1	Engelman	0	0	1	0	NNP	0	1	2	1	JA	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	8	3	NP	1	3	5	2	NNP	0	3	4	1	Mukohara	3	3	4	0	NN	0	4	5	1	T	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	Zejnullahu	6	6	7	0	NN	0	7	8	1	K	7	7	8	0	,	0	8	9	1	,	8	8	9	0	VP	0	9	20	2	VBZ	0	9	10	1	Lifshits	9	9	10	0	NP	0	10	20	7	NP	0	10	11	1	NN	0	10	11	1	E	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Borras	12	12	13	0	NNP	0	13	14	1	AM	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Gale	15	15	16	0	NN	0	16	17	1	CM	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	16
Allelic	36934	36941	JJ	allelic	O	_	_
dilution	36942	36950	NN	dilution	O	_	_
obscures	36951	36959	VBZ	obscure	O	_	_
detection	36960	36969	NN	detection	O	_	_
of	36970	36972	IN	of	O	_	_
a	36973	36974	DT	a	O	_	_
biologically	36975	36987	RB	biologically	O	_	_
significant	36988	36999	JJ	significant	O	_	_
resistance	37000	37010	NN	resistance	O	_	_
mutation	37011	37019	NN	mutation	O	_	_
in	37020	37022	IN	in	O	_	_
EGFR	37023	37027	NN	egfr	B-GENE	_	_
amplified	37028	37037	VBD	amplify	O	_	_
lung	37038	37042	NN	lung	O	_	_
cancer	37043	37049	NN	cancer	O	_	_
.	37049	37050	.	.	O	_	_
D	1
2
1	0	amod
2	1	nsubj
2	12	ccomp
3	9	prep_of
7	6	advmod
9	5	det
9	7	amod
9	8	nn
9	11	prep_in
12	3	nsubj
12	14	dobj
14	13	nn
EOX
Y	1
ROOT	0	0	16	1	S	1	0	16	3	NP	1	0	2	2	JJ	0	0	1	1	Allelic	0	0	1	0	NN	0	1	2	1	dilution	1	1	2	0	VP	0	2	15	2	VBZ	0	2	3	1	obscures	2	2	3	0	SBAR	0	3	15	1	S	1	3	15	2	NP	0	3	12	2	NP	0	3	4	1	NN	0	3	4	1	detection	3	3	4	0	PP	0	4	12	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	12	2	NP	3	5	10	4	DT	0	5	6	1	a	5	5	6	0	ADJP	1	6	8	2	RB	0	6	7	1	biologically	6	6	7	0	JJ	0	7	8	1	significant	7	7	8	0	NN	0	8	9	1	resistance	8	8	9	0	NN	0	9	10	1	mutation	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	in	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	EGFR	11	11	12	0	VP	0	12	15	2	VBD	0	12	13	1	amplified	12	12	13	0	NP	1	13	15	2	NN	0	13	14	1	lung	13	13	14	0	NN	0	14	15	1	cancer	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	4
J	37051	37052	NNP	J	O	_	_
Clin	37053	37057	NNP	Clin	O	_	_
Invest	37058	37064	NNP	Invest	O	_	_
.	37064	37065	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
EOX
Y	1
ROOT	0	0	4	1	NP	2	0	4	4	NNP	0	0	1	1	J	0	0	1	0	NNP	0	1	2	1	Clin	1	1	2	0	NNP	0	2	3	1	Invest	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	6
2006	37066	37070	CD	2006	O	_	_
;	37070	37071	:	;	O	_	_
116:2695	37071	37079	CD	116:2695	O	_	_
‚	37079	37080	CD	‚	O	_	_
Äì2706	37080	37086	NN	äì2706	O	_	_
.	37086	37087	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2006	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	116:2695	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì2706	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
26	37088	37090	CD	26	O	_	_
.	37090	37091	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	26	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	18
Faber	37092	37097	NNP	Faber	O	_	_
AC	37098	37100	NN	ac	O	_	_
,	37100	37101	,	,	O	_	_
Dufort	37102	37108	NNP	Dufort	O	_	_
FJ	37109	37111	NNP	FJ	O	_	_
,	37111	37112	,	,	O	_	_
Blair	37113	37118	NNP	Blair	O	_	_
D	37119	37120	NNP	D	O	_	_
,	37120	37121	,	,	O	_	_
Wagner	37122	37128	NNP	Wagner	O	_	_
D	37129	37130	NNP	D	O	_	_
,	37130	37131	,	,	O	_	_
Roberts	37132	37139	NNP	Roberts	O	_	_
MF	37140	37142	NN	mf	O	_	_
,	37142	37143	,	,	O	_	_
Chiles	37144	37150	NNP	Chiles	O	_	_
TC	37151	37153	NNP	TC	O	_	_
.	37153	37154	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
EOX
Y	1
ROOT	0	0	18	1	NP	0	0	18	4	NP	1	0	2	2	NNP	0	0	1	1	Faber	0	0	1	0	NN	0	1	2	1	AC	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	17	9	NP	1	3	5	2	NNP	0	3	4	1	Dufort	3	3	4	0	NNP	0	4	5	1	FJ	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Blair	6	6	7	0	NNP	0	7	8	1	D	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Wagner	9	9	10	0	NNP	0	10	11	1	D	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Roberts	12	12	13	0	NN	0	13	14	1	MF	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Chiles	15	15	16	0	NNP	0	16	17	1	TC	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	22
Inhibition	37155	37165	NN	inhibition	O	_	_
of	37166	37168	IN	of	O	_	_
phosphatidylinositol	37169	37189	NN	phosphatidylinositol	B-GENE	_	_
3-	37190	37192	CD	3-	I-GENE	_	_
kinase	37193	37199	NN	kinase	I-GENE	_	_
mediated	37200	37208	VBN	mediate	O	_	_
glucose	37209	37216	NN	glucose	O	_	_
metabolism	37217	37227	NN	metabolism	O	_	_
coincides	37228	37237	VBZ	coincide	O	_	_
with	37238	37242	IN	with	O	_	_
resveratrol	37243	37254	NN	resveratrol	O	_	_
induced	37255	37262	VBD	induce	O	_	_
cell	37263	37267	NN	cell	O	_	_
cycle	37268	37273	NN	cycle	O	_	_
arrest	37274	37280	NN	arrest	O	_	_
in	37281	37283	IN	in	O	_	_
human	37284	37289	JJ	human	O	_	_
diffuse	37290	37297	JJ	diffuse	O	_	_
large	37298	37303	JJ	large	O	_	_
B-cell	37304	37310	NN	b-cell	O	_	_
lymphomas	37311	37320	NNS	lymphoma	O	_	_
.	37320	37321	.	.	O	_	_
D	1
11
0	4	prep_of
4	2	nn
4	3	num
4	5	vmod
5	8	ccomp
7	6	nn
8	7	nsubj
8	10	prep_with
11	0	nsubj
11	14	dobj
14	12	nn
14	13	nn
14	20	prep_in
20	16	amod
20	17	amod
20	18	amod
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	11	2	NP	0	0	1	1	NN	0	0	1	1	Inhibition	0	0	1	0	PP	0	1	11	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	11	2	NP	2	2	5	3	NN	0	2	3	1	phosphatidylinositol	2	2	3	0	CD	0	3	4	1	3-	3	3	4	0	NN	0	4	5	1	kinase	4	4	5	0	VP	0	5	11	2	VBN	0	5	6	1	mediated	5	5	6	0	SBAR	0	6	11	1	S	1	6	11	2	NP	1	6	8	2	NN	0	6	7	1	glucose	6	6	7	0	NN	0	7	8	1	metabolism	7	7	8	0	VP	0	8	11	2	VBZ	0	8	9	1	coincides	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	with	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	resveratrol	10	10	11	0	VP	0	11	21	2	VBD	0	11	12	1	induced	11	11	12	0	NP	0	12	21	2	NP	2	12	15	3	NN	0	12	13	1	cell	12	12	13	0	NN	0	13	14	1	cycle	13	13	14	0	NN	0	14	15	1	arrest	14	14	15	0	PP	0	15	21	2	IN	0	15	16	1	in	15	15	16	0	NP	4	16	21	5	JJ	0	16	17	1	human	16	16	17	0	JJ	0	17	18	1	diffuse	17	17	18	0	JJ	0	18	19	1	large	18	18	19	0	NN	0	19	20	1	B-cell	19	19	20	0	NNS	0	20	21	1	lymphomas	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	3
Biochem	37322	37329	NNP	Biochem	O	_	_
Pharmacol	37330	37339	NNP	Pharmacol	O	_	_
.	37339	37340	.	.	O	_	_
D	1
1
1	0	nn
EOX
Y	1
ROOT	0	0	3	1	NP	1	0	3	3	NNP	0	0	1	1	Biochem	0	0	1	0	NNP	0	1	2	1	Pharmacol	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	6
2006	37341	37345	CD	2006	O	_	_
;	37345	37346	:	;	O	_	_
72:1246	37346	37353	CD	72:1246	O	_	_
‚	37353	37354	CD	‚	O	_	_
Äì1256	37354	37360	NN	äì1256	O	_	_
.	37360	37361	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2006	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	72:1246	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì1256	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
27	37362	37364	CD	27	O	_	_
.	37364	37365	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	27	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	9
Dibble	37366	37372	NNP	Dibble	O	_	_
CC	37373	37375	NN	cc	O	_	_
,	37375	37376	,	,	O	_	_
Asara	37377	37382	NNP	Asara	O	_	_
JM	37383	37385	NN	jm	O	_	_
,	37385	37386	,	,	O	_	_
Manning	37387	37394	VBG	man	O	_	_
BD	37395	37397	NN	bd	O	_	_
.	37397	37398	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
1	7	appos
4	3	nn
7	6	amod
EOX
Y	1
ROOT	0	0	9	1	NP	0	0	9	6	NP	1	0	2	2	NNP	0	0	1	1	Dibble	0	0	1	0	NN	0	1	2	1	CC	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Asara	3	3	4	0	NN	0	4	5	1	JM	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	VBG	0	6	7	1	Manning	6	6	7	0	NN	0	7	8	1	BD	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	15
Characterization	37399	37415	NN	characterization	O	_	_
of	37416	37418	IN	of	O	_	_
Rictor	37419	37425	NN	rictor	O	_	_
phosphorylation	37426	37441	NN	phosphorylation	O	_	_
sites	37442	37447	NNS	site	O	_	_
reveals	37448	37455	VBZ	reveal	O	_	_
direct	37456	37462	JJ	direct	O	_	_
regulation	37463	37473	NN	regulation	O	_	_
of	37474	37476	IN	of	O	_	_
mTOR	37477	37481	NN	mtor	B-GENE	_	_
complex	37482	37489	NN	complex	I-GENE	_	_
2	37490	37491	CD	2	I-GENE	_	_
by	37492	37494	IN	by	O	_	_
S6K1	37495	37499	NN	s6k1	B-GENE	_	_
.	37499	37500	.	.	O	_	_
D	1
5
0	4	prep_of
4	2	nn
4	3	nn
5	0	nsubj
5	7	dobj
5	13	prep_by
7	6	amod
7	10	prep_of
10	9	nn
10	11	num
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	5	2	NP	0	0	1	1	NN	0	0	1	1	Characterization	0	0	1	0	PP	0	1	5	2	IN	0	1	2	1	of	1	1	2	0	NP	2	2	5	3	NN	0	2	3	1	Rictor	2	2	3	0	NN	0	3	4	1	phosphorylation	3	3	4	0	NNS	0	4	5	1	sites	4	4	5	0	VP	0	5	14	3	VBZ	0	5	6	1	reveals	5	5	6	0	NP	0	6	12	2	NP	1	6	8	2	JJ	0	6	7	1	direct	6	6	7	0	NN	0	7	8	1	regulation	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	of	8	8	9	0	NP	1	9	12	3	NN	0	9	10	1	mTOR	9	9	10	0	NN	0	10	11	1	complex	10	10	11	0	CD	0	11	12	1	2	11	11	12	0	PP	0	12	14	2	IN	0	12	13	1	by	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	S6K1	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	4
Mol	37501	37504	NNP	Mol	O	_	_
Cell	37505	37509	NNP	Cell	O	_	_
Biol	37510	37514	NNP	Biol	O	_	_
.	37514	37515	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
EOX
Y	1
ROOT	0	0	4	1	NP	2	0	4	4	NNP	0	0	1	1	Mol	0	0	1	0	NNP	0	1	2	1	Cell	1	1	2	0	NNP	0	2	3	1	Biol	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	6
2009	37516	37520	CD	2009	O	_	_
;	37520	37521	:	;	O	_	_
29:5657	37521	37528	CD	29:5657	O	_	_
‚	37528	37529	CD	‚	O	_	_
Äì5670	37529	37535	NN	äì5670	O	_	_
.	37535	37536	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2009	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	29:5657	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì5670	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
28	37537	37539	CD	28	O	_	_
.	37539	37540	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	28	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Egan	37541	37545	NNP	Egan	O	_	_
DF	37546	37548	NNP	DF	O	_	_
,	37548	37549	,	,	O	_	_
Shackelford	37550	37561	NNP	Shackelford	O	_	_
DB	37562	37564	NNP	DB	O	_	_
,	37564	37565	,	,	O	_	_
Mihaylova	37566	37575	NNP	Mihaylova	O	_	_
MM	37576	37578	NN	mm	O	_	_
,	37578	37579	,	,	O	_	_
Gelino	37580	37586	NN	gelino	O	_	_
S	37587	37588	NN	s	O	_	_
,	37588	37589	,	,	O	_	_
Kohnz	37590	37595	NNP	Kohnz	O	_	_
RA	37596	37598	NN	ra	O	_	_
,	37598	37599	,	,	O	_	_
Mair	37600	37604	NNP	Mair	O	_	_
W	37605	37606	NNP	W	O	_	_
,	37606	37607	,	,	O	_	_
et	37608	37610	FW	et	O	_	_
al.	37611	37613	FW	al.	O	_	_
.	37613	37614	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	4	NP	1	0	2	2	NNP	0	0	1	1	Egan	0	0	1	0	NNP	0	1	2	1	DF	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	20	11	NP	1	3	5	2	NNP	0	3	4	1	Shackelford	3	3	4	0	NNP	0	4	5	1	DB	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Mihaylova	6	6	7	0	NN	0	7	8	1	MM	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	Gelino	9	9	10	0	NN	0	10	11	1	S	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Kohnz	12	12	13	0	NN	0	13	14	1	RA	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Mair	15	15	16	0	NNP	0	16	17	1	W	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	17
Phosphorylation	37615	37630	NN	phosphorylation	O	_	_
of	37631	37633	IN	of	O	_	_
ULK1	37634	37638	NN	ulk1	B-GENE	_	_
(	37639	37640	CD	(	B-GENE	_	_
hATG1	37640	37645	NN	hatg1	I-GENE	_	_
)	37645	37646	CD	)	O	_	_
by	37647	37649	IN	by	O	_	_
AMP	37650	37653	NN	amp	B-GENE	_	_
activated	37654	37663	VBN	activate	I-GENE	_	_
protein	37664	37671	NN	protein	I-GENE	_	_
kinase	37672	37678	NN	kinase	I-GENE	_	_
connects	37679	37687	VBZ	connect	O	_	_
energy	37688	37694	NN	energy	O	_	_
sensing	37695	37702	VBG	sense	O	_	_
to	37703	37705	TO	to	O	_	_
mitophagy	37706	37715	NN	mitophagy	O	_	_
.	37715	37716	.	.	O	_	_
D	1
11
0	4	prep_of
0	7	prep_by
4	2	nn
4	3	num
4	5	num
7	8	vmod
8	10	dobj
10	9	nn
11	0	nsubj
11	12	dobj
12	13	vmod
13	15	prep_to
EOX
Y	1
ROOT	0	0	17	1	S	1	0	17	3	NP	0	0	11	3	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	6	2	IN	0	1	2	1	of	1	1	2	0	NP	2	2	6	4	NN	0	2	3	1	ULK1	2	2	3	0	CD	0	3	4	1	(	3	3	4	0	NN	0	4	5	1	hATG1	4	4	5	0	CD	0	5	6	1	)	5	5	6	0	PP	0	6	11	2	IN	0	6	7	1	by	6	6	7	0	NP	0	7	11	2	NP	0	7	8	1	NN	0	7	8	1	AMP	7	7	8	0	VP	0	8	11	2	VBN	0	8	9	1	activated	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	protein	9	9	10	0	NN	0	10	11	1	kinase	10	10	11	0	VP	0	11	16	2	VBZ	0	11	12	1	connects	11	11	12	0	NP	0	12	16	2	NP	0	12	13	1	NN	0	12	13	1	energy	12	12	13	0	VP	0	13	16	2	VBG	0	13	14	1	sensing	13	13	14	0	PP	0	14	16	2	TO	0	14	15	1	to	14	14	15	0	NP	0	15	16	1	NN	0	15	16	1	mitophagy	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	2
Science	37717	37724	NN	science	O	_	_
.	37724	37725	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	NP	0	0	2	2	NN	0	0	1	1	Science	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	6
2011	37726	37730	CD	2011	O	_	_
;	37730	37731	:	;	O	_	_
331:456	37731	37738	CD	331:456	O	_	_
‚	37738	37739	CD	‚	O	_	_
Äì461	37739	37744	NN	äì461	O	_	_
.	37744	37745	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2011	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	331:456	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì461	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
29	37746	37748	CD	29	O	_	_
.	37748	37749	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	29	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Zheng	37750	37755	NNP	Zheng	O	_	_
B	37756	37757	NNP	B	O	_	_
,	37757	37758	,	,	O	_	_
Jeong	37759	37764	NNP	Jeong	O	_	_
JH	37765	37767	NNP	JH	O	_	_
,	37767	37768	,	,	O	_	_
Asara	37769	37774	NNP	Asara	O	_	_
JM	37775	37777	NN	jm	O	_	_
,	37777	37778	,	,	O	_	_
Yuan	37779	37783	NNP	Yuan	O	_	_
YY	37784	37786	NNP	YY	O	_	_
,	37786	37787	,	,	O	_	_
Granter	37788	37795	NNP	Granter	O	_	_
SR	37796	37798	NN	sr	O	_	_
,	37798	37799	,	,	O	_	_
Chin	37800	37804	NNP	Chin	O	_	_
L	37805	37806	NNP	L	O	_	_
,	37806	37807	,	,	O	_	_
et	37808	37810	FW	et	O	_	_
al.	37811	37813	FW	al.	O	_	_
.	37813	37814	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	4	NP	1	0	2	2	NNP	0	0	1	1	Zheng	0	0	1	0	NNP	0	1	2	1	B	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	20	11	NP	1	3	5	2	NNP	0	3	4	1	Jeong	3	3	4	0	NNP	0	4	5	1	JH	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Asara	6	6	7	0	NN	0	7	8	1	JM	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Yuan	9	9	10	0	NNP	0	10	11	1	YY	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Granter	12	12	13	0	NN	0	13	14	1	SR	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Chin	15	15	16	0	NNP	0	16	17	1	L	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	14
Oncogenic	37815	37824	JJ	oncogenic	O	_	_
B-RAF	37825	37830	NN	b-raf	O	_	_
negatively	37831	37841	RB	negatively	O	_	_
regulates	37842	37851	VBZ	regulate	O	_	_
the	37852	37855	DT	the	O	_	_
tumor	37856	37861	NN	tumor	O	_	_
suppressor	37862	37872	NN	suppressor	O	_	_
LKB1	37873	37877	NN	lkb1	B-GENE	_	_
to	37878	37880	TO	to	O	_	_
promote	37881	37888	VB	promote	O	_	_
melanoma	37889	37897	NN	melanoma	O	_	_
cell	37898	37902	NN	cell	O	_	_
proliferation	37903	37916	NN	proliferation	O	_	_
.	37916	37917	.	.	O	_	_
D	1
3
1	0	amod
3	1	nsubj
3	2	advmod
3	9	xcomp
7	4	det
7	5	nn
7	6	nn
9	7	nsubj
9	8	aux
9	12	dobj
12	10	nn
12	11	nn
EOX
Y	1
ROOT	0	0	14	1	S	2	0	14	4	NP	1	0	2	2	JJ	0	0	1	1	Oncogenic	0	0	1	0	NN	0	1	2	1	B-RAF	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	negatively	2	2	3	0	VP	0	3	13	2	VBZ	0	3	4	1	regulates	3	3	4	0	S	1	4	13	2	NP	3	4	8	4	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	tumor	5	5	6	0	NN	0	6	7	1	suppressor	6	6	7	0	NN	0	7	8	1	LKB1	7	7	8	0	VP	1	8	13	2	TO	0	8	9	1	to	8	8	9	0	VP	0	9	13	2	VB	0	9	10	1	promote	9	9	10	0	NP	2	10	13	3	NN	0	10	11	1	melanoma	10	10	11	0	NN	0	11	12	1	cell	11	11	12	0	NN	0	12	13	1	proliferation	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	3
Mol	37918	37921	NNP	Mol	O	_	_
Cell	37922	37926	NN	cell	O	_	_
.	37926	37927	.	.	O	_	_
D	1
0
0	1	dep
EOX
Y	1
ROOT	0	0	3	1	NP	0	0	3	3	NP	0	0	1	1	NNP	0	0	1	1	Mol	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	Cell	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	6
2009	37928	37932	CD	2009	O	_	_
;	37932	37933	:	;	O	_	_
33:237	37933	37939	CD	33:237	O	_	_
‚	37939	37940	CD	‚	O	_	_
Äì247	37940	37945	NN	äì247	O	_	_
.	37945	37946	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2009	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	33:237	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì247	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
30	37948	37950	CD	30	O	_	_
.	37950	37951	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	30	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	6
Hsieh	37952	37957	NNP	Hsieh	O	_	_
AC	37958	37960	NN	ac	O	_	_
,	37960	37961	,	,	O	_	_
Moasser	37962	37969	NNP	Moasser	O	_	_
MM	37970	37972	NN	mm	O	_	_
.	37972	37973	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	1	0	2	2	NNP	0	0	1	1	Hsieh	0	0	1	0	NN	0	1	2	1	AC	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Moasser	3	3	4	0	NN	0	4	5	1	MM	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	15
Targeting	37974	37983	NN	targeting	O	_	_
HER	37984	37987	NN	her	O	_	_
proteins	37988	37996	NNS	protein	O	_	_
in	37997	37999	IN	in	O	_	_
cancer	38000	38006	NN	cancer	O	_	_
therapy	38007	38014	NN	therapy	O	_	_
and	38015	38018	CC	and	O	_	_
the	38019	38022	DT	the	O	_	_
role	38023	38027	NN	role	O	_	_
of	38028	38030	IN	of	O	_	_
the	38031	38034	DT	the	O	_	_
non	38035	38038	JJ	non	O	_	_
target	38039	38045	NN	target	O	_	_
HER3	38046	38050	NN	her3	B-GENE	_	_
.	38050	38051	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
2	5	prep_in
2	8	prep_in
2	13	prep_of
5	4	nn
5	8	conj_and
8	7	det
13	10	det
13	11	amod
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	NP	0	0	15	4	NP	2	0	3	3	NN	0	0	1	1	Targeting	0	0	1	0	NN	0	1	2	1	HER	1	1	2	0	NNS	0	2	3	1	proteins	2	2	3	0	PP	0	3	9	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	9	3	NP	1	4	6	2	NN	0	4	5	1	cancer	4	4	5	0	NN	0	5	6	1	therapy	5	5	6	0	CC	0	6	7	1	and	6	6	7	0	NP	1	7	9	2	DT	0	7	8	1	the	7	7	8	0	NN	0	8	9	1	role	8	8	9	0	PP	0	9	14	2	IN	0	9	10	1	of	9	9	10	0	NP	3	10	14	4	DT	0	10	11	1	the	10	10	11	0	JJ	0	11	12	1	non	11	11	12	0	NN	0	12	13	1	target	12	12	13	0	NN	0	13	14	1	HER3	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	4
Br	38052	38054	NN	br	O	_	_
J	38055	38056	NN	j	O	_	_
Cancer	38057	38063	NN	cancer	O	_	_
.	38063	38064	.	.	O	_	_
D	1
0
0	2	dep
2	1	nn
EOX
Y	1
ROOT	0	0	4	1	NP	0	0	4	3	NP	0	0	1	1	NN	0	0	1	1	Br	0	0	1	0	NP	1	1	3	2	NN	0	1	2	1	J	1	1	2	0	NN	0	2	3	1	Cancer	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	6
2007	38065	38069	CD	2007	O	_	_
;	38069	38070	:	;	O	_	_
97:453	38070	38076	CD	97:453	O	_	_
‚	38076	38077	CD	‚	O	_	_
Äì457	38077	38082	NN	äì457	O	_	_
.	38082	38083	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2007	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	97:453	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì457	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
31	38084	38086	CD	31	O	_	_
.	38086	38087	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	31	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	13
Carraway	38088	38096	NNP	Carraway	O	_	_
KL.	38097	38100	NNP	KL.	O	_	_
,	38100	38101	,	,	O	_	_
3rd	38102	38105	CD	3rd	O	_	_
E3	38106	38108	NN	e3	B-GENE	_	_
ubiquitin	38109	38118	NN	ubiquitin	I-GENE	_	_
ligases	38119	38126	NNS	ligase	I-GENE	_	_
in	38127	38129	IN	in	O	_	_
ErbB	38130	38134	NN	erbb	B-GENE	_	_
receptor	38135	38143	NN	receptor	I-GENE	_	_
quantity	38144	38152	NN	quantity	O	_	_
control	38153	38160	NN	control	O	_	_
.	38160	38161	.	.	O	_	_
D	1
1
1	0	nn
1	6	appos
6	3	num
6	4	nn
6	5	nn
6	11	prep_in
11	8	nn
11	9	nn
11	10	nn
EOX
Y	1
ROOT	0	0	13	1	NP	0	0	13	4	NP	1	0	2	2	NNP	0	0	1	1	Carraway	0	0	1	0	NNP	0	1	2	1	KL.	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	12	2	NP	3	3	7	4	CD	0	3	4	1	3rd	3	3	4	0	NN	0	4	5	1	E3	4	4	5	0	NN	0	5	6	1	ubiquitin	5	5	6	0	NNS	0	6	7	1	ligases	6	6	7	0	PP	0	7	12	2	IN	0	7	8	1	in	7	7	8	0	NP	3	8	12	4	NN	0	8	9	1	ErbB	8	8	9	0	NN	0	9	10	1	receptor	9	9	10	0	NN	0	10	11	1	quantity	10	10	11	0	NN	0	11	12	1	control	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	5
Semin	38162	38167	NNP	Semin	O	_	_
Cell	38168	38172	NNP	Cell	O	_	_
Dev	38173	38176	NNP	Dev	O	_	_
Biol	38177	38181	NNP	Biol	O	_	_
.	38181	38182	.	.	O	_	_
D	1
3
3	0	nn
3	1	nn
3	2	nn
EOX
Y	1
ROOT	0	0	5	1	NP	3	0	5	5	NNP	0	0	1	1	Semin	0	0	1	0	NNP	0	1	2	1	Cell	1	1	2	0	NNP	0	2	3	1	Dev	2	2	3	0	NNP	0	3	4	1	Biol	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	6
2010	38183	38187	CD	2010	O	_	_
;	38187	38188	:	;	O	_	_
21:936	38188	38194	CD	21:936	O	_	_
‚	38194	38195	CD	‚	O	_	_
Äì943	38195	38200	NN	äì943	O	_	_
.	38200	38201	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2010	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	21:936	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì943	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
32	38202	38204	CD	32	O	_	_
.	38204	38205	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	32	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	31
Diamonti	38206	38214	NNP	Diamonti	O	_	_
AJ	38215	38217	NNP	AJ	O	_	_
,	38217	38218	,	,	O	_	_
Guy	38219	38222	NNP	Guy	O	_	_
PM	38223	38225	NNP	PM	O	_	_
,	38225	38226	,	,	O	_	_
Ivanof	38227	38233	NNP	Ivanof	O	_	_
C	38234	38235	NNP	C	O	_	_
,	38235	38236	,	,	O	_	_
Wong	38237	38241	NNP	Wong	O	_	_
K	38242	38243	NNP	K	O	_	_
,	38243	38244	,	,	O	_	_
Sweeney	38245	38252	NNP	Sweeney	O	_	_
C	38253	38254	NNP	C	O	_	_
,	38254	38255	,	,	O	_	_
Carraway	38256	38264	NNP	Carraway	O	_	_
KL.	38265	38268	NNP	KL.	O	_	_
,	38268	38269	,	,	O	_	_
3rd	38270	38273	JJ	3rd	O	_	_
An	38274	38276	DT	a	O	_	_
RBCC	38277	38281	NN	rbcc	O	_	_
protein	38282	38289	NN	protein	O	_	_
implicated	38290	38300	VBN	implicate	O	_	_
in	38301	38303	IN	in	O	_	_
maintenance	38304	38315	NN	maintenance	O	_	_
of	38316	38318	IN	of	O	_	_
steady-state	38319	38331	JJ	steady-state	O	_	_
neuregulin	38332	38342	NN	neuregulin	B-GENE	_	_
receptor	38343	38351	NN	receptor	I-GENE	_	_
levels	38352	38358	NNS	level	O	_	_
.	38358	38359	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
1	7	appos
1	10	appos
1	13	appos
1	16	appos
1	18	appos
1	22	vmod
4	3	nn
7	6	nn
10	9	nn
13	12	nn
16	15	nn
18	21	dep
21	19	det
21	20	nn
22	24	prep_in
24	29	prep_of
29	26	amod
29	27	nn
29	28	nn
EOX
Y	1
ROOT	0	0	31	1	NP	0	0	31	3	NP	0	0	22	13	NP	1	0	2	2	NNP	0	0	1	1	Diamonti	0	0	1	0	NNP	0	1	2	1	AJ	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Guy	3	3	4	0	NNP	0	4	5	1	PM	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Ivanof	6	6	7	0	NNP	0	7	8	1	C	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Wong	9	9	10	0	NNP	0	10	11	1	K	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Sweeney	12	12	13	0	NNP	0	13	14	1	C	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Carraway	15	15	16	0	NNP	0	16	17	1	KL.	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	0	18	22	2	NP	0	18	19	1	JJ	0	18	19	1	3rd	18	18	19	0	NP	2	19	22	3	DT	0	19	20	1	An	19	19	20	0	NN	0	20	21	1	RBCC	20	20	21	0	NN	0	21	22	1	protein	21	21	22	0	VP	0	22	30	2	VBN	0	22	23	1	implicated	22	22	23	0	PP	0	23	30	2	IN	0	23	24	1	in	23	23	24	0	NP	0	24	30	2	NP	0	24	25	1	NN	0	24	25	1	maintenance	24	24	25	0	PP	0	25	30	2	IN	0	25	26	1	of	25	25	26	0	NP	3	26	30	4	JJ	0	26	27	1	steady-state	26	26	27	0	NN	0	27	28	1	neuregulin	27	27	28	0	NN	0	28	29	1	receptor	28	28	29	0	NNS	0	29	30	1	levels	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	14
Proceedings	38360	38371	NNP	Proceedings	O	_	_
of	38372	38374	IN	of	O	_	_
the	38375	38378	DT	the	O	_	_
National	38379	38387	NNP	National	O	_	_
Academy	38388	38395	NNP	Academy	O	_	_
of	38396	38398	IN	of	O	_	_
Sciences	38399	38407	NNPS	Sciences	O	_	_
of	38408	38410	IN	of	O	_	_
the	38411	38414	DT	the	O	_	_
United	38415	38421	NNP	United	O	_	_
States	38422	38428	NNPS	States	O	_	_
of	38429	38431	IN	of	O	_	_
America	38432	38439	NNP	America	O	_	_
.	38439	38440	.	.	O	_	_
D	1
0
0	4	prep_of
0	10	prep_of
0	12	prep_of
4	2	det
4	3	nn
4	6	prep_of
10	8	det
10	9	nn
EOX
Y	1
ROOT	0	0	14	1	NP	0	0	14	5	NP	0	0	1	1	NNP	0	0	1	1	Proceedings	0	0	1	0	PP	0	1	7	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	7	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	NNP	0	3	4	1	National	3	3	4	0	NNP	0	4	5	1	Academy	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NNPS	0	6	7	1	Sciences	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NNP	0	9	10	1	United	9	9	10	0	NNPS	0	10	11	1	States	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	13	1	NNP	0	12	13	1	America	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	6
2002	38441	38445	CD	2002	O	_	_
;	38445	38446	:	;	O	_	_
99:2866	38446	38453	CD	99:2866	O	_	_
‚	38453	38454	CD	‚	O	_	_
Äì2871	38454	38460	NN	äì2871	O	_	_
.	38460	38461	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2002	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	99:2866	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì2871	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
33	38462	38464	CD	33	O	_	_
.	38464	38465	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	33	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Turke	38466	38471	NNP	Turke	O	_	_
AB	38472	38474	NNP	AB	O	_	_
,	38474	38475	,	,	O	_	_
Zejnullahu	38476	38486	NNP	Zejnullahu	O	_	_
K	38487	38488	NNP	K	O	_	_
,	38488	38489	,	,	O	_	_
Wu	38490	38492	NNP	Wu	O	_	_
YL	38493	38495	NNP	YL	O	_	_
,	38495	38496	,	,	O	_	_
Song	38497	38501	NN	song	O	_	_
Y	38502	38503	NN	y	O	_	_
,	38503	38504	,	,	O	_	_
Dias-Santagata	38505	38519	NN	dias-santaga	O	_	_
D	38520	38521	NN	d	O	_	_
,	38521	38522	,	,	O	_	_
Lifshits	38523	38531	VBZ	lifshit	O	_	_
E	38532	38533	NN	e	O	_	_
,	38533	38534	,	,	O	_	_
et	38535	38537	FW	et	O	_	_
al.	38538	38540	FW	al.	O	_	_
.	38540	38541	.	.	O	_	_
D	1
15
1	0	nn
1	4	appos
1	7	appos
1	10	appos
1	13	appos
4	3	nn
7	6	nn
10	9	nn
13	12	nn
15	1	nsubj
15	16	dobj
16	19	appos
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	15	10	NP	1	0	2	2	NNP	0	0	1	1	Turke	0	0	1	0	NNP	0	1	2	1	AB	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Zejnullahu	3	3	4	0	NNP	0	4	5	1	K	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Wu	6	6	7	0	NNP	0	7	8	1	YL	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	Song	9	9	10	0	NN	0	10	11	1	Y	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	Dias-Santagata	12	12	13	0	NN	0	13	14	1	D	13	13	14	0	,	0	14	15	1	,	14	14	15	0	VP	0	15	20	2	VBZ	0	15	16	1	Lifshits	15	15	16	0	NP	0	16	20	3	NP	0	16	17	1	NN	0	16	17	1	E	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	35
Preexistence	38542	38554	NN	preexistence	O	_	_
and	38555	38558	CC	and	O	_	_
clonal	38559	38565	JJ	clonal	O	_	_
ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	38566	38641	NN	ôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøºôøº	O	_	_
MEK	38643	38646	NN	mek	B-GENE	_	_
inhibition	38647	38657	NN	inhibition	O	_	_
leads	38658	38663	VBZ	lead	O	_	_
to	38664	38666	TO	to	O	_	_
PI3K	38667	38671	NN	pi3k	B-GENE	_	_
/	38671	38672	:	/	B-GENE	_	_
AKT	38672	38675	NN	akt	I-GENE	_	_
activation	38676	38686	NN	activation	O	_	_
by	38687	38689	IN	by	O	_	_
relieving	38690	38699	VBG	relieve	O	_	_
a	38700	38701	DT	a	O	_	_
negative	38702	38710	JJ	negative	O	_	_
feedback	38711	38719	NN	feedback	O	_	_
on	38720	38722	IN	on	O	_	_
ERBB	38723	38727	NN	erbb	O	_	_
receptors	38728	38737	NNS	receptor	O	_	_
12	38738	38740	CD	12	O	_	_
/	38740	38741	:	/	O	_	_
8/14	38741	38745	CD	8/14	O	_	_
,	38745	38746	,	,	O	_	_
6:54	38747	38751	CD	6:54	O	_	_
PM	38752	38754	NN	pm	O	_	_
selection	38755	38764	NN	selection	O	_	_
of	38765	38767	IN	of	O	_	_
MET	38768	38771	NN	met	O	_	_
amplification	38772	38785	NN	amplification	O	_	_
in	38786	38788	IN	in	O	_	_
EGFR	38789	38793	NN	egfr	O	_	_
mutant	38794	38800	JJ	mutant	O	_	_
NSCLC	38801	38806	NN	nsclc	O	_	_
.	38806	38807	.	.	O	_	_
D	1
6
0	5	conj_and
5	2	amod
5	3	nn
5	4	nn
6	0	nsubj
6	5	nsubj
6	8	prep_to
6	22	dobj
8	11	dep
11	9	punct
11	10	nn
11	13	prepc_by
11	21	punct
13	16	dobj
13	19	prep_on
16	14	det
16	15	amod
19	18	nn
19	20	dep
22	26	appos
26	24	num
26	25	nn
26	29	prep_of
29	28	nn
29	33	prep_in
33	31	nn
33	32	amod
EOX
Y	1
ROOT	0	0	35	1	S	1	0	35	3	NP	0	0	6	3	NP	0	0	1	1	NN	0	0	1	1	Preexistence	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	NP	3	2	6	4	JJ	0	2	3	1	clonal	2	2	3	0	NN	0	3	4	1	ÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøºÔøº	3	3	4	0	NN	0	4	5	1	MEK	4	4	5	0	NN	0	5	6	1	inhibition	5	5	6	0	VP	0	6	34	3	VBZ	0	6	7	1	leads	6	6	7	0	PP	0	7	22	2	TO	0	7	8	1	to	7	7	8	0	NP	0	8	22	2	NP	0	8	9	1	NN	0	8	9	1	PI3K	8	8	9	0	PRN	1	9	22	3	:	0	9	10	1	/	9	9	10	0	NP	0	10	21	2	NP	1	10	12	2	NN	0	10	11	1	AKT	10	10	11	0	NN	0	11	12	1	activation	11	11	12	0	PP	0	12	21	2	IN	0	12	13	1	by	12	12	13	0	S	0	13	21	1	VP	0	13	21	3	VBG	0	13	14	1	relieving	13	13	14	0	NP	2	14	17	3	DT	0	14	15	1	a	14	14	15	0	JJ	0	15	16	1	negative	15	15	16	0	NN	0	16	17	1	feedback	16	16	17	0	PP	0	17	21	2	IN	0	17	18	1	on	17	17	18	0	NP	0	18	21	2	NP	1	18	20	2	NN	0	18	19	1	ERBB	18	18	19	0	NNS	0	19	20	1	receptors	19	19	20	0	NP	0	20	21	1	CD	0	20	21	1	12	20	20	21	0	:	0	21	22	1	/	21	21	22	0	NP	0	22	34	3	NP	0	22	23	1	CD	0	22	23	1	8/14	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	0	24	34	2	NP	2	24	27	3	CD	0	24	25	1	6:54	24	24	25	0	NN	0	25	26	1	PM	25	25	26	0	NN	0	26	27	1	selection	26	26	27	0	PP	0	27	34	2	IN	0	27	28	1	of	27	27	28	0	NP	0	28	34	2	NP	1	28	30	2	NN	0	28	29	1	MET	28	28	29	0	NN	0	29	30	1	amplification	29	29	30	0	PP	0	30	34	2	IN	0	30	31	1	in	30	30	31	0	NP	2	31	34	3	NN	0	31	32	1	EGFR	31	31	32	0	JJ	0	32	33	1	mutant	32	32	33	0	NN	0	33	34	1	NSCLC	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	3
Cancer	38808	38814	NN	cancer	O	_	_
Cell	38815	38819	NN	cell	O	_	_
.	38819	38820	.	.	O	_	_
D	1
0
0	1	dep
EOX
Y	1
ROOT	0	0	3	1	NP	0	0	3	3	NP	0	0	1	1	NN	0	0	1	1	Cancer	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	Cell	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	6
2010	38821	38825	CD	2010	O	_	_
;	38825	38826	:	;	O	_	_
17:77	38826	38831	CD	17:77	O	_	_
‚	38831	38832	CD	‚	O	_	_
Äì88	38832	38836	NN	äì88	O	_	_
.	38836	38837	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2010	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	17:77	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì88	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
34	38838	38840	CD	34	O	_	_
.	38840	38841	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	34	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	3
Hubbard	38842	38849	NNP	Hubbard	O	_	_
SR.	38850	38852	NNP	SR.	O	_	_
.	38852	38853	.	.	O	_	_
D	1
1
1	0	nn
EOX
Y	1
ROOT	0	0	3	1	NP	1	0	3	3	NNP	0	0	1	1	Hubbard	0	0	1	0	NNP	0	1	2	1	SR.	1	1	2	0	.	0	2	3	1	.	2	2	3	0
EOS
T	9
The	38854	38857	DT	the	O	_	_
juxtamembrane	38858	38871	NN	juxtamembrane	O	_	_
region	38872	38878	NN	region	O	_	_
of	38879	38881	IN	of	O	_	_
EGFR	38882	38886	NN	egfr	B-GENE	_	_
takes	38887	38892	VBZ	take	O	_	_
center	38893	38899	NN	center	O	_	_
stage	38900	38905	NN	stage	O	_	_
.	38905	38906	.	.	O	_	_
D	1
5
2	0	det
2	1	nn
2	4	prep_of
5	2	nsubj
5	7	dobj
7	6	nn
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	5	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	juxtamembrane	1	1	2	0	NN	0	2	3	1	region	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	EGFR	4	4	5	0	VP	0	5	8	2	VBZ	0	5	6	1	takes	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	center	6	6	7	0	NN	0	7	8	1	stage	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	2
Cell	38907	38911	NN	cell	O	_	_
.	38911	38912	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	NP	0	0	2	2	NN	0	0	1	1	Cell	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	6
2009	38913	38917	CD	2009	O	_	_
;	38917	38918	:	;	O	_	_
137:1181	38918	38926	CD	137:1181	O	_	_
‚	38926	38927	CD	‚	O	_	_
Äì1183	38927	38933	NN	äì1183	O	_	_
.	38933	38934	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2009	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	137:1181	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì1183	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
35	38935	38937	CD	35	O	_	_
.	38937	38938	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	35	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	21
Jura	38939	38943	NNP	Jura	O	_	_
N	38944	38945	NNP	N	O	_	_
,	38945	38946	,	,	O	_	_
Endres	38947	38953	NNP	Endres	O	_	_
NF	38954	38956	NN	nf	B-GENE	_	_
,	38956	38957	,	,	I-GENE	_	_
Engel	38958	38963	NNP	Engel	I-GENE	_	_
K	38964	38965	NNP	K	I-GENE	_	_
,	38965	38966	,	,	O	_	_
Deindl	38967	38973	NNP	Deindl	B-GENE	_	_
S	38974	38975	NN	s	I-GENE	_	_
,	38975	38976	,	,	I-GENE	_	_
Das	38977	38980	NN	da	I-GENE	_	_
R	38981	38982	NN	r	I-GENE	_	_
,	38982	38983	,	,	O	_	_
Lamers	38984	38990	NNP	Lamers	O	_	_
MH	38991	38993	NNP	MH	O	_	_
,	38993	38994	,	,	O	_	_
et	38995	38997	FW	et	O	_	_
al.	38998	39000	FW	al.	O	_	_
.	39000	39001	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
4	3	nn
4	7	appos
4	10	appos
4	13	appos
4	16	appos
4	19	appos
7	6	nn
10	9	nn
13	12	nn
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	NP	0	0	21	4	NP	1	0	2	2	NNP	0	0	1	1	Jura	0	0	1	0	NNP	0	1	2	1	N	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	20	11	NP	1	3	5	2	NNP	0	3	4	1	Endres	3	3	4	0	NN	0	4	5	1	NF	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Engel	6	6	7	0	NNP	0	7	8	1	K	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Deindl	9	9	10	0	NN	0	10	11	1	S	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	Das	12	12	13	0	NN	0	13	14	1	R	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Lamers	15	15	16	0	NNP	0	16	17	1	MH	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	FW	0	18	19	1	et	18	18	19	0	FW	0	19	20	1	al.	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	14
Mechanism	39002	39011	NN	mechanism	O	_	_
for	39012	39015	IN	for	O	_	_
activation	39016	39026	NN	activation	O	_	_
of	39027	39029	IN	of	O	_	_
the	39030	39033	DT	the	O	_	_
EGF	39034	39037	NN	egf	B-GENE	_	_
receptor	39038	39046	NN	receptor	I-GENE	_	_
catalytic	39047	39056	JJ	catalytic	I-GENE	_	_
domain	39057	39063	NN	domain	I-GENE	_	_
by	39064	39066	IN	by	O	_	_
the	39067	39070	DT	the	O	_	_
juxtamembrane	39071	39084	NN	juxtamembrane	O	_	_
segment	39085	39092	NN	segment	O	_	_
.	39092	39093	.	.	O	_	_
D	1
0
0	2	prep_for
0	8	prep_of
8	4	det
8	5	nn
8	6	nn
8	7	amod
8	12	prep_by
12	10	det
12	11	nn
EOX
Y	1
ROOT	0	0	14	1	NP	0	0	14	4	NP	0	0	1	1	NN	0	0	1	1	Mechanism	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	for	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	activation	2	2	3	0	PP	0	3	13	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	13	2	NP	4	4	9	5	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	EGF	5	5	6	0	NN	0	6	7	1	receptor	6	6	7	0	JJ	0	7	8	1	catalytic	7	7	8	0	NN	0	8	9	1	domain	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	by	9	9	10	0	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	juxtamembrane	11	11	12	0	NN	0	12	13	1	segment	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	2
Cell	39094	39098	NN	cell	O	_	_
.	39098	39099	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	NP	0	0	2	2	NN	0	0	1	1	Cell	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	6
2009	39100	39104	CD	2009	O	_	_
;	39104	39105	:	;	O	_	_
137:1293	39105	39113	CD	137:1293	O	_	_
‚	39113	39114	CD	‚	O	_	_
Äì1307	39114	39120	NN	äì1307	O	_	_
.	39120	39121	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	2009	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	137:1293	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì1307	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
36	39122	39124	CD	36	O	_	_
.	39124	39125	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	36	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	15
Northwood	39126	39135	NNP	Northwood	O	_	_
IC	39136	39138	NN	ic	O	_	_
,	39138	39139	,	,	O	_	_
Gonzalez	39140	39148	NNP	Gonzalez	O	_	_
FA	39149	39151	NNP	FA	O	_	_
,	39151	39152	,	,	O	_	_
Wartmann	39153	39161	NNP	Wartmann	O	_	_
M	39162	39163	NNP	M	O	_	_
,	39163	39164	,	,	O	_	_
Raden	39165	39170	NNP	Raden	O	_	_
DL	39171	39173	NNP	DL	O	_	_
,	39173	39174	,	,	O	_	_
Davis	39175	39180	NNP	Davis	O	_	_
RJ	39181	39183	NN	rj	O	_	_
.	39183	39184	.	.	O	_	_
D	1
1
1	0	nn
1	4	appos
1	7	appos
1	10	appos
1	13	appos
4	3	nn
7	6	nn
10	9	nn
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	NP	0	0	15	10	NP	1	0	2	2	NNP	0	0	1	1	Northwood	0	0	1	0	NN	0	1	2	1	IC	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Gonzalez	3	3	4	0	NNP	0	4	5	1	FA	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Wartmann	6	6	7	0	NNP	0	7	8	1	M	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	11	2	NNP	0	9	10	1	Raden	9	9	10	0	NNP	0	10	11	1	DL	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Davis	12	12	13	0	NN	0	13	14	1	RJ	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	21
Isolation	39185	39194	NN	isolation	O	_	_
and	39195	39198	CC	and	O	_	_
characterization	39199	39215	NN	characterization	O	_	_
of	39216	39218	IN	of	O	_	_
two	39219	39222	CD	two	O	_	_
growth	39223	39229	NN	growth	B-GENE	_	_
factor	39230	39236	NN	factor	I-GENE	_	_
stimulated	39237	39247	VBN	stimulate	I-GENE	_	_
protein	39248	39255	NN	protein	I-GENE	_	_
kinases	39256	39263	NNS	kinase	I-GENE	_	_
that	39264	39268	WDT	that	O	_	_
phosphorylate	39269	39282	VBP	phosphorylate	O	_	_
the	39283	39286	DT	the	O	_	_
epidermal	39287	39296	JJ	epidermal	B-GENE	_	_
growth	39297	39303	NN	growth	I-GENE	_	_
factor	39304	39310	NN	factor	I-GENE	_	_
receptor	39311	39319	NN	receptor	I-GENE	_	_
at	39320	39322	IN	at	O	_	_
threonine	39323	39332	NN	threonine	O	_	_
669	39333	39336	CD	669	O	_	_
.	39336	39337	.	.	O	_	_
D	1
7
0	2	conj_and
0	6	prep_of
6	4	num
6	5	nn
7	0	nsubj
7	2	nsubj
7	9	dobj
9	8	nn
9	11	rcmod
11	10	nsubj
11	16	dobj
16	12	det
16	13	amod
16	14	nn
16	15	nn
16	18	prep_at
18	19	num
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	7	2	NP	0	0	3	3	NN	0	0	1	1	Isolation	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	NN	0	2	3	1	characterization	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	of	3	3	4	0	NP	2	4	7	3	CD	0	4	5	1	two	4	4	5	0	NN	0	5	6	1	growth	5	5	6	0	NN	0	6	7	1	factor	6	6	7	0	VP	0	7	20	2	VBN	0	7	8	1	stimulated	7	7	8	0	NP	0	8	20	2	NP	1	8	10	2	NN	0	8	9	1	protein	8	8	9	0	NNS	0	9	10	1	kinases	9	9	10	0	SBAR	1	10	20	2	WHNP	0	10	11	1	WDT	0	10	11	1	that	10	10	11	0	S	0	11	20	1	VP	0	11	20	2	VBP	0	11	12	1	phosphorylate	11	11	12	0	NP	0	12	20	2	NP	4	12	17	5	DT	0	12	13	1	the	12	12	13	0	JJ	0	13	14	1	epidermal	13	13	14	0	NN	0	14	15	1	growth	14	14	15	0	NN	0	15	16	1	factor	15	15	16	0	NN	0	16	17	1	receptor	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	at	17	17	18	0	NP	0	18	20	2	NN	0	18	19	1	threonine	18	18	19	0	CD	0	19	20	1	669	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	4
J	39338	39339	NNP	J	O	_	_
Biol	39340	39344	NNP	Biol	O	_	_
Chem	39345	39349	NNP	Chem	O	_	_
.	39349	39350	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
EOX
Y	1
ROOT	0	0	4	1	NP	2	0	4	4	NNP	0	0	1	1	J	0	0	1	0	NNP	0	1	2	1	Biol	1	1	2	0	NNP	0	2	3	1	Chem	2	2	3	0	.	0	3	4	1	.	3	3	4	0
EOS
T	6
1991	39351	39355	CD	1991	O	_	_
;	39355	39356	:	;	O	_	_
266:15266	39356	39365	CD	266:15266	O	_	_
‚	39365	39366	CD	‚	O	_	_
Äì15276	39366	39373	NN	äì15276	O	_	_
.	39373	39374	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	1991	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	266:15266	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì15276	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
T	2
37	39375	39377	CD	37	O	_	_
.	39377	39378	.	.	O	_	_
D	1
0
EOX
Y	1
ROOT	0	0	2	1	FRAG	0	0	2	2	NP	0	0	1	1	CD	0	0	1	1	37	0	0	1	0	.	0	1	2	1	.	1	1	2	0
EOS
T	33
Takishima	39379	39388	NNP	Takishima	O	_	_
K	39389	39390	NNP	K	O	_	_
,	39390	39391	,	,	O	_	_
Griswold-Prenner	39392	39408	NNP	Griswold-Prenner	O	_	_
I	39409	39410	NNP	I	O	_	_
,	39410	39411	,	,	O	_	_
Ingebritsen	39412	39423	NNP	Ingebritsen	O	_	_
T	39424	39425	NN	t	O	_	_
,	39425	39426	,	,	O	_	_
Rosner	39427	39433	NNP	Rosner	O	_	_
MR.	39434	39437	NNP	MR.	O	_	_
Epidermal	39438	39447	NNP	Epidermal	B-GENE	_	_
growth	39448	39454	NN	growth	I-GENE	_	_
factor	39455	39461	NN	factor	I-GENE	_	_
(	39462	39463	CD	(	I-GENE	_	_
EGF	39463	39466	NN	egf	I-GENE	_	_
)	39466	39467	NN	)	I-GENE	_	_
receptor	39468	39476	NN	receptor	I-GENE	_	_
T669	39477	39481	NN	t669	I-GENE	_	_
peptide	39482	39489	NN	peptide	I-GENE	_	_
kinase	39490	39496	NN	kinase	O	_	_
from	39497	39501	IN	from	O	_	_
3T3-L1	39502	39508	NN	3t3-l1	O	_	_
cells	39509	39514	NNS	cell	O	_	_
is	39515	39517	VBZ	be	O	_	_
an	39518	39520	DT	a	O	_	_
EGF	39521	39524	NN	egf	B-GENE	_	_
stimulated	39525	39535	VBD	stimulate	I-GENE	_	_
"	39535	39536	``	"	I-GENE	_	_
MAP	39536	39539	NN	map	I-GENE	_	_
"	39539	39540	''	"	I-GENE	_	_
kinase	39541	39547	NN	kinase	I-GENE	_	_
.	39547	39548	.	.	O	_	_
D	1
27
1	0	nn
1	4	appos
1	7	appos
1	17	appos
4	3	nn
7	6	nn
17	9	nn
17	10	nn
17	11	nn
17	12	nn
17	13	nn
17	14	num
17	15	nn
17	16	nn
17	20	dep
20	18	nn
20	19	nn
20	23	prep_from
23	22	nn
26	1	nsubj
26	24	cop
26	25	det
27	26	dep
27	28	punct
27	29	dobj
27	30	punct
27	31	nsubj
EOX
Y	1
ROOT	0	0	33	1	SINV	1	0	33	4	S	1	0	27	2	NP	0	0	24	7	NP	1	0	2	2	NNP	0	0	1	1	Takishima	0	0	1	0	NNP	0	1	2	1	K	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	1	3	5	2	NNP	0	3	4	1	Griswold-Prenner	3	3	4	0	NNP	0	4	5	1	I	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	1	6	8	2	NNP	0	6	7	1	Ingebritsen	6	6	7	0	NN	0	7	8	1	T	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	0	9	24	2	NP	8	9	18	9	NNP	0	9	10	1	Rosner	9	9	10	0	NNP	0	10	11	1	MR.	10	10	11	0	NNP	0	11	12	1	Epidermal	11	11	12	0	NN	0	12	13	1	growth	12	12	13	0	NN	0	13	14	1	factor	13	13	14	0	CD	0	14	15	1	(	14	14	15	0	NN	0	15	16	1	EGF	15	15	16	0	NN	0	16	17	1	)	16	16	17	0	NN	0	17	18	1	receptor	17	17	18	0	NP	0	18	24	2	NP	2	18	21	3	NN	0	18	19	1	T669	18	18	19	0	NN	0	19	20	1	peptide	19	19	20	0	NN	0	20	21	1	kinase	20	20	21	0	PP	0	21	24	2	IN	0	21	22	1	from	21	21	22	0	NP	1	22	24	2	NN	0	22	23	1	3T3-L1	22	22	23	0	NNS	0	23	24	1	cells	23	23	24	0	VP	1	24	27	2	VBZ	0	24	25	1	is	24	24	25	0	NP	1	25	27	2	DT	0	25	26	1	an	25	25	26	0	NN	0	26	27	1	EGF	26	26	27	0	VP	0	27	31	4	VBD	0	27	28	1	stimulated	27	27	28	0	``	0	28	29	1	"	28	28	29	0	NP	0	29	30	1	NN	0	29	30	1	MAP	29	29	30	0	''	0	30	31	1	"	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	kinase	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	14
Proceedings	39549	39560	NNP	Proceedings	O	_	_
of	39561	39563	IN	of	O	_	_
the	39564	39567	DT	the	O	_	_
National	39568	39576	NNP	National	O	_	_
Academy	39577	39584	NNP	Academy	O	_	_
of	39585	39587	IN	of	O	_	_
Sciences	39588	39596	NNPS	Sciences	O	_	_
of	39597	39599	IN	of	O	_	_
the	39600	39603	DT	the	O	_	_
United	39604	39610	NNP	United	O	_	_
States	39611	39617	NNPS	States	O	_	_
of	39618	39620	IN	of	O	_	_
America	39621	39628	NNP	America	O	_	_
.	39628	39629	.	.	O	_	_
D	1
0
0	4	prep_of
0	10	prep_of
0	12	prep_of
4	2	det
4	3	nn
4	6	prep_of
10	8	det
10	9	nn
EOX
Y	1
ROOT	0	0	14	1	NP	0	0	14	5	NP	0	0	1	1	NNP	0	0	1	1	Proceedings	0	0	1	0	PP	0	1	7	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	7	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	NNP	0	3	4	1	National	3	3	4	0	NNP	0	4	5	1	Academy	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NNPS	0	6	7	1	Sciences	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NNP	0	9	10	1	United	9	9	10	0	NNPS	0	10	11	1	States	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	13	1	NNP	0	12	13	1	America	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	6
1991	39630	39634	CD	1991	O	_	_
;	39634	39635	:	;	O	_	_
88:2520	39635	39642	CD	88:2520	O	_	_
‚	39642	39643	CD	‚	O	_	_
Äì2524	39643	39649	NN	äì2524	O	_	_
.	39649	39650	.	.	O	_	_
D	1
0
0	4	dep
3	2	number
4	3	num
EOX
Y	1
ROOT	0	0	6	1	NP	0	0	6	4	NP	0	0	1	1	CD	0	0	1	1	1991	0	0	1	0	:	0	1	2	1	;	1	1	2	0	NP	1	2	5	2	QP	1	2	4	2	CD	0	2	3	1	88:2520	2	2	3	0	CD	0	3	4	1	‚	3	3	4	0	NN	0	4	5	1	Äì2524	4	4	5	0	.	0	5	6	1	.	5	5	6	0
EOS
C	1746
145	40	39	44	1173
85	49	49	57	637
1	20	19	21	8
318	7	6	8	1838
106	45	45	47	178
277	10	8	11	1430
78	9	9	10	563
54	15	13	16	415
155	23	21	41	1243
108	15	14	16	27
152	0	0	1	1212
135	10	10	13	36
310	6	3	12	1810
1	8	7	9	5
10	42	39	43	105
308	4	2	5	1806
4	26	23	27	32
24	17	15	27	218
230	0	0	6	1545
213	5	5	8	1471
247	7	6	8	1596
155	10	10	15	1239
161	21	20	33	265
59	7	6	26	460
10	3	3	6	96
328	16	15	17	1873
43	35	33	36	347
263	11	9	12	1662
178	4	2	5	1343
105	42	39	43	816
12	37	35	38	136
7	12	11	19	58
82	10	9	11	475
8	38	36	39	80
147	9	8	14	1187
147	13	11	14	583
162	12	11	13	1293
155	19	18	20	619
93	1	0	2	619
121	10	7	19	955
3	11	10	12	20
105	27	27	28	94
43	26	24	30	345
311	3	0	5	1812
55	4	3	5	421
139	16	15	22	1115
299	0	0	1	1780
232	3	3	4	1548
30	41	41	42	86
81	6	5	10	607
96	19	17	20	728
215	4	2	5	1480
173	0	0	3	1333
257	4	3	5	1643
158	21	20	22	1264
181	2	2	5	1356
35	20	19	37	290
148	10	9	14	1184
227	16	15	17	1531
84	5	4	8	263
315	10	8	11	1430
45	8	6	18	358
60	1	0	2	464
12	44	44	46	115
122	17	16	18	20
102	6	6	7	716
130	3	3	4	1048
51	15	13	16	84
91	12	12	19	686
12	51	48	52	140
89	7	7	16	659
50	20	18	21	387
126	10	9	11	988
112	15	12	18	879
23	2	1	3	17
143	28	27	29	902
334	9	8	20	1892
85	34	32	35	631
64	23	22	27	500
290	1	0	9	1752
149	12	11	19	1184
152	34	32	37	1220
126	27	27	36	1009
229	1	1	2	77
50	0	0	1	361
312	4	2	5	1814
55	19	19	20	416
11	7	5	8	84
15	28	28	34	165
134	17	15	20	1079
23	17	15	24	210
285	7	6	8	1461
131	6	6	11	1055
111	15	14	23	874
218	39	39	40	94
328	7	5	8	1865
120	2	0	3	947
43	14	14	36	342
52	12	12	19	409
136	18	17	19	1096
224	2	0	4	1519
13	23	23	50	24
69	16	13	19	529
218	23	22	36	1492
39	6	5	7	322
228	8	7	9	1277
58	15	13	16	453
190	16	15	17	1381
114	18	18	27	898
300	10	9	11	1786
135	0	0	1	1082
97	7	7	8	453
149	16	14	19	1063
119	8	7	9	940
107	1	0	10	840
202	1	0	2	1432
129	71	67	82	1044
133	19	17	20	1075
117	53	53	55	929
7	20	20	23	3
27	0	0	17	234
228	14	13	15	699
51	26	23	27	396
140	20	19	21	1121
145	31	30	36	1120
329	0	0	14	1875
102	22	22	28	789
96	24	21	25	623
168	2	1	3	1325
296	12	12	16	1776
112	10	9	18	878
85	11	10	14	625
262	11	10	12	1656
153	35	34	36	1230
91	0	0	4	682
157	35	34	39	1263
38	13	10	36	313
149	7	5	8	1184
9	16	15	18	85
314	16	15	17	1808
98	14	11	15	713
140	33	31	34	84
164	11	11	14	1309
252	19	18	20	1353
174	4	2	5	1335
132	16	14	30	1062
36	31	30	35	302
10	37	36	38	104
194	4	3	20	1390
162	23	22	24	1298
204	1	0	2	1251
278	0	0	6	1716
154	14	13	15	108
194	16	15	17	1395
292	2	0	4	1759
326	0	0	6	1862
7	47	45	48	65
5	15	15	18	36
81	3	1	10	606
318	10	9	11	1465
22	15	14	18	200
268	18	18	23	1681
153	5	4	6	619
22	5	4	6	198
128	22	21	30	1026
333	4	3	5	1884
269	2	0	4	1519
319	11	10	21	263
33	8	8	9	275
121	26	25	27	20
42	2	0	5	336
303	0	0	6	1793
190	1	0	22	1374
151	9	8	13	1206
64	20	20	22	499
117	1	0	2	20
120	9	9	20	949
143	21	19	26	1153
56	19	19	22	422
50	12	12	13	386
233	10	9	11	1566
180	4	3	20	1347
143	8	8	26	1150
145	41	41	42	1119
123	19	17	20	261
128	18	13	19	1024
127	13	13	18	1017
83	22	21	25	617
90	52	52	54	1
30	32	31	54	263
55	24	22	26	425
15	14	12	24	160
148	0	0	1	1119
14	14	12	15	157
30	9	9	10	256
94	5	4	12	711
105	28	28	30	179
201	4	2	7	1428
185	1	0	9	1362
9	25	24	26	90
55	21	20	22	417
203	4	3	20	1437
117	26	25	27	923
214	0	0	14	1427
92	17	17	25	692
47	10	10	11	235
25	19	19	22	23
275	16	15	17	1706
65	17	15	18	506
190	21	18	22	1382
215	0	0	6	1479
318	1	0	14	1835
104	8	6	11	801
122	36	36	39	23
146	6	3	7	1063
153	11	11	12	1223
23	12	11	13	20
127	6	5	7	350
140	9	9	51	1120
65	5	4	8	263
10	24	23	28	100
155	18	18	19	1221
71	25	24	26	87
10	19	19	20	94
290	4	3	5	1752
85	28	27	29	595
56	25	24	38	433
139	5	5	6	841
97	9	9	10	716
124	26	25	31	996
26	0	0	4	228
190	7	6	8	1377
141	18	17	19	1138
268	22	21	23	200
3	25	25	26	24
150	12	11	13	1200
76	33	33	39	581
100	32	31	33	763
32	0	0	1	131
62	10	10	16	483
237	19	18	20	1353
277	6	6	7	1429
123	3	2	4	975
208	10	8	11	1455
81	12	11	17	609
193	0	0	1	1387
4	0	0	1	18
195	20	20	23	837
21	2	2	3	187
100	25	25	33	657
261	0	0	1	902
25	2	0	3	38
26	11	9	19	231
63	13	13	20	491
64	17	17	18	49
30	1	0	6	253
250	0	0	6	1613
107	9	8	10	20
93	52	52	57	155
132	2	2	12	1059
96	30	29	31	730
124	20	19	31	994
159	9	8	10	1259
7	49	49	70	66
319	29	28	34	1852
156	11	10	31	1251
128	5	4	6	975
225	0	0	7	1520
58	30	26	36	199
267	19	18	20	1353
316	4	2	5	1833
12	1	1	11	127
293	0	0	6	1760
150	24	22	25	1203
76	23	7	39	573
106	15	12	49	829
73	1	1	6	211
330	0	0	2	1369
145	33	33	36	114
263	2	0	13	1660
280	13	12	14	1725
155	34	33	37	813
183	4	2	5	1360
157	32	32	39	1262
335	2	0	4	1598
275	7	6	8	1703
73	15	15	16	95
6	4	3	5	45
60	9	5	17	465
123	40	38	41	837
273	6	0	13	1696
22	38	38	39	195
48	42	41	46	379
92	4	3	5	398
273	11	9	12	1697
93	18	18	21	23
7	24	24	25	51
78	7	5	8	588
106	8	7	11	757
7	23	22	24	60
79	26	25	27	598
340	0	0	6	1915
106	47	47	49	179
237	16	12	17	1577
138	8	7	11	1103
10	20	20	38	99
146	19	18	20	20
101	39	38	40	96
129	43	43	44	921
34	1	0	2	282
102	31	30	48	791
252	4	3	5	1575
298	0	0	6	1778
275	10	9	11	1704
5	19	17	29	42
37	23	18	24	307
66	23	22	24	516
206	4	2	5	1451
164	1	0	25	1304
7	7	6	8	57
4	36	36	39	23
11	19	19	26	114
38	17	14	18	315
140	22	21	40	1122
74	15	14	16	20
113	10	10	48	882
25	9	7	10	223
8	19	19	23	75
141	21	19	22	902
106	43	42	44	773
320	0	0	3	1333
135	6	6	7	1080
25	29	28	33	227
108	10	7	11	853
319	33	31	34	1853
314	18	18	22	1817
328	4	3	20	1870
22	11	11	12	197
9	19	19	28	87
105	12	11	13	20
93	16	15	43	699
268	14	9	15	1678
9	23	21	26	87
93	56	54	57	145
316	0	0	6	1832
111	5	2	8	871
334	18	18	20	895
69	4	3	5	20
14	4	4	10	155
35	15	12	19	287
295	13	12	14	1768
107	16	16	22	844
54	5	4	8	413
97	12	12	21	734
143	13	12	14	20
13	0	0	1	141
228	16	16	21	1540
14	9	6	10	156
100	27	27	33	657
85	20	20	29	626
262	20	19	21	1353
152	26	26	31	954
59	9	9	26	461
11	43	42	44	102
123	33	32	35	85
268	15	15	22	1676
166	1	0	3	1319
46	0	0	9	360
315	4	2	7	1428
13	35	35	40	152
15	9	8	10	20
98	40	40	41	453
319	19	18	21	85
99	2	2	3	716
38	24	23	36	317
88	1	1	5	649
195	6	6	8	1
138	31	28	32	165
197	4	2	5	1414
48	37	36	39	378
53	6	4	14	412
95	3	2	16	721
90	55	54	56	22
122	9	9	44	963
90	22	21	53	263
73	13	13	21	562
68	7	7	12	521
143	6	6	7	1149
101	23	23	36	774
329	8	4	13	1876
124	25	25	26	921
98	16	16	17	731
333	7	6	8	1885
100	8	8	11	38
24	10	9	15	216
213	12	11	13	1251
102	45	44	48	794
310	11	8	12	1811
153	9	8	10	1223
88	4	3	5	362
114	16	14	27	897
287	1	0	3	1748
11	24	24	26	115
144	7	6	8	1158
66	15	13	16	145
74	21	18	22	568
235	0	0	6	1570
69	11	11	12	520
65	20	19	30	507
315	0	0	14	1427
233	2	2	5	1564
219	2	0	4	1502
57	0	0	24	441
339	0	0	14	1427
133	15	15	20	1074
19	21	20	25	185
331	0	0	6	1879
106	5	4	11	829
80	18	17	22	602
111	12	10	23	873
296	7	7	11	1775
108	2	0	3	852
11	37	36	41	120
56	17	16	18	421
94	1	0	2	20
164	23	23	24	1315
30	5	3	6	255
72	5	4	6	20
76	10	10	22	575
162	26	25	27	1299
137	10	9	17	1099
23	4	4	5	207
99	9	8	10	751
120	5	5	8	870
13	15	13	16	146
210	4	2	5	1459
25	17	16	33	225
87	8	7	9	636
71	8	8	10	1
220	4	2	5	1504
277	4	2	7	1428
303	4	2	5	1794
102	14	14	15	179
146	1	1	7	1181
153	30	29	36	1229
72	9	8	19	556
237	13	13	14	1581
19	24	22	25	186
130	16	15	17	951
336	0	0	6	1896
70	18	17	19	532
90	27	25	28	84
27	5	3	6	238
218	38	37	39	1500
214	10	8	11	1430
198	0	0	1	1415
121	5	5	19	954
27	12	12	13	235
162	39	37	40	1302
256	17	17	18	86
203	16	15	17	1389
270	4	2	5	1685
161	18	16	19	84
145	28	27	29	1170
164	13	13	14	1314
59	2	0	3	192
296	4	2	6	1774
195	27	26	35	1409
144	4	4	5	1119
85	16	0	19	622
103	4	3	5	27
104	11	11	13	800
91	16	14	19	146
155	40	38	41	1248
130	9	5	23	1048
280	19	18	20	1353
339	6	6	7	1429
208	4	3	5	1454
43	13	11	14	341
117	11	11	52	918
28	11	11	14	248
145	45	45	59	1175
71	30	30	33	550
40	1	0	2	324
61	30	30	38	469
86	23	22	24	20
161	1	0	8	1276
126	4	4	5	921
123	16	15	52	979
13	39	37	40	153
122	2	2	5	950
315	6	6	7	1429
338	13	12	20	1900
324	2	0	5	1859
7	16	16	17	49
113	42	41	48	890
106	1	0	2	619
35	36	34	37	295
296	2	2	4	1771
90	46	45	50	679
9	30	29	31	92
119	10	10	11	921
72	1	0	2	45
66	2	2	10	511
162	14	14	18	1294
43	16	16	23	343
217	4	3	20	1484
75	3	1	4	569
110	8	6	13	865
30	26	22	27	261
124	1	1	6	990
22	33	32	40	163
150	2	2	5	845
204	12	12	16	1447
57	10	10	11	445
176	8	6	12	1339
127	17	15	18	1019
85	40	39	44	633
126	32	29	36	1010
99	8	8	9	179
7	36	35	48	62
190	10	9	11	1379
19	6	5	7	182
218	35	35	39	1499
118	26	25	27	453
127	0	0	1	921
119	0	0	6	939
89	11	10	13	661
102	18	17	21	788
106	18	18	20	1
195	24	23	25	1408
140	28	27	38	263
103	12	10	13	763
71	22	22	26	87
242	13	12	14	1595
328	19	18	20	1353
284	0	0	1	1734
242	16	15	17	1596
27	2	2	11	235
129	9	9	16	1028
142	15	15	18	38
129	32	30	33	1037
56	35	33	38	243
245	4	2	5	1600
157	26	24	27	1260
49	6	5	7	381
102	27	24	28	790
17	5	3	9	171
129	86	84	87	1047
85	5	4	8	624
176	11	10	12	1340
40	19	16	23	327
54	10	10	13	414
123	25	24	26	28
199	1	0	15	1416
56	0	0	1	429
4	4	3	5	27
195	14	12	15	84
68	16	16	21	524
87	14	13	18	642
102	34	33	35	22
319	0	0	6	1843
268	7	4	8	1679
90	37	35	38	87
106	32	32	39	87
140	36	35	38	85
50	6	4	21	383
77	23	21	24	586
195	18	18	19	86
131	8	7	10	1053
85	43	42	44	20
140	43	41	51	1128
119	25	22	30	945
134	6	4	7	910
253	2	0	3	65
180	19	18	20	1353
33	10	9	11	276
291	10	9	12	1758
276	6	6	15	1709
107	4	3	5	841
71	11	10	12	28
139	1	0	2	1111
94	17	17	32	715
67	3	1	4	517
130	12	12	13	921
285	10	9	11	1461
180	0	0	1	1344
44	20	19	21	321
300	19	18	20	1353
11	32	30	33	119
51	34	32	47	399
247	4	3	8	1603
274	0	0	1	1698
152	13	12	37	1215
85	25	25	29	628
233	6	5	7	458
93	13	13	15	1
43	0	0	3	339
201	10	8	11	1430
285	4	3	17	1461
161	24	24	29	837
7	26	25	27	52
90	3	2	4	636
134	1	0	2	45
334	13	13	14	1491
29	6	5	10	251
78	19	17	20	591
153	27	25	28	1203
7	29	27	30	61
263	7	4	8	1661
126	42	41	48	1012
98	5	3	6	631
10	34	33	38	103
86	1	1	4	639
327	0	0	1	1864
164	21	21	22	1317
156	19	17	22	714
57	2	1	3	20
217	13	12	14	1488
317	0	0	1	1834
288	4	2	5	1750
217	1	0	21	1482
35	32	31	33	289
51	36	36	47	400
126	35	34	36	20
338	23	22	24	1908
26	18	17	19	233
35	3	0	4	284
164	4	3	5	1305
129	12	10	42	1033
99	17	16	18	362
13	11	9	16	144
252	7	6	8	1575
129	6	3	9	1031
92	11	8	12	690
29	8	7	10	252
312	0	0	6	1813
5	10	7	16	38
203	1	0	21	1395
204	15	14	16	1423
195	3	2	4	20
12	42	42	45	138
110	21	20	25	868
10	10	10	17	97
9	13	11	14	84
232	6	6	7	1550
110	10	10	13	36
118	21	20	24	937
148	7	6	14	1191
69	22	21	26	530
158	28	28	31	23
286	0	0	11	1743
30	43	43	47	87
21	17	17	21	193
116	17	16	18	504
257	7	6	8	1644
62	21	19	22	463
75	5	5	6	563
126	2	1	3	1002
204	6	4	7	1445
80	24	23	29	604
129	40	40	41	657
12	40	39	41	1
191	1	1	2	77
2	8	8	13	10
88	29	28	33	28
119	29	27	30	946
62	15	12	16	484
98	42	42	44	747
101	3	2	6	770
70	6	3	12	533
102	12	12	15	787
249	2	0	4	1598
118	8	7	11	934
115	27	26	28	902
300	16	15	17	1434
43	28	27	30	346
242	10	9	11	1575
38	35	32	36	320
102	44	44	45	784
295	10	9	11	1767
71	16	14	17	84
228	12	11	24	1538
237	0	0	21	1573
68	11	9	12	522
110	1	1	4	23
221	0	0	1	1505
319	26	24	34	1850
128	11	11	19	1023
11	10	9	14	111
272	7	6	8	1688
314	4	3	5	1818
296	8	8	11	1676
7	48	48	49	49
105	69	68	72	813
86	18	17	24	642
154	3	2	4	17
14	2	1	3	154
11	3	0	4	108
237	12	12	13	1581
61	33	32	41	479
153	1	1	2	1221
257	10	9	11	1645
203	19	18	20	1353
6	15	13	19	47
40	10	5	13	325
56	37	37	38	235
314	13	12	14	1821
87	17	16	18	20
6	11	6	19	46
11	22	21	25	115
190	13	12	14	1380
256	5	5	7	1
295	19	18	20	1353
164	6	6	24	1306
132	29	28	30	22
80	14	14	15	563
82	5	3	6	611
281	3	3	12	1728
92	20	20	23	693
208	1	0	2	1453
181	0	0	9	1354
262	2	2	21	1653
62	18	17	19	210
132	33	32	37	829
105	3	3	4	716
105	15	15	36	812
71	37	37	40	553
86	15	14	24	641
159	19	18	20	163
68	0	0	1	520
147	1	0	2	641
121	14	12	19	225
218	41	40	44	1501
77	4	3	15	582
169	4	2	5	1328
21	26	26	27	24
124	8	7	9	20
84	13	11	14	600
149	2	2	3	1119
23	8	6	9	208
331	4	2	5	1880
38	8	8	36	311
161	28	26	29	837
192	4	2	5	1386
72	14	11	19	557
123	36	36	41	837
248	10	10	15	1610
93	30	30	37	703
105	30	30	31	94
176	1	0	13	1336
217	16	15	17	1489
24	0	0	1	207
326	4	2	5	1863
109	9	8	12	717
4	6	6	39	28
336	4	2	5	1897
238	6	5	9	1584
140	11	11	13	1
51	31	30	32	398
262	14	13	15	1575
126	13	12	14	1006
90	10	10	12	1
169	0	0	6	1327
162	9	8	36	1290
101	44	42	57	778
25	5	5	10	222
285	16	15	17	1742
233	7	6	8	200
154	22	21	23	1236
129	57	53	64	1042
24	14	12	15	217
171	4	3	5	1330
44	12	8	13	351
306	5	4	9	1799
136	11	11	12	24
52	7	6	19	406
281	14	13	15	1730
243	9	6	10	1597
291	0	0	5	1756
138	21	21	22	95
338	17	9	24	1906
57	7	7	10	36
156	6	5	9	263
73	5	5	6	24
242	7	6	8	1593
144	20	19	27	1162
44	4	3	5	350
27	8	7	11	239
30	37	35	38	84
232	4	3	5	1556
232	10	9	11	1558
77	14	12	15	463
43	22	20	23	344
9	8	7	9	28
132	5	5	7	1055
22	12	8	21	199
157	5	4	8	717
24	6	5	7	84
61	29	29	41	478
205	0	0	2	1449
117	19	19	20	921
122	7	6	8	27
199	10	9	11	1420
136	1	0	5	1089
204	10	9	11	1446
144	17	17	27	1161
35	24	23	37	291
69	25	24	26	531
163	45	44	46	1303
4	13	13	16	29
145	7	6	15	1166
194	10	9	11	1393
117	14	13	19	225
162	33	32	36	1301
105	66	65	67	822
2	15	15	21	12
197	0	0	6	1413
83	1	0	2	20
64	1	0	2	84
195	31	30	32	1373
36	34	33	35	303
319	16	14	17	84
277	12	12	13	1431
278	4	2	5	1717
181	14	13	15	1357
26	14	13	19	232
106	30	30	46	835
333	1	0	15	1882
300	4	3	20	1783
125	21	20	22	20
162	17	16	18	420
211	0	0	1	165
122	43	42	44	916
328	13	10	14	1867
90	14	5	56	667
124	12	11	17	992
123	5	5	6	921
52	0	0	1	131
267	10	9	11	1672
79	10	9	11	595
35	7	7	19	285
12	16	16	17	131
190	6	6	7	1372
168	0	0	4	1326
164	19	19	20	1314
252	10	9	11	1575
8	2	0	7	72
124	14	14	17	993
188	0	0	6	1370
140	52	52	60	224
142	1	0	2	841
185	4	3	8	1364
90	31	31	32	86
35	29	27	37	292
85	1	1	16	623
93	42	42	45	36
93	11	10	14	698
275	19	18	20	1353
4	18	17	27	30
55	41	40	42	428
33	0	0	5	277
262	5	4	6	1654
76	31	28	39	580
91	9	8	10	7
30	46	45	47	87
38	29	28	36	319
280	1	0	8	1453
151	18	15	29	1209
31	5	4	6	272
74	9	8	10	20
295	16	15	17	1769
328	1	0	21	1868
101	16	15	17	772
291	4	2	5	1757
228	3	3	25	1535
51	7	7	27	262
136	15	15	19	1095
201	12	12	13	1431
90	33	33	38	87
194	7	6	8	1392
85	56	51	57	638
33	27	25	28	281
199	7	6	8	1419
230	4	2	5	1546
286	4	2	11	1744
338	1	0	24	1902
106	0	0	1	716
136	9	9	12	1092
100	3	2	11	756
7	43	43	44	64
129	35	34	42	1038
8	15	13	29	74
156	14	13	15	763
124	30	28	31	958
66	17	17	18	515
111	0	0	8	870
314	21	19	22	1824
94	29	29	32	718
333	10	9	11	1886
223	3	0	17	1515
228	5	4	7	1533
88	16	15	20	652
129	16	16	20	1034
151	6	5	13	1205
105	38	38	59	815
217	10	9	11	1487
222	1	0	21	1506
145	54	54	59	1177
12	8	5	11	129
232	9	9	10	1552
225	3	2	6	1521
100	44	44	52	131
98	33	33	44	744
248	8	3	15	1609
140	2	1	3	17
126	7	6	19	1004
256	19	19	24	837
40	16	16	17	323
218	21	21	22	1491
97	20	19	21	20
267	7	6	8	1671
318	16	16	20	1622
137	4	3	8	1097
117	39	39	42	23
256	13	11	14	84
159	3	2	4	619
66	9	8	10	513
61	12	11	41	473
27	21	20	24	243
30	53	53	54	271
161	10	10	12	1
121	16	16	19	23
0	4	4	6	1
81	9	8	10	254
286	14	12	21	1746
120	17	15	20	952
314	1	0	31	1816
58	29	29	30	197
167	6	6	11	1321
177	1	0	3	1341
38	10	10	13	314
252	1	0	14	1616
33	14	8	15	279
30	13	13	14	257
195	9	8	10	28
56	4	4	5	430
62	0	0	1	445
100	6	5	11	757
186	10	9	11	101
2	29	27	30	15
96	15	15	20	727
115	24	24	25	902
26	3	2	4	208
88	32	31	33	656
152	17	15	37	1216
105	8	8	59	810
228	6	5	9	1536
227	4	3	20	1526
212	13	12	14	1467
123	9	8	52	350
218	6	3	7	1495
212	16	15	17	1468
23	23	23	24	24
13	4	4	16	142
30	29	29	55	262
44	15	13	24	352
139	13	12	22	1114
7	41	37	42	63
10	16	16	18	97
120	11	11	20	950
21	15	14	27	192
41	24	22	25	335
244	2	0	4	1598
94	7	7	12	712
126	45	44	48	1013
139	8	7	9	101
277	0	0	14	1427
301	7	4	8	1790
105	32	31	36	814
338	11	11	12	1491
97	3	2	8	731
155	27	26	28	1240
5	4	2	5	37
99	6	6	18	750
232	7	6	8	1557
30	15	15	56	258
59	17	16	26	462
162	20	19	27	1291
222	13	12	14	1512
233	0	0	5	1563
113	31	29	32	887
117	3	3	52	916
117	45	45	46	927
116	11	10	12	453
80	21	20	22	362
17	1	0	9	170
52	18	16	19	410
62	4	3	5	278
142	10	9	14	950
182	1	0	3	1358
227	7	6	8	1528
44	1	0	5	349
227	10	9	11	1529
194	13	12	14	1394
222	16	15	17	1513
7	69	66	70	71
83	17	15	18	611
80	33	31	34	605
194	19	18	20	1353
5	12	12	16	40
115	22	22	28	902
334	16	12	20	1893
157	13	13	18	24
129	3	3	6	1032
161	22	22	23	86
106	29	28	30	57
132	36	35	37	20
324	7	6	8	1860
70	11	8	12	535
143	25	24	26	350
319	8	8	22	262
339	4	2	7	1428
145	20	19	23	1030
19	14	14	19	183
174	0	0	6	1334
117	29	29	32	924
325	0	0	2	1369
71	20	20	21	86
48	26	26	27	375
46	8	5	9	362
38	22	21	23	316
256	2	0	3	261
340	4	2	5	1916
154	19	18	23	1235
105	49	49	56	818
112	0	0	1	870
100	41	40	42	22
71	0	0	6	540
306	2	0	15	1798
272	1	0	26	1687
115	4	3	5	350
157	1	0	2	1254
307	2	1	3	1804
65	7	7	10	36
135	3	2	4	975
108	26	22	27	856
68	10	10	11	519
41	14	13	15	333
253	8	7	12	1627
36	27	23	28	301
51	10	9	20	263
83	9	8	14	614
3	21	21	24	23
152	10	6	11	1214
128	2	1	3	45
138	5	3	11	1102
188	4	2	5	1371
10	14	13	17	98
3	2	1	3	17
218	32	32	40	1498
13	32	30	33	151
30	40	39	53	265
290	7	6	8	1752
28	0	0	1	131
217	7	6	8	1486
48	45	43	46	347
107	40	35	41	850
41	5	5	8	332
101	46	46	57	780
50	10	7	13	384
128	24	24	30	1027
128	7	7	10	845
272	21	17	22	1688
300	13	12	14	1787
236	0	0	1	1572
126	25	25	36	1008
21	22	22	27	195
256	16	15	18	85
9	27	27	28	24
65	28	28	30	262
143	17	17	26	1152
132	11	8	12	1061
203	6	6	7	1433
68	20	19	21	20
328	9	9	10	1866
113	21	20	23	884
157	38	37	39	1264
232	20	19	21	1353
7	54	52	70	67
66	4	4	10	512
159	6	6	10	1033
94	15	13	32	714
162	5	3	40	1287
22	39	38	40	120
45	13	13	16	356
28	19	18	20	249
100	49	47	52	767
94	18	18	19	716
65	26	24	30	509
318	19	18	20	1353
58	24	22	25	455
71	19	18	40	265
90	30	29	53	265
137	7	6	8	1098
250	4	2	5	1614
200	20	19	21	108
88	24	22	25	654
33	4	2	5	278
76	14	12	22	576
255	4	2	5	1631
77	8	6	15	583
40	27	26	31	329
122	0	0	5	960
2	2	0	3	9
101	51	50	52	751
89	4	3	5	658
218	0	0	28	1494
98	20	18	23	742
145	2	2	3	1119
131	25	24	26	504
262	1	0	22	1652
4	8	8	10	1
125	14	12	15	843
338	7	6	8	1905
5	28	27	29	20
145	35	35	36	95
36	21	20	28	300
154	8	7	9	163
61	27	25	41	477
23	19	19	24	211
332	0	0	1	902
48	12	12	13	373
103	8	8	13	798
288	0	0	6	1749
258	9	8	12	1648
43	7	6	8	340
128	17	15	18	1025
115	10	8	11	895
108	20	20	21	95
318	13	12	14	1836
140	37	37	38	86
145	58	58	59	24
237	4	4	20	1574
101	35	31	36	776
109	18	16	19	856
90	40	40	43	622
222	7	6	8	1510
272	12	12	13	1688
185	7	6	8	1366
167	2	0	12	1320
85	45	45	46	635
144	26	22	27	1163
18	18	17	28	175
0	150	150	153	3
140	25	25	27	1
122	34	32	39	225
237	10	9	11	1575
85	47	47	57	636
11	27	26	35	117
201	0	0	14	1427
240	4	2	5	1587
222	10	9	11	1511
138	17	15	22	1105
21	20	20	23	22
258	3	0	7	1646
60	11	11	17	466
306	8	7	9	1332
124	4	4	5	355
11	48	45	49	123
129	63	59	64	1043
150	6	6	25	1198
276	14	7	15	1710
47	2	0	3	366
321	4	2	5	1856
112	5	5	8	28
114	0	0	10	894
51	2	0	27	388
11	13	12	14	113
209	3	0	5	1457
87	11	10	18	641
203	10	9	11	1440
237	7	6	8	1575
201	6	6	7	1429
190	4	3	5	1376
4	30	28	31	33
313	0	0	1	1815
30	18	17	56	259
214	6	6	7	1429
212	10	9	11	1466
266	0	0	1	1666
3	7	5	17	19
253	10	10	11	370
208	13	12	14	1340
105	23	22	36	813
183	0	0	6	1359
74	4	3	5	564
155	6	4	9	1238
258	6	5	7	1500
64	16	13	17	497
97	17	14	21	735
8	33	33	39	79
203	13	12	14	1441
102	4	1	21	785
129	19	18	20	27
171	1	0	6	1329
106	26	24	27	84
253	11	11	15	1625
76	21	20	22	70
40	30	29	31	330
81	16	14	17	610
10	30	29	31	102
281	9	5	12	1729
51	18	17	20	85
30	21	20	55	260
57	31	30	32	335
270	0	0	6	1684
7	27	27	28	49
167	8	8	9	1323
88	6	6	7	635
13	7	6	16	143
124	21	21	22	921
275	1	0	21	1453
65	10	9	18	504
84	1	0	2	619
65	1	0	2	20
265	0	0	6	1664
280	16	15	17	1726
272	4	3	5	1453
55	14	14	35	424
9	17	17	18	86
131	22	22	25	36
262	17	16	18	1658
314	10	9	11	1820
24	22	20	27	219
283	4	2	5	1733
107	19	19	22	845
97	14	14	17	736
155	12	12	13	416
297	0	0	2	1777
136	13	13	19	1094
305	1	0	6	1796
51	21	21	27	87
36	16	13	17	299
162	6	6	7	1289
119	20	18	30	943
214	4	2	7	1428
113	44	44	45	890
105	53	53	56	23
18	27	22	28	177
122	23	21	44	967
92	15	14	25	691
129	81	78	82	1045
77	11	10	15	584
220	0	0	6	1503
15	23	22	24	163
206	0	0	6	1450
37	4	1	5	304
109	6	4	7	859
167	10	10	11	1324
151	12	11	13	362
228	20	18	21	1541
150	20	18	25	1201
153	23	22	28	1227
129	1	0	9	1030
265	4	2	5	1665
71	28	27	33	549
100	38	37	52	764
144	12	11	16	1159
141	15	15	19	1137
58	5	3	6	452
223	15	11	16	1518
144	15	14	16	988
117	23	23	25	115
106	38	34	39	837
207	0	0	1	1452
319	20	20	21	86
79	2	2	5	594
76	3	3	4	563
93	8	6	46	697
301	12	10	13	1791
70	27	26	28	538
116	4	2	18	909
257	1	0	12	1641
279	0	0	1	1718
110	4	1	5	863
101	20	19	57	773
105	58	58	59	820
115	20	19	21	904
13	21	21	50	147
137	16	15	17	102
143	4	4	5	744
113	27	24	36	885
64	19	19	20	94
45	3	3	18	357
63	19	15	20	492
69	7	7	10	21
161	6	3	8	1277
95	13	11	16	714
110	18	17	19	20
113	40	37	41	889
232	17	16	21	1559
314	29	26	30	1826
95	7	5	16	713
158	5	4	16	763
199	4	3	5	1418
294	0	0	1	1762
70	19	17	20	536
123	22	22	24	1
255	0	0	6	1630
53	0	0	1	131
116	8	6	18	910
16	4	2	8	168
222	4	3	20	1508
19	18	18	20	1
48	35	34	39	377
75	8	7	9	571
145	11	9	15	1167
133	10	10	13	594
1	17	16	21	6
104	12	12	21	802
150	10	8	11	1199
252	13	12	14	1465
293	4	2	5	1761
164	15	15	24	1310
58	17	17	18	445
233	23	20	24	1568
223	9	5	10	1516
162	30	29	31	1300
195	1	0	4	1399
24	24	24	27	220
25	14	14	33	224
79	0	0	11	592
180	1	0	21	1345
275	13	12	14	1705
140	55	54	60	225
33	19	18	20	280
36	3	3	12	297
314	24	24	30	1825
8	22	21	23	76
12	21	18	22	132
322	0	0	1	890
132	19	18	22	1064
117	60	59	61	810
242	4	3	17	1591
135	25	23	26	1088
103	6	6	13	797
11	40	39	41	108
76	19	16	22	578
289	0	0	1	434
37	20	20	23	308
86	12	12	13	640
55	28	28	29	416
61	5	5	6	445
272	10	9	11	1691
71	34	33	40	551
176	5	3	12	1337
22	29	27	40	202
190	26	25	27	1373
37	22	22	23	309
20	10	8	16	187
17	8	7	9	22
338	20	18	24	1907
63	8	8	11	490
262	8	7	9	1655
196	0	0	3	1333
99	14	11	18	751
90	5	5	12	668
27	23	23	24	235
104	17	16	18	240
55	6	6	35	422
44	10	9	11	348
115	6	6	11	900
226	0	0	1	1523
3	3	3	4	18
225	4	4	6	1522
61	17	16	18	475
323	1	0	3	1858
247	1	0	9	1602
146	8	8	9	1119
144	2	1	3	17
189	0	0	1	1372
232	1	0	21	1553
8	31	30	32	78
98	28	26	31	743
36	10	7	11	298
108	18	17	21	813
19	1	0	2	20
314	7	6	8	1819
210	0	0	6	1458
38	4	2	5	310
108	29	27	30	463
38	33	32	35	321
136	4	3	5	163
295	1	0	21	1763
87	4	1	9	644
140	39	39	40	837
108	22	22	25	23
129	26	23	27	1036
218	15	9	16	1496
59	25	19	26	463
328	10	9	11	1872
27	16	15	17	235
90	8	7	11	669
51	41	41	44	403
184	0	0	1	1361
246	0	0	1	1601
3	19	18	26	22
113	5	2	6	881
121	23	21	27	958
200	12	8	13	1425
28	5	4	8	247
339	10	8	11	1430
83	11	11	14	615
107	26	26	29	23
101	27	27	28	24
158	15	14	16	163
48	17	16	18	374
90	16	15	17	20
195	32	29	35	1410
164	9	8	24	1307
105	25	25	26	805
308	0	0	6	1805
256	23	21	24	837
117	9	5	52	917
178	0	0	6	1342
152	19	19	37	1217
61	3	1	4	470
7	65	64	70	70
95	0	0	1	716
113	0	0	6	880
256	8	7	9	28
133	3	3	6	1070
241	0	0	1	1588
135	20	20	26	1086
67	8	7	9	518
180	16	15	17	1352
71	5	2	6	541
307	0	0	4	1803
43	4	0	8	337
252	16	16	20	1622
37	8	6	9	305
111	2	2	5	337
227	13	12	14	1530
44	23	21	24	354
21	6	6	10	170
105	63	63	67	821
286	7	6	8	1745
295	4	3	20	1765
19	12	12	14	178
306	13	10	14	1802
57	9	9	19	444
2	20	17	21	13
223	5	5	8	1517
213	9	9	13	1472
117	57	56	61	930
61	23	22	41	476
85	23	22	29	627
41	3	0	8	331
123	47	47	48	355
271	0	0	1	1686
142	0	0	1	1119
276	4	2	15	1708
132	24	24	30	1065
1	2	1	3	4
30	52	52	53	256
48	33	30	39	376
155	30	29	31	163
55	8	8	11	23
57	28	26	29	448
212	7	6	8	1465
65	13	11	14	157
93	34	34	37	668
260	0	0	6	1649
101	48	48	57	781
3	16	16	18	1
154	11	10	15	1233
192	0	0	6	1385
337	0	0	1	1898
187	0	0	3	1369
239	0	0	1	1585
151	3	3	13	1204
29	1	0	2	250
94	11	9	12	713
3	14	14	17	21
264	0	0	3	1663
132	26	26	30	114
285	1	0	18	1461
61	9	8	10	210
157	11	10	18	1256
121	2	1	3	619
280	4	3	8	1705
115	18	16	28	902
85	37	36	38	582
180	7	6	8	1349
156	2	2	3	1221
98	0	0	1	716
143	1	0	2	841
113	35	33	36	888
212	1	0	21	1461
147	20	17	21	853
74	6	6	10	565
126	23	22	36	1007
142	7	7	14	949
73	11	9	21	561
181	6	2	7	1355
141	11	10	22	1135
214	12	12	13	1431
138	19	19	22	114
117	16	16	19	23
217	19	18	20	1353
233	13	12	24	1567
78	3	2	8	587
319	22	22	34	837
34	7	5	8	283
80	12	10	13	600
110	14	14	15	716
333	13	12	14	1887
125	6	3	7	999
309	0	0	1	1807
90	0	0	4	665
64	8	8	9	445
172	2	1	5	1332
298	4	2	5	1779
235	4	2	5	1571
133	8	8	20	1071
98	36	36	44	745
267	13	12	14	1673
122	30	27	31	32
63	1	0	2	20
195	17	16	35	265
13	27	27	33	150
52	10	8	11	408
15	33	30	34	165
302	0	0	3	1663
195	22	22	23	837
46	16	16	21	363
151	20	20	29	1211
68	14	14	21	523
51	19	19	20	86
268	3	3	15	1677
46	29	26	30	365
35	10	9	19	286
0	146	146	148	1
15	4	2	5	158
242	1	0	18	1589
18	6	5	11	173
234	2	0	4	1502
227	0	0	21	1524
15	26	25	27	102
113	18	13	48	883
162	1	0	41	1286
129	38	37	42	1039
65	22	22	30	508
12	24	24	28	133
60	16	14	17	463
134	10	10	12	115
212	4	3	20	1461
213	3	3	8	1470
93	28	27	37	702
80	5	3	8	263
91	6	5	10	684
16	7	6	8	84
200	6	5	13	1424
26	7	5	19	230
113	47	46	48	890
79	16	14	20	596
62	17	17	18	474
89	3	3	4	657
248	6	5	7	1492
45	12	12	13	355
102	42	41	48	793
228	7	7	8	49
186	3	1	4	1367
94	23	22	26	717
129	41	40	42	658
91	3	2	4	398
123	51	50	52	988
280	10	10	20	1724
282	2	0	4	1731
310	1	0	13	1808
118	18	14	19	936
127	3	2	4	1015
153	20	17	21	1220
283	0	0	6	1732
216	0	0	1	86
157	28	28	39	1261
132	7	4	12	1060
12	46	46	52	139
15	20	19	24	162
101	50	50	51	179
55	2	0	37	420
146	16	15	17	1180
48	0	0	1	370
57	15	14	16	210
133	13	10	14	1062
122	12	11	13	865
203	7	6	8	1439
254	1	0	6	1629
48	10	7	13	371
12	30	30	52	135
7	2	2	21	56
329	12	10	13	1877
141	4	2	5	1024
142	13	12	14	952
64	18	17	27	498
99	20	19	21	186
165	0	0	3	1318
35	18	17	19	289
114	9	5	10	895
334	6	6	10	1888
200	8	8	10	1422
180	10	9	11	1350
94	33	33	36	23
93	23	22	24	240
18	10	8	11	174
11	0	0	3	109
9	5	5	7	1
122	13	13	14	921
227	19	18	20	1353
267	4	3	20	1669
152	4	3	11	1213
260	4	2	5	1650
160	2	0	3	1274
155	14	12	15	1240
8	6	4	7	47
321	0	0	6	1855
70	24	22	25	537
93	45	44	46	504
228	23	22	24	20
161	13	12	14	28
106	21	20	46	263
138	13	12	22	1104
107	24	23	41	846
46	3	2	4	361
248	4	4	5	1491
119	16	12	17	942
104	19	19	21	747
137	13	12	17	1100
338	27	27	32	1901
339	12	12	13	1431
222	19	18	20	1353
248	14	12	15	1611
57	21	20	24	447
153	15	15	21	1225
286	20	16	21	1747
131	15	14	16	20
141	0	0	5	1023
101	10	8	11	713
78	13	11	14	362
146	14	14	15	1179
212	19	18	20	1353
118	0	0	1	921
36	1	0	2	296
74	0	0	1	563
318	4	3	5	1723
140	4	4	5	1119
191	0	0	3	1383
55	30	27	35	426
285	13	12	14	1741
56	28	26	29	435
140	50	47	51	32
145	52	51	53	28
24	2	2	15	214
8	28	27	29	77
229	0	0	3	1383
296	0	0	11	1773
32	5	5	8	274
57	5	5	8	38
135	16	16	19	949
194	1	0	21	1388
117	51	48	52	927
180	13	12	14	1351
272	15	14	16	1688
90	49	48	50	20
56	30	30	38	436
90	19	19	21	1
240	0	0	6	1586
107	32	31	41	849
7	57	56	70	68
51	44	41	47	402
51	4	3	5	20
37	16	15	24	306
27	10	9	11	240
2	25	24	30	14
48	7	7	10	372
200	1	0	15	1423
110	24	23	25	57
59	16	15	17	458
101	0	0	2	115
138	26	25	32	1108
62	7	6	8	278
116	14	14	18	912
9	2	0	3	82
238	0	0	4	1583
107	29	29	30	716
4	34	31	39	34
58	33	32	36	200
123	30	28	31	84
118	12	12	19	935
231	0	0	1	1547
10	27	26	28	101
7	18	13	19	59
199	13	12	14	1421
157	20	19	21	1259
96	3	2	4	20
300	7	6	8	1752
315	12	12	13	1431
100	21	21	22	716
2	12	10	13	11
140	57	57	60	23
267	16	15	17	1674
135	8	5	13	1084
7	0	0	21	55
158	13	13	14	94
245	0	0	6	1599
123	34	34	35	86
267	1	0	21	1667
117	37	35	42	225
334	0	0	7	1890
338	26	25	27	1903
145	14	13	15	22
47	8	6	11	243
51	46	46	47	404
40	22	20	23	328
338	4	3	5	1904
63	6	5	11	489
12	27	26	28	134
88	19	18	20	622
304	0	0	1	309
275	4	3	20	1701
272	24	23	25	1695
300	1	0	21	1781
130	22	20	23	1052
155	36	36	37	95
107	14	12	22	843
105	45	44	46	186
4	21	20	27	31
237	15	15	16	1582
146	12	11	20	1184
251	0	0	1	1615
280	7	6	8	1723
41	17	15	19	334
79	19	18	20	20
164	17	17	24	1311
93	40	39	43	263
EOD
